	sourceLang	targetLang	sourceString	targetString	en-mt
0	en	ln	 about how long have these symptoms been going on? 	basymptomi oyo ewumeli mikolo boni?	how many days do these symptoms last?
1	en	ln	 and all chest pain should be treated this way especially with your age 	mpe bampasi nyonso ya ntolo esengeli esalisama mpona kobika lolenge oyo mpona mibu na yo	and all chest pains must be treated to survive this way for your age
2	en	ln	 and along with a fever 	mpe elongo na fefele	and with the flower
3	en	ln	 and also needs to be checked your cholesterol blood pressure 	mpe esengeli kotala tansio ya cholesterole na yo	and your cholesterol levels should be checked
4	en	ln	 and are you having a fever now? 	mpe yo ozali na fefele sikoyo?	and you have a flower now?
5	en	ln	 and are you having this chest pain now? 	mpe ozali na mpasi na ntolo sikoyo?	and do you have chest pain now?
6	en	ln	 and besides do you have difficulty breathing 	mpe ozali na mpasi ya kopema	and you have difficulty breathing
7	en	ln	 and can you tell me what other symptoms are you having along with this? 	mpe okoki koyebisa ngai basymptomi misusu ozali na yango elongo na oyo?	and can you tell me any other symptoms you have along with this?
8	en	ln	 and how high has your fever been 	mpe fefele na yo ezalaki makasi ndenge nini	and how strong was your flower
9	en	ln	 and i have a cough too 	mpe nazali lisusu na kosukosu	and i have a cough again
10	en	ln	 and i have a little cold and a cough 	mpe nazali na malili moke na kosukosu	and I have a mild cold with a cough
11	en	ln	 and i'm really having some bad chest pain today 	mpe lelo nazali komona mpasi makasi na ntolo	and today I am experiencing severe chest pain
12	en	ln	 and is this the right time for your hay fever 	pe oyo tango ekoki pona fievre nayo ya foin	and this time it&#39;s time for your hay fever
13	en	ln	 and it get the chest pain 	mpe ekomi na ntolo	and it reaches the chest
14	en	ln	 and i think i have a little bit of a fever 	mpe nakanisi nazali nan fefele moke	and I think I am nan little flower
15	en	ln	 and i want you to describe where the chest pain is 	mpe nalingi yo olimbola ngai esika mpasi ya ntolo ezali	and I want you to explain to me where the chest pain is
16	en	ln	 and they're having some fevers as well 	mpe bazali na fefele moke mpe	and they have a little flower too
17	en	ln	 and with your history of diabetes 	mpe na lisolo na yo ya diabeti	and in your history of diabetes
18	en	ln	 and you know it feels like my chest is like gonna crush 	mpe oyebi ezali kosala lekola ntolo na ngai ekobukana	and you know it&#39;s like my chest is going to break
19	en	ln	 and you know people cough on me all the time 	mpe oyobe bato bazali kokosola likolo na ngai bangona nyonso	and whatever people are testifying against me they are all
20	en	ln	 and you're having chest pain 	mpe ozali na mpasi na ntolo	and you have chest pain
21	en	ln	 and you said this is a pressure in your chest 	mpe olobi oyo ezali kilo na tolo	and you say this is heavy on the chest
22	en	ln	 anyone in the family have a heart problem heart disease heart attack high cholesterol high blood pressure 	moto na libota azali kobela motema, motema ya kokangama tansio ya komata	family member has heart disease, heart attack high blood pressure
23	en	ln	 any other symptoms or problems that you notice with the muscle aches? 	yo omoni basymptomi misusu to mikakatano na mpasi ya misisa?	have you noticed any other symptoms or problems with muscle pain?
24	en	ln	 are there other people sick as you at home with your same symptoms? 	bato misusu na ndako na yo bazali kobela na basymptomi moko oyo ya yo?	are other people in your household suffering from the same symptoms as you?
25	en	ln	 are you having any other symptoms? 	yo ozali na basymptomi misusu?	you have other symptoms?
26	en	ln	 are you having any shortness of breath? 	ozali kokata mpema?	are you cutting your breath?
27	en	ln	 are you still having the chest pain 	ozali kaka na mpasi na ntolo	you just have a chest pain
28	en	ln	 because this is flu season 	mpo oyo ezali ntango ya grippe	because this is flu season
29	en	ln	 but also we shouldn't be put aside for the heart cardiac origin chest pain 	mpe esengeli te totiama mpembeni bokono ya motema oyo etumboli mpasi ya ntolo	and we should not ignore the heart disease that causes chest pain
30	en	ln	 but a more important problem now is this chest pain 	 kasi mokakatano ya makasi sik’oyo eza pasi na tolo 	but the biggest problem now is the pain in the neck
31	en	ln	 but i have difficulty breathing 	 kasi na pasi ya kopema	but with difficulty in breathing
32	en	ln	 but i know lot of people cough on me 	 kasi nayebi bato ebele bazo kosolela nga	but I know a lot of people are talking to me
33	en	ln	 but we need to treat every chest pain with the utmost seriousness 	 kasi esengeli totala likambo ya pasi na tolo na boyoki motema pasi penza 	but we must look at the pain in the chest with great sadness
34	en	ln	 but you're breathing all right right now right? 	 kasi nde sik’oyo ozo pema nayo malamu eza boye? 	but now you&#39;re breathing well is this?
35	en	ln	 'cause of this chest pain i totally forgot 	 ntina ya pasi ya tolo na bosani mobimba na yango	the cause of chest pain in complete oblivion of it
36	en	ln	 does it feel like somebody squeezing your chest 	 eza sala lokola moto azo fina yo nakati ya tolo nayo	it feels like someone is kissing you in the middle of your chest
37	en	ln	 do still feel like shortness of breath 	 ezo monana kaka lokola pema mokuse	it just looks like a short breath
38	en	ln	 do they complain of being sick similar symptoms? 	 bazo lela kobela na basymptomi ya ndenge moko? 	are they crying sick with the same symptoms?
39	en	ln	 do you have any other chronic like high blood pressure or anything like that? 	 oza na kobela mosusu ya chroniki lokola tension ya makila to eloko ya ndenge wana? 	do you have any other chronic illness like high blood pressure or something like that?
40	en	ln	 do you have any other diseases chronic medical problems like diabetes? 	 oza na mabela mosusu ya chroniki pona monganga lokola mokakatano ya diabeti? 	do you have any other chronic breasts for the doctor like diabetes problem?
41	en	ln	 do you have any shortness of breath with that chest pain? 	 oza na boyoki pema mokusa elongo na pasi wana ya tolo? 	do you feel short of breath with that chest pain?
42	en	ln	 do you have high blood pressure? 	 oza na tension ya makila emata? 	do you have high blood pressure?
43	en	ln	 do you have some shortness of breath goes with that? 	 oza na pema kamwa mokuse elongo na oyo wana? 	do you have a surprisingly short breath with that one?
44	en	ln	 do you know what symptoms she was having? 	 oyebi basymptomi ya ndenge nini azalaki na yango? 	do you know what kind of symptoms he had?
45	en	ln	 do you see the image? 	 ozo mona elili ? 	do you see the shadow ?
46	en	ln	 drink plenty of fluids today 	 mela biloko ya mayi mingi lelo	drink plenty of liquids today
47	en	ln	 however i take tests for the diabetes 	 kasi nde salisa tesite pona diabeti	but treat tesite for diabetes
48	en	ln	 however she has symptoms quite similar to mine 	 kasi nde aza basymptomi ekokani kamwa na yanga	but he has symptoms surprisingly similar to mine
49	en	ln	 how high is your fever? 	 fievre nayo emati na niveau nini ? 	what level has your fever gone up to ?
50	en	ln	 how' s your blood pressure? 	 tansion nayo ya makila eza ndenge nini? 	what is your blood pressure like?
51	en	ln	 if you continue to have high fevers 	 soki ozo landela kaka koyoka bafievre emata 	if you keep just hearing the fevers go up
52	en	ln	 if you have a fever of a hundred and two or higher 	 soki ozali na fievre ya kama na mibale to likolo	if you have a fever of two hundred or higher
53	en	ln	 if you think that your symptoms or problems warrant a better look 	 soki okanisi ete basymptomi nayo ekomi mikakatano ezo senga batala yango malamu	if you think your symptoms are becoming problems it needs to be looked at carefully
54	en	ln	 i got a fever yesterday 	 nazalaki na fievre lobi loleki 	i had a fever yesterday
55	en	ln	 i got a slight fever too 	 naza na fievre moke lisusu 	i have a little fever again
56	en	ln	 i had a fever yesterday 	 nazalaki na fievre lobi loleki 	i had a fever yesterday
57	en	ln	 i have a sharp pain here in the chest 	 naza na pasi ya songe awa na kati ya tolo 	i have a songe pain here in the chest
58	en	ln	 i have some difficulty breathing too 	 naza na kamwa pasi pe pona kopema	i&#39;m surprisingly painful and to breathe
59	en	ln	 i'll send you an image 	 na kotindela yo elili	by sending you a shadow
60	en	ln	 i'm having some chest pain today 	 nazo yoka kamwa pasi na tolo mokolo ya lelo 	i feel strange pain in my chest today
61	en	ln	 i'm just having some headaches and some fever today 	 nazo yoka moto kobeta kamwa na fievre mokolo ya lelo	i feel fire beating amazing with fever today
62	en	ln	 in my opinion it is flu 	 na ndenge nazo monela eza grippe	and the way I see it&#39;s the flu
63	en	ln	 in my opinion this is a little flu 	 na ndenge nazo monela oyo eza grippe moke	and as far as I&#39;m concerned this is a minor flu
64	en	ln	 is it like some heavy heavy person sitting on your chest? 	 ezo sala neti moto ya monene afandeli yo na tolo nayo? 	does it feel like a big person is sitting on your lap?
65	en	ln	 it all started with the headaches and with the fever about the same time 	 nionso ebandaki na moto pasi pe na fievre elongo tango moko	it all started with hot flashes and fever together at the same time
66	en	ln	 it hurts in the middle of my chest 	 ezo swa na kati-kati ya tolo nanga	it swallows in the middle of my neck
67	en	ln	 it is a pressure like chest pain 	 eza compression lokola pasi ya tolo	it&#39;s compression like chest pain
68	en	ln	 it is in my chest 	 eza nakati ya tolo nanga	it&#39;s in the middle of my chest
69	en	ln	 it is in the center of my chest 	 eza na kati-kati ya tolo nanga	it&#39;s in the middle of my chest
70	en	ln	 it is in the center of the chest 	 eza na kati-kati ya tolo 	it’s in the middle of the chest
71	en	ln	 i've got pain in my chest 	 nazo yoka pasi na kati ya tolo nanga	i feel pain in my chest
72	en	ln	 i've very concerned of this chest pain 	 nazo banga pona pasi ya tolo oyo	i&#39;m scared for this chest pain
73	en	ln	 i want you to tell me in describing this chest pain 	 nalingi olobela nga na bolimboli pasi ya tolo yango 	i want you to talk to me about the pain of the chest
74	en	ln	 like high blood pressure or diabetes 	 lokola tension ya makila emata to diabeti	such as high blood pressure or diabetes
75	en	ln	 like right in the center of the chest 	 lokola kaka nakati-kati ya tolo	just like in the middle of the chest
76	en	ln	 now for the fever you can take a tachipirina sweet 	 sik’oyo pona fievre oko komela tachipirina sweet 	now for fever you will take tachipirina sweet
77	en	ln	 now mary how many days have you had the symptoms 	 sik’oyo mary mikolo boni osi yoki basymptomi yango	now mary how many days have you felt the symptoms
78	en	ln	 now you said you have a chest pain 	 sik’oyo olobi oza na pasi ya tolo	now you say you have a sore throat
79	en	ln	 occasionally i have some chest pain 	 tango mosusu nazalaka na pasi na tolo	sometimes i have a sore throat
80	en	ln	 okay are you having any other symptoms along with this other than just the pain 	 namoni, bongo nde ozo yoka basymptomi mosusu elongo longola kaka pasi ya tolo	I see, so you feel the other symptoms together besides the chest pain
81	en	ln	 or somebody sitting on your chest? 	 to moto afandeli yo na tolo? 	or someone sitting on your lap?
82	en	ln	 pretty much the same with the fever and the cough headache and muscle pains 	 eza kaka ndenge moko na moto kobeta, na fievre, kosu-kosu ,na pasi ya misuni	it&#39;s just like a fire beating, with fever, coughing ,and muscle pain
83	en	ln	 right in the middle of my chest 	 kaka na kati-kati ya tolo nanga	just in the middle of my neck
84	en	ln	 show me on this image where you feel the pain 	 lakisa nga na elili oyo esika nini ozo yokela pasi	show me in this picture where you are hurting
85	en	ln	 since you have a fever 	 lokola ozali na fievre	as you have a fever
86	en	ln	 so do you think that some of these symptoms could be related to being pregnant? 	 boye okanisi basymptomi mike-mike mosusu eko kozala mpo oza na zemi? 	so do you think there will be some minor symptoms because you are pregnant?
87	en	ln	 so your children are having some of the same symptoms? 	 boye bana nayo baa na basymptomi mike-mike lokola yayo? 	so your kids have the same minor symptoms as you?
88	en	ln	 tell me about your chest pain 	 lobela nga pasi ya tolo nayo	tell me about your chest pain
89	en	ln	 the fever increases at night 	 fievre ekomaka makasi na butu	fever worsens at night
90	en	ln	 the fever i've had for the last two days 	 fievre oyo nazalaki na yango mikolo mibale oyo eleki	the fever I had the last two days
91	en	ln	 the fever started to increase last night 	 fievre ebandaki kokoma makasi butu eleki	fever started getting worse last night
92	en	ln	 this is doctor porter in the emergency room triage center 	 awa dokutele porter na triage ya centre ya urgence	here dokutele porter in emergency center triage
93	en	ln	 well can you tell me a little bit more about your chest pain? 	 malamu, oko koyebisa nga kamwa mingi ya pasi ya tolo nayo? 	well, will you tell me how much of your chest pain?
94	en	ln	 well i feel a pain in the front of my body here in my chest 	 bo, nazo yoko pasi liboso ya nzoto nanga awa nakati ya tolo nanga	bo, i feel pain in front of my body here in my chest
95	en	ln	 well i've been having a strong pain in my chest 	 bo, nazo yoka pasi ya makasi na kati ya tolo nanga 	bo, i feel a sharp pain in my chest
96	en	ln	 well when i have that pain in my chest 	 bo, tango nazalaka na pasi wana na kati tolo nanga	bo, when I have that pain in my chest
97	en	ln	 what kinda pain do you have in your chest? 	 pasi ya ndenge nini oza na yango na tolo nayo?	what kind of pain do you have in your chest?
98	en	ln	 when this chest pain started? 	 tango pasi yango ya tolo ebandaki ? 	when did the headache start?
99	en	ln	 where do you have the pain in the chest? 	 esika nini ozo yokela pasi yango kati ya tolo? 	where do you feel the pain in your chest?
100	en	ln	 where you feel this chest pain eel this chest t 	 esika nini ozo yokela pasi yango ya tolo na tolo yango 	where are you feeling that chest pain in the chest
101	en	ln	 you feel like tightness on your chest 	 ozo yoka lokola tolo nayo ezo kangama	you feel like your throat is sticking
102	en	ln	 you know i got diabetes and stuff 	 oyebi naza na diabeti na biloko mosusu	you know I have diabetes and stuff
103	en	ln	 you said you're having this chest pain 	 olobaki ozo yoka pasi yango ya tolo	you said you feel that pain in the neck
104	en	ln	 Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020 	 Motango ya bato oyo bazobela maladi ya coronavirisi (COVID-19) ezokoma mingi noki na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, banda mokolo ya 1 sanza ya yambo kino mokolo ya 15 sanza ya misato 2020 	The number of coronavirus cases (COVID-19) is increasing rapidly in Europe/European Economic Area and the UK, from 1 January to 15 March
105	en	ln	 The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on the country, the COVID-19 pandemic is progressing rapidly in all countries. 	 Soki totali bato nyonso oyo bazobela maladi ya coronavirisi (COVID-19) bazomonisa bilembo ya ndenge moko na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, yango ezondimisa ete, ata eza na banivo ekeseni na kotalela mokili mokomoko, maladi ya COVID-19 ezopanzana noki na mikili nyonso. 	Considering that all people infected with the coronavirus (COVID-19) show similar symptoms in Europe/European Economic Area and the UK, this confirms that, although there are different levels from country to country, the disease of COVID-19 is spreading rapidly across the globe.
106	en	ln	 Based on the experience from Italy, countries, hospitals and intensive care units should increase their preparedness for a surge of patients with COVID-19 who will require healthcare, and in particular intensive care. 	 Na kotalela makambo oyo esalemi na Italie, mikili, balopitalo mpe bisika ya soins intensifs basengeli mpenza kobongama mpo na koyamba bato mingi ya maladi ya COVID-19 oyo ekosenga ete basalisa bango, mingimingi na soins intensifs. 	Based on the experience in Italy, countries, hospitals and intensive care units should be fully prepared to accommodate the large number of COVID-19 patients who will require treatment, especially in intensive care.
107	en	ln	 On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. 	 Na mokolo ya 31 sanza ya zomi na mibale 2019, bakangaki bato mingi na maladi ya mpema oyo eyebani te na mboka Wuhan, na etuka ya Hubei, na Chine. 	On December 31, 2019, several people were confirmed with an unknown respiratory disease in Wuhan, Hubei Province, China.
108	en	ln	 On 9 January 2020, the China Center for Disease Control and Prevention reported the causative agent as being a novel coronavirus now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 	 Na mokolo ya 9 sanza ya yambo 2020, Centre ya Chine oyo ebundisaka mpe ebatelaka maladi elobaki ete maladi yango eutaki na lolenge ya sika ya coronavirisi oyo babengi sikoyo maladi ya makasi ya mpema coronavirisi 2 (SARS-CoV-2). 	On January 9, 2020, the China Centers for Disease Control and Prevention said the outbreak was caused by a new strain of the coronavirus now called acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
109	en	ln	 Since, the illness resulting from SARS-CoV-2 infection has been named coronavirus disease (COVID-19). 	 Banda wana, bazobenga maladi oyo eutaka na SARS-CoV-2 ete maladi ya coronavirisi (COVID-19). 	Since then, the disease caused by SARS-CoV-2 has been referred to as the coronavirus (COVID-19).
110	en	ln	 Evidence to date is that ca 80% of individuals with COVID-19 have a mild disease, i.e. a respiratory tract infection with or without pneumonia, and most of these recover. 	 Bilembeteli tozali na yango lelo emonisi ete bato 80% oyo baza na COVID-19 baza na maladi ya mwa moke, ndakisa maladi ya mpema elongo to kozanga mpasi ya kopema, mpe mingi na bango bazobika. 	The evidence we have today shows that 80% of people with COVID-19 have a mild illness, such as asthma with or without breathing difficulties, and most of them recover.
111	en	ln	 In ca 14% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care. 	 Na bato 14%, COVID-19 ezouta na maladi makasi oyo ezosenga bakota lopitalo, ebongo bato 6% bazobela maladi makasi mpenza mpe ezosenga bazala na soins intensifs. 	In 14% of the population, COVID-19 is caused by a serious illness that requires hospitalization, while 6% are very seriously ill and require intensive care.
112	en	ln	 The mortality of patients hospitalised due to COVID-19 is ca 4%. 	 Motango ya bato bakoti lopitalo mpo na COVID-19 oyo bazokufa eza 4%. 	The death rate from COVID-19 hospitalization is 4%.
113	en	ln	 In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/European Economic Area (EU/EEA) country and the United Kingdom (UK) and compare them to that of Hubei Province, China. 	 Na bolukiluki oyo, tozotala ndenge makambo ezosalema na makambo nyonso ya COVID-19 na mokili mokomoko ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni (UK) mpe tozokokokanisa yango na oyo ya etuka ya Hubei, na Chine. 	In this study, we examine the trends in all cases of COVID-19 in each European/European Economic Area country and the United Kingdom (UK) and compare them with those in Hubei Province, China.
114	en	ln	 We also compare the current number of COVID-19 cases in EU/EEA countries and the UK with that in Italy during 31 January–15 March 2020. 	 Tozokokanisa mpe motango ya sikoyo ya bato bazobela COVID-19 na mikili ya Eropa/Esika ya Nkita ya Eropa pe na Royaume-Uni na oyo ya Italie banda na mokolo ya 31 sanza ya yambo kino na mokolo ya 15 sanza ya misato 2020. 	We also compare the current number of COVID-19 cases in Europe/European Economic Area and the UK with those in Italy from 31 January to 15 March
115	en	ln	 COVID-19 cases in EU/EEA countries and the UK 	 Bato bazobela COVID-19 na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni	Cases of COVID-19 in Europe/European Economic Area and the UK
116	en	ln	 Subsequent to China, COVID-19 underwent further geographical spread and the dynamic of the COVID-19 pandemic in the rest of the world currently follows that of this country. 	 Ndenge esalemaki na Chine, COVID-19 epanzanaki na bamboka mosusu mpe maladi wana ya COVID-19 ezopanzana ndenge moko na mikili mosusu kaka ndenge esalemaki mboka wana. 	As it happened in China, COVID-19 spread to other countries and that COVID-19 disease is spreading in the same way in other countries just as it did in that country.
117	en	ln	 On 11 March 2020, the Director General of the World Health Organization (WHO) declared COVID-19 a pandemic. 	 Na mokolo ya 11 sanza ya misato 2020, diretere ya organisation mondiale de la santé (OMS) alobaki ete COVID-19 eza maladi mabe. 	On March 11, 2020, the director of the World Health Organization (WHO) declared COVID-19 a serious disease.
118	en	ln	 In the 5 March issue of Eurosurveillance 2020, Spiteri et al. reported on the first European confirmed COVID-19 cases according to the WHO case definition. 	 Na mokolo ya 5 sanza ya misato likambo ya Eurosurveillance 2020, Spiteri mpe baninga na ye, elobelaki bato ya Eropa ya liboso oyo babeli COVID-19 na kotalela ndimbola oyo OMS ezopesa. 	On March 5, the Eurosurveillance 2020 event, by Spiteri and colleagues, described the first European cases of COVID-19 according to the WHO definition.
119	en	ln	 In the EU/EEA, the first three confirmed cases were reported by France on 24 January 2020 in persons returning from Wuhan, Hubei Province, China. 	 Na mikili ya Eropa/Esika ya Nkita ya Eropa, bato misato ya liboso oyo bazwaki maladi elobamaki na France na mokolo ya 24 sanza ya yambo 2020; eza bato oyo bautaki na Wuhan, na etuka ya Hubei, na Chine mpe bazongaki na France. 	In Europe/European Economic Area, the first three cases were reported in France on 24 January 2020; they are people who came from Wuhan, Hubei Province, China and returned to France.
120	en	ln	 As at 15 March 2020, COVID-19 cases had been detected in all 30 EU/EEA countries and the United Kingdom (UK), whereby between 31 December 2019 and that date included, 39,768 cases and 1,727 deaths had been reported, with 17,750 cases and 1,441 deaths from Italy alone. 	 Na mokolo ya 15 sanza ya misato 2020, bato bazalaki kobela maladi ya COVID-19 na mikili nyonso 30 ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni (UK), mpe banda mokolo ya 31 sanza ya zomi na mibale 2019 mpe kotanga dati wana, bato 39 768 babeli yango mpe bato 1 727 bakufaki na maladi wana mpe na Italie mpamba bato 17 750 bazwaki yango kasi bato 1 441 bakufaki. 	As of 15 March 2020, there were confirmed cases of COVID-19 in all 30 European/European Economic Area countries and the United Kingdom (UK), and since 31 December 2019 as well to that date, 39,768 cases and 1,727 deaths and in Italy alone 17,750 cases but 1,441 deaths.
121	en	ln	 Obtaining cumulative number and cumulative incidence of COVID-19 cases 	 Kozwa motango nyonso mpe bato nyonso oyo bazwi COVID-19 	Get the total number and total number of people infected with COVID-1
122	en	ln	 At the European Centre for Disease Prevention and Control (ECDC), the notified COVID-19 case counts in each country worldwide, obtained from only official sources such as the countries’ Ministry of Health, national and regional health authorities and the WHO, are updated each day at 8:00 a.m. 	 Na centre ya Eropa oyo ebundisaka mpe ebatelaka maladi (ECDC), motango ya bato ya COVID-19 na mokili mokomoko, oyo bazwaka kaka na ba source officiel na ndakisa ministere ya santé ya mikili nyonso, bakonzi ya santé ya mokili mpe ya etuka mpe na OMS, etyamaka ya sika mokolo nyonso na 8H00 na ntongo. 	According to the European Center for Disease Control and Prevention (ECDC), the number of COVID-19 cases in each country, which is obtained only from official sources such as international health ministries, global and regional health authorities and WHO, is updated daily at 8:00 am.
123	en	ln	 These data were used for assessing the trends of COVID-19 in EU/EEA and the UK, and comparing them to that in Italy. 	 Basalelaki bansango wana mpo na koyeba ndenge COVID-19 ezopanzana na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, mpe bakokanisaka yango na ya Italie. 	They used this information to determine the spread of COVID-19 in Europe/European Economic Area countries and the UK, and compared it with that of Italy.
124	en	ln	 As a proxy of the prevalence of active COVID-19 cases, we calculated the 14-day truncated cumulative incidence of COVID-19 cases, thus taking into account the natural course of COVID-19, in each EU/EEA country and the UK, during the 1 January–15 March 2020 period. 	 Na oyo etali ndenge bato oyo baza mpenza na maladi ya COVID-19, totalelaka mikolo 14 oyo yango ekomaka makasi mpo na bato ya COVID-19, yango wana totalelaka ndenge COVID-19 ekolaka, na mokili mokomoko ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, na eleko ebandi na 1 sanza ya liboso kino 15 sanza ya misato 2020. 	In terms of the actual incidence of COVID-19, we look at the 14 days it becomes more severe for COVID-19 people, so we look at the development of COVID-19, in each European country/European Economic Area and in the United Kingdom, in the period from 1 January to 15 March 2020.
125	en	ln	 We also presented the cumulative number of notified cases of each country as at 15 March 2020 8:00 a.m. compared with that of Italy for the 31 January–15 March 2020 period. 	 Topesaki mpe motango nyonso ya bato ya maladi na mokili mokomoko na mokolo ya 15 sanza ya misato 2020 na 8H00 na ntongo, tokokanisaki yango na motango ya Italie banda na mokolo ya 31 sanza ya yambo kino na mokolo ya 15 sanza ya misato 2020. 	We also provided the total number of patients in each country as of March 15, 2020 at 8H00 am, compared with the Italian total from January 31 to March 15, 2020.
126	en	ln	 Trends of COVID-19 in EU/EEA countries and the UK 	 Ndenge bato bazobela COVID-19 na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni	Prevalence of COVID-19 in Europe/European Economic Area and the UK
127	en	ln	 The trends in the 14-day truncated cumulative incidence of COVID-19 cases in EU/EEA countries and the UK generally followed that of Hubei Province (China) (Figure 1). 	 Ndenge bato bazokolisa maladi COVID-19 na mikolo 14 na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni ezolanda ndenge esalemaki na etuka ya Hubei (Chine) (Motango1). 	The 14-day spread of COVID-19 in Europe/European Economic Area and the UK follows that of Hubei Province (China) (Figure1).
128	en	ln	 For the EU/EEA and the UK overall, the cumulative incidence of COVID-19 started to increase around 21 February and then increased sharply around 28 February 2020 (Supplementary material). 	 Mpo na mikili ya Eropa/Esika ya Nkita ya Eropa mpe Royaume-Uni, maladi ya COVID-19 ebandaki kokoma mingi pene ya mokolo ya 21 sanza ya mibale mpe na nsima ekomaki mwa mingi pene ya mokolo ya 28 sanza ya mibale 2020 (Bansango mosusu). 	For Europe/European Economic Area and the UK, the incidence of COVID-19 started to peak around 21 February and then peaked slightly around 28 February 2020 (Other Information ).
129	en	ln	 This was mostly driven by the rapid increase in the number of reported cases from Italy, but all other EU/EEA countries and the UK showed similar increasing trends of the cumulative incidence of COVID-19 (Supplementary material). 	 Esimbamaki mingi na motango ya bato mingi oyo bazalaki kozwa maladi yango na Italie, kasi na mikili nyonso ya Eropa/Esika ya Nkita ya Eropa motango ya bato ya maladi COVID-19 ezalaki mpe komata ndenge moko (Bansango mosusu). 	It was mainly affected by the high number of cases in Italy, but in all European countries/European Economic Area the number of COVID-19 cases was also increasing (Other News).
130	en	ln	 Figure 2 shows the cumulative number of COVID-19 cases, in EU/EEA countries and the UK compared with that in Italy for the 31 January–15 March 2020 period. 	 Motango 2 ezomonisa motango nyonso ya bato bazobela COVID-19, na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni soki tokokanisi yango na oyo ya Italie banda na mokolo ya 31 sanza ya yambo kino na mokolo ya 15 sanza ya misato 2020. 	Figure 2 shows the total number of COVID-19 cases, in Europe/European Economic Area countries and the UK compared to Italy from 31 January to 15 March 2020.
131	en	ln	 It highlights that, as at 15 March 8:00 a.m., 15 other EU/EEA countries and the UK had already reported a total number of cases comparable to that of Italy just 3 weeks prior or less. 	 Ezomonisa ete, na mokolo ya 15 sanza ya misato na 8H00 na ntongo, mikili 15 mosusu ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni ezalaki na motango ya bato ya maladi wana ndenge moko na Italie kaka mwa bamposo 3 to moke liboso. 	It shows that, on March 15th at 8:00 am, 15 other European/European Economic Area countries and the UK had the same number of these patients as Italy just 3 weeks or less earlier . . . .
132	en	ln	 Our results indicate that the number of notified cases of COVID-19 is rapidly increasing in the EU/EEA and the UK. 	 Ba résultat na biso ezolakisa ete motango bato oyo bazwi COVID-19 ezomata makasi na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni. 	Our results show that the number of people infected with COVID-19 is increasing significantly in Europe/European Economic Area countries and the UK.
133	en	ln	 The observed trends in the cumulative incidence of COVID-19 suggest that the pandemic is progressing at a comparable speed in all countries. 	 Makambo tomoni na bato nyonso bazobela COVID-19 ezolakisa ete maladi mabe ezopanzana ndenge moko na mikili misusu. 	The facts we have seen in all cases of COVID-19 show that the disease is spreading in the same way as in other countries.
134	en	ln	 This is despite countries being at different stages, variations in national public health responses, and possibly different case definitions in countries and different protocols for selecting patients that must be tested for confirmation of COVID-19, including catch-up testing. 	 Eza bongo ata mikili eza na banivo ekeseni, bato oyo basalaka mosala ya monganga bazosunga bato ndenge moko te, mpe mbala mosusu kolimbola maladi na ndenge mosusu na mikili mpe mibeko ekeseni mpo na kopona bato ya maladi oyo basengeli kosalisa ekzame mpo na koyeba soki baza na COVID-19, ata mpe kosala ekzame na nsima. 	This is the case even though countries have different levels, medical professionals do not treat people the same way, and there may be different definitions of disease in different countries and different rules for selecting patients who should be tested for COVID-19, even testing later.
135	en	ln	 Early March 2020, doctors in the affected regions of Italy described a situation in which ca 10% of patients with COVID-19 required intensive care and media sources reported that hospitals and intensive care units in these regions had already reached their maximum capacity. 	 Na ebandeli ya sanza ya misato 2020, minganga ya Italie bisika maladi ezalaki, balobaki ete bato ya maladi 10% oyo baza na COVID-19 baza na mposa ya soins intensifs mpe bapanzi-nsango balobaki ete soins intensifs ya balopitalo ya bituka wana etondaki koleka ndelo. 	In early March 2020, Italian doctors where the disease was reported that 10% of patients with COVID-19 needed intensive care and the media reported that intensive care hospitals in these provinces were overcrowded . . . .
136	en	ln	 Data on admission of COVID-19 cases in a hospital and/or an intensive care unit are currently available at EU/EEA level for only 6% and 1% cases, respectively (data not shown). 	 Bansango ya bato ya COVID-19 oyo bakotaki lopitalo mpe/to na soins intensifs eza sikoyo na mikili ya Eropa/Esika ya Nkita ya Eropa mpo na bato 6% mpamba mpe 1%, (bansango elakisami te). 	Data on COVID-19 patients admitted to hospital and/or intensive care are currently available in Europe/European Economic Area countries for only 6% and 1%, respectively (data not shown).
137	en	ln	 They should, however, be collected in a systematic fashion to complement current surveillance data that focus on the number of reported cases and the number of deaths. 	 Kasi, basengeli kosangisa yango malamumalamu mpo na kobakisa yango na bansango ya sika oyo ezolobeli mingi motango ya bato oyo baza na maladi mpe motango ya baoyo bakufi. 	However, they need to be carefully compiled to supplement the latest information that focuses on morbidity and mortality rates.
138	en	ln	 A study performed in 2010–11 showed a large variation in the availability of intensive care and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 population in Portugal. 	 Bolukiluki moko oyo esalemaki na 2010–11 emonisaki mbongwana monene na soins intensifs mpe ya bambeto ya katikati na Eropa, ezalaki 29,2 na Allemagne mpe bambeto 4,2 mpo na bato 100 000 na Portugal. 	A study conducted in 2010–11 found significant changes in intensive care and intermediate beds in Europe, being 29.2 in Germany and 4.2 beds per 100,000 in Portugal.
139	en	ln	 This means that countries may have more or less resources than Italy (12.5 intensive care and intermediate care beds per 100,000 population in 2010–11). 	 Elimboli ete mikili ekoki kozala na makoki mingi to moke koleka Italie (12,5 soins intensif mpe bambeto ya katikati mpo na bato 100 000 na 2010–11). 	It explains that countries may have more or less capacity than Italy (12.5 intensive care and intermediate beds per 100 000 people in 2010–11).
140	en	ln	 Modelling scenarios related to healthcare capacity saturation, with estimates for each EU/EEA country and the UK of the prevalence of hospitalised COVID-19 cases associated with a &gt; 90% risk of exceeding intensive care bed capacity, are provided in the sixth update of the ECDC rapid risk assessment on COVID-19. 	 Kobongisa makambo ya kosalisa bato ya maladi elekeli minganga, mpo motango ya pene mpo na mokili nyonso ya Eropa/Esika ya Nkita ya Eropa mpe Royaume-Uni na kotalela bato bakoti lopitalo mpo na COVID-19 mpe mpo na a &gt; 90% ya likama ya kozanga bambeto na soins intensif, epesami na makambo ya sika ya motoba ya ECDC mpo na botaleli ya lombango ya likama ya COVID-19. 	Improving patient care goes beyond physicians, with approximate figures for the entire European/European Economic Area and UK countries based on hospitalizations for COVID-19 and for a &gt; 90% risk of lack of intensive care beds, provided in the ECDC&#39;s sixth update to the COVID-19 risk assessment.
141	en	ln	 Since cases have so far clustered in certain regions in EU/EEA countries and the UK, and hospitals and intensive care units usually serve a defined regional catchment population, information about cases and intensive care beds should preferably be made available at the Nomenclature of territorial units for statistics 2 (NUTS-2) level. 	 Mpo bato ya maladi bakomi mingi na bisika mosusu na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni, mpe balopitalo na bisika ya soins intensifs esalelamaka mbala mingi mpo na kobomba bato ya etuka moko boye, bansango etali bamaladi mpe bambeto ya soins intensifs esengeli ezala libre na eteni ebengami Nomenclature ya biteni ya nivo ya bansango 2 (NUTS-2). 	Because patients have increasingly arrived elsewhere in European/European Economic Area countries and the United Kingdom, and hospitals in intensive care units are often used to store people from a particular region, information about diseases and beds of intensive care should be exempt from the section called Nomenclature of News Level Sections 2 (NUTS-2).
142	en	ln	 The experience from Italy and the current trends in other countries show that the COVID-19 pandemic is progressing rapidly in the EU/EEA and the UK. 	 Makambo esalemi na Italie mpe oyo ezosalema sikoyo na mikili mosusu emonisi ete maladi mabe ya COVID-19 ezopanzana noki na mikili ya Eropa/Esika ya Nkita ya Eropa mpe na Royaume-Uni. 	Experience in Italy and current developments in other countries show that the COVID-19 pandemic is spreading rapidly in Europe/European Economic Area and the UK.
143	en	ln	 Countries, hospitals and intensive care units should thus prepare themselves for a scenario of sustained community transmission of SARS-CoV-2 and an increase in the number of patients with COVID-19 requiring healthcare, and in particular intensive care, such as the one occurring in the affected regions of Italy. 	 Mikili, balopitalo mpe bisika ya soins intensifs esengeli komibongisa na ndenge ya bakosala makambo soki bato mingi bazwi SARS-CoV-2 mpe soki motango ya bato oyo bazwi COVID-19 oyo bazoluka lisalisi ekomi mingi, mpe mingimingi na soins intensif, na ndakisa oyo ezosalema na bamboka ya Italie esika maladi wana ezali. 	Countries, hospitals and intensive care units need to prepare in a way that they will respond to a mass SARS-CoV-2 outbreak and an increase in the number of COVID-19 patients seeking treatment, and especially in intensive care, such as the one that is occurring in the Italian countryside where the disease is endemic.
144	en	ln	 As pointed out in the recent ECDC rapid risk assessment, a rapid, proactive and comprehensive approach is essential to delay the spread of SARS-COV-2, with a shift from a containment to a mitigation approach, as the anticipated rapid increase in the number of cases may not provide decision makers and hospitals enough time to comprehend, accept and adapt their response accordingly if not implemented ahead of time. 	 Ndenge bamonisaki yango na botaleli ya lombango ya likama oyo esalemaki kala te na ECDC, metode ya noki, ya malamu mpe ebongi mpenza eza ntina mpo na kokanga SARS-COV-2 nzela epanzana te, kolongola likebi na bato oyo bazozwa maladi mpe kotya yango na kokitsa ntalo ya contamintaion; mpo koluka koyeba liboso ndenge bato mingi bakobela ekosalisa mpenza te bato bazwaka bikateli mpe balopitalo bakozala te na ntango ya kokanga ntina na yango, kondima yango mpe kobongama na kosunga soki bameki yango te liboso. 	As highlighted in the recent emergency risk assessment conducted by the ECDC, rapid, effective and appropriate methods are essential to prevent SARS-COV-2 from spreading, diverting attention from infected people and putting it on reduce the cost of contamintaion; because trying to predict how many people will get sick will not really help decision makers and hospitals will not have time to understand it, accept it and be ready to help if it is not tried first.
145	en	ln	 The rapid risk assessment also lists the public health measures to mitigate the impact of the pandemic. 	 Botaleli ya lombango ya likama ezolobela mpe bibongiseli ya sante ya bato mingi mpo na kolembisa bokoli ya maladi mabe. 	The emergency assessment also addresses public health measures to slow the progression of the disease.
146	en	ln	 There is a short window of opportunity during which countries have the possibility to further increase their control efforts to slow down the spread of SARS-CoV-2 and decrease the pressure on healthcare. 	 Eza na mwa libaku moke na ntango oyo mikili ezali na libaku ya kobakisa controle ya milende bazosala mpo na kosala ete SARS-CoV-2 epanzana mingi te mpe kokotisa pression na minganga. 	There is little opportunity at this time for countries to increase control of their efforts to reduce the spread of SARS-CoV-2 and put pressure on doctors.
147	en	ln	 Failing this, it is likely that the healthcare systems of other EU/EEA countries will face a surge of patients that require intensive care within the coming days or weeks. 	 Soki basali yango te, bibongiseli ya sante ya mikili mosusu ya Eropa/Esika ya Nkita ya Eropa ekozala na bato mingi lisusu oyo bakobela mpe ekosenga batya bango na soins intensifs na mikolo to na bamposo ezoya. 	If they do not, the health systems of other European/European Economic Area countries will have many more patients who will need to be placed in intensive care in the coming days or weeks.
148	en	ln	 The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans. 	 Kobima ya maladi ya coronavirisi 2019 (COVID-19), oyo euti na maladi makasi ya mpéma (SARS) coronavirirsi 2 (SARS-CoV-2), esi ebomi bato koleka 3 000 mpe ezwi bato koleka 80 000 na Chine mpe na bisika mosusu na mokili mobimba, yango esali ete ekoma likama monene mpo na bato. 	The outbreak of the 2019 coronavirus (COVID-19), caused by the severe respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has already killed more than 3,000 people and infected more than 80,000 in China and elsewhere worldwide, making it a major threat to humanity.
149	en	ln	 Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 might also be transmitted from the bats and causes similar symptoms through a similar mechanism. 	 Na boyokani na ndeko na yango virisi, SARS-CoV, oyo esalaki bankoto ya bato babela SARS na 2003, ekoki kozala ete SARS-CoV-2 eutaki mpe na bangembo mpe eza na bilembo ya ndenge moko mpe ekotaka na ndenge moko. 	Compared to its sibling virus, SARS-CoV, which caused thousands of SARS cases in 2003, SARS-CoV-2 may have also originated in mosquitoes and has similar symptoms and entry patterns.
150	en	ln	 However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women. 	 Atako bongo, COVID-19 eza makasi mingi te mpe ezoboma bato mingi te lokola SARS kasi ezopanzana na bato mingi mpe ezonyokola mingi mibange koleka bilenge mpe ezozwa mingi mibali koleka basi. 	Nevertheless, COVID-19 is less severe and less deadly than SARS but it is more widespread and affects the elderly more than the young and affects more men than women.
151	en	ln	 In response to the rapidly increasing number of publications on the emerging disease, this article attempts to provide a timely and comprehensive review of the swiftly developing research subject. 	 Ndenge mikanda oyo ezolobela maladi yango ezokoba kokoma mingi, mokano ya lisolo oyo eza ya kopesa bansango eyei na ntango malamu mpe na kolobela misala ya bolukiluki oyo ezosalema na likambo oyo. 	As the literature on the disease continues to increase, the aim of this article is to provide timely information and discussion of ongoing research activities in this area.
152	en	ln	 We will cover the basics about the epidemiology, etiology, virology, diagnosis, treatment, prognosis, and prevention of the disease. 	 Tokolobela makambo ya ntina na oyo etali epidemiologie, etiologie, virologie, ndenge ya koyeba yango, ndenge ya kobikisa, pronostique, mpe libateli na maladi yango. 	We will discuss the basics of epidemiology, etiology, virology, diagnosis, treatment, prognosis, and protection against the disease.
153	en	ln	 Although many questions still require answers, we hope that this review helps in the understanding and eradication of the threatening disease. 	 Ata soki mituna mingi eza nanu te na biyano, tokanisi ete lisolo oyo ekosalisa yo na koyeba mpe kosilisa maladi oyo ya mabe. 	Even though many questions are still unanswered, we hope this article will help you identify and treat this devastating disease.
154	en	ln	 The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease. 	 Fete ya printemps ya mokolo ya 25 sanza ya yambo 2020 ekomi oyo ekokani na moko te mpe oyo bato nyonso ya Chine bakobosana te, mpo bayebisaki bango babima libanda te na fete mobimba mpe na eleko ya bamposo mingi nsima mpo na kobima ya maladi moko ya sika ya makasi. 	The January 25, 2020 Spring Festival has become a unique and memorable one for all Chinese people, as they were told not to go outside throughout the festival and for a period of several weeks after due to the outbreak of a new disease compulsory.
155	en	ln	 The virus is highly homologous to the coronavirus (CoV) that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003; thus, it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the associated disease was named CoV Disease-19 (COVID-19). 	 Virisi yango ekokani mingi na coronavirisi (CoV) oyo ezalaki maladi ya makasi ya mpema (SARS) na 2003; ebongo babengaki yango SARS-CoV-2 na organisation mondiale de la sante (OMS) na mokolo ya 11 sanza ya mibale 2020, mpe maladi oyo yango ebimisi babengi yango CoV Maladi-19 (COVID-19). 	The virus is very similar to the coronavirus (CoV) that caused the acute respiratory syndrome (SARS) in 2003; so it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the disease it caused is called CoV Disease-19 (COVID-19).
156	en	ln	 The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world. 	 Maladi yango mabe ebandaki na mboka Wuhan, na Chine, mpe epanzanaki noki na Chine mobimba mpe na pene ya mikili 50 na mokili mobimba. 	The deadly disease originated in Wuhan, China, and quickly spread throughout China and nearly 50 countries worldwide.
157	en	ln	 As of March 2, 2020, the virus has resulted in over 80,000 confirmed cases of COVID-19, with more than 40,000 patients discharged and over 3,000 patients who died. 	 Na mokolo ya 2 sanza ya misato 2020, virisi wana esalaki ete bato koleka 80 000 babela COVID-19, ebongo bato koleka 40 000 babikaki mpe babimiaki na lopitalo kasi bato koleka 3 000 bakufaki. 	As of March 2, 2020, the virus had caused more than 80,000 infections, with more than 40,000 recoveries and discharges but more than 3,000 deaths.
158	en	ln	 WHO warns that COVID-19 is “public enemy number 1” and potentially more powerful than terrorism. 	 OMS akebisi ete COVID-19 eza “monguna ya nimero 1 ya bato” mpe ekoki kozala makasi koleka terorizme. 	The WHO warns that COVID-19 is “mankind’s number 1 enemy” and could be more serious than terrorism.
159	en	ln	 According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, over 200 papers have been published on COVID-19 including its virology, epidemiology, etiology, diagnosis, and treatment since the first report on January 7, 2020 that determined the sequence of the virus isolated from multiple patients. 	 Na kotalela PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), na nse ya sanza mibale, bato basi babimisaki masolo koleka 200 oyo ezolobela COVID-19 ata mpe virologie, epidemiologie, etiologie, ndenge ya koyeba yango, mpe ndenge ya kosalisa yango, banda basalaki rapore ya liboso na mokolo ya 7 sanza ya yambo 2020 oyo ezolimbola ndenge virisi ezopanzana na bato mingi. 	According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, women published more than 200 articles covering COVID-19 including virology, epidemiology, etiology, and diagnosis it, and its treatment, since the first report on January 7, 2020 describing the widespread spread of the virus.
160	en	ln	 This review attempts to summarize the research progress in the new and swiftly developing subject area. 	 Lisolo oyo ezomeka kolobela na mokuse bolukiluki oyo ezosalema na likambo oyo ya sika oyo ezopanzana noki. 	This article attempts to summarize the ongoing research in this new and rapidly expanding field.
161	en	ln	 Whenever possible, we will try to compare COVID-19 with SARS and another CoV-caused disease, Middle East respiratory syndrome (MERS, an outbreak in 2012). 	 Soki likoki ezali, tokomeka kokokanisa COVID-19 na SARS mpe maladi mosusu oyo eutaki na CoV, maladi ya mpema ya moyen-orient (MERS, oyo ebimaki na 2012). 	Where possible, we will attempt to compare COVID-19 with SARS and another outbreak caused by CoV, middle eastern respiratory syndrome (MERS, published in 2012).
162	en	ln	 We will also discuss what we have learned so far regarding the prevention and prognosis of the disease as well as some remaining yet urgent questions. 	 Tokolobela mpe makambo oyo tosi toyekoli na oyo etali kobundisa mpe pronostique ya maladi wana mpe mituna mosusu ya ntina mingi. 	We will also discuss what we have learned about the attack and prognosis of this disease and other important questions.
163	en	ln	 CoVs have been traditionally considered nonlethal pathogens to humans, mainly causing approximately 15% of common colds 4. 	 Bato balobaka ete CoVs eza mpenza te maladi oyo ebomaka bato, mingimingi esalaka ete bato 15% bayoka malili 4. 	CoVs are said to be not necessarily a deadly disease, usually causing 4 colds in 15% of the population.
164	en	ln	 However, in this century, we have encountered highly pathogenic human CoVs twice, i.e., SARS-CoV and MERS-CoV, which caused an outbreak originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with horrible morbidity and mortality. 	 Kasi, na siekle oyo, tosi tokutani na bavirisi CoVs oyo ebelisaka bato mbala mibale, na ndakisa, SARS-CoV mpe MERS-CoV, oyo ebimisaki maladi oyo eutaki na Chine na 2003 mpe na Arabie Saudite na 2012, mpe epanzanaki noki na mikili mosusu mpe ezalaki kozwa bato mingi mpe koboma bato ebele mpenza. 	However, in this century, we have encountered double-pathogenic CoVs, for example, SARS-CoV and MERS-CoV, which caused outbreaks in China in 2003 and Saudi Arabia in 2012, respectively, and spread rapidly to other countries and it took many people and killed many people.
165	en	ln	 Therefore, the current COVID-19 is the third CoV outbreak in the recorded history of humans. 	 Yango wana, COVID-19 ya sikoyo eza CoV ya misato oyo ebima na lisolo ya bomoi ya bato. 	Therefore, the current COVID-19 is the third CoV to emerge in human history.
166	en	ln	 As shown in Fig. ​Fig.1,1, clusters of pneumonia that had unknown origins were first reported from Wuhan on December 31, 2019 to the China National Health Commission. 	 Ndenge bamonisi yango na motango. ​Motango 1,1, liboke ya maladi ya mpema oyo esika euta eyebani te elobelamaki na mbala ya liboso na Wuhan na mokolo ya 31 sanza ya mibale 2019 na lisanga ya Chine oyo etalaka makambo ya kolongono ya nzoto. 	As shown in the figure. Number 1.1, a group of respiratory diseases of unknown origin, was first reported in Wuhan on February 31, 2019 by the Chinese Ministry of Health.
167	en	ln	 Seven days later the sequence of the CoV was released. 	 Mikolo nsambo na nsima babimisaki ndenge CoV ebandaka. 	Seven days later they revealed how CoV starts.
168	en	ln	 On January 15, 2020 the first fatal case from Wuhan was reported. 	 Na mokolo ya 15 sanza ya yambo 2020 moto ya liboso akufaki na Wuhan. 	On January 15, 2020, the first person died in Wuhan.
169	en	ln	 Meanwhile, the epidemic rapidly spread to the neighboring cities, provinces, and countries. 	 Na ntango wana, maladi yango ezalaki kopanzana noki na bingumba, na bituka mpe na mikili ya pene. 	At the time, the disease was spreading rapidly in neighboring cities, provinces, and countries.
170	en	ln	 On January 20, the infection of health-care providers was reported, suggesting that human-to-human transmission was possible. 	 Na mokolo ya 20, balobaki ete minganga bazwi maladi yango, yango emonisaki ete moto akoki kopesa yango na moto mosusu. 	On the 20th, a medical diagnosis was made, indicating that it could be transmitted from person to person.
171	en	ln	 On January 23, the city of Wuhan was locked down with all its public transportation stopped. 	 Na mokolo ya 23 sanza ya yambo, bakangaki engumba Wuhan mpe transpore ya bato nyonso ezalaki kosala lisusu te. 	On January 23, Wuhan was closed down and public transport was out of order.
172	en	ln	 On January 24 the first clinical study on the disease reported that, out of 41 patients with confirmed cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source. 	 Na mokolo ya 24 sanza ya yambo, babandaki kosala bolukiluki ya maladi wana, na kati ya bato 41 oyo bazalaki kobela yango, bato 21 mpamba bakomaki na zando ya mbisi ya mbu ya Wuhan esika oyo maladi yango ebandaki na nyama moko oyo eyebani te. 	On January 24, the outbreak began, with only 21 of 41 patients arriving at the Wuhan seafood market where the outbreak was caused by an unknown animal.
173	en	ln	 On January 30, WHO declared the outbreak a global health emergency. 	 Na mokolo ya 30 sanza ya yambo, OMS elobaki ete maladi wana eza likama mpo na mokili mobimba. 	On January 30, the WHO declared the disease a global threat.
174	en	ln	 By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. ​(Fig.2).2). 	 Na ntango tozosala rapore oyo, maladi yango esi epanzani na Chine mobimba mpe na mikili misusu pene ya 50 na mokili mobimba (Motango. ​(Motango.2).2). 	At the time of writing, the disease has already spread throughout China and nearly 50 other countries worldwide (Fig. 2).
175	en	ln	 As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined. 	 Ndenge makambo ezondongwana noki, bonene na yango ya nsuka mpe makasi na yango eyebani nanu te. 	Due to the rapidity of the changes, its ultimate extent and intensity are not yet known.
176	en	ln	 On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA). 	 Na mokolo ya 11 sanza ya mibale 2020, bolukiluki na bato ya maladi 8 866 tanga mpe bato 4 021 oyo bazalaki mpenza na COVID-19 emonisaki makambo ya sika na ntina na maladi mabe ndenge eza na nse (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA). 	As of February 11, 2020, a study of 8,866 patients including 4,021 people who were actually infected with COVID-19 revealed new information about the disease as below (https://mp.weixin. qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
177	en	ln	 SARS-CoV-2 infected people of all ages, but mainly at the age of 30-65. 	 SARS-CoV-2 ezozwa bato ya mbula nyonso, kasi mingimingi bato ya mbula 30-65. 	SARS-CoV-2 affects people of all ages, but especially people aged 30-65.
178	en	ln	 Almost half (47.7%) of the infected individuals were over 50 years old, very few were under 20, and only 14 infected individuals were under the age of 10. 	 Pene ya katikati (47,7%) ya bato oyo babelaki baza na mbula koleka 50, moke mpenza baza na mbula na nse ya 20, mpe bato 14 mpamba ya maladi bazalaki na mbula na nse ya 10. 	Almost half (47.7%) of the patients are over 50 years of age, very few are under 20 years of age, and only 14 patients were under 10 years of age.
179	en	ln	 SARS-CoV-2 infected more men (0.31/100,000) than women (0.27/100,000). 	 SARS-CoV-2 ezwaki mingi mibali (0,31/100 000) koleka basi(0,27/100 000). 	SARS-CoV-2 affected more males (0.31/100 000) than females(0.27/100 000).
180	en	ln	 COVID-19 expanded in clusters mainly in and around Hubei. 	 COVID-19 epanzanaki na bituluku mingimingi na Hubei mpe pene na yango. 	COVID-19 spread in clusters mainly in and around Hubei.
181	en	ln	 COVID-19 took an average of 5 (2-9) days from onset to diagnosis. 	 COVID-19 ezwaki na mwayene mikolo 5 (2-9) banda ebandeli kino mokolo bamonaki yango. 	COVID-19 took an average of 5 (2-9) days from onset to diagnosis.
182	en	ln	 The average incubation period was 4.8 (3.0-7.2) days. 	 Mwayene ya mikolo oyo maladi esalaka liboso emonana eza mikolo 4,8 (3,0-7,2). 	The average duration of disease before onset is 4.8 days (3.0-7.2).
183	en	ln	 The average time from onset to death was 9.5 (4.8-13) days. 	 Mwayene ya mikolo banda ebandeli na yango kino liwa eza mikolo 9,5 (4,8-13). 	The average time from onset to death is 9.5 days (4.8-13).
184	en	ln	 The basic reproductive number (R0) was 3.77 (95% CI: 3.51-4.05), and the adjusted R0 was 2.23-4.82. 	 Motango ya kobotisa yango (R0) eza 3,77 (95% CI: 3,51-4,05), mpe kobongwana ya R0 ezalaki 2,23-4,82. 	The reproducibility rate (R0) is 3.77 (95% CI: 3.51-4.05), and the conversion of R0 was 2.23-4.82.
185	en	ln	 The number of infected people increased exponentially before 23 Jan. 2020, matching the time of massive transportation before the Spring Festival in China. 	 Motango ya bato oyo bazwi maladi emataki mingi liboso ya mokolo ya 23 ya sanza ya yambo 2020; yango ekokani na ntango oyo bato basalelaki transpore mingi na fete ya printemps na Chine. 	The number of cases increased significantly before January 23, 2020; this coincides with the peak of transpore use during the spring festival in China.
186	en	ln	 The mortality of patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the adjusted mortality of all the patients was 3.06% (95% CI: 2.02-4.59%). 	 Bato ya maladi oyo kokufa ezalaki 1,44% (95% CI: 1,10-1,86%), mpe kobongwana ya motango ya bato bakufaki eza 3,06% (95% CI: 2,02-4,59%). 	Patient mortality was 1.44% (95% CI: 1.10-1.86%), and mortality rate conversion was 3.06% (95% CI: 2.02-4.59%) ).
187	en	ln	 Three major risk factors for COVID-19 were sex (male), age (≥60), and severe pneumonia. 	 Makambo misato ya minene ya likama ya COVID-19 ezalaki sexe (mobali), mbula (≥60), mpe mpema makasi. 	The three main risk factors for COVID-19 were sex (male), age (≥60), and dyspnea.
188	en	ln	 CoVs are a subfamily of large and enveloped viruses containing a single strand of sense RNA. 	 CoVs eza na kati ya libota monene ya bvirisi mpe na kati ya bavirisi oyo eza na mwa boyokani na RNA. 	CoVs belong to a large family of bviruses and are among the viruses that have some RNA relatedness.
189	en	ln	 They can be divided into four genera, i.e., alpha, beta, gamma, and delta, of which alpha- and beta-CoVs are known to infect humans. 	 Tokoki kokabola yango na biteni minei, na ndakisa., alpha, beta, gamma, mpe delta, ebongo alpha- na beta-CoVs eyebani ete ezwaka bato. 	We can divide them into four categories, namely., alpha, beta, gamma, and delta, so alpha- and beta-CoVs are known to infect humans.
190	en	ln	 The envelope spike (S) glycoprotein binds to its cellular receptors angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane fusion occurs. 	 Nsonge ya (S) glycoproteine ekangamaka na ba recepteur na yango ya angiotensine mpe ebongalaka enzyme 2 (ACE2) mpe dipeptidyl peptidase 4 (DPP4) mpo na SARS-CoV mpe MERS-CoV, mpe na nsima membrane esanganaka. 	The tip of the (S) glycoprotein binds to its angiotensin receptors and modifies enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then the membrane fuses.
191	en	ln	 The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus. 	 Virisi RNA ebimaka na cytoplasme; nsima ya kopanzana ya virisi wana, virisi RNA eyaka na kati ya anvelope ya glycoproteine mpe baproteine nucleocapside esalaka vesicule oyo eza na virion, oyo esanganaka na plazma mpo na kobimisa virisi. 	Virus RNA is released from the cytoplasm; after the virus spreads, the RNA virus comes inside the glycoprotein envelope and the nucleocapsid proteins form the virion-containing vesicle, which assembles in the plasma to produce the virus.
192	en	ln	 The first genomic sequence of SARS-CoV-2 was reported on January 10, 2020. 	 Genome ya liboso ya SARS-CoV-2 emonanaki na mokolo ya 10 sanza ya yambo 2020. 	The first genome of SARS-CoV-2 was discovered on January 10,
193	en	ln	 SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan. 	 Bamonaki ete SARS-CoV-2 ezalaki lolenge ya sika ya beta-CoV oyo ezalaki na na identité 99,98% ya makila na kati ya bandakisa 10 oyo bazwaki na esika oyo yango ebimaki na mbala ya liboso, na zando Huanan ya koteka banyama ya mbu na Wuhan. 	They found that SARS-CoV-2 was a new strain of beta-CoV that had with 99.98% identity of blood in 10 samples collected from the area of its first outbreak, the Huanan pet sales market of sea and Wuhan.
194	en	ln	 SARS-CoV-2 is genetically more similar to SARS-CoV than to MERS-CoV. 	 SARS-CoV-2 ekokani mpenza na SARS-CoV kasi na MERS-CoV te. 	SARS-CoV-2 is very similar to SARS-CoV but not to MERS-CoV.
195	en	ln	 Through transmission electron microscopy, SARS-CoV-2 particles were found in ultrathin sections of human airway epithelium. 	 Na nzela ya kopanzana ya electron ya mikroskope, biteni ya SARS-CoV-2 emonanaka na nzoto ya bato na nzela ya kopema. 	Through microscopic electron scattering, fragments of SARS-CoV-2 are detected in the human body through inhalation.
196	en	ln	 Human ACE2 was found to be a receptor for SARS-CoV-2 as well as SARS-CoV. 	 Bamonaki ete ACE2 ya bato ezalaki eloko ezwaka SARS-CoV-2 mpe SARS-CoV. 	Human ACE2 was found to be a receptor for both SARS-CoV-2 and SARS-CoV.
197	en	ln	 However, the S protein of SARS-CoV-2 binds to human ACE2 more weakly than that of SARS-CoV, which is coincident with the fact that SARS-CoV-2 causes less severe infection in patients than SARS-CoV. 	 Kasi, proteine S ya SARS-CoV-2 ekangami makasi te na ACE2 ya bato koleka ya SARS-CoV, oyo eyokani na likambo oyo ete SARS-CoV-2 ezopesa bato maladi ya makasi te lokola SARS-CoV. 	However, the S protein of SARS-CoV-2 binds less tightly to human ACE2 than that of SARS-CoV, which is consistent with the fact that SARS-CoV-2 does not infect humans as severely as SARS-CoV.
198	en	ln	 SARS-CoV-2 can also form a novel short protein encoded by orf3b and a secreted protein encoded by orf8. 	 SARS-CoV-2 ekoki mpe kosala proteine ya moke ya sika oyo euti na orf3b mpe ebimisaka proteine euti na orf8. 	SARS-CoV-2 can also synthesize a novel small protein from orf3b and produce a protein from orf8.
199	en	ln	 The orf3b of SARS-CoV-2 may play a role in the viral pathogenicity and inhibit the expression of IFNβ; however, orf8 does not contain any known functional domain or motif. 	 Lolenge orf3b ya SARS-CoV-2 ekoki kozala na mokumba makasi na kobima ya virisi wana mpe komonisa bilembo ya IFNβ; kasi, orf8 ezalaka te na mosala to motif oyo eyebana. 	The orf3b form of SARS-CoV-2 may play a strong role in the emergence of that virus and the expression of IFNβ signals; however, orf8 has no known function or motif.
200	en	ln	 On February 18, 2020, Zhou, et al., reported the cryo-EM structure of the full-length human ACE2 at 2.9 Å resolution in complex with the amino acid transporter B0AT1. 	 Na mokolo ya 18 sanza ya mibale 2020, Zhou, mpe baninga, elobelaki nzoto ya cryo-EM ya ACE2 ya bato ya molai mpenza na 2,9 Å ya mindondo ezalaki na eloko ememaka aside amino B0AT1. 	On February 18, 2020, Zhou, and colleagues, reported a 2.9 Å complex human ACE2 cryo-EM body contained the amino acid carrier B0AT1.
201	en	ln	 They found that the complex, which had open and closed conformations, was assembled as a dimer and the ACE2-B0AT1 complex can bind two S proteins, which provides evidence for CoV recognition and infection. 	 Bamonaki ete mindondo wana, oyo ezalaki kofungwama mpe kokangama, esangisamaki esika moko mpe ACE2-B0AT1 ya mindondo ekoki kosangisa baproteine S mibale, oyo ezopesa bilembeteli ya koyeba CoV mpe maladi wana. 	They found that these complexes, which were open and closed, were fused together and that the ACE2-B0AT1 complex can fuse two S proteins, providing evidence of CoV recognition and these diseases.
202	en	ln	 B0AT1 may become a therapeutic target for drug screening to suppress SARS-CoV-2 infection. 	 B0AT1 ekoki kokoma eloko ya kosalela bankisi mpo na kosilisa maladi ya SARS-CoV-2. 	B0AT1 could become a drug target for SARS-CoV-2.
203	en	ln	 The origin and intermediate host 	 Esika eutaka mpe esika ya mibale oyo efandaka 	Source and secondary habitat
204	en	ln	 It has been known that both SARS-CoV and MERS-CoV originated from bats and were transmitted to humans via civet cats and camels, respectively. 	 Eyebani ete SARS-CoV mpe MERS-CoV eutaki na bangembo mpe epesamaki na bato na nzela ya banyau civet mpe bakamela. 	It is known that SARS-CoV and MERS-CoV originated in ticks and were transmitted to humans via civet buffalo and camels.
205	en	ln	 Through a phylogenetic comparison of SARS-CoV-2 with other CoVs, bats were considered the native host of SARS-CoV-2 as the new virus is 96% identical to two SARS-like CoVs from bats called bat-SL-CoVZX45 and bat-SL-CoVZX21. 	 Soki tosali bokokanisi na kati ya SARS-CoV-2 na ba CoVs mosusu, bangembo nde bato bazalaki na SARS-CoV-2 mpo virisi oyo ya sika ekokani na 96% na bavirisi CoVs oyo ekokokani na ba SARS mibale oyo eutaki na bangembo oyo babengaka bat-SL-CoVZX45 mpe bat-SL-CoVZX21. 	Comparing SARS-CoV-2 with other CoVs, pigs were the most infected with SARS-CoV-2 because this new virus is 96% similar to CoVs viruses similar to the two SARS from so-called pigs bat-SL-CoVZX45 and bat-SL-CoVZX21.
206	en	ln	 However, what intermediate host helped the virus cross the species barrier to infect humans remains unknown, and the transmission route is yet to be elucidated. 	 Kasi, eloko oyo esalisaki virisi na kolongwa na banyama mpo eya kokota na bato eyebani nanu te, mpe toyebi nanu te ekotaki na nzela nini. 	However, what helped the virus move from animals to humans is still unknown, and we do not know how it entered.
207	en	ln	 Ji, et al., proposed snakes as a carrier of the virus from bats to humans which involved homologous recombination within the S protein. 	 Ji, mpe baninga na ye, balobaki ete banyoka nde ememaki virisi wana uta na bangembo mpe ekotisaki yango na bato; mpe esanganaki na kati ya proteine S. 	Ji, and his colleagues, claimed that snakes carried the virus from bats and introduced it into humans; and assembled into the S protein.
208	en	ln	 According to a study, researchers in Guangzhou, China, suggested that pangolins - long-snouted, ant-eating mammals often used in traditional Chinese medicine - are the potential intermediate host of SARS-CoV-2 based on 99% genetic homology in a CoV discovered in pangolins and SARS-CoV-2. 	 Na kotalela bolukiluki moko, balukiluki esalemaki na Guangzhou, na Chine, balobaki ete bapangolin - oyo ezali banyama ebengami mamifere oyo basalelaka mbala mingi lokola bankisi ya bokoko na Chine - eza oyo mbala mosusu esika ya mibale oyo SARS-CoV-2 efandaka na kotalela 99% ya makila ya ndenge moko na CoV oyo bamonaki na bapangolin mpe na SARS-CoV-2. 	According to a study, researchers in Guangzhou, China, said that pangolins - mammals commonly used as traditional medicine in China - are probably the second largest host of SARS-CoV-2 out of % of blood similar to CoV detected in pangolins and SARS-CoV-2.
209	en	ln	 However, 1% difference spread all over two genomes is still a big difference; thus, conclusive results for concrete evidence are awaited (Fig. ​(Fig.33). 	 Kasi, bokeseni ya 1% etaleli bavirisi mibale eza kaka bokeseni monene; yango wana, tozokoba kozela bosukisi ya solosolo (Mot. ​(Mot.33). 	However, a 1% difference between the two viruses is still a significant difference; therefore, we continue to wait for the true conclusion (Mot. (Mot.33).
210	en	ln	 The physicochemical properties of SARS-CoV-2 are largely not yet known. 	 Makambo ya physique mpe ya chimie ya SARS-CoV-2 eyebani nanu ata moke te. 	The physical and chemical aspects of SARS-CoV-2 are still completely unknown.
211	en	ln	 SARS-CoV and MERS-CoV can survive in vitro for 48 hours in a dry environment and up to 5 days under 20 °C and 40%-50% humidity. 	 SARS-CoV mpe MERS-CoV ekoki kozala na bomoi na libanda ya esika oyo bazalaka na bomoi na bangonga 48 na esika ya kokauka mpe kino na mikolo 5 na nse ya 20 °C mpe na 40%-50% na esika ya malili. 	SARS-CoV and MERS-CoV can survive outside their natural habitat for 48 hours in a dry environment and up to 5 days below 20 °C and 40%-50% in a humid environment.
212	en	ln	 SARS-CoV-2 may possess similar properties. 	 SARS-CoV-2 ekoki kozala na bizaleli ya ndenge moko. 	SARS-CoV-2 may have similar characteristics.
213	en	ln	 It has been reported that SARS-CoV-2 is sensitive to ultraviolet rays and heat at 56 °C for 30 minutes; ether, 75% ethanol, chlorine-containing disinfectant, peracetic acid, chloroform, and other fatty solvents, but not chlorhexidine, can effectively inactivate the virus. 	 Bato bazoloba ete SARS-CoV-2 ekokaka te na ba rayons ultraviolet mpe moto na badegre 56 °C na miniti 30; to, 75% ya ethanole, desinfectant oyo eza na chlore, aside perasetique, chloroforme, mpe bankisi mosusu ya koboma mikrobe, kasi te chlorhexidine, ekoki mpenza koboma virisi wana. 	It has been suggested that SARS-CoV-2 is immune to ultraviolet rays and fire at 56 degrees °C for 30 minutes; or, 75% ethanol, a disinfectant containing chlorine, peracetic acid, chloroform, and other disinfectants, but not chlorhexidine, can effectively kill the virus.
214	en	ln	 The entire human population generally lacks immunity to SARS-CoV-2 and hence is susceptible to the novel virus. 	 Bato nyonso bazangi mikrobe oyo ebundisaka SARS-CoV-2, yango wana virisi oyo ya sika ekoki kozwa bango. 	Everyone lacks antibodies to SARS-CoV-2, so this new virus can infect them.
215	en	ln	 Currently, no detailed study has been reported regarding the immunological response to SARS-CoV-2. 	 Sikoyo, basali nanu te bolukiluki ya mozindo na oyo etali ndenge ya kobundisa SARS-CoV-2. 	Currently, no comprehensive studies have been conducted on the mechanisms of action against SARS-CoV-2.
216	en	ln	 Thus, we can only refer to previous studies on other CoVs, especially SARS-CoV and MERS-CoV (Fig. ​(Fig.4).4). 	 Yango wana, tokoki kolobela kaka bolukiluki ya kala na oyo etali ba CoVs mosusu, mingimingi SARS-CoV mpe MERS-CoV (Mot. ​(Mot.4).4). 	Therefore, we can only mention previous research on other CoVs, especially SARS-CoV and MERS-CoV (Mot. (Mot.4).4).
217	en	ln	 In general, after a virus invades the host, it is first recognized by the host innate immune system through pattern recognition receptors (PRRs) including C-type lectin-like receptors, Toll-like receptor (TLR), NOD-like receptor (NLR), and RIG-I-like receptor (RLR). 	 Mbala mingi, soki virisi ekoteli eloko moko, mikrobe oyo ebundisaka maladi mabe eyebaka yango na nzela ya mayele ya koyeba biloko mosusu (PRRs) tanga mpe lolenge na yango C ya biloko oyo ememaka yango, biloko ememaka yango oyo eza neti Toll(TLR), mpe oyo eza neti NOD (NLR), mpe oyo eza neti RIG-I (RLR). 	Usually, when a virus invades an object, the immune system recognizes it by protein recognition systems (PRRs) including its type C of vectors, vectors such as Toll(TLR), and this is like NOD (NLR), and this is like RIG-I (RLR).
218	en	ln	 Through different pathways, the virus induces the expression of inflammatory factors, maturation of dendritic cells, and synthesis of type I interferons (IFNs) which limit the spreading of the virus and accelerate macrophage phagocytosis of viral antigens. 	 Na lisalisi ya banzela ekeseni, virisi ebimisaka mpasi na nzoto, ekolisaka baselile dentritique, mpe esangisaka na mokuse ba interferon oyo eza neti I (IFNs) oyo ekangaka virisi nzela mpo epanzana te mpe esalaka ete biloko oyo ekangaka virisi nzela ebima noki. 	Through a variety of mechanisms, the virus causes inflammation, enlarges dentritic cells, and synthesizes I-like interferons (IFNs) that inhibit viral replication and accelerate the release of viral inhibitors.
219	en	ln	 However, the N protein of SARS-CoV can help the virus escape from the immune responses. 	 Kasi, proteine N ya SARS-CoV ekoki kosalisa virisi na kokima bopusi ya mikrobe oyo ebundisaka maladi. 	However, the N protein of SARS-CoV may help the virus evade the immune response.
220	en	ln	 Soon, the adaptive immune response joins the fight against the virus. 	 Kala mingi te, mikrobe oyo ebundisaka virisi esanganaka mpo na kobundisa yango. 	More recently, antiviral bacteria have joined forces to fight it.
221	en	ln	 T lymphocytes including CD4+ and CD8+ T cells play an important role in the defense. 	 Balymfosite T tanga mpe CD4+ mpe CD8+ baselile T esalaka mosala makasi na kobundisa maladi. 	T lymphocytes read and CD4+ and CD8+ T cells play an active role in fighting disease.
222	en	ln	 CD4+ T cells stimulate B cells to produce virus-specific antibodies, and CD8+ T cells directly kill virus-infected cells. 	 CD4+ baselile T elendisaka baselile B mpo na kobimisa mikrobe oyo ebundisaka virisi, mpe CD8+ baselile T ebomaka mbala moko baselile oyo virisi ekoteli yango. 	CD4+ T cells stimulate B cells to produce antibodies, and CD8+ T cells immediately kill infected cells.
223	en	ln	 T helper cells produce proinflammatory cytokines to help the defending cells. 	 Baselile ya kosalisa T ebimisaka ba cytokine oyo ebimisaka mokusa mpo na kosalisa baselile oyo ebundaka. 	Helper T cells produce cytokines that produce tumors to help fighting cells.
224	en	ln	 However, CoV can inhibit T cell functions by inducing apoptosis of T cells. 	 Kasi, CoV ekoki kopekisa selile T esala mosala na yango na modele ya kokufa baselile T. 	However, CoV can inhibit T cell function in a model of T cell death.
225	en	ln	 The humoral immunity including complements such as C3a and C5a and antibodies is also essential in combating the viral infection. 	 Mikrobe oyo ebundisaka maladi oyo esanganaka ndakisa C3a mpe C5a mpe ba anti corps eza mpe ntina mpo na kobundisa virisi oyo. 	Combined antibodies such as C3a and C5a and antibodies are also important to fight the virus.
226	en	ln	 For example, antibodies isolated from a recovered patient neutralized MERS-CoV. 	 Na ndakisa, ba anti corps oyo balongolaki na bato oyo babikaki ebomaki MERS-CoV. 	For example, antibodies isolated from survivors killed MERS-CoV.
227	en	ln	 On the other hand, an overreaction of the immune system generates a large number of free radicals locally that can cause severe damages to the lungs and other organs, and, in the worst scenario, multi-organ failure and even death. 	 Kasi, reaction ya koleka ndelo ya mikrobe oyo ebundisaka maladi ekoki kobimisa ba radicale mingi koleka na nzoto mpe yango ekoki kobebisa bapoumon mpe binama mosusu, mpe likambo ya mabe koleka, ekoki kosala ete binama mingi esala lisusu te mpe nkutu ekoki komema na liwa. 	However, an overreaction of the immune system can produce too many free radicals in the body and this can damage the lungs and other organs, and worse, it can cause massive organ failure and even lead to death.
228	en	ln	 The SARS-CoV-2 infection, featured by clustering onset, is more likely to affect elderly people with comorbidities and pregnant women. 	 Maladi ya SARS-CoV-2 , oyo ekabwanaka na ebandeli, ezozwa mingi mibange oyo baza na maladi mosusu mpe basi ya zemi. 	SARS-CoV-2 disease , which splits early, mostly affects the elderly with other illnesses and pregnant women.
229	en	ln	 It is common that for people who are exposed to a large number of viruses or whose immune functions are compromised, they have higher chance to be infected than others. 	 Mbala mingi bato oyo bakutanaka na bavirisi mingi to oyo mikrobe na bango oyo ebundisaka maladi elemba, baza na likama mingi ya kozwa maladi oyo koleka bato mosusu. 	People who are exposed to multiple viruses or whose immune systems are weakened are often at a higher risk than others.
230	en	ln	 The estimated mean incubation period of SARS-CoV-2 is 1-14 days, mostly 3-7 days based on a study of the first 425 cases in Wuhan. 	 Eleko oyo maladi ya SARS-CoV-2 esalaka mpo emonana eza mikolo 1-14, mingimingi mikolo 3-7 na kotalela bolukiluki esalemaki na bato 425 ya liboso oyo bazwaki yango na Wuhan. 	The duration of SARS-CoV-2 infection is 1-14 days, usually 3-7 days based on a study of the first 425 cases in Wuhan.
231	en	ln	 However, a study on 1,099 cases demonstrates that the incubation period was 3 days on average and ranged from 0 to 24 days. 	 Kasi, bolukiluki oyo esalemaki na bato 1 099 emonisi ete eleko oyo maladi esalaka mpo emonana ezalaki mikolo 3 na mwayene mpe ebandaki na mikolo 0 kino na 24. 	However, a study of 1,099 subjects found that the duration of disease to manifestation averaged 3 days and ranged from 0 to 24 days.
232	en	ln	 A more recent study, as described above, demonstrates that the incubation period was 4.8 (3.0-7.2) days based on the demography of 8,866 cases. 	 Bolukiluki moko ya sika mpenza, ndenge balobeli yango na likolo, elakisi ete eleko oyo maladi esalaka mpo emonana ezalaki mikolo 4,8 (3,0-7,2) na kotalela bato 8 866 oyo balandelaki. 	A relatively recent study, as described above, indicates that the median time to disease manifestation was 4.8 days (3.0-7.2) based on 8,866 followed individuals.
233	en	ln	 It is very important for health authorities to adjust the effective quarantine time based on the most accurate incubation period, thus preventing infected but symptomless people from transmitting the virus to others. 	 Eza na ntina mingi mpo na minganga na kobongola eleko ya kotya moto na quarantaine na kotalela eleko ya solo oyo maladi esalaka mpo emonana, ebongo ekokanga nzela mpo bato oyo baza na bilembo ya maladi bapesa bato mosusu virisi te. 	It is important for doctors to adjust the quarantine period based on the actual time it takes for the disease to appear, thus preventing people with symptoms from spreading the virus to others.
234	en	ln	 As a common practice, individuals exposed to, or infected by, the virus are usually required to be quarantined for 14 days. 	 Ndenge esalemaka mbala mingi, mpo na bato oyo bakutanaki na bato ya maladi oyo to baza na maladi yango, virisi wana esengaka ete batya yango na quarantaine mikolo 14. 	As is often the case, for people who have been in contact with these patients or are infected, the virus requires 14 days of quarantine.
235	en	ln	 Should the quarantine time be extended to 24 days? 	 Esengeli nde mikolo ya quarantaine ekoma mikolo 24? 	Should the quarantine period be extended to 24 days?
236	en	ln	 Fever is often the major and initial symptom of COVID-19, which can be accompanied by no symptom or other symptoms such as dry cough, shortness of breath, muscle ache, dizziness, headache, sore throat, rhinorrhea, chest pain, diarrhea, nausea, and vomiting. 	 Fievre eza mbala mingi elembo ya ntina mingi mpe ya liboso ya COVID-19, oyo ekoki koya yango moko to na bilembo mosusu na ndakisa kosukosu ya makasi, kokatana ya mpema, mpasi na misisa, vertige, moto mpasi, mongongo mpasi, kokangama ya zolo, mpasi na ntolo, pulupulu, mposa ya kosanza, mpe kosanza. 	Fever is often the most important and first symptom of COVID-19, which can come alone or with other symptoms such as severe cough, shortness of breath, muscle pain, dizziness, headache, sore throat, stuffy nose , chest pain, diarrhea, nausea, and vomiting.
237	en	ln	 Some patients experienced dyspnea and/or hypoxemia one week after the onset of the disease. 	 Bato mosusu ya maladi bapemaka na mpasi mpe/to bazangaka mpema mwa moke mposo moko na nsima ya ebandeli ya maladi. 	Some patients have shortness of breath and/or shortness of breath for a week after the onset of illness.
238	en	ln	 In severe cases, patients quickly progressed to develop acute respiratory syndrome, septic shock, metabolic acidosis, and coagulopathy. 	 Na bandakisa ya makasi, bato ya maladi bakomaki noki na mpasi ya kopema, motema ebetaka malamu te, nzoto ebimisaka aside mingi, mpe makila ezokoka kokangama te. 	In severe examples, patients quickly became short of breath, irregular heartbeat, excessive acid production, and blood clotting.
239	en	ln	 Patients with fever and/or respiratory symptoms and acute fever, even without pulmonary imaging abnormalities, should be screened for the virus for early diagnosis. 	 Bato oyo baza na fievre mpe/to mpasi ya kopema mpe fievre ya makasi, ata soki bakanisi ete baza na mpasi na poumon, basengeli kosala bango ekzame mpo na koyeba soki baza na maladi wana. 	People with fever and/or difficulty breathing and high fever, even if they think they have a pulmonary disorder, should be tested for the condition.
240	en	ln	 A demographic study in late December of 2019 showed that the percentages of the symptoms were 98% for fever, 76% for dry cough, 55% for dyspnea, and 3% for diarrhea; 8% of the patients required ventilation support. 	 Bolukiluki na mwa ndambo ya bato oyo esalemaki na nsuka ya sanza ya zomi na mibale 2019 emonisaki ete bilembo ya maladi ezalaki 98% mpo na fievre, 76% mpo na kosukosu, 55% mpo na vertige, mpe 3% mpo na pulupulu; 8% ya bato bazalaki na mposa ya lisalisi ya mopepe. 	A cohort study conducted in late December 2019 found that symptoms were 98% for fever, 76% for cough, 55% for dizziness, and 3% for pneumonia; 8% of subjects required ventilation.
241	en	ln	 Similar findings were reported in two recent studies of a family cluster and a cluster caused by transmission from an asymptomatic individual. 	 Bazwaki makambo ya ndenge moko na bolukiluki mibale ya sika oyo basalaki na biloko oyo ebimisaka maladi mpe oyo epanzaka yango na bato oyo baza na yango te. 	Similar results were obtained in two recent studies of disease-causing and spreading agents in naïve individuals.
242	en	ln	 Comparably, a demographic study in 2012 showed that MERS-CoV patients also had fever (98%), dry cough (47%), and dyspnea (55%) as their main symptoms. 	 Kasi, bolukilluki oyo esalemaki na 2012 emonisaki ete bato oyo bazobela MERS-CoV mpe mingi bazalaki na fievre (98%), kosukosu ya makasi (47%), mpe mpema mokuse (55%) na kati ya bilembo ya minene. 	However, research conducted in 2012 found that MERS-CoV patients and most had fever (98%), severe cough (47%), and shortness of breath (55%) among the main symptoms.
243	en	ln	 However, 80% of them required ventilation support, much more than COVID-19 patients and consistent with the higher lethality of MERS than of COVID-19. 	 Kasi, 80% na bango bazalaki na mposa ya lisalisi ya mopepe, mingi koleka bato oyo bazobela COVID-19 mpe ezoboma bato ndeko moko na MERS kasi lokola COVID-19. 	However, 80% of them needed air support, more than people with COVID-19 and it kills people the same as MERS but like COVID-1
244	en	ln	 Diarrhea (26%) and sore throat (21%) were also observed with MERS patients. 	 Pulupulu (26%) mpe mongongo mpasi (21%) emonanaki mpe na bato oyo bazalaki kobela MERS. 	Fever (26%) and hoarseness (21%) were also reported in patients with MERS.
245	en	ln	 In SARS patients, it has been demonstrated that fever (99%-100%), dry cough (29%-75%), dyspnea (40%-42%), diarrhea (20-25%), and sore throat (13-25%) were the major symptoms and ventilation support was required for approximately 14%-20% of the patients. 	 Na bato oyo bazalaki kobela SARS, emonanaki ete fievre (99%-100%), kosukosu ya makasi (29%-75%), vertige (40%-42%), pulupulu (20-25%), mpe mongongo mpasi (13-25%) ezalaki bilembo ya minene mpe bato pene ya 14%-20% bazalaki na mposa ya lisalisi ya mopepe. 	In SARS patients, fever (99%-100%), severe cough (29%-75%), dizziness (40%-42%), pneumonia (20-25%), and voice pain ( 13-25%) were major symptoms and approximately 14%-20% individuals required ventilatory support.
246	en	ln	 By February 14, the mortality of COVID-19 was 2% when the confirmed cases reached 66,576 globally. 	 Na mokolo ya 14 sanza ya mibale, bato bakufaki na COVID-19 bazalaki 2% ntango motango ya bato ekomaki 66 576 na mokili mobimba. 	As of February 14, the death toll from COVID-19 was 2% as the total number of people worldwide reached 66,5
247	en	ln	 Comparably, the mortality of SARS by November 2002 was 10% of 8,096 confirmed cases. 	 Soki tosali bokokanisi, bato oyo bakufaki na SARS na sanza ya zomi na moko 2002 bazalaki 10% na kati ya bato 8 096 oyo babelaki yango. 	By comparison, SARS deaths in November 2002 were 10% of the 8,096 cases.
248	en	ln	 For MERS, based on a demographic study in June 2012, the mortality was 37% of 2,494 confirmed cases. 	 Mpo na MERS, na kotalela bolukiluki na motango ya bato oyo esalemaki na sanza ya motoba 2012, bato oyo bakufaki bazalaki 37% na kati ya bato 2 494 oyo babelaki yango. 	For MERS, based on a population-based survey conducted in June 2012, the mortality rate was 37% out of 2,494 cases.
249	en	ln	 An earlier study reported that the R0 of SARS-CoV-2 was as high as 6.47 with a 95% confidence interval (CI) of 5.71-7.23, whereas the R0 of SARS-CoV only ranged from 2 to 4. 	 Bolukiluki ya liboso emonisaki ete R0 ya SARS-CoV-2 ezalaki 6,47 mpe 95% interval ya confiance (CI) ya 5,71-7,23, kasi R0 ya SARS-CoV ezalaki kaka banda 2 kino 4. 	Preliminary research showed that the R0 for SARS-CoV-2 was 6.47 and a 95% confidence interval (CI) of 5.71-7.23, but the R0 for SARS-CoV only ranged from 2 to 4.
250	en	ln	 A comparison of SARS-CoV-2 with MERS-CoV and SARA-CoV regarding their symptoms, mortality, and R0 is presented in Table ​Table1.1. 	 Kokokanisa SARS-CoV-2 na MERS-CoV mpe SARA-CoV na oyo etali bilembo, motango ya bakufi, mpe R0 emonisami na Tablo​Tablo 1.1. 	Comparison of SARS-CoV-2 with MERS-CoV and SARA-CoV in terms of symptoms, mortality, and R0 is shown in Table
251	en	ln	 The above figures suggest that SARS-CoV-2 has a higher ability to spread than MERS-CoV and SARS-CoV, but it is less lethal than the latter two. 	 Mitango oyo eza likolo emonisi ete SARS-CoV-2 eza na makoki mingi ya kopanzana koleka MERS-CoV mpe SARS-CoV, kasi ezoboma bato moke koleka mibale oyo ya nsuka. 	The above figures show that SARS-CoV-2 is more likely to spread than MERS-CoV and SARS-CoV, but kills fewer people than the latter two.
252	en	ln	 Thus, it is much more challenging to control the epidemic of SARS-CoV-2 than those of MERS-CoV and SARS-CoV. 	 Yango wana, eza mpasi mingi na kobundisa maladi mabe ya SARS-CoV-2 koleka oyo ya MERS-CoV mpe SARS-CoV. 	Therefore, it is more difficult to fight SARS-CoV-2 than MERS-CoV and SARS-CoV.
253	en	ln	 Clustered onset often happens in the same family or from the same gathering or vehicle such as a cruise ship. 	 Mbala mingi maboke ebimaka na libota moko to na esika moko to eyaki neti masuwa. 	Collections often come from a family or a place or came as a ship.
254	en	ln	 Patients often have a history of travel or residence in Wuhan or other affected areas or contact with infected individuals or patients in the recent two weeks before the onset. 	 Mbala mingi bato ya maladi eza bato oyo basalaki mobembo na to bafandaka kuna to bisika mosusu oyo maladi yango ekotaki to bazwaki yango na bato na bamposo mibale liboso ete ebanda. 	Patients are usually people who traveled to or lived in or elsewhere where the disease entered or was infected with people in the two weeks before it started.
255	en	ln	 However, it has been reported that people can carry the virus without symptoms longer than two weeks and cured patients discharged from hospitals can carry the virus again, which sends out an alarm to increase the time for quarantine. 	 Kasi, emonani ete bato bakoki komema virisi wana kozanga kozala na bilembo na eleko eleki mposo mibale mpe bato oyo babikaki oyo babimaki na lopitalo bakoki kozala lisusu na virisi wana, yango wana esengeli kobakisa mikolo ya quarantaine. 	However, it appears that people can carry the virus without symptoms in the past two weeks and survivors who have been discharged from hospital may be infected again, so the quarantine period should be extended.
256	en	ln	 Patients have normal or reduced number of peripheral white blood cells (especially lymphocytes) at the early stage. 	 Bato ya maladi oyo baza na motango ya baselile ya mpembe ya makila ya normal to moke (mingimingi balymphocyte) na ebandeli mpenza ya maladi. 	Patients with normal or low white blood cell counts (especially lymphocytes) very early in the disease.
257	en	ln	 For example, lymphopenia with white blood cell count &lt; 4×109/L including lymphocyte count &lt; 1×109/L, and elevated aspartate aminotransferase levels and viremia were found in 1,099 COVID-19 patients. 	 Ndakisa, lymphopenia na selile ya mpembe ya makila count &lt; 4×109/L elongo na lymphocyte count &lt; 1×109/L, mpe motango mingi ya aspartate aminotransferase mpe viremia emonanaki na bato ya maladi 1 099 ya COVID-19. 	For example, lymphopenia with white blood cell count &lt; 4×109/L along with lymphocyte count &lt; 1×109/L, and high levels of aspartate aminotransferase and viremia were observed in 1,099 COVID-19 patients.
258	en	ln	 The levels of liver and muscle enzymes and myoglobin were increased in the blood of some patients, and C-reactive protein and erythrocyte sedimentation were increased in the blood of most patients. 	 Nivo ya foie mpe ya misisa ya ba-enzyme mpe myoglobine ezalaki komata na makila ya bato mosusu ya maladi, mpe baproteine C na erythrocyte emataki na makila ya bato mingi ya maladi. 	Liver and tissue levels of enzymes and myoglobin were elevated in the blood of some patients, and erythrocyte C proteins were elevated in the blood of most patients.
259	en	ln	 In patients with severe cases, the level of D-dimer, a fibrin degradation product present in the blood, was elevated, and lymphocyte count was progressively reduced. 	 Na bato oyo bazalaki kobela makasi, nivo ya dimer D, kolemba ya mosisa moko oyo ezalaka na makila, emataka, mpe lymphocyte ebandaki kokita malembemalembe. 	In the severely ill, levels of dimer D, a blood vessels, rose, and lymphocytes began to decline.
260	en	ln	 Abnormalities in chest radiography are found in most COVID-19 patients and featured by bilateral patchy shadows or ground glass opacity in the lungs. 	 Bampasi na ntolo emonanaki na bato mingi oyo babelaki COVID-19 mpe emonisaki bisika ya molili ya ndenge moko te to bisika ya molili na bapoumon. 	Chest pains were seen in many patients with COVID-19 and showed irregular dark spots or dark spots on the lungs.
261	en	ln	 Patients often develop an atypical pneumonia, acute lung injury, and acute respiratory distress syndrome (ARDS). 	 Mbala mingi bato ya maladi bazalaki na maladi ya mpema, kozoka makasi na poumon, mpe mpasi makasi ya kopema (ARDS). 	Patients often had respiratory failure, acute lung injury, and acute acute respiratory distress syndrome (ARDS).
262	en	ln	 When ARDS happens, uncontrolled inflammation, fluid accumulation, and progressive fibrosis severely compromise the gas exchange. 	 Soki ARDS esalemi, mpasi ya makasi, komata ya mai, mpe kobeba ya fibrose esalaka ete mopepe eleka na mpasi. 	Once ARDS occurs, severe pain, fluid rise, and worsening fibrosis result in difficult airflow.
263	en	ln	 Dysfunction of type-I and type-II pneumocytes decreases the surfactant level and increases surface tension, thus reducing the ability of the lungs to expand and heightening the risk of lung collapse. 	 Kosala malamu te ya lolenge I mpe II ya pneumocytes ekitisaka nivo ya surfactant mpe ematisaka esika ya mpasi, yango wana ekitisaka makoki ya bapoumon ya kofungwama mpe esalaka ete likama ya kopanza poumon ekoma mingi. 	Dysfunction of types I and II pneumocytes decreases surfactant levels and enhances the lesion area, therefore reducing the ability of the lungs to expand and increasing the risk of lung collapse.
264	en	ln	 Therefore, the worst chest radiographic findings often parallel the most severe extent of the disease. 	 Yango wana, maladi makasi ya bapoumon oyo bazwaki ezalaki mbala mingi na boyokani na mpasi makasi ya maladi wana. 	Therefore, the severe lung disease diagnosed was often associated with the severity of that disease.
265	en	ln	 On February 18, 2020, the first pathological analysis of COVID-19 demonstrated the desquamation of pneumocytes, hyaline membrane formation, and interstitial lymphocyte infiltration, and multinucleated syncytial cells in the lungs of a patient who died of the disease, consistent with the pathology of viral infection and ARDS and similar to that of SARS and MERS patients. 	 Na mokolo ya 18 sanza ya mibale 2020, analyse ya liboso ya COVID-19 emonisaki kobeba ya ba pneumocyte, biteni ya hyaline, mpe kotoboka ya kati ya lymphocyte, mpe mwa bambuma na selile na bapoumon ya bato oyo bakufaki na maladi yango; eyokani na pathologie ya virisi yango mpe ARDS mpe ekokani na oyo ya bato oyo babelaki SARS mpe MERS. 	On February 18, 2020, the first COVID-19 analysis revealed pneumocyte damage, hyaline fragments, and intralymphocyte rupture, and some cell clumps in the lungs of the victims; is consistent with the pathology of the virus and ARDS and similar to that of patients with SARS and MERS.
266	en	ln	 The detection of SARS-CoV-2 RNA via reverse-transcriptase polymerase chain reaction (RT-PCR) was used as the major criteria for the diagnosis of COVID-19. 	 Koyeba SARS-CoV-2 RNA na nzela ya makambo oyo esalemaka mpe ememaka na (RT-PCR) esalelamaki neti elembo ya ntina mingi mpo na koyeba COVID-19. 	Detection of SARS-CoV-2 RNA by RT-PCR has been used as a key indicator for the diagnosis of COVID-1
267	en	ln	 However, due to the high false-negative rate, which may accelerate the epidemic, clinical manifestations started to be used for diagnosis (which no longer solely relied on RT-PCR) in China on February 13, 2020. 	 Kasi, mpo na nivo ya makasi ya makambo ya lokuta, oyo ekoki kosala ete maladi mabe ekoma makasi mingi, babandaki kosalela bilembo ya maladi mpo na koyeba yango (bazalaki kosuka kaka te na RT-PCR) na Chine na mokolo ya 13 sanza ya mibale 2020. 	However, due to the severe level of false positives, which can make malignancies more severe, the use of diagnostic markers (not limited to RT-PCR) was introduced in China on 13 February 2020.
268	en	ln	 A similar situation also occurred with the diagnosis of SARS. 	 Likambo ya ndenge moko esalemaki mpo na koyeba SARS. 	A similar thing happened with the diagnosis of SARS.
269	en	ln	 Therefore, a combination of disease history, clinical manifestations, laboratory tests, and radiological findings is essential and imperative for making an effective diagnosis. 	 Yango wana, kosangisa masolo ya maladi oyo, ndenge ebimaki, baekzame ya laboratoire, mpe makambo bamonaki na radiographie eza ntina mingi mpe ekosalisa mpo na koyeba makasi diagnostique. 	Therefore, a combination of the history of this disease, its presentation, laboratory tests, and radiographic findings is very important and will help to determine the diagnostic strength.
270	en	ln	 On February 14, 2020, the Feng Zhang group described a protocol of using the CRISPR-based SHERLOCK technique to detect SARS-CoV-2, which detects synthetic SARS-CoV-2 RNA fragments at 20 × 10-18 mol/L to 200 × 10-18 mol/L (10-100 copies per microliter of input) using a dipstick in less than an hour without requiring elaborate instrumentation. 	 Na mokolo ya 14 sanza ya mibale 2020, lisanga Feng Zhang balimbolaki mayele moko na kosalelaka mayele esimbami na CRISPR SHERLOCK mayele ya koyeba SARS-CoV-2, mpo na koyeba SARS-CoV-2 RNA na 20 × 10-18 mol/L to 200 × 10-18 mol/L (motango 10-100 na microlitre moko) basalelaki jauge na nse ya ngonga moko kozanga basala makambo ya mindondomindondo. 	On February 14, 2020, the Feng Zhang group described a method using the CRISPR SHERLOCK-based SARS-CoV-2 detection method, to detect SARS-CoV-2 RNA at 20 × 10-18 mol/L or 200 × 10-18 mol/L (number 10-100 per microliter) were gauged in less than an hour without elaborate procedures.
271	en	ln	 Hopefully, the new technique can dramatically enhance the sensitivity and convenience if verified in clinical samples. 	 Tozolikya ete, mayele oyo ya sika ekoki kobongola makasi sensibilite mpe lolenge malamu ya kosalela yango, soki endimami nsima ya kotalela yango. 	Hopefully, these new technologies can drastically change the sensitivity and efficiency of their use, if approved after evaluation.
272	en	ln	 Due to the lack of experience with the novel CoV, physicians can mainly provide supportive care to COVID-19 patients, while attempting a variety of therapies that have been used or proposed before for the treatment of other CoVs such as SARS-CoV and MERS-CoV and other viral diseases (Table ​(Table2).2). 	 Mpo bayebi malamu te CoV ya sika, minganga bakoki kaka kosalisa mwa moke bato oyo bazobela COVID-19, ntango bazozela bankisi mingi oyo basi basalela to oyo bazalaki kokanisa liboso kosalela mpo na kobikisa bato ya CoVs mosusu na ndakisa SARS-CoV mpe MERS-CoV mpe maladi euti na virisi (Tablo ​(Tablo2).2). 	Because they are not fully aware of the new CoV, doctors can only partially treat COVID-19 patients, while waiting for many drugs that women have used or previously thought to use to cure people of other CoVs such as SARS-CoV and MERS-CoV and viral diseases (Table ​ (Table2).2).
273	en	ln	 These therapies include current and potential treatments with antiviral drugs, immunosuppressants, steroids, plasma from recovered patients, Chinese medicine, and psychological support. 	 Bankisi yango eza bankisi ya sika mpe oyo bakoki kosalela oyo eza na nkisi ya bambuma, immunosuppresseurs, basteroide, plazma euti na bato ya maladi, nkisi ya bokoko ya Chine, mpe lisalisi ya minganga. 	These medicines are new and available medicines that include herbal medicines, immunosuppressants, steroids, plasma from patients, traditional Chinese medicine, and medical treatment.
274	en	ln	 Even plasma from recovered patients was proposed to be used for treatment. 	 Balobaki bakoki kosalela ata plazma oyo euti na moto ya maladi lokola nkisi. 	They said they could even use plasma from a patient as a therapy.
275	en	ln	 Pharmaceutical companies are racing to develop antibodies and vaccines against the virus. 	 Bakompani oyo esalaka bankisi bazosala makasi mpo na kosala bankisi mpe mangwele ya virisi oyo. 	Pharmaceutical companies are working to develop drugs and vaccines for the virus.
276	en	ln	 SARS-CoV-2 mainly attacks the lungs in the beginning and probably also attacks, to a lesser degree, other organs that express ACE2, such as the gastrointestinal system and the kidneys. 	 SARS-CoV-2 ebundisaka mingimingi bapoumon na ebandeli mpe mbala mosusu ebundisaka mwa moke binama mosusu ya nzoto oyo ezalaka na ACE2, na ndakisa estoma na misopo mpe bangeyi. 	SARS-CoV-2 primarily attacks the lungs initially and probably somewhat attacks other ACE2-positive organs, such as the stomach and intestines.
277	en	ln	 Nevertheless, respiratory dysfunction and failure are the major threat to the patients and the major cause of death. 	 Atako bongo, mpasi ya kopema mpe kobungisa makanisi eza makama minene mpo na bato mingi ya maladi mpe yango nde ezoboma mingi. 	Nevertheless, dyspnea and dementia are major risk factors for many patients and are the leading cause of death.
278	en	ln	 Thus, respiratory support is critical to relieve the symptoms and save lives and includes general oxygen therapy, high-flow oxygen, noninvasive ventilation, and invasive mechanical ventilation depending on the severity of the disease. 	 Yango wana, kosalisa na kopema eza ntina mingi mpo na kolembisa bilembo ya maladi mpe kobikisa bato mpe yango etaleli kopesa oxygene lokola nkisi, kopesa oxygene mingi, kokotisa mopepe kozanga kokotisa eloko na nzoto ya moto, mpe kokotisa na nzoto eloko ezokotisa mopepe na kotalela makasi ya maladi. 	Therefore, respiratory therapy is essential for symptom relief and survival and involves therapeutic oxygenation, oxygenation, noninvasive ventilation, and intensity-based ventilation of the disease.
279	en	ln	 Patients with severe respiratory symptoms have to be supported by extracorporeal membrane oxygenation (ECMO), a modified cardiopulmonary bypass technique used for the treatment of life-threatening cardiac or respiratory failure. 	 Bato ya maladi oyo baza na mpasi ya makasi ya kopema, basalisaki bango na eleko moko oyo ekotisaka oxygene (ECMO), mayele moko ya sika ya kokotisa eloko na motema oyo basalelaki mpo na kobikisa maladi makasi ya motema to bato oyo mpema ekatanaki. 	Patients with severe respiratory distress were treated with periodic oxygen maintenance (ECMO), a novel implant technique that has been used to save severe heart attacks or people who have stopped breathing.
280	en	ln	 In addition, the maintenance of electrolyte balance, the prevention and treatment of secondary infection and septic shock, and the protection of the functions of the vital organs are also essential for SARS-CoV-2 patients. 	 Lisusu, kobatela equilibre ya electrolyte, kobundisa mpe kobikisa maladi ya mibale mpe maladi makasi, mpe kobatela binama ya bomoi eza ntina mingi mpo na bato oyo bazobela SARS-CoV-2. 	Furthermore, maintaining electrolyte balance, fighting and curing secondary and severe disease, and protecting vital organs are critical for people infected with SARS-CoV-2.
281	en	ln	 It has been known that a cytokine storm results from an overreaction of the immune system in SARS and MERS patients. 	 Eyebani ete komata ya cytokine na reaction ya koleka ndelo ya mikrobe oyo ebundisaka maladi ya bato oyo bazobela SARS mpe MERS. 	Cytokine upregulation in the immune overreaction of patients with SARS and MERS is known.
282	en	ln	 Cytokine storm is a form of systemic inflammatory response featured by the release of a series of cytokines including TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, and MCP-1. 	 Cytokine eza lolenge moko ya mpasi oyo ebimaka na ba cytokine mingi na ndakisa TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, mpe MCP-1. 	Cytokine is a type of pain produced by several cytokines including TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, and MCP-1.
283	en	ln	 These cytokines induce immune cells to release a vast number of free radicals which are the major cause of ARDS and multiple organ failure. 	 Ba cytokine epusaka baselile oyo ebundisaka maladi na kobimisa ba radicale mingi oyo ekeseni oyo ebimisaka mbala mingi ARDS mpe kobebisa binama. 	Cytokines stimulate immune cells to produce many different free radicals that often result in ARDS and organ damage.
284	en	ln	 Immunosuppression is essential in the treatment of cytokine storms, especially in severe patients. 	 Immunosuppresseur eza ntina mingi mpo na kobikisa cytokine, mingimingi na bato oyo bazobela makasi. 	Immunosuppressant is very important for cytokine rescue, especially in critically ill people.
285	en	ln	 Corticosteroids and tocilizumab, an anti-IL6 monoclonal antibody, have been used to treat cytokine storm. 	 Corticosteroide mpe tocilizumabe, IL6 moko oyo ebundisaka maladi, basalelaki yango mpo na kobikisa cytokine. 	Corticosteroid and tocilizumab, an IL6 immunosuppressant, were used for cytokine rescue.
286	en	ln	 Other immunosuppression treatments for cytokine storm include the modulation of T cell-directed immune response; the blockade of IFN-γ, IL-1, and TNF; JAK inhibition; blinatumomab; suppressor of cytokine signaling 4; and HDAC inhibitors. 	 Bankisi mosusu ya immunosuppresseur mpo na cytokine ezali kosalela selile T oyo eza na boyokani na mikrobe oyo ebundisaka maladi; blockade ya IFN-γ, IL-1, mpe TNF; JAK inhibation; blinatumomabe; suppresseur ya cytokine oyo ezolakisa 4; mpe HDAC ba inhibateur. 	Other cytokine-specific immunosuppressive drugs include the use of an immune-mediated T cell; blockade of IFN-γ, IL-1, and TNF; JAK inhibition; blinatumomabe; suppressor of cytokine expression 4; and HDAC inhibitors.
287	en	ln	 Steroids, as immunosuppressants, were widely used in the treatment of SARS to reduce the severity of inflammatory damage. 	 Ba steroide, lokola ba immunosuppresseur, basalelaki yango mingi lokola nkisi ya SARS mpo na kokitisa mpasi oyo esalemi. 	Steroids, as immunosuppressants, have been widely used as treatment for SARS to reduce the pain caused.
288	en	ln	 However, steroids at high dosages were not beneficial to severe lung injury in SARS and COVID-19 patients. 	 Kasi, basteroide oyo ezalaka na doze mingi ezalaki ntina te mpo na mpota ya poumon na bato oyo babelaki SARS mpe COVID-19. 	However, high-dose steroids were not a cause of lung injury in patients with SARS and COVID-19.
289	en	ln	 Instead, they may cause severe side effects, especially avascular osteonecrosis, dramatically affecting the prognosis. 	 Kasi, ekoki komema bampasi mosusu, mingimingi na baselile ya makila, mpe ebebisaki mingi pronostique. 	However, it can lead to other complications, especially in blood cells, and significantly worsened the prognosis.
290	en	ln	 Nevertheless, short courses of corticosteroids at low-to-moderate doses have been recommended to be used prudently for critically ill COVID-19 patients. 	 Atako bongo, badoze ya moke ya corticosteroide, basengaki kopesa yango na mayele mpo na bato ya maladi ya COVID-19 oyo bazalaki kobela makasi. 	Low doses of corticosteroid, nevertheless, were advised to be administered judiciously for critically ill COVID-19 patients.
291	en	ln	 At the time of writing, no effective antiviral therapy has been confirmed. 	 Na ntango tozokoma, eza nanu te na nkisi oyo eyebani mpo na virisi oyo. 	As of this writing, there is no known cure for this virus.
292	en	ln	 However, intravenous administration with remdesivir, a nucleotide analog, has been found to be efficacious in an American patient with COVID-19. 	 Kasi, kopesa na misisa remdesivir, analogue ya nucleotide, emonanaki ete ezosalisa mingi bato ya Amerika oyo bazobela COVID-19. 	However, intravenous administration of remdesivir, a nucleotide analog, has been shown to significantly improve American patients with COVID-19.
293	en	ln	 Remdesivir is a novel antiviral drug developed by Gilead initially for the treatment of diseases caused by Ebola and Marlburg viruses. 	 Remdesivir eza nkisi ya kobundisa virisi oyo esalemaki na ebandeli na Gileadi mpo na kosalisaka bato oyo bazalaki kobela Ebola mpe Marlburg. 	Remdesivir is an antiviral drug originally developed by Gilead to treat people with Ebola and Marlburg.
294	en	ln	 Later, remdesivir also demonstrated possible inhibition of other single stranded RNA viruses including MERS and SARS viruses. 	 Na nsima, remdesivir mpe emonisaki ete ekoki kosalisa mpo na bavirisi mosusu ya RNA ata mpe virisi MERS na SARS. 	Later, remdesivir also proved useful against other RNA viruses including MERS virus and SARS.
295	en	ln	 Based on these, Gilead has provided the compound to China to conduct a pair of trials on SARS-CoV-2-infected individuals, and the results are highly anticipated. 	 Na kotalela makambo wana, Gilead epesi biloko wana na Chine mpo na komeka yango na bato oyo bazobela SARS-CoV-2, mpe bato bazozela mpenza resultat na yango. 	Based on these facts, Gilead has offered these products to China for testing in SARS-CoV-2 patients, and the results are eagerly awaited.
296	en	ln	 In addition, baricitinb, interferon-α, lopinavir/ritonavir, and ribavirin have been suggested as potential therapies for patients with acute respiratory symptoms. 	 Lisusu, bato balobaki ete baricitinbe, interferone-α, lopinavire/ritonavire, mpe ribavirin, ekoki kosalisa bato oyo baza na mpasi makasi ya kopema. 	In addition, baricitinb, interferon-α, lopinavir/ritonavir, and ribavirin, have been reported to be effective in patients with severe respiratory distress syndrome.
297	en	ln	 Diarrhea, nausea, vomiting, liver damage, and other adverse reactions can occur following combined therapy with lopinavir/ritonavir. 	 Pulupulu, mposa ya kosanza, kosanza, kobeba ya foie, mpe ba reaction mosusu ya mabe ekoki komonana soki basangisi nkisi wana na lopinavire/ritonavire. 	Fever, urge to vomit, vomiting, liver damage, and other adverse reactions may be seen when this drug is combined with lopinavir/ritonavir.
298	en	ln	 The interaction of these treatments with other drugs used in the patients should be monitored carefully. 	 Kosangisa bankisi oyo na bankisi mosusu oyo basalelaki mpo na bato mosusu ya maladi, esengeli kokengela yango malamu mpenza. 	The combination of these drugs with other drugs that have been used for other patients should be closely monitored.
299	en	ln	 Plasma from recovered patients and antibody generation 	 Plazma ya bato oyo babikaki mpe biloko ebundisaka maladi	Survivors&#39; plasma and antibodies
300	en	ln	 The collection of the blood from patients who recovered from a contagious disease to treat other patients suffering from the same disease or to protect healthy individuals from catching the disease has a long history. 	 Kosangisa makila ya bato oyo babikaki na maladi mabe mpo na kosalisa bato mosusu oyo bazobela maladi wana moko to mpo na kobatela bato oyo baza nzoto kolongono mpo bazwa te maladi wana ebanda kala. 	Blood transfusions from survivors of a serious illness to treat others with the same disease or to protect healthy people from contracting the same disease have a long history.
301	en	ln	 Indeed, recovered patients often have a relatively high level of antibodies against the pathogen in their blood. 	 Ya solo, mbala mingi bato oyo babika baza na ba-anti corps ya makasi mpo na kobundisa mikrobe na makila na bango. 	Indeed, survivors often have strong antibodies to fight infection in their blood.
302	en	ln	 Antibodies are an immunoglobulin (Ig) produced by B lymphocytes to fight pathogens and other foreign objects and they recognize unique molecules in the pathogens and neutralize them directly. 	 Ba anticorps eza immunoglobuline (Ig) oyo euti na ba lymphocytes B mpo na kobundisa mikrobe mpe biloko mosusu ya mabe mpe eyebaka bamolekile oyo eza na mikrobe mpe na nsima koboma yango. 	Antibodies are immunoglobulins (Ig) produced by B lymphocytes to fight viruses and other harmful substances and recognize infected molecules and then kill them.
303	en	ln	 Based on this, plasma was collected from the blood of a group of patients who recovered from COVID-19 and was injected into 10 seriously ill patients. 	 Na kotalela makambo oyo, bazwaka mbala mingi plazma na makila ya bato oyo babelaki kasi babika na COVID-19 mpe botiubaki yango na bato 10 oyo bazalaki kobela makasi. 	Based on these data, plasma is usually collected from the blood of patients who have survived COVID-19 and transfused into 10 critically ill patients.
304	en	ln	 Their symptoms improved within 24 hours, accompanied by reduced inflammation and viral loads and improved oxygen saturation in the blood. 	 Bayokaki malamu nsima ya bangonga 24; mpasi na virisi ekitaki mpe esalaki ete oxygene ekita te na makila. 	They felt better after 24 hours; the pain in the virus decreased and prevented a decrease in blood oxygenation.
305	en	ln	 However, verification and clarification are necessary to propose the method for large-scale use before specific therapies are not yet developed. 	 Kasi, verification mpe clarification eza ntina mingi mpo na topesa likanisi ya kosalela metode wana mpo na kosalela yango liboso babimisa nkisi ya solo. 	However, verification and clarification is so important that we suggest using this method for use before the actual drug is released.
306	en	ln	 In addition, given the therapeutic effects, some disadvantages associated with the plasma should be considered carefully. 	 Lisusu, mpo na mabe oyo nkisi ememaka, esengeli kotalela malamumalamu makama mosusu ya plazma. 	Furthermore, because of the side effects of the drug, other risks of plasma must be carefully considered.
307	en	ln	 For example, antibodies can overstimulate the immune response and cause cytokine release syndrome, which is potentially a life-threatening toxicity. 	 Na ndakisa, anticorps ekoki kolendisa mikrobe oyo ebundisaka maladi mpe ekoki kosala ete cytokine ebima; oyo eza mabe mingi mpo na bomoi. 	For example, an antibody can stimulate the immune system and induce cytokine production; this is very bad for life.
308	en	ln	 The concentration of antibodies in the blood is usually low, and the demand for the plasma is large to treat critically ill patients. 	 Kosangisa ba anticorps na makila ezalaka mbala mingi na nse, mpe bosengi ya plazma eza mingi mpo na kosalisa bato bazobela. 	The concentration of antibodies in the blood is usually low, and the demand for plasma is high to treat patients.
309	en	ln	 It is difficult to develop and produce specific antibodies rapidly enough to fight against a global epidemic. 	 Eza mpasi na kosala mpe kobimisa ba anticorps ya sikisiki mpo na kobundisa maladi mabe ya monene. 	It is difficult to develop and produce specific antibodies against major diseases.
310	en	ln	 Thus, it is more critical and practical to isolate B cells from recovered patients and identify the genetic codes encoding effective antibodies or screen for effective antibodies against essential proteins of the virus. 	 Yango wana, eza ntina mingi mpe ebongi na kokabola baselile B ya bato oyo babiki mpe koyeba bokasi ya ba anticorps wana to komema yango mpo na koyeba soki ba anticorps wana ekoki kobundisa baproteine ya virisi. 	Therefore, it is very important and appropriate to isolate B cells from survivors and determine the effectiveness of these antibodies or to carry them to determine whether these antibodies can fight viral proteins.
311	en	ln	 This way, we can readily scale up the production of the antibodies. 	 Na ndenge wana, tokokoka nde kosala noki ba anticorps. 	In this way, we will be able to make antibodies faster.
312	en	ln	 TCM has been used to treat a variety of diseases in China for thousands of years. 	 Babanda kosalela TCM mpo na kosalisa maladi mingi na Chine banda bambula mingi. 	TCM has been used to treat many diseases in China for many years.
313	en	ln	 However, its effects largely rely on a combination of multiple components in a formula that varies depending on the diagnosis of a disease based on the theories of TCM. 	 Kasi, makama na yango eutaka na ndenge basangisaka biloko mingi na ndenge ekeseni na kotalela lolenge maladi ezali na kolandaka makanisi ya TCM. 	However, its risks stem from the combination of many ingredients in different ways depending on the nature of the disease following TCM concepts.
314	en	ln	 Most of the effective components remain unknown or are vague as it is difficult to extract and verify such components or their optimal combinations. 	 Biloko mingi oyo esalisaka eyebani nanu te to eyebani bongobongo mpo eza mpasi na kobimisa mpe ko verifier biloko yango mpe ndenge malamu ya kosangisa yango. 	Many of these ingredients are not yet known or are only known because of the difficulty in producing and verifying these ingredients and the best way to combine them.
315	en	ln	 Currently, due to the lack of effective and specific therapy for COVID-19, TCM has become one of the major alternative treatments for patients with light to moderate symptoms or for those who have recovered from severe stages. 	 Sikoyo, mpo tozangi nkisi ya makasi mpe ya sikisiki mpo na COVID-19, TCM ekomi moko ya bankisi mpo na bato oyo baza na bilembo ya mike to ya pete to baoyo babiki na maladi makasi. 	Now, because we lack a strong and specific cure for COVID-19, TCM has become one of the treatments for people with mild to moderate symptoms or those who have survived a serious illness.
316	en	ln	 For example, Shu Feng Jie Du capsules and Lian Hua Qing Wen capsules were found to be effective for COVID-19 treatment. 	 Na ndakisa, bato bamonaki ete nkisi ya capsule Shu Feng Jie Du mpe Lian Hua Qing Wen ezosalisa mingi na kobikisa bokono ya COVID-19. 	For example, Shu Feng Jie Du and Lian Hua Qing Wen capsules have been found to be very effective in curing COVID-1
317	en	ln	 Top cure rates in the treatment of COVID-19 patients were observed in several provinces in China that used TCM in 87% of their patients, including Gansu (63.7%), Ningxia (50%), and Hunan (50%), whereas Hubei province, which used TCM in only approximately 30% of its COVID-19 patients, had the lowest cure rate (13%). 	 Bato mingi oyo babikaki na kozwaka nkisi ya COVID-19, emonanaki na bituka mingi ya Chine oyo basalelaka TCM na bato ya maladi 87%, na ndakisa Gansu (63,7%), Ningxia (50%), mpe Hunan (50%), kasi na etuka ya Hubei, oyo esalelaki TCM kaka na bato pene ya 30% oyo bazalaki kobela COVID-19, bato moko nde babikaki (13%). 	The highest rates of survival with COVID-19 therapy were observed in several provinces in China where TCM is practiced in 87% of patients, including Gansu (63.7%), Ningxia (50%), and Hunan (50%) [ 1 ]. , but in Hubei Province, which used TCM only in about 30% of patients with COVID-19, only one person survived (13%).
318	en	ln	 However, this is quite a rough comparison as many other impact factors such as the number and severity of the patients should be included in the evaluation. 	 Kasi, bokokanisi oyo eza mpasi mpo makambo mosusu na ndakisa motango ya bato ya maladi mpe makasi ya maladi esengeli kotalelama mpe ntango ya botaleli wana. 	However, this comparison is difficult because other factors such as number of patients and disease severity need to be considered as well as the timing of these assessments.
319	en	ln	 On February 18, 2020, Boli Zhang and coworkers published a study to compare western medicine (WM) treatment alone with combined treatment of WM and TCM. 	 Na mokolo ya 18 sanza ya mibale 2020, Boli Zhang mpe baninga na ye babimisaki bolukiluki moko mpo na kokokanisa kimonganga ya eropa (WM) yango moko na nkisi ya WM mpe TCM. 	On February 18, 2020, Boli Zhang and colleagues published a study comparing European medicine (WM) itself with WM and TCM therapy.
320	en	ln	 They found that the times needed for body temperature recovery, symptom disappearance, and hospitalization were remarkably shorter in the WM+TCM group than in the WM only group. 	 Bamonaki ete ntango oyo baza na yango mposa mpo chaleur ekita na nzoto, mpo bilembo esila, mpe na lopitalo ezalaki moke na etuluku WM+TCM koleka na etuluku WM mpamba. 	They found that the time needed for heat to subside, for symptoms to resolve, and for hospitalization was less in the WM+TCM group than in the WM-only group.
321	en	ln	 Most impressively, the rate for symptomatic worsening (from light to severe) was remarkably lower for the WM+TCM group than for the WM only group (7.4% versus 46.2%) and the mortality was lower in the WM+TCM group than WM only group (8.8% versus 39%). 	 Eloko ezokamwisa mingi eza ete ndenge bilembo ezokoma makasi (banda na moke kino na makasi) ezalaki na nse mingi mpo na etuluku WM+TCM koleka na etuluku WM mpamba (7,4% kontre 46,2%) mpe bato oyo bakufaki bazalaki moke na etuluku WM+TCM koleka na etuluku WM mpamba (8,8% kontre 39%). 	What is most surprising is that the severity of symptoms (from mild to severe) was significantly lower for the WM+TCM group than in the WM alone group (7.4% versus 46.2%) and there were fewer deaths at the WM+TCM group compared with the WM only group (8.8% versus 39%).
322	en	ln	 Nevertheless, the efficacy and safety of TCM still await more well-controlled trials at larger scales and in more centers. 	 Atako bongo, bokasi mpe bolamu ya TCM ezozela kaka endimisama nsima ya komeka yango na bato mingi mpe na bisika mingi. 	Nevertheless, the efficacy and effectiveness of TCM still awaits confirmation after it has been tried in many populations and in many settings.
323	en	ln	 It would also be intriguing to characterize the mechanism of actions and clarify the effective components of TCM treatments or their combinations if possible. 	 Ezobenda mpe likebi na koyeba ndenge makambo esalemaka mpe kolimbola makasi ya biloko oyo eza na bankisi ya TCM to ndenge basangisaka yango soki likoki ezali. 	It also focuses on identifying mechanisms and describing the strength of ingredients in TCM medicines or combinations where possible.
324	en	ln	 Patients with suspected or confirmed COVID-19 mostly experience great fear of the highly contagious and even fatal disease, and quarantined people also experience boredom, loneliness, and anger. 	 Bato oyo bakanisi bakoki kozala na COVID-19 to oyo baza na yango, mbala mingi babangaka mingi maladi oyo ebomaka, mpe bato oyo batye na quarantaine bamitungisaka mingi, bamiyokaka bango moko mpe bazalaka na nkanda. 	People who think they may have or have COVID-19 are often more afraid of the deadly disease, and quarantined people are more anxious, lonely and angry.
325	en	ln	 Furthermore, symptoms of the infection such as fever, hypoxia, and cough as well as adverse effects of the treatments such as insomnia caused by corticosteroids can lead to more anxiety and mental distress. 	 Lisusu, bilembo ya kozwa maladi na ndakisa fievre, kozanga oxygene, mpe kosukosu mpe bampasi mosusu eutaka na nkisi na ndakisa kozanga mpongi oyo corticoseroide ebimisaka ekoki komema basusi mingi mpe kotungisama na makanisi. 	In addition, symptoms of infection such as fever, lack of oxygen, and cough and other medical side effects such as corticosteroid-induced insomnia can lead to increased anxiety and depression.
326	en	ln	 In the early phase of the SARS outbreak, a range of psychiatric morbidities including persistent depression, anxiety, panic attacks, psychomotor excitement, psychotic symptoms, delirium, and even suicidality were reported. 	 Na ebandeli ntango SARS ebimaki, balobaki ete bato yango bamonisaki bizaleli mingi na ndakisa kotungisama mingi na makanisi, basusi, kosutuka, kosala makambo bisalasala, kobosana makambo, kobungisa makanisi, mpe nkutu koluka komiboma. 	Initially when SARS appeared, it was reported that these people exhibited a range of behaviors including depression, anxiety, panic attacks, aggression, forgetfulness, dementia, and even suicidal attempts.
327	en	ln	 Mandatory contact tracing and quarantine, as a part of the public health responses to the COVID-19 outbreak, can make people more anxious and guilty about the effects of the contagion, quarantine, and stigma on their families and friends. 	 Koluka bato oyo moto azobela akutanaki na bango mpe kotya bato na quarantaine mpo na kobatela bango na COVID-19, ekoki kosala ete bato bamitungisa mingi mpe bazala na ngambo mpo bapesi bato mosusu maladi, kozala na quarantaine, mpe mpasi bamemi na mabota mpe baninga. 	Identifying contacts and quarantines to protect against COVID-19 can lead to increased anxiety and guilt for infecting others, being quarantined, and causing pain to family and friends.
328	en	ln	 Thus, mental health care should be provided to COVID-19 patients, suspected individuals, and people in contact with them as well as the general public who are in need. 	 Yango wana, basengeli kopesa lisalisi ya maladi ya moto na bato oyo baza na COVID-19, baoyo bakanisi bakoki kozala na yango, mpe na bato nyonso oyo baza na mposa na yango. 	Therefore, individual health care should be provided to people with COVID-19, those who think they may have it, and all those who need it.
329	en	ln	 The psychological support should include the establishment of multidisciplinary mental health teams, clear communications with regular and accurate updates about the SARS-CoV-2 outbreak and treatment plans and the use of professional electronic devices and applications to avoid close contact with each other. 	 Lisalisi ya maladi ya moto esengeli kotalela kopona ekipi ya bato mingi oyo basalisaka bato ya maladi ya moto, kosolola mbala na mbala na polele nyonso mpe kopesa bansango ya sika ya solo mpo na kobima ya SARS-CoV-2 mpe bankisi bazokana kobimisa mpe kosalela ba-apareyi mpe baprograme mpo na koboya kozala pembeni na bato mosusu. 	Hospice care should consider selecting a multidisciplinary hospice team, regular open communication and providing accurate updates on the emergence of SARS-CoV-2 and medications planned production and use of the -isolation devices and programs.
330	en	ln	 Effective vaccines are essential for interrupting the chain of transmission from animal reservoirs and infected humans to susceptible hosts and are often complementary to antiviral treatment in the control of epidemics caused by emerging viruses. 	 Mangwele ya solo eza na ntina mingi mpo na kosukisa kopanzana ya virisi na banyama mpe na bato oyo baza na yango mpe na biloko mosusu mpe mbala mingi eyokanaka na nkisi ya virisi mpo na kobundisa maladi makasi oyo euti na bavirisi ya sika. 	True vaccines are essential to stop the spread of the virus to animals and humans and other objects and are often combined with antiviral therapy to combat severe illness caused by new viruses.
331	en	ln	 Efforts have been made to develop S protein-based vaccines to generate long-term and potent neutralizing antibodies and/or protective immunity against SARS-CoV. 	 Milende ezosalema mpo na kobimisa mangwele uta na proteine S mpo na kobimisa ba anticorps ya ntango molai mpe oyo ekoki koboma mpe/to kobatela bato na SARS-CoV. 	Efforts are underway to produce vaccines from the S protein to produce long-lasting and lethal antibodies and/or protect against SARS-CoV.
332	en	ln	 Live-attenuated vaccines have been evaluated in animal models for SARS. 	 Basi bameki mangwele oyo ezosalisa bomoi na bambisi mpo na SARS. 	They have tested life-saving vaccines in fish for SARS.
333	en	ln	 However, the in vivo efficacy of these vaccine candidates in elderly individuals and lethal-challenge models and their protection against zoonotic virus infection have yet to be determined before a clinical study is initiated. 	 Kasi, bokasi ya solo ya mangwele wana na mibange mpe na bato oyo baza na maladi makasi mpe libateli na bango na bavirisi euti na banyama eyebani nanu te liboso bolukiluki ya solo ebanda na nzoto ya bato. 	However, the true efficacy of these vaccines in the elderly and critically ill and their protection against animal-derived viruses remains unknown before real research begins in humans.
334	en	ln	 This is probably because SARS died down 17 years ago and no new case has been reported since. 	 Eza mbala mosusu mpo SARS eisilaki mibu 17 ekoki mpe moto mosusu te abela maladi yango banda na ntango wana. 	It is probably because SARS ended 17 years ago and no one else has been infected since then.
335	en	ln	 In contrast, sporadic cases and clusters of MERS continue to occur in the Middle East and spread to other regions owing to the persistence of zoonotic sources in endemic areas. 	 Na bokeseni, bato mokomoko mpe mwa bituluku ya bato bazokoba kozwa virisi MERS na moyen orient mpe ezopanzana na bisika mosusu mpo eutaka na banyama. 	In contrast, individuals and small groups of people continue to be infected with the MERS virus in the Middle East and it is spreading elsewhere because it is transmitted from animals.
336	en	ln	 Vaccination strategies have been developed for MERS by using inactivated virus, DNA plasmids, viral vectors, nanoparticles, virus-like particles and recombinant protein subunits and some have been evaluated in animal models. 	 Basi basali mayele ya kotobola mangwele ya MERS na kobomaka virisi wana, DNA ya baselile, biloko oyo ememaka bavirisi, na biloko ya mike mpenza, biloko oyo eza neti virisi mpe biteni ya proteine ya virisi mpe bameka mosusu na banyama. 	They have developed a vaccine against MERS by killing the virus, cellular DNA, vectors, in tiny particles, virus-like particles and viral protein fragments and other animal tests.
337	en	ln	 The development of a safe and effective vaccine against SARS-CoV-2 for non-immune individuals is an urgent and critical task for controlling the ongoing epidemic. 	 Kosala mangwele ebongi mpe ya makasi mpo na kobundisa SARS-CoV-2 mpo na bato oyo baza na mangwele na yango te eza ntina mingi mpe mosala makasi mpo maladi mabe oyo ekende mosika te. 	Developing an appropriate and robust vaccine against SARS-CoV-2 for people who do not have a vaccine is critical and challenging to prevent the spread of the disease.
338	en	ln	 However, it is challenging to overcome the difficulty because of the long period of time (averaged 18 months) needed for vaccine development and the dynamic variations of CoVs. 	 Kasi, eza mpasi na kolonga mikakatano mpo esengaka ntango mingi (pene ya basanza 18 ) mpo na kosala mangwele mpe mpo lolenge mingi ya CoVs. 	However, it is difficult to overcome the challenges because it takes a long time (about 18 months) to develop a vaccine and because of the many types of CoVs.
339	en	ln	 As a novel disease, COVID-19 has just started to manifest its full clinical course throughout thousands of patients. 	 Mpo eza maladi ya sika, COVID-19 ebandi kaka komonisa bokasi na yango na bato mwa mingi. 	Because it is a new disease, COVID-19 is just starting to show its effects in a few more people.
340	en	ln	 In most cases, patients can recover gradually without sequelae. 	 Na bandakisa mingi, bato oyo babeli yango bakoki kobika malembemalembe kozanga kotikala na bilembo na yango. 	In many instances, patients can slowly recover without remaining symptomatic.
341	en	ln	 However, similar to SARS and MERS, COVID-19 is also associated with high morbidity and mortality in patients with severe cases. 	 Kasi, ndenge ezalaki mpo na SARS mpe MERS, COVID-19 ezobangisa bato oyo bazobela yango mpe ezoboma bato oyo bazobela yango makasi. 	However, as was the case with SARS and MERS, COVID-19 terrifies infected people and kills severely infected people.
342	en	ln	 Therefore, building a prognosis model for the disease is essential for health-care agencies to prioritize their services, especially in resource-constrained areas. 	 Yango wana, kosala modele mpo na koyeba maladi oyo eza ntina mingi mpo na minganga mpo batya na esika ya liboso mosala na bango, mingimingi na bisika oyo makoki eza mingi te. 	Therefore, modeling for the diagnosis of this disease is essential for physicians to prioritize their work, especially in resource-limited settings.
343	en	ln	 Based on clinical studies reported thus far, the following factors may affect or be associated with the prognosis of COVID-19 patients (Table ​(Table33): 	 Na kotalela bolukiluki oyo basi basali na nzoto ya bato, makambo oyo ekoki kozala na bopusi to na boyokani na ndenge ya koyebela bato oyo baza na COVID-19 (Tablo ​(Tablo33): 	Based on research conducted by women in the human body, the following factors may influence or be associated with the diagnosis of people with COVID-19 (Table 33):
344	en	ln	 Age: Age was the most important factor for the prognosis of SARS, which is also true for COVID-19. 	 Mbula: Mbula eza likambo ya ntina mingi mpo na koyeba pronostique ya SARS, oyo eza mpe solo mpo na COVID-19. 	Rainfall: Rainfall is a very important factor in determining the prognosis of SARS, which is also true for COVID-1
345	en	ln	 COVID-19 mainly happened at the age of 30-65 with 47.7% of those patients being over 50 in a study of 8,866 cases as described above. 	 COVID-19 ebimaki mingimingi na bato ya mibu 30-65 mpo 47,7% ya bato oyo babelaka bazalaki na mibu koleka 50 na bolukiluki oyo basalaki na bato 8 866 ndenge balimboli yango likolo. 	COVID-19 occurred mainly in people aged 30-65 because 47.7% of patients were over 50 years of age in the study of 8,866 people as described above.
346	en	ln	 Patients who required intensive care were more likely to have underlying comorbidities and complications and were significantly older than those who did not (at the median age of 66 versus 51), suggesting age as a prognostic factor for the outcome of COVID-19 patients. 	 Bato ya maladi oyo baza na mposa ya soins intensifs bamonisaki bilembo mosusu ya mabe mpe mpasi mpe bazalaki mikolo mingi koleka baoyo bamonisaki yango te (soki tokokanisi mibu 66 mpe 51), emonisi ete mbula eza moko ya makambo oyo ekosalisa koyeba soki moto oyo azobela COVID-19 akobika to te. 	Patients in need of intensive care showed more adverse symptoms and pain and were older than those who did not (compared 66 and 51 years), suggesting that age is one of the factors that will help determine whether a person is infected with COVID-1 -19 will survive or not.
347	en	ln	 Sex: SARS-CoV-2 has infected more men than women (0.31/100,000 versus 0.27/100,000), as described above. 	 Sexe: SARS-CoV-2 ezozwa mibali mingi koleka basi (0,31/100 000 kontre 0,27/100 000), ndenge balimboli likolo. 	Gender: SARS-CoV-2 affects males more frequently than females (0.31/100 000 versus 0.27/100 000), as described above.
348	en	ln	 Comorbidities and complications: Patients with COVID-19 who require intensive care are more likely to suffer from acute cardiac injury and arrhythmia. 	 Bilembo mosusu mpe bampasi: Bato oyo bazobela COVID-19 oyo baza na mposa ya soins intensifs bakonyokwama mingi na mpasi ya mpema mpe motema ekobeta malamu te. 	Other symptoms and symptoms: People with COVID-19 who need intensive care will often suffer from shortness of breath and irregular heartbeat.
349	en	ln	 Cardiac events were also the main reason for death in SARS patients. 	 Maladi ya motema ezalaki mpe ntina makasi ya liwa na bato oyo babelaki SARS. 	Heart disease was also the leading cause of death in SARS patients.
350	en	ln	 It has been reported that SARS-CoV-2 can also bind to ACE2-positive cholangiocytes, which might lead to liver dysfunctions in COVID-19 patients. 	 Balobi ete SARS-CoV-2 ekoki kozala ndenge moko na ACE2 cholangiocytes, oyo ekoki kosala ete foie esala malamu te na bato oyo bazobela COVID-19. 	They say that SARS-CoV-2 may be similar to ACE2 cholangiocytes, which can cause liver dysfunction in COVID-19 patients.
351	en	ln	 It is worth noting that age and underlying disease are strongly correlated and might interfere with each other. 	 Ebongi koyeba ete mbula mpe maladi ya kala eza na boyokani makasi mpe ekoki kosangana. 	It’s worth noting that age and pre-existing conditions are strongly associated and can interact.
352	en	ln	 Abnormal laboratory findings: The C-reactive protein (CRP) level in blood reflects the severity of inflammation or tissue injury and has been proposed to be a potential prognostic factor for disease, response to therapy, and ultimate recovery. 	 Mbeba oyo emonani na laboratoire: Nivo ya proteine C (CRP) na makila emonisaka bonene ya mpasi to mpasi eza na misisa mpe balobi ete eza moko ya makambo ezomema maladi oyo, oyo ezosalisa mpo na kozwa nkisi, mpe nsukansuka mpo na kobika. 	Laboratory findings: Blood levels of protein C (CRP) reflect the severity of pain or pain in the muscles and have been suggested to be one of the risk factors for the disease, which contribute to treatment, and ultimately recovery.
353	en	ln	 The correlation of CRP level to the severity and prognosis of COVID-19 has also been proposed. 	 Boyokani ya nivo ya bokasi ya CRP mpe pronostique ya COVID-19 elobelamaki mpe. 	The association of CRP severity level and COVID-19 prognosis was also discussed.
354	en	ln	 In addition, elevated lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) may also help predict the outcome. 	 Lisusu, lactate dehydrogenase ya likolo (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), mpe creatine kinase (CK) ekoki kosalisa na koyeba soki moto akobika to te. 	In addition, elevated lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) may help predict survival.
355	en	ln	 These enzymes are expressed extensively in multiple organs, especially in the heart and liver, and are released during tissue damage. 	 Ba-enzyme wana ebimaki mingi na binama mingi, mingimingi na motema mpe na foie, mpe ebimaka ntango tissue ebebaka. 	These enzymes were overexpressed in many organs, especially the heart and liver, and are released during tissue damage.
356	en	ln	 Thus, they are traditional markers for heart or liver dysfunctions. 	 Yango wana, mbala mingi yango nde esalaka ete motema to foie esala malamu te. 	As a result, it is often the cause of heart or liver failure.
357	en	ln	 Major clinical symptoms: Chest radiography and temporal progression of clinical symptoms should be considered together with the other issues for the prediction of outcomes and complications of COVID-19. 	 Bilembo minene ya maladi: Radiographie ya ntolo mpe bokoli ya moke ya bilembo ya maladi esengeli kotalelama elongo na makambo mosusu mpo na koyeba soki moto akobika na COVID-19 mpe soki ekotungisa ye mingi. 	Major Signs and Symptoms: A chest x-ray and mild development of symptoms should be considered in conjunction with other factors to determine survival and distress.
358	en	ln	 Use of steroids: As described above, steroids are immunosuppressant commonly used as an adjunctive therapy for infectious diseases to reduce the severity of inflammatory damage. 	 Kosalela basteroide: Ndenge tolimboli yango na likolo, basteroide eza ba immunosuppresseur oyo tosalelaka mbala mingi lokola nkisi mpo na maladi euti na virisi mpo na kolembisa bokasi ya mpasi. 	Use of steroids: As described above, steroids are immunosuppressants that we often use as a treatment for viral infections to weaken the severity of the pain.
359	en	ln	 Since a high dosage of corticosteroids was widely used in severe SARS patients, many survivors suffered from avascular osteonecrosis with life-long disability and poor life quality. 	 Mpo basalelaki bacorticosteroide mingi na bato oyo babelaki SARS ya makasi, bato mingi oyo babikaki babelaki maladi ya kozanga baselile ya makila mpe bazalaki na bambeba na nzoto bomoi mobimba mpe bomoi ya malamu te. 	Because of the extensive use of corticosteroids in severe SARS cases, many survivors developed anemia and lifelong disabilities and poor quality of life.
360	en	ln	 Thus, if needed, steroids should be used at low dosage and for a short time in COVID-19 patients. 	 Yango wana, soki esengeli, basengeli kosalela doze moke ya basteroide mpe mpo na ntango mokuse na bato oyo bazobela COVID-19. 	Therefore, if necessary, low doses of steroids and for short periods of time should be used in patients with COVID-19.
361	en	ln	 Mental stress: As described above, during the COVID-19 outbreak many patients have suffered from extraordinary stress as they often endured long periods of quarantine and extreme uncertainty and witnessed the death of close family members and fellow patients. 	 Kotungisama na makanisi: Ndenge tolimboli likolo, ntango COVID-19 ebimaki, bato mingi babelaki maladi ya komitungisa na makanisi mpo balekisaki mikolo mingi na quarantaine mpe bazalaki motema likololikolo mpe bamonaki liwa ya bato ya libota na bango mpe ya bato mosusu oyo bazalaki kobela. 	Depression: As mentioned above, when COVID-19 broke out, many people suffered from depression because they spent many days in quarantine and were depressed and saw the deaths of their family members and other patients.
362	en	ln	 It is imperative to provide psychological counseling and long-term support to help these patients recover from the stress and return to normal life. 	 Eza ntina mingi na kopesa batoli ya minganga mpe lisalisi ya ntango molai mpo na kosunga bato oyo ya maladi mpo babika na mitungisi wana mpe bazongela bomoi na bango ndenge bamesana. 	It’s very important in providing medical advice and long-term treatment to help these patients recover from these concerns and resume their normal lives.
363	en	ln	 According to demographic studies so far, COVID-19 seems to have different epidemiological features from SARS. 	 Na kotalela bolukiluki oyo basi basali, ezomonana ete COVID-19 eza na makambo mosusu oyo ekeseni na SARS. 	Based on the research done by women, it appears that COVID-19 has some differences from SARS.
364	en	ln	 In addition to replicating in the lower respiratory tract, SARS-CoV-2 can efficiently replicate in the upper respiratory tract and causes mild or no symptoms in the early phase of infection, similar to other CoVs that cause common colds. 	 Longola ndenge ezokoma mingi na nzela ya kopema ya nse, SARS-CoV-2 ekoki kobotama na nzela ya kopema ya likolo mpe kobimisa bilembo ya pete to nkutu elembo moko te ntango maladi ebandi sika, ndenge moko na ba CoVs mosusu oyo epesaka malili. 	In addition to spreading frequently through the lower respiratory tract, SARS-CoV-2 can be reproduced in the upper respiratory tract and cause mild symptoms or even no symptoms at new onset of illness, similar to other cold-causing CoVs.
365	en	ln	 Therefore, infected patients at the early phase or incubation period can produce a large amount of virus during daily activities, causing great difficulty for the control of the epidemic. 	 Yango wana, bato oyo baza na yango na ebandeli to na eleko oyo esalaka liboso ya kobima bakoki kobimisa bavirisi mingi na mosala ya mokolo na mokolo, ebongo esala ete ezala mpasi na kobundisa maladi mabe oyo. 	Therefore, people with it in the early stages or in the pre-emergence period may excrete more viruses in daily activities, thus making it difficult to fight this deadly disease.
366	en	ln	 However, the transmission of SARS-CoV was considered to occur when the patients are severely ill, while most transmission did not happen at the early phase. 	 Kasi, emonani ete SARS-CoV ezopesama ntango moto azobela mpenza makasi, kasi kopesama mingi esalemaki te na ebandeli. 	However, it appears that SARS-CoV is transmitted when a person is really severely ill, but mass transmission did not occur initially.
367	en	ln	 Thus, the current outbreak of COVID-19 is much more severe and difficult to control than the outbreak of SARS. 	 Yango wana, kobima ya sikoyo ya COVID-19 eza makasi mingi mpe mpasi mingi na kobundisa koleka oyo ya SARS. 	Therefore, the current outbreak of COVID-19 is much stronger and more difficult to fight than that of SARS.
368	en	ln	 Great efforts are currently underway in China including the lockdown of Wuhan and surrounding cities and continuous quarantine of almost the entire population in hopes of interrupting the transmission of SARS-CoV-2. 	 Milende makasi ezosalema na Chine ndakisa kopekisa bato batambola na Wuhan mpe na bingumba ya zingazinga mpe kokoba kotya mboka mobimba na quarantaine na elikya ya kokanga SARS-CoV-2 nzela mpo ezwa te bato mosusu. 	Strong efforts will be made in China for example restricting travel to Wuhan and surrounding cities and continuing to place the entire country under quarantine in hopes of stopping SARS-CoV-2 from infecting others.
369	en	ln	 Although these actions have been dramatically damaging the economy and other sectors of the country, the number of new patients is declining, indicating the slowdown of the epidemic. 	 Ata milende wana ya makasi ebebisi mpenza makambo ya mbongo mpe makambo mosusu ya mboka, motango ya bato ya maladi ya sika ezokita, ezomonisa ete maladi mabe ezolemba. 	Although these aggressive efforts have severely damaged the country&#39;s economy and other affairs, the number of new cases has been declining, indicating that the disease is weakening.
370	en	ln	 The most optimistic estimate is that the outbreak will end by March and the downswing phase will last for 3-4 months. 	 Estimation ya malamu mpenza eza ete kobima wana ekosuka na sanza ya misato mpe eleko ya kolembisa yango ekozwa basanza 3-4. 	The best estimate is that that release will end in March and the weakening period will take 3-4 months.
371	en	ln	 However, some other experts are not that optimistic. 	 Atako bongo, bato mosusu ya mayele bandimi likambo wana te. 	Still, some scholars disagree.
372	en	ln	 Paul Hunter, et al., estimated that COVID-19, which seems substantially more infectious than SARS, will not end in 2020. 	 Paul Hunter, mpe baninga na ye, bakanisi ete COVID-19, oyo bamoni ete ezozwa bato mingi koleka SARS, ekosuka te na 2020. 	Paul Hunter, and his colleagues, believe that COVID-19, which has been found to be more contagious than SARS, will not end in
373	en	ln	 Ira Longini, et al., established a model to predict the outcome of the epidemic and suggested that SARS-CoV-2 could infect two-thirds of the global population. 	 Ira Longini, na baninga na ye, basalaki modele moko mpo na koyeba resultat ya maladi mabe mpe balobi ete SARS-CoV-2 ekoki kozwa bato mibale na kati ya bato misato na mokili mobimba. 	Ira Longini, and colleagues, developed a model to predict the outcome of malignancy and estimate that SARS-CoV-2 can infect two out of three people worldwide.
374	en	ln	 A Canadian group reported that SARS-CoV-2 was detected in both mid-turbinate and throat swabs of patients who recovered and left the hospital 2 weeks earlier, which indicates that the newly identified virus could become a cyclical episode similar to influenza. 	 Etuluku moko ya Canada elobi ete SARS-CoV-2 bamonaki ndambo ya turbinate mpe nsoyi ya mongongo ya bato ya maladi oyo babikaki mpe babimaki na lopitalo mposo 2 liboso; yango emonisi ete virisi oyo ya sika ekoki kokoma maladi oyo ebimaka mbala na mbala neti grippe. 	A Canadian group reports that SARS-CoV-2 was detected in part of the turbinates and vocal cords of surviving patients who had been discharged 2 weeks earlier; this suggests that this new virus could become a recurrent flu-like illness.
375	en	ln	 However, promising signs have occurred in China based on the declining number of new cases, indicating the current strategies might have been working. 	 Kasi, bilembo ya malamu emonanaki na Chine ndenge motango ya bato ya maladi ya sika ezokita, yango emonisi ete mayele ya sikoyo ezobota mbuma. 	However, there have been positive signs in China as the number of new cases decreases, indicating that current strategies are paying off.
376	en	ln	 Ebola was originally predicted to cause up to a million cases with half a million deaths. 	 Na ebandeli balobaki ete Ebola ekoboma bato pene ya milio moko mpe katikati ya milio bakokufa. 	Ebola was initially estimated to kill about one million people and half a million deaths.
377	en	ln	 However, via strict quarantine and isolation, the disease has eventually been put under control. 	 Kasi, na nzela ya mibeko ya makasi ya quarantaine mpe kotya bato na isolement, nsukansuka balonga maladi wana. 	However, through strict quarantine and isolation measures, the disease was eventually overcome.
378	en	ln	 It is possible, similar to SARS-CoV, that SARS-CoV-2 might become weaker in infectivity and eventually die down or become a less pathogenic virus co-existent with humans. 	 Ekoki kosalema mpe, ndenge esalemaki na SARS-CoV, ete makasi ya SARS-CoV-2 ekoki kolemba mpe nsukansuka kosila to kokoma virisi ya makasi te mpo na bato. 	It is also possible, as happened with SARS-CoV, that the strength of SARS-CoV-2 may weaken and eventually disappear or become a weak virus for humans.
379	en	ln	 A comparison of the epidemic of COVID-19 with that of SARS and MERS is provided below (Fig. ​(Fig.55). 	 Bokokanisi na kati ya maladi ya COVID-19 na oyo ya SARS mpe MERS ezali na nse (Mot. ​(Mot.55). 	Comparisons between COVID-19 and SARS and MERS are low (Mot. (Mot.55).
380	en	ln	 SARS-CoV-2 is highly transmittable through coughing or sneezing, and possibly also through direct contact with materials contaminated by the virus. 	 SARS-CoV-2 ezopesama makasi na nzela ya kosukosu to etye, mpe mbala mosusu na nzela ya biloko oyo esi ezwi virisi. 	SARS-CoV-2 is strongly transmitted through coughing or sneezing, and possibly through objects that have already been infected with the virus.
381	en	ln	 The virus was also found in feces, which raises a new possibility of feces-to-mouth transmission. 	 Bamonaki mpe virisi na nyei, yango emonisi ete likoki ezali ete eutaki na nyei mpe ekotaki na monoko. 	The virus was also found in saliva, suggesting that it may have originated in saliva and entered the mouth.
382	en	ln	 A recent study on 138 cases reported that 41% of the cases were possibly caused by nosocomial infections, including 17 patients with other prior diseases and 40 health-care providers. 	 Bolukiluki basala kala te na bato 138 emonisi ete 41% ya bato ya maladi bazwaki yango te na maladi euti na lopitalo, na ndakisa bato 17 ya maladi oyo bazalaki na maladi mosusu mpe minganga to ba infirmier 40. 	A recent study of 138 people found that 41% of patients were not infected with hospital-acquired infections, including 17 patients with other conditions and 40 doctors or nurses.
383	en	ln	 Thus, great precaution should be used to protect humans, especially health-care providers, social workers, family members, colleagues, and even bystanders in contact with patients or infected people. 	 Yango wana, tosengeli kosalela mayele ya makasi mpo na kobatela bato, mingimingi minganga, bato oyo basalisaka bato, bato ya libota, baninga, mpe nkutu bato ya pembeni oyo bakutanaki na bato oyo baza na maladi wana. 	Therefore, we need to implement aggressive safety measures, especially physicians, therapists, family members, friends, and even neighbors who have been in contact with these patients.
384	en	ln	 The first line of defense that could be used to lower the risk of infection is through wearing face masks; both the use of surgical masks and N95 respirator masks (series # 1860s) helps control the spread of viruses. 	 Eloko ya liboso ya kobundisa oyo ekoki kosalisa na kokitsa likama ya kozwa maladi eza kolata eloko ya kozipa zolo mpe monoko; kosalela masque ya minganga mpe masque ya kopemela N95 (nimero# 1860s) ezosalisa mpo na kokanga virisi nzela epanzana te. 	The first line of defense that can help reduce the risk of infection is to wear a mask; using a medical mask and N95 respirator (number# 1860s) helps to stop the virus from spreading.
385	en	ln	 Surgical face masks prevent liquid droplets from a potentially infected individual from traveling through the air or sticking onto surfaces of materials, where they could be passed on to others. 	 Masque ya minganga ekangaka nzela mpo mai oyo euti na moto oyo aza na maladi wana elongwa te na nzoto na ye mpo ekende na mopepe to ekangama na biloko, esika ekoki kopesama na bato mosusu. 	Medical masks block the way for fluids from an infected person to leave their body to become airborne or trapped in objects, where they can be passed on to others.
386	en	ln	 However, only N95 (series # 1860s) masks can protect against the inhalation of virions as small as 10 to 80 nm, with only 5% of the virions being able to penetrate completely; SARS-CoV-2 is similar to SARS-CoV in size and both are approximately 85 nm. 	 Kasi, kaka ba masque N95 (nimero # 1860s) nde ekoki kobatela na virisi ata ya moke ya 10 kino 80 nm, mpe 5% mpamba ya virisi ekoki kokota mobimba; SARS-CoV-2 eza ndenge moko na SARS-CoV na monene mpe nyonso mibale eza pene ya 85 nm. 	However, only N95 masks (issue # 1860s) can protect against viruses even smaller than 10 to 80 nm, and only 5% of viruses can penetrate completely; SARS-CoV-2 is similar in size to SARS-CoV and both are about 85 nm.
387	en	ln	 Since particles can penetrate even five surgical masks stacked together, health-care providers in direct contact with patients must wear N95 (series # 1860s) masks but not surgical masks. 	 Mpo biteni na yango ekoki kokota soki tosangisa ba masque ya minganga mitano elongo, minganga oyo bazokutana na bato ya maladi basengeli kolata ba masque N95 (nimero# 1860s) kasi ba masque ya minganga te. 	Because parts of it can fit if we combine five medical masks together, doctors contacting patients should wear N95 masks (number# 1860s) and not medical masks.
388	en	ln	 In addition to masks, health-care providers should wear fitted isolation gowns in order to further reduce contact with viruses. 	 Longola ba masque, minganga basengeli kolata bagan ya malamu mpo bazala te na mabaku mingi ya kosimba bavirisi. 	In addition to masks, doctors should wear proper gloves to reduce the chances of touching viruses.
389	en	ln	 Viruses can also infect an individual through the eyes. 	 Bavirisi ekoki kokotela mpe moto na miso. 	Viruses can also get into the eyes.
390	en	ln	 On January 22, 2020, a doctor was infected with SARS-CoV-2 although he wore an N95 mask; the virus might have entered his body through his inflammatory eyes. 	 Na mokolo ya 22 sanza ya yambo 2020, monganga moko azwaki maladi ya SARS-CoV-2 ata soki alataki masque N95; mbala mosusu virisi ekotaki na nzoto na ye na nzela miso na ye oyo ezalaki kosala mpasi. 	On January 22, 2020, a doctor contracted SARS-CoV-2 despite wearing an N95 mask; perhaps the virus entered his body through his aching eyes.
391	en	ln	 Thus, health-care providers should also wear transparent face shields or goggles while working with patients. 	 Yango wana, minganga basengeli kolata biloko mosusu ya mpembe ya kozipa miso to maneti ntango bazosalisa bato ya maladi. 	Therefore, doctors should wear some white goggles or sunglasses when treating patients.
392	en	ln	 For the general public in affected or potentially affected areas, it is highly suggested that everybody wash their hands with disinfectant soaps more often than usual, try to stay indoors for self-quarantine and limit contact with potentially infected individuals. 	 Mpo na bato nyonso oyo baza na bisika oyo eza na virisi to ekoki kozala na yango, eza ntina mingi ete bango nyonso basokola maboko na savon oyo ebomaka mikrobe mbala mingi koleka ndenge basalaka, batikala na ndako na komitya na quarantaine na ndenge na bango moko mpe na kokutana na bato oyo mbala mosusu baza na maladi wana. 	For all people in areas where the virus is or may be, it is very important that they all wash their hands with antiseptic soap more often than usual, stay at home and quarantine themselves in their own way as well in contact with people who may have the disease.
393	en	ln	 Three feet is considered an appropriate distance for people to stay away from a patient. 	 Bametre mibale eza distance elongobani oyo bato basengeli kozala mosika na moto ya maladi. 	Two meters is the appropriate distance that people should keep away from a sick person.
394	en	ln	 These actions are effective methods to lower the risk of infection as well as prevent the spread of the virus. 	 Kosala makambo oyo eza lolenge ya malamu ya kokitisa likama ya kozwa maladi mpe kokanga virisi nzela mpo epanzana te. 	Doing these things is the best way to reduce the risk of getting sick and prevent the virus from spreading.
395	en	ln	 Although SARS-CoV-2 came as a new virus to the human world, its high homology to SARS-CoV as reported on 7 January 2020 should have caused high alert to China based on her deep memory of the SARS outbreak in 2003. 	 Ata soki SARS-CoV-2 ebimaki neti virisi ya sika na mokili ya bato, ekokani mingi na SARS-CoV ndenge balobaki yango na mokolo ya 7 sanza ya yambo 2020, esengelaki ekebisa bato mingi na Chine mpo bayebi malamu ndenge SARS ebimaki na 2003. 	Even if SARS-CoV-2 emerged as a new virus in the human world, very similar to SARS-CoV as reported on January 7, 2020, it should have warned many people in China because they are well aware of the 2003 outbreak of SARS.
396	en	ln	 However, not until 19 January 2020 did the director of the Center of Disease Control of Wuhan comfort the citizens by saying that the novel virus has low contagiousness and limited reproductivity from human to human and that it is not a problem to prevent and contain the disease. 	 Kasi, kino na mokolo ya 19 sanza ya yambo 2020 diretere ya centre ya kobundisa maladi ya Wuhan akitisaki bato motema ndenge alobaki ete virisi oyo ya sika ezopesama mpenza te na bato mpe ezobotama mingi te na bato mpe ete eza mpasi na kokanga yango mpe kosukisa yango. 	However, as of January 19, 2020, the director of the Wuhan Disease Control Center reassured the public that the new virus is rarely transmitted and reproduced in humans and that it is difficult to contain and eradicate . . . .
397	en	ln	 This message remarkably relaxed the alarm of the public, especially when the entire country was preparing for the Spring Festival, and the critical time was missed to contain the disease at its minimal scale in Wuhan. 	 Nsango wana etindaki bato bakipe na bango te, mingimingi ntango mboka mobimba ezalaki kobongisa fete ya printemps, mpe babungisaki ntango wana ya ntina mingi mpo na kokanga maladi wana nzela na Wuhan mpo epanzana te. 	The news caused a stir, especially when the whole country was preparing for the spring festival, and they missed that crucial time to stop the spread of the disease in Wuhan.
398	en	ln	 The disease control agencies in China may take this hard lesson and make critical improvements in the future. 	 Lisanga ya kobundisa maladi na Chine ekoki kozwa liteya wana ya mabe mpe kosala mbongwana ebongi na mikolo ezoya. 	The disease control community in China can learn this bad lesson and make appropriate changes in the future.
399	en	ln	 For example, these agencies should be (1) more careful when making public announcements as every word counts to citizens and can change their attitude and decisions; (2) more sensitive and reactive to unusual information from clinics rather than waiting for formal reports from doctors or officials; (3) more restrictive to contain a potential epidemic at its early stage rather than attempting to comfort the public; and (4) more often to issue targeted and effective drills to increase the public's awareness about epidemic diseases and to test and improve the response system of the society periodically. 	 Na ndakisa, masanga oyo esengeli (1) kotya likebi mingi ntango bazoloba liboso ya bato mpo bato ya mboka bandimelaka bango mpe ekoki kobongola bizaleli mpe bikateli na bango; (2) kokeba mpe kokanga maboko te na bansango ezouta na balopitalo na esika ya kozela barapore ezouta na minganga to bakonzi; (3) kozwa bikateli ya makasi mpo na kobundisa maladi mabe na ebandeli na yango na esika ya koluka kokotisa bato motema; mpe (4) kobimisa mayele ya ntina mpe ya malamu mpo na kosalisa bato bayeba malamu makambo etali maladi mabe mpe baekzame mpe kobongisa makambo ya kosala soki mpasi ya ndenge wana ebimi. 	For example, these communities need to (1) pay more attention when speaking in public because they are trusted by the community and can influence their attitudes and decisions; (2) be cautious and not interfere with information from hospitals rather than waiting for reports from doctors or authorities; (3) taking aggressive measures to combat epidemics at an early stage rather than trying to convince people; and (4) develop practical and effective strategies to improve awareness of malignancies and tests and improve responses to such crises.
400	en	ln	 The outbreak of COVID-19 caused by the novel virus SARS-CoV-2 started in the end of December 2019. 	 Kobima ya COVID-19 oyo na virisi SARS-CoV-2 ya sika ebandaki na nsuka ya sanza ya zomi na mibale 2019. 	The emergence of this COVID-19 with the new SARS-CoV-2 virus began in late December
401	en	ln	 In less than two months, it has spread all over China and near 50 other countries globally at the time of this writing. 	 Na eleko oyo na nse ya basanza mibale, epanzanaki na Chine mobimba mpe na pene ya mikili 50 mosusu na mokili mobimba ntango tozokoma makambo oyo. 	In this period of less than two months, it has spread across China and around 50 other countries around the world as of this writing.
402	en	ln	 Since the virus is very similar to SARS-CoV and the symptoms are also similar between COVID-19 and SARS, the outbreak of COVID-19 has created a sense of SARS recurring. 	 Mpo virisi yango ekokani mingi na SARS-CoV mpe billembo na yango eza na bokokani na kati ya COVID-19 mpe SARS, kobima ya COVID-19 esali neti eza nde SARS ezongi lisusu. 	Because the virus is very similar to SARS-CoV and its symptoms are similar to those of COVID-19 and SARS, the emergence of COVID-19 has made it seem like it is a resurgence of SARS.
403	en	ln	 However, there are some remarkable differences between COVID-19 and SARS, which are essential for containing the epidemic and treating the patients. 	 Kasi, eza mpe na bokeseni ya monene na kati ya COVID-19 mpe SARS, oyo eza ntina mpo na kokanga maladi oyo nzela mpe kobikisa bato oyo bazobela yango. 	However, there are also significant differences between COVID-19 and SARS, which are important for containing the disease and saving people who are infected.
404	en	ln	 COVID-19 affects more elderly individuals than youth and more men than women, and the severity and death rate are also higher in elderly individual than in youth. 	 COVID-19 ezozwa mingi mibange koleka bilenge mpe mibali koleka basi, mpe eza mpasi mingi mpe ezoboma mingi mibange koleka bilenge. 	COVID-19 affects more elderly people than young people and men than women, and it is more painful and more deadly for the elderly than young people.
405	en	ln	 SARS has higher mortality than COVID-19 (10.91% versus 1.44%). 	 SARS ezoboma bato mingi koleka COVID-19 (10,91% kontre 1,44%). 	SARS kills more people than COVID-19 (10.91% versus 1.44%).
406	en	ln	 COVID-19 patients transmit the virus even when they are symptomless whereas SARS patients do so usually when they are severely ill, which causes much greater difficulty to contain the spread of COVID-19 than SARS. 	 Bato oyo bazobela COVID-19 bapesaki virisi nkutu ata ntango bazalaki na bilembo ya maladi te kasi bato oyo babelaki SARS bapesaka basusu virisi kaka soki bazobela makasi, yango wana eza mpasi mingi na kokanga COVID-19 nzela mpo epanzana te koleka SARS. 	People with COVID-19 gave the virus even when they had no symptoms but people with SARS only give the virus to others when they are very sick, so it is more difficult to stop COVID-19 from spreading than SARS.
407	en	ln	 This partially explains why SARS-CoV-2 spread much faster and broader than SARS-CoV. 	 Yango ezolimbola mwa moke mpo na nini SARS-CoV-2 ezopanzana mingi mpe bisika mingi koleka SARS-CoV. 	This explains somewhat why SARS-CoV-2 is more widespread and more widespread than SARS-CoV.
408	en	ln	 The regular RNA assay for SARS-CoV-2 can be negative in some COVID-19 patients. 	 Soki tosali ekzame ya normal ya RNA ya SARS-CoV-2, mbala mosusu ekozala te na bato mosusu oyo bazobela COVID-19. 	If we do a normal SARS-CoV-2 RNA test, it probably won’t be found in some people who are sick with COVID-1
409	en	ln	 On the other hand, cured patients can be positive for the virus again. 	 Kasi, bato oyo babiki bakoki lisusu kozwa virisi wana. 	However, survivors can re-infect the virus.
410	en	ln	 These findings dramatically increase the risk of virus spreading. 	 Makambo oyo ezomatisa mpenza likama ya kopanza virisi bisika mingi. 	These factors greatly increase the risk of spreading the virus in many areas.
411	en	ln	 Given such rapid progress in research on COVID-19, several critical issues remain to be solved, as follows: 	 Mpo bolukiluki ya COVID-19 ezokende liboso noki mpenza, eza na makambo mingi ya ntina oyo esengeli kobongisa, na ndakisa: 	Because COVID-19 research is advancing so rapidly, there are several key areas that need to be addressed, for example:
412	en	ln	 Where did SARS-CoV-2 come from? 	 SARS-CoV-2 eutaki na wapi? 	Where did SARS-CoV-2 come from?
413	en	ln	 Although 96% genetic homolog was found between SARS-CoV-2 and two bat SARS-like CoVs, we still cannot conclude that SARS-CoV-2 is from bats. 	 Ata soki makambo ya ndenge moko 96% emonani na kati ya SARS-CoV-2 mpe bavirisi mibale SARS CoVs oyo euti na ngembo, tokoki nanu te koloba ete SARS-CoV-2 eutaki na bangembo. 	Even though 96% identity is found between SARS-CoV-2 and the two mosquito-derived SARS CoVs, we cannot yet conclude that SARS-CoV-2 originated in mosquitoes.
414	en	ln	 What animal was the intermediate species to transmit the virus from the original host, say bats, to humans? 	 Virisi elekaki na banyama nini ntango elongwaki na esika efandaka, toloba eza bangembo, kino na bato? 	What animals did the virus pass through when it moved from its habitat, let’s say it’s bats, to humans?
415	en	ln	 Without knowing answers to #1 and 2, we cannot efficiently cut the transmission, and the outbreak can relapse at any time. 	 Kozanga koyeba biyano na motuna ya #1 mpe 2, tokoki te kosukisa yango mpo epanzana te, mpe ekoki kobima lisusu na ntango nyonso. 	Without knowing the answers to questions #1 and 2, we can’t suspend them from expanding, and they could resurface at any time.
416	en	ln	 Although molecular modeling and biochemical assays have demonstrated that SARS-CoV-2 binds to ACE2, how exactly does the virus enter the airway cells and cause subsequent pathological changes? 	 Atako kobongisa bamolekile mpe baekzame ya biochimie emonisaki ete SARS-CoV-2 eza na boyokani na ACE2, toyebi te na bosolo ndenge virisi ekotaka na baselile ya likolo ya kopema mpe esalaka ete mbongwana esalema? 	Although molecular preparation and biochemical tests have shown that SARS-CoV-2 is related to ACE2, do we not know for sure how the virus enters the surface respiratory cells and causes the transformation?
417	en	ln	 Does the virus also bind ACE2-expressing cells in other organs? 	 Virisi eza mpe na boyokani na ACE2- na baselile ya binama mosusu? 	Is the virus also related to ACE2- in cells of other organs?
418	en	ln	 Without clear answers to these questions, we cannot achieve fast and accurate diagnosis and effective treatment. 	 Kozanga koyeba biyano ya polele na mituna wana, tokoki te koyeba nkisi ya makasi mpe ebongi mpo na yango. 	Without clear answers to these questions, we cannot determine the strongest and most appropriate cure.
419	en	ln	 How long will the epidemic last? 	 Maladi oyo ekosala mbula boni? 	How long will this disease last?
420	en	ln	 How is the virus genetically evolving during transmission among humans? 	 Ndenge nini virisi ekolaka na makila na nzoto ya bato? 	How does the virus grow in the bloodstream in humans?
421	en	ln	 Will it become a pandemic worldwide, die down like SARS or relapse periodically like the flu? 	 Ekokoma maladi mabe na mokili mobimba, ekosuka libela neti SARS to ekobimaka mbala na mbala neti grippe? 	Will it become a global pandemic, end up permanently like SARS or will it come out frequently like the flu?
422	en	ln	 It is essential but may take some time to search for answers to the above and many other questions. 	 Eza ntina mingi kasi ekoki kozwa ntango mingi mpo na kozwa biyano na mituna oyo eza likolo mpe na mituna mingi mosusu. 	It is very important but it can take a long time to get answers to the above questions and many others.
423	en	ln	 However, with whatever expense it may demand, we have no other choice but to stop the epidemic as soon as possible and bring our life back to normal. 	 Kasi, ata soki ekosenga tobungisa nini, eloko tosengeli kosala eza kaka kokanga maladi mabe nzela noki mpe bomoi na biso ezonga ndenge ezalaki. 	But, no matter what it costs us to lose, all we have to do is stop the disease quickly and get our lives back to normal.
424	en	ln	 Zoonotic origins of human coronaviruses 	Coronavirisi ya bato eutaki na banyama	Human coronaviruses came from animals
425	en	ln	 Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. 	Ndenge ebongwanaka mpe emesanaka esala ete bacoronavirisi (CoVs) ekola mpe biloko oyo ebombaka yango, ata mpe bato, banda mibu mingi.	How it changes and adapts has contributed to the development of coronaviruses (CoVs) and their hosts, including humans, for many years.
426	en	ln	 Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. 	Liboso ya 2003, eyebanaki ete mibale ya ba CoVs (HCoVs) ya bato epesaka maladi ya makasi te, na ndakisa malili.	Before 2003, it was known that two human CoVs (HCoVs) cause mild illnesses, such as colds.
427	en	ln	 The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. 	Kobima ya maladi makasi ya mpema (SARS) mpe maladi ya mpema ya moyen orient (MERS) emonisi ndenge maladi ya HCoV ekoki konyokola bato mpe koboma bango.	The outbreaks of severe acute respiratory syndrome (SARS) and middle eastern respiratory syndrome (MERS) have highlighted the oppressive and deadly effects of HCoV infections.
428	en	ln	 The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. 	Kobima ya SARS-CoV-2 na katikati ya Chine na nsuka ya 2019 etye CoVs na esika ya liboso mpe ekamwisi biso na ndenge ezopanzana noki kasi ekiti ndenge ezobelisa bato koleka ndeko na yango SARS-CoV.	The emergence of SARS-CoV-2 in central China in late 2019 has put CoVs in the spotlight and surprised us with its rapid spread but lower incidence than its cousin SARS-CoV.
429	en	ln	 HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. 	Maladi HCoV eutaka na banyama mpe koyeba banyama oyo ebimisaki HCoVs ekosalisa biso mpe.	HCoV disease is animal born and knowing which animals produced HCoVs will also help us.
430	en	ln	 Most HCoVs originated from bats where they are non-pathogenic. 	Ba HCoVs mingi eutaki na bangembo kasi ebimisaka maladi te.	Most HCoVs originated from ticks but do not cause disease.
431	en	ln	 The intermediate reservoir hosts of some HCoVs are also known. 	Biloko ya katikati oyo ememaka ba HCoVs misusu eyabani mpe.	Intermediates carrying other HCoVs have also been identified.
432	en	ln	 Identifying the animal hosts has direct implications in the prevention of human diseases. 	Koyeba banyama oyo ememaka yango eza na bopusi mingi na kobundisa maladi oyo bato bazali kobela.	Identifying vectors has a significant impact on the fight against human disease.
433	en	ln	 Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. 	Koluka koyeba boyokani na kati ya biloko oyo ememaka CoV na banyama ekoki mpe kosalisa mingi na koyeba maladi ya CoV kati na bato.	Investigating the relationships among CoV vectors in animals may also greatly aid in diagnosing CoV disease in humans.
434	en	ln	 In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. 	Na lisolo oyo, tokolobela na mokuse makambo toyebi mpo na ba HCoVs nsambo, mpe tokotya likebi na lisolo ya bokundoli na yango mpe ndenge eutaka na banyama mpe biloko oyo esalisaka na kopanza yango.	In this article, we will summarize what we know about the seven HCoVs, focusing on the history of their recall and their origin from animals and vectors.
435	en	ln	 Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. 	Likambo ya ntina eza ete tokokanisaka mpe tokesenisaka ba HCoVs mingi na kotalela ndenge virisi ekolaka mpe ndenge genoma esanganaka.	Importantly, we compare and contrast many HCoVs based on virus growth and genome assembly.
436	en	ln	 The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. 	Maladi ya CoV ya sikoyo ya 2019 (COVID-19) elobelami na lisolo oyo.	The current 2019 CoV disease (COVID-19) is discussed in this article.
437	en	ln	 In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted. 	Lisusu, ezolobela mpe masengami mpo na kolonga kobongola biloko ememaka maladi mpe ekweli na yango na ndenge virisi ekolaka mpe ekomaka makasi.	Furthermore, it also discusses the requirements for successful mutations and their consequences as the virus grows and becomes stronger.
438	en	ln	 Coronaviruses (CoVs) belong to the family Coronaviridae, which comprises a group of enveloped, positive-sensed, single-stranded RNA viruses. 	Bacoronavirisi (CoVs) eza na libota ya Coronaviridae, oyo eza na etuluku moko ya bavirisi ya makasi ya RNA.	Coronaviruses (CoVs) belong to the family Coronaviridae, which belongs to a group of strong RNA viruses.
439	en	ln	 These viruses harbouring the largest genome of 26 to 32 kilobases amongst RNA viruses were termed “CoVs” because of their crown-like morphology under electron microscope. 	Bavirisi oyo ezalaka na ba genome ya minene ya 26 kino 32 kilobases na kati ya bavirisi RNA, babengaki yango “CoVs” mpo ezalaki neti na motole na microscope ya electronique.	Viruses with large genomes of 26 to 32 kilobases among RNA viruses were called “CoVs” because they looked like a crown under an electron microscope.
440	en	ln	 Structurally, CoVs have non-segmented genomes that share a similar organization. 	Na nzoto na yango, CoVs ezalaka te na ba genome ekatana oyo esalema ndenge moko.	Physically, CoVs do not have identically formed truncated genomes.
441	en	ln	 Approximately two thirds of the genome contain two large overlapping open reading frames (ORF1a and ORF1b), which are translated into the pp1a and pp1ab replicase polyproteins. 	Pene ya ba genome mibale na kati ya misato ezali na etandi ya polele mibale (ORF1a mpe ORF1b), oyo ebongolami kati ya pp1 mpe pp1ab ekelamu na baproteine.	Approximately two out of three genomes contain two open stretches (ORF1a and ORF1b), which are translated between pp1 and pp1ab creatures into proteins.
442	en	ln	 The polyproteins are further processed to generate 16 non-structural proteins, designated nsp1~16. 	Baproteine mingi esalelamaka lisusu mpo na kobimisa baproteine 16 ezanga nzoto, ebengami nsp1~16.	Several proteins are reused to produce 16 naked proteins, designated nsp1~16.
443	en	ln	 The remaining portion of the genome contains ORFs for the structural proteins, including spike (S), envelope (E), membrane (M) and nucleoprotein (N). 	Eteni etikali ya genome eza na ORFs mpo na nzoto ya baproteine, ata mpe nsonge (S), loposo (E), membrane (M) mpe nucleoproteine (N).	The rest of the genome contains ORFs for protein bodies, including tip (S), skin (E), membrane (M) and nucleoprotein (N).
444	en	ln	 A number of lineage-specific accessory proteins are also encoded by different lineages of CoVs. 	Mwa baproteine ya sikisiki eza mpe na bakode na milongo ekeseni ya CoVs.	A few specific proteins are also encoded by different sequences of CoVs.
445	en	ln	 Based on the difference in protein sequences, CoVs are classified into four genera (alpha-CoV, beta-CoV, gamma-CoV and delta-CoV), among which the beta-CoV genera contains most HCoVs and is subdivided into four lineages (A, B, C and D). 	Na kotalela bokeseni na molongo ya proteine, batyaka ba CoVs na milongo minei ya minene (alpha-CoV, beta-CoV, gamma-CoV mpe delta-CoV), mpe beta-CoV ezalaka na ba HCoVs mingi mpe ekabwanaka na milongo minei (A, B, C mpe D).	Based on differences in protein sequence, CoVs are classified into four major classes (alpha-CoV, beta-CoV, gamma-CoV and delta-CoV), and beta-CoV contains more HCoVs and is divided into four classes (A). , B, C and D).
446	en	ln	 Phylogenetic evidence has shown that bats and rodents serve as the gene source of most alpha-CoVs and beta-CoVs, while birds are the main reservoir of gamma-CoVs and delta-CoVs. 	Bilembeteli ya bagene emonisi ete bangembo mpe bampuku bazali eutelo ya gene ya ebandeli ya bamikrobe mingi ya alpha-CoVs mpe beta-CoVs, kasi bandeke bazali nde esika monene oyo gamma-CoVs mpe delta-CoVs eutaka.	Genetic evidence suggests that ticks and flies are the primary genetic source of most alpha-CoVs and beta-CoVs, but birds are the major source of gamma-CoVs and delta-CoVs.
447	en	ln	 For thousands of years, CoVs have constantly crossed species barriers and some have emerged as important human pathogens. 	Na bankoto ya bambula, CoVs ekutanaka mbala mingi na bandelo ya midele mpe misusu ekoma bavirisi ya makasi ya bato.	Over thousands of years, CoVs have repeatedly encountered modern boundaries and some have become potent human viruses.
448	en	ln	 To date, seven human CoVs (HCoVs) are known. 	Kino lelo, bavirisi CoVs (HCoVs) nsambo ya bato eyebani.	To date, seven human CoVs (HCoVs) have been identified.
449	en	ln	 Among them HCoV-229E and HCoV-NL63 are alpha-CoVs. 	Na kati na yango HCoV-229E mpe HCoV-NL63 bazali alpha-CoVs.	Of these HCoV-229E and HCoV-NL63 are alpha-CoVs.
450	en	ln	 The other five beta-CoVs include HCoV-OC43, HCoV-HKU1, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2. 	Mitano oyo etikali beta-CoVs eza na HCoV-OC43, HCoV-HKU1, maladi makasi ya mpema ya coronavirisi (SARS-CoV), maladi ya mpema ya coronavirisi ya moyen orient (MERS-CoV) mpe SARS-CoV-2.	The remaining five beta-CoVs include HCoV-OC43, HCoV-HKU1, severe coronary respiratory syndrome (SARS-CoV), Middle Eastern respiratory syndrome (MERS-CoV) and SARS-CoV-2
451	en	ln	 HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63 usually cause mild symptoms, like common cold and/or diarrhea. 	Mbala mingi HCoV-229E, HCoV-OC43, HCoV-HKU1 mpe HCoV-NL63 bazali na bilembo ya pete, neti malili mpe/to pulupulu.	HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63 usually have mild symptoms, such as cold and/or flu.
452	en	ln	 In contrast, SARS-CoV, MERS-CoV and the newly-identified SARS-CoV-2 are highly pathogenic, causing severe lower respiratory tract infection in relatively more patients with a higher chance to develop acute respiratory distress syndrome (ARDS) and extrapulmonary manifestations. 	Na bokeseni, SARS-CoV, MERS-CoV mpe SARS-CoV-2 oyo ebimi sika ezali makasi mingi, ezokanga makasi nzela ya kopema ya nse na bato mingi ya maladi oyo bazali na chance mingi ya kobela maladi ya mpema euti na basusi (ARDS) mpe bampasi mosusu na poumon.	In contrast, the newly emerged SARS-CoV, MERS-CoV and SARS-CoV-2 are more potent, severely obstructing the lower respiratory tract in many patients with a higher chance of developing acute respiratory distress syndrome (ARDS). ) and other pulmonary disorders.
453	en	ln	 The first HCoV-229E strain, B814, was isolated from the nasal discharge of patients with common cold in mid-1960s. 	Elembo ya liboso ya HCoV-229E, B814, bazwaki yango na biloko ebimaka na zolo ya bato ya maladi oyo bazalaki na malili na katikati ya mibu 1960.	The first isolate of HCoV-229E, B814, was isolated from nasal secretions of patients with a cold in the mid-1960s.
454	en	ln	 Since then, more knowledge was accumulated through extensive studies on HCoV-229E and HCoV-OC43, both of which cause self-limiting symptoms. 	Banda ntango wana, bolukiluki ya mingi esalisaka na koyeba malamu HCoV-229E mpe HCoV-OC43, oyo nyonso mibale ebimisaka bilembo mingi te.	Since then, extensive research has helped better identify HCoV-229E and HCoV-OC43, both of which cause fewer symptoms.
455	en	ln	 Indeed, the concept had been widely accepted that infection with HCoVs is generally harmless until the outbreak of SARS. 	Ya solo, bato mingi bandimaki likanisi wana ete maladi ya HCoVs esalaka mabe te kino ntangu SARS ebimaki.	Indeed, many people accepted that notion that HCoVs infection was harmless until the emergence of SARS.
456	en	ln	 The SARS outbreak occurred in 2003 is one of the most devastating in current history, infecting over 8,000 people with a crude case fatality of approximately 10%. 	Kobima ya SARS na 2003 ezali moko ya maladi mabe makasi ya mikolo na biso, ezwaki bato koleka 8,000 mpe bato pene ya 10% bakufaki.	The 2003 outbreak of SARS is one of the most severe epidemics of modern times, infecting more than 8,000 people and killing nearly 10% of the population.
457	en	ln	 Ten years later, the Middle East respiratory syndrome (MERS) outbreak resulted in a persistent epidemic in the Arabian Peninsula with sporadic spreading to the rest of the world. 	Nsima ya bambula zomi, maladi ya mpema ya moyen orient (MERS) ekomaki maladi ya makasi na péninsule ya Arabie mpe epanzanaki mwa moke na mokili mobimba.	A decade later, middle eastern respiratory syndrome (MERS) became an epidemic in the Arabian peninsula and spread somewhat throughout the world.
458	en	ln	 The 2019 novel HCoV (2019-nCoV), which has subsequently been renamed SARS-CoV-2, is the causative agent of the ongoing epidemic of coronavirus disease 2019 (COVID-19), which has claimed more than 3,120 lives and infected more than 91,000 people as of March 3, 2020. 	HCoV (2019-nCoV) ya sika ya 2019, oyo bapesi yango nkombo SARS-CoV-2, yango nde ebimisa maladi ya coronavirisi 2019 (COVID-19), oyo esi ebomi bato koleka 3 120 mpe ezwi bato koleka 91 000 kino na mokolo ya 3 sanza ya misato 2020.	The new 2019 HCoV (2019-nCoV), named SARS-CoV-2, is the cause of the 2019 coronavirus (COVID-19), which has already killed more than 3,120 people and infected more than 91,000 to date of 3 March
459	en	ln	 The alarm has been ringing and the world has to prepare for the coming pandemic of SARS-CoV-2. 	Likebisi epesami mpe mokili mobimba ezali komilengela mpo na pandemi ya SARS-CoV-2.	A warning has been issued and the world is preparing for the SARS-CoV-2 pandemic.
460	en	ln	 All seven HCoVs have a zoonotic origin from bats, mice or domestic animals. 	Ba HCoVs nyonso nsambo euti na banyama, elingi koloba bangembo, bampuku, to banyama mosusu ya ndako.	All seven HCoVs are of animal origin, namely bats, flies, or other domestic animals.
461	en	ln	 Multiple lines of evidence support an evolutionary origin of all HCoVs from bats, where viruses are well adapted and non-pathogenic but show great genetic diversity. 	Bilembeteli mingi ezomonisa ete ba HCoVs nyonso euta na bangembo, esika bavirisi elingaka kofanda mpe esalaka eloko te kasi ezalaka na balolenge mingi mpenza.	There is ample evidence that all HCoVs originate from insects, where the viruses like to live and do nothing but come in many forms.
462	en	ln	 The COVID-19 epidemic has presented enormous medical, scientific, social and moral challenges to China and the world. 	Pandemi ya COVID-19 eza mpasi mingi mpo na minganga, bato ya siansi, mpo na bomoi mpe mimeseno ya bato ya Chine mpe ya mokili mobimba.	The COVID-19 pandemic is very difficult for doctors, scientists, for the lives and cultures of people in China and around the world.
463	en	ln	 Tracing the zoonotic origins of HCoVs provides a framework to understand the natural history, driving force and restriction factors of species jumping. 	Kolandela banyama esika oyo HCoVs euta ezali kosalisa na koyeba lisolo ya bozalisi, nguya ya botambwisi mpe makambo oyo ekangaka bikelamu oyo epumbwaka nzela.	Tracking the animal source of HCoVs is helping to determine the natural history, driving forces and constraints of flying organisms.
464	en	ln	 This might also guide or facilitate the search for the reservoir, intermediate and amplifying animal host(s) of SARS-CoV-2, with important implications in the prevention of future spillovers. 	Ekoki mpe kokamba to kosalisa na bolukiluki ya koyeba esika efandaka, esika elekaka mpe kobongisa ba(nyama) oyo ebombaka maladi yango ya SARS-CoV-2, mpe milende oyo esengeli kosalema mpo na kokanga yango nzela epanzana te na mikolo oyo ezali koyaka.	It may also lead or assist in research to identify the habitat, transit route and repair of the SARS-CoV-2 harbor(s), and efforts to contain it from spreading in the future.
465	en	ln	 In this review we present an overview of the zoonotic origins, interspecies transmission and pathogenesis of HCoVs. 	Na lisolo oyo tozali kolobela na mokuse esika banyama yango bauti, ndenge ezali kopesama na bikelamu mosusu mpe bavirisi ya HCoVs.	In this article we briefly discuss the origin of these animals, how they are transmitted to other organisms and HCoVs viruses.
466	en	ln	 Particularly, we highlight and discuss the common theme that parental viruses of HCoVs are typically non-pathogenic in their natural reservoir hosts but become pathogenic after interspecies transmission to a new host. 	Mingimingi, tozali kobeta nsete mpe tozali kolobela moto ya likambo ya ntina ete bavirisi minene ya HCoVs epesaka te maladi na esika oyo yango efandaka kasi ekomaka kopesa maladi soki euti na ekelamu moko mpe ekomi kofanda na esika ya sika.	Specifically, we underscore and address the key point that major HCoVs do not cause disease in their host but become pathogenic when they originate from an organism and colonize a new environment.
467	en	ln	 We also review the trend of HCoV evolution in which the increase in transmissibility often comes with the decrease in pathogenicity. 	Tolobeli mpe ndenge HCoV ezokola mpe ndenge mbala mingi ntango epesamaka na bikelamu mosusu esalaka ete epesa maladi mingi te.	We also discuss how HCoV evolves and how often when transmitted to other organisms it makes it less pathogenic.
468	en	ln	 The outcome of the ongoing SARS-CoV-2 outbreak is also discussed in this context. 	Resultat ya kobima ya SARS-CoV-2 elobelami mpe na lisolo oyo.	The result of the emergence of SARS-CoV-2 is also discussed in this article.
469	en	ln	 Animal CoVs have been known since late 1930s. 	CoVs ya banyama eyebana banda nsuka ya mibu 1930.	Animal CoVs have been known since the late 1930s.
470	en	ln	 Before the first isolation of HCoV-229E strain B814 from the nasal discharge of patients who had contracted common cold, different CoVs had been isolated in various infected animals, including turkey, mouse, cow, pig, cat and dog. 	Liboso ya kozwa elembo ya liboso ya HCoV-229E, B814, na miyoyo ya zolo ya bato oyo babelaki malili, bazwaki deja CoVs na banyama mingi, na ndakisa dindon, mpuku, ngombe, ngulu, nyau mpe mbwa.	Before the first detection of HCoV-229E, B814, in the nasal mucosa of cold patients, CoVs had already been detected in many animals, including turkeys, foxes, cattle, pigs, buffalo and dogs.
471	en	ln	 In the past decades, seven HCoVs have been identified. 	Na bambula eleki, bato bamona ba HCoVs nsambo.	In recent years, seven HCoVs have been identified.
472	en	ln	 A brief summary of the history of HCoV discovery in chronological order (Table ​1) would be informative and instructive. 	Lisolo ya mokuse ya bokundoli ya HCoV na molongo oyo esalemaki (Tablo ​1) ekozala ntina mingi mpe ekoteya makambo mingi.	A brief overview of HCoV in the series (Table 1) will be useful and informative.
473	en	ln	 The first HCoV-229E strain was isolated from the respiratory tract of patients with upper respiratory tract infection in the year of 1966, and was subsequently adapted to grow in WI-38 lung cell lines. 	Babimisaki elembo ya liboso ya HCoV-229E na nzela ya kopema ya bato oyo bazalaki na maladi ya nzela ya kopema ya lokolo na mobu 1966, mpe na nsima ekolaki na baselile ya lipulupulu WI-38.	They first characterized HCoV-229E in the respiratory tract of patients with foot-and-mouth disease in 1966, and subsequently grew it in WI-38 lung cells.
474	en	ln	 Patients infected with HCoV-229E presented with common cold symptoms, including headache, sneezing, malaise and sore-throat, with fever and cough seen in 10~20% cases. 	Bato ya maladi oyo bazalaki na HCoV-229E bazalaki na bilembo mingi ya malili na moto mpasi, etye, mingai mpe mongongo mpasi na fievre mpe kosukosu emonanaki na bato 10~20%.	Patients infected with HCoV-229E had many symptoms of cold with headache, fever, chills and sore throat with fever and cough seen in 10~20% of the population.
475	en	ln	 Later in 1967, HCoV-OC43 was isolated from organ culture and subsequent serial passage in brains of suckling mice. 	Na nsima na 1967, HCoV-OC43 ebimaki na mimeseno ya binama mpe elekaki na boongo ya mpuku oyo ezomela mabele.	Then in 1967, HCoV-OC43 emerged from organ cultures and passed through the mammalian mouse brain.
476	en	ln	 The clinical features of HCoV-OC43 infection appear to be similar to those caused by HCoV-229E, which are symptomatically indistinguishable from infection with other respiratory tract pathogens such as influenza A viruses and rhinoviruses. 	Emonani ete bilembo ya maladi ya HCoV-OC43 ekokani na oyo ya HCoV-229E, oyo eza mpenza ndenge moko na maladi oyo esalaka ete nzela ya mpema ebela, na ndakisa bavirisi ya grippe A mpe ya ba rhinovirus.	The symptoms of HCoV-OC43 appear to be similar to those of HCoV-229E, which is essentially the same as respiratory tract infections, such as influenza A and rhinoviruses.
477	en	ln	 Both HCoV-229E and HCoV-OC43 are distributed globally, and they tend to be predominantly transmitted during the season of winter in temperate climate. 	HCoV-229E mpe HCoV-OC43 epanzani na mokili mobimba, mpe mbala mingi epesamaka na eleko ya malili.	HCoV-229E and HCoV-OC43 circulate throughout the world, and are usually transmitted in winter.
478	en	ln	 Generally, the incubation time of these two viruses is less than one week, followed by an approximately 2-week illness. 	Mbala mingi, mikolo oyo bavirisi mibale oyo esalaka mpo emonana ezalaka na nse ya mposo moko, na nsima moto abelaka na eleko ya pene ya mposo 2.	The days for the two viruses to appear are usually less than a week, followed by a period of about 2 weeks.
479	en	ln	 According to a human volunteer study, healthy individuals infected with HCoV-229E developed mild common cold. 	Na kotalela bolukiluki ya ofele oyo bato basalaki, bato ya nzoto kolongono oyo bazwi HCoV-229E bayokaka malili mbala mingi.	According to free human studies, healthy people infected with HCoV-229E experience chills more often.
480	en	ln	 Only a few immunocompromised patients exhibited severe lower respiratory tract infection. 	Kaka bato ya maladi moke ba oyo kolongono ya nzoto ezali ya kolemba nde babelaki makasi maladi ya nse ya kopema.	Only a few patients with poor health developed severe lower respiratory disease.
481	en	ln	 SARS, also known as “atypical pneumonia”, was the first well documented HCoV-caused pandemic in human history and the etiological agent is SARS-CoV, the third HCoV discovered. 	SARS, oyo ebengami mpe “maladi ya mimpulupulu”, ezalaki HCoV ya mikanda ya byekoli ya liboso oyo esalaki pandemi katin na lisolo ya bomoi ya bato mpe eutaki na SARS-CoV, HCoV ya misato oyo bato bamonaki.	SARS, also referred to as “lung disease”, was the first academic HCoV to cause a pandemic katin in human history and originated from SARS-CoV, the third HCoV identified by humans.
482	en	ln	 The first case of SARS can be traced back to late 2002 in Guangdong Province of China. 	Moto ya liboso oyo azwaki SARS ekoki kozala ete ezalaki na mobu 2002 na Guangdong, etuka moko ya Chine.	The first case of SARS may have been in 2002 in Guangdong, a province in China.
483	en	ln	 The SARS epidemic resulted in 8,096 reported cases with 774 deaths, spreading across many countries and continents. 	Maladi ya SARS ezwaki bato 8,096 mpe bato 774 bakufaki, epanzanaki na mikili mingi mpe na bakontina mingi.	The SARS outbreak, which infected 8,096 people and killed 774, spread to many countries and continents.
484	en	ln	 Apart from the super-spreaders, it was estimated that each case could give rise to approximately two secondary cases, with an incubation period of 4 to 7 days and the peak of viral load appearing on the 10th day of illness. 	Longola biloko oyo ememaka yango, emonanaki ete moto nyonso oyo azwi yango akoki kopesa yango na bato pene ya mibale; mikolo oyo esalaka mpo emonana ezali 4-7 mpe kokoma makasi na mokolo ya 10 nsima ya kozwa yango.	In addition to the carriers, it was found that each recipient could pass it on to nearly two people; the days it does appear is 4-7 and become stronger by the 10th day after ingestion.
485	en	ln	 Patients infected with SARS-CoV initially present with myalgia, headache, fever, malaise and chills, followed by dyspnea, cough and respiratory distress as late symptoms. 	Bato oyo bazwi SARS-CoV, na ebandeli bazalaka na mpasi na misisa, moto mpasi, fefele, mingai, mpe bayokaka malili, na nsima bayokaka neti mpema ezokatana, kosukosu mpe mitungisi ya kopema.	People infected with SARS-CoV initially experience muscle pain, burning sensation, fever, chills, and chills, followed by shortness of breath, coughing and difficulty breathing.
486	en	ln	 Lymphopenia, deranged liver function tests, and elevated creatine kinase are common laboratory abnormalities of SARS. 	Kokita ya baselile ebengami lymphocyte, kobebisama ya misala ya mabale, mpe komata ya creatine kinase ezali na kati ya bambeba ya SARS oyo emonanaka mingi.	Decreased lymphocyte counts, impaired spleen function, and elevated creatine kinase are among the most common defects of SARS.
487	en	ln	 Diffuse alveolar damage, epithelial cell proliferation and an increase of macrophages are also observed in SARS patients. 	Kobeba ya ba alveolaire, kobima ya noki ya baselile epitheliale mpe komata ya ba macrophage emonanaka mpe na bato oyo babeli SARS.	Alveolar damage, rapid epithelial cell outgrowth and macrophage increase are also observed in SARS patients.
488	en	ln	 Approximately 20-30% of patients subsequently require intensive care and mechanical ventilation. 	Pene ya bato 20-30% oyo bazwi yango bakotaka na esika oyo batyaka bato ya kobela makasi mpe bakozala na mposa ya lisalisi ya mopepe.	Approximately 20-30% of infected individuals enter the intensive care unit and will require ventilatory support.
489	en	ln	 In addition to lower respiratory tract, multiple organs including gastrointestinal tract, liver and kidney can also be infected in these severe cases, usually accompanied with a cytokine storm, which might be lethal particularly in immunocompromised patients. 	Lisusu nse ya nzela ya kopema, binama mingi na ndakisa mosopo ya bilei, mabale mpe bangeyi ekoki kobeba soki maladi eza makasi, mbala mingi esalaka ete ba cytokine ekoma mingi, nde yango ekoki koboma bato oyo kolongono ya nzoto elemba.	Also down the respiratory tract, many organs such as the esophagus, spleen and lungs can be damaged in severe cases, often causing an increase in cytokines, which can kill people with weakened health.
490	en	ln	 The virus was first isolated from the open lung biopsy of a relative of the index patient who travelled to Hong Kong from Guangzhou. 	Bamonaki virisi yango mbala ya liboso na ekzame ya mosuni ya lipulupulu ya ndeko ya moto oyo azalaki kobela yango oyo alongwaki na Guangzhou mpe akendaki na Hong Kong.	The virus was first detected in a flesh examination of the sputum of a relative of the patient who traveled from Guangzhou to Hong Kong.
491	en	ln	 Since then, tremendous efforts have been dedicated to HCoV research. 	Banda ntango wana, bato basala milende mingi mpo na kosala bolukiluki ya HCoV.	Since then, many efforts have been made to test for HCoV.
492	en	ln	 HCoV-NL63 was isolated from a 7-month-old child from the Netherlands during late 2004. 	Bazwaki HCoV-NL63 na mwana moko ya basanza 7 na pays-bas na nsuka ya mobu 2004.	HCoV-NL63 was detected in a 7-month-old child in the Netherlands in late 2004.
493	en	ln	 It was initially found to be prevalent in young children, the elderly and immunocompromised patients with respiratory illnesses. 	Emonanaki liboso ete ezalaki mingi na bilenge, na mibange mpe na bato ya maladi oyo kolongono ya nzoto elemba mpe oyo bazalaka na maladi ya mpema.	It has previously been shown to be more common in young people, the elderly, and patients with frail and respiratory diseases.
494	en	ln	 Presentation of coryza, conjunctivitis, fever, and bronchiolitis is common in the disease caused by HCoV-NL63. 	Bilembo na zolo, conjonctivite, fefele, mpe maladi ya mpema emonanaka mingi na maladi oyo euti na HCoV-NL63.	Symptoms in the throat, conjunctivitis, fever, and respiratory disease are common in HCoV-NL63 infection.
495	en	ln	 Another independent study described the isolation of the same virus from a nasal specimen from an 8-month-old boy suffering from pneumonia in the Netherlands. 	Bolukiluki mosusu elobelaki ete babimisaki virisi moko wana na biloko oyo eutaki na zolo ya mwana-mobali moko ya basanza 8 oyo azalaki kobela maladi ya mimpulupulu na pays-bas.	Another study reported that the same virus was isolated from the nasal secretions of an 8-month-old boy with pneumonia in the Netherlands.
496	en	ln	 Although it was identified in Netherlands, it is actually distributed globally. 	Ata bamonaki yango na pays-bas, epanzanaki na bato nyonso.	Even though they saw it in the netherlands, it spread to everyone.
497	en	ln	 It has been estimated that HCoV-NL63 accounts for approximately 4.7% of common respiratory diseases, and its peak incidence occurs during early summer, spring and winter. 	Emonani ete HCoV-NL63 esalaka ete bato pene ya 4,7% babela maladi ya mpema, mpe bato mingi bazwaki yango na ebandeli ya eleko ya moyi makasi, eleko ya mbula, mpe eleko ya mpio makasi.	HCoV-NL63 has been shown to cause respiratory illness in approximately 4.7% of the population, with the highest number of cases occurring during the early summer, fall, and winter months.
498	en	ln	 HCoV-NL63 is associated with obstructive laryngitis, also known as croup. 	HCoV-NL63 ememaka mpe maladi ya mpema oyo ekangaka laryngite, oyo babengaka mpe croupe.	HCoV-NL63 also leads to the obstructive respiratory disease laryngitis, also called croup.
499	en	ln	 In the same year, HCoV-HKU1 was isolated from a 71-year-old man who had been hospitalized with pneumonia and bronchiolitis in Hong Kong. 	Na mbula moko wana, bazwaki HCoV-HKU1 na mobali moko ya mibu 71 oyo akotaki lopitalo mpo na maladi ya mimpulupulu mpe bronchiolite na Hong Kong.	In the same year, HCoV-HKU1 was detected in a 71-year-old man hospitalized with pneumonia and bronchiolitis in Hong Kong.
500	en	ln	 Besides community-acquired pneumonia and bronchiolitis, HCoV-HKU1 was reported to be associated with acute asthmatic exacerbation. 	Longola maladi ya mimpulupulu mpe bronchiolite, emonani ete HCoV-HKU1 ezali mpe na boyokani na asthme ya makasi mpenza.	In addition to lung disease and bronchiolitis, HCoV-HKU1 also appears to be associated with very severe asthma.
501	en	ln	 Similar to HCoV-NL63, HCoV-229E and HCoV-OC43, HCoV-HKU1 was found worldwide, causing mild respiratory diseases. 	Ndenge ezalaki mpo na HCoV-NL63, HCoV-229E mpe HCoV-OC43, bamonaki HCoV-HKU1 na mokili mobimba, mpe esalaki ete bato babela maladi ya mpema.	As was the case for HCoV-NL63, HCoV-229E and HCoV-OC43, HCoV-HKU1 was detected worldwide, causing respiratory infections.
502	en	ln	 All these four community-acquired HCoVs have been well adapted to humans and are generally less likely to mutate to cause highly pathogenic diseases, though accidents did occur for unknown reasons as in the rare case of a more virulent subtype of HCoV-NL63, which has recently been reported to cause severe lower respiratory tract infection in China. 	Ba HCoVs minei nyonso oyo emesanaka malamu na bato mpe mbala mingi ezalaka mpasi mpo ebimisaka maladi ya makasi mingi te, ata soki aksida esalemaki mpo na bantina eyebani te mpe na bandakisa oyo esalemaka mingi te mpo na lolenge moko ya HCoV-NL63 ya makasi mingi, oyo balobaki kala mingi te ete ezopesa mwa moke maladi ya nse ya nzela ya kopema na Chine.	All four HCoVs that adapt well to humans and are usually unlikely to cause less severe disease, even if the accident occurred for unknown reasons and in rare instances of a more severe HCoV-NL63 strain, which was recently reported to cause a small amount of lower respiratory tract infections in China.
503	en	ln	 Generally, when these HCoVs acquire the abilities to transmit efficiently and to maintain themselves continuously within humans, they also become less virulent or pathogenic. 	Mbala mingi, ntango ete ba HCoVs oyo bakoki kopesama malamu mpenza kati na bato mpe kozala ntango nyonso na nzoto ya bato, bakomaka makasi mingi te to babelisaka mpenza te.	Usually, when HCoVs that can be transmitted very efficiently between humans and constantly exist in human bodies, they do not become very severe or completely infectious.
504	en	ln	 MERS-CoV was first isolated in 2012 from the lung of a 60-year-old patient who developed acute pneumonia and renal failure in Saudi Arabia. 	Babimisaki MERS-CoV na mbala ya liboso na 2012 na lipulupulu ya moto moko ya maladi ya mibu 60 oyo azalaki na mpasi makasi na mimpulupulu mpe bangeyi ebebaki na Aradie Saudite.	MERS-CoV was first isolated in 2012 from the lungs of a 60-year-old patient with severe lung pain and damaged lungs in Saudi Arabia.
505	en	ln	 Whereas most of the laboratory-confirmed cases originate from the Middle East, imported cases with occasional secondary spreads to close contacts have been reported in various European countries and Tunisia. 	Ata mingi ya bato ya maladi yango bautaki na moyen orient, epanzanaki na bato misusu mpo bantango mosusu na bazalaka na bokutani makasi na mikili mingi ya Eropa mpe na Tunisie.	Even though most of the patients came from the middle east, it spread to other people because sometimes in have close contact in many European countries and Tunisia.
506	en	ln	 Another secondary outbreak occurred in South Korea in 2015 with 186 confirmed cases. 	Kobima mosusu ya moke esalemaki na Coree du sud na 2015 mpe ezwaki bato 186.	Another smaller outbreak occurred in South Korea in 2015 and claimed 186 lives.
507	en	ln	 Clinical manifestations of MERS resemble those of SARS, characterized by progressive acute pneumonia. 	Bilembo ya MERS ekokani na oyo ya SARS, emonanaka mingi na maladi makasi ya mimpulupulu.	The symptoms of MERS are similar to those of SARS, most commonly with severe lung disease.
508	en	ln	 Unlike SARS, many patients with MERS also developed acute renal failure, which is thus far unique for MERS among HCoV-caused diseases. 	Na bokeseni na SARS, bato mingi oyo babelaki MERS babelaki mpe maladi makasi ya bangeyi, oyo lolenge moko te na maladi ya MERS kati ya bamaladi misusu ya HCoV.	In contrast to SARS, many patients with MERS also developed severe anthrax, which is unlike MERS among other HCoV diseases.
509	en	ln	 More than 30% of patients present with gastrointestinal symptoms, such as diarrhea and vomiting. 	Bato ya maladi koleka 30 bazalaki na bilembo na maladi eutaka na misopo, ndakisa pulupulu mpe kosanza.	More than 30 patients had symptoms of urinary tract infections, such as pneumonia and vomiting.
510	en	ln	 As of February 14, 2020, over 2500 laboratory confirmed cases were reported with a high case fatality of 34.4%, making MERS-CoV one of the most devastating viruses known to humans. 	Na mokolo ya 14 sanza ya mibale 2020, balobaki ete ezali na bato koleka 2500 oyo bazali mpenza na maladi wana mpe bato 34,4% bakufaki; yango esali ete MERS-CoV ezala moko ya bavirisi oyo ebomaka bato mingi.	As of February 14, 2020, there are more than 2,500 confirmed cases and 34.4% deaths; this makes MERS-CoV one of the deadliest viruses.
511	en	ln	 During middle to late December 2019, clusters of pneumonia patients retrospectively known to be associated with SARS-CoV-2 infection were detected in Wuhan, Hubei Province, China. 	Pene ya nsuka ya sanza ya zomi na mibale 2019, bato oyo bazalaki na maladi ya mpema oyo eyebanaki kala ete baza na maladi ya SARS-CoV-2 bamonanaki na Wuhan, na etuka ya Hubei, na Chine.	Towards the end of December 2019, respiratory cases previously known to be infected with SARS-CoV-2 were reported in Wuhan, Hubei Province, China.
512	en	ln	 World Health Organization declared the ongoing outbreak of lower respiratory tract infection caused by SARS-CoV-2 a Public Health Emergency of International Concern and also named the disease COVID-19. 	Organisation Mondial ya Sante elobaki ete maladi wana ya nzela ya nse ya kopema oyo euti na SARS-CoV-2 ezali likambo ya mbalakaka ya kolongono ya nzoto oyo ezali kotungisa mokili mobimba mpe epesaki yango nkombo COVID-19.	The World Health Organization declared this lower respiratory tract infection caused by SARS-CoV-2 a global health emergency and named it COVID-1
513	en	ln	 As of March 3, 2020, 90,053 cases have been confirmed worldwide, with a crude case fatality of 3.4%. 	Na mokolo ya 3 sanza ya misato 2020, bato 90,053 bazalaki kobela yango na mokili mobimba, mpe bato oyo bakufaki bazalaki 3,4%.	As of March 3, 2020, there were 90,053 cases worldwide, with a mortality rate of 3.4%.
514	en	ln	 Notably, the case fatality in Hubei, China is 4.2%, whereas the one outside of it is 1.2%. 	Likambo ya ntina, motango ya bato bakufaki na Hubei, na Chine ezali 4,2%, kasi oyo ya libanda na yango ezali 1,2%.	Significantly, the mortality rate in Hubei, China is 4.2%, but that outside it is 1.2%.
515	en	ln	 SARS-CoV-2 causes severe respiratory infection like SARS-CoV and MERS-CoV, presented as fever, cough and dyspnea. 	SARS-CoV-2 ebimisaka maladi ya makasi ya mpema neti SARS-CoV mpe MERS-CoV; emonisaka yango na nzela ya fefele, kosukosu mpe mpasi ya kopema.	SARS-CoV-2 causes severe respiratory diseases such as SARS-CoV and MERS-CoV; it is manifested by fever, cough, and difficulty breathing.
516	en	ln	 Diarrhea is also seen in some patients. 	Bato misusu ya maladi bazalaki mpe na pulupulu.	Some patients also had pneumonia.
517	en	ln	 Pneumonia is one of the most severe symptoms and can progress rapidly to acute respiratory distress syndrome. 	Maladi ya poumon ezali moko ya bilembo makasi mpe ekoki kokoma noki maladi makasi ya mpema.	Lung disease is one of the most severe symptoms and can quickly become a severe respiratory disease.
518	en	ln	 Although SARS-CoV and SARS-CoV-2 are very similar due to high nucleotide sequence homology of 82%, they cluster into different branches in the phylogenetic tree. 	Ata soki SARS-CoV na SARS-CoV-2 ekokani mingi mpo ebimisaka ba nucleotide mingi 82%, ekabwani na biteni mingi na bituluku ya bamaladi.	Even though SARS-CoV and SARS-CoV-2 are very similar in that they produce 82% more nucleotides, they are very fragmented in disease groups.
519	en	ln	 SARS-CoV-2 is apparently less pathogenic but more transmissible compared to SARS-CoV and MERS-CoV. 	Emonani ete SARS-CoV-2 eza makasi mingi te kasi epanzanaka na bato mingi soki tososoli yango pene ya SARS-CoV mpe MERS-CoV.	SARS-CoV-2 appears to be less severe but spreads to more people when compared to SARS-CoV and MERS-CoV.
520	en	ln	 Asymptomatic subjects infected with SARS-CoV-2 have been reported and might contribute to its rapid spreading around the world. 	SARS-CoV-2 emonanaki mpe na bato oyo bazalaki na bilembo na yango te mpe mbala mosusu esalaki ete yango epanzana noki na mokili mobimba.	SARS-CoV-2 has also been detected in asymptomatic individuals and likely contributed to its rapid global spread.
521	en	ln	 Comparing and contrasting SARS-CoV-2 with the other six HCoVs reveal similarities and differences of great interest. 	Koyokanisa mpe kokokanisa SARS-CoV-2 na ba HCoVs motoba mosusu emonisi makambo ya ndenge moko mpe oyo ekeseni oyo ezali kobenda mpenza likebi.	Matching and comparing SARS-CoV-2 with the other six HCoVs reveals very interesting similarities and differences.
522	en	ln	 First, the incubation period and the duration of the course of HCoV disease are very similar. 	Ya liboso, mikolo oyo maladi esalaka liboso ya kobima mpe mikolo oyo maladi yango eumelaka eza mpenza ndenge moko.	First, the days before the disease appears and the days it lasts are very similar.
523	en	ln	 In this regard, SARS-CoV-2 follows the general trend of the other six HCoVs. 	Na likambo oyo, SARS-CoV-2 eza ndenge moko na makambo minene na ba HCoVs motoba misusu.	In this respect, SARS-CoV-2 is similar in major features to the other six HCoVs.
524	en	ln	 Second, the severity of symptoms of COVID-19 lies between SARS-CoV and the four community-acquired HCoVs (i.e. HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63). 	Ya mibale, makasi ya bilembo ya COVID-19 ezali na kati ya SARS-CoV mpe ba HCoVs minei mosusu (na ndakisa, HCoV-229E, HCoV-OC43, HCoV-HKU1 mpe HCoV-NL63).	Second, the severity of COVID-19 symptoms is shared by SARS-CoV and four other HCoVs (eg, HCoV-229E, HCoV-OC43, HCoV-HKU1 and HCoV-NL63).
525	en	ln	 On one hand, SARS-CoV-2 infection exhibits features that are more commonly seen during infection with community-acquired HCoVs, including the presentation of non-specific, mild or even no symptoms. 	Na ndambo moko, maladi ya SARS-CoV-2 esalaka bilembo oyo emonanaka mbala mingi na ntango ya maladi ya HCoVs oyo ezwami kati na bato, ata mpe kobimisa bilembo oyo eyebani te, ya moke, to nkutu ata elembo moko te.	In part, SARS-CoV-2 infection causes symptoms typically observed during infection with HCoVs acquired between humans, even causing unrecognized, mild, or even no symptoms.
526	en	ln	 On the other hand, a small subset of severe cases of COVID-19 can also be seen as in the case of SARS-CoV infection, although the ratio is a bit lower. 	Na ndambo mosusu, mwa bato moke oyo babelaki COVID-19 ya makasi bakoki komonana mpe lekola na maladi ya SARS-CoV, ata motango eza na mwa nse.	On the other hand, a small number of people who have had severe COVID-19 illness may also be diagnosed with SARS-CoV, although the numbers are slightly lower.
527	en	ln	 Third, the transmission of SARS-CoV-2 also shows interesting patterns characteristic of both community-acquired HCoVs and SARS-CoV. 	Ya misato, kopesama ya SARS-CoV-2 emonisi mpe mimeseno ya ndenge moko na HCoVs oyo ezalaka na bato mpe SARS-CoV.	Third, the transmission of SARS-CoV-2 also shows similar trends to HCoVs present in humans and SARS-CoV.
528	en	ln	 On one hand, the transmissibility of SARS-CoV-2 is at least as high as that of community-acquired HCoVs. 	Lisusu, kopesama ya SARS-CoV-2 ezali likolo mingi koleka oyo ya HCoVs oyo ezalaka na bato.	Furthermore, the transmission of SARS-CoV-2 is much higher than that of typical HCoVs in humans.
529	en	ln	 On the other hand, it remains to be verified whether the transmissibility of SARS-CoV-2 decreases after passages in humans as in the cases of SARS-CoV and MERS-CoV. 	Na ndambo mosusu, esengeli totalela lisusu soki kopesama ya maladi SARS-CoV-2 ezali kokita nsima ya kozwa bato ndenge esalemaki na SARS-CoV mpe MERS-CoV.	In the other half, we need to reassess whether the transmission of SARS-CoV-2 is declining after human infection as has been the case with SARS-CoV and MERS-CoV.
530	en	ln	 Finally, same as the other HCoVs, SARS-CoV-2 can be detected in fecal samples. 	Na nsuka, ndenge moko na ba HCoVs mosusu, SARS-CoV-2 ekoki komonana na nyei.	Finally, similar to other HCoVs, SARS-CoV-2 can be detected in feces.
531	en	ln	 Whether fecal-oral transmission of SARS-CoV-2 plays an important role as in the case of SARS-CoV at least under some circumstance remains to be clarified by future studies. 	Atako virisi SARS-CoV-2 epesaki bato maladi na nzela ya nyei ezali na ntina mingi ndenge esalemaki mpo na SARS-CoV esengeli bolukiluki mosusu elimbola yango malamu na mikolo oyo ezali koyaka.	Although the SARS-CoV-2 virus infected humans through the salivary gland it is important that what happened to SARS-CoV should be better defined by further research in the future.
532	en	ln	 It is also of particularly great interest to see whether SARS-CoV-2 might exhibit seasonality as in the cases of community-acquired HCoVs. 	Ezali kobenda mpenza likebi na koyeba soki SARS-CoV-2 ekoki kobima na bileko ndenge esalemaka mpo na HCoVs oyo ezalaka na bato.	It is particularly intriguing to determine whether SARS-CoV-2 can evolve seasonally as occurs for HCoVs in humans.
533	en	ln	 Nevertheless, the features of SARS-CoV-2 including its transmissibility, pathogenicity and sustainable spreading after passages in humans will be influential on the ultimate fate of the ongoing outbreak of COVID-19. 	Atako bongo, makambo mosusu ya SARS-CoV-2 mpe ndenge epesamaka, ndenge ebimaka mpe ndenge epanzanaka na nsima ya kokoma na nzoto ya bato ekozala na bopusi na kopanzana ya COVID-19.	Nevertheless, other aspects of SARS-CoV-2 and its mode of transmission, emergence and spread after reaching the human body will influence the spread of COVID-19.
534	en	ln	 All four community-acquired HCoVs causing mild symptoms have been well adapted to humans. 	Ba HCoVs nyonso oyo ezalaka na bato ebimisaka bilembo ya mike oyo emesana na nzoto ya bato.	All HCoVs in humans produce mild symptoms that are adapted to the human body.
535	en	ln	 From another perspective, it might also be true that humans have been well adapted to these four HCoVs. 	Na ndenge mosusu, ekoki kozala mpe solo ete bato basi bamesana na ba HCoVs minei oyo.	Alternatively, it may also be true that women adapt to these four HCoVs.
536	en	ln	 In other words, both could be the survivors of ancient HCoV pandemics. 	Na koloba mosusu, nyonso mibale ekoki kozala bauta na pandemi ya HCoV kala mpe ebika.	In other words, both may have come from an HCoV pandemic in the past and survived.
537	en	ln	 HCoVs that cause severe diseases in humans and humans who developed severe HCoV diseases have been eliminated. 	HCoVs oyo ebelisaki bato maladi makasi mpe bato oyo babelaki maladi makasi ya HCoV, balongolaki bango maladi yango.	HCoVs that caused severe disease and severe HCoV disease were excluded.
538	en	ln	 For this to happen, HCoVs have to replicate in humans to sufficient extent to allow the accumulation of adaptive mutations that counteract host restriction factors. 	Mpona esalema, esengeli HCoVs ebotama na nzoto ya bato ya kokoka mpo ba oyo ya sika babima mpona kobundisa bipekiseli ya esika oyo ezali.	For this to happen, HCoVs must be reproduced in perfect human bodies so that new ones can emerge to fight the barriers of the environment.
539	en	ln	 In this sense, the longer the SARS-CoV-2 outbreak persists and the more people that it infects, the greater chance that it will fully adapt to humans. 	Na ndenge wana, soki SARS-CoV-2 eumeli mingi mpe soki bato mingi babeli yango, libaku na yango yakomesana na nzoto ya bato ezali ebele.	Thus, the longer SARS-CoV-2 persists and the more people are infected, the greater the chance of it adapting to the human body.
540	en	ln	 If it adapts well, its transmission in humans would be difficult to stop by quarantine or other infection control measures. 	Soki emeseni malamu, ekozala mpasi bato bakanga kolekisama na yango na nzela ya konfinema to banzela misusu ya kosimba maladi.	If it is well adapted, it will be difficult for people to control its transmission through confinement or other means of infection.
541	en	ln	 For many years, the four community-acquired CoVs circulate in human populations, triggering common cold in immunocompetent subjects. 	Na boumeli ya bambula mingi, ba CoVs minei oyo ezwaka bato ezali kotambola na kati ya bato, mpe ezali kopesa malili na bato oyo makasi ya nzoto ya kobumdela elemba.	For decades, four infectious CoVs have been circulating among humans, inflicting chills on people whose immune systems have weakened.
542	en	ln	 These viruses do not need an animal reservoir. 	Bavirisi oyo bazali na mposa ya kobatama kati na banyama te.	These viruses do not need to be harvested in animals.
543	en	ln	 In contrast, highly pathogenic SARS-CoV and MERS-CoV have not adapted to humans well and their transmission within humans cannot be sustained. 	Na bokeseni, SARS-CoV na MERS-CoV oyo ebelisaka mingi emesana te na nzoto ya bato mpe ndenge moko te ezali mpona kokanga kopanzana na yango na kati ya bato.	In contrast, the highly pathogenic SARS-CoV and MERS-CoV are not adapted to the human body and there is no way to prevent their spread among humans.
544	en	ln	 They need to maintain and propagate in their zoonotic reservoirs and seek the chance to spillover to susceptible human targets, possibly via one or more intermediate and amplifying hosts. 	Ekosenga etikala mpe epanzana kaka na kati ya banyama mpe koluka libaku ya kokota na bato, mingimingi na nzela ya eloko moko to biloko mingi mpe ya malamu oyo ekoki komema yango.	It will need to remain and spread only among animals and find an opportunity to enter humans, especially through a substance or more and better vectors.
545	en	ln	 SARS-CoV-2 has features that are similar to both SARS-CoV/MERS-CoV and the four community-acquired HCoVs. 	SARS-CoV-2 eza na bilembo oyo ekokani na oyo ya SARS-CoV/MERS-CoV mpe HCoVs minei mosusu oyo bato bazwaka.	SARS-CoV-2 has symptoms similar to those of SARS-CoV/MERS-CoV and four other human-infected HCoVs.
546	en	ln	 It is highly transmissible like community-acquired HCoVs, at least for the time being. 	Epanzanaka makasi lokola ba HCoVs oyo bato bazwaka, ata kaka mpo na sikoyo.	It spreads as strongly as human-acquired HCoVs, at least for now.
547	en	ln	 However, it is more pathogenic than community-acquired HCoVs and less pathogenic than SARS-CoV or MERS-CoV. 	Kasi, ebelisaka makasi koleka HCoVs oyo bato bazwaka kasi ebelisaka makasi te lokola SARS-CoV to MERS-CoV.	However, it is more severely infectious than HCoVs that infect humans but not as severely infectious as SARS-CoV or MERS-CoV.
548	en	ln	 It remains to be seen whether it will adapt fully to humans and circulate within humans without a reservoir or intermediate animal host. 	Tokozela na koyeba soki ekomesana mpenza na bato mpe ekotambola na kati ya bato kozanga biloko oyo ememaka yango to banyama oyo ememaka yango.	We will have to wait and see if it will fully adapt to humans and move among humans without vessels or vector animals.
549	en	ln	 Before discussing the animal origins of HCoVs, it will serve us well to discuss the definitions and characteristics of evolutionary, natural, reservoir, intermediate and amplifying hosts of HCoVs. 	Liboso ya kolobela esika HCoVs eutaka, ekozala malamu tolobela bandimbola na yango mpe ndenge ekolaka, bozalisi, esika efandaka, bisika elekaka mpe biloko oyo ekomisaka yango HCoVs makasi.	Before discussing the origin of HCoVs, it would be useful to discuss their definitions and growth patterns, nature, habitat, transit sites and factors that make them virulent HCoVs.
550	en	ln	 An animal serves as the evolutionary host of an HCoV if it harbours a closely related ancestor sharing high homology at the level of nucleotide sequence. 	Nyama nde eza esika HCoV ekolaka soki efandi nkoko moko oyo eza na boyakani makasi na kokola ya nucleotide.	Animals are where HCoV evolves if they inhabit an ancestor that is closely related to nucleotide evolution.
551	en	ln	 The ancestral virus is usually well adapted and non-pathogenic in this host. 	Nkoko ya virisi emesana makasi mpe epesaka maladi te na eloko oyo, oyo ebombaka bango.	The ancestor of the virus is strongly adapted and does not cause disease in this, which hides them.
552	en	ln	 Likewise, a reservoir host harbours HCoV continuously and for long term. 	Ndenge moko, eloko moko oyo ememaka HCoV ekomaka kobomba yango na eleko ya molai.	Similarly, an HCoV vector becomes harbored over a longer period of time.
553	en	ln	 In both cases, the hosts are naturally infected and are the natural hosts of HCoV or its parental virus. 	Na bandakisa nyonso mibale, biloko oyo ebombaka yango ezwaka maladi mpe esika ebongi mpo na kobomba HCoV to na virisi oyo ebota yango.	In both examples, the reservoirs get infected and the environment is suitable for harboring HCoV or the parent virus.
554	en	ln	 In contrast, if the HCoV is newly introduced to an intermediate host right before or around its introduction to humans, it is not well adapted to the new host and is often pathogenic. 	Kasi, soki HCoV ekoti sika na esika ya malamu oyo ebombaka yango liboso to pene ya kokota na nzoto ya bato, emesanaka malamu te na esika ya sika mpe mbala mingi epesaka maladi.	However, once HCoV is newly introduced into a favorable reservoir before or about to enter the human body, it adapts poorly to the new environment and often causes disease.
555	en	ln	 This intermediate host can serve as the zoonotic source of human infection and play the role of an amplifying host by allowing the virus to replicate transiently and then transmitting it to humans to amplify the scale of human infection. 	Esika oyo ya mibale oyo efandaka ekoki kozala banyama oyo epesaka maladi na bato mpe esalisaka mingi na kokomisa yango makasi ndenge epesaka virisi nzela ya kobota mpe na nsima kokota na nzoto ya bato mpe kopusa likolo ndenge ezali kobelisa bato mingi.	This secondary habitat can be animals that cause disease in humans and play a major role in making it stronger as it allows the virus to reproduce and then enter the human body and push up as it infects more people.
556	en	ln	 An HCoV can undergo a dead-end infection if it cannot sustain its transmission within the intermediate host. 	HCoV ekoki kopesa maladi oyo ebomaka soki bakoki kokanga yango te nzela ya kopanzana kati ya eloko ya mibale oyo ebombaka yango.	HCoV can cause fatal infection if it cannot be stopped from spreading within its secondary storage medium.
557	en	ln	 On the contrary, HCoVs can also adapt to the intermediate host and even establish long-term endemicity. 	Kasi, HCoVs ekoki mpe komesana na esika ya mibale oyo efandi mpe nkutu eumela na bisika efandaka.	However, HCoVs can also adapt to a second host and even persist in habitats.
558	en	ln	 In this case, the intermediate host becomes a natural reservoir host. 	Na ndakisa oyo, esika ya mibale oyo efandaka ekomaka esika na yango ya malamu ya kofanda.	In this example, the second habitat becomes its ideal habitat.
559	en	ln	 Epidemiological data revealed retrospectively that the index case of SARS had a contact history with game animals. 	Bansango ya maladi mabe emonisaki ete bato oyo babelaki SARS bazalaka na lisolo ya boyokani banda kala na banyama ya kosakana.	Epidemic reports have indicated that SARS patients have a long history of contact with toy animals.
560	en	ln	 Subsequent seroprevalence investigations indicated that animal traders had a higher prevalence of anti-SARS-CoV IgG compared with that of the general population. 	Bolukiluki basalaki na maladi oyo yango epesaka emonisi ete bato batekaka banyama baza na likoki makasi ya kobundisa SARS-CoV IgG soki tokokanisi yango na bato nyonso.	Studies on the diseases it causes have shown that pet traders have a higher susceptibility to SARS-CoV IgG compared to the general population.
561	en	ln	 Masked palm civets (Paguma larvata) and a racoon dog in live animal markets were first identified to carry SARS-CoV-like viruses that are almost identical to SARS-CoV. 	Banyama ebengami civette palmée masquée (Paguma larvata) mpe mbwa moko ya vivverin na bazando ya banyama ya bomoi, bamonaki na mbala ya liboso ete ezalaka na bavirisi oyo ekokani na SARS-CoV oyo eza mpenza ndenge moko na SARS-CoV.	Animals called the masked palm civet (Paguma larvata) and a livestock market dog were found for the first time to contain SARS-CoV-like viruses that are exactly the same as SARS-CoV.
562	en	ln	 This was indirectly supported by the fact that no further SARS was reported after killing all civets in the markets. 	Basungaki yango mpo bamonaki ete ba SARS misusu emonanaki nsima ya koboma ba civette nyonso na bazando.	This was supported by the observation that some SARS cases had been detected after all the civets had been killed in the markets.
563	en	ln	 However, it has been reported that masked palm civets from the wild or farms without exposure to the live animal markets were largely negative for SARS-CoV, suggesting that masked palm civets might only serve as the intermediate amplifying host but not the natural reservoir of SARS-CoV. 	Kasi, balobi ete ba civette palmée masquée oyo euti na zamba to na bilanga kozanga ete batya yango na bazando ya banyama ya bomoi ata mokok te ezalaki SARS-CoV, yango emonisi ete mbala mosusu ba civette wana ezalaka kaka esika ya mibale virisi SARS-CoV efandaka kasi ezali esika na yango ya libosoliboso te.	However, masked palm civets from the wild or farms without any exposure to live animal markets have been reported to be SARS-CoV, suggesting that these civets may only be a secondary source of SARS-CoV virus it lives but is not its primary habitat.
564	en	ln	 Notably, since 80% of the different animals in the markets in Guangzhou have anti-SARS-CoV antibodies, the possibilities that multiple species of small mammals might also serve as intermediate amplifying hosts of SARS-CoV cannot be excluded. 	Likambo ezali kobenda likebi, mpo 80% banyama oyo bazalaka na bazando ya Guangzhou bazali na ba anticorps oyo ebundisaka SARS-CoV, tokoki kokanisa mpe ete banyama mosusu ya mike bazali esika ya mibale oyo bavirisi ya SARS-CoV efandaka.	Interestingly, because 80% of animals in Guangzhou markets have antibodies against SARS-CoV, it is also conceivable that some small animals are a secondary host for SARS-CoV viruses.
565	en	ln	 All of these appear to be dead-end hosts of SARS-CoV. 	Nyonso wana ezali bisika ya suka oyo SARS-CoV efandaka.	All of these are the final residences of SARS-CoV.
566	en	ln	 Subsequent search for the natural animal host of SARS-CoV unveiled a closely related bat CoV, termed SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), which exists in Chinese horseshoe bats. 	Bolukiluki mosusi na banyama oyo ebombaka SARS-CoV emonisaki boyokani makasi na ngembo ya CoV, oyo babengi SARS Rhinolophus ya ngembo CoV HKU3 (SARSr-Rh-BatCoV HKU3), oyo ezalaka na ngembo ya libende ya mpunda oyo ezalaka na Chine.	Further research in animals harboring SARS-CoV has shown a strong association with the CoV mosquito, SARS Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), which is found in the Chinese horseshoe bat.
567	en	ln	 These bats are positive for anti-SARS-CoV antibodies and genome sequence of SARSr-Rh-BatCoV HKU3. 	Bangembo oyo bazali na ba anti corps oyo ebundisaka SARS-CoV mpe genome ya SARSr-Rh-BatCoV HKU3.	Cattle with antibodies against SARS-CoV and the SARSr-Rh-BatCoV HKU3 genome.
568	en	ln	 This and other bat CoVs share 88-92% nucleotide sequence homology with SARS-CoV. 	Ngembo oyo mpe ngembo ya CoVs ezali na 88-92% ya ba nucleotide ya ndenge moko na SARS-CoV.	This strain and the CoVs strain have 88-92% nucleotide identity to SARS-CoV.
569	en	ln	 These studies have laid the foundation for the new concept that bats host emerging human pathogens. 	Balukiluki oyo esalisa mpo na kobimisa likanisi ya sika ete bangembo nde bamema maladi oyo bato bazwa.	These researchers have helped to develop a new theory that ticks are the carriers of human disease.
570	en	ln	 Several SARS-like CoVs (SL-CoVs) have also been identified from bats, but none except for one designated WIV1 can be isolated as live virus. 	Bamona mpe ete ba CoVs (SL-CoVs) mingi oyo ezali neti SARS euta na bangembo, kasi kaka WIV1 kati na nyonso ekoki kolobama ete ezali virisi oyo ezali na bomoi.	They also found that many SARS-like CoVs (SL-CoVs) originate from ticks, but only WIV1 of all can be considered a living virus.
571	en	ln	 Human angiotensin converting enzyme 2 (ACE2) is known to be the receptor of SARS-CoV. 	Eyebani ete enzyme 2 (ACE2) oyo ebongolaka angiotensine ya bato nde eza ebombeli ya SARS-CoV.	Human angiotensin-converting enzyme 2 (ACE2) is known to be the reservoir of SARS-CoV.
572	en	ln	 WIV1 derived from fecal sample of bats was demonstrated to use bat, civet and human ACE2 as receptor for cell entry. 	WIV1 oyo euti na nyei ya bangembo esalelamaki mpo na komonisa ndenge ya kosalela ngembo, civet mpe bato ACE2 neti esika ya koyamba baselile oyo ezali kokota.	WIV1 from the mosquito nest was used to demonstrate the use of mosquito, civet and human ACE2 as a host for invading cells.
573	en	ln	 Intriguingly, sera of convalescent SARS patients were capable of neutralizing WIV1. 	Likambo ya ntina ezali ete, sera ya bato oyo bazalaki kobika na SARS ekokaki koboma WIV1.	Importantly, sera from SARS survivors could kill WIV1.
574	en	ln	 Thus far, WIV1 represents the most closely related ancestor of SARS-CoV in bats, sharing 95% nucleotide sequence homology. 	Kino sikoyo, WIV1 ezali nkoko ya pene ya SARS-CoV na bangembo, mpo ezali ba nucleotide 95% ya ndenge moko.	So far, WIV1 is the closest ancestor of SARS-CoV in bats, because they are 95% nucleotides identical.
575	en	ln	 Albeit the high homology between these two viruses, it is generally believed that WIV1 is not the immediate parental virus of SARS-CoV and bats are not the immediate reservoir host of SARS-CoV. 	Ata boyokani ezali mingi na kati ya bavirisi mibale oyo, mbala mingi bato bandimaka ete WIV1 ezali te esika ya mibale oyo virisi ya SARS-CoV efandaka mpe bangebo bazali te esika oyo SARS-CoV efandaka.	Despite the many similarities between the two viruses, it is generally accepted that WIV1 is not the second host of SARS-CoV virus and that baboons are not the host of SARS-CoV.
576	en	ln	 Phylogenetic analysis clusters MERS-CoV to the same group as bat CoV-HKU4 and bat CoV-HKU5. 	Botaleli ya boyokani na yango ya ba MERS-CoV na etuluku moko na ngembo CoV-HKU4 mpe ngembo CoV-HKU5.	Analysis of its association of MERS-CoVs in a group with cow CoV-HKU4 and cow CoV-HKU5.
577	en	ln	 Bat CoV-HKU4 and MERS-CoV utilize the same host receptor, dipeptidyl peptidase 4 (DPP4), for virus entry. 	Ngembo ya CoV-HKU4 mpe MERS-CoV esalelaka eloko moko mpo na koboya, dipeptidyl peptidase 4 (DPP4), mpo na kokotisa virisi.	Both CoV-HKU4 and MERS-CoV use a resistance factor, dipeptidyl peptidase 4 (DPP4), to insert the virus.
578	en	ln	 RNA-dependent RNA polymerase sequences of MERS-CoV are phylogenetically closer to counterparts in bat beta-CoVs identified from Europe and Africa. 	RNA-etaleli RNA polymerase oyo elandi MERS-CoV ezali maladi moke oyo ezali pene ya ngembo mosusu ya beta-CoVs oyo bamonaki na Eropa mpe na Afrika.	The RNA-dependent RNA polymerase following MERS-CoV is a rare disease close to the other beta-CoVs detected in Europe and Africa.
579	en	ln	 Up to now, no live MERS-CoV can be found in wild bats. 	Kino sikoyo, tokoki komona te ata MERS-CoV moko ya bomoi na bangembo ya zamba.	So far, we have not been able to detect any live MERS-CoV in wild boars.
580	en	ln	 MERS-CoV and its closest relative bat CoV-HKU25 share only 87% nucleotide sequence homology. 	MERS-CoV mpe oyo ya libota na ye ya pene ngembo CoV-HKU25 ezali na 87% ya nucleotide ya ndenge moko.	MERS-CoV and its close relative CoV-HKU25 have 87% nucleotide identity.
581	en	ln	 Thus, bats might not be the immediate reservoir host of MERS-CoV. 	Yango wana, bangembo bakoki te bisika ya libosoliboso oyo MERS-CoV efandaka.	Therefore, mosquitoes cannot be the primary habitats of MERS-CoV.
582	en	ln	 On the other hand, studies in Middle East have shown that dromedary camels are seropositive for MERS-CoV-specific neutralizing antibodies, same as camels of Middle East origin in multiple African countries. 	Kasi, bolukiluki na moyen orient emonisi ete bakamela ya dromadaire ezalaka na MERS-CoV oyo ebomaka makila oyo ebundisaka maladi, ndenge moko na bakamela euta na moyen orient oyo ezali na mikili mingi ya Afrika.	However, studies in the middle east have shown that dromadarian camels carry immune-killing MERS-CoV, as do camels from the middle east which is found in many African countries.
583	en	ln	 Live MERS-CoV identical to the virus found in humans was isolated from the nasal swabs of dromedary camels, further indicating that camels serve as the bona fide reservoir host of MERS-CoV. 	MERS-CoV ya bomoi ya ndenge moko na virisi oyo bamonaka na bato, babimisaki yango na zolo ya bakamela ya dromadaire, emonisi lisisu ete bakamela ezali bisika oyo MERS-CoV efandaka.	A viable MERS-CoV similar to the virus found in humans was isolated from the nasal passages of dromadarian camels, further suggesting that camels are hosts for MERS-CoV.
584	en	ln	 It is also noteworthy that generally mild symptoms but massive virus shedding were observed in camels experimentally infected with MERS-CoV. 	Ezali mpe ntina mpo mbala mingi bilembo ya pete kasi ya ntina mingi ya kopanzana ya virisi emonanaki na bakamela oyo batelelaki oyo ezalaka na MERS-CoV.	It is also important because mild but significant signs of viral spread have often been observed in restrained camels carrying MERS-CoV.
585	en	ln	 Notably, infected camels shed viruses not only through respiratory route but also through fecal-oral route, which is also the main route for virus shedding from bats. 	Likambo ya ntina, bakamela oyo ezalaki na maladi epanzaki virisi kaka te na nzela ya kopema kasi mpe banda na nyei kino na monoko, yango ezali mpe nzela oyo virisi eutaka na bangembo mpe ekoteli biso.	Importantly, infected camels spread the virus not only through the respiratory tract but also from the throat to the mouth, which is also the route through which the virus comes from the insects and enters us.
586	en	ln	 However, questions still remain since many confirmed cases of MERS have no contact history with camels prior to symptom onset, plausibly ascribed to human-to-human transmission or unknown transmission routes involving unrecognized animal species that harbour MERS-CoV. 	Kasi, mituna ezali kaka mpo bato mingi oyo babela MERS bakutanaki te na bakamela liboso ete maladi wana ebanda, mbala mosusu moto moko apesaki basusu to toyebi te ndenge epesamaki uta na banyama eyebani te oyo ezalaki na MERS-CoV.	However, questions remain because most MERS patients were not exposed to camels prior to the onset of that disease, perhaps someone transmitted it to others or we do not know how it was transmitted from unknown animals carrying MERS-CoV.
587	en	ln	 SARS-CoV-2 shares 96.2% nucleotide homology with a bat CoV RaTG13 isolated from Rhinolophus affinis bats. 	SARS-CoV-2 ezali na 96,2% ya ba nucleotide ya ndenge moko na ngembo CoV RaTG13 oyo bazwaki na bangembo Rhinolophus affinis.	SARS-CoV-2 has 96.2% nucleotide identity to CoV RaTG13 isolated from Rhinolophus affinis.
588	en	ln	 As in the cases of SARS-CoV and MERS-CoV, the sequence divergence between SARS-CoV-2 and RaTG13 is too great to assign parental relationship. 	Lokola na bandakisa ya SARS-CoV mpe MERS-CoV, bokeseni eza kati na SARS-CoV-2 mpe RaTG13 eza makasi mpenza yango wana mwaye ezali te ya koloba bauta esika moko.	As in the examples of SARS-CoV and MERS-CoV, the differences between SARS-CoV-2 and RaTG13 are so strong that there is no way to say they came from the same place.
589	en	ln	 That is to say, bats might not be the immediate reservoir host(s) of SARS-CoV-2 unless almost identical bat CoVs are found in future. 	Elingi koloba, bangembo ekoki te esika to bisika ya mibale oyo ebombaka SARS-CoV-2 longola kaka soki tomoni oyo ezali ndenge moko na ngembo ya CoVs na mikolo ezoya.	That is, vectors cannot harbor secondary SARS-CoV-2 reservoirs or sites unless we see similar vectors of CoVs in the future.
590	en	ln	 Presumably, the intermediate animal hosts of SARS-CoV-2 should be among the wildlife species sold and killed at the Huanan Seafood Wholesale Market, with which many of the initial cases of COVID-19 were associated, indicative of a probable animal-to-human transmission event. 	Emonani ete, nyama oyo ezali esika ya mibale ya SARS-CoV-2 esengeli kozala na kati ya banyama ya zamba oyo batekaka mpe babomaka biloko ya mbu na Huanan, esika oyo bato bakanisaka ete bavirisi mingi ya COVID-19 eutaki, emonisi ete mbala mosusu bato bazwaki yango na banyama.	Apparently, the animal that is the second focal point of SARS-CoV-2 must have been involved in wild seafood sales and slaughter in Huanan, the suspected source of most of the COVID-19 viruses, suggests that it is likely humans inherited it from animals.
591	en	ln	 Several recent studies based on metagenomic sequencing have suggested that a group of endangered small mammals known as pangolins (Manis javanica) could also harbour ancestral beta-CoVs related to SARS-CoV-2. 	Bolukiluki mingi na oyo etali metagenome emonisi ete etuluku moko ya banyama oyo ezali na likama oyo babengaka bapangolin (Manis javanica) ekoki kozala bankoko ya beta-CoVs oyo ezali na boyokani na SARS-CoV-2.	Extensive metagenomic research suggests that an endangered group of pangolins (Manis javanica) may be the ancestors of beta-CoVs associated with SARS-CoV-2.
592	en	ln	 These novel pangolin CoV genomes share 85-92% nucleotide sequence homology with SARS-CoV-2. 	Bagenome ya pangolin ya sika ya CoV ekaboli 85-92% ya ba nucleotide ya ndenge moko na SARS-CoV-2.	New CoV pangolin genomes share 85-92% nucleotide identity with SARS-CoV-2.
593	en	ln	 However, they are equally closely related to RaTG13 with about 90% identity at the level of nucleotide sequence. 	Kasi, bakokani mpenza na RaTG13 mpo ezali ndenge moko na 90% na nivo ya ba nucleotide.	However, they are very similar to RaTG13 because they are 90% identical at the nucleotide level.
594	en	ln	 They cluster into two sub-lineages of SARS-CoV-2-like viruses in the phylogenetic tree, one of which share a more similar receptor binding domain (RBD) with SARS-CoV-2, with 97.4% amino acid sequence identity. 	Liboke na yango na milongo mibale ya mike ya bavirisi ya SARS-CoV-2 oyo euti na nzete, oyo eza ndenge moko na esika ya kouta ndenge moko (RBD) na SARS-CoV-2, 97,4% ya amino aside na yango.	It is composed of two small plant-derived SARS-CoV-2 virus lines, which share the same region of origin (RBD) as SARS-CoV-2, 97.4% of its amino acid sequence . . . .
595	en	ln	 In stark contrast, the RBDs of SARS-CoV-2 and RaTG13 are more divergent, albeit a higher degree of sequence homology genome-wide. 	Na kokesene makasi, RBDs ya SARS-CoV-2 mpe ya RaTG13 ekeseni mingi, ata ezali na bokokani makasi na nivo ya ba genome.	In sharp contrast, the RBDs of SARS-CoV-2 and RaTG13 are very different, even though they have strong similarities at the level of the genomes.
596	en	ln	 An earlier study on diseased pangolins also reported the detection of viral contigs from lung samples, which turn out to be similarly related to SARS-CoV-2. 	Bolukiluki moko ya kala na ba pangolin oyo bakufa emonisi ete ezalaki na bavirisi na bapoumon, mpe ezalaki ndenge moko na SARS-CoV-2.	A previous study on dead pangolins found that there were viruses in the lungs, and they were similar to SARS-CoV-2.
597	en	ln	 This study adopted different assembly methods and manual curation to generate a partial genome sequence comprising about 86.3% of the full-length viral genome. 	Bolukiluki oyo esalelaka mayele mosusu mpo na kosangisa na kobikisa mpo babimisa genome oyo ezali kati ya 86,3% ya molai mobimba ya virisi ya genome.	This research uses other techniques to combine with rescue to produce a genome that is between 86.3% of the total length of the virus genome.
598	en	ln	 We cannot exclude the possibility that pangolin is one of the intermediate animal hosts of SARS-CoV-2. 	Tokoki koboya te ete pangolin akoki kozala moko ya bisika ya mibale oyo ebombaka SARS-CoV-2.	We cannot rule out the possibility that the pangolin may be one of the secondary reservoirs for SARS-CoV-2.
599	en	ln	 However, currently there is no evidence in support of a direct pangolin origin of SARS-CoV-2 due to the sequence divergence between SARS-CoV-2 and pangolin SARS-CoV-2-related beta-CoVs. 	Kasi, kala mingi ezali na bilembeli oyo endimisi ete SARS-CoV-2 eutaka mpenza na pangolin mpo na bokeseni oyo ezali kati ya SARS-CoV-2 mpe pangolin SARS-CoV-2 oyo ekokani na beta-CoVs.	However, there has long been convincing evidence that SARS-CoV-2 does originate from pangolins because of the differences between SARS-CoV-2 and pangolin SARS-CoV-2 which are similar to beta-CoVs.
600	en	ln	 In addition, the distance between SARS-CoV-2 and RaTG13 is even shorter than that between SARS-CoV-2 and pangolin SARS-CoV-2-related beta-CoVs. 	Lisusu, mosika na kati ya SARS-CoV-2 mpe RaTG13 ezali moke mpenza koleka na kati ya SARS-CoV-2 mpe SARS-CoV-2 euti na bangolin beta-CoVs.	Furthermore, the distance between SARS-CoV-2 and RaTG13 is significantly smaller than between SARS-CoV-2 and SARS-CoV-2 from bangolin beta-CoVs.
601	en	ln	 The evolutionary pathway of SARS-CoV-2 in bats, pangolins and other mammals remains to be established. 	Bokoli ya nzela ya SARS-CoV-2 na bangembo, ba pangolin mpe banyama moko eyebani naino te.	The development of the SARS-CoV-2 pathway in goats, pangolins and other animals is not yet known.
602	en	ln	 Whereas the highest sequence homology has been found in the RBDs between SARS-CoV-2 and pangolin, SARS-CoV-2-related beta-CoVs, SARS-CoV-2 and RaTG13 share the highest genome-wide sequence homology. 	Ata boyokani ya makasi ezali na kati ya RBDs na SARS-CoV-2 mpe pangolin, SARS-CoV-2- ya beta-CoVs, SARS-CoV-2 mpe RaTG13 ezali na bagenome mingi mpenza ya ndenge moko.	Even though there is strong similarity among RBDs in SARS-CoV-2 and pangolin, SARS-CoV-2- of beta-CoVs, SARS-CoV-2 and RaTG13 have very many similar genomes.
603	en	ln	 It is highly speculative that the high degree of similarity between the RBDs of pangolin SARS-CoV-2-related beta-CoVs and SARS-CoV-2 is driven by selectivity-mediated convergent evolution. 	Bato bazoloba mingi ete bokokani ya mingi makasi na kati ya RBDs ya pangolin SARS-CoV-2 ya beta-CoVs mpe SARS-CoV-2 euti na ndenge ekolaka na ndenge ya kokabwana mingi.	It has been widely suggested that the most strong similarity in the pangolin SARS-CoV-2 RBDs of beta-CoVs and SARS-CoV-2 results from their highly discrete maturation.
604	en	ln	 A counter-proposal is in favour of a recombination between a pangolin SARS-CoV-2-related beta-CoV and RaTG13 in the third wild animal species. 	Likanisi ekeseni mpo na bosangani na kati ya pangolin moko ya SARS-CoV-2- mpe beta-CoV na RaTG13 na molongo ya minei ya banyama ya zamba.	A different view for the association in the same pangolin of SARS-CoV-2- and beta-CoV with RaTG13 in the fourth order of wildlife.
605	en	ln	 As a driving force in evolution, recombination is widespread among beta-CoVs. 	Mayele oyo esalemaka mingi na evolution, kosangana lisusu esalemaka mingi na kati ya beta-CoVs.	A common evolutionary strategy, recombination occurs frequently among beta-CoVs.
606	en	ln	 The jury is still out on the immediate zoonotic origin of SARS-CoV-2. 	Jury eyebi kaka te nyama nini ezali esika oyo SARS-CoV-2 eutaka.	The jury is still out on which animal is the source of SARS-CoV-2.
607	en	ln	 Besides the highly pathogenic HCoVs, the zoonotic origin of HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 have also been studied. 	Longola maladi moyo HCoVs epesaka, basi bayekoli mpe soki HCoV-229E, HCoV-OC43, HCoV-NL63 mpe HCoV-HKU1 euta na banyama.	In addition to the disease caused by HCoVs, women have also studied whether HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 originate from animals.
608	en	ln	 Phylogenetic evidence indicated that both HCoV-NL63 and HCoV-229E might have originated from bat CoVs, while the parental viruses of HCoV-OC43 and HCoV-HKU1 have been found in rodents. 	Bilembeteli ya phylogenetique emonisi ete mbala mosusu HCoV-NL63 mpe HCoV-229E eutaki na ngembo CoVs, kasi bavirisi ya HCoV-OC43 mpe HCoV-HKU1 euta na ba rongeur.	Phylogenetic evidence suggests that HCoV-NL63 and HCoV-229E probably originated from mosquito CoVs, whereas HCoV-OC43 and HCoV-HKU1 viruses originated from rodents.
609	en	ln	 It has been reported that a bat CoV termed ARCoV.2 (Appalachian Ridge CoV) detected in North American tricolored bat displayed close relationship with HCoV-NL63. 	Barapore emonisi ete ngembo ya CoV oyo babengi ARCoV.2 (Appalachian Ridge CoV) bamonaki yango na Amerika ya norde, mpe ngembo ya langi misato ezalaki na boyokani makasi na HCoV-NL63.	Barapore notes that a CoV strain called ARCoV.2 (Appalachian Ridge CoV) was detected in North America, and the tricolor strain was closely related to HCoV-NL63.
610	en	ln	 On the other hand, HCoV-229E was genetically related to another bat CoV, termed Hipposideros/GhanaKwam/19/2008, which was detected in Ghana, while camelids have also been suspected as its intermediate host. 	Na ngambo mosusu, HCoV-229E ezalaka ndenge moko na CoV mosusu ya ngembo, oyo babengaki Hipposideros/GhanaKwam/19/2008, oyo bamonaki na Ghana, kasi balobaki ete esika na yango ya mibale ya kofanda ezalaki camelidés.	Conversely, HCoV-229E is identical to another gecko CoV, designated Hipposideros/GhanaKwam/19/2008, which was detected in Ghana, but its secondary host was reported to be camelids.
611	en	ln	 For clarity, the current knowledge on animal origins of known HCoVs is summarized in Figure ​1 and Table 2. 	Mpo na koyeba malamu, boyebi ya sika ete HCoVs euta na banyama, bamonisi yango na mokuse na Motango​1 mpe Tablo 2.	For clarity, the latest knowledge that HCoVs originate from animals is summarized in Figure 1 and Table
612	en	ln	 Phylogenetic analysis has provided evidence for interspecies transmission events of HCoVs in the history. 	Botaleli ya phylogenetique emonisi bilembeteli ete na lisolo na yango HCoVs euta na ekelamu moko mpe eleki na basusu.	Phylogenetic analysis reveals evidence that historically HCoVs originate from one organism and are passed on to others.
613	en	ln	 When HCoV-OC43 crossed species to infect humans from domestic livestock around 1890, a pandemic of respiratory infection was recorded. 	Ntango HCoV-OC43 eutaka na ekelamu moko mpe eleki na mosusu mpo ekota na bato longwa na bibwele pene ya 1890, balobaki ebimisaki maladi moko ya mpema.	When HCoV-OC43 originated from one organism and passed to another to enter humans from livestock around 1890, it was said to have caused a respiratory illness.
614	en	ln	 The interspecies transmission history of HCoV-229E is less clear. 	Lisolo oyo emonisi ndenge HCoV-229E eutaki na ekelamu moko mpe eleki na mosusu ezali polele te.	The history of HCoV-229E transmission from one organism to another is unclear.
615	en	ln	 Bat alpha-CoVs closely related to HCoV-229E have been found. 	Basi bamona ete alpha-CoVs ya ngembo ezali na boyokani makasi na HCoV-229E.	They found that alpha-CoVs of the goat are highly related to HCoV-229E.
616	en	ln	 Between them there is an alpaca alpha-CoV. 	Na kati na yango ezali na alpaca alpha-CoV moko.	Among them is an alpaca alpha-CoV.
617	en	ln	 Several lines of evidence support the transmission of virus from bats to humans directly. 	Bilembetli mingi endimisi ete virisi wana eutaki na bangembo ebongo bapesaki yango mbala moko na bato.	There is a lot of evidence that the virus came from bats and was immediately transmitted to humans.
618	en	ln	 First, humans but not alpacas might have contact with bats in a shared ecological niche. 	Ya liboso, bato kasi ba alpaca te nde ekutanaki na bangembo na esika oyo bafandaka.	First, humans and not alpacas have been exposed to ticks in their natural habitat.
619	en	ln	 Instead, humans have close contact with alpacas. 	Atako bongo, bato bazali na boyokani ya pembeni mpenza na ba alpaca.	Still, humans have a very close relationship with alpacas.
620	en	ln	 Second, HCoV-229E-related bat alpha-CoVs are diverse and non-pathogenic in bats, whereas alpaca alpha-CoV caused an outbreak of respiratory disease in infected animals. 	Ya mibale, HCoV-229E- euta na ngembo, alpha-CoVs ekeseni mpe epesaka maladi te na bangembo, kasi alpha-CoV alpaca ebimisaki maladi ya mpema na banyama oyo bazalaki na yango.	Second, HCoV-229E- is derived from goats, alpha-CoVs are different and do not cause disease in goats, but alpha-CoV alpaca caused respiratory disease in infected animals.
621	en	ln	 Finally, alpaca alpha-CoV has not been found in feral animals. 	Na nsuka, alpha-CoV alpaca emonana te na nyei ya banyama.	Finally, alpha-CoV alpaca was not detected in animal feces.
622	en	ln	 Thus, the possibility cannot be excluded that alpacas obtain the HCoV-229E-related alpha-CoV from humans. 	Yango wana, tokoki koboya te mbala moko ete ba alpaca bazwaki HCoV-229E ya alpha-CoV na bato.	Therefore, we cannot simultaneously exclude that alpacas were infected with HCoV-229E of alpha-CoV in humans.
623	en	ln	 In fact, bats are the direct source of human pathogenic viruses including rabies virus, Ebola virus, Nipah virus and Hendra virus. 	Ya solo, bangembo bazali na ebandeli ya bavirisi mingi oyo ememela bato maladi, na ndakisa virisi ya bampuku, virisi ya Ebola, virisi Nipah mpe virisi Hendra.	Indeed, mosquitoes are the source of many disease-causing viruses, such as mosquito virus, Ebola virus, Nipah virus, and Hendra virus.
624	en	ln	 It is therefore not too surprising that bats might transmit HCoV-229E to humans directly. 	Yango wana ezali kokamwisa te soki mbala mosusu bangembo nde bato bapesaki bato mbala moko virisi HCoV-229E.	It is therefore not surprising that the HCoV-229E virus may have been directly transmitted to humans by mice.
625	en	ln	 Alternatively, whereas bat alpha-CoVs serve as the gene pool of HCoV-229E, alpacas and dromedary camels might serve as intermediate hosts that transmit viruses to humans, exactly as in the case of MERS-CoV. 	To, ata alpha-CoVs ngembo yango nde epesa makila na yango na CoV-229E, ba alpaca mpe bakamela dromadaire ekoki kozala esika ya mibale oyo efandaka oyo ememelaka bato bavirisi, kaka ndenge esalemaki mpo na MERS-CoV.	Or, even if the alpha-CoVs donated their blood to CoV-229E, alpacas and dromadarian camels may be secondary habitats that transmit viruses to humans, as was the case with MERS-CoV.
626	en	ln	 MERS-CoV serves as an excellent example of interspecies transmission from bats to dromedary camels and from dromedary camels to humans. 	MERS-CoV ezali ndakisa ya malamu emonisa ndenge virisi eutaki na bangembo mpe ekomaka na bakamela dromadaire mpe longwa na bakamela dromadaire mpe ekotela bato.	MERS-CoV is a good example of how the virus came from pigs to dromadaries and from dromadaries to humans.
627	en	ln	 The evolutionary origin of MERS-CoV from bats is known at its initial identification and has also been strengthened by subsequent findings. 	Bokoli ya esika MERS-CoV euta banda na bangembo eyebani ndenge bamonaki yango na ebandeli mpe makambo bamona nsima epusaka na kondima bango.	The development of the source of MERS-CoV since the initial discovery of MERS-CoV is known and subsequent findings lead to their belief.
628	en	ln	 It is obvious that bats provide a rich pool of virus species for interspecies exchange of genetic fragments and interspecies transmission. 	Eyebani ete bangembo bazali na bavirisi mingi oyo ekabolamaka na kati ya bikelamu mingi mpe ndenge eutaka na ekelamu moko mpe ekotaka na ekelamu mosusu.	Ticks are known to carry many viruses that are distributed among many organisms and that they are transmitted from one organism to another.
629	en	ln	 Longevity, densely packed colonies, close social interaction and strong ability to fly are all favourable conditions for bats to be an ideal 'virus spreader'. 	Kuwemela, kofanda bituluku moko, kozala na boyokani ya pene mpenza mpe makoki makasi ya kopumbwa ezali malamu mpenza mpo bangembo bazala ekelamu ya ‘kopanza virisi’.	Fighting, living in groups, close relationships and strong flight abilities are ideal for ants to be &#39;virus-spreading&#39; creatures.
630	en	ln	 On the other hand, MERS-CoV has been introduced to dromedary camels for decades. 	Na ngambo mosusu, MERS-CoV ekotela bakamela dromadaire banda kala.	On the other hand, MERS-CoV has been infecting dromadarian camels for a long time.
631	en	ln	 It is well adapted to these camels that have turned from an intermediate host to a stable and natural reservoir host. 	Emesana mingi na bakamela wana yango wana ezalaka lisusu te esika na yango ya mibale ya kofanda kasi esika ebonga mpe ya malamu mpo na yango.	It is so used to these camels that it is no longer its second home but a suitable and comfortable place for it.
632	en	ln	 MERS-CoV causes very mild disease and maintains a relatively low mutation rate in these animals. 	MERS-CoV ebimisaka maladi ya makasi te mpe epanzanaka mingi mpenza na kati ya banyama wana.	MERS-CoV does not cause severe disease and is extremely widespread among these animals.
633	en	ln	 Its sporadic transmission to humans is an accident and humans remain a dead-end host of MERS-CoV as its transmission cannot be sustained. 	Ndenge ekota na bato ezali libaku mpe bato bakotikala kolata yango suka mpo kopanzana ya MERS-CoV ekoki kolanda te.	The way it enters humans is an opportunity and people will continue to wear it eventually because the spread of MERS-CoV cannot continue.
634	en	ln	 In contrast to the role of camels in the transmission of MERS-CoV, the role of pangolins, if there is any, in the transmission of SARS-CoV-2 is different. 	Na kokesena na mokumba ya bakamela na kopanzana ya MERS-CoV, mokumba ya bapangolin, soki ekoki kozala, na kopanzana ya SARS-CoV-2 eza ya kokesena.	Unlike the role of camels in the spread of MERS-CoV, the role of pangolins, if any, in the spread of SARS-CoV-2 is different.
635	en	ln	 Particularly, pangolin beta-CoVs are highly pathogenic in pangolins. 	Mingimingi, beta-CoVs pangolin epesaka maladi mingi na bapangolin.	In particular, pangolin beta-CoVs are highly pathogenic in pangolins.
636	en	ln	 They might be a dead-end host for SARS-CoV-2-related beta-CoVs, similar to civets in the case of SARS-CoV. 	Bakozala esika ya liwa mpona SARS-CoV-2 mpe beta-CoVs, ndenge moko na ba civette mpo na SARS-CoV.	They will be a deadly source for SARS-CoV-2 and beta-CoVs, just as civets are for SARS-CoV.
637	en	ln	 Several possibilities for interspecies transmission of SARS-CoV-2 from animals to humans have to be ruled in or ruled out in future studies. 	Ezali na makoki mingi mpo SARS-CoV-2 euta na ekelamu moko mpe ekota na mosusu, uta na banyama mpe ekotela bato, kasi ekosenga nde bolukiluki ya mikolo ezali koyaka nde endimisa yango.	There is a high potential for SARS-CoV-2 to be transmitted from one organism to another, from animals to humans, but future research will need to confirm this.
638	en	ln	 First, bats could be the reservoir host of a SARS-CoV-2-related virus almost identical to SARS-CoV-2. 	Ya liboso, bangembo ekoki kozala esika bavirisi SARS-CoV-2 efandaka oyo ekokani mpenza na SARS-CoV-2.	First, mosquitoes may be home to SARS-CoV-2 viruses that closely resemble SARS-CoV-2.
639	en	ln	 Humans might share the ecological niche with bats through butchering or coal mining. 	Bato bakoki kokabola esika moko elongo na bangembo na nzela ya koboma bango to na mine ya makala.	People can share a place with the bangers by killing them or in a coal mine.
640	en	ln	 Second, pangolins could be one of intermediate amplifying host to which a SARS-CoV-2-related virus had been newly introduced. 	Liboso, ba pangolin bakoki kozala moko ya bisika ya mibale ya malamu oyo virisi SARS-CoV-2 ekota kala te.	First, pangolins may be one of the second best sites for the recent entry of the SARS-CoV-2 virus.
641	en	ln	 Humans contract the virus through butchering and consumption of game meat. 	Bato bazwaka virisi na nzela ya koboma banyama mpe kolya mosuni ya banyama.	Humans contract the virus through slaughter and consumption of animal meat.
642	en	ln	 It is possible that many mammals including domestic animals are susceptible to SARS-CoV-2. 	Ekoki kozala ete banyama babengami bamamifere ata banyama efandaka na ndako ekoki kozwa SARS-CoV-2.	It is possible that mammals and even domestic animals can contract SARS-CoV-2
643	en	ln	 A survey of domestic and wild animals for antibodies is warranted. 	Bolukiluki na banyama ya ndako mpe ya zamba mpo na kosala ba anticorps ebongi mpenza.	Research in domestic and wild animals to develop antibodies is particularly appropriate.
644	en	ln	 Third, as mentioned above, recombination and adaptation of SARS-CoV-2 might have occurred in a third species that has contact with both bats and pangolins. 	Ya misato, ndenge tolobeli likolo, kosangisa lisusu mpe komesana ya SARS-CoV-2 mbala mosusu esalemaki na ekelamu ya misato oyo ekutanaki na bangembo mpe bapangolin.	Third, as discussed above, recombination and adaptation of SARS-CoV-2 likely occurred in a third organism that contacted baboons and pangolins.
645	en	ln	 The search for the animal origins of SARS-CoV-2 is still on. 	Bazali kosala bolukiluki mpo na koyeba esika SARS-CoV-2 euta.	The source of SARS-CoV-2 is being investigated.
646	en	ln	 Apart from different types of the animal hosts, three major factors on the viral side are also important in facilitating CoVs to cross species barriers. 	Longola balolenge wana ya banyama oyo ekoki kozala na yango, makambo misato ya minene etali virisi oyo eza mpe ntina mingi mpo na kosalisa CoVs ezali kokota na bikelamu mosusu.	In addition to these potential animal species, three major aspects of the virus that is also important for the treatment of CoVs are the infection of other organisms.
647	en	ln	 First of all, their relatively high mutation rates in RNA replication. 	Ya liboso, ndenge etambolaka mingi na RNA mpe ebotaka.	First, how it travels a lot with RNA and reproduces.
648	en	ln	 In comparison to other single-stranded RNA viruses, the estimated mutation rates of CoVs could be regarded as “moderate” to “high” with an average substitution rate being ~10-4 substitution per year per site 2, depending on the phase of CoV adaptation to novel hosts. 	Na bokeseni na bavirisi mosusu ya RNA, ndenge CoVs etambolaka ekoki kotalelama neti “ya malamu” mpe “ya makasi” mpe echangaka na ~10-4 na mbula moko na bisika 2, na kotalela lolenge ya CoV ndenge ezali komesana na bisika na yango ya sika.	Unlike other RNA viruses, the movement of CoVs can be considered “normal” and “robust” and changes at ~10-4 times per year in 2 environments, depending on the type of CoV as it adapts to its environment money.
649	en	ln	 CoVs have a proof-reading exoribonuclease, deletion of which results in exceedingly high mutability and attenuation or even inviability. 	CoVs ezali na botangi moko ya exoribonuclease, koboma yango ekoki kosala ete ebotama lisusu mingi mpenza mpe kokitisa bokasi na yango to nkutu ekoka kokola te.	CoVs have a single exoribonuclease reading, killing them can cause them to reproduce dramatically and reduce their effectiveness or even fail to grow.
650	en	ln	 Interestingly, the nucleotide analogue Remdesivir is known to suppress CoV replication through inhibition of this exoribonuclease and the RNA-dependent RNA polymerase. 	Likambo ezali kobenda likebi ezali ete eyebani ete nucleotide ya ntina ya Remdesivir ebomaka kobotama ya CoV ndenge ekangaka exoribonuclease oyo mpe RNA oyo eutaka na polymerase RNA.	Interestingly, the core nucleotide of Remdesivir is known to kill CoV replication as it blocks this exoribonuclease and RNA from RNA polymerase.
651	en	ln	 Remdesivir is one of most promising anti-SARS-CoV-2 agents to be tested in clinical trials. 	Remdesivir eza moko ya bankisi ya malamu mingi ya SARS-CoV-2 oyo esengeli bameka yango na bato.	Remdesivir is one of the most effective SARS-CoV-2 drugs that needs to be tested in humans.
652	en	ln	 Nevertheless, mutation rates of CoVs are about a million times higher than those of their hosts. 	Atako bongo, motango ya mutation ya CoVs ezali likolo pene ya milio moko koleka ya bisika oyo efandaka.	Nevertheless, the mutation rate of CoVs is higher by about one million than the habitats.
653	en	ln	 In addition, mutation rate is often high when CoVs are not well adapted to the host. 	Lisusu, mbala mingi motango ya mutation ezalaki mingi soki CoVs emesani te na esika na yango ya sika.	Moreover, the mutation rate was usually higher if CoVs were not adapted to their new environment.
654	en	ln	 Compared to SARS-CoV with a high mutation rate, the mutation rate of SARS-CoV-2 is apparently lower, suggestive of a higher level of adaptation to humans. 	Soki tokokanisi yango na SARS-CoV oyo ezali na motango ya mutation ya likolo, emonani ete motango ya mutation ya SARS-CoV-2 ezali na nse, oyo ezali komonisa ete emesanaka mingi mpenza na bato.	Compared to SARS-CoV with a higher mutation rate, SARS-CoV-2 appears to have a lower mutation rate, indicating that it adapts significantly more to humans.
655	en	ln	 Presumably, it has already been adapted to another host close to humans. 	Tokoki koloba ete, esi emesana na esika mosusu ya kofanda oyo ezli pene na bato.	In a sense, it has adapted to another settlement that is close to people.
656	en	ln	 In addition to SARS-CoV-2, this also applies to MERS-CoV, which is well adapted to dromedary camels. 	Longola SARS-CoV-2, etali mpe MERS-CoV, oyo emesana malamu na bakamela dromadaire.	In addition to SARS-CoV-2, it also applies to MERS-CoV, which is well adapted to dromadarian camels.
657	en	ln	 Theoretically, it is unlikely that genetic drift would render vaccines and antivirals against SARS-CoV-2 ineffective quickly. 	Na maloba, ezali mpo mbongwana ya genotype ekobimisa mangwele mpe bankisi ya kobundisa virisi SARS-CoV-2 mpo noki ezala makasi te.	In words, it is because the genotype change will produce vaccines and anti-SARS-CoV-2 virus drugs so that it soon becomes weaker.
658	en	ln	 Second, the large RNA genome in CoVs exerts extra plasticity in genome modification for mutations and recombination, thereby increasing the probability for interspecies co-evolution, which is advantageous for the emergence of novel CoVs when the conditions become appropriate. 	Ya mibale, genome RNA ya monene oyo ezali na CoVs ezala na mwa bopusi na mbongwana oyo esalemaka mpe na bozongi na yango, yango wana ematisaka makoki na yango ya kokola, mpe ezali malamu mpo na kobima ya CoVs ya sika ntango makambo ekobonga.	Second, the large RNA genome containing CoVs is relatively sensitive to mutations and replication, thus increasing their ability to evolve, and is conducive to the emergence of new CoVs when conditions improve.
659	en	ln	 This is supported by the copious unique open reading frames and protein functions encoded towards the 3′ end of the genome. 	Likambo oyo esimbami na ndenge bakadre na yango efungwamaka mpe mosala ya proteine ebimisaka 3’ nsuka ya genome.	This fact is underpinned by the fact that its frames open and the activity of the protein releases the 3&#39; end of the genome.
660	en	ln	 Third, CoVs randomly and frequently switch templates during RNA replication through a unique “copy-choice” mechanism. 	Ya misato, CoVs ebongolaka ndenge na yango kaka boye mpe mbala mingi ntango ebongolaka RNA na nzela ya mayele ya kokamwa ya “kopona-kopi”.	Third, CoVs change shape just so and often when modifying RNA through a remarkable “selective-copy” mechanism.
661	en	ln	 In a host that serves as the mixing vessel, strand switching occurs frequently during CoV RNA transcription. 	Na esika oyo efandaka mpe oyo esalaka na kosangisa yango, ebongwanaka mbala mingi na ntango ya kokoma CoV RNA.	In the environment in which it resides and in which it interacts, it changes several times during CoV RNA transcription.
662	en	ln	 Highly homologous full-length and subgenomic RNAs could recombine to generate new CoVs. 	Ba RNAs ya milai mingi ya ndenge moko mpe ba genome ya mike ekoki kosangana mpo na kobimisa CoVs ya sika.	Very long similar RNAs and small genomes can combine to produce novel CoVs.
663	en	ln	 Phylogenetic evidence of natural recombination has been found in both HCoV-HKU1 and HCoV-OC43, as well as animal CoVs such as bat SL-CoV and batCoV-HKU9. 	Bilembeteli ya phylogenetique ya kosangana ya normal emonanaki na HCoV-HKU1 mpe HCoV-OC43, mpe na CoVs nyama na ndakisa SL-CoV ngembo mpe batCoV-HKU9.	Phylogenetic evidence of normal mixing was observed in HCoV-HKU1 and HCoV-OC43, and in animal CoVs such as SL-CoV ngambo and batCoV-HKU9.
664	en	ln	 Virus-host interaction in relation to transmission 	Boyakani ya virisi na esika virisi efandaka na oyo etali ndenge epanzanaka	The relationship of the virus to the viral environment in terms of how it spreads
665	en	ln	 Besides three viral factors stated above, viral interaction with host receptor is another key factor influential on interspecies transmission. 	Longola makambo misato ya virisi oyo tolobeli na likolo, boyokani ya virisi na esika efandaka ezali eloko mosusu ya ntina na oyo etali ndenge eutaka na bikelamu moko mpe ekota na ekelamu mosusu.	In addition to the three aspects of the virus mentioned above, the relationship of the virus to its habitat is another important factor in its transmission from one organism to another.
666	en	ln	 Herein, recombination of SARS-CoV is taken as a typical example, which also showed evidence of positive selection during interspecies transmission events. 	Na kati, kosangana ya SARS-CoV elobelami neti ndakisa, mpe emonisi ete epanzaka maladi ntangu ekutaka na ekelamu moko mpe ekotaka na ekelamu mosusu.	In it, the SARS-CoV combination is discussed as an example, and shows that it spreads disease when it meets one organism and enters another.
667	en	ln	 Based on the comparative analysis between isolates of human and civet SARS-CoVs, SARS-CoV is thought to undergo rapid adaptation in different hosts, particularly with mutations at the RBD of the S protein. 	Na kolanda botaleli ya kokesenisa na kati ya bato mpe nyama civet SARS-CoVs, emonani ete SARS-CoV ekokoba kobongwana noki na bisika oyo efandaka, mingimingi ndenge etambolaka na RBD ya proteine S.	Based on the comparative analysis of human and civet SARS-CoVs, it appears that SARS-CoV will continue to evolve rapidly in its habitats, particularly as it moves with the S protein RBD.
668	en	ln	 Generally, the RBD in the S protein of a CoV interacts with the cellular receptor and is intensely selected by the host antibody response. 	Mbala mingi, RBD ya proteine S ya CoV ezalaka na boyokani na baselile oyo ezwaka yango mpe eponamaka mingi na anticorp ya esika ekei kofanda.	The RBD of the CoV S protein is usually associated with host cells and is highly selective for the host antibody.
669	en	ln	 In SARS-CoV, the RBD is in the 318th to 510th amino acids on the S1 fragment, which binds to the human ACE2 as well as its coreceptors for viral entry. 	Na SARS-CoV, RBD ezali na aside amino ya 318 kino ya 510 na eteni ya S1 , oyo esanganaka na ACE2 ya bato mpe bisika mosusu oyo virisi ekotaka.	In SARS-CoV, the RBD consists of amino acids 318 to 510 in the S1 segment , which associates with human ACE2 and other viral entry sites.
670	en	ln	 The RBD of SARS-CoV is capable of recognizing the ACE2 receptors of various animals, including bat, civet, mouse and raccoon dog, allowing interspecies transmission of the virus. 	RBD ya SARS-CoV ekoki koyeba bikoko ezwaka ACE2 ya banyama mingi, na ndakisa ngembo, civet, mpuku mpe mbwa ya zamba, yango esalisaka virisi euta na ekelamu moko mpe ekota na ekelamu mosusu.	The RBD of SARS-CoV can be detected by chickens that infect the ACE2 of many animals, such as foxes, civets, foxes and wild dogs, which allows the virus to move from one organism to another.
671	en	ln	 In fact, only 6 amino acid residues were observed to be different from human and civet viral isolates in the RBD and 4 of them locate in the receptor-binding motif for interaction with the ACE2 receptor. 	Ya solo, batika ya ba-amino aside 6 mpamba emonanaki ete ekeseni na bato mpe virisi ya civet oyo babimisaki na RBD mpe 4 kati na yango oyo ezali na eloko ezwaka yango ezalaka na boyokani na eloko ezwaka ACE2.	Indeed, only 6 amino acid residues were found to be different from human and RBD-produced civet viruses and 4 of these receptor-bearing ones are associated with the ACE2 receptor.
672	en	ln	 Civet SARS-CoV has K479N and S487T mutations in its RBD, which might increase the affinity of the interaction of spike protein with human ACE2 receptor. 	SARS-CoV civet ezali na mbongwana ya K479N mpe ya S487T na RBD na yango, mpe yango ematisaka boyakani kati ya proteine ya nsonge na ACE2 ya bato oyo ezwaka yango.	SARS-CoV civet contains both the K479N and the S487T changes in its RBD, and this enhances the interaction between the peak protein and the ACE2 of human hosts.
673	en	ln	 In other words, these two amino acid substitutions might be critical to viral adaption to humans. 	Na maloba mosusu, biloko mibale oyo ezwaka esika ya aside amino ekoki kozala ntina mingi mpo virisi emesana na nzoto ya bato.	In other words, two amino acid substitutions may be essential for the virus to adapt to the human body.
674	en	ln	 It is noteworthy that SARS-CoV-2 shares the same cellular receptor with SARS-CoV. 	Eza ntina koyeba ete SARS-CoV-2 eza ya ndenge moko oyo ebombaka yango neti SARS-CoV.	It is important to note that SARS-CoV-2 is a strain that hides itself as SARS-CoV.
675	en	ln	 A 30% difference between SARS-CoV-2 and SARS-CoV in the S1 unit of the S protein implicates that the binding affinity of its S protein with human ACE2 might have altered. 	Bokeseni ya 30% na kati ya SARS-CoV-2 mpe SARS-CoV na eteni S1 ya proteine S emonisi ete boyokani ya proteine S na yango na ACE2 ya bato ekoki kobongwana.	The 30% difference between SARS-CoV-2 and SARS-CoV in the S1 portion of the S protein suggests that the interaction of its S protein with human ACE2 may be altered.
676	en	ln	 Indeed, a cryo-EM study indicates a 10- to 20-fold higher affinity of this binding than that between human ACE2 and SARS-CoV S protein. 	Ya solo, bolukiluki moko ya cryo-EM emonisi ete boyokani ya 10- kino 20- ya bosangani oyo koleka oyo eza kati ya ACE2 ya bato mpe SARS-CoV ya proteine S.	Indeed, a cryo-EM study suggests a 10- to 20-fold greater affinity for this interaction than that between human ACE2 and S-protein SARS-CoV.
677	en	ln	 It will also be of interest to determine whether any other coreceptor might be required for SARS-CoV-2 transmission. 	Ekozala mpe ntina na koyeba soki ekosenga eloko mosusu mpo na kopanza SARS-CoV-2.	It will also be important to determine whether something else will be needed to spread SARS-CoV-2
678	en	ln	 Intriguingly, HCoV-NL63 also binds to ACE2 but with a different part of S. 	Likambo ezokamwisa, HCoV-NL63 esanganaka mpe na ACE2 kasi na eteni mosusu ya S.	Interestingly, HCoV-NL63 also associates with ACE2 but with a different S component.
679	en	ln	 There exist many other HCoV receptors, such as aminopeptidase N for HCoV-229E, and 9-O-acetylated sialic acid for HCoV-OC43. 	Ezali na biloko mingi mosusu oyo eyambaka HCoV, na ndakisa aminopeptidase N mpo na HCoV-229E, mpe 9-O-aside sialique acetylé mpo na HCoV-OC43.	There are many other HCoV receptors, including aminopeptidase N for HCoV-229E, and acetylated 9-O-sialic acid for HCoV-OC43.
680	en	ln	 They might also account for successful adaptation of these CoVs in humans after interspecies transmission from their animal hosts. 	Ekoki mpe kosalisa na ndenge ba CoVs oyo ekokaka komesana na nzoto ya bato nsima ya kouta na banyama esika ezalaka.	It may also help with the ability of these CoVs to adapt to the human body after originating from animals.
681	en	ln	 In addition to cellular receptors, the outcome of interspecies transmission of HCoVs is also governed by other host dependency and restriction factors. 	Longola baselila oyo eyambaka yango, matomba ya ndenge HCoVs eutaka ekelamu moko mpe ekotaka na ekelamu mosusu etambwisami na boyokani na yango na bisika mosusu oyo efandaka mpe makambo oyo ekangaka yango nzela.	In addition to host cells, the effects of how HCoVs move from one organism to another are governed by their interactions with other habitats and barriers.
682	en	ln	 The divergence of these host proteins between humans and natural reservoir hosts of HCoVs such as bats, dromedary camels and rodents might constitute a barrier to interspecies transmission. 	Bokeseni ya baproteine ya bisika oyo efandaka na kati ya bato mpe esika oyo biloko oyo ebombaka HCoVs ezalaka na ndakisa bangembo, bakamela dromadaire mpe ba rongeur ekoki kozala eloko oyo ekopekisa yango euta ne ekelamu moko mpe ekota na mosusu.	Protein diversity of habitats among humans and the location of reservoirs of HCoVs such as geese, dromadarian camels and rodents may be a barrier to transmission from ne one organism to another.
683	en	ln	 HCoVs have to usurp host dependency factors and subvert host restriction factors for a successful interspecies transmission. 	HCoVs esengeli kozwa ya esika ya eloko ebomaka yango mpe kobongola makambo oyo ekangaka yango nzela mpo ezwa likoki ya kouta na ekelamu moko mpe kokota na ekelamu mosusu.	HCoVs must acquire of the environment that kills it and change the factors that prevent it from being able to move from one organism to another.
684	en	ln	 In this regard, molecular determinants in this important area of virus-host interaction remain to be identified and characterized. 	Na likambo oyo, eloko esalisaka na koyeba molekile na likambo ya ntina oyo etali boyokani na kati ya virisi mpe esika efandaka eyebani kaka te mpe ekosenga kolukaluka.	In this case, the contribution of molecular identification to the important issue of interactions in the virus and its environment is still unknown and will require investigation.
685	en	ln	 An unbiased genome-wide screening of host dependency and restriction factors for SARS-CoV-2 using the state-of-the-art technology of CRISPR might be fruitful. 	Depistage ya malamu ya dependance ya genome mpe makambo oyo ekangaka yango nzela mpo na SARS-CoV-2 oyo esalelaka mayele makasi ya CRISPR ekoki kosalisa.	Better screening of genome dependence and constraining factors for SARS-CoV-2 using strong CRISPR technology may help.
686	en	ln	 Emergence of novel HCoVs: back to ground zero 	Kobima ya HCoVs ya sika: kozonga na ebandeli	Emergence of new HCoVs: back to the beginning
687	en	ln	 The diversity of bat CoVs provides ample opportunities for the emergence of novel HCoVs. 	Bokeseni ya CoVs ngembo ezali kopesa makambo mingi mpo na kobima ya HCoVs ya sika.	The diversity of CoVs in the field provides many factors for the emergence of new HCoVs.
688	en	ln	 In this sense, bat CoVs serve as the gene pool of HCoVs. 	Na ndimbola, CoVs ngembo ezali esika oyo HCoVs eutaka.	By definition, CoVs ngambo is the source of HCoVs.
689	en	ln	 In addition, rapid mutation and genetic recombination also drive HCoV evolution and serve as two important steps in this process. 	Lisusu, mutation ya noki mpe kosangana ya ba gene esalisaka mpe na bokoli ya HCoV mpe ezalaka bitambe mibale ya ntina na likambo oyo.	Moreover, rapid mutation and gene integration also contribute to HCoV progression and are two important steps in this process.
690	en	ln	 For example, the acquisition or loss of novel protein-coding genes has the potential to drastically modify viral phenotypes. 	Na ndakisa, kozwa to kobungisa codage ya ba gene ya proteine ezali na likoki ya kobongola mingi mpenza boyokani na kati ya bavirisi.	For example, gain or loss of protein gene coding has the potential to dramatically alter interactions within viruses.
691	en	ln	 Among SARS-CoV accessory proteins, ORF8 has been thought to be important in adaptation to humans, as SARS-CoV-related bat viruses were isolated but found to encode divergent ORF8 proteins. 	Na kati ya biloko ya baproteine SARS-CoV, emonani ete ORF8 eza ntina mingi mpo emesana na nzoto ya bato, mpo bavirisi ya ngembo ya SARS-CoV, batyaki yango mopanzi kasi emonanaki ezalaka lolenge mosusu ya kobombana ya baproteine ORF8.	Among the SARS-CoV proteins, ORF8 appears to be the most important for adaptation to the human body, because SARS-CoV anthrax viruses, have been set aside but have been found to be another latent form of ORF8 proteins.
692	en	ln	 A 29-nucleotide deletion characteristic of SARS-CoVs has been found in strains isolated at the beginning of the human epidemic. 	Bamonaki ete babomaki 29-nucleotide ya SARS-CoVs oyo batyaka na mopanzi na ebandeli ya maladi mabe epai ya bato.	They found that the 29-nucleotide flanker of SARS-CoVs was killed at the onset of malignancy in humans.
693	en	ln	 This deletion splits ORF8 into ORF8a and ORF8b and is thought to be an adaptive mutation that promotes the switch of hosts. 	Koboma oyo ekabola ORF8 na ORF8a mpe ORF8b mpe bakanisi eza eloko oyo esalisaka yango elongwa na esika mpe ekota na bisika mosusu.	This kill separates ORF8 from ORF8a and ORF8b and is thought to be what helps it move from one site to another.
694	en	ln	 Besides, SARS-CoV has a possible recombination history with lineages of alpha- and gamma-CoVs, where a large number of smaller recombinant regions were identified in the RNA-dependent RNA polymerase. 	Lisusu, SARS-CoV ekoki kosangana lisusu na molongo ya alpha- mpe gamma-CoVs, esika bosangani mingi ya mikemike emonanaki na RNA oyo euta na RNA ya polymerase.	Furthermore, SARS-CoV can recombine with the alpha- and gamma-CoVs sequence, where many minor combinations have been observed with RNA from RNA polymerase.
695	en	ln	 Recombination locations were also identified in the nsp9, most of nsp10, and parts of nsp14. 	Bisika ya kosangisa yango emonanaki mpe na nsp9, mingi ya nsp10, mpe biteni ya nsp14.	Sites of this fusion were also observed in nsp9, most of nsp10, and fragments of nsp14.
696	en	ln	 Likewise, it has been shown that the epidemic MERS-CoV experienced recombination events between different lineages, which occurred in dromedary camels in Saudi Arabia. 	Ndenge moko, emonani ete maladi mabe ya MERS-CoV esanganaki na kati ya milongo mingi, oyo esalemaki na bakamela dromadaire ya Arabie Saudite.	Similarly, MERS-CoV malignancies appear to have been associated in several lines, which were carried out in Saudi Arabian dromadarian camels.
697	en	ln	 Besides SARS-CoV and MERS-CoV, recombination events have also been observed in other HCoVs, in which the HCoVs recombine with other animal CoVs in their non-structural genes. 	Longola SARS-CoV mpe MERS-CoV, makambo ya kosangana emonanaki mpe na ba HCoVs mosusu, na kati na yango HCoVs esanganaki na CoVs ya nyama mosusu na ba gene na yango.	In addition to SARS-CoV and MERS-CoV, fusion events have also been observed in other HCoVs, in which HCoVs have fused with other animal CoVs in their genes.
698	en	ln	 It should also be cautioned that artificial selection can contribute to unintended changes in viral genomes, most likely resulting from relieving viruses from selection pressures exerted, such as by the host immune system. 	Esengeli mpe kokeba mpo kopona oyo ya lokuta ekoki komema na mbongwana tokanaki te ya ba genome oyo ememaka bavirisi, mpe ekoki ete elembisa bavirisi na bopusi oyo ezali kokutana na yango, na ndakisa mikrobe oyo ebundisaka maladi na nzoto ya bato oyo bazalo na yango.	Care must also be taken because spurious selection may lead to unintended changes in viral vector genomes, and may weaken viruses against the influences they face, such as host immune responses.
699	en	ln	 An example of these effects is the loss of a full-length ORF4 in the HCoV-229E prototype strain, owing to a two-nucleotide deletion. 	Na ndakisa moko ya makambo wana ezali kobungisa mobimba ya ORF4 na HCoV-229E prototype, oyo esalemaki mpo babomaki ba nucleotide mibale.	For example one of these features is the complete loss of ORF4 in the HCoV-229E prototype, which occurred because two nucleotides were killed.
700	en	ln	 While intact ORF4 could be observed in bat and camel viruses related to HCoV-229E, the alpaca alpha-CoV displays a single nucleotide insertion, resulting in a frameshift. 	Ata ORF4 oyo ebebi te ekoki komonana na ngembo mpe na bavirisi ya bakamela oyo ezali na boyokani na HCoV-229E, alpha-CoV alpaca emonisaki kobakisama ya nucleotide moko, esalaki ete kadre ebongwana.	Although an intact ORF4 can be observed in geese and HCoV-229E-related camel viruses, alpha-CoV alpaca exhibited a single nucleotide amplification, causing a frame shift.
701	en	ln	 Last but not least, the evolution of novel HCoVs is also driven by the selection pressure in their reservoir hosts. 	Ya nsuka kasi ya ntina, kokola ya HCoVs ya sika euti na bopusi ezali na bisika efandaka.	Last but not least, the development of new HCoVs results from the impact it has on habitats.
702	en	ln	 Asymptomatic or only mild symptoms were detected when bats were infected with CoVs, indicating the mutual adaptation between CoVs and bats. 	Kozanga bilembo to kozala na bilembo kaka moke emonanaki ntango bangembo bazwaki CoVs, yango emonisi komesana na kati ya CoVs mpe bangembo.	No symptoms or only minimal symptoms were observed when ticks were exposed to CoVs, indicating adaptation among CoVs and ticks.
703	en	ln	 It appeared that bats are well adapted to CoVs anatomically and physiologically. 	Emonani ete bangembo emeseni mpenza na CoVs na makambo ya anatomie mpe ya physiologie.	It appears that bats are quite anatomically and physiologically adapted to CoVs.
704	en	ln	 For example, defects in the activation of pro-inflammatory response in bats efficiently reduce the pathology triggered by CoVs. 	Na ndakisa, bambeba na kobimisa mukusa malamumalamu na bangembo ekitisaki maladi oyo CoVs ekoki kobimisa.	For example, deficiencies in the proper removal of mushrooms from insects have reduced the disease that CoVs can cause.
705	en	ln	 Besides, the natural killer cell activity in bats is suppressed due to upregulation of inhibitory natural killer cell receptor NKG2/CD94 and low expression level of major histocompatibility complex class I molecules. 	Lisusu, selile oyo ebomaka bangembo ekufaki mpo bamatisaki selile oyo ebomaka yango mpenza NKG2/CD94 mpe emonisaki nivo ya nse ya histocompatibilié ya makasi ya mindondomindondo ya bamolecule ya kelasi I.	Moreover, the germ cell died because the specific killer cell NKG2/CD94 was upregulated and showed low levels of complex histocompatibility of class I molecules.
706	en	ln	 Moreover, the high level of reactive oxygen species (ROS) generated from high metabolic activity of bats could both suppress CoV replication and affects proofreading by exoribonuclease, thus providing the selection pressure for the generation of virus strains highly pathogenic when introduced into a new host. 	Lisusu, nivo ya makasi ya bandakisa ya oxygene (ROS) oyo eutaka na metabolisme makasi ya bangembo ekoki koboma CoV to ebotama mpe kozala na bopusi na botangi na yango na nzela ya exoribonuclease, yango wana esalisaka na kopona bopusi ya bavirisi oyo epesaka mpenza maladi soki ekoki na esika ya sika.	Furthermore, high levels of reactive oxygen species (ROS) resulting from the intense metabolism of guinea pigs can kill CoV or be reproduced and affect its processing by exoribonuclease, thus helping to selectively affect truly pathogenic viruses if enough in a new location.
707	en	ln	 More pathogenic CoV strains might also evolve by recombination, leading to the acquisition of novel proteins or protein features for host adaptation. 	Maladi mingi ya CoV ekoki mpe kokola na nzela ya kosangana, ekomema na kozwa baproteine ya sika to baproteine mpo na komesana na esika ya efandi.	Many CoV diseases can also evolve by mating, leading to the acquisition of new proteins or proteins to adapt to the environment.
708	en	ln	 Thus, it is not by chance that three novel HCoVs have emerged in the past two decades. 	Yango wana, eza te kaka chance ndenge ba HCoVs misato ya sika ebimaki na bambula ntuku mibale oyo eleki.	Therefore, it’s not just chance that three new HCoVs have emerged in the past two decades.
709	en	ln	 CoVs are non-pathogenic or cause mild symptoms in their reservoir hosts such as bats and camels. 	CoVs epeska te maladi to ebimisaka te bilembo ya mike na bisika efandaka na ndakisa na bangembo mpe na bakamela.	CoVs do not cause disease or cause minor symptoms in habitats such as goats and camels.
710	en	ln	 They replicate robustly without eliciting a strong host immune response. 	Ebotamaka mingi kozanga kosalela mikrobe ebundisaka maladi ya moto oyo aza na yango.	It is often reproduced without the use of bacteria that fight the disease of the infected person.
711	en	ln	 Herein lie the secrets of why asymptomatic carriers are seen and what causes the severe cases in human infection. 	Awa nde esika baseleke ya koyeba soki bato oyo bazali na bilembo te bamonana mpe oyo esalaka ete ebelisa bato makasi mpenza.	This is where the secrets of asymptomatic detection lie and what makes it so infectious.
712	en	ln	 The severe symptoms are mainly due to the hyperactivation of immune response and the cytokine storm wherein the stronger the immune response, the more severe the lung damage. 	Bilembo ya makasi euti mingimingi na hyperactivation ya mikrobe oyo ebundisaka maladi mpe ba cytokine mingi na esika mikrobe oyo ebundisaka maladi ezalaka makasi, mpe yango ebebisaka poumon mingi.	Severe symptoms are mainly due to hyperactivation of the immune system and high levels of cytokines in a strong immune environment, resulting in extensive lung damage.
713	en	ln	 In contrast, in asymptomatic carriers, the immune response has been de-coupled from CoV replication. 	Na kokesena, na bato ya maladi oyo bazali na bilembo te, mikrobe oyo ebundisaka maladi oyo euti na kobotama ya CoV esalaka mbala mibale.	In contrast, in asymptomatic patients, the immune response resulting from CoV replication is doubly effective.
714	en	ln	 The same strategy of delinking the immune response might have beneficial effects in anti-SARS-CoV-2 therapy. 	Mayele ya lolenge moko kolongola mikrobe oyo ebundisaka maladi ekoki kozala na bopusi malamu na nkisi ya SARS-CoV-2.	Similar strategies removing the immune system may have a positive impact on the treatment of SARS-CoV-2.
715	en	ln	 The interferon response is particularly strong in bats. 	Interferon esalaka makasi mpenza mingimingi na bangembo.	Interferon is especially effective in infections.
716	en	ln	 Thus, administration of type I interferon at least in the early phase of SARS-CoV-2 infection in humans should be beneficial. 	Yango wana, kopesa interferon ya lolenge I ata kaka na ebandeli ya maladi ya SARS-CoV-2 na nzoto ya bato esengeli esalisa mingi.	Therefore, delivery of type I interferon at least at the very beginning of SARS-CoV-2 infection in humans should be very helpful.
717	en	ln	 In addition, NLRP3 inflammasome activation in bats is defective. 	Lisusu, koningisa NLRP3 na inflammasome na bangembo esimbaka te.	Furthermore, shaking NLRP3 with the inflammasome in monkeys does not work.
718	en	ln	 By this reasoning, inhibition of NLRP3 inflammasome with MCC950 might be useful in the treatment of COVID-19. 	Na kotalela makanisi oyo, koningisa NLRP3 na inflammasome elongo na MCC950 ekoki kosalisa na kozwa nkisi ya COVID-19.	Based on these considerations, immobilization of NLRP3 to the inflammasome together with MCC950 may aid in COVID-19 therapy.
719	en	ln	 The emergence of SARS-CoV-2 follows the general theme by which SARS-CoV and MERS-CoV arose. 	Kobima ya SARS-CoV-2 ezali kolanda moto ya likambo moko oyo esalaka ete SARS-CoV mpe MERS-CoV ebima.	The emergence of SARS-CoV-2 follows the fire of the same event that causes the emergence of SARS-CoV and MERS-CoV.
720	en	ln	 Whereas a bat beta-CoV sharing 95% nucleotide homology with SARS-CoV has been found, there also exists a bat-CoV sharing 96% nucleotide homology with SARS-CoV-2. 	Ata emonana ete beta-CoV ya ngembo ezali na 95% ya nucleotide ya ndenge moko na SARS-CoV, bat-CoV ezali na 96% ya ba nucleotide ya ndenge moko na SARS-CoV-2.	Although it was found that the beta-CoV of the goat has 95% nucleotide identity to SARS-CoV, the bat-CoV has 96% nucleotide identity to SARS-CoV-2
721	en	ln	 Whereas civets and other animals in the markets have been found to harbour viruses identical to SARS-CoV, immediate intermediate hosts for SARS-CoV-2 have not been identified. 	Ata emonanaki ete ba civet mpe banyama mosusu na bazando ezali na bavirisi ya lolenge moko na SARS-CoV, bisika ya sika oyo SARS-CoV-2 ekendaka kofanda ezali ndenge moko.	Even though civets and other market animals have been found to carry viruses of the same type as SARS-CoV, the new migrations of SARS-CoV-2 are similar.
722	en	ln	 Pangolin beta-CoVs strikingly homologous to SARS-CoV-2 have been found, indicating that pangolins might serve as one of intermediate hosts or pangolin beta-CoVs could contribute gene fragments to the final version of SARS-CoV-2. 	Emonani ete beta-CoVs ya pangolin ekokani mingi mpenza na SARS-CoV-2, emonisi ete bapangolin bakoki kozala esika moko oyo bavirisi wana efandaka to beta-CoVs ya bapangolin esalisaka na kokabola ba gene ya nsuka ya SARS-CoV-2.	It appears that pangolin beta-CoVs are very similar to SARS-CoV-2, suggesting that pangolins may be a common host for these viruses or that pangolin beta-CoVs contribute to final gene distribution of SARS-CoV-2.
723	en	ln	 Although questions remain, there is no evidence that SARS-CoV-2 is man-made either deliberately or accidentally. 	Ata mituna ezali kaka, ezali te na bilembeteli emonisi ete SARS-CoV-2 esalemi na bato ezali na nko to na kidiba.	While questions remain, there is no evidence that human-induced SARS-CoV-2 is deliberate or malicious.
724	en	ln	 CoVs have returned to the limelight due to the recent outbreak of SARS-CoV-2. 	Bato bazongeli kolobela mingi CoVs mpo na epalangana ya sika ya SARS-CoV-2.	There has been a renewed focus on CoVs due to the new SARS-CoV-2 outbreak.
725	en	ln	 The study of CoVs in bats and other animals has drastically changed our perception of the importance of zoonotic origins and animal reservoirs of HCoVs in human transmission. 	Boyekoli ya CoVs na bangembo mpe na banyama mosusu ebongoli mpenza ndenge na biso ya kotalela kondima soki HCoVs euta na banyama mpe banyama oyo ebombaka yango liboso epesa yango na bato.	Studies of CoVs in baboons and other animals have dramatically changed our view of whether HCoVs originate from animals and animals that harbor them before transmitting them to humans.
726	en	ln	 Pervasive evidence has shown that SARS-CoV, MERS-CoV and SARS-CoV-2 have a bat origin and are transmitted to humans via intermediate hosts. 	Bilembeteli ya solo te emonisi ete SARS-CoV, MERS-CoV mpe SARS-CoV-2 euta na ngembo mpe ekotaka na bato na nzela ya biloko mosusu oyo ebombaka yango.	There is no conclusive evidence that SARS-CoV, MERS-CoV and SARS-CoV-2 originate from mosquitoes and enter humans through other vectors.
727	en	ln	 Given that SARS-CoV infection originates from the contact between humans and civets in the markets, closing wet markets and killing civets therein could have effectively ended the SARS epidemic. 	Mpo maladi ya SARS-CoV euti na bokutani kati na bato mpe ba civet na bazando, kokanga bazando ya banyama ya mobesu mpe koboma ba civet oyo eza kuna ekokoki kosukisa maladi ya SARS.	Because SARS-CoV is caused by contact between humans and civets in markets, closing wildlife markets and killing the civets there could end the SARS outbreak.
728	en	ln	 By the same reasoning, pangolins should be removed from wet markets to prevent zoonotic transmission, in view of the discovery of multiple lineages of pangolin beta-CoVs closely related to SARS-CoV-2. 	Na makanisi moko wana, basengeli kolongola bapangolin na bazando ya banyama ya mobesu mpo na kokanga nzela ete banyama epesa biso te maladi wana, mpo makambo mingi emonisi ete ba beta-CoVs mingi oyo euti na pangolin ezali na boyokani na SARS-CoV-2.	In the same vein, pangolins should be removed from poultry markets to prevent the animals from transmitting this disease to us, as there is considerable evidence that many pangolin-derived beta-CoVs are related to SARS-CoV-2.
729	en	ln	 However, whether and how SARS-CoV-2 is transmitted to humans through pangolins and other mammals remain to be clarified in future investigations. 	Kasi, bolukiluki oyo ekosalema na mokilo ezali koya ekosalisa na koyeba soki bato bazwaki mpenza SARS-CoV-2 na bapangolin mpe banyama mosusu.	However, future studies will help determine if humans have actually contracted SARS-CoV-2 from pangolins and other animals.
730	en	ln	 On the other hand, MERS-CoV has existed in dromedary camels for a long time. 	Na ndambo mosusu, MERS-CoV ekotela bakamela dromadaire banda kala.	On the other hand, MERS-CoV has been infecting dromadarian camels for a long time.
731	en	ln	 These camels serve as an important tool for transportation as well as a main source of meat, milk, leather and wool products for the local people. 	Bakamela bazali na mokumba ya ntina mpo na komema maladi wana na bato, lolenge moko na misuni, miliki, mposo ya nyama mpe biloko ya laine mpona bato ya mboka.	Camels play an important role in transmitting the disease to humans, as do meat, milk, hides and wool products for the local people.
732	en	ln	 They are widely distributed across the Middle East and Africa. 	Ekabolama mingi na moyen orient mpe na Afrika.	Widely distributed in the middle east and Africa.
733	en	ln	 It is therefore impossible to sacrifice all camels for the control of MERS, as what was done in wild animal markets in China to prevent the spreading of SARS-CoV and SARS-CoV-2. 	Yango wana likoki ezali te ya koboma bakamela nyonso mpo na kobundisa MERS, ndenge esalemaki na bazando ya banyama ya zamba na Chinae mpo na kokanga SARS-CoV mpe SARS-CoV-2 nzela epanzana te.	It is therefore not possible to slaughter all camels to combat MERS, as was done in wildlife markets in Chinae to stop SARS-CoV and SARS-CoV-2 from spreading.
734	en	ln	 To stop the recurrent outbreaks of MERS, a comprehensive approach should be taken to develop effective vaccines against MERS-CoV for camels, in combination with other infection control measures. 	Mpo na kokanga MERS nzela ebima lisusu te, tosengeli kosala bolukiluki ya malamu mpo na kobimisa mangwele ebongi mpo na MERS-CoV ya bakamela, mpe kotya bipekiseli mosusu mpo na kobundisa maladi wana.	To stop MERS from re-emerging, we need to conduct effective research to develop an appropriate vaccine for camel MERS-CoV, and put in place additional restrictions to combat that disease.
735	en	ln	 As we are not able to eliminate these viruses, new genotypes might emerge to cause outbreaks. 	Lokolo tokoki te kosilisa bavirisi oyo, bagenome ya sika ekoki kobimisa maladi mosusu.	Since we cannot eradicate these viruses, new genomes can cause other diseases.
736	en	ln	 A variety of zoonotic CoVs are circulating in the wild. 	Ba CoVs mingi ezali kotambola na kati ya zamba.	Many CoVs are circulating in the wild.
737	en	ln	 Particularly, bat CoVs with zoonotic potential are so diverse. 	Mingimingi, CoVs ya banyama oyo ekoki kobima na lolenge mingi mpenza.	In particular, these animal CoVs can occur in a myriad of forms.
738	en	ln	 There are plenty of opportunities that these zoonotic CoVs evolve and recombine, resulting in the emergence of new CoVs that are more transmissible and/or deadly in humans in future. 	Ezali na mabaku mingi mpenza mpo ba CoVs oyo ya banyama ekola mpe esangana lisusu, ebongo ebimisa CoVs ya sika oyo ekopanzana mingi mpe/to ekoboma bato mingi na mikolo ezali koya.	There are far too many opportunities for these animal CoVs to grow and recombine, thus producing new CoVs that will spread more widely and/or kill more people in the future.
739	en	ln	 The culture of eating wild animals in some places of China should be abandoned to reduce unnecessary contact between humans and animals. 	Ezaleli ya kolya mbisi ya zamba na bisika mosusu ya Chine esengeli kosuka mpo bato bakutana lisusu mingi te na banyama.	The practice of eating wild fish in some parts of China needs to end so that human contact with the animals is reduced.
740	en	ln	 With the ordeals of SARS, MERS and COVID-19, a better preparedness and response plan should be in place. 	Ndenge SARS, MERS mpe COVID-19 enyokoli biso, tosengeli komibongisa mpe kosala mwango ya kobundisa yango.	As SARS, MERS and COVID-19 plague us, we need to prepare and plan to fight them.
741	en	ln	 In fact, many viruses have existed in the planet for a very long time. 	Ya solo, bavirisi mingi bafandi na planete na biso banda kala mpenza.	Indeed, many viruses have inhabited our planet for a very long time.
742	en	ln	 They stay in their own natural reservoirs until there is a chance for spillover. 	Efandaka na bisika na yango kino ezwaka libaku ya kobima.	It stays in its places until it has a chance to emerge.
743	en	ln	 Although bats have many features that favours the spreading of viruses, the chance for humans to be in contact with bats and other wildlife species can be minimized if people are educated to stay away from them. 	Ata ete bangembo bazali na bizaleli mingi oyo esalaka ete bavirisi wana epanzana mingi, tokoki kosala ete bato bakutana lisusu mingi te na bangembo mpe banyama mosusu ya zamba soki toteyi bato na kotikala mosika na banyama wana.	Although ticks have many of the characteristics that make these viruses more likely to spread, we can reduce human exposure to ticks and other wildlife by educating people to stay away from these animals.
744	en	ln	 Continuous surveillance in mammals is necessary for better understanding of the ecology of CoVs and their natural hosts, which will prove useful in preventing animal-to-human transmission and future outbreaks. 	Kolanda kokengela bamamifere ezali ntina mingi mpo na koyeba ndenge CoVs ezalaka mpe bisika oyo yango efandaka, ebongo ekosalisa na kokanga nzela mpo banyama epesa te bato bavirisi wana mpe ebima lisusu te na mikolo ezali kooya.	Continued surveillance of mammals is essential to understand the nature and habitat of CoVs, thus helping to prevent animal transmission of these viruses and future recurrence.
745	en	ln	 To conclude, the most effective way to prevent viral zoonosis is for humans to stay away from the ecological niches of the natural reservoirs of the zoonotic viruses. 	Mpo na kosukisa, lolenge eleki malamu ya kokanga nzela na bavirisi oyo eutaka na banyama ezali ete bato bazala mosika na bisika oyo banyama wana ya zamba oyo ezalaka na bavirisi wana efandaka.	In conclusion, the best way to contain animal-borne viruses is for people to stay away from the habitats of these wild animals that carry these viruses.
746	en	ln	 Several pieces in the puzzle of the zoonotic origin of SARS-CoV-2 are still missing. 	Kino sikoyo toyebi nanu malamu te makambo mosusu etali esika oyo SARS-CoV-2 ya banyama eutaka.	So far we still do not know enough about the source of animal SARS-CoV-2.
747	en	ln	 First, if bats transmit an ancestral virus of SARS-CoV-2 to pangolins, it will be of interest to see under what circumstances bats and pangolins could share the same ecological niche. 	Ya liboso, soki bangembo epesaki bapangolin virisi ya kala ya SARS-CoV-2, ekozala malamu na koyeba na ndenge nini bangembo na bapangolin bafandaka esika moko.	First, if ticks infected pangolins with the old SARS-CoV-2 virus, it would be useful to know how ticks and pangolins coexist.
748	en	ln	 Second, if bats play a more direct role in human transmission, how humans get into contact with bats should be determined. 	Ya mibale, soki bangembo nde bato bapesaki mbala moko virisi wana na bato, esengeli toyeba ndenge nini bato bakutanaki na bangembo.	Second, if insects directly transmitted the virus to humans, we need to know how humans were exposed to insects.
749	en	ln	 Third, if a third mammal acts as the true intermediate host, how it interacts with the different species including humans, bats and pangolins has to be clarified. 	Ya misato, soki mamifere ya misato nde azali esika ya mibale ya solo oyo virisi efandaka, esengeli kolimbola malamu ndenge nini ekutanaka na bikelamu mosusu ata mpe bato, bangembo mpe bapangolin.	Third, if the third mammal is the second true host of the virus, its interactions with other organisms including humans, monkeys, and pangolins need to be well defined.
750	en	ln	 Finally, since many mammals including domestic animals might be susceptible to SARS-CoV-2, both surveillance and experimental infection should be conducted. 	Ya nsuka, mpo bamamifere mingi ata mpe banyama ya ndako ekoki kozala na SARS-CoV-2, esengeli mpe koluka kokengela yango mpe koluka koyeba soki ezalaka na maladi wana.	Finally, because many mammals including domestic animals can be infected with SARS-CoV-2, surveillance and susceptibility testing should also be attempted.
751	en	ln	 Should it be a bat, a pangolin or another mammal, it is expected that SARS-CoV-2 or its parental viruses that are almost identical will be identified in its natural hosts in future. 	Ezali nde ngembo, pangolin to mamifere mosusu, esegami ete tozela SARS-CoV-2 to bavirisi mosusu oyo ebimisaka yango oyo ekokani mpenza na yango, ekoyebana na bisika oyo efandaka na mikolo ezali koya.	Whether it is a deer, pangolin or other mammal, it is expected that SARS-CoV-2 or other viruses that cause it that are closely related to it will be identified in their habitats in the future.
752	en	ln	 Continued investigations in this area will elucidate the evolutionary pathway of SARS-CoV-2 in animals, with important implications in the prevention and control of COVID-19 in humans. 	Kokoba kolandela makambo wana ekoki kosalisa na koyeba ndenge SARS-CoV-2 ekolaka na banyama, mpe yango eza na bopusi mingi na kobundisa mpe kobatela bato na COVID-19.	Continued monitoring of these data may help understand how SARS-CoV-2 develops in animals, and this has a significant impact on the fight against and protection against COVID-1
753	en	ln	 Updating the diagnostic criteria of COVID-19 “suspected case” and “confirmed case” is necessary 	 Mis-à-jour ya boyebeli “cas bakaniseli” eza na bokono ya COVID-19 na “cas endimami” eza na ntina penza 	An update on the definition of “suspected case” of COVID-19 and “confirmed case” is very important
754	en	ln	 On 6 February 2020, our team had published a rapid advice guideline for diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infection, and this guideline provided our experience and make well reference for fighting against this pandemic worldwide. 	 Na 6 Février 2020, lisanga nabiso epubliaki lisungi ya toli ya bombango pona koyebela pe kobelisa bokono ya kpokoso ya coronavirus yasika 2019 (2019-nCoV), bongo lisungi yango epesaki lolenge ya biso toyebeli na bobelesi pona kobundisa pandemi oyo ya mokili mobimba. 	On February 6, 2020, our community published an emergency advisory tool for diagnosing and treating the 2019 pandemic coronavirus (2019-nCoV), so the tool provided our known approach to treatment to combat this global pandemic.
755	en	ln	 However, the coronavirus disease 2019 (COVID-19) is a new disease, our awareness and knowledge are gradually increasing based on the ongoing research findings and clinical practice experience; hence, the strategies of diagnosis and treatment are also continually updated. 	 Kasi, bokono ya coronavirus 2019 (COVID-19) eza yasika, boyebi na bwania bwabiso mpona yango ezo mata moke-moke na botali makundoli mazo monana pe bisaleli ya cliniki bizo yebana; bongo wana nde eza bastrategie ya diaginositiki pe bobelesi ezo landama kotiama à jour. 	However, the 2019 coronavirus (COVID-19) is local, our knowledge and understanding of it is slowly increasing as evidence becomes available and clinical tools become available; so these are the diagnostic strategies and treatment is followed put up to date.
756	en	ln	 In this letter, we answered one comment on our guideline and provided the newest diagnostic criteria of “suspected case” and “confirmed case” according to the latest Diagnosis and Treatment Guidelines for COVID-19 (seventh version) that issued by the National Health Committee of the People’s Republic of China. 	 Na mokanda oyo, topesaki eyano na commentaire moko na lisungi nabiso pe topesi critere ya boyebeli yasika-sika pona “cas bakaniseli” pe “cas endimami” na bolandi Diagnostiki ya suka penza lisungi ya kobelesa pona COVID-19 (version ya sambo) oyo ebimisami na bakonzi ya Comite National ya Sante ya Republika Populaire ya Chine. 	In this paper, we responded to a comment on our support and provided local identification criteria for “suspected cases” and “approved cases” following the release of the most recent Diagnosis of Treatment Support for COVID-19 (seventh version). by officials of the National Health Committee of the People’s Republic of China.
757	en	ln	 In December 2019, the 2019 novel coronavirus (2019-nCoV) has caused an outbreak, which is now officially named as the coronavirus disease 2019 (COVID-19) and the virus has been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 	 Na Decemba 2019, coronavirus yasika 2019, (2019-nCoV) ebimisi kpokoso, oyo ezo bengama na loyalo bokono ya coronavirus 2019 (COVID-19) ebongo virus yango eye kobengama syndrome respiratoire acute coronavirus 2 (SARS-CoV-2). 	In December 2019, the local coronavirus 2019, (2019-nCoV) caused a pandemic, which is officially known as the coronavirus disease 2019 (COVID-19) so the virus is known as acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
758	en	ln	 On 11 March 2020, WHO characterized COVID-19 as a pandemic. 	 Na 11 Mars 2020, WHO elimboli COVID-19 mpo ebengama pandemie. 	On 11 March 2020, WHO defined COVID-19 as a pandemic.
759	en	ln	 In order to fight against the SARS-CoV-2 infection, our team has developed a rapid advice guideline and that has been published online in Military Medical Research on 06 February 2020. 	 Mpona kobunda na bokono ya SARS-CoV-2, lisanga nabiso ekolisi lisungi ya toli ya bombango bongo yango nde ezali publie na molongo ya Interneti na Bokundoli ya Medical ya Basoda ya 06 Fefrier 2020. 	To combat SARS-CoV-2, our community has developed an emergency advisory service so that is what is published online in the Military Medical Memorial of 06 February
760	en	ln	 It has attracted a great attention since published. 	 Ebendi batangi mingi banda publication na yango. 	It has attracted many readers since its publication.
761	en	ln	 Note however that COVID-19 is a new disease, our awareness and knowledge is gradually increasing based on the ongoing research findings and clinical practice experience; hence, the strategies of diagnosis and treatment are also continually updated. 	 Kasi nde yeba ete COVID-19 eza yasika, boyebi na bwania bwabiso mpona yango ezo mata moke-moke na botali makundoli mazo monana pe bisaleli ya cliniki bizo yebana; bongo wana nde eza bastrategie ya diaginosiitiki pe bobelesi ezo landama kotiama à jour. 	But know that COVID-19 is local, our knowledge and intelligence about it is slowly increasing as evidence becomes available and clinical tools become available; so these are the diagnostic strategies and treatment is followed put up to date.
762	en	ln	 For instance the Diagnosis and Treatment Guidelines for COVID-19 issued by the National Health Committee of the People’s Republic of China (http://www.nhc.gov.cn/), among 16 January 2020 to 3 March 2020, has issued a total of seven editions with some contexts being substantively changed. 	 Ndakisa masungi ya Diagnositiki na Bobelesi pona COVID-19 ebimisamaki na Comite National ya Sante ya Republika Populaire ya Chine (http://www.nhc.gov.cn/), kati-kati ya 16 Janvier 2020 tii 3 Mars 2020, esi ebimisi ba edition sambo bongo nde bacontexte mosusu ezali kobongwana makasi. 	For example the Diagnostic and Treatment guide for COVID-19 published by the National Health Committee of the People&#39;s Republic of China (http://www.nhc.gov.cn/), between January 16, 2020 and March 3, 2020, has already been published seven editions so some contexts are changing dramatically.
763	en	ln	 Now our guideline received a comment by Zhou et al., they introduced a simple scoring proposal based on their clinical experience. 	 Sik’oyo lisungi nabiso ezwaki commentaire moko na Zhou et al., bakotisaki lolenge ya pete-pete ya kopesa bapoint na bolandi ya experience nabango ya cliniki. 	Now our contribution received a comment from Zhou et al., they introduced a simple scoring method in their clinical experience follow-up.
764	en	ln	 Their work added new evidence for our guideline and also make valuable reference for this pandemic worldwide. 	 Mosala nabango ebakisi bilembo yasika mpo na lisungi pe esali botindi ya ntina pona pandemie mokili mobimba. 	Their work adds local clues to relief and creates an important referral for the global pandemic.
765	en	ln	 We endorse their significant work and express our thanks. 	 Toyambi mosala nabango ya ntina monene pe totondi bango botondi. 	We welcome their important work and thank them.
766	en	ln	 However, their work also needs update according to the latest Diagnosis and Treatment Guidelines for COVID-19 (Trial seventh version) and recently studies. 	 Kasi, mosala nabango pe ezo senga mis-à -jour na botali Masungi ya Diagnostiki pe Bobelesi yasika pona COVID-19 (Meka version ya sambo) mayekoli ma leki. 	However, their work also requires an update in view of the Diagnostic Support and Localization for COVID-19 (Try the seventh version) previous studies.
767	en	ln	 According to the seventh edition (3 March 2020), to confirm the suspected case needs to combine any one item of epidemiological history features with two items of clinical manifestations to make a comprehensive analysis, or needs to meet three items of clinical manifestations if without clear epidemiological history: 	 Na bolandi edition ya sambo (3 Mars 2020), pona kondima cas bakaniseli ezo senga bosangisi ya itemi moko ya lisolo ya bikila-kila ya epidemiologie na ba itemi mibale ya ba manifestation ya cliniki pona kosala analyse mobimba, to eza na posa etondisa ba itemi misato ya ba manifestation ya cliniki soki ezangi moi ya nsango ya epidemiologie: 	According to the seventh edition (3 March 2020), case acceptance is considered to require the combination of one item of epidemiological medical history and two items of clinical manifestations to conduct a complete analysis, or it needs to fill in the items three clinical manifestations if without the sun of epidemiological information:
768	en	ln	 Epidemiological history: (1) a history of travel or residence in Wuhan city and surrounding areas, or other communities where COVID-19 cases had been reported in the last 14 days before symptom onset; (2) a history of contact with SARS-CoV-2 infectious cases (with positive nucleic acid test); (3) a history of contacting with patients with fever or respiratory symptoms from Wuhan city and surrounding areas, or other communities where COVID-19 had been reported in the last 14 days before symptom onset; (4) a history of contacting with cluster of confirmed cases (≥ 2 cases with fever and/or respiratory symptoms occurred within 2 weeks in small areas, such as home, office, class of school, etc). 	 Nsango ya Epidemiologie: (1) nsango ya mobembo to ya bofandi na mboka Wuhan pe pembeni nango, to masanga mosusu ya bacas ya COVID-19 esalami lapolo mikolo 14 eleki liboso basymptomi ebanda; (2) nsango ya bokangani na cas ya SARS-CoV-2 (teste positive ya noyau ya acide nucleiki); (3) nsango ya bokangani ma mobeli ya nzoto fievre to basymptomi ya kopema awuti na mboka Wuhan na bisika ya pembeni to lisusu masanga mosusu esika basali lapolo ya bacas ya COVID-19 na mikolo 14 eleki liboso ya basymptomi ya ebandeli; (4) nsango ya bokangani na liboke ya bacas endimami (≥ cas 2 na fievre pe/to basymptomi ya kopema kati ya poso 2 na bisika mike, ndakisa ndako, bilo, kelasi ya sikola, bnb). 	Epidemiological Information: (1) information of travel or residence in and around Wuhan, or other groups of COVID-19 cases reported 14 days before the onset of symptoms; (2) linkage information to a SARS-CoV-2 case (nucleic acid nucleus positive test); (3) news of contact with a patient with fever or respiratory symptoms from Wuhan in neighboring areas or other communities where cases of COVID-19 have been reported in the past 14 days prior to initial symptoms; (4) confirmed case group contact information (≥ 2 cases with fever and/or respiratory symptoms within 2 weeks in small areas, eg home, office, school, bnb).
769	en	ln	 Clinical manifestations: (1) fever and/ or respiratory symptoms; (2) with imaging features of COVID-19 infection; (3) total white blood cell counts showing normal, decreased, or reduced lymphocyte count in the early onset stage. 	 Bamanifestation ya cliniki: (1) fievre pe/to basymptomi ya bopemi; (2) na bilembo ya bilili ya bokono ya COVID-19 ; (3) lotango ya baglobule ya pembe nionso ezo lakisa normale, ekita, to lotango ya lymphocyte ekita na tango ya ebandeli. 	Clinical manifestations: (1) fever and/or respiratory symptoms; (2) with symptoms of COVID-19 images; (3) all white blood cell counts show normal, decreased, or decreased lymphocyte counts at baseline.
770	en	ln	 Diagnosing the confirmed case should base on suspected case with any one item of pathogenic or serological evidence as following: (1) real-time PCR test positive for SARS-CoV-2; (2) viral whole genome sequencing showing high homogeneity to the known novel coronaviruses; (3) positive for the specific IgM antibody and IgG antibody to SARS-CoV-2 in serum test; or a change of the SARS-CoV-2-specific IgG antibody from negative to positive, or titer rising ≥4 times in the recovery phase above that in the acute phase. 	 Diagnostiki ya cas endimami esengeli ezala nase ya cas bakaniseli na itemi ata moko ya ekenenge to evidence ya serologie evidence lokola elandi awa: (1) teste ya PCR ya temps reel positive pona SARS-CoV-2; (2) bolandi ya genome mobimba ezo lakisa homogeneite emata na ba coronavirus yasika eyebani; (3) eza positive pona IgM specifiki ya anticorps pe IgG anticorps na SARS-CoV-2 na teste ya serume; to mbongwana na IgM ya SARS-CoV-2-specific IgG anticorps uta negative ti positive, to kobuta ya titer ≥ mbala 4 na phase ya recouvrement likolo ya cas phase ya songe. 	The diagnosis of an accepted case must be based on a suspected case with at least one item of evidence or serological evidence evidence as follows: (1) a positive real-time PCR test for SARS-CoV-2; (2) genome-wide sequencing shows increased homogeneity in coronaviruses of known location; (3) positive for antibody-specific IgM and IgG antibodies to SARS-CoV-2 by serum assay; or a change in IgM of SARS-CoV-2-specific IgG antibody from negative to positive, or a rise of titer ≥ 4-fold in the overlap phase over the mosquito phase case.
771	en	ln	 We can see that the real-time PCR test for nucleic acid in respiratory tract or blood samples was added to the second (18 January 2020) and third (22 January 2020) editions. 	 Toko komona ete teste ya PCR ya temps reel pona acide nucleiki na nzela ya kopemela to echantillon ya makila ebakisamaki na ba edition ya mibale (18 Janvier 2020) pe ya misato (22 Janvier 2020). 	We will note that the real-time PCR test for nucleic acid by breath or blood sample was added in the second (January 18, 2020) and third (January 22, 2020) editions.
772	en	ln	 The pathogenic detection of blood sample was added to the fourth (27 January 2020) and fifth (8 February 2020) editions; and then the serological evidence was added to the seventh edition. 	 Bokundoli ya ekenenge ya echantillon ya makila ebakisamaki na ba edition ya mine (27 Janvier 2020) pe ya mitano (8 Février 2020); pe evidence ya serologie ebakisamaki na edition ya sambo . 	The blood sample ekenenge summary was added in the fourth (January 27, 2020) and fifth (February 8, 2020) editions; and serological evidence was added in the seventh edition .
773	en	ln	 These modifications based on the researchers continued work that to search for an optimal nucleic acid detection kit for rapid diagnosis, as well as the samples from respiratory tract including blood sampling, which increased the availability of different specimens, and supported bringing the specific antibody positive result into the confirmed criteria. 	 Bambongwana yango na botali ya bakundoli elandelaki mosala ete pona koluka bisaleli ya diaginositiki ya bombango pona bokundoli optimal ya acide nucleiki, elongo na echantillon ya nzela ya bopemeli tia nakati echantillon ya makila, mutu ebutisaki bobelemi ya ba endimeli ya ndenge ebele, pe esungaki bomemi ya resultat ya anticorps specifiki positive na bacritiki endimama. 	These changes in memory analysis followed the work that in finding early diagnostic tools for optimal nucleic acid memory, including respiratory tract samples including blood samples, one reduced the proximity of multiple beliefs, and supported the introduction of a positive specific antibody result in critically accepted.
774	en	ln	 Besides, there are more and more evidence that remind us to caution with the atypical symptomatic and asymptomatic patients. 	 Lisusu, ba evidence ezo matisama oyo ezo rappeler biso ete to bimisa miso na babeli baza atypiki symptomatiki na asymptomatiki. 	Also, there is increasing evidence that reminds us to keep an eye out for patients who are atypically symptomatic and asymptomatic.
775	en	ln	 Hence, the flow chart of Zhou et al. should be updated, as they classified the person without clinical symptoms as “low risk”. 	 Pona kolanda, graphiki ya Zhou et al. esengeli etiamama à jour, lokola batiaki moto azanga basymptome cliniki esika ya “riske ya moke“. 	For reference, the graph of Zhou et al. it should be updated, as a person without clinical symptoms is placed in a “low risk” area.
776	en	ln	 The score system also needs to be verified in further clinical practice and studies. 	 Systemi ya ba point pe esengeli ezala vérifié na masaleli pe mayekoli ya cliniki ya kobakisa. 	The point system also needs to be verified with additional clinical tools and studies.
777	en	ln	 To conclude, we hope more direct evidence coming up and call for readers to provide their comments. 	 Mpona kosukisa, toza na elikia ete ba evidence ya libela ekobakisama pe ebengi batangi bapesa ndenge bamoneli.	Finally, we hope that permanent evidence will be added and invite readers to provide their views.
778	en	ln	 For the diagnosis of “suspected case” and “confirmed case”, we suggest to trace and obey the newest guidelines of their home countries. 	 Mpona diaginositiki ya “cas ekaniselami” pe “endimami” tozo belela kolanda pe kotosa nde masungi yasika mazo uta na bikolo na bango. 	For the diagnosis of “suspected” and “confirmed” cases we call for following and following the local guidelines available from their countries.
779	en	ln	 Our team will also timely update our guideline to offer help. 	 Lisanga nabiso pe ekosala mis a jour na tango ekoka lisungi nabiso pona kopesa lisalisi. 	Our community will also update in time our assistance to provide assistance.
780	en	ln	 Bangladesh reports five new deaths due to COVID-19, a daily highest 	Bangladesh epesi rapor ete bato misato bakufi na COVID-19, koleka mikolo misusu	Bangladesh has reported three deaths from COVID-19, more than in previous days
781	en	ln	 Yesterday, Bangladesh has confirmed five new deaths due to COVID-19 on the day. 	Lobi, Bangladesh epesi sango ete bato mitano bakufi na COVID-19 na mokolo moko.	Yesterday, Bangladesh reported five deaths from COVID-19 in a single day.
782	en	ln	 This is the highest number of fatalities in a day due to the virus. 	Oyo ezali kufa ya likolo koleka na virisi oyo.	This is the highest death rate from this virus.
783	en	ln	 As of yesterday, Bangladesh's Institute of Epidemiology, Disease Control and Research (IEDCR) reported the number of recorded infected cases included 114 active cases and 33 recovered cases who were staying home. 	Lobi, Institut ya Bangladesh ya bapandemi, Kolandela Maladi na Bolukiluki (IEDCR) balobi ete motango bato bazali na maladi ezali 114 mpe 33 oyo bazalaki kofanda na ndako babiki.	Yesterday, the Bangladesh Institute of Epidemics, Disease Surveillance and Research (IEDCR) said the number people infected is 114 and 33 who were staying at home have survived.
784	en	ln	 A total of 17 deaths have been recorded. 	Bato 17 bakufi.	17 people have been killed.
785	en	ln	 In an online news briefing, the director of IEDCR, Dr Meerjady Sabrina Flora, said the fatalities included four males and one female. 	Na basango ya internet, Directeur ya IEDCR, Dr Meerjady Sabrina Flora, alobi ete bato oyo bakufi ezali mibali mibale mpe basi mibale.	In online news, IEDCR Director Dr Meerjady Sabrina Flora said the victims were two men and two women.
786	en	ln	 According to Dr Meerjady, two cases were aged above 60, two between 51 and 60, and one 41-50 years old. 	Mpona Dr Meerjady, mibale bazali na mibu 60, mibale mibu kati na 51 te 60, mpe moko kati na mibu 41 te 50.	For Dr Meerjady, two are aged 60, two aged between 51 not 60, and one aged between 41 not
787	en	ln	 She also said two of the victims were from Dhaka. 	Alobi mpe ete mibale ya bato oyo bakufi bawuti Dhaka.	He also said two of the victims were from Dhaka.
788	en	ln	 The World Health Organization (WHO) declared COVID-19 a pandemic on March 11. 	Organization Mondial ya Sante (OMS) ebengi COVID-19 pandemi mokolo ya 11 sanza ya liboso.	The World Health Organization (WHO) declared COVID-19 a pandemic on January
789	en	ln	 A hospital official told Anadolu Agency, a local news outlet, that one of the deceased was Jalal Saifur Rahman, a director of Bengali Anti-Corruption Commission, who was cared for at the Kuwait Maitree Hospital. 	Moto azali kosala na lepital alobi na Anadolu Agency, esika ya basango ya mboka, moko ya bato oyo akufi ezali Jalal Saifur Rahman, Directeur ya commission ya Kotelema-Moyibi, oyo azalaki na lepital ya Kuwait Maitree.	A person working at the hospital told Anadolu Agency, a local news outlet, that one of the dead was Jalal Saifur Rahman, Director of the Stand-Up-Theft commission, who was at Kuwait Maitree Hospital.
790	en	ln	 On Saturday, in an online video announcement, Bangladeshi Road Transport and Bridges Minister Obaidul Quader said public transport would be shut down for longer than initially planned, until this coming Saturday. 	Na mokolo ya mposo, na video ya basango na internet, Ministre ya nzela na Bangladesh Obaidul Quader alobaki ete babis ekokanga mpona mikolo ebele, ti mokolo ya mposo oyo ezali koyaka.	On Sunday, in an online news video, Bangladesh Road Minister Obaidul Quader said buses would be closed for several days, until next Sunday.
791	en	ln	 This public transport shutdown had initially started on March 26 and was planned to end on Saturday, April 4. 	Kokanga ya babis oyo ebandaki mokolo ya 26 sanza ya misato mpe esengelaki esila mokolo ya mposo, sanza ya minei na mokolo ya 4.	This babies catch began on March 26th and is scheduled to end on Sunday, April 4th.
792	en	ln	 Transport of essential goods -- medical, fuel and food -- was still allowed. 	Komema biloko oyo ezali na ntina – bankisi, mafuta ya mituka na ya bilei – ekoki koleka.	Transportation of essential commodities – medicines, motor and food fuel – can be bypassed.
793	en	ln	 The first recorded incidents of COVID-19 infection in Bangladesh were on March 8, in two people who returned from Italy and also the wife of one of them. 	Bamaladi ya liboso ya COVID-19 na Bangladesh ezalaki mokolo ya 8 sanza ya misato, na bato mibale oyo bautaki Italie mpe mwasi ya moko na bango.	The first cases of COVID-19 in Bangladesh were on March 8, with two people from Italy and the wife of one of them.
794	en	ln	 As of March 19, these three had already recovered. 	Na mokolo ya 19 sanza ya misato, bato oyo misato babikaki.	On March 19, these three survived.
795	en	ln	 SARS-CoV-2 surpasses one million infections worldwide 	SARS-Cov-2 eleki bamaladi moko na milio na mokili mobimba	SARS-Cov-2 has infected more than one million people worldwide
796	en	ln	 On Thursday, the total number of cases of the SARS-CoV-2 coronavirus infections surpassed one million worldwide, Johns Hopkins University data indicated. 	Na mokolo ya minei, motango ya ba oyo babeli na SARS-CoV-2 maladi ya coronavirisi elekaki milio moko na mokili, elobi makomi ya Johns Hopkins.	On Thursday, the number of SARS-CoV-2 coronavirus cases worldwide exceeded one million, according to Johns Hopkins.
797	en	ln	 At least 52 thousand deaths were linked to COVID-19, the disease caused by the coronavirus. 	Kufa 52 ezalaki ya COVID-19, maladi oyo euti na coronavirisi.	Fifty-two deaths were from COVID-1
798	en	ln	 The milestone came the same day Malawi confirmed its first coronavirus infections and Zambia had its first coronavirus-related death. 	Molongi wana eye mokolo oyo Malawi na Zambie bazalaki na ya bango ya liboso oyo azalaki kobela coronavirisi.	The victory came on the day Malawi and Zambia had their first coronavirus case.
799	en	ln	 North Korea claimed, as of Thursday, it was one of the few countries remaining free of coronavirus infections. 	Na Corée ya Nordi balobaki ete, na mokolo ya minei, bazalaki mboka ya liboso kati na bamboka oyo bazalaki na bato ya kobela coronavirisi te.	North Korea said on Thursday it was the first country to be free of the virus.
800	en	ln	 By yesterday, the World Health Organization reported 1,051,635 confirmed cases, including 79,332 cases in the twenty four hours preceding 10 a.m. Central European Time (0800 UTC) on April 4. 	Lobi, Organization Mondial ya Sante epesi sango ya 1,051,635 oyo bazalaki kobela mpe 79,332 na mokolo 1 uta 10h Ngonga ya Europe (0800UTC) na mokolo ya 4 sanza ya minei 4.	Yesterday, the World Health Organization reported 1,051,635 cases and 79,332 in 1 day as of 10am European Time (0800UTC) on 4 April 4th.
801	en	ln	 In the United States, over 244 thousand coronavirus cases were recorded, linking to at least 5,900 deaths. 	Na États-Unis, koleka ya bato ya kobela nkoto 244 na coronavirisi, mpe kufa 5,900.	In the United States, more than 244,000 coronavirus cases, and 5,900 deaths.
802	en	ln	 CBS News reported, citing Johns Hopkins University data, there were over 1,000 US deaths on Wednesday caused by coronavirus infections. 	Basango ya CBS elobi ete, nsima ya Université ya Johns Hopkins, bato ya kokufa na maladi ya coronavirisi bazalaki 1,000 na mokolo ya misato.	CBS reports that, after Johns Hopkins University, the death toll from the virus was 1,000 on Wednesday.
803	en	ln	 Around the world, countries announced stricter measures to inhibit the disease from spreading. 	Na mokili, bamboka batieli mibeko makasi mpona kosukisa kopalangana ya virisi.	Around the world, countries have imposed strict measures to stop the spread of the virus.
804	en	ln	 On Thursday, Sergei Sobyanin, the mayor of Moscow, extended the city lockdown to May 1. 	Na mokolo ya minei, Sergei Sobyanin, Maire ya Moscow, apusaki konfinema ti mokolo ya 1 sanza ya mitano.	On Thursday, Moscow Mayor Sergei Sobyanin extended the curfew until May
805	en	ln	 Nationally, President Vladimir Putin declared Russians would continue to be paid without going to work until April 30. 	Na mboka nyonso, Mokambi Vladimir Putin alobaki ete bato ya Russie bakotikala kozwa lifuti ata soki bazali kokende mosala te ti sanza ya minei mokolo ya 30.	In every country, President Vladimir Putin said that Russians will continue to receive wages even if they are not going to work until April 30th.
806	en	ln	 The parliament of Portugal voted to extend the national state of emergency by 15 days; the vote passed with 215 votes in favor, ten abstentions, and one vote against. 	Parlement ya Portugal aponaki kopusa konfinema na mikolo 15; vote elekaki na 215 vote, zomi bazalaki te, mpe moko aboyaki yango.	The Portuguese parliament chose to extend the curfew by 15 days; the vote passed by 215 votes, ten abstentions, and one abstention.
807	en	ln	 Saudi Arabia extended curfews in the holy cities of Mecca and Medina to last the entire day; previously, the curfew was only in effect between 3 p.m. and 6 a.m. 	Na Arabie Saudi bapusaki konfinema na bamboka ya santu ya Mecca na Medina mpona mokolo mobimba; liboso, konfinema ezalaki kaka mpona 3h ya mpokwa ti 6h ya ntongo.	In Saudi Arabia they pushed confinement in the holy cities of Mecca and Medina for the day; previously, confinement was only for 3pm to 6am.
808	en	ln	 Thailand planned to implement a curfew between 10 p.m. and 4 a.m. 	Thailand ebongamaki na couvre-fe na 10h ya mpokwa ti 4h ya ntongo.	Thailand was prepared for a curfew from 10pm to 4am.
809	en	ln	 The governor of Ohio, Mike DeWine, announced the state had extended its stay-at-home order until May 1. 	Gouverneur ya Ohio, Mike DeWine alobaki ete egumba ekopusa kofanda-na-ndako ti mokolo ya 1 ya sanza ya mitano.	Ohio Governor Mike DeWine said the city will push the stay-at-home until May 1st.
810	en	ln	 Stores in Australia lower toilet paper limits per transaction 	 Babutik na Australie basukisaki boni y aba papiergenik moto moko akoki ko somba 	Shops in Australia have limited how much paper a person can buy
811	en	ln	 On Sunday and Saturday evening, Australian store chains Woolworths and Coles lowered their purchase restrictions on toilet paper to two and one package per transaction in all stores on national level, respectively. 	 Na mokolo ya lomingo mpe ya mposo nab utu, butik ya Australie babengi Woolworths na Coles batiaki mibeko na kosomba papiergenik na moko to mibale na moto na babutik nyonso ya mboka. 	On Sunday and Sunday night, Australian supermarkets Woolworths and Coles imposed rules on buying papiergenik at one or two per person in all local stores.
812	en	ln	 ALDI also introduced a one-pack limit, on Monday. 	 ALDI mpe akotisaki mibeko ya moko kaka na moto, na mokolo ya liboso. 	ALDI also introduced only one-per-person, first-day policies.
813	en	ln	 These limitations were posted as messages on the checkouts, and on the chains' Facebook pages. 	 Mibeko oyo ekomamaki na mokanda libanda ya butik mpe na Facebook na bango. 	These rules are posted outside the shop and on their Facebook.
814	en	ln	 Buyers were reportedly stocking up due to fears of COVID-19 in case people need to self-isolate. 	 Bato bazalaki kosomba ebele mpona bomo ete COVID-19 ekoki kotinda bato bakangama na ndako. 	People were buying so much for life that COVID-19 could force people to stay indoors.
815	en	ln	 On Wednesday, Woolworths also limited toilet paper purchases for home delivery to one pack per order. 	 Na mokolo ya misato, Woolworths mpe ekotisi mibeko na misala ya livraison-domicile na papiergenik boni moto akoki kosomba. 	On Wednesday, Woolworths also introduced restrictions on home-delivery services on how much papiergenik a person can buy.
816	en	ln	 These changes followed the previous four-pack per transaction restriction introduced by Woolworths and Coles on March 4 and 5 respectively. 	 Mibeko oyo elandaki ya minei kaka na moto na Woolworths na Coles mokolo ya 4 na 5 sanza ya misato. 	These offenses were followed by the fourth same person at Woolworths and Coles on 4th and 5th March.
817	en	ln	" Coles, in its March 8 media release, reported that with the four-pack restriction in place, ""many stores are still selling out within an hour of delivery"", and called the demand ""unprecedented"", while ALDI, in a Facebook post on Tuesday, called it ""unexpected"". "	 Coles, na basango na ye ya mokolo ya 8 sanza ya misato, alobaki ete mibeko ya minei-na-moto ekotaki, ‘’babutik misusu biloko ezali kosila kaka na ngonga moko soki biloko eye mpe abengi mposa ya bato ‘ya koleka’, ntango ALDI, na Facebook na mokolo ya mibale abengaki yango ‘Ya koleka’. 	Coles, in its March 8 news release, said the four-person rules kicked in, &#39;&#39;some stores are running out of items in as little as an hour if the items arrive and called demand &#39;overwhelming&#39;, period ALDI, on Facebook on Monday called it &#39;Outstanding&#39;.
818	en	ln	" Sales went up in a ""sharp increase"" last week, according to a Woolworths spokesperson. "	 Koteka ‘emataki makasi’ mposo oyo eleki, elobi moto ya Woolworths. 	Sales &#39;rose sharply&#39; this past week, the Woolworths man said.
819	en	ln	 Costco's store in Canberra also limited the allowed amount to two packs last week. 	 Butik ya Costo a Canberra mpe asukisaki na mibale na moto mposo oyo eleki. 	The Costo store in Canberra also ended up with two on fire this past week.
820	en	ln	 To further alleviate the shortage, Coles ordered bigger packages from suppliers and increased delivery frequency, Woolworths ordered extra stock, while ALDI made stocks for a planned Wednesday special available early. 	 Mpona kosepelisa mitungisi oyo biloko ezalaki kosila, Coles asengaki biloko mingi, Woolwoths asengaki mpe mingi, AlDI asengaki biloko ya mokolo ya misato oyo ezali koyaka mikolo mingi liboso. 	To satisfy concerns that supplies were running out, Coles ordered more supplies, Woolwoths ordered more, AlDI ordered Wednesday supplies arriving days in advance.
821	en	ln	 Russell Zimmerman, executive director of the Australian Retailers Association, said that retailers try to raise stock, but local council restrictions on the timing of truck-deliveries make it hard. 	 Russell Zimmerman, Executive Directeur ya Association ya Bateki na Australie alobaki ete, bateki bazali komatisa biloko ya koteka, kasi mibeko ya mboka ezali kotungisa bango makasi. 	Russell Zimmerman, Executive Director of the Australian Retailers Association said, retailers are increasing sales, but local regulations are a serious concern.
822	en	ln	 He expects rising production costs, as suppliers try to meet demand, and fewer specials. 	 Bato bayeba ete makasi ya kosala biloko esengeli emata mpona kotondisa mposa ya bato. 	People should know that production capacity must increase to meet human demand.
823	en	ln	 On Tuesday, ALDI announced that following the early release of stock, some stores can't run the Wednesday special. 	 Na mokolo ya mibale, ALDI alobaki ete nsima oyo babimisaki biloko mikolo liboso, babutik misusu bako zala na Special ya mokolo ya misato te. 	On Monday, ALDI said that after they released items days earlier, some stores would not have the Wednesday Special.
824	en	ln	 In a News.com.au report, Dr Gary Mortimer, retail expert from Queensland University of Technology, said the stores fill the stock every night. 	 Na rapor ya news.com.au, Dr Gary Mortimer, moteki ya koyeba makasi na Universite ya Technologu na Queensland alobaki babutik ekotisaka biloko batu nyonso. 	In a report by news.com.au, Dr Gary Mortimer, a well-known retailer at Queensland University of Technology, said shops import goods for everyone.
825	en	ln	 He remarked toilet paper is a bulky item, leading to low quantity of stocks in numbers, and, when sold out, leaves vast shelf spaces empty, hardening the feeling of a shortage. 	 Amonaki ete papiergenik ezali eloko ya monene, mpona bongo te ekotaka mukie, mpe ekendeke noki, ekikaka bisika ya butik pamba, yango nde ekotisaka lisusu kobanga ya kosila ya biloko. 	He found that papiergenik is a bulky material, so it doesn’t enter slowly, and go away quickly, leaving empty shop spaces, which adds to the fear of running out of goods.
826	en	ln	" ""Coles and Woolworths have a view [that] if there was plenty of stuff on the shelf, if product like toilet rolls and sanitiser could be [bought] and are there in quantities, you would probably minimise the panic"" said Russell Zimmerman per ABC News. "	 ‘’Coles na Woolworths balobi solo (ete) soki biloko ezalaki mingi na butik, soki biloko lokola papiergenik na kisi ya kosokola maboko ekokaki (kosombama) na mingi, nkasi bomo mpe ekiti’’ elobi Russell Zimmerman na Basango ya ABC. 	&#39;&#39;Coles and Woolworths do say (that) if there was more stuff in the store, if things like papiergenik and hand sanitizer could (be bought) in larger quantities, the boom also went down&#39;&#39; Russell Zimmerman told ABC News.
827	en	ln	 Recycled toilet paper producer Who Gives a Crap said on last Wednesday they'd run out of stock. 	 Moto oyo asalaka ba Papiergenik nkombo Who Gives a Crap alobi na mokolo ya misato oyo eleki bazalaki lisusu na biloko te. 	Papiergenik maker Who Gives a Crap said by last Wednesday they were out of stock.
828	en	ln	 Kimberly-Clark, which makes Kleenex Toilet Tissue, and Solaris Paper which makes Sorbent, emphasized they were working 24/7 to maintain the supply, according to the News.com.au report. 	 Kimberly-Clark, oyo asalaka papier ya Kleenex, na mosali ya papier ya Solaris oyo esalaka Sorbent, balobaki ete bazali na mosala 24/7 mpona kotondisa mposa ya bato, nsima ya basango ya news.com.au. 	Kimberly-Clark, the maker of Kleenex paper, and Solaris paper maker Sorbent, said they were working 24/7 to meet demand, after news.com.au reports.
829	en	ln	 Domain.com, a real estate site, reported some property sellers offering free toilet paper to the first bidder on auctions in Melbourne, when fewer auctions were held because of buyers having time off on the long weekend of Labour Day. 	 Domain.com, bato ya mosala ya ba ndako balobaki ete bakolo ndako misusu bazalaki kopesa paiergenik ya ofele na moto ya liboso oyo akopesa talo mpona kosomba ndako, ntango bato bazalaki kosomba lisusu mingi te mpo ete bazalaki na eloko te ya kosala na suka ya mposo ya mokolo ya basali. 	Domain.com, real estate officials said some landlords were offering free paiergenik to the first bidder, while people were buying less because they had nothing to do on the weekend of Labor Day.
830	en	ln	 The Thursday edition of NT News, a daily printed in Darwin, included an eight-page insert meant to be cut up and used as toilet paper. 	 Basango ya mokolo ya minei ya NT News, basanga ya kotanga ya Darwin, ezalaki na papier mwambe oyo bato bakokaki kokata mpona kosalisa lekola papiergenik. 	Thursday&#39;s NT News, Darwin&#39;s reading groups, featured eight pieces of paper that people could cut to help look like papiergenik.
831	en	ln	 The stores were originally reluctant to impose restrictions, according to a report from ABC Australia on March 3 in which they said they had no plans to introduce restrictions on the purchases. 	 Liboso babutik balingaki te kokotisa mibeko, rapor ya Australi ya ABC elobi mokolo ya 3 ya sanza ya misato bazalaki na mposa te ya kosukisa biloko boni bato bazalaki kosomba. 	Previously retailers were reluctant to introduce the rules, an ABC Australian report said on March 3 they were unwilling to limit how much people were buying.
832	en	ln	 Russell Zimmerman added that other products are also in high demand, including masks, sanitiser, dried goods, handwash and flour. 	 Russell Zimmerman alobaki ete bato bazali mpe na mposa makasi ya biloko misusu, lokola bamask, bakisi ya bopeto, bilei ya kokauka, ya kosokola maboko mpe farine. 	Russell Zimmerman said people are also in dire need of other items, such as masks, hygiene products, dry food, hand sanitizer and flour.
833	en	ln	 Similarly, outside of Australia, on Sunday evening online British supermarket Ocado was observed limiting purchases of Andres toilet paper to two 12-roll packs. 	 Mpe, libanda ya Australie, na mokolo ya loming nab utu na butik ya Ocado na Angleterre bamonaki ete bato bazalaki kosomba lisusu mingi ya papiergenik ya Andre te na mibale ya packet ya 12. 	And, outside Australia, on Monday night Ocado stores in England found that people were no longer buying most of Andre&#39;s papiergenik in two 12-packs.
834	en	ln	 World Health Organization declares COVID-19 pandemic 	 Organization Mondial ya Sante ebengi COVID-19 pandemi 	The World Health Organization has called COVID-19 a pandemic
835	en	ln	 On Wednesday, the World Health Organization (WHO) declared the ongoing outbreak of COVID-19 — the disease caused by coronavirus SARS-CoV-2 — to be a pandemic. 	 Na mokolo ya misato, Organisation Mondial ya Sante (OMS) ebengaki kopalangana ya maladi oyo ya COVID-19 – Maladi oyo euti na coronavirisi ya SARS-CoV-2 – ezali pandemi. 	On Wednesday, the World Health Organization (WHO) declared the outbreak of COVID-19 – a disease caused by the SARS-CoV-2 coronavirus – a pandemic.
836	en	ln	" Although the word ""pandemic"" only refers to how widely a disease has spread, not how dangerous specific cases are, the WHO noted the need to drive governments to action: "	 Ata ete nkombo ‘pandemi’ elandi kaka ndege nini malady etamboli molayi, kasi makasi na yango te, OMS emonaki ntina ya bagouvernema babanda mosala: 	Although the name &#39;pandemic&#39; refers only to the duration of the disease, not its severity, the WHO saw the need for governments to take action:
837	en	ln	" ""All countries can still change the course of this pandemic. "	 ‘’Bamboka nyonso bakoki kosukisa pandemic oyo. 	&#39;&#39;All countries can end this pandemic.
838	en	ln	" If countries detect, test, treat, isolate, trace and mobilize their people in the response,"" said Tedros Adhanom Ghebreyesus, the Director-General of the WHO. "	 Soki bamboka bamoni, basali baekzame, ba salisi bato, batie konfinema mpe balandeli mpe basangani bato mpona etumba,’’ elobi Tedros Adhanom Ghebreyesus, irector-general ya OMS. 	If countries find out, they test, they treat, they quarantine and they track and mobilize people for the fight,” said Tedros Adhanom Ghebreyesus, WHO irector-general.
839	en	ln	" ""We are deeply concerned both by the alarming levels of spread and severity and by the alarming levels of inaction."" "	 ‘’tozali na kobanga na ndenge nini ezali kopalangana mpe na ndenge nini eloko te ezali kosalema.’’ 	&#39;&#39;we&#39;re appalled at how widespread it is and how nothing is being done.&#39;&#39;
840	en	ln	" According to Dr. Tom Frieden, formerly the director of the United States' Centers for Disease Control and Prevention, the pandemic is ""unprecedented."" "	 Elobi Dr. Tom Frieden, oyo azalaki directeur ya kala ya Esika oyo Elandelaka bamaladi mpe Esukisaka yango mpona Etats Unis, pandemic ezala ‘ya bikamwa.’ 	According to Dr. Tom Frieden, former director of the Centers for Disease Control and Prevention for the United States, called the pandemic &#39;miraculous.
841	en	ln	" He said, in remarks published by CNN in February, ""other than influenza, no other respiratory virus has been tracked from emergence to continuous global spread."" "	 Alobi ete, na oyi basango ya CNN epesaki na sanza ya mibale, ‘’libanda ya influenza, maladi mosusu te ya mpema elandanaki na likama to na kopalangana na mokili.’’ 	He said that, according to CNN reports in February, &#39;&#39;outside of influenza, no other respiratory disease has been as dangerous or widespread in the world.
842	en	ln	" Ghebreyesus expressed a similar view, saying ""we have never before seen a pandemic sparked by a coronavirus."" "	 Ghebreyesus alobaki mpe bongo, alobaki ‘’nani totikali komona pandemi oyo salami na coronavirisi te’.’ 	Ghebreyesus said the same, saying &#39;&#39;who is left to see a pandemic caused by the coronavirus&#39;
843	en	ln	" He continued, ""and we have never before seen a pandemic that can be controlled at the same time."" "	 Alobi lisusu, ‘’mpe nani tomona te pandemi oyo ekoki kosukisama.’’ 	He added, &#39;&#39;and who do we not see this pandemic can be brought to an end.&#39;&#39;
844	en	ln	 The new status as a pandemic follows the WHO's decision in January to declare the outbreak a public health emergency of international concern. 	 Ebengami ya pandemi euti na ekateli ya OMS na sanza ya liboso kobenga yango likama ya kolongono mpona mokili mobimba. 	The call for a pandemic comes from a WHO decision in January to call it a global health threat.
845	en	ln	" The United States' National Institute of Allergy and Infectious Disease's director, Dr. Anthony Fauci, said of the outbreak, ""bottom line, it's going to get worse."" "	 Dr ya Institu ya BaAlergie a Etats Unis na ya ba Maladi Anthony Fauci, alobaki ‘’nsima makambo eko beba makasi.’’ 	Dr. Anthony Fauci of the US Institute of Allergy and Diseases, said &#39;&#39;then things will get worse.
846	en	ln	 As of Thursday, Associated Press reported there were at least 126,000 cases of COVID-19 worldwide, resulting in over 4,600 deaths. 	 Na mokolo ya minei, Basango ya Bomoko bapesi rapor ete kati 126,000 ya ba oyo babelaki COVID-19 na mokili 4,600 bakufaki. 	On Thursday, the United Nations reported that of the 126,000 cases worldwide, 4,600 had died.
847	en	ln	 The 2019–20 coronavirus pandemic is an ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 	 Na 2019-20 Pandemi ya coronavirisi ezali pandemic ya coronavirisi ya 2019 (COVID-19), euti na maladi ya mpema ya coronavirisi 2 (SARS-CoV-2). 	In 2019-20 The coronavirus pandemic is the 2019 coronavirus pandemic (COVID-19), caused by the respiratory syndrome coronavirus 2 (SARS-CoV-2).
848	en	ln	 The outbreak was identified in Wuhan, China, in December 2019, declared to be a Public Health Emergency of International Concern on 30 January 2020, and recognized as a pandemic on 11 March 2020. 	 Maladi emonanaki na Whuhan, Chine, na sanza ya zomi na mibale 2019, ekomaki likama ya kolongono ya bato mokolo ya 30 sanza ya liboso 2020, mpe ebengami pandemi mokolo ya 11 sanza ya misato 2020. 	The disease was discovered in Wuhan, China, in December 2019, became a public health threat on January 30, 2020, and was declared a pandemic on March 11,
849	en	ln	 As of 10 April 2020, approximately 1.61 million cases of COVID-19 have been reported in 210 countries and territories, resulting in approximately 97,000 deaths. 	 Na sanza ya minei mokolo ya 10 2020, bato 1.61milio bazalaki na COVID-19 ezalaka na bamboka mpe bisika 210, oyo ememaki kufa 97,000. 	As of April 10, 2020, there were 1.61million cases of COVID-19 in 210 countries and territories, leading to 97,000 deaths.
850	en	ln	 About 364,000 people have recovered. 	 Bato 364,000 bakiki. 	364,000 people died.
851	en	ln	 The case fatality rate has been estimated to be 4% in China, while globally ranging from 13.04% in Algeria to .08% in New Zealand. 	 Kufa ezali na 4% na Chine, na mokili ezali na 13.04% na Algerie mpe .08% na Nouvelle Zealand. 	Death rates are 4% in China, with global rates of 13.04% in Algeria and .08% in New Zealand.
852	en	ln	 Common symptoms include fever, cough and shortness of breath. 	 Basymptomi ezali, fefele, kosukosu na mpema ya mokuse. 	Symptoms include, fever, cough and shortness of breath.
853	en	ln	 Complications may include pneumonia and acute respiratory distress syndrome. 	 Bacomplication ezali pneumonia, mpasi na kopema. 	Complications include pneumonia, difficulty breathing.
854	en	ln	 The time from exposure to onset of symptoms is typically around five days, but may range from two to fourteen days. 	 Soki malady ekoteli nzoto lelo, ekozwa mikolo mitano to zomi na mibale mpona basymptom ebanda. 	If the disease enters the body today, it will take five to twelve days for symptoms to begin.
855	en	ln	 There is no known vaccine or specific antiviral treatment. 	 Vaccin to kisi na yango eyebani te. 	There is no known vaccine or cure.
856	en	ln	 Primary treatment is symptomatic and supportive therapy.Recommended preventive measures include hand washing, covering one's mouth when coughing, maintaining distance from other people, and monitoring and self-isolation for people who suspect they are infected. 	 Liboso bako salisa basymptom mpe kosunga yo obika. Mpona kosukisa maladi esengeli yo osokola maboko, kanga zolo to monoko soki ozali kokosola, fanda mosika na bato, mpe kososola na komona ba oyo bazali na konfinema mpo ete bazalaki esika moko na moto oyo azwaki maladi yando. 	First they will treat the symptoms and help you recover. To end the disease you need to wash your hands, cover your nose or mouth if you cough, stay away from people, and be aware of those who are confined because they were in the same contact with the infected person.
857	en	ln	 Authorities worldwide have responded by implementing travel restrictions, quarantines, curfews, workplace hazard controls, and facility closures. 	 Mikonzi na mokili mobimba batie mibeko mpona kokanga ba nzela, konfinema, ngonga ya kokota mpe kobima ndako, biloko ya kobatela nzoto na bisika ya mosala, mpe kokanga bisika. 	Officials around the world have imposed road closures, curfews, curfews, workplace protective equipment, and closures.
858	en	ln	 The pandemic has led to severe global socioeconomic disruption, the postponement or cancellation of sporting, religious, political and cultural events, and widespread shortages of supplies exacerbated by panic buying. 	 Pandemi emonisi nkita ya mokili mpasi, kopusa to kokata masano, ba eklesia, makambo ya politik na ya kosepela, mpe ndenge biloko ezali lisusu mingi te na mokili mpo ete bato bazalaki kosomba mingi na bomo. 	The pandemic has seen the world economy suffer, pushing or cutting sports, churches, politics and entertainment, and the decline in the world’s resources because people were buying more in life.
859	en	ln	 Schools and universities have closed either on a nationwide or local basis in 193 countries, affecting approximately 99.4 percent  of the world's student population. 	 Bakelasi na ba universite bakangi na mokili mobimba to na ba egumba na ba mboka 193, etungisi bana ya kelasi 99.4 pourcent ya population. 	Classes and universities have been closed worldwide or in cities in 193 countries, affecting students 99.4 percent of the population.
860	en	ln	 Misinformation about the virus has spread online, and there have been incidents of xenophobia and discrimination against Chinese people, other people of East and Southeast Asian descent and appearance, and others from areas with significant virus cases. 	 Kozanga koyeba maloba ya solo na virisi etandani na internet, mpe xenophobie emonani mingi na koyina ya bachinois, mpe bato ya Est na Sud ya Est ya Asie mpe ba oyo ya pene, mpe ba oyo na bisika oyo virisi ezali. 	Ignorance of the true words about the virus is widespread on the Internet, and xenophobia is evident in hatred of the Chinese, people of East and Southeast Asia and those nearby, and those in areas where the virus is present.
861	en	ln	 Due to reduced travel and closures of heavy industry, there has been a decrease in air pollution and carbon emissions. 	 Nsima ya kokanga ba nzela, carbone na mopepe ekiti. 	After the roads are closed, carbon in the air decreases.
862	en	ln	 Health authorities in Wuhan, China (the capital of Hubei province) reported a cluster of pneumonia cases of unknown cause on 31 December 2019, and an investigation was launched in early January 2020. 	 Bakonzi na Wuhan, Chine (egumba ya monene ya Hubei) bamonaki kobela mingi ya pneumonia mokolo ya 31 sanza ya zomi na mibale 2019, mpe etid ebandaki mpona kososola yango ebandeli ya sanza ya liboso 2020. 	Authorities in Wuhan, China (the largest city in Hubei) detected the highest number of pneumonia cases on December 31, 2019, and etid began to detect it in early January
863	en	ln	 The cases mostly had links to the Huanan Seafood Wholesale Market and so the virus is thought to have a zoonotic origin. 	 Ba oyo babelaki bautaki nzando ya banyama ya Huanan mpe elobami ete virisi euti kuna mpe ezali zoonotic. 	Those who became ill came from the Huanan livestock market and the virus is said to have originated there and is zoonotic.
864	en	ln	 The virus that caused the outbreak is known as SARS-CoV-2, a newly discovered virus closely related to bat coronaviruses, pangolin coronaviruses, and SARS-CoV.The earliest known person with symptoms was later discovered to have fallen ill on 1 December 2019, and that person did not have visible connections with the later wet market cluster. 	 Virisi oyo ememi maladi ebengami SARS-CoV-2, virisi ya sika oyo euti na coronavirisi ya bangembo, coronavirisi ya bapagolin na SARS-CoV. Moto ya liboso oyo azalaki na basymptomi abelaki mokolo ya 1 sanza ya zomi na mibale na 2019, mpe moto wana bayebaki te soki ye awutaki nzando wana. 	The disease-causing virus is called SARS-CoV-2, a new virus derived from the chicken coronavirus, peacock coronavirus and SARS-CoV. The first person with symptoms called on December 1, 2019, and the person was not known to be from that market.
865	en	ln	 Of the early cluster of cases reported in December 2019, two-thirds were found to have a link with the market. 	 Na ba oyo babelaki na 2019, mingi ya ndambo na bango eyabanaki ete bautaki zando. 	Of those who died in 2019, more than half were known to be from the market.
866	en	ln	 On 13 March 2020, an unverified report from the South China Morning Post suggested that a case traced back to 17 November 2019, in a 55-year-old from Hubei province, may have been the first.On 26 February 2020, the WHO reported that, as new cases reportedly declined in China but suddenly increased in Italy, Iran, and South Korea, the number of new cases outside China had exceeded the number of new cases within China for the first time. 	 Na mokolo ya 13 sanza ya misato 2020, rapor euti Sud ya Chine na Morning Post elobaki ete kobela ebandaki na mokolo ya 17 sanza ya zomi na moko 2019, na moto ya miaka 55 na Hubei. Na mokolo ya 26 sanza ya mibale 2020, OMS elobaki bato ya kobela ekitaki na Chine kasi ebandaki komata na Italy, na Iran mpe na Core ya Sud, bato ya kobela balekaki oyo ya Chine. 	On March 13, 2020, a report from South China in the Morning Post said the outbreak began on November 17, 2019, in a 55-year-old man in Hubei. On February 26, 2020, the WHO said cases had declined in China but had started to rise in Italy, Iran and South Korea, with cases exceeding those in China.
867	en	ln	 There may be substantial underreporting of cases, particularly among those with milder symptoms. 	 Ekoki koloba ete toyebi te bato boni bazali na kobela kati na ba oyo bazali na basymptomi mukie. 	It may be said that we do not know how many people are sick among those with mild symptoms.
868	en	ln	 By 26 February, relatively few cases had been reported among youths, with those 19 and under making up 2.4% of cases worldwide.The United Kingdom's chief scientific adviser, Patrick Vallance, estimated that 60% of the British population would need to become infected before effective herd immunity could be achieved. 	 Na mokolo ya 26 sanza ya mibale, bato ya kobela mukie bazalaki bajeune, ba oyo ya miaka 19 ekiti bazalaki 2.4% na mikili. Mokonzi ya etid ya science na Angleterre, Patrick Vallance, amonaki ete 60% ya population na Bretagne esengeli bazwa maladi mpo ete nzoto ya bato ebanda kolenda yango. 	As of February 26, the number of cases was younger, with the 19-year-old decline to 2.4% nationally. The head of the British scientific etid, Patrick Vallance, found that 60% of the population in Britain needs to be infected for the human body to start to digest it.
869	en	ln	 Cases refers to the number of people who have been tested for COVID-19, and whose test has been confirmed positive according to official protocols. 	 Bacas ezali boni ya bato bazali na COVID-19, ba oyo baekzame elobi ete bazali na yango, elobi mibeko. 	Cases are the number of people with COVID-19, those who test positive, the law says.
870	en	ln	 As of 23 March, no country had tested more than 3% of its population, and many countries have had official policies not to test those with only mild symptoms, such as Italy, the Netherlands, Spain, and Switzerland. 	 Na mokolo ya 23 na sanza ya misato, mboka moto te esalaki baekzame koleka 3% ya population na bango, mpe bamboka mingi batiaki mibeko ya kosala ekzame te na bato oyo bazali na basymptomi mukie, lokola Italy, Netherland, Espagne na Switzerland. 	As of March 23, no country had tested more than 3% of their population, and many countries have imposed no-screening rules on people with mild symptoms, such as Italy, the Netherlands, Spain and Switzerland.
871	en	ln	 A study published on 16 March found that in China, up to 23 January, an estimated 86% of COVID-19 infections had not been detected, and that these undocumented infections were the infection source for 79% of documented cases. 	 Etid moko oyo babimisaki mokolo ya 16 sanza y amisato na Chine ti mokolo ya 23 sanza ya libobo, emoni ete 86% ya ba oyo bazalaki kobela na COVID-19 bayebanaki te, mpe bango moto bapanzaki malady na 79% ya ba oyo bayebani. 	An estimate released from March 16 to January 23 in China found that 86% of those infected with COVID-19 were unknown, and they spread the disease to 79% of those known.
872	en	ln	 A statistical analysis published 30 March estimated that numbers of infections in Italy were considerably greater than the reported cases. 	 Ba limero moko oyo babimisaki na mokolo ya 30 sanza ya misato emonaki ete bamaladi na Italie bazalaki ebele koleka oyo balobaki. 	Figures released on March 30 showed that the number of cases in Italy was higher than reported.
873	en	ln	 The initial estimates of the basic reproduction number (R0) for COVID-19 were 1.4 to 2.4. 	 Kopalangana ya (R0) COVID-19 ezali 1.4 to 2.4. 	The prevalence of (R0) COVID-19 is 1.4 or
874	en	ln	 A study published by the US Center for Disease Control and Prevention has concluded that it may be 5.7. 	 Etid moko oyo babimisaki na esika ya kolandela Maladi mpe kopekisa yango na US elobi ete ekoki kozala 5.7. 	An Etid released by the Center for Disease Surveillance and Prevention in the US says it could be 5.7.
875	en	ln	 Most people with COVID-19 recover. 	 Bato mingi oyo bazali kobela COVID-19 bazali kobika. 	The majority of COVID-19 patients are recovering.
876	en	ln	 For those who do not, the time from development of symptoms to death has been between 6 and 41 days, with the most common being 14 days. 	 Mpona ba oyo bazali kobika te, ngonga ya basymptomi mpe na ya liwa ezali mikolo 6 ti 41, na oyo ya mingi mikolo 14. 	For those who do not survive, the duration of symptoms and death is 6 to 41 days, with a maximum of 14 days.
877	en	ln	 As of 10 April 2020, approximately 97,000 deaths had been attributed to COVID-19. 	 Na mokolo ya 10 sanza ya minei 2020, bato 97,000 bakufi na COVID-19. 	As of April 10, 2020, 97,000 people have died of COVID-1
878	en	ln	 In China, as of 5 February about 80% of deaths were in those over 60, and 75% had pre-existing health conditions including cardiovascular diseases and diabetes.Official tallies of deaths from the COVID-19 pandemic generally refer to dead people who tested positive for COVID according to official protocols. 	 Na Chine, na mokolo ya 5 sanza ya mibale 80% y aba oyo bakufaki bazalaki na miaka 60 to mingi, mpe 75% bazalaki na bamaladi misusu lokola malady ya motema na diabetes. Ba oyo bakufi na COVID-19 ezali ba oyo ekzame elakisaki ete bazali na COVID ndenge mibeko elobi. 	In China, on February 5 80% of those who died were aged 60 or older, and 75% had other diseases such as heart disease and diabetes. Those who have died of COVID-19 are those who tested positive for COVID-19 as required by law.
879	en	ln	 The number of true fatalities from COVID-19 may be much higher, as it may not include people who die without testing - e.g. at home, in nursing homes, etc. 	 Limero ya solo ya bato oyo bakufi na COVID-19 ekoki kozala mingi koleka, kasi emoni te bato oyo basali ekzame te – lokola, na ndako, na ndako ya bakoko, mpe mingi. 	The actual number of people who have died from COVID-19 may be much higher, but it doesn’t take into account people who haven’t been tested – like, at home, at the grandparents’ house, and more.
880	en	ln	 Partial data from Italy found that the number of excess deaths during the pandemic exceeded the official COVID death tally by a factor of 4-5x. 	 Etid ya ndambo oyo euti Italie emoni ete bato oyo bakufi na COVID eleki 4-5x oyo bango basosolaki. 	A half-dozen reports from Italy found that the death toll from COVID-19 was 4-5x higher than they realized.
881	en	ln	" A spokeswoman for the U.S. Centers for Disease Control and Prevention (CDC) acknowledged ""We know that [the stated death toll] is an underestimation"", a statement corroborated by anecdotal reports of undercounting in the U.S. Such underestimation often occurs in pandemics, such as the 2009 H1N1 swine flu epidemic.The first confirmed death was in Wuhan on 9 January 2020. "	 Moto ya U.S ya Esika ya Kolandela Maladi mpe kopekisa yango (CDC) emoni ete ‘’To yebi ete (balimero ya kufa ya mboka) ezali ya solo te mpo ezali mukie’’, elobami bayekoli ya barapor ya U.S. Balimero ya mukie boye esalemaka mingi na bapandemi, lokola na pandemi ya 2009 na H1N1 kosukosu ya bangulu. Kufa ya libosso na Wuhan ezalaki na mokolo ya 9 sanza ya liboso na 2020. 	The US Centers for Disease Control and Prevention (CDC) said &#39;&#39;We know that (the country&#39;s death toll) is inaccurate because it&#39;s low,&#39;&#39; say US reporters Such low numbers are common in pandemics, such as the 2009 H1N1 swine cough pandemic. The first death in Wuhan was on January 9,
882	en	ln	 The first death outside mainland China occurred on 1 February in the Philippines, and the first death outside Asia was in France on 14 February. 	 Kufa ya libosso na Chine ezalaki mokolo ya 1 sanza ya mibale na Philippines, mpe kufa libanda ya Asie ezalaki na France mokolo ya 14 sanza ya mibale. 	The first death in China was on February 1 in the Philippines, and the death outside Asia was in France on February
883	en	ln	 By 28 February, outside mainland China, more than a dozen deaths each were recorded in Iran, South Korea, and Italy. 	 Na mokolo ya 28 sanza ya mibale, libanda ya Chinne, bato mingi na zomi na mibale bakufaki na Iran, Core ya Sud mpe na Italie. 	On February 28, outside China, more than a dozen people died in Iran, South Korea and Italy.
884	en	ln	 By 13 March, more than forty countries and territories had reported deaths, on every continent except Antarctica.Several measures are commonly used to quantify mortality. 	 Na mokolo ya 13 sanza ya misato, bamboka ntuku minei bazalaki na bato oyo bakufaki na maladi, na ba mboka nyonso kasi na Antartik te. Misala mingi ezali kosalema mpona koyebani bato boni bakufi. 	As of March 13, forty countries had deaths from disease, in all but Antarctica. More work is underway to determine the death toll.
885	en	ln	 These numbers vary by region and over time, and are influenced by the volume of testing, healthcare system quality, treatment options, time since initial outbreak, and population characteristics such as age, sex, and overall health.The death-to-case ratio reflects the number of deaths divided by the number of diagnosed cases within a given time interval. 	 Balimero oyo ezali ndenge mosusu na bisika mingi, mpe elandi ba ekzame oyo ezali kosalema, mpe ndenge ya balepital, ndenge ya kosalisa, ntango banda kopalangana ebandaki, mpe misusu etali population lokola miaka, nzoto ya mwasi to ya mibali, mpe kolongono ya moto. Kufa kati ya balimero ezali kati ya ba oyo bazali kobela. 	These figures vary in many areas, and track ongoing testing, and hospital status, treatment, time since the outbreak began, and other population factors such as age, gender, and health. Death among the numbers is among the sick.
886	en	ln	 Based on Johns Hopkins University statistics, the global death-to-case ratio is 6.0% (97,039/1,617,204) as of 10 April 2020. 	 Mpona bastatistik ya Johns Hopkins Universite, kufa kati na ba oyo bazali kobela ezali 6.0% (97,039/1,617,204) uta mokolo ya 10 sanza ya minei 2020. 	According to Johns Hopkins University statistics, mortality among patients is 6.0% (97,039/1,617,204) as of April 10,
887	en	ln	 The number varies by region. 	 Limero etaliesika na yango. 	The number depends on its location.
888	en	ln	 In China, estimates for the death-to-case ratio decreased from 17.3% (for those with symptom onset 1–10 January 2020) to 0.7% (for those with symptom onset after 1 February 2020).Other measures include the case fatality rate (CFR), which reflects the percent of diagnosed people who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected (diagnosed and undiagnosed) who die from a disease. 	 Na chine, kufa kati na ba oyo bazali kobela ezali 17.3% (Ya ba oyo bazali na basymptomi mikolo ya 1-10 sanza ya liboso 2020) na 0.7% (mpona ba oyo na basymptomi mokolo ya 1 sanza ya mibale 2020). Ba ndenge misusu ezali limero y aba oyo bakufi (CFR), oyo elakisi pourcentahe y aba oyo bazalaki na malady mpe bakufi, mpe limero y aba oyo bazali na malady (IFR) oyo etali pourcentage y aba oyo bazali na maladi (oyo ekzame elobi) mpe bakufi na malady. 	In China, mortality among patients is 17.3% (For those with symptoms 1-10 January 2020) and 0.7% (for those with symptoms 1 February 2020). Other methods include the death rate (CFR), which refers to the percentage of people who were sick and died, and the infection rate (IFR) which refers to the percentage of people who are sick (reported by the test) and died of malady.
889	en	ln	 These statistics are not timebound and follow a specific population from infection through case resolution. 	 Ba statistic oyo ezali ya ngonga moko te, elandi ndege nini makambo ezali kokende na mokili mpe na population. 	These statistics are not of the same hour, they follow trends in the world and population.
890	en	ln	 A number of academics have attempted to calculate these numbers for specific populations. 	 Ba academi mingi emeki komona ba limero oyo mpona ba population ebele. 	Many academies have tried to see these numbers for many populations.
891	en	ln	 The University of Oxford's Centre for Evidence-Based Medicine estimates that the infection fatality rate for the pandemic as a whole is between 0.1% and 0.39%. 	 Esika ya Etid ya Bakisi na Universite ya Oxford emoni ete kufa ya malady ezali kati ya 0.1% ti 0.39 	The Etid Center for Drugs at Oxford University estimates mortality between 0.1% and 0.39
892	en	ln	 The upper estimate of this range is consistent with the results from the first random testing for COVID-19 in Germany, and a statistical study analysing the impact of testing on CFR estimates. 	 Limero ya likolo ezali moko na oyo Germany esalaki Etid ya COVID-19, mpe etid ya statistic nakomona baekzame ya CFR. 	The top number is one that Germany did Etid of COVID-19, and etid of statistics I will see CFR tests.
893	en	ln	 The WHO asserts that the pandemic can be controlled. 	 OMS elobi ete pandemic oyo ekoki kolandelama. 	The WHO says the pandemic can be monitored.
894	en	ln	 The peak and ultimate duration of the outbreak are uncertain and may differ by location. 	 Mikolo oyo pandemic oyo eko wumela eyebani te mpe etali esika na esika 	The duration of the pandemic is unknown and varies from place to place
895	en	ln	" Maciej Boni of Penn State University stated, ""Left unchecked, infectious outbreaks typically plateau and then start to decline when the disease runs out of available hosts. "	 Maciej Boni ya Penn State Universite elobi, ‘’Soki esosolami malamu te, malady ekoki kokita soki bisika na yango ya kobatama ezali lisusu te. 	Maciej Boni of Penn State University says, &#39;&#39;If not properly understood, the disease can subside if its hiding places are no longer available.
896	en	ln	" But it's almost impossible to make any sensible projection right now about when that will be"". "	 Kasi ndenge ya koyeba ezali te mikolo oyo na ndenge eko zala’’. 	But there&#39;s no way of knowing these days on how it&#39;s going to be&#39;&#39;.
897	en	ln	" The Chinese government's senior medical adviser Zhong Nanshan argued that ""it could be over by June"" if all countries can be mobilized to follow the WHO's advice on measures to stop the spread of the virus. "	 Gouvernema ya bayekoli ya bakonzi ya Chine na Zhong Nanshan balobi ete ‘’ ekoki kosila na sanza ya motoba’’ soki bamboka nyonso balandi toil ya OMS na ndenge nini kolandela virisi. 	The student government of Chinese officials in Zhong Nanshan said it &#39;&#39;could be completed by June&#39;&#39; if all countries followed the WHO guidelines on how to track the virus.
898	en	ln	" On 17 March, Adam Kucharski of the London School of Hygiene &amp; Tropical Medicine stated that SARS-CoV-2 ""is going to be circulating, potentially for a year or two"". "	 Na mokolo ya 17 sanza ya misato, Adam Kucharski ya Kelasi ya London mpona Bopeto &amp; Kisi ya Tropical alobaki ete SARS-CoV-2’’ ekotambola mpona mbula moko to mibale’’. 	On March 17, Adam Kucharski of the London School of Hygiene &amp; Tropical Medicine said that SARS-CoV-2&#39;&#39; will run for a year or two&#39;
899	en	ln	" According to the Imperial College study led by Neil Ferguson, physical distancing and other measures will be required ""until a vaccine becomes available (potentially 18 months or more)"". "	 Mpona Etid ya College ya Imperial oyo Neil Ferguson asali, emoni ete kofanda mosika na bato mpe mibeko misusu oyo esengeli ezali malamu ‘’ti oyo tokokoma na vaccine (ekoki kozwa ba mbula 18 to mingi)’’. 	For the Imperial College Etid by Neil Ferguson, it found that staying away from people and other necessary measures is best &#39;&#39;until we get to a vaccine (it could take 18 years or more)&#39;
900	en	ln	" William Schaffner of Vanderbilt University stated, ""I think it's unlikely that this coronavirus—because it's so readily transmissible—will disappear completely"" and it ""might turn into a seasonal disease, making a comeback every year"". "	 William Schaffner ya Vanderbilt Universite alobi, ‘’Nayebi te soki ezali ete coronavirisi – mpo ete ekobosama noki – ekokende libela’’ mpe ekoki kokoma malady oyo eyakaka mpe ekendeke, ekoki kozonga ba mbula nyonso’’. 	William Schaffner of Vanderbilt University said, &#39;&#39;I don&#39;t know if it&#39;s that the coronavirus – because it will be forgotten soon – will go away forever&#39;&#39; and it could become a disease that comes and goes, it can come back every year.
901	en	ln	 The virulence of the comeback would depend on herd immunity and the extent of mutation. 	 Ntando na yango ya kozonga etali ndenge nini nzoto ya bato ekokoma makasi na kobundela yango mpe soki ekomi makasi koleka. 	Its recovery time depends on how strong the immune system becomes and whether it becomes stronger.
902	en	ln	 Symptoms of COVID-19 can be relatively non-specific and infected people may be asymptomatic. 	 Basymptomi ya COVID-19 ekoki kozala mingi mpe bato oyo bazala na maladi bakoki koyeba te. 	Symptoms of COVID-19 can be severe and patients may not recognize them.
903	en	ln	 The two most common symptoms are fever (88%) and dry cough (68%). 	 Basymptomi mibale oyo ezali mingi ezali fefele (88%) mpe kosukosu ya kokauka (68%). 	The two most common symptoms are fever (88%) and dry cough (68%).
904	en	ln	 Less common symptoms include fatigue, respiratory sputum production (phlegm), loss of the sense of smell, shortness of breath, muscle and joint pain, sore throat, headache, chills, vomiting, hemoptysis, diarrhea, or cyanosis.The WHO states that approximately one person in six becomes seriously ill and has difficulty breathing. 	 Basymptomi ya mikie lokola bolembu ya nzoto, maladi ya mpema, kobungisa ya koyoka solo, mpeka ya kokatana, mpasi na mikua, engine, motu mpasi, malili na kolenga ya nzoto, hemoptysis, pulupulu, to cyanosis. OMS elobi ete moto moko na motoba ako bela makasi mpe akozala na mpasi ya kopema. 	Minor symptoms such as weakness, respiratory disease, loss of hearing, amputation, pain in the ribs, engine, headache, chills, hemoptysis, pneumonia, or cyanosis. The WHO says one in six people will become seriously ill and have difficulty breathing.
905	en	ln	 The U.S. Centers for Disease Control and Prevention (CDC) lists emergency symptoms as difficulty breathing, persistent chest pain or pressure, sudden confusion, difficulty waking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.Further development of the disease can lead to severe pneumonia, acute respiratory distress syndrome, sepsis, septic shock and death. 	 Na U.S Esika ya kolandela bamaldi mpe kosukisa yango (CDC) ekomi basymptom ya likama lokola mpasi na kopema, mpasi na tolo to kilo na tolo, kobunga koyeba makambo, mpasi na kotambola, mbembo ya motani; kokende lepital noki esengami soki basymptomi oyo ezali. Lisusu maladi ekoki kobenga pneumonia, maladi ya nzela ya mpema, sepsis mpe liwa. 	In the US the Centers for Disease Control and Prevention (CDC) lists danger symptoms such as difficulty breathing, chest pain or heaviness in the chest, loss of consciousness, difficulty walking, nausea; immediate hospitalization is recommended if these symptoms are present. Also disease can call pneumonia, respiratory tract infections, sepsis and death.
906	en	ln	 Some of those infected may be asymptomatic, with no clinical symptoms but with test results that confirm infection, so researchers have issued advice that those with close contact to confirmed infected people should be closely monitored and examined to rule out infection. 	 Misusu oyo bazali na maladi bakoki kozala na basymptomi te, na basymtomi te kasi na baekzame oyo elakisi maladi, nde yango bayekoli bapesi toil ete ba oyo bazalaki pene ya ba oyo baekzame emonaki bango na maladi esengeli basosola bango malamu. 	Some who are sick may have no symptoms, no symptoms but tests that indicate the disease, so researchers recommend that those who have been close to those who have been diagnosed with the disease should be understood.
907	en	ln	 Chinese estimates of the asymptomatic ratio range from few to 44%. 	 Chine elobi ete bato oyo bazali na basymptomi te ekoki kozala 44%. 	China says the asymptomatic rate is as high as 44%.
908	en	ln	 The usual incubation period (the time between infection and symptom onset) ranges from one to 14 days; it is most commonly five days.As an example of uncertainty, the estimate of the fraction of people with COVID-19 who lost their sense of smell was initially 30% and later fell to 15%. 	 Ntango ya kisi mpona kokota malamu (Ntango maladi esimbi moto mpe basymptomi ebandi koyaka) ezali mokolo moko to 14; mingi-mingi ezali mikolo mitano. Lokola kozanga koyeba, bato boni bazali na COVID-19 oyo babungisi koyooka solo bazalaki 30% mpe bakitaki na 15%. 	The treatment time for successful penetration (When the disease is infected and symptoms start to appear) is 1 to 14 days; usually five days. Like ignorance, the proportion of people with COVID-19 who have lost their hearing has dropped from 30% to 15%.
909	en	ln	 Some details about how the disease is spread are still being determined. 	 Toli na ndenge nini malady ezali kopalangana eyebani. 	Advise on how malady is spreading known.
910	en	ln	 The disease is believed to be primarily spread during close contact and by small droplets produced during coughing, sneezing, or talking; with close contact being within 1 to 2 metres (3 to 6 feet). 	 Bandimi ete malayi ezali kopalangana soki bato bazali pene mpe na ba soyi mikie oyo ebimaka soki moto akosoli, asali itche, to azali koloba; kozala pene ezali 1 to 2 metres (3 to 6 ft). 	Malaria is believed to be spread by human proximity and by tiny sneezes produced by sneezing, itching, or talking; closeness is 1 to 2 meters (3 to 6 ft).
911	en	ln	 Studies have found that an uncovered coughing can lead to droplets travelling up to 4.5 metres (15 feet) to 8.2 metres (27 feet). 	 Ba etid emoni ete soyi ya kokosola ekoko kotambola 4.5metres (15 feet) to 8.2 metres (27feet). 	The etid have found that the snow leopard will walk 4.5metres (15 feet) or 8.2 meters (27feet).
912	en	ln	 Some have proposed that the virus may also be transmitted by small droplets that stay for more prolonged periods in the air, that may be generated during speech.Respiratory droplets may also be produced during breathing out, including when talking, though the virus is not generally airborne. 	 Bato misusu balobi ete virisi ekoki mpe kopalangana na ba mayi ya nzoto ya mikie oyo etikalaka na mopepe ba ngonga molayi, oyo esalemaka ntango moto azali koloba. Ba mayi ya kopema mpe ntango moto azali kopema, mpe kotambola, virisi ezali na kati ya mopepe te. 	Some people say that the virus can also spread through small bodily fluids that remain in the air for hours, which occur when a person speaks. Breathing fluids and when a person breathes, and walks, the virus is not in the air.
913	en	ln	 The droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. 	 Matangi ya mayi ekoki kotoka n amonoko to zolo ya bato oyo bazali pene, bakoki mpe kopema yango. 	Drops of water can flow from the mouths or noses of nearby people, who can also breathe them.
914	en	ln	 Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolized and thus result in airborne spread. 	 Kotia tube na kati ya mongonga mpona Cardiopulmonary resuscitation (CPR) ekoki kosala ete matangi ya kopema ekona na kati ya nzoto. 	Inserting a tube into the throat for Cardiopulmonary resuscitation (CPR) can cause breathing fluid to flow into the body.
915	en	ln	 It may also spread when one touches a contaminated surface, including skin, and then touches their eyes, nose, or mouth. 	 Ekoki mpe kopanzana soki moto asimbi esika oyo ezali na matangi, mpe mposo ya nzoto, mpe tango bazali kosimba miso, zolo na monoko. 	It can also be spread by touching the area with tears, and skin, and when touching the eyes, nose and mouth.
916	en	ln	 While there are concerns it may spread by faeces, this risk is believed to be low. 	 Misusu balobi ete ekoki kotambola na kati ya tufi, kasi oyo ezalia kobanga mukie kaka. 	Some say it can walk in the mud, but this is just a little scary.
917	en	ln	 The Government of China denied the possibility of faecal-oral transmission of SARS-CoV-2.The virus is most contagious during the first three days after onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease. 	 Gouvernema ya Chine aboyi ete SARS-CoV-2 ekoki kotambola na kati ya tufi. Virisi ezali kopangalana makasi na mikolo misato ya liboso ya nsima ya basymptomi, kasi ekoki kotambola ata soki basymptomi ezali te mpe na mikolo ya suka ya virisi. 	The Chinese government denies that SARS-CoV-2 can travel in tuff. The virus spreads most strongly in the first three days after symptoms, but can move even in the absence of symptoms and in the last days of the virus.
918	en	ln	 People have tested positive for the disease up to three days before onset of symptoms suggesting transmission is possible before developing significant symptoms. 	 Bato bamonani kozala na maladi mikolo misato nsima ya kozwa malady, yango nde elobi ete moto akoki kopanza yango soki nani azali na basymptomi te. 	People have been found to be sick three days after contracting the disease, which means that it can be spread by anyone who has no symptoms.
919	en	ln	 Only few reports of laboratory-confirmed asymptomatic cases exist, but asymptomatic transmission has been identified by some countries during contact tracing investigations. 	 Kaka ba etid mukie ya laboratoire emoti ete ba oyo bazangi basymptomi bazali kasi bato ya basymptomi bamonani na ba mboka misusu ntango bazali kolanda ba oyo bazalaki pene na ba oyo bazwami na malady. 	Only a few laboratory studies have shown that asymptomatic cases exist but symptomatic cases have been reported in other countries when following up those who have been close to infected persons.
920	en	ln	 The European Centre for Disease Prevention and Control (ECDC) states that while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.The virus survives for hours to days on surfaces. 	 Esika ya Kopekisa Maladi mpe Kolandela yango ya Europe (ECD) elobi eyebani ya solo te ndenge nini maladi ezali kotambola kaka boye, moto moko akoki kopanza yango na bato mibale to misato. Virisi ekoki kowumela ba ngonga molayi na likolo ya biloko. 	The European Center for Disease Control and Prevention (ECD) says it is not known exactly how the disease spreads, one person can spread it to two or three people. The virus can persist for hours on surfaces.
921	en	ln	 Specifically, the virus was found to be detectable for up to three days on plastic (polypropylene) and 304 stainless steel, for one day on cardboard, and for up to four hours on copper. 	 Mpo, virisi emonanaki likolo ya Plastic (polypropylene) ti mikolo misato ya koleka mpe na libende ya 304, mpona mokolo moko na carton, mpe mikolo minei na motako. 	For, the virus was detected on Plastic (polypropylene) up to three days ago and on 304 steel, for one day on cardboard, and four days on copper.
922	en	ln	 This, however, varies based on the humidity and temperature.Pets and other animals have tested positive for COVID-19. 	 Kasi, oyo etali soki esika yango ezali mulunge to molunge te. Bambwa na banyama misusu bakoki kozala na COVID-19. 	However, this depends on whether the environment is hot or not. Dogs and other animals can be infected with COVID-1
923	en	ln	 There is no evidence animals can pass the virus on to humans, though British authorities advise washing one's hands after contact with animals, like after contact with other surfaces infected people could have touched. 	 Etid moko te elobi ete banyama bakoki kopesa virisi yango na bato, kasi bakonzi na Angleterre ba lobi esengeli moto asokola maboko nsima ya kosimba banyama, lekola na nsima ya kosimbabisika oyo bato ya maladi basimbi. 	There is no evidence that animals can transmit the virus to humans, but authorities in England say people should wash their hands after handling animals, such as after touching infected areas.
924	en	ln	 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus, first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan. 	 Syndrome ya Maladi ya Makasi ya kopema ya coronavirisi 2 (SARS-CoV-2) ezali sika, moto ya liboso ya kozala na yango batiaki ye mosina na bato oyo bazali na pneumonia to maladi ya kopema na Wuhan.	The Severe Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is new, the first case was infected with pneumonia or respiratory illness in Wuhan.
925	en	ln	 All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.Outside the human body, the virus is killed by household soap, which dissolves its protective envelope.SARS-CoV-2 is closely related to the original SARS-CoV. 	 Nyonso ya SARS-CoV-2 ya sika ezali kosalema na bisika oyo yango ezali. Libanda ya nzoto ya moto, virisi ekoki kofanda likolo ya sabuni nsima eko bozanma mpe ekufi. SARS-CoV-2 ezali moko ya libota ya SARS-CoV. 	All of the new SARS-CoV-2 is occurring locally. Outside the human body, the virus can sit on the soap and then it will die. SARS-CoV-2 is a member of the SARS-CoV family.
926	en	ln	 It is thought to have a zoonotic origin. 	 Balobi ete ekoki kowuta esika ya banyama. 	They say it can come from animals.
927	en	ln	 Genetic analysis has revealed that the coronavirus genetically clusters with the genus Betacoronavirus, in subgenus Sarbecovirus (lineage B) together with two bat-derived strains. 	 Kososola bagenetik emoni coronavirisi na kati ya baninga ya Betacoronavirisi, na bisika ya Sarbecovirisi (nzela ya B) bomoko na mibale oyo euti na ba ngembo. 	Genetic analysis has identified coronaviruses among Betacoronavirus relatives, instead of Sarbecoviruses (pathway B) one in two from ticks.
928	en	ln	 It is 96% identical at the whole genome level to other bat coronavirus samples (BatCov RaTG13). 	 Ezali 96% bomoko na genome oyo ya coronavirisi oyo euti na bangembo (batCov RaTG13). 	It is 96% identical to this bat-derived coronavirus genome (batCov RaTG13).
929	en	ln	 In February 2020, Chinese researchers found that there is only one amino acid difference in certain parts of the genome sequences between the viruses from pangolins and those from humans. 	 Na sanza ya mibale na 2020, etid na Chine emoni ete oyo ekaboli bango ezali kaka amino acid moko na bisika misusu ya genome ya virisi ya nkakolo na oyo ya bato. 	In February 2020, etid in China discovered that what separates them is just one amino acid in other parts of the gonorrhea virus genome from that of humans.
930	en	ln	 Whole-genome comparison to date has found at most 92% of genetic material shared between pangolin coronavirus and SARS-CoV-2, which is insufficient to prove pangolins to be the intermediate host. 	 Genome nyonso emonani na 92% ya oyo bankakolo na bato bazali na coronavirisi mpe SARS-CoV-2, oyo ekoki te koloba ete maladi euti na bankakolo. 	All genomes are found in 92% of those in humans with coronavirus and SARS-CoV-2, which cannot be attributed to humans.
931	en	ln	 Infection by the virus can be provisionally diagnosed on the basis of symptoms, though confirmation is ultimately by reverse transcription polymerase chain reaction (rRT-PCR) of infected secretions or CT imaging. 	 Maladi nsima ya virisi ekoki komonana kati ya basymptomi, kasi kososola mpona kondima yango esengeli esalema na kotala na ndenge ya kati polymérase (rRT-PCR) ya bisika oyo ezali na maladi na elili ya CT. 	Postviral disease may be seen among the symptoms, but diagnosis should be made by rRT-PCR of infected areas on CT scans.
932	en	ln	 A study comparing PCR to CT in Wuhan has suggested that CT is significantly more sensitive than PCR, though less specific, with many of its imaging features overlapping with other pneumonias and disease processes. 	 Etid mpona komona nini ekaboli PCR na CT na Wuhan emon ete CT ezali komona koleka PCR, kasi esosoli kaka likambo moko te, mpo ete bilili mingi ezali komonana na bamaladi ya pneumonia mpe misusu. 	Etid to see what separates PCR from CT in Wuhan emon that CT is more visible than PCR, but it just doesn&#39;t understand the same thing, because more images are seen in pneumonia and other diseases.
933	en	ln	" As of March 2020, the American College of Radiology recommends that ""CT should not be used to screen for or as a first-line test to diagnose COVID-19"". "	 Na sanza ya misato 2020, College ya BaAmeriquain ya Radiology elobi ete ‘’CT ekoki kosalema te mpona ba oyo babeli sika na COVID-19’’. 	In March 2020, the American College of Radiology said &#39;&#39;CT is not available for newly diagnosed patients with COVID-1
934	en	ln	 The WHO has published several RNA testing protocols for SARS-CoV-2, with the first issued on 17 January. 	 OMS ebimisaki manuskri na baekzame mingi ya RNA mpona SARS-CoV-2, ya liboso ebimaki na sanza ya mokolo ya 17. 	The WHO published a manuscript with several RNA tests for SARS-CoV-2, the first of which was published on 17 May.
935	en	ln	 The test uses real-time reverse transcription polymerase chain reaction (rRT-PCR). 	 Ekzame esalisi komona ezaleli ya ba polymerase (rRT-PCR). 	The assay helps see the behavior of polymerases (rRT-PCR).
936	en	ln	 The test can be done on respiratory or blood samples. 	 Ekzame ekoki kosalema na mpena to na makila. 	The test can be done with a smear or blood.
937	en	ln	 Results are generally available within a few hours to days. 	 Baresulta ekoyebana na ba ngonga mikie oyo elandi to na mikolo. 	Results will be announced in the next few hours or days.
938	en	ln	 Generally this test is carried out on a nasopharyngeal swab though a throat swab may also be used.A number of laboratories and companies are developing serological tests, which detect antibodies. 	 Kasi baekzame oyo esalemi ya kotoka mayi ya zolo mpe ya kati ya mongongo. Balaboratoir mingi na bacompani bazali kosala baekzame ya serological oyo ekomona ba anticorps. 	But these tests have been done of nasal and vocal cord drainage. Many laboratories and companies are developing serological tests that will detect antibodies.
939	en	ln	 As of 6 April 2020, none of these has been proved sufficiently accurate to be approved for widespread use. 	 Na mokolo ya 6 sanza ya minei 2020, ata moko te ya oyo emonanaki kozala ya solo mpo ete bato mingi baselela yango. 	As of April 6, 2020, none of this proved to be realistic for widespread use.
940	en	ln	 In the US a serological test developed by Cellex has been approved for emergency use by certified laboratories only. 	 Na US eloko ya ekzame moko ya serologi oyo esalemi na Cellex endimani mpona kosalisama ya likama kaka mpona ba laboratoir. 	In the US a serological test product developed by Cellex is approved for emergency treatment only for laboratories.
941	en	ln	 Characteristic imaging features on radiographs and computed tomography (CT) of people who are symptomatic include asymmetric peripheral ground glass opacities and absent pleural effusions. 	 Bilili ya radio nay a tomography ya ordinateur (CT) ya bato oyo bazali na basymptomi te ezali na talatala ya opak mpe kosangana mingi ya makila esali te. 	Radio nay a computed tomography (CT) images of asymptomatic individuals have opaque mirrors and excessive blood pooling has not resulted.
942	en	ln	 The Italian Radiological Society is compiling an international online database of imaging findings for confirmed cases. 	 Societe ya Radio ya baItalien ezali kosala esika moko na internet mpona komona bilili ya bato oyo bazali kobela. 	The Italian Radio Society is working on an online site to see pictures of people who are sick.
943	en	ln	 Due to overlap with other infections such as adenovirus, imaging without confirmation by PCR is of limited specificity in identifying COVID-19. 	 Mpo ete ezali kovukama na bamaldi mingi lekola adenovirisi, elili na kozanga komona na PCR ezali mukie mpona komona COVID-19. 	Because it is infected with many diseases such as adenovirus, the shadow of PCR failure is small to detect COVID-1
944	en	ln	 A large study in China compared chest CT results to PCR and demonstrated that though imaging is less specific for the infection, it is faster and more sensitive, suggesting its consideration as a screening tool in epidemic areas. 	 Etid ya monene na Chine emoni ba tolo na CT mpe na PCR elobi ete bilili ezali koloba mingi te, ezali noki mpe ezali kosola malamu te, mpona koloba ete esalisama na etumba oyo ya pandemic. 	China&#39;s largest CT and PCR tests say the images are less accurate, faster and less clear, to say they have helped fight the pandemic.
945	en	ln	 Artificial intelligence-based convolutional neural networks have been developed to detect imaging features of the virus with both radiographs and CT. 	 Bayele ya Artificiel mpona komona ba nerf nakati ya moto soki virisi ezali na Radio to CT. 	Artificial Intelligence to see nerves inside a person if the virus is present on Radio or CT.
946	en	ln	 Strategies for preventing transmission of the disease include maintaining overall good personal hygiene, washing hands, avoiding touching the eyes, nose, or mouth with unwashed hands, and coughing or sneezing into a tissue and putting the tissue directly into a waste container. 	 Misala mpona kopekisa kopanzana ys malady ezali kopetola nzoto malamu, kosokola maboko, mpona kosimga elongi te, zolo, to monoko na mabokok oyo esokolami te, mpe kokosola to kosala itche na kati ya elamba mpe kobwaka yango noki na poubelle. 	Measures to prevent the spread ys disease include good hygiene, washing hands, not touching face, nose, or mouth with unwashed hands, and scratching or itching in clothing and disposing of it immediately in the trash.
947	en	ln	 Those who may already have the infection have been advised to wear a surgical mask in public. 	 Ba oyo bakoki kozala na malady esengeli balata mask na libanda ya ndako. 	Those who may be infected should wear a mask outside the home.
948	en	ln	 Physical distancing measures are also recommended to prevent transmission.Many governments have restricted or advised against all non-essential travel to and from countries and areas affected by the outbreak. 	 Kofanda mosika na bato mpe. Ba gouvernema mingi basukisi to bakati bato kosala banzela oyo ezali na ntina te na bamboka oyo bazali na pandemic. 	Stay away from people too. Many governments have suspended or cut off unnecessary road construction in pandemic countries.
949	en	ln	 However, the virus has reached the stage of community spread in large parts of the world. 	 Kasi, virisi ekomi esika ya kopalangana kati na bato na mokili mombimba. 	However, the virus has become a global epidemic.
950	en	ln	 This means that the virus is spreading within communities, and some community members don't know where or how they were infected.Health care providers taking care of someone who may be infected are recommended to use standard precautions, contact precautions, and eye protection.Contact tracing is an important method for health authorities to determine the source of an infection and to prevent further transmission. 	 Oyo elingi koloba ete virisi ezali kopanzana kati na bato na lingomba, magonba misusu ba yebi te ndenge nini to wapi bazalaki maladi. Banganga oyo bazali kosalisa bato ya kobela esengeli basalisa toli ya kobatela nzoto na kofanda mosika mpe kobatela miso. Kolanda ya bato ezali ntina makasi mpona mikonzi na koyeba esika oyo maladi euti mpona kosukisa yango. 	This means that the virus is spreading among people in the church, some religions do not know how or where they were sick. Physicians treating patients should follow the precautionary advice of staying away from each other and keeping an eye on them. Follow-up is essential for authorities to identify the source of the disease and eradicate it.
951	en	ln	 The use of location data from mobile phones by governments for this purpose has prompted privacy concerns, with Amnesty International and over 100 other organizations issuing a statement calling for limits on this kind of surveillance. 	 Gouvernema kosalisa komona esika ya telephone ebangisi bato, Amnesty International na ba organisation misusu 100 mpona ndenge bazali kotia miso na makambo ya bato. 	The government&#39;s help to see the telephone booth has frightened people, Amnesty International and 100 other organizations for their attention to human rights.
952	en	ln	 Various mobile apps have been implemented or proposed for voluntary use, and as of April 7, 2020, over a dozen expert groups were working on privacy-friendly solutions, such as using Bluetooth to log a user's proximity to other cellphones. 	 Baaplications mingi ya telephone esalemi mpona kosalisama, na mokolo ya 7 sanza ya minei 2020, koleka zomi na mibale ya bayekoli bazalaki kosala na mosala ya kobatela makambo ya bato, lekola kosalisa Bluetooth mpona koyeba bato bazali pene ndenge nini na batelephone mosusu. 	Many phone applications have been developed to help, as of April 7, 2020, more than a dozen students were working on privacy, such as using Bluetooth to determine how close people are to other phones.
953	en	ln	 Users then receive a message if they've been in close contact with someone who has tested positive for COVID-19.Misconceptions are circulating about how to prevent infection; for example, rinsing the nose and gargling with mouthwash are not effective. 	 Nsima bato bakozwa message ete bazalaki pene na moto oyo azali na COVID-19. Lekuta ezali kotambola na ndenge nini kopekisa maladi; lekola kosokola zolo mpe kosokola monoko na kissi ya monoko, nyonso ezali solo te. 	People will then receive a message that they were close to someone with COVID-1 Lies are going on about how to prevent disease; like rubbing your nose and rubbing your mouth with a mouth kiss, all are not true.
954	en	ln	 There is no COVID-19 vaccine, though many organizations are working to develop one. 	 Vaccin mpona COVID-19 ezali te, kasi ba organization mingi bazali kosala mosala mpona ete ezala. 	There is no vaccine for COVID-19, but many organizations are working to make it available.
955	en	ln	 Hand washing is recommended to prevent the spread of the disease. 	 Kosokola maboko esengami mpona kopekisa ete malady epanzana na bato. 	Hand washing is required to prevent the spread of disease.
956	en	ln	 The CDC recommends that people wash hands often with soap and water for at least twenty seconds, especially after going to the toilet or when hands are visibly dirty; before eating; and after blowing one's nose, coughing, or sneezing. 	 CDC esengi bato basokola maboko ba mbala ebele na sabuni na mayi mpona baseconde ntuku mibale, nsima ya kokenda kabine to soki maboko ezali na vindo; liboso ya kolia bilei; mpe nsima ya kopopola zolo, kokosola, mpe kosala itche. 	The CDC recommends that people wash their hands several times with soap and water for twenty seconds, after going to the toilet or if their hands are wet; before eating a meal; and after blowing nose, sneezing, and itching.
957	en	ln	 This is because outside the human body, the virus is killed by household soap, which bursts its protective bubble. 	 Oyo ezali mpo ete libanda ya nzoto ya moto, virisi ekoki kobamama na sabuni ya ndako, oyo ekotobola ndako na yango ya kobatama. 	This is because outside the human body, the virus can be transmitted with household soap, which will destroy its breeding ground.
958	en	ln	 CDC further recommended using an alcohol-based hand sanitizer with at least 60% alcohol by volume when soap and water are not readily available. 	 CDC apesi lisusu toil ete kosokola maboko na kisi oyo ezali na 60% ya lotoko koleka mayi na sabuni ezali mingi te. 	The CDC also recommends that hand washing with a 60% mild solution is less common than soap and water.
959	en	ln	 The WHO advises people to avoid touching the eyes, nose, or mouth with unwashed hands. 	 OMS apesi bato toil batika kosimba miso, zolo to monoko na maboko oyo esokwami te. 	WHO advises people to stop touching their eyes, nose or mouth with unwashed hands.
960	en	ln	 Surfaces may be decontaminated with a number of solutions (within one minute of exposure to the disinfectant for a stainless steel surface), including 62–71% ethanol, 50–100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, and 0.2–7.5% povidone-iodine. 	 Bisika ekoki kozala na maladi mpe na basolutionimingi (na minute moko ya komipesa na kozwa malady na koboma microbe na libende), mpe 62-71% ya ethanol, 50-100% ya isopropanol, 0.1% ya sodium hypochloride, 0.5% ya hygrogen peroxide, mpe na 0.2%-7.5% ya povidone-iodine. 	Surfaces can be disinfected and many solutions (per minute of committing to disinfection with iron disinfection), and 62-71% ethanol, 50-100% isopropanol, 0.1% sodium hypochlorite, 0.5% hygrogen peroxide , and 0.2%-7.5% povidone-iodine.
961	en	ln	 Other solutions, such as benzalkonium chloride and chrohexidine gluconate, are less effective. 	 Basolution misusu, lekola benzalkonium chloride na chroxedine gluconate, ezali makasi mingi te. 	Other solutions, such as benzalkonium chloride and chroxedine gluconate, are less potent.
962	en	ln	 The CDC recommends that if a COVID case is suspected or confirmed at a facility such as an office or day care, all areas such as offices, bathrooms, common areas, shared electronic equipment like tablets, touch screens, keyboards, remote controls, and ATM machines used by the ill persons, should be disinfected. 	 CDC epesi toil ete soki moto na COVID amonani na lepital to bakanisi akoki kozala na COVID, lokola mpe na mosala, kelasi ya bana, bisika nyonso lekola douche, esika ya kofanda, ba electronic ya kokabola, ba ecran, ba clavier, ba command ya tele, mpe ba machine ATM oyo moto ya kobela asimbi, esengeli kopetola yango. 	The CDC advises that if a person with COVID is diagnosed in the hospital or suspected of having COVID, as well as at work, kindergarten, anywhere such as shower, living area, shared electronics, screens, keyboards, controls of television, and ATM machines touched by the patient should be cleaned.
963	en	ln	 Health organizations recommended that people cover their mouth and nose with a bent elbow or a tissue when coughing or sneezing, and disposing of any tissue immediately. 	 Ba organization ya kolongono esengi bato bakanga monoko mpe zolo na kati ya couode ya liboko to na elamba mpona kokosola to kosala itche, mpe kobwaka yango noki. 	Health organizations recommend that people cover their mouth and nose with the elbow of the hand or a cloth to avoid coughing or itching, and dispose of it immediately.
964	en	ln	 Surgical masks are recommended for those who may be infected, as wearing a mask can limit the volume and travel distance of expiratory droplets dispersed when talking, sneezing, and coughing. 	 Bamask ya lepital esengeli mpona ba oyo bazali na maladi, mpo ete kolata mask ekoki kosukisa nzela ya matangi ntango moto azali koloba, kosala itche to kokosola. 	Hospital masks are necessary for those who are sick, as wearing a mask can interrupt the flow of tears when speaking, itching or sneezing.
965	en	ln	 The WHO has issued instructions on when and how to use masks. 	 OMS epesi mibeko mpona ntango nini kolata bamask. 	WHO has given guidelines for when to wear masks.
966	en	ln	" According to Stephen Griffin, a virologist at the University of Leeds, ""Wearing a mask can reduce the propensity [of] people to touch their faces, which is a major source of infection without proper hand hygiene.""Masks have also been recommended for use by those taking care of someone who may have the disease. "	 Stephen Griffin, moyekoli ya bavirisi na universite ya Leeds, alobi ‘’kolata mask ekoki kopekisa bato na kosimba simba elongi, mpo yango ezali ntina ebele ya nzela oyo maladi ezali kokota. ‘’Bamask mpe ekoki kolatama mpona moto oyo azali kosalisa moto oyo koki kozala na malady. 	Stephen Griffin, a virologist at the University of Leeds, said &#39;&#39;wearing a mask can prevent people from touching their faces, because that&#39;s the main reason the disease is spreading. &#39;&#39;Masks can also be worn for someone who is caring for someone who may be sick.
967	en	ln	 The WHO has recommended the wearing of masks by healthy people only if they are at high risk, such as those who are caring for a person with COVID-19, although they also acknowledge that wearing masks may help people avoid touching their face. 	 OMS elobi bato oyo bazali kobela te esengeli balata mask kaka soki bazali na risk ya kozwa maladi, lekola ba oyo bazali kosunga moto oyo azali kobela COVID-19, kasi ba moni mpe ntina mpo ete bato batika kosimba simba elongi na bango.	The WHO says people who are not sick should only wear masks if they are at risk of getting sick, such as those caring for someone with COVID-19, but they also see the need for people to stop touching their faces.
968	en	ln	 Several countries have started to encourage the use of face masks by members of the public. 	 Ba mboka mingi bakomi kosenga bato balata bamask na libanda ya ndako. 	Many countries are requiring people to wear masks outside the home.
969	en	ln	 In the U.S., the CDC recommends wearing non-medical face mask made out of cloth.China has specifically recommended the use of disposable medical masks by healthy members of the public, particularly when coming into close contact (1 metre (3 ft) or less) with other people. 	 Na U.S, CDC esengi bato balata bamask oyo esalemi na etendi. Chine esengi bato balata bamask oyo elatamaka kaka mbala moko mpona ba oyo bazali kobela te, ntina mingi soki bazali kopusana pene (1 metre (3ft) to mukie) ya bato misusu. 	In the US, the CDC recommends that people wear masks made of tea. China requires people to wear disposable masks for those who are not sick, especially if they are getting close (1 meter (3ft) or less) to other people.
970	en	ln	 Hong Kong recommends wearing a surgical mask when taking public transport or staying in crowded places. 	 Hong Kong esengi bato balata bamask ya lepital ntango bazali na babis to na bisika oyo bato ebele bazali. 	Hong Kong requires people to wear hospital masks when in buses or crowded places.
971	en	ln	 Thailand's health officials are encouraging people to make cloth facemasks at home and wash them daily. 	 Bakonzi ya kolongono na Thailand basengi bato balata mask ya etendi na ndako mpe basokola yango mokolo nyonso. 	Health officials in Thailand have urged people to wear a mask at home and wash it daily.
972	en	ln	 The Czech Republic and Slovakia banned going out in public without wearing a mask or covering one's nose and mouth. 	 Na Republique ya Tcheque mpe na Slovaki batie mibeko oyo epekisi bato babima libanda soki balati mask oyo ekangi zolo na monoko te. 	The Czech Republic and Slovakia have imposed laws banning people from going outside without wearing a mask covering their nose and mouth.
973	en	ln	 On 16 March, Vietnam requested everyone to wear a face mask when going to public areas in order to protect themselves and others. 	 Na mokolo ya 16 sanza ya misato, Vietnam asengaki bato nyonso balata bamask ntango bazali kobima libanda mpona komibatelama mpe kobatela baninga. 	On March 16, Vietnam asked everyone to wear masks when going outside to protect themselves and others.
974	en	ln	 The Austrian government mandated that everyone entering a grocery store must wear a face mask. 	 Gouvernema ya Australie asengaki ete moto nyonso oyo azali kokota zando esengeli alata mask ya elongi. 	The Australian government has required everyone entering the market to wear a face mask.
975	en	ln	 Israel has asked all residents to wear face masks when in public. 	 Israel esengaki bato balata mask soki bazali libanda ya ndako. 	Israel requires people to wear masks when outside the home.
976	en	ln	 Taiwan, which has been producing ten million masks per day since mid-March, required passengers on trains and intercity buses to wear face masks on 1 April. 	 Taiwan, oyo ezali kosala bamilio zomi ya bamask na mokolo uta katikati ya sanza ya misato, basengaki bato nyonso na train mpe na ba bus balata bamask banda mokolo ya 1 sanza ya minei. 	Taiwan, which has been producing tens of millions of masks a day since mid-March, has required everyone on trains and buses to wear masks since April
977	en	ln	 Panama has made it obligatory to wear a face mask whenever going outside, while also recommending the manufacture of a homemade face mask for those who cannot purchase face masks. 	 Panama esalisi yango mobeko oyo esengeli moto nyono alanda soki bazali kobima libanda ya ndako, mpe bapesi mpe toil kosala bamask ya etendi na ndako mpona ba oyo bakoki kosomba mask te. 	Panama has made it a requirement for everyone to follow when going outside, and has also offered toil to make homemade masks for those who cannot afford them.
978	en	ln	 Face masks have also been widely used in Japan, South Korea, Malaysia, and Singapore. 	 Bamask esalemi mingi na Japan, Core ya Sud mpe Malasie mpe na Singapore. 	Masks are widely manufactured in Japan, South Core and Malaysia as well as Singapore.
979	en	ln	 Social distancing (also known as physical distancing) includes infection control actions intended to slow the spread of disease by minimizing close contact between individuals. 	 Kofanda mosika na bato (to kozala mosika na bato) ezali kopekisa bamaladi oyo ekoki kopekisa kosukisa kopalangana ya maladi nako sukisa kofanda bomoko ya bato. 	Isolation (or isolation) prevents diseases that can prevent the spread of disease by ending social isolation.
980	en	ln	 Methods include quarantines; travel restrictions; and the closing of schools, workplaces, stadiums, theatres, or shopping centres. 	Bametod misusu ezali quarantaine; kokanga ba nzela; mpe kokanga ba kelasi, bisika ya mosala, bastade, ba teatre, mpe bisika ya minene ya babutik ebele. 	Other methods include quarantine; closing the roads; and the closure of schools, workplaces, stadiums, theaters, and many shopping malls.
981	en	ln	 Individuals may apply social distancing methods by staying at home, limiting travel, avoiding crowded areas, using no-contact greetings, and physically distancing themselves from others. 	 Bato bakoki kosalisa kofanda mosika ya bato na kofanda na ndako, kosala nzela te, kotika kokende bisika oyo bato ebele bazali, kosimba bato te, mpe kozala mosika na bato. 	People can help stay away from people by staying indoors, not making the road, avoiding crowded places, not touching people, and staying away from people.
982	en	ln	 Many governments are now mandating or recommending social distancing in regions affected by the outbreak. 	 Ba gouvernema mingi bazali kokotisa mibela ya kofanda mosika na bato na bisika oyo epanzani makasi na maladi. 	Many governments are introducing quarantine measures in high-risk areas.
983	en	ln	 The maximum gathering size recommended by US government bodies and health organizations was swiftly reduced from 250 people (if there was no known COVID-19 spread in a region) to 50 people, and later to 10 people. 	 Gouvernema ya US alobi ete bato bakoki kozala lisanga kaka soki bazali 250 to mukie (Soki COVID-19 emonani te na lingomba na bango) to 50, mpe nsima balobi 10. 	The US government says people can only be in a group if they are 250 or fewer (If COVID-19 is not detected in their church) or 50, and then they say
984	en	ln	" On 22 March 2020, Germany banned public gatherings of more than two people.Older adults and those with underlying medical conditions such as diabetes, heart disease, respiratory disease, hypertension, and compromised immune systems face increased risk of serious illness and complications and have been advised by the CDC to stay home as much as possible in areas of community outbreak.In late March 2020, the WHO and other health bodies began to replace the use of the term ""social distancing"" with ""physical distancing"", to clarify that the aim is to reduce physical contact while maintaining social connections, either virtually or at a distance. "	 Na mokolo ya 22 sanza ya misato 2020, Germany ekataki makambo ya kosangana ya bato 2 to mingi. Bato ya mikolo mpe ba oyo bazali kobela na bamaladi misusu lokola diabete, maladi ya motema, maladi ya kopema, tension, mpe kozanga systeme ya immunite ya nzoto ya makasi bakoki kobela makasi CDC alobi esengeli batikala na ndako na bisika oyo kopalangana ya maladi ezali. Suka ya sanza ya misato 2020, OMS mpe bisika misusu ya kolongona bakomi ko benga ‘Kozala mosika’ na ‘kofanda mosika’, mpona koloba ete esengeli zonto na yo ezala mosika kasi esengeli bato basolola na internet to na mosika. 	On March 22, 2020, Germany cut the number of 2 or more participants. Seniors and those suffering from other illnesses such as diabetes, heart disease, respiratory disease, high blood pressure, and lack of a strong immune system can become seriously ill the CDC says they should stay home in areas where there is a spread of disease. By the end of March 2020, the WHO and other health authorities will be calling &#39;Stay away&#39; and &#39;stay away&#39;, to mean that your body should be away but people should communicate online or remotely.
985	en	ln	" The use of the term ""social distancing"" had led to implications that people should engage in complete social isolation, rather than encouraging them to stay in contact with others through alternative means.Some authorities have issued sexual health guidelines for use during the pandemic. "	 Koloba ‘Kozala mosika’ elobi na bato esengeli basolola at ate na bato, bazala kaka bango moko, kasi esengeli bato basolola soki bakoki. Ba gouvernema misusu bakotisi toil ya kosangana nzoto na pandemic oyo. 	Saying &#39;Stay away&#39; tells people they should talk at ate with people, just be alone, but people should talk if they can. Some governments have introduced sexual toil in this pandemic.
986	en	ln	 These include recommendations to only have sex with someone you live with, who does not have the virus or symptoms of the virus. 	 Ezali na toil ya kosangana nzoto kaka na moto ozali kofanda ndako moko na ye, oyo azali na virisi to basymptomi te. 	There is toil to have sex only with someone you live in the same house with, who has no virus or symptoms.
987	en	ln	 Self-isolation at home has been recommended for those diagnosed with COVID-19 and those who suspect they have been infected. 	 Konfinema na ndako esengami mpona ba oyo bazali na COVID-19 mpe ba oyo bakanisi bazali na yango. 	Home confinement is required for those with COVID-19 and suspected cases.
988	en	ln	 Health agencies have issued detailed instructions for proper self-isolation.Many governments have mandated or recommended self-quarantine for entire populations living in affected areas. 	 Bisika ya kolongono epesi toil mpona konfinema ya malamu. Bagouvernema mingi batie mibeko to basengi konfinema ya bato nyonso na bisika oyo maladi ezali. 	Health facilities provide toil for proper confinement. Many governments have imposed laws or required public quarantine in outbreak areas.
989	en	ln	 The strongest self-quarantine instructions have been issued to those in high risk groups. 	 Mibeko ya konfinema ya makasi epesami na ba oyo bakoki kozwa maladi noki. 	Strict quarantine measures are imposed on those who are susceptible to infection.
990	en	ln	 Those who may have been exposed to someone with COVID-19 and those who have recently travelled to a country or region with widespread transmission have been advised to self-quarantine for 14 days from the time of last possible exposure. 	 Ba oyo bazalaki pene na moto oyo azali na COVID-19 mpe ba oyo bauti nzela na bisika to bamboka oyo ezali na maladi makasi kofanda na konfinema mpona mikolo 14. 	Those who have been close to a person with COVID-19 and those who have traveled from seriously ill areas or countries stay in quarantine for 14 days.
991	en	ln	 Strategies in the control of an outbreak are containment or suppression, and mitigation. 	 Ndenge ya kobundela kopalangana oyo eza kosukisa to kokitisa to kozongisa yango nsima. 	How to fight this spread is to stop or reduce or reverse it.
992	en	ln	 Containment is undertaken in the early stages of the outbreak and aims to trace and isolate those infected as well as introduce other measures of infection control and vaccinations to stop the disease from spreading to the rest of the population. 	 Kosukisa ezali kosalema na ebandeli ya kopalangana ezali kolanda bato mpe kokonfine ba oyo bazali na maladi mpe kosala misusu oyo ekozongisa maladi nsima mpe kopesa ba vaccine na bato mpona kokitisa malady na population. 	The end is being done at the beginning of the outbreak is to track people and confine those who are sick and do other things that will reverse the disease and vaccinate people to reduce the disease in the population.
993	en	ln	 When it is no longer possible to contain the spread of the disease, efforts then move to the mitigation stage: measures are taken to slow the spread and mitigate its effects on the healthcare system and society. 	 Ntango ekomi mpasi kokanga kopalangana ya maladi, mosalo siko oyo ekomi ya: kokitisa kopalangana ya virisi na lingomba. 	As it becomes harder to contain the spread of disease, the task now becomes: reducing the spread of the virus in the church.
994	en	ln	 A combination of both containment and mitigation measures may be undertaken at the same time. 	 Mosala ya kosukisa na kokitisa ekoki kosalema elongo moko. 	The task of terminating and reducing can be done simultaneously.
995	en	ln	 Suppression requires more extreme measures so as to reverse the pandemic by reducing the basic reproduction number to less than 1.Part of managing an infectious disease outbreak is trying to decrease the epidemic peak, known as flattening the epidemic curve. 	 Kokitisa esengi ete mosala mingi esalema mpona kobalola panama na kokitisa kopanza na yango na moto 1. Kolandela maladi ezali kokitisa kopusana ya nzela ya pandemic, eyo ebengami kokitisa pusa ya pandemic. 	Reduction requires more work to turn panama around by reducing its spread to 1 person. Disease surveillance is reducing the approach of the pandemic path, which is called pandemic push reduction.
996	en	ln	 This decreases the risk of health services being overwhelmed and provides more time for vaccines and treatments to be developed. 	 Oyo ekitisaki risk ya bisika ya kosalisa nzoto etonda mingi mpe epesi ntango mpona vaccine na kisi esalama. 	This reduced the risk of overcrowding and allowed time for vaccines and drugs to be developed.
997	en	ln	 Non-pharmaceutical interventions that may manage the outbreak include personal preventive measures, such as hand hygiene, wearing face-masks, and self-quarantine; community measures aimed at physical distancing such as closing schools and cancelling mass gathering events; community engagement to encourage acceptance and participation in such interventions; as well as environmental measures such surface cleaning.More drastic actions aimed at containing the outbreak were taken in China once the severity of the outbreak became apparent, such as quarantining entire cities and imposing strict travel bans. 	 Makambo oyo ezali ya lepital te oyo ekoki kosalisa mpe esali kopesisa maladi eyaka ezali kosokola maboko, kolata bamask, konfinema; mibeko ya ligomba mpona kofanda mosika na bato lekola kokanga ba kelasi mpe kopekisa bato mingi basangana; kondima ya ligomba na kosala makambo oyo; mpe kopetola likola ya biloko na egumba. Mibeko misusu ya makasi ezwamaki na Chine ntango ete likama ekomaki monene, batiaki egumba mobimba na konfinema mpe bakangi ba nzela. 	Non-hospital measures that can help and cause transmission include hand washing, wearing masks, confinement; church social distancing rules such as closing classes and banning mass gatherings; the faith of the church in doing these things; and cleaning up the city. Some strict measures were taken in China when the disaster escalated, the entire city was placed under quarantine and roads were closed.
998	en	ln	 Other countries also adopted a variety of measures aimed at limiting the spread of the virus. 	 Ba mboka misusu batie mibeko mpona kosukisa virisi. 	Some countries have imposed laws to eradicate the virus.
999	en	ln	 South Korea introduced mass screening and localized quarantines, and issued alerts on the movements of infected individuals. 	 Core ya Sud ebandaki kosale ba ekzame ya minene mpe babongisaki bisika ya konfinema, mpe bapekisi bato batambola mingi. 	The South Core began conducting extensive tests and improved quarantine facilities, and restricted movement.
1000	en	ln	 Singapore provided financial support for those infected who quarantined themselves and imposed large fines for those who failed to do so. 	 Singapore epesaki mbongo na ba oyo bamitiaki na konfinema mpe batiaki etumbu mpona ba oyo baboyaki kosala yango. 	Singapore gave money to those who confined themselves and imposed penalties for those who refused to do so.
1001	en	ln	 Taiwan increased face mask production and penalized hoarding of medical supplies.Simulations for Great Britain and the United States show that mitigation (slowing but not stopping epidemic spread) and suppression (reversing epidemic growth) have major challenges. 	 Taiwan ematisaki kosala bamask mpe batiaki etumba na ba oyo bazalaki kombomba bamask ebele. Oyo esali Angleterre na Etats Unis elakisi (kopusa nsima kasi kosukisa kopalangana ya pandemi) été kosukisa (kozongisa pandemi nsima) ezali makasi mingi. 	Taiwan increased mask production and put a war on those who were hiding too many masks. What has happened to England and the United States means (delaying but stopping the spread of the pandemic) that stopping (reversing the pandemic) is very difficult.
1002	en	ln	 Optimal mitigation policies might reduce peak healthcare demand by 2/3 and deaths by half, but still result in hundreds of thousands of deaths and health systems being overwhelmed. 	 Mibeko ya kosukisa ekoki kosalisa ba oyo bazali kosala na balepital na kokitisa boni ya bato bazali kokende na 2/3 mpe kokata kufa na ndambo mpe mpasi ya ba oyo bazali kosala mosala na lepital. 	Final legislation can help hospital workers reduce the number of people attending by 2/3 and cut the death and suffering of hospital workers by half.
1003	en	ln	 Suppression can be preferred but needs to be maintained for as long as the virus is circulating in the human population (or until a vaccine becomes available, if that comes first), as transmission otherwise quickly rebounds when measures are relaxed. 	 Kosukisa ekoki kozala malamu kasi esengeli ekende liboso kaka soki virisi mpe ezali kaka na kati ya bato (to ti mokolo oyo vaccine eko yaka), mpo ete kopalangana ezongaka soki bato bakeyi liboso na mibeko ya kosukisa te. 	Termination may be effective but should only proceed if the virus is also still in the population (or until the day a vaccine arrives), because the spread will resume if people do not proceed with termination measures.
1004	en	ln	 Long-term intervention to suppress the pandemic causes social and economic costs. 	 Mibeko ya ntango molayi na kosukisa pandemic ekozala talo mpona ligomba mpe nkita. 	Long-term measures to end the pandemic will be costly for society and the economy.
1005	en	ln	 There are no specific antiviral medications approved for COVID-19, but development efforts are underway, including testing of existing medications. 	 Kisi ya kobikisa nani ezali te mpona CODI-19, kasi mosala ya kosalela yango ezali, mpe na komeka bakisi oyo ezali. 	There is no cure for CODI-19, but there is work to be done, and in testing available drugs.
1006	en	ln	 Taking over-the-counter cold medications, drinking fluids, and resting may help alleviate symptoms. 	 Komela kisi ya kosukosu oyo osombi na pharmacy, komela ba mayi, mpe kolala malamu ekoki kosalisa na ba symptom. 	Taking over-the-counter cough medicine, drinking fluids, and getting enough sleep can help with symptoms.
1007	en	ln	 Depending on the severity, oxygen therapy, intravenous fluids, and breathing support may be required. 	 Soki ezali makasi koleka, thepari ya oxygen, kolekisa biloko na kati ya mongongo, mpe bamachine ya kopema ekoki kosalisa. 	If it is more severe, thepari of oxygen, passage of substances into the voice, and breathing machines may help.
1008	en	ln	 The use of steroids may worsen outcomes. 	 Kosalisa ba steroids ekoki kotumbola makambo na ndenge ya mabe. 	Steroid treatment can make things worse.
1009	en	ln	 Several compounds that were previously approved for treatment of other viral diseases are being investigated for use in treating COVID-19. 	 Basymptomi mingi endimamaki kosalisama na bakisi y aba maladi ya ba virisi misusu ezali na etid mpona kosalisama mpona COVID-19. 	Many symptoms approved for treatment with antiviral drugs are etid to treat for COVID-1
1010	en	ln	" The WHO also stated that some ""traditional and home remedies"" can provide relief of the symptoms caused by SARS-CoV-19. "	 OMS mpe alobaki ‘’bakisi misusu ya mboka mpe ya ndako’’ ekoki kosalisa basymptomi oyo ya SARS-CoV-19. 	The WHO also said &#39;&#39;other local and home remedies&#39;&#39; can treat these SARS-CoV-19 symptoms.
1011	en	ln	 Increasing capacity and adapting healthcare for the needs of COVID-19 patients is described by the WHO as a fundamental outbreak response measure. 	 Komatisa mpe kobungisa balepital mpona mposa y aba oyo bazali kobela na COVID-19 ezali ntina makasi na etumba oyo elobi OMS. 	Increasing and losing hospitals for the needs of COVID-19 patients is a key factor in the fight, according to the WHO.
1012	en	ln	 The ECDC and the European regional office of the WHO have issued guidelines for hospitals and primary healthcare services for shifting of resources at multiple levels, including focusing laboratory services towards COVID-19 testing, cancelling elective procedures whenever possible, separating and isolating COVID-19 positive patients, and increasing intensive care capabilities by training personnel and increasing the number of available ventilators and beds. 	 ECDC na biro ya Europe ya OMS babimisi mibeko mpona balepital ba banganga mpona kosalisa biloko na bisika misusu ya kolongono, lekola kosalisa laboratoir na baekzame ya COVID-19, kopekisa ba mposa misusu ya bato ya kobela, kotia mosika to na konfinema ba oyo bazali na COVID-19, mpe komatisa ndenge ya kosalisa bato na kotangisa bato ya lepial mpe kozala na bamachine ya pema mingi na ba mbeto. 	The ECDC and the WHO European office have issued guidelines for medical hospitals to provide services to other health facilities, such as providing laboratory tests for COVID-19, restricting certain needs of patients, isolating or confining those with COVID-19, and increase treatment by lepial education and more ventilators in beds.
1013	en	ln	 There are various theories about where the very first case (the so-called patient zero) may have originated. 	 Maloba ezali mingi na esika oyo moto ya maladi oyo ya liboso (oyo babengi patient zero) euti. 	There is a lot of talk about where this first patient (called patient zero) comes from.
1014	en	ln	 The first known case of the novel coronavirus may trace back to 1 December 2019 in Wuhan, Hubei, China. 	 Moto ya kobela ya liboso na coronavirisi ya sika akoki kouta mokolo ya 1 sanza ya zomi na mibale 2019 na Wuhan, Hubei, Chine. 	The first case of the new coronavirus may come from December 1, 2019 in Wuhan, Hubei, China.
1015	en	ln	 Within a month, the number of coronavirus cases in Hubei gradually increased. 	 Na sanza moko, bato oyo bazalaki na maladi ya coronavirisi na Hubei emataki makasi. 	In a month, the number of coronavirus cases in Hubei rose sharply.
1016	en	ln	 These were mostly linked to the Huanan Seafood Wholesale Market, which also sold live animals, and one theory is that the virus came from one of these kinds of animals; or, in other words, has a zoonotic origin.A pneumonia cluster of unknown cause was observed on 26 December and treated by the doctor Zhang Jixian in Hubei Provincial Hospital, who informed the Wuhan Jianghan CDC on 27 December. 	 Bazalaki bato oyo bazalaki na banzela ya zando ya Huanan, oyo ezalaki koteka banyama ya bomoi pe, mpe maloba moko elobi ete virisi yango euti na banyama oyo; to; oyo misusu balobi ewuti na banyama ya zamba to ezali zoonotic. Bato mingi bazalaki kobela pneumona na mokolo ya 26 sanza ya zomi mpe basilisaki bango na monganga Zhang Jixian na Lepital ya egumba ya Hubei, ayebisaki CDC ya Jianghan na Wuhan na mokolo ya 27 sanza ya zomi. 	They were people on the streets of the Huanan market, which sold live animals as well, and one rumor has it that the virus came from these animals; either; some of which have been reported to originate from wild animals or are zoonotic. Several people were suffering from pneumonia on Oct. 26 and were treated by Dr. Zhang Jixian at Hubei City Hospital, told the Jianghan CDC in Wuhan on Oct. 27.
1017	en	ln	" On 30 December, a group of doctors at Wuhan Central Hospital alerted their colleagues of a ""SARS-like coronavirus"". "	 Na mokolo ya 30 sanza ya zomi mibale, lisanga ya banganga na Lepital ya Egumba ya Wuhan bayebisaki baninga ete maladi moko ya ‘’SARS-lekola-coronavirisi’’ ezalaki kotambola. 	On December 30, a group of doctors at Wuhan City Hospital told friends that a &#39;&#39;SARS-like-coronavirus&#39;&#39; outbreak was circulating.
1018	en	ln	 Eight of these doctors, including Li Wenliang, were admonished by the police for spreading false rumours, and another, Ai Fen, was reprimanded by her superiors for raising the alarm. 	 Mwambe ya banganga, mpe Li Wenliang, basimbaki bango na police mpo ete balobaki makambo ya lekuta, Ai Fen, bakataki ye mosala na bakonzi na ye mpo ete abimisaki likama yango. 	Eight priests, including Li Wenliang, were detained by the police for making false statements, Ai Fen, was suspended by his superiors for revealing the accident.
1019	en	ln	 The Wuhan Municipal Health Commission later released a public notice on 31 December and informed the WHO. 	 Commission ya kolongono ya egumba ya Wuhan babimisaki sango mokolo ya 31 sanza ya zomi mpe bayebisaki OMS. 	The Wuhan City Health Commission issued a statement on October 31 and informed the WHO.
1020	en	ln	 Enough cases of unknown pneumonia had been reported to health authorities in Wuhan to trigger an investigation in early January.During the early stages of the outbreak, the number of cases doubled approximately every seven and a half days. 	 Bato mingi oyo bazalaki kobela pneumona bafundaki bango na basali ya kolongono na Wuhan mpo ete basosola yango na ebandeli ya sanza ya liboso. Mikolo ya liboso ya kopalangana ya maladi, limero ya bato oyo bazalaki kobela ezalaki komata makasi na mikolo nsambo to na ndambo ya mokolo. 	Many people with pneumonia were reported to health workers in Wuhan for diagnosis early in the first month. In the early days of the outbreak, the number of cases rose sharply in seven or half days.
1021	en	ln	 In early and mid-January 2020, the virus spread to other Chinese provinces, helped by the Chinese New Year migration and Wuhan being a transport hub and major rail interchange. 	 Na ebandeli mpe na katikati na sanza ya liboso na 2020, virisi ekotaki ba egumba misusu na Chines, esungamaki na feti ya ebandeli ya mbula mpe mpo ete Wuhan ezali esika ya nzela oyo batrai ezali kosuka ebele. 	In early and mid-January 2020, the virus entered other cities in China, helped by the New Year&#39;s Eve holiday and because Wuhan is a traffic stop.
1022	en	ln	 On 20 January, China reported nearly 140 new cases in one day, including two people in Beijing and one in Shenzhen. 	 Na mokolo ya 20 sanza ya liboso, Chine elobaki ete bazalaki na bato ya kobela 140 na mokolo moko, mpe bato mibale na Beinjing na moko na Shenzhen. 	On January 20, China reported 140 cases in one day, with two cases in Beinjing and one in Shenzhen.
1023	en	ln	 Later official data shows that 6,174 people had already developed symptoms by 20 January 2020.As of 26 March, the United States has overtaken China and Italy with the highest number of confirmed cases in the world.As of 9 April 2020, more than 1.61 million cases have been reported worldwide; more than 97,000 people have died and more than 364,000 have recovered. 	 Nsima balimero ya gouvernema elakisi 6,174 ya bato oyo bazalaki na basymptomi na mokolo ya 20 sanza ya liboso 2020. Na mokolo ya 26 ya sanza ya misato, Etats Unis eleki Chine na Italie na bato mingi koleka oyo bazali na maladi na mokili. Na mokolo ya 9 sanza ya minei 2020, koleka bato 1.61 milio bazalaki kobela na mokili; koleka 97,000 bakufaki mpe koleka 364,000 babikaki. 	Then government figures show 6,174 people with symptoms as of January 20, 2020. As of March 26, the United States has surpassed China and Italy with the highest number of cases in the world. As of April 9, 2020, more than 1.61 million people were sick worldwide; more than 97,000 died and more than 364,000 survived.
1024	en	ln	 Around 200 countries and territories have had at least one case. 	 Bamboka 200 mpe bisika nazalaki na mwa moto moko ya kobela. 	200 towns and places I had some one sick person.
1025	en	ln	 Due to the pandemic in Europe, many countries in the Schengen Area have restricted free movement and set up border controls. 	 Likolo ya pandemic na Europe, ba mboka mingi na Schengen bapekisa bato batambola mingi mpe bakangaki ba nzela. 	Because of the pandemic in Europe, many Schengen countries have banned travel and closed roads.
1026	en	ln	 National reactions have included containment measures such as quarantines (known as stay-at-home orders, shelter-in-place orders, or lockdown) and curfews.As of 2 April, nearly 300 million people, or about 90% of the population, are under some form of lockdown in the United States, more than 50 million people are in lockdown in the Philippines, about 59 million people are in lockdown in South Africa, and 1.3 billion people are in lockdown in India. 	 Bato batiami na konfinema na mokili (mibeko ya ebengami kofanda na ndako, kitala na ndako, to konfinema) mpe kotia ban tango ya kobima libanda. Na mokolo ya 2 sanza ya minei, bato 300 milio to 90% ya population, bazali na konfinema ya ndenge moko na Etats Unis, koleka 50 milio bato bazali na konfinema na Philippines, koleka 59 milio bazali na konfinema na Afrik di sid, mpe 1.3 bilio na konfinema na Inde. 	People are placed under ground confinement (so-called stay at home, home quarantine, or confinement rules) and set bans on going outside. As of April 2, 300 million people or 90% of the population, are under similar quarantine in the United States, more than 50 million people are under quarantine in the Philippines, more than 59 million are under quarantine in South Africa, and bilio and confined to India.
1027	en	ln	 On 26 March, 1.7 billion people worldwide were under some form of lockdown, which increased to 2.6 billion people two days later—around a third of the world's population. 	 Na mokolo ya 26 sanza ya misato, 1.7 bilio ya baton a mokili bazalaki na konfinema, oyo etindaki bato 2.6 bilio na mokili mikolo kaka mibale oyo elekaki bakota konfinema – mwa nyonso ya population ya mokili mobimba. 	As of March 26, 1.7 billion people in the world were under quarantine, which prompted 2.6 billion people in the world just two days ago to go into quarantine – almost all of the world’s population.
1028	en	ln	 The first confirmed case of COVID-19 has been traced back to 1 December 2019 in Wuhan; one unconfirmed report suggests the earliest case was on 17 November. 	 Moto ya liboso yo abelaki COVID-19 bamoni ete ezalaki na mokoli ya 1 na sanza ya zomi na mibale 2019 na Wuhan, misusu balobi ete ekoki kozala mokolo ya 17 sanza ya zomi na moko. 	The first case of COVID-19 was confirmed in December 2019 in Wuhan, some suggest it could be November
1029	en	ln	 Doctor Zhang Jixian observed a cluster of pneumonia cases of unknown cause on 26 December, upon which her hospital informed Wuhan Jianghan CDC on 27 December. 	 Monganga Zhang Jixian amonaki bato ya kobela ya pneumonia mingi na mokolo ya 26 sanza ya zomi na mibale, mpe nsima lepital na ye eyebisaki CDC ya Jianghan na Wuhan na mokolo ya 27 sanza ya zomi na mibale. 	Dr. Zhang Jixian saw several cases of pneumonia on December 26, and then his hospital notified the Jianghan CDC in Wuhan on December 27.
1030	en	ln	 Initial genetic testing of patient samples on 27 December 2019 indicated the presence of a SARS-like coronavirus. 	 Baekzame ya liboso oyo emonaki genetic y aba oyo bazalaki kobela na mokolo ya 27 sanza ya zomi na mibale 2019 emonaki SARS-lekola ya- coronavirisi. 	The first genetic tests of the sick y aba on December 27, 2019 revealed SARS-like of- coronavirus.
1031	en	ln	 A public notice was released by Wuhan Municipal Health Commission on 31 December. 	 Commission ya Kolongono na Egumba ya Wuhan epesaki sango na mokolo ya 31 sanza ya zomi na moko. 	The Wuhan City Health Commission reported on November
1032	en	ln	 The WHO was informed on the same day. 	 OMS mpe epesaki sango mokolo wana. 	The WHO also provided information that day.
1033	en	ln	" As these notifications occurred, doctors in Wuhan were warned by police for ""spreading rumours"" about the outbreak. "	 Ntango basango oyo ezalaki kosalema, banganga na Wuhan bapekisaki bango na police balboa lokuta te na likama wana. 	While this news was being made, priests in Wuhan were prevented by police from balboa not lying about the accident.
1034	en	ln	" The Chinese National Health Commission initially claimed that there was no ""clear evidence"" of human-to-human transmission. "	 Commission ya mboka mpona kolongono na Chine elobaki ete malady yando ezali kotambola kati na bato te ‘’eloko te elakisi yango’’. 	China&#39;s National Health Commission said yando is not circulating among people &#39;&#39;nothing indicates it&#39;
1035	en	ln	" In late January, the Chinese government launched a radical campaign later described by the Chinese Communist Party general secretary Xi Jinping as a ""people's war"" to contain the spread of the virus. "	 Na suka ya sanza ya liboso, gouvernema ya Chine abandaki compagne oyo babengaki na secretaire general ya politik ya bacommunist Xi Jinping ete bazali na ‘’etumba’’ ya kolanda kopalangana ya virisi. 	In late January, the Chinese government launched a campaign called by Communist Political Secretary-General Xi Jinping that they were in a &#39;&#39;war&#39;&#39; to keep up with the spread of the virus.
1036	en	ln	" In what has been described as ""the largest quarantine in human history"", a cordon sanitaire was announced on 23 January stopping travel in and out of Wuhan, which was extended to a total of 15 cities in Hubei, affecting a total of about 57 million people. "	 Oyo babengi ezali lekola ‘’konfinema ya monene na masolo ya mokili’’, mosala ya kolongono ebandaki mokolo ya 23 na sanza ya liboso kopekisa banzela ya kokota mpe kobima Wuhan, oyo esalemaki na ba egumba 15 na Hubei, mpona bato 57 milio. 	Described as the &#39;&#39;largest lockdown in world history&#39;&#39;, the health operation began on January 23 closing entry and exit routes to Wuhan, which was imposed in 15 cities in Hubei, for 57 million people.
1037	en	ln	 Private vehicle use was banned in the city. 	 Mituka ya bato epekisamaki na egumba. 	Private cars were banned in the city.
1038	en	ln	 Chinese New Year (25 January) celebrations were cancelled in many places. 	 Feti ya ebandeli ya sanza na Chine (25 sanza ya liboso) esukisamaki. 	The celebration of the beginning of the moon in China (25th of the first month) was concluded.
1039	en	ln	 The authorities also announced the construction of a temporary hospital, Huoshenshan Hospital, which was completed in 10 days. 	 Bakonzi mpe babandaki kotonga lepital ya huoshenshan oyo basilisaki na mikolo 10. 	The authorities also began the construction of the huoshenshan hospital which was completed in 10 days.
1040	en	ln	 Another hospital was built afterwards, Leishenshan Hospital, to handle additional patients. 	 Lepital mosusu esalemaki nsima, lepital ya leishenshan, mpona kosalisa bato ya kobela. 	Another hospital was later established, the Leishenshan Hospital, to treat the sick.
1041	en	ln	 In addition to newly constructed hospitals, China also converted 14 other facilities in Wuhan, such as convention centers and stadiums, into temporary hospitals.On 26 January, the government instituted further measures to contain the COVID-19 outbreak, including issuing health declarations for travellers and extending the Spring Festival holiday. 	 Lisusu mpe na balepital ya sika, Chine ebongisaki mpe bisika 14 na Wuhan, lekola ba stade na bisika ya lisanga ya mineinei, na balepital. Na mokolo ya 26 sanza ya liboso, gouvernema ebandaki kolandela kopalangana ya COVID-19, mpe kopesa toil na ba oyo bazalaki kosala nzela na feti ya Spring. 	In addition to the new hospitals, China has also renovated 14 facilities in Wuhan, such as stadiums and four-story community centers, with hospitals. On January 26, the government began monitoring the spread of COVID-19, and issuing toil to those making their way to the Spring Festival.
1042	en	ln	 Universities and schools around the country were also closed. 	 Ba universite na bakelasi na mboka ekangaki. 	Universities and schools in the country closed.
1043	en	ln	 The regions of Hong Kong and Macau instituted several measures, particularly in regard to schools and universities. 	 Ba egumba na Hong Kong bakotisaki mibeko mingi, mpona oyo etali ba kelasi na ba universite. 	The cities in Hong Kong have introduced many laws, regarding classes and universities.
1044	en	ln	 Remote working measures were instituted in several Chinese regions. 	 Kasala mosala na mosika ebandaki na ba egumba na Chine. 	Remote work started in cities in China.
1045	en	ln	 Travel restrictions were enacted in and outside of Hubei. 	 Bakotisaki mibeko ya kokanga banzela na Hubei. 	Road closures were introduced in Hubei.
1046	en	ln	 Public transport was modified, and museums throughout China were temporarily closed. 	 Babis ekomaki ndenge mosusu, mpe na bamuse na kati ya Chine ekangaki. 	Babis became different, and with muses within China it caught on.
1047	en	ln	" Control of public movement was applied in many cities, and it has been estimated that about 760 million people (more than half the population) faced some form of outdoor restriction.After the outbreak entered its global phase in March, Chinese authorities took strict measures to prevent the virus from ""importing"" from other countries. "	 Kolandela kotambola ya bato esalemaki na ba egumba ebele, mpe elobami ete bato 760 milio (eleki ndambo ya population) bapekisamaki kobima libanda. Nsima oyo malady ekotaki na sanza ya misato, gouvernema ya Chine ekotisaki mibeko ya makasi mpona kopekisa virisi ekota ba mboka misusu. 	Traffic monitoring was carried out in several cities, and it is estimated that 760 million people (more than half the population) were banned from going outside. After the outbreak in March, the Chinese government introduced strict measures to prevent the virus from spreading to other countries.
1048	en	ln	 For example, Beijing has imposed a 14-day mandatory quarantine for all international travellers entering the city.On 23 March, mainland China only one case had transmitted domestically in the five days prior, in this instance via a traveller returning to Guangzhou from Istanbul. 	 Lekola, na Beijing batiaki mibeko ya konfinema ya mikolo 14 mpona bato nyonso oyo bauti ba mboka misusu. Na mokolo ya 23 sanza ya misato, Chine ezalaki kaka na moto moko oyo azwaki maladi na kati ya mboka na mikolo mitano, eutaki na moto moko oyo autaki Guangzhou azalaki kozonga na Istanbul. 	Yesterday, Beijing imposed a 14-day quarantine for all foreign arrivals. As of March 23, China had only one domestic case in five days, from a person returning to Istanbul from Guangzhou.
1049	en	ln	 On 24 March 2020, Chinese Premier Li Keqiang reported that the spread of domestically transmitted cases has been basically blocked and the outbreak has been controlled in China. 	 Na mokolo ya 24 sanza ya misato 2020, moto ya liboso ya Chine Li Keqiang alobaki ete kopalangana ya maladi na ba oyo bazali kati na mboka esimbamaki mpe Chine alandaki likama yango malamu. 	On March 24, 2020, Chinese Premier Li Keqiang said the spread of the disease among those in the country had been contained and China was closely monitoring the threat.
1050	en	ln	 The same day travel restrictions were eased in Hubei, apart from Wuhan, two months after the lockdown was imposed.The Chinese Ministry of Foreign Affairs announced on 26 March 2020 that entry for visa or residence permit holders would be suspended from 28 March onwards, with no specific details on when this policy will end. 	 Mokolo wana kaka bakangaki banzela na Hubei, batikaki Wuhan, ba sanza mibale nsima ya konfinema. Ministre ya bapaya ya Chine na Hubei alobaki mokolo ya 26 sanza ya misato 2020 ete bakoki kopesa ba visa ten a mikanda ya kokota mboka mikolo oyo te banda mokolo ya 28 sanza ya misato mpe emati, bayebisaki te mobeko oyo ekosila mokolo nini. 	The same day they closed roads in Hubei, they left Wuhan, two months after the lockdown. China&#39;s Foreign Minister in Hubei said on March 26, 2020 that visas ten a entry permits can not be issued today since March 28 and increased, they did not say when the rule will expire.
1051	en	ln	 Those who wish to enter China will have to apply for visas in Chinese embassies or consulates. 	 Ba oyo balingi kokota Chine bakosenga visa na Ambassade ya Chine to na Consulaire. 	Those wishing to enter China will apply for a visa at the Chinese Embassy or Consulate.
1052	en	ln	 The Chinese government encouraged businesses and factories to re-open on 30 March, and provided monetary stimulus packages for firms.The State Council declared a day of mourning to begin with a national three-minute moment of silence on 10:00 4 April, coinciding with Qingming Festival, although the central government asked families to pay their respects online in observance of physical distancing as to avoid a renewed COVID-19 outbreak. 	 Gouvernema ya Chine epesaki toil na ba companie bafondolo mokolo ya 30 sanza ya misato, mpe bapesaki mbongo mukie na ba oyo bazali na ba companie. Bakonzi ya egumba basengaki ete mokolo ya kolela ezala na 10:00 mokolo 4 sanza ya minei, ekutamaki na feti ya Qingming, kasi gouvernema ya monene esengaki bato bakanisa bato na internet mpona kotosa kozala mosika na bato mpona pandemic ya COVID-19. 	The Chinese government gave toil to the companies closed on March 30, and gave small amounts of money to the owners of the companies. City officials called for a day of mourning at 10:00 am on April 4, coinciding with the Qingming festival, but the central government urged people to remember people online to observe social distancing due to the COVID-19 pandemic.
1053	en	ln	 COVID-19 was confirmed to have spread to South Korea on 20 January 2020 from China. 	 COVID-19 epanzanaki na Core ya Sud na mokolo ya 20 sanza ya liboso 2020 na Chine. 	COVID-19 spread to South Korea on January 20, 2020 in China.
1054	en	ln	 The nation's health agency reported a significant increase in confirmed cases on 20 February, largely attributed to a gathering in Daegu of a new religious movement known as the Shincheonji Church of Jesus. 	 Esika ya egumba ya kolongono balobaki ete bato ya kobela bazali komata mokolo ya 20 sanza ya minei, ezalaki mpona lisanga oyo esalemaki na losambo ya Daegu oyo babengi Eklesia ya Yesu ya Shincheonji. 	The city&#39;s health center said the increase in cases on April 20 was due to a Daegu religious group called the Shincheonji Church of Jesus.
1055	en	ln	 Shincheonji devotees visiting Daegu from Wuhan were suspected to be the origin of the outbreak. 	 Bato ya Shincheonji oyo bakendaki Daegu na Wuhan bamonaki ete bango moto bapanzaki malady. 	Shincheonji people who went to Daegu and Wuhan were found to have spread the disease.
1056	en	ln	 As of 22 February, among 9,336 followers of the church, 1,261 or about 13% reported symptoms.South Korea declared the highest level of alert on 23 February 2020. 	 Na mokolo ya 22 sanza ya mibale, bato 9,336 ya Eklesia, 1,261 to 13% bazalaki na basymptomi. Core ya Sud ezalaki na mingi ya bato ya kobela ya mokolo ya 23 sanza ya mibale 2020. 	On February 22, 9,336 members of the Church, 1,261 or 13% were symptomatic. The South Core had the majority of the February 23, 2020 cases.
1057	en	ln	 On 28 February, more than 2,000 confirmed cases were reported in Korea, rising to 3,150 on 29 February. 	 Na mokolo ya 28 sanza ya mibale, koleka bato 2,000 bazalaki na maladi na Kore, emataki na 3,150 na mokolo ya 29 sanza ya mibale. 	On February 28th, more than 2,000 people were sick in Korea, rising to 3,150 on February 29th.
1058	en	ln	 All South Korean military bases were quarantined after tests confirmed that three soldiers were positive for the virus. 	 Bisika nyonso ya bato ya limpimgo ya Core ya Sud batiaki bango na konfinema nsima ya kosala bango ekzame bamonaki ete bato ya limpimgo misato bazalaki na virisi. 	All South Korean prisoners were quarantined after three prisoners tested positive for the virus.
1059	en	ln	 Airline schedules were also affected and therefore they were changed.South Korea introduced what was considered the largest and best-organized programme in the world to screen the population for the virus, and isolate any infected people as well as tracing and quarantining those who contacted them. 	 Ba ngona ya mpepo mpe emonaki mpasi. Core ya Sud ebandaki mosala oyo ya liboso mpe ya monene na moili mpona kosala ekzame ya population ya virisi, mpe kokonfine ba oyo bazalaki na yango mpe kolande ba oyo bazalaki pene na bango. 	Flight hours also suffered. The South Core began this first and largest operation in the dark to test the virus population, and confine those who had it and track those close to them.
1060	en	ln	 Screening methods included mandatory self-reporting of symptoms by new international arrivals through mobile application, drive-thru testing for the virus with the results available the next day, and increasing testing capability to allow up to 20,000 people to be tested every day. 	 Mosala ya kosala ekzame esengelaki bato bango moko bayaka liboso soki bazali na basymptomi mpona ba oyo bauti mboka ya mopaya bakoki koyebisa na application ya telephone,ba nzela ya public ya mituka mpe ezalaki kosala ekzame ya virisi mpe ematisaki mosala ya kosala ekzame na 20,000 ya bato oyo basalelami ekzame na mokolo moko. 	The testing required people to come forward if they had symptoms so those from abroad could report the phone application, public roads and was testing for the virus and increased the testing to 20,000 people used examination in a day.
1061	en	ln	 South Korea's programme is considered to be a success in controlling the outbreak despite not quarantining entire cities.The South Korean society was initially polarized on President Moon Jae-in's response to the crisis. 	 Emonanaki ete rogram ya Core ya Sud ezalaki kolandela maladi malamu soki ata batiaki ba egumba na konfinema te. Societe ya Core ya Sud babebisamaki na mokambi Jae-in na oyo ye alobaki likolo ya likama oyo. 	It turned out that the South Korean rogram was monitoring the disease well even if the cities were not quarantined. South Korean society were destroyed by President Jae-in on what he said about this disaster.
1062	en	ln	 Many Koreans signed petitions either calling for the impeachment of Moon over what they claimed to be government mishandling of the outbreak, or praising his response. 	 Ba Coreen mingi batiaki elembo mpo ete ye alongola na mosala mpona oyo bango babengaki kosimba maladi malamu te, to kosepela na nini ye alobaki. 	Many Coreen signed for him to be fired for what they called poor handling of the disease, or not liking what he said.
1063	en	ln	 On 23 March, it was reported that South Korea had the lowest one-day case total in four weeks. 	 Na mokolo ya 23 sanza ya misato, balobaki Core ya Sud ezalaki na kobelo ya mukie na ba mposo minei mpo ezalaki kaka moto moko. 	On March 23, the South Core was reported to have had a small bell in four weeks because there was only one person.
1064	en	ln	 On 29 March it was reported that beginning 1 April all new overseas arrivals will be quarantined for two weeks. 	 Na mokolo ya 29 sanza ya misato elobamaki ete banda mokolo ya 1 bato nyonso oyo bauti mboka ya mopaya bakokota konfinema mpona ba mposo minei. 	On March 29 it was announced that from 1st all immigrants would be quarantined for four weeks.
1065	en	ln	 Per media reports on 1 April, South Korea has received requests for virus testing assistance from 121 different countries. 	 Na ndenge basango elobi na mokolo ya 1 sanza ya minei, Bato basengaki Core ya Sud biloko ya ekzame na bamboka 121. 	As per reports on April 1, People have requested South Core for examination materials in 121 villages.
1066	en	ln	 Iran reported its first confirmed cases of SARS-CoV-2 infections on 19 February in Qom, where, according to the Ministry of Health and Medical Education, two people died later that day. 	 Iran emonaki bato na maladi ya SRS-CoV-2 na mokolo ya 19 sanza ya mibale na Qom, esika oyo mpona ministere ya kolongono mpe ya kotanga kolongono, bato mibale bakufaki mokolo yango. 	Iran reported a case of SRS-CoV-2 on February 19 in Qom, where according to the Ministry of Health and Nursing, two people died that day.
1067	en	ln	 Early measures announced by the government included the cancellation of concerts and other cultural events, sporting events, and Friday prayers, and closures of universities, higher education institutions, and schools. 	 Gouvernema abandaki mosala ya noki na kokanga ba concerts, masano, losambo ya mokolo ya mitani, mpe kokanga ba universite be bisika misusu ya kotanga na bakelasi. 	The government began swift action by closing concerts, games, Friday worship, and closing universities be other places of learning to classes.
1068	en	ln	 Iran allocated five trillion rials to combat the virus. 	 Iran ebimisaki mbongo trilio misato mpona kobundela virisi. 	Iran spent three trillion dollars to fight the virus.
1069	en	ln	 President Hassan Rouhani said on 26 February 2020 that there were no plans to quarantine areas affected by the outbreak, and only individuals would be quarantined. 	 Mokamdi Hassan Rouhani alobaki mokolo ya 26 sanza ya mibale 2020 ete bango balingaki te kotia baton a konfinema na bisika oyo baton a malady bazalaki, kaka bango moto bakokota konfinema. 	President Hassan Rouhani said on February 26, 2020 that they did not want to put people in quarantine in places where people were sick, only they would enter the quarantine.
1070	en	ln	 Plans to limit travel between cities were announced in March, although heavy traffic between cities ahead of the Persian New Year Nowruz continued. 	 Mosala ya kosukisa banzela na kati ya egumba ebandaki na sanza ya misato, kasi embouteyage monene na babalabala ezalaki liboso ya feti ya ebandeli ya sanza ya Ersian Nowruz. 	Work on completing roads in the city began in March, but the major traffic jam on the streets was ahead of the early holiday of the month of Ersian Nowruz.
1071	en	ln	 Shia shrines in Qom remained open to pilgrims until 16 March 2020.Iran became a centre of the spread of the virus after China during February. 	 Bisika ya losambo na Shia ekangaki ten a pilgrims ti mokolo ya 16 sanza ya misato 2020. Iran akomaki mboka oyo ezalaki na malady makasi koleka nsima ya Chine na sanza ya mibale. 	Shia places of worship have closed ten a pilgrims until March 16, 2020. Iran became the second most affected country after China in February.
1072	en	ln	 Amidst claims of a cover-up of the extent of the outbreak in Iran, more than ten countries had traced their cases back to Iran by 28 February, indicating that the extent of the outbreak may be more severe than the 388 cases reported by the Iranian government by that date. 	 Ata oyo balobaki ete bango bazalaki kobomba basekele ya palangana na Iran, bamboka zomi eleki balobaki moto na bango ya liboso ya kobela autaki Iran na mokolo ya 28 sanza ya mibale, koloba ete maladi ezali makasi ya koleka bato ya kobela 388 oyo gouvernema ya Iran elobi. 	Despite claiming to be keeping secrets of the spread in Iran, the past ten countries reported their first case from Iran on February 28, saying the disease is more severe than the Iranian government&#39;s 388 cases . . . .
1073	en	ln	 The Iranian Parliament was shut down, with 23 of its 290 members reported to have had tested positive for the virus on 3 March. 	 Parlement ya Iran ekangaki, mpo ete 23 ya 290 ya baton a bango bamonanaki na virisi mokolo ya 3 sansa ya misato. 	Iran&#39;s parliament closed, after 23 of its 290 members tested positive for the virus on Wednesday.
1074	en	ln	 On 12 March, the Human Rights Watch urged the Iranian prison authorities to unconditionally release the human rights defenders detained for peaceful dissent, and to also temporarily release all the eligible prisoners. 	 Na mokolo ya 12 sanza ya misato, bato ya Kososola Bonsoni ya Bato basengaki bakonzi ya boloko ya Iran babimisa bato oyo bazalaki kobundela bonsoni ya bato mpe kobimisa mpona tango mokuse bato misusu oyo bazalaki na boloko. 	On March 12, Human Rights Watch called on Iranian prison authorities to release human rights activists and temporarily release other prisoners.
1075	en	ln	 It stated that there is a greater risk of the virus to spread in closed institutions like detention centres, which also lack adequate medical care. 	 Elobaki ete risk ya virisi ezali makasi na kopalangana na kati ya boloko, oyo bazali na balepital ya malamu te. 	It said the risk of the virus is high in spreading within prisons, which do not have adequate hospitals.
1076	en	ln	 On 15 March, the Iranian government reported 100 deaths in a single day, the most recorded in the country since the outbreak began. 	 Na mokolo ya 15 sanza ya misato, gouvernema ya Iran ekomaki na bato 100 oyo bakufaki na mokolo moko, ya mingi koleka na mboka uta pandemic ebandaki. 	On March 15, the Iranian government recorded 100 deaths in a single day, the highest in the country since the pandemic began.
1077	en	ln	 At least 12 sitting or former Iranian politicians and government officials had died from the disease by 17 March. 	 12 ya bato ya politik na gouvernema ya Iran bakufaki na maladi yango na mokolo ya 17 sanza ya misato. 	12 politicians in the Iranian government died of the disease on 17 March.
1078	en	ln	 By 23 March, Iran was experiencing 50 new cases every hour and one new death every ten minutes due to coronavirus. 	 Na mokolo ya 23 sanza ya misato, Iran ezalaki na bato ya kobela 50 na ngonga moko mpe moko azalaki kokufa na baminute 10 na coronavirisi. 	As of March 23, Iran had 50 cases per hour and one death every 10 minutes from the virus.
1079	en	ln	 According to a WHO official, there may be five times more cases in Iran than what is being reported. 	 Mpona bato ya OMS, bato ya Iran ekoki kozala mitano koleka na oyo balobi. 	For WHO officials, Iranians may be five more than they say.
1080	en	ln	 It is also suggested that U.S. sanctions on Iran may be affecting the country's financial ability to respond to the viral outbreak. 	 Elobami mpe ete mibeko oyo Etats Unis atie Iran etungisi nkita na bango na kobundela virisi ya pandame. 	It is also said that US sanctions against Iran have affected their economy in the fight against the pandemic virus.
1081	en	ln	 The UN High Commissioner for Human Rights has demanded economic sanctions to be eased for nations most affected by the pandemic, including Iran. 	 Commisariat ya Likolo ya ONU mpona Bonsoni ya bato esengi ete mibeko oyo ezali kotungisa nkita ya bamboka esukisama mpona pandemi, lokola oyo ya Iran. 	The UN High Commissioner for Human Rights has called for an end to laws that are affecting the economy of countries because of the pandemic, such as that in Iran.
1082	en	ln	 The outbreak was confirmed to have spread to Italy on 31 January, when two Chinese tourists tested positive for SARS-CoV-2 in Rome. 	 Pandemi epanzamaki na Italy na mokolo ya 31 sanza ya liboso, ntango bachinois mibale bamonanaki na SARS-CoV-2 na Rome. 	The pandemic broke out in Italy on January 31, when two Chinese were diagnosed with SARS-CoV-2 in Rome.
1083	en	ln	 Cases began to rise sharply, which prompted the Italian government to suspend all flights to and from China and declare a state of emergency. 	Bato ya kobela ebandaki komata noki makasi esengaki gouvernema ya Italie ekanga nzela ya ba mpepo oyo ezali kouta Chine mpe abenga likambo yango likama. 	The rapid rise in cases prompted the Italian government to suspend flights from China and call the situation a disaster.
1084	en	ln	 An unassociated cluster of COVID-19 cases was later detected, starting with 16 confirmed cases in Lombardy on 21 February.On 22 February, the Council of Ministers announced a new decree-law to contain the outbreak, including quarantining more than 50,000 people from 11 different municipalities in northern Italy. 	 Lisanga ya bato mingi oyo bazalaki na COVID-19 emonanaki, ebandaki na bato 16 na lombardy na mokolo ya 21 sanza ya mibale, na mokolo ya 22 sanza ya mibale, Lisanga ya Toli ya baministre elobaki ete mibeko ya sika ezali mpona kolandela pandemi, lekola konfinema ya bato 50,000 koleka na ba egumba 11 na Nord ya Italie. 	The highest number of cases of COVID-19 was detected, starting with 16 people in lombardy on 21 February, on 22 February, the Council of Ministers said that new measures are in place to monitor the pandemic, lekola confinement of more than 50,000 people in 11 cities in Northern Italy.
1085	en	ln	" Prime Minister Giuseppe Conte said, ""In the outbreak areas, entry and exit will not be provided. "	 Ministre ya liboso Giuseppe Conte alobaki, ‘’Na bisika oyo pandemic ebeti makasi, kokota na kobima eko zala te. 	Prime Minister Giuseppe Conte said, &#39;&#39;In areas hit hard by the pandemic, there will be no entry and exit.
1086	en	ln	" Suspension of work activities and sports events has already been ordered in those areas.""On 4 March, the Italian government ordered the full closure of all schools and universities nationwide as Italy reached 100 deaths. "	 Kosukisa ya mosala mpe na masano ebandi na bisika wana misusu. ‘’Na mokolo ya 4 sanza ya misato, gouvernema ya Italie asengaki bakanga ba kelasi na ba universite nyonso na mboka ntango oyo Italie akomaki na bato 100 oyo bakufaki na maladi. 	The end of work and play begins in those other places. &#39;&#39;On March 4, the Italian government ordered the closure of classes at all universities in the country when Italy reached 100 deaths from the disease.
1087	en	ln	 All major sporting events, including Serie A football matches, were to be held behind closed doors until April, but on 9 March, all sport was suspended completely for at least one month. 	 Masano nyonso ya minene, mpe Footbal ya serie A, elingaki ezalema na kati ya esika bakangi baporte na sanza ya minei, kasi na mokolo ya 9 sanza ya misato, masano nyonso ekatanaki mpona sanza moko kokende liboso. 	All major games, including Series A Football, were supposed to be held behind closed doors in April, but on March 9, all games were suspended for a month.
1088	en	ln	 On 11 March, Prime Minister Conte ordered stoppage of nearly all commercial activity except supermarkets and pharmacies.On 6 March, the Italian College of Anaesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) published medical ethics recommendations regarding triage protocols that might be employed. 	 Na sanza ya misato mokolo ya 11, minister ya liboso Conte atindaki ba business nyonso oyo bazali koteka biloko bakanga batika kaka bazando na bapharmacy. Na mokolo ya 6 sanza ya misato, Colle ya Italie ya Anaesthesie, Analgesie, Resuscitation mpe Kolsalisa makasi (SIAARTI) ebimisi etid ya sante mpona ndenge nini kokabola biliko. 	On March 11, Prime Minister Conte ordered all businesses selling goods to close and leave only markets and pharmacies. On March 6, the Italian College of Anaesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) issued a health etid on how to distribute the gifts.
1089	en	ln	 On 19 March, Italy overtook China as the country with the most coronavirus-related deaths in the world after reporting 3,405 fatalities from the pandemic. 	 Na mokolo y a19 sanza ya misato, Italy elekaki Chines na bato oyo bakufaki na coronavirisi mpe mokili nyonso ekomaki na bato ya kokufa 3,405 na pandemic. 	On March 19, Italy surpassed China in the number of deaths from the coronavirus and the worldwide death toll from the pandemic reached 3,4
1090	en	ln	 On 22 March, it was reported that Russia had sent nine military planes with medical equipment to Italy. 	 Na mokolo ya 22 sanza ya misato, elobamaki ete Russie etindaki bam pepo libwa na biloko ya lepital na Italie. 	On March 22, Russia reportedly sent nine planes with hospital supplies to Italy.
1091	en	ln	 As of 5 April, there were 128,948 confirmed cases, 15,887 deaths, and 21,815 recoveries in Italy, with the majority of those cases occurring in the Lombardy region. 	 Na mokolo ya 5 sanza ya minei, bato ya kobela bazalaki 128,948, 15,887 bakufaki, mpe 21,815 babikaki na Italy, mingi na bango bazalaki na Lombardy. 	As of April 5, there were 128,948 cases, 15,887 deaths, and 21,815 survivors in Italy, mostly in Lombardy.
1092	en	ln	 A CNN report indicated that the combination of Italy's large elderly population and inability to test all who have the virus to date may be contributing to the high fatality rate. 	 Rapor ya CNN elobaki ete bato ya mikolo na Italy oyo bakokaki kozwa ekzame te moto esali ete bazala na kufa mingi. 	A CNN report said that older people in Italy who could not get tested have a higher mortality rate.
1093	en	ln	 The United Kingdom's response to the virus first emerged as one of the most relaxed of the affected countries, and until 18 March 2020, the British government did not impose any form of social distancing or mass quarantine measures on its citizens. 	 Mosala ya Angletere ya liboso mpona kobundela virisi ebandaki malembe na bamboka oyo esimbaki, mpe na mokolo ya 18 sanza ya misato 2020, gouvernema ya Angleterre akotisaki mibeko ata moko te mpona kozala mosika na bato to konfinema na bato ya mboka. 	The UK’s initial efforts to fight the virus have been slow in the affected countries, and as of 18 March 2020, the UK government has not introduced any social distancing or confinement measures.
1094	en	ln	 As a result, the government received criticism for the perceived lack of pace and intensity in its response to concerns faced by the public.On 16 March, Prime Minister Boris Johnson made an announcement advising against all non-essential travel and social contact, suggesting people work from home where possible and avoid venues such as pubs, restaurants, and theatres. 	 Mpe bongo, bato basepelaki ten a gouvvernema mpo ete basalaki mingi te mpona likama oyo ezali kati na bato. Na mokolo ya 16 sanza ya misato, minister ya liboso Boris Johnson alobaki ete bato batika kobima libanda ya mboka soki ezali ntina makasi te mpe bazala mosika na bato mpe bakenda te bisika lekola babar, malewa, mpe bateatre. 	And so, people were happy ten a gouvvernema because they didn’t do much about the danger among the people. On March 16, Prime Minister Boris Johnson said people should stop leaving the country unless absolutely necessary and stay away from people and not go to places like bars, pubs, and theatres.
1095	en	ln	 On 20 March, the government announced that all leisure establishments such as pubs and gyms were to close as soon as possible, and promised to pay up to 80% of workers' wages to a limit of £2,500 per month to prevent unemployment in the crisis.On 23 March, the Prime Minister announced tougher social distancing measures, banning gatherings of more than two people and restricting travel and outdoor activity to that deemed strictly necessary. 	 Na mokolo ya 20 sanza ya misato, gouvrnema alobaki ete bisika nyonso ya kosepelisa nzoto lokola bagyms esengelaki bakanga, mpe bako futa baton a bango ya mosala 80% ya salaire na bango to £2,500 na sanza mpo ete bato batika kozanga mosala. Na mokolo ya 23 saza ya misato, minister ya liboso akotisaki mibeko ya makasi mpona kozala mosika na bato, akataki lisanga nyonso ya koleka bato mibale mpe akangaki banzela mpe atikaki kaka makambo ya libanda oyo zali mpeza na ntina makasi. 	On March 20, the gouvrnema said all gyms would have to close, and their workers would be paid 80% of their salaries or £2,500 a month to stop unemployment. On March 23, the prime minister introduced strict social distancing measures, cut off all gatherings of more than two people and closed roads and left only the most important outdoor activities.
1096	en	ln	 Unlike previous measures, these restrictions were enforceable by police through the issuing of fines and the dispersal of gatherings. 	 Lokola ya liboso te, mibeko oyo esengelaki esosolama na Police na kotia bato etumba mpe kopanza soki bato basangani. 	Unlike the first, these rules had to be understood by the Police by putting people in a fight and dispersing if people gathered.
1097	en	ln	" Most businesses were ordered to close, with exceptions for businesses deemed ""essential"", including supermarkets, pharmacies, banks, hardware shops, petrol stations, and garages. "	 Babusiness ebele balobaki na bango bakanga, etikala kaka babusiness oyo ezali na ‘’ntina makasi’’ lekola bazando, ba pharmacy, babank, bisika ya kosomba biloko ya kosala mosala, bastation, mpe bisika ya kobatela mituka. 	Several businesses were told to close, leaving only &#39;&#39;essential&#39;&#39; businesses such as markets, pharmacies, banks, service stations, stations, and car parks.
1098	en	ln	 On 20 January, the first known case of COVID-19 was confirmed in the Pacific Northwest state of Washington in a man who had returned from Wuhan on 15 January. 	 Na mokolo ya 20 sanza ya liboso, moto ya liboso na malady ya COVID-19 azalaki na Pacific Northwest egumba ya Washington na mobali oyo autaki Wuhan mokolo ya 15 sanza ya liboso. 	On January 20, the first case of COVID-19 was in the Pacific Northwest city of Washington in a man from Wuhan on January
1099	en	ln	 The White House Coronavirus Task Force was established on 29 January. 	 Ekipi ya Ndako ya Mpembe esalemaki mokolo ya 29 sanza ya liboso. 	The White House team was formed on January 29th.
1100	en	ln	 On 31 January, the Trump administration declared a public health emergency, and placed restrictions on entry for travellers from China. 	 Na mokolo ya 31, biro ya trump elobaki ete oyo ezali likama ya kolongono, mpe bakotisaki mibeko mpona banzela ya Chine. 	On the 31st, the trump office said this was a health hazard, and introduced rules for Chinese roads.
1101	en	ln	 On 28 January 2020, the Center for Disease Control—the leading public health institute of the U.S. government—announced they had developed their own testing kit. 	 Na mokolo ya 28 sanza ya liboso 2020, Esika ya Kolandela Bamaladi – elandani ya Institu ya kolongono ya bato mpona gouvernema ya U.S- balobaki ete basali biloko ya ekzame ya bango moko. 	On January 28, 2020, the Centers for Disease Control – a successor of the Institutes of Public Health for the US government- announced that it had developed its own test kits.
1102	en	ln	 Despite doing so, the United States had a slow start in testing, which obscured the true extent of the outbreak at the time. 	 Nsima ya kosala yango, Etats Unis ebandaki kosala ba ekzame nsima, oyo eningisaki bosolo ya pandemic nan tango oyo. 	After doing so, the United States began testing later, which shook the reality of the pandemic at this time.
1103	en	ln	 Testing was marred by defective test kits produced by the federal government in February, a lack of federal government approval for non-government test kits (by academia, companies and hospitals) until the end of February, and restrictive criteria for people to qualify for a test until early March (a doctor's order was required thereafter). 	 Biloko ya kosala ekzame esalemaki na gouvernema federal na sanza ya mibale, kozanga kondima ya gouvernema ya federal mpona biloko ya ekzame oyo eliki etid te (na academie, bacompanie to balepital) ti suka ya sanza ya mibale, mpe batoli mingi mpona bato oyo bakokaki komisalisa ekzame ti ebandeli ya sanza ya misato (mokanda ya monganga esengamaki). 	Testing materials were developed by the federal government in February, no federal approval for non-etid testing materials (in academia, companies or hospitals) until the end of February, and more advice for people who could help themselves exam until early March (prescription required).
1104	en	ln	 By 27 February, The Washington Post reported fewer than 4,000 tests had been conducted in the United States. 	 Na mokolo ya 27 sanza ya mibale, Washington Post areportaki mukie yaba ekzame 4,000 esalemaki na Etats Unis. 	On February 27, the Washington Post reported a few of the 4,000 tests conducted in the United States.
1105	en	ln	 By 13 March, The Atlantic reported that less than 14,000 tests had been conducted. 	 Na mokolo ya 13 sanza ya misato, Atlantic ereportaki mukie ya baekzame 14,000 esalemaki. 	On March 13, Atlantic reported a small number of 14,000 tests had been conducted.
1106	en	ln	" On 22 March, the Associated Press reported: ""Many people who have symptoms and a doctor's order have waited hours or days for a test.""After the first death in the United States was reported in Washington state on 29 February, Governor Jay Inslee declared a state of emergency, an action that was soon followed by other states. "	 Na mokolo ya 22 sanza ya misato, Associated Press ereportaki: ‘’Bato mingi oyo bazali na basymptomi mpe mokanda ya monganga bazelaki ba ngonga milayi to mikolo mpona kosala ekzame.’’ Nsima moto ya liboso oto akufaki na Etats Unis atangamaki na Washington mokolo ya 29 sanza ya mibale, gouverneur Jay Inslee abenganki yango likama ya kolongono mpona egumba, nsiima mboka mobimba elandaki yango. 	On March 22, the Associated Press reported: &#39;&#39;Many people with symptoms and a prescription have waited hours or days for testing.&#39;&#39; Then the first auto death in the United States was announced in Washington on On February 29, Governor Jay Inslee called it a health hazard for the city, after which the rest of the country followed suit.
1107	en	ln	 Schools in the Seattle area cancelled classes on 3 March, and by mid-March, schools across the country were shutting down.On 6 March 2020, the United States was advised of projections for the impact of the new coronavirus on the country by a group of epidemiologists at Imperial College London. 	 Bakelasi na Seattle bakangaki na mokolo ya 3 sanza ya misato, mpne na katikati ya sanza ya misato, bakelasi na kati ya mboka ebandaki kokanga. Na mokolo ya 6 sanza ya misato 2020, bayebisaki Etats Unis ndenge nini bamoni likambo ya coronavirisu oyo ekokende na bayekolo ya pandemic na College ya Imperial na Angleterre. 	Schools in Seattle closed on March 3, mpne mid-March, schools in the interior began closing. On March 6, 2020, the United States was informed of the coronavirus outbreak that would go to pandemic students at Imperial College in England.
1108	en	ln	 On the same day President Trump signed the Coronavirus Preparedness and Response Supplemental Appropriations Act, which provided $8.3 billion in emergency funding for federal agencies to respond to the outbreak. 	 Mokolo wana kaka Mokambi Trump atiaki elembo na mokanda ya mosala ya kobundela coronavirisi, oyo ezalaki $8.3 billion yam bongo ya likama mpona ba agence federal na kobundela pandemic. 	The same day President Trump signed into law the coronavirus task force, which was $8.3 billion yam at risk for federal agencies fighting the pandemic.
1109	en	ln	 Corporations imposed employee travel restrictions, cancelled conferences, and encouraged employees to work from home. 	 Bacorporation bapekisaki na mibeko ete basali na bango basala nzela, bakangaki kosangana, mpe balobaki na bato basala uta bandako na bango. 	Corporations legally prohibited their employees from working the road, restricted participation, and told people to work from their homes.
1110	en	ln	 Sports events and seasons were cancelled.On 11 March, Trump announced travel restrictions for most of Europe, excluding the United Kingdom, for 30 days, effective 13 March. 	 Masano ya saiso mpe ekatanaki. Na mokolo ya 11 sanza ya misato, Trump alobaki ete mibeko ya kokanga nzela ezalaki mpona Europe nyonso, kasi Angleterre te, mpona mikolo 30, kobanda mokolo ya 13 sanza ya misato. 	The saiso games were also interrupted. On March 11, Trump said the curfews were for all of Europe, but not the UK, for 30 days, starting March 13th.
1111	en	ln	 The following day, he expanded the restrictions to include the United Kingdom and Ireland. 	 Mokolo mosusu oyo elandaki, apanzaki mibeko yango mpona ezale mpe mpona Angleterre ya Ireland. 	The next day, he broke the laws for the nation and for England Ireland.
1112	en	ln	 On 13 March, he declared a national emergency, which made federal funds available to respond to the crisis. 	 Na mokolo ya 13 sanza ya misato, abengaki yango likama ya national, nde yango ebimisaki mbongo ya federal mpona kobundela pandemic. 	On March 13, he called it a national disaster, which released federal funds to fight the pandemic.
1113	en	ln	 Beginning on 15 March, many businesses closed or reduced hours throughout the U.S. to try to reduce the spread of the virus. 	 Ebandeli ya 15 sanza ya misato, babusiness mingi bakangaki to bakitisaki ba ngonga ya misala na U.S mpona kokitisa kopalangana ya virisi. 	Beginning March 15, many businesses closed or reduced operating hours in the US to reduce the spread of the virus.
1114	en	ln	 By 17 March, the epidemic had been confirmed in all 50 states and in the District of Columbia.On 23 March, it was reported that New York City had 10,700 cases of the coronavirus, more than the total number of cases in South Korea. 	 Na mokolo ya 17 sanza ya misato, pandemic ezalaki na ba egumba 50 mpe na Columbie, Na mokolo ya 23 sanza ya misato, new York ezalaki na bato ya kobela 10,700 na coronavirisi, koleka nyonso oyo ya Core ya Sud. 	As of March 17, the pandemic had 50 cities and Columbia, As of March 23, new York had 10,700 coronavirus cases, more than any of the South Core.
1115	en	ln	 On 25 March, the governor said that social distancing seemed to be working, as estimates of case doubling slowed from 2.0 days to 4.7 days. 	 Na mokolo ya 25 sanza ya misato, gouverneur alobaki ete kofanda na mosika na bato ezalaki kosimba, mpo ete na oyo bato ya kobela bazala 2.0 na mokolo ekomaki 4.7 na mokolo. 	On March 25, the governor said isolation was working, so that from 2.0 cases a day to 4.7 a day.
1116	en	ln	 As of 28 March, there were 32,308 confirmed cases in New York City, and 672 people had died from the virus.On 26 March, the United States was reported to have more confirmed coronavirus infection cases than any other country in the world, including China and Italy.As of 8 April, 400,335 cases have been confirmed in the United States, and 12,841 people have died. 	 Na mokolo ya 28 sanza ya misato, ezalaki na 32,308 ya bato ya kobela na New York, mpe 672 bato bakufaki na virisi. Na mokolo ya 26 sanza ya misato Etats Unis ezalaki na bato ya kobela na coronavirisi ya koleka bamboka nyonso na mokili, Chine na Italie mpe. Na mokolo ya 8 sanza ya minei, 400,335 ya bato ya kobela bazalaki na Etats Unis, mpe 12,841 bakufaki. 	As of March 28, there were 32,308 cases in New York, and 672 deaths from the virus. On March 26 the United States had the highest number of coronavirus cases in the world, followed by China and Italy. As of April 8, there were 400,335 cases in the United States, and 12,841 deaths.
1117	en	ln	 Per media reports on 30 March, U.S. President Trump has decided to extend social distancing guidelines until 30 April. 	 Basanga ya 30 sanza ya msiato elobaki ete, na U.S. Mokambi Trump alobaki batia makasi mibeko ya kozala mosika na bato mokolo ya 30 sanza ya minei. 	The July 30 issues reported that, in the US President Trump said to tighten social distancing on April
1118	en	ln	 On the same day, the USNS Comfort, a hospital ship with about 1000 beds, made anchor in New York. 	 Na mokolo wana mpe, USNS Comfor, lepital ya bwato na bambeto 1000, ekomaki na New York. 	On the same day, the USNS Comfor, a 1,000-bed ship hospital, arrived in New York.
1119	en	ln	 On 3 April, the U.S. had a record 884 deaths due to the coronavirus in a 24-hour period. 	 Na mokolo ya 3 sanza ya minei, U.S ezalaki na 884 ya bato oyo bakufaki na coronavirisi na ba ngonga 24. 	As of April 3, the US had 884 deaths from the virus in 24 hours.
1120	en	ln	 In the state of New York the cases have exceeded 100,000 people on 3 April.The White House has been criticized for downplaying the threat and controlling the messaging by directing health officials and scientists to coordinate public statements and publications related to the virus with the office of Vice-President Mike Pence. 	 Na New York bato ya kobela balekaki 100,000 na mokolo ya 3 sanza ya minei. Bato basepelaki te na Ndako ya Mpembe mpo ete bazwaki yango na ntina mingi te mpe kotia miso na maloba nini ezalaki kotambola na bayekoli ya kolongogo mpe ya science na kobongisa nini mboka elingi koloba mpe bamanuskri ya virisi na biro ya vice-president Mike Pence. 	In New York the number of cases exceeded 100,000 on April People were unhappy with the White House because they didn&#39;t take it seriously and kept an eye on the words that were circulating in the science and technology industry and the virus manuscripts in Vice President Mike Pence&#39;s office.
1121	en	ln	 Overall approval of Trump's management of the crisis has been polarized along partisan lines. 	 Kondima ya ndenge Trump azali kolandela likambo emonani mabe na bato misusu. 	The belief in how Trump is prosecuting the case seems wrong to some people.
1122	en	ln	 Some U.S. officials and commentators criticized the U.S. reliance on importation of critical materials, including essential medical supplies, from China. 	 Bakonzi misusu ya U.S mpe ba oyo balobaka makambo basepeli ten a U.S mpo ete bango batiaki elikia mingi na biloko oyo ezali kouta libanda ya mboka lekola biloko ya kosalisa bokono ya ntina makasi, ya Chine. 	Some US officials and commentators are unhappy with the US for relying heavily on imports such as Chinese drugs.
1123	en	ln	 An analysis of air travel patterns was used to map and predict patterns of spread and was published in The Journal of Travel Medicine in mid-January 2020. 	 Etid ya kosala nzela esalemaki mpona kolandela ndenge virisi epalangani ezalaki na Journal ya Kosala Nzela ya Kolongono na katikati ya sanza ya liboso 2020. 	The roadmap estimate developed to track the spread of the virus was published in the Healthy Roadmap Journal in mid-January
1124	en	ln	 Based on 2018 information from the International Air Transport Association, Bangkok, Hong Kong, Tokyo, and Taipei had the largest volume of travellers from Wuhan. 	 Na oyo Association ya nzela ya pepo elobaki na 2018, Bangkok, hong kong, Tokyo, na Taipei bazalaki na bato mingi oyo bautaki Wuhan. 	According to the Airline Association in 2018, Bangkok, hong kong, Tokyo, and Taipei had the highest number of passengers from Wuhan.
1125	en	ln	 Dubai, Sydney, and Melbourne were also reported as popular destinations for people travelling from Wuhan. 	 Dubai, Sydney, na Melbourne bazalaki mpe bisika oyo bato mingi bazalaki kosala nzela uta Wuhan. 	Dubai, Sydney, and Melbourne were also popular destinations making their way from Wuhan.
1126	en	ln	 Bali was reported as least able among the 20 most popular destination cities in terms of preparedness, while cities in Australia were considered most able.Australia released its Emergency Response Plan for Novel Coronavirus (COVID-19) on 7 February. 	 Bali ezalaki mboka oyo bato bazalaki kokende mingi ten a bisika populaire y aba egumba 20 oyo basosolaki na ndenge ya kobongama, ntango ba egumba na Australie emonanaki kozala na likama makasi. Australie abimisaki ya ye Plan ya mosala mpona likama ya coronavirisi ya sika (COVID-19) mokolo ya 7 sanza ya mibale. 	Bali was the least frequented country among the 20 popular destinations of the 20 cities that were systematically identified, while cities in Australia appeared to be most vulnerable. Australia released its Action Plan for the New Coronavirus (COVID-19) Emergency on 7 February.
1127	en	ln	 It stated that much was yet to be discovered about COVID-19, and that Australia would emphasize border control and communication in its response to the pandemic. 	 Elobaki ete esengelaki mingi eyebana na cOVID-19, mpe Australie ekokotisa mibeko ya nzela ya ngambo mpe ya koyebisa bato makambo ya pandemic. 	It said much needed to be known about cOVID-19, and Australia would introduce sideline and pandemic notification legislation.
1128	en	ln	 On 21 March, a human biosecurity emergency was declared in Australia. 	 Na mokolo ya 21 sanza ya misato, likama ya biosecurite ya bato ebandaki na Australie. 	On 21 March, a human biosecurity threat began in Australia.
1129	en	ln	 Owing to the effective quarantine of public transport in Wuhan and Hubei, several countries have planned to evacuate their citizens and diplomatic staff from the area, primarily through chartered flights of the home nation, with Chinese authorities providing clearance. 	 Ezalaki na konfinema ya babis na Wuhan mpe na Hubei, bamboka mingi babongamaki kobimisa bato na bango ya politik na bisika wana, liboso na mpepo ya mboka, na kondima ya bakonzi ya Chine. 	There was a babies quarantine in Wuhan and Hubei, many countries were prepared to evacuate their politicians from these areas, first by domestic aircraft, with the consent of the Chinese authorities.
1130	en	ln	 Canada, the United States, Japan, India, Sri Lanka, Australia, France, Argentina, Germany, and Thailand were among the first to plan the evacuation of their citizens. 	 Canada, Etats Unis, Japan, Inde, Sri Lanka, Australie, France, Argentine, Germany, na Thailand bazalaki bato ya liboso oyo babimisaki bato na bango. 	Canada, the United States, Japan, India, Sri Lanka, Australia, France, Argentina, Germany, and Thailand were the first to evacuate.
1131	en	ln	 Pakistan has said that it will not be evacuating any citizens from China. 	 Pakistan elobaki ete ekobimisa moto na bango moko na a Chine. 	Pakistan claimed to produce their own man in a China.
1132	en	ln	 On 7 February, Brazil evacuated 34 Brazilians or family members in addition to four Poles, a Chinese person, and an Indian citizen. 	 Na mokolo ya 7 sanza ya mibale, Brazil ebimisaki bato ya Brazil 34 to baboti na linsungi ya bato ya Poland minei, moto ya Chine moko, mpe moto ya Inde. 	On February 7, Brazil released 34 Brazilians or parents with the help of four Poles, one Chinese, and one Indian.
1133	en	ln	 The citizens of Poland, China, and India deplaned in Poland, where the Brazilian plane made a stopover before following its route to Brazil. 	 Bato ya Poland, Chine na ya Inde babongamaki na Poland, bato ya Brazil bazwaki basukisaki mpepo mpe bakeyi na Brazil. 	The Polish, Chinese and Indians were prepared in Poland, the Brazilians got finished the flight and went to Brazil.
1134	en	ln	 Brazilian citizens who went to Wuhan were quarantined at a military base near Brasília. 	 Bato ya Brazil oyo bakendaki Wuhan bakotaki konfinema na esika moko pene na esika ya bato ya limpimgo ya Brazil. 	Brazilians who went to Wuhan were confined to a facility near the Brazilian quarantine facility.
1135	en	ln	 On the same day, 215 Canadians (176 from the first plane, and 39 from a second plane chartered by the U.S. government) were evacuated from Wuhan to CFB Trenton to be quarantined for two weeks. 	 Na mokolo wana mpe, 215 bato ya Canada (176 oyo bazalaki na mpepo, mpe 39 oyo bazalaki na mpepo mosusu ya gouvernema ya U.S) babimisaki bango Wuhan na kokende konfinema na CFB Trenton mpona ba mposo mibale. 	On the same day, 215 Canadians (176 passengers, and 39 passengers on other US government flights) were evacuated from Wuhan to confinement at CFB Trenton for two weeks.
1136	en	ln	 On 11 February, another plane of 185 Canadians from Wuhan landed at CFB Trenton. 	 Mokolo ya 11 sanza ya mibale, mpepo mosusu na bato ya Canada 185 oyo bautaki Wuhan basukaki na CB Trenton. 	On February 11, another flight with 185 Canadians from Wuhan ended up at CB Trenton.
1137	en	ln	 Australian authorities evacuated 277 citizens on 3 and 4 February to the Christmas Island Detention Centre, which had been repurposed as a quarantine facility, where they remained for 14 days. 	 Bakonzi ya Australoe babimisaki baton a bango 277 na mokolo ya 3 na 4 ya sanza ya mibale na esika ya kosimba bato ya Christmas Island, oyo ebongamaki mpona konfinema, bazalaki kuna mikolo 14. 	Australoian authorities evacuated their 277 passengers on 3 and 4 February from the Christmas Island detention centre, which was designed for confinement, where they remained for 14 days.
1138	en	ln	 A New Zealand evacuation flight arrived in Auckland on 5 February; its passengers (including some from Australia and the Pacific) were quarantined at a naval base in Whangaparoa, north of Auckland. 	 Na Nouvelle Zeland mpepo oyo ezalaki kobimisa bato ekomaki mokolo ya 5 sanza ya mibale; bato oyo bazalaki na kati (misusu mpe ya Australie mpe Pacific) bakendaki konfinema na Whangaparoa, Nord ya Auckland. 	In New Zealand the evacuation flight arrived on 5 February; passengers (some also Australian and Pacific) were confined to Whangaparoa, North Auckland.
1139	en	ln	 On 15 February, the United States announced that it would evacuate Americans aboard the cruise ship Diamond Princess. 	 Na mokolo ya 15 sanza ya mibale, Etats Unis elobaki ekobimisa bato ya Amerik oyo bazala na bwato ya Diamond Pricess. 	On February 15, the United States said it would release Americans on board the Diamond Pricess.
1140	en	ln	 On 21 February, a plane carrying 129 Canadian passengers who had been evacuated from Diamond Princess landed in Trenton, Ontario. 	 Na mokolo ya 21 sanza ya mibale, mpepo oyo ememaki bato ya Canada 129 oyo bautaki Diamond Princess bakomaki na Trenton, Ontario. 	On February 21, the flight carrying 129 Canadians from Diamond Princess arrived in Trenton, Ontario.
1141	en	ln	 In early March, the Indian government began evacuating its citizens from Iran.On 14 March a South African Airways aircraft chartered by the South African Government repatriated 112 South African citizens. 	 Na ebandeki ya sanza ya misato, gouvernema ya Italie abandaki kobimisa bato na Iran. Na mokolo ya 14 sanza ya misato Mpepo ya Sid Afrik oyo ya gouvernema ya Sid Afrik ebimisaki bato ya Sid Afrik 112. 	In early March, the Italian government began evacuating people from Iran. On 14 March this South African government airliner evacuated 112 South Africans.
1142	en	ln	 Medical screening was performed prior to departure, and four South Africans who were showing signs of coronavirus were left behind to mitigate risk. 	 Baekzame esalemaki, mpe bato minei ya Sid Afrik oyo bazalaki na basymptomi ya coronavirisi batikalaki mpona kobatela basusu. 	Tests were conducted, and four South Africans with symptoms of the coronavirus remained to protect others.
1143	en	ln	 Only South Africans who tested negative were repatriated. 	 Kaka bato ya Sid Afrik oyo ekzame elobaki ete bazali na malady te babimaki. 	Only South Africans who tested negative came out.
1144	en	ln	 Test results cleared all the South Africans, including the flight crew, pilots, hotel staff, police and soldiers involved in the humanitarian mission who, as a precautionary measure, all remained under observation and in quarantine for a 14-day period at The Ranch Resort. 	 Baekzame esungaki bato ya Sid Afrik mpe bato oyo bazalaki komema mpe kosala na kati yam pepo basalaki ekzame, bato ya hotel, police, bambila oyo bazalaki na mosala, ezalaki mpona komibatela, nyonso batikalaki kososola bango mpona mikolo 14 na Ranch Resort. 	The tests helped South Africans and the passengers and passengers on the plane were tested, hotel staff, police, guards on duty, it was for self-defense, all remained unconscious for 14 days at the Ranch Resort.
1145	en	ln	 On 20 March, the United States began to partially withdrawal its troops from Iraq due to the pandemic. 	 Na mokolo ya 20 sanza ya misato, Etats Unies ebandaki kobenda bato ba bango na Irap likolo ya pandemi. 	On March 20, the United States began withdrawing its troops from Iraq over the pandemic.
1146	en	ln	 On 5 February, the Chinese foreign ministry stated that 21 countries (including Belarus, Pakistan, Trinidad and Tobago, Egypt, and Iran) had sent aid to China. 	 Na mokolo ya 5 sanza ya mibale, minister ya bapaya ya Chine elobaki ete bamboka 21 (Delarus, Pakistan, Trinidad mpe Tobago, Egypt, Iran mpe na kati) batindaki lisungi na Chine. 	On February 5, the Chinese Foreign Ministry said that 21 countries (Delarus, Pakistan, Trinidad and Tobago, Egypt, Iran and in) had sent aid to China.
1147	en	ln	 Some Chinese students at American universities joined together to help send aid to virus-stricken parts of China, with a joint group in the greater Chicago area reportedly managing to send 50,000 N95 masks to hospitals in the Hubei province on 30 January.The humanitarian aid organization Direct Relief, in coordination with FedEx, sent 200,000 face masks along with other personal protective equipment, including gloves and gowns, by emergency airlift to the Wuhan Union Hospital by 30 January. 	 Bana ya kelasi misusu ya Chine na Universite na Amerik basanganako mpona kontinda lisungi na bisika ya Chine oyo bazalaki na virisi makasi, mpe na lisanga mosusu na Chicago batindaki bamask 50,000 N95 na balepital na Hubei mokolo ya 30 sanza ya liboso. Organization ya kosunga bato Direct Relie, na bomoko ya FedEX, batindaki bamask 200,000 mpe na biloko misusu ya kobatela nzoto, lekola bagan, barobe, na mpepo ya biloko ya likama na lepital ya Union ya Wuhan mokolo ya 30 sanza ya liboso. 	Some Chinese students at a university in the United States are joining forces to send aid to areas in China hit hard by the virus, and another group in Chicago sent 50,000 N95 masks to hospitals in Hubei on January Aid organization Direct Relie, in partnership with FedEX, sent 200,000 masks and other personal protective equipment, such as gloves, gowns, and a plane of emergency supplies to Wuhan&#39;s Union Hospital on January
1148	en	ln	" On 5 February, Bill and Melinda Gates announced a $100 million donation to the WHO to fund vaccine research and treatment efforts along with protecting ""at-risk populations in Africa and South Asia"". "	 Na mokolo ya 5 sanza ya mibale, Bill na Melinda Gates balobaki ete bapesi OMS $100 milio mpona etid ya vaccine mpe mosala ya kosalisa mpe na ‘’kobatela bapopulation oyo bazali na likama na Afrik mpe na Sud ya Asie’’. 	On February 5, Bill and Melinda Gates announced that they had pledged $100 million to the WHO for vaccine development and treatment and to &#39;&#39;protect vulnerable populations in Africa and South Asia&#39;
1149	en	ln	 Interaksyon reported that the Chinese government donated 200,000 masks to the Philippines on 6 February, after Senator Richard Gordon shipped 3.16 million masks to Wuhan. 	 Interaksyon alobaki ete gouvernema ya chine epesaki 200,000 mask na Philippines na mokolo ya 6 sanza ya mibale, nsima oyo Senateur Richard Gordon atindaki bamask 3.16milio na Wuhan. 	Interaksyon said the Chinese government donated 200,000 masks to the Philippines on February 6, after Senator Richard Gordon sent 3.16million masks to Wuhan.
1150	en	ln	 On 19 February, the Singapore Red Cross announced that it would send $2.26 million worth of aid to China. 	 Na mokolo ya 19 sanza ya mibale, Croix Rouge ya Singapore elobaki ete babongisa $2.26 milio mpona kosalisa Chine. 	On February 19, the Singapore Red Cross said it had set aside $2.26 million to help China.
1151	en	ln	 Japan donated one million face masks to Wuhan, Turkey dispatched medical equipment, Russia sent more than 13 tonnes of medical supplies to Wuhan, Malaysia announced a donation of 18 million medical gloves to China, Germany delivered various medical supplies including 10,000 Hazmat suits, and the United States donated 17.8 tons of medical supplies to China and promised an additional $100 million in financial support to affected countries.After cases in China seemed to stabilize, the country has been sending aid to various nations hit by the pandemic. 	 Japan epesaki bamask ya million moko na Wuhan, Turkey epesaki biloko ya kosalisa bokono, Russie epesaki 13 tonnes ya biloko ya kosalisa bokono na Wuhan, Malasie elobaki ekopesa 18 milion ya bagan na Chine, Germany epesaki biloko ya kosalisa mingi lekola 10,000 robe ya hazmat, mpe Etats Unis epesaki 17.8 tons ya biloko ya kosalisa bokono na Chine mpe balobaki ete mbongo $100 milio ezali na nzela mpona ba mboka oyo bazali na likama. Nsima bato ya kobela na Wuhan esukaki makasi, mboka etikalaki kotinda lisungi na ba mboka ebele oyo bazalaki na pandemi. 	Japan donated 1 million masks to Wuhan, Turkey donated medical supplies, Russia donated 13 tons of medical supplies to Wuhan, Malaysia said it would donate 18 million bagan to China, Germany donated more medical supplies like 10,000 hazmat gowns, and the United States donated 17.8 tons of medical supplies to China and said $100 million was on the way for countries in need. After the number of cases in Wuhan decreased, the country stopped sending aid to several pandemic countries.
1152	en	ln	 In March, China, Cuba and Russia sent medical supplies and experts to help Italy deal with its coronavirus outbreak. 	 Na sanza ya misato, Chine, Cuba na Russie batindaki biloko ya kosalisa maladi mpe minganga mpo na kosalisa bato ya Italie na kobunda na coronavirisi.	In March, China, Cuba and Russia sent medical supplies and doctors to help Italians fight the coronavirus.
1153	en	ln	 Businessman Jack Ma sent 1.1 million testing kits, 6 million face masks, and 60,000 protective suits to Addis Ababa, Ethiopia for distribution by the African Union. 	 Moto ya mombongo Jack MA atindaki biloko ya komona maladi 1,1 milio, bamasque 6 milio, mpe bilamba ya kobatela nzoto 60 000 na Addis Abeba, na Ethiopie mpo ete Union Africaine ekabola yango. 	Businessman Jack MA sent 1.1 million diagnostic kits, 6 million masks, and 60,000 protective clothing to Addis Ababa, Ethiopia for distribution by the African Union.
1154	en	ln	 He later sent 5,000 testing kits, 100,000 face masks and 5 ventilators to Panama. 	 Na nsima ye atindaki biloko 5 000 ya komona maladi bamasque 100 000 mpe ba ventillateur 5 na Panama. 	He then shipped 5,000 medical equipment 100,000 masks and 5 ventilators to Panama.
1155	en	ln	 Ma also donated medical supplies to Canada.The Netherlands, Spain, Turkey, Georgia, and the Czech Republic expressed their concerns over Chinese-made masks and test kits. 	 Monsieur Ma apesaki mpe bisaleli ya minganga na Canada. Pays-bas, Espagne, Turquie, Georgie, mpe Rèpublique tchèque balobaki ete bazalaki na mitungisi mpo na bamasque mpe biloko ya komona maladi oyo euti Chine. 	Mr. Ma also donated medical equipment to Canada. The Netherlands, Spain, Turkey, Georgia, and the Czech Republic reported concerns about masks and diagnostic equipment imported from China.
1156	en	ln	 For instance, Spain withdrew 58,000 Chinese-made coronavirus testing kits with an accuracy rate of just 30%, meanwhile, the Netherlands recalled 600,000 Chinese face masks which were defective. 	 Na ndakisa, Espagne baboyaki biloko 58 000 ya komona maladi ya coronavirisi oyo eutaki na Chine ezalaki kolakisa ba resultat ya solo kaka na 30%, na nsima, Pays-bas bazongisaka bamasque 600 000 ya Chine mpo ezalaki ya kobeba.	For example, Spain rejected 58,000 coronavirus test kits from China showing only 30% accurate results, followed by the Netherlands recalling 600,000 Chinese masks because they were defective.
1157	en	ln	 Belgium recalled 100,000 unusable masks, thought to be from China, but were in fact from Colombia. 	 Belgique ezongisaki bamasque 100 000 oyo basalelaki te, mpo bakanisaki eutaki na Chine, kasi na koloba ya solo eutaki na Colombie. 	Belgium recalled 100,000 unused masks, thought to have come from China, but in fact from Colombia.
1158	en	ln	 On the other hand, Chinese aid has been well-received in parts of Latin America and Africa.On 2 April, the World Bank launched emergency support operations for developing countries. 	 Kasi, bayamabaki malamu lisungi ya Chine na bamboka mosusu ya Amerique Latine mpe na Afrika. Na mokolo ya 2 sanza ya minei, banque mondiale ebandaki misala ya lombangu mpo na kosalisa mikili ya bobola. 	However, Chinese support was well received in other Latin American and African countries. On April 2, the World Bank launched emergency measures to help poor countries.
1159	en	ln	 The WHO has commended the efforts of Chinese authorities in managing and containing the epidemic. 	 OMS ekumisaki milende wana ya bakonzi ya Chine na ndenge bazolandela mpe kokanga maladi mabe nzela mpo epanzana te. 	The WHO praised the efforts of the Chinese authorities in monitoring and containing the spread of the disease.
1160	en	ln	" The WHO noted the contrast between the 2002–2004 SARS outbreak, where Chinese authorities were accused of secrecy that impeded prevention and containment efforts, and the current crisis where the central government ""has provided regular updates to avoid panic ahead of Lunar New Year holidays"". "	 OMS elobelaki bokeseni eza na kati ya kobima ya SARS 2002-2004, epai wapi bakonzi ya Chine bafundami ete bazolobela te makambo polele na milende basalaki te mpo na kobundisa mpe kokanga maladi wana nzela mpe ete maladi ya sikoyo, oyo bakonzi “bazopesa mbala na mbala bansango ya sika mpo na koboya kobangisa bato na liboso ya fete ya Ebandeli ya Mbula’’. 	The WHO noted the difference between the 2002-2004 SARS outbreak, where Chinese authorities are accused of not being transparent about their efforts to fight and contain the disease and that the current outbreak, which the authorities “repeatedly report new messages to avoid scaremongering in the run-up to the New Year&#39;s Eve celebration&#39;&#39;.
1161	en	ln	" On 23 January, in reaction to the central authorities' decision to implement a transportation ban in Wuhan, WHO representative Gauden Galea remarked that while it was ""certainly not a recommendation the WHO has made"", it was also ""a very important indication of the commitment to contain the epidemic in the place where it is most concentrated"" and called it ""unprecedented in public health history"".On 30 January, following confirmation of human-to-human transmission outside China and the increase in the number of cases in other countries, the WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC), the sixth PHEIC since the measure was first invoked during the 2009 swine flu pandemic. "	 Na mokolo ya 23 sanza ya yambo, na kolandela ekateli oyo bakonzi bazwaki ya kopekisa transpore nyonso na Wuhan, momonisi ya OMS Gauden Galea alobaki ete ata soki ‘’ezalaki mpenza te toli oyo OMS epesaki’’, ezalaki ‘’likambo ya malamu emonisaki ete komipesa ya makasi ata soki eza esika moko’’ mpe ye abengaki yango ‘likambo oyo esalema nanu te na makambo ya kolongono ya nzoto”. Na mokolo ya 30 sanza ya liboso, ntango bayebaki ete moto apesi moto mosusu maladi wana na ibanda ya Chine mpe komata ya motango ya bato ya maladi na mikili mosusu, OMS elobaki ete maladi oyo eza Urgence de santé publique de portée internationale (USPPI), PHEIC ya motoba banda bazwa bibongiseli mpo na kosukisa grippe ya makasi ya 2009. 	On January 23, following up on the authorities&#39; decision to ban all transpore in Wuhan, WHO representative Gauden Galea said that even if &#39;&#39;it wasn&#39;t necessarily the advice given by the WHO&#39;&#39;, it was &#39;&#39;a positive indication that strong commitment even in one place&#39;&#39; and he called it &#39;unprecedented in health care&#39; On January 30, following the discovery of the disease outside China and the increase in the number of cases in other countries, the WHO declared the disease a Public Health Emergency of International Scope (USPPI), The sixth PHEIC since taking measures to end the pandemic of 2009 influenza.
1162	en	ln	" WHO Director-General Tedros Adhanom said that the PHEIC was due to ""the risk of global spread, especially to low- and middle-income countries without robust health systems. "	 Diretere general ya OMS Tedros Adhanom alobaki ete PHEIC ekoki “kopanzanana mokili mobimba, mingimingi na mikili ya bobola oyo baza te na balopitalo ya malamu. 	WHO Director-General Tedros Adhanom said PHEIC could “spread around the world, especially in poor countries that do not have adequate hospitals.
1163	en	ln	" In response to the implementations of travel restrictions, Tedros stated that ""there is no reason for measures that unnecessarily interfere with international travel and trade"" and that the ""WHO doesn't recommend limiting trade and movement."" "	 Nsima ya kopekisa mibembo, Tedros alobaki ete “eza na ntina te batya mibeko oyo ezopekisa kosala mibembo mpe mombongo kati na mikili” mpe ete ‘’OMS ezopesa te nzela ya kopekisa bato mombongo to ezopesa bato nzela ya kosala mibembo.” 	After the travel ban, Tedros said that “there is no need to impose restrictions on international travel and trade” and that &#39;&#39;the WHO does not impose trade restrictions or travel restrictions.”
1164	en	ln	" On 5 February, the WHO appealed to the global community for a $675 million contribution to fund strategic preparedness in low-income countries, citing the urgency to support those countries which ""do not have the systems in place to detect people who have contracted the virus, even if it were to emerge"". "	 Na mokolo ya 5 sanza ya mibale, OMS esengaki mikili bapesa mbongo 675 milio ya badolare mpo na kosunga milende ya komibongisa mpo na mikili ya bobola, alobaki ete lisalisi eza ya lombangu na mikili wana oyo “eza te na bibongiseli mpo na koyeba bato oyo bazwi virisi wana, ata soki ekobima”. 	On February 5, the WHO called on countries to contribute $675 million to support preparedness efforts for poor countries, saying aid is urgent in those countries that “don’t have systems to identify victims that virus, even if it comes out”.
1165	en	ln	" Tedros further made statements declaring that ""we are only as strong as our weakest link"" and urged the international community to ""invest today or pay more later"".On 11 February, the WHO in a press conference established COVID-19 as the name of the disease. "	 Tedros alobaki lisusu ete ‘’toza makasi ndenge moko na lien na biso ya pete mpenza” mpe asengaki mikili “na komipesa lelo to na kofuta mingi na nsima.” Na mokolo ya 11 sanza ya mibale, na conference de presse moko, OMS elobaki ete COVID-19 eza nkombo ya maladi wana.	Tedros also said that &#39;&#39;we are equally strong in our very simple link” and urged countries &quot;to commit today or pay more later.&quot; On February 11, at a press conference, the WHO said that COVID-19 is the name of the disease.
1166	en	ln	" On the same day, Tedros stated that UN Secretary-General António Guterres had agreed to provide the ""power of the entire UN system in the response"". "	 Kaka na mokolo wana, Tedros alobaki ete secrétaire général ya ONU António Guterres andimaki kopesa “makasi ya ebongiseli mobimba ya ONU mpo na kobundisa yango.”	On the same day, Tedros said that UN Secretary-General António Guterres had agreed to devote &quot;the forces of the entire UN system to the fight.&quot;
1167	en	ln	" A UN Crisis Management Team was activated as a result, allowing coordination of the entire United Nations response, which the WHO states will allow them to ""focus on the health response while the other agencies can bring their expertise to bear on the wider social, economic and developmental implications of the outbreak"". "	 Ekipi ya ONU oyo ekipaka makambo ya lombango ebandaki mosaka, epesaki nzela ete ONU mobimba esangana na etumba wana, oyo OMS ete ekosalisa na kotya “likebi na makambo ya kolongono ya nzoto ntango bibongiseli mosusu ezomema mayele na bango mpo na kotala makambo etali bomoi ya bato, makambo ya mbongo, mpe ya kokolisa makambo ya mboka.” 	The UN emergency team began brown, allowing the entire UN to join the fight, which the WHO said would help focus “on health issues while other agencies bring their expertise to bear on human life , finance, and community development.”
1168	en	ln	" On 14 February, a WHO-led Joint Mission Team with China was activated to provide international and WHO experts on the ground in China to assist in the domestic management and evaluate ""the severity and the transmissibility of the disease"" by hosting workshops and meetings with key national-level institutions and to conduct field visits to assess the ""impact of response activities at provincial and county levels, including urban and rural settings"".On 25 February, the WHO declared that ""the world should do more to prepare for a possible coronavirus pandemic,"" stating that while it was still too early to call it a pandemic, countries should nonetheless be ""in a phase of preparedness"". "	 Na mokolo ya 14 sanza ya mibale, ekipe ya OMS na Chine babandaki kosala elongo mpo na kosalisa minganga ya mikili mingi mpe ya OMS makoki ya kosalisa Chine na kobundisa maladi wana mpe kotala “makasi ya maladi wana mpe ndenge ezopesama na bato” na nzela ya ba-atelier mpe makita na bibongiseli ya ntina ya mikili mingi mpe kosala vizite mpo na koyeba “bopusi ya misala ya kobundisa maladi na etuka wana mpe na mokili wana, ata mpe na bingumba na bamboka.” Na mokolo ya 25 sanza ya mibale, OMS elobaki ete “mokili esengeli kosala makambo mingi mpo na komibongisa na maladi mabe ya coronavirisi,” alobaki ete ata tokoki nanu te kobenga yango maladi mabe, mikili esengeli “kozala ya kobongama.’’ 	On February 14, the WHO team in China began working together to enable international and WHO doctors to help China fight the disease and to assess “the severity of the disease and its transmission to humans” through workshops and meetings with key international organizations and visits to learn about “the impact of disease control activities in that region and that country, including urban and rural areas.” On February 25, the WHO said that “the world needs to do more to prepare for the coronavirus pandemic,” saying that although we cannot yet call it a pandemic, countries need to “be prepared.
1169	en	ln	" In response to a developing outbreak in Iran, the WHO sent a Joint Mission Team there to assess the situation.On 28 February, WHO officials said that the coronavirus threat assessment at the global level would be raised from ""high"" to ""very high"", its highest level of alert and risk assessment. "	 Mpo na kobundisa maladi na Iran, OMS etindaki ekipe moko kuna mpo na kotalela likambo yango. Na mokolo ya 28 sanza ya mibale, bakonzi ya OMS balobaki ete likama ya coronavirisi na mokili mobimba eza “likolo” kasi esengeli kokoma “likolo koleka,” nivo ya makasi koleka ya bokengi mpe ya likama. 	To combat the disease in Iran, the WHO sent a team there to assess the situation. On February 28, WHO officials said the global coronavirus risk was “high” but should become “higher,” the highest level of safety and risk.
1170	en	ln	" Mike Ryan, executive director of the WHO's health emergencies program, warned in a statement that ""This is a reality check for every government on the planet: Wake up. "	 Mike Ryan, diretere ya likama ya kolongono ya nzoto ya OMS ya makambo ya lombango, akebisaki na bansango ete “Oyo ezali likambo ya solo oyo mokili nyonso ya planete esengeli kolandela: Bo lamuka. 	Mike Ryan, WHO emergency health risk director, warned in the news that “This is the reality that every planet must follow: Wake up.
1171	en	ln	" This virus may be on its way and you need to be ready,"" urging that the right response measures could help the world avoid ""the worst of it"". "	 Mbala mosusu virisi oyo eza na koya mpe esengele komibongisa,” alobaki ete esengeli kozwa bibongiseli ebongi oyo ekosalisa mpo “makambo ebeba te koleka ndelo” na mokili. 	Maybe this virus is coming and we need to prepare,” he said, adding that appropriate measures should be taken to prevent “excessive deterioration” in the world.
1172	en	ln	" Ryan further stated that the current data did not warrant public health officials to declare a global pandemic, saying that such a declaration would mean ""we're essentially accepting that every human on the planet will be exposed to that virus."" "	 Ryan alobaki lisusu ete bansango ya sikoyo ezopesa te bakonzi ya makambo ya kolongono ya nzoto makoki ya koloba ete ezali malabi mabe; alobi ete koloba bongo elimboli ete “tozondima mpenza ete moto nyonso na mabele akozwa virisi oyo.’’ 	Ryan also said that current information doesn&#39;t give health officials the right to say it&#39;s bad medicine; he says that means that “we absolutely believe that everyone on earth will get the virus.”
1173	en	ln	 On 11 March, the WHO declared the coronavirus outbreak a pandemic. 	 Na mokolo ya 11 sanza ya misato, OMS elobaki ete coronavirisi eza maladi mabe. 	On March 11, the WHO declared the coronavirus a pandemic.
1174	en	ln	" The Director-General said that the WHO was ""deeply concerned both by the alarming levels of spread and severity, and by the alarming levels of inaction"".The WHO has faced significant criticism for what is seen as inadequate handling of the pandemic, including the late declaration of a public health emergency and the classification of the virus as a pandemic. "	 Diretere général alobaki ete OMS “ezali komitungisa mingi na ndenge ezopanzana mingi mpe na makasi na yango, mpe na ndenge tozosala eloko moko te.” Bato mingi basepeli te na OMS mpo bamoni ete bazolandela makambo wana malamu te, na ndakisa balobaki na retard ete eza urgence na makambo ya kolongono ya nzoto mpe ete virisi oyo eza maladi mabe. 	The Director-General said that WHO “is deeply concerned about its prevalence and intensity, and that we are not doing anything.” Many people are unhappy with the WHO because they feel that these issues are not being followed up properly, for example they lately declared it a health emergency and that the virus is a serious disease.
1175	en	ln	 The backlash included a petition for the WHO Director-General Tedros Adhanom to tender his resignation, signed by 733,000 people as of 6 April. 	 Na mokolo ya 6 sanza ya minei, bato 733,000 batyaki maboko na mokanda mpo na kosenga diretere général ya OM Tedros Adhanom a demissioné. 	On April 6, 733,000 people signed a petition demanding the resignation of OM Director General Tedros Adhanom.
1176	en	ln	 On 26 March 2020, dozens of UN human rights experts emphasized respecting the rights of every individual during the COVID-19 pandemic. 	 Na mokolo ya 26 sanza ya misato 2020, bato mingi ya mayele ya lotomo ya bato ya ONU babetaki nsete na kotosa lotomo ya moto nyonso na ntango oyo ya maladi mabe ya COVID-19. 	On 26 March 2020, several UN human rights experts stressed the importance of respecting everyone’s rights during this COVID-19 pandemic.
1177	en	ln	 The expert group stated that everyone is entitled to life-saving interventions and the government holds this responsibility. 	 Etuluku ya bato ya mayele balobaki ete esengeli kobikisa moto nyonso mpe baguvernema eza na mokumba wana. 	The panel said everyone needs to be saved and governments have that responsibility.
1178	en	ln	 The group stressed that the lack of resources or health insurance should never serve as a justification for discrimination against a specific group. 	 Bato yango balobaki ete kozanga mbongo to assurance ya maladi eza ntina ya konyokola etuluku moko ya bato. 	They said that lack of money or health insurance is a reason to oppress a group of people.
1179	en	ln	 The experts underscored that every individual has the right to health, including people with disabilities, belonging to minority groups, older people, internally displaced people, the homeless, those living in extremely poor conditions, people in detention, as well as refugees and other unspecified groups in need of government support. 	 Bato ya mayele balobaki ete moto nyonso aza na lotomo ya kozala nzoto kolongono, ata mpe bibosono, bato oyo bazali na lisanga ya bato moke, mibange, bato oyo bakima na mboka na bango moko, bato bazangi ndako, babola ya makasi, bato ya boloko, mpe ba refuzie ata mpe bato oyo etuluku na bango eyebani te, guvernema esengeli kosalisa bango. 	The experts said that everyone has the right to health, including the disabled, members of minority communities, the elderly, refugees, the homeless, the extremely poor, prisoners , and refugees, including those of unknown nationality, should be assisted by the government.
1180	en	ln	 International governmental organizations are addressing the economic and social impacts of the COVID-19 crisis. 	 Bagouvernema ya mikili bazozwa bibongiseli mpo na kobongisa makambo ya mbongo mpe ya bomoi euti na maladi ya COVID-19. 	Governments are taking measures to improve the financial and social situation caused by the COVID-19 pandemic.
1181	en	ln	 The Organisation for Economic Co-operation and Development has launched a platform to provide timely and comprehensive information on policy responses in countries around the world, as well as viewpoints and advice. 	 Organisation ya coopération économique et développement esali esika moko mpo na bansanga ya sika mpe ya malamu na makambo oyo mikili ezosala mpo na kobundisa maladi oyo, ata mpe makanisi na batoli. 	The Organization for Economic Cooperation and Development has created a forum for updates and best practices on what countries are doing to combat the disease, including ideas and recommendations.
1182	en	ln	 From policies to strengthen health systems and the world economy to addressing the effects of lockdown and restrictions on travel, the digital hub includes a Country Policy Tracker, and aims to help countries learn from each other and to facilitate a co-ordinated global response to the coronavirus challenge. 	 Bonsomi mpo na kolendisa systeme ya kolongono ya nzoto mpe nkita ya mokili mobimba na kobundisa bopusi ya confinement mpe ya bipekiseli ya kosala mobembo, hub ya internet eza na eloko elandelaka politiki ya mboka, mpe esalisaka mikili bayekola na mikili mosusu mpe esalisa bango na kobunda na bampasi ya coronavirisi. 	Free to strengthen the global health system and economy by countering the impact of lockdowns and travel restrictions, the internet hub has a political tracker, and helps countries learn from other countries and help them cope with the pains of the coronavirus.
1183	en	ln	 The Chinese government has been criticized by the United States, UK Minister for the Cabinet Office Michael Gove, and Brazil President Jair Bolsonaro's son Eduardo Bolsonaro for its handling of the pandemic, which began in the Chinese province of Hubei. 	 Etats-Unis elobeli guvernema ya Chine mabe, ministre ya Cabinet ya Royaume-Uni Michael Gove, mpe Edouardo Bolsonaro, mwana ya prezida ya brésil Jair Bolsonaro mpo na ndenge bazobundisa maladi mabe oyo, oyo ebandaki na etuka Hubei na Chine. 	The United States has criticized the Chinese government, UK Cabinet Secretary Michael Gove, and Edouardo Bolsonaro, son of Brazilian President Jair Bolsonaro, for their handling of the outbreak, which originated in China&#39;s Hubei province.
1184	en	ln	 A number of provincial-level administrators of the Communist Party of China (CPC) were dismissed over their handling of the quarantine efforts in Central China, a sign of discontent with the political establishment's response to the outbreak in those regions. 	 Bato mosusu ya biro ya parti communiste ya Chine (PCC) balongolaki bango na mosala na ndenge bazolandela milende ya Chine ya kotya bato na quarantaine na Chine Central, elakisi ete bato bazosepela te na ndenge bakonzi bazosala makambo na bisika wana. 	Some members of the Communist Party of China (CPC) bureaucracy have been sacked from monitoring China&#39;s quarantine efforts in Central China, indicating public discontent with the authorities&#39; handling of the situation in these areas.
1185	en	ln	 Some commentators believe that this move was intended to protect Chinese Communist Party general secretary Xi Jinping from the public's anger over the coronavirus outbreak. 	 Bapanzi-nsango mosusu bazondima ete ntina ya likambo wana eza ya kobatela sécrétaire général ya parti communiste ya Chine Xi Jinping, mpo bato basilika ye te nde coronavirisi. 	Some journalists believe the move is to protect Chinese Communist Party Secretary General Xi Jinping from the coronavirus.
1186	en	ln	 Some Chinese officials, e.g. Zhao Lijian rejected an earlier acknowledgement of the coronavirus outbreak starting in Wuhan, in favour of conspiracy theories about the COVID-19 originating from the U.S. or Italy. 	 Bakonzi mosusu ya Chine, na ndakisa Zhao Lijian awanganaki ete coronavirisi ebandaki na Wuhan, mpe kotalela kofunda euti na Etats-Unis mpe na Italie ete COVID-19 basalaki yango kosala. 	Some Chinese officials, such as Zhao Lijian, have denied that the coronavirus originated in Wuhan, and consider accusations from the United States and Italy that COVID-19 caused it.
1187	en	ln	" The U.S. administration of Donald Trump has referred to the coronavirus as ""Chinese virus"" or ""Wuhan virus"" saying that China's ""censorship supercharged a virus that has now turned into a global pandemic"", which has in turn been criticized by some critics as racism and ""distract[ing] from his administration's failure to contain the disease"". "	 Guvernema ya États-Unis ya Donald Trump elobi ete coronavirisi eza ‘virisi ya Chine” to “virisi ya Wuhan” mpe alobi ete Chine “ebongaki sekele ya virisi oyo ekomi maladi mabe na mokili mobimba,” bato mosusu balobi ete maloba wana eza koyina bato mpo na loposo na bango mpe “ezozipa foti ya guvernema na ye ndenge bazokoka te kobundisa maladi oyo.” 	The US government of Donald Trump has described the coronavirus as a &#39;Chinese virus&#39; or &quot;Wuhan virus&quot; and said China &quot;has solved the secret of the virus that has become a global pandemic,&quot; some saying the comments are hateful for their race and “covers up the fault of his government for not being able to fight this disease.”
1188	en	ln	" The Daily Beast obtained a U.S. government cable outlining a communications stratagem with apparent origins in the National Security Council, with the strategy being quoted as ""Everything is about China. "	 Daily Beast azwaki kable moko ya gouvernema ya États-Unis emonisi masolo na conseil ya sécurite ya mboka, ebongo balobi ete masolo yango nyonso “Ezalaki kolobela kaka Chine. 	The Daily Beast obtained a U.S. government cable showing conversations with the country’s security council, so they say all of the conversations “Focused exclusively on China.
1189	en	ln	" We're being told to try and get this messaging out in any way possible, including press conferences and television appearances.""Outlets such as Politico, Foreign Policy, and Bloomberg have claimed that China's efforts to send aid to virus-stricken countries is part of a propaganda push for global influence. "	 Bazoyebisa biso tomeka mpe tolongola nsango wana na ndenge nyonso, ezala na conference de presse mpe na televizio.” Politico, mayele ya bapaya, mpe bloomberg balobi ete milende ya Chine ezosala mpo na kotinda lisalisi na mikili oyo virisi ekoteli bango eza na kati ya kampanye bazosala mpo bazala na bopusi na mokili mobimba. 	They’re telling us to try and get rid of that message by all means, both in a press conference and on television.” Politico, foreign intelligence, and bloomberg say China&#39;s efforts to send aid to countries affected by the virus are part of a campaign to influence the world.
1190	en	ln	" EU foreign policy chief Josep Borrell warned that there is ""a geo-political component including a struggle for influence through spinning and the 'politics of generosity'"". "	Josep Borrell moto ya Eunion Européenne atalaka makambo ya bapaya akebisaki ete eza ‘’likambo ya koluka kozwa nguya na nzila ya espionage mpe ‘mayele ya kokaba.’” 	Josep Borrell, the European Union&#39;s foreign policy chief, warned that it was &#39;&#39;a case of trying to gain power through espionage and &#39;giving intelligence.&#39;”
1191	en	ln	" Borrell also said that ""China is aggressively pushing the message that, unlike the US, it is a responsible and reliable partner."" "	 Borell alobaki mpe ete “Chine ezotinda kotinda maloba na makasi ete, na kokesena na États-Unis, aza moninga ya malamu mpe ya kotyela motema.’’	Borell also said that “China is forcing the message that, unlike the United States, she is a good and reliable friend.&#39;&#39;
1192	en	ln	 China has also called for the US to lift its sanctions off of Syria, Venezuela and Iran, while reportedly sending aid to the latter two countries. 	 Chine esengi mpe États-Unis alongola bitumbu oyo etyela Syrie, Venezuela mpe Iran, mpe alobi ete atindi lisungi na mikili mibale oyo ya nsuka. 	China has also called on the United States to lift sanctions on Syria, Venezuela and Iran, saying it has sent aid to the latter two countries.
1193	en	ln	 Jack Ma's donation of 100,000 masks to Cuba was blocked by US sanctions on 3 April. 	 Bamasque 100 000 oyo Jack Ma atindaki na Cuba, bakangaki yango na mokolo ya 3 sanza ya minei mpo na etumbu ya États-Unis. 	Jack Ma&#39;s shipment of 100,000 masks to Cuba was seized on April 3 because of U.S. sanctions.
1194	en	ln	 US authorities have also been accused of diverting aid meant for other nations to their own country. 	 Bafundi mpe bakonzi ya États-Unis ete bazobotola lisalisi oyo batindelaki mikili mosusu mpo na bango moko. 	They also accuse US officials of withholding aid sent to other countries for themselves.
1195	en	ln	 And there have been mask-related disputes reported between other countries, such as Germany, Austria and Switzerland; and the Czech Republic and Italy. 	 Mpe baloki ete bamboka mosusu mpe baswana mpo na bamasque, na ndakisa Allemagne, Austriche, na Swisse; mpe Republique tcheque na Italie. 	And they predict that other countries will also fight over masks, such as Germany, Austria, and Switzerland; and Czech Republic and Italy.
1196	en	ln	 In addition, Turkey seized hundreds of ventilators destined for Spain. 	 Lisusu, Turquie akangaki ba ventillateur oyo esengaki ekende na Espagne. 	Also, Turkey blocked the fans requested to go to Spain.
1197	en	ln	 In early March, the Italian government criticized the European Union's lack of solidarity with coronavirus-affected Italy. 	 Na ebandeli ya sanza ya misato, guvernema ya Italie esepelaki te na kozanga bomoko ya Union Européenne na likambo ya maladi ya coronavirisi na Italie. 	In early March, the Italian government was unhappy with the lack of unity from the European Union on the coronavirus outbreak in Italy.
1198	en	ln	" Maurizio Massari, Italy's ambassador to the EU, said that ""Only China responded bilaterally. "	 Maurizio Massari, Ambasadere ya Italie na Union Européenne, alobaki ete “Chine mpamba esalaki makambo mpo na bolamu na bango mibale. 	Maurizio Massari, Italian Ambassador to the European Union, said that “Only China acted in mutual interest.
1199	en	ln	" Certainly, this is not a good sign of European solidarity."" "	 Ya solo, eza te elembo malamu te mpo na bomoko ya Eropa.’’ 	Of course, it&#39;s not a bad sign for European unity.&#39;&#39;
1200	en	ln	 On 22 March, after a phone call with Italian Prime Minister Giuseppe Conte, Russian president Vladimir Putin arranged the Russian army to send military medics, special disinfection vehicles, and other medical equipment to Italy. 	 Na mokolo ya 22 sanza ya misato, nsima ya kosolola na telefone na Ministre ya liboso Giuseppe Conte, prezida ya Russie, Vladimir Putin atindaki basoda ya Russie oyo baza minganga, mituka ya koboma mikrobe, mpe biloko mosusu ya kosalisa kolongono ya nzoto na Italie. 	On March 22, after a telephone conversation with Prime Minister Giuseppe Conte, Russian President Vladimir Putin sent Russian troops of doctors, disinfectants, and other medical supplies to Italy.
1201	en	ln	" Italy's La Stampa newspaper cited an anonymous ""high-level political source"" that 80 percent of Russia's aid was ""useless or of little use to Italy"". "	 Zulunalo ya Italie La Stampa elobaki ete “mokonzi moko ya monene ya politiki” oyo aboyaki kopesa nkombo, alobaki ete 80 pourcent ya lisungi ya Rissue “ezalaki na ntina te to ntina moke mpo na Italie.”	A “senior political official” who declined to be named said that 80 percent of Rissue’s support “had little or no significance for Italy,” reported the Italian newspaper La Stampa.
1202	en	ln	" The source accused Russia of embarking on a ""geopolitical and diplomatic"" charm offensive. "	 Moto yango afundaki Russie ete ezobanda bitumba mpo na ‘kozwa bamboka mpe kolonga na politiki.” 	The man accused Russia of waging wars for &#39;conquest and political victory.
1203	en	ln	 The President of Lombardy, Attilio Fontana, and Italian Foreign Minister Luigi Di Maio dismissed the media reports and expressed their gratitude. 	 Prezida ya Lombardy, Attilio Fontana, na ministre ya bapaya Luigi Di Maio bawanganaki bansango wana mpe bapesaki botondi na bango. 	Lombardy President Attilio Fontana and Foreign Minister Luigi Di Maio denied the reports and expressed their gratitude.
1204	en	ln	 Russia also sent a cargo plane with medical aid to the United States. 	 Russie mpe atindaki mpe mpepo na biloko ya kosalisa kolongono ya nzoto na Etats-Unis. 	Russia also also sent aircraft with medical supplies to the United States.
1205	en	ln	" Kremlin spokesman Dmitry Peskov said that ""when offering assistance to US colleagues, [Putin] assumes that when US manufacturers of medical equipment and materials gain momentum, they will also be able to reciprocate if necessary."" "	Molobi ya Kremlin, Dimitry Peskov, alobaki ete “ntango batindaki lisalisi na baninga na bango”ya États-Unis, [Putin] akanisaki ete ntango bakompani ya États-Unis ekozongela mosala na bango ndenge ezalaka, bakosala mpe bongo soki esengeli.” 	Kremlin spokesman Dimitry Peskov said that “when they sent aid to their U.S. partners,” [Putin] assumed that when U.S. companies returned to normal operations, they would do the same if necessary.”
1206	en	ln	" The planned NATO ""Defender 2020"" military exercise in Germany, Poland, and the Baltic states, the largest NATO war exercise since the end of the Cold War, will be held on a reduced scale. "	 Ngalisisi ya basoda ya OTAN oyo esengelaki kosalema na “Defender 2020” na Allemagne, Pologne, mpe na Pays Baltes, ngalasisi ya monene koleka oyo OTAN asala na nsima ya nsuka ya bitumba ebengami guerre froide, ekosalema na date mosusu. 	NATO&#39;s “Defender 2020” military exercises in Germany, Poland, and the Baltic States, the largest NATO exercise since the end of the Cold War, will be held at a later date.
1207	en	ln	" The Campaign for Nuclear Disarmament's general secretary Kate Hudson criticized the Defender 2020 exercise: ""In the current public-health crisis, it jeopardizes the lives not only of the troops from the US and the many European countries participating but the inhabitants of the countries in which they are operating.""The Iranian government has been heavily affected by the virus, with around two dozen parliament members infected as well as fifteen other current or former political figures. "	 Kate Hudson, sécretaire général ya kampanye mpo na kosilisa mandoki ya Nikleyere alobaki mabe mpo na ngalasisi wana ya Defender 2020: “Na mpasi ya sikoyo ya kolongono ya nzoto, eza kotya na likama kaka te bomoi ya basoda bauti na États-Unis mpe na mikili mingi ya Eropa oyo bazosangana kasi mpe ya bato ya mikili oyo bakosala yango.” “Kala mingi te guvernema ya Iran etungisamaki mingi na virisi oyo, mpe bato zomi na mibale ya parlema baza na maladi wana mpe bato zomi na mitano mosusu ya politiki ya sika mpe ya kala.	Kate Hudson, secretary-general of the Campaign to End Nuclear Weapons, criticized the Defender 2020 exercise: “In the current health crisis, it is not only endangering the lives of soldiers from the United States and other countries most of the European participants but also of the participating countries.” “Recently the Iranian government was very affected by this virus, and twelve members of parliament have the disease and fifteen other politicians, both new and old.
1208	en	ln	 Iran's President Hassan Rouhani wrote a public letter to world leaders asking for help on 14 March 2020, saying that his country is struggling to fight the outbreak due to lack of access to international markets as a result of the United States sanctions against Iran.The outbreak has prompted calls for the United States to adopt social policies common in other wealthy countries, including universal health care, universal child care, paid family leave, and higher levels of funding for public health. 	 Prezida ya Iran, Hassan Rouhani, akomaki mokamda ya polele na bakonzi ya mokili mobimba mpo na kosenga lisungi na mokolo ya 14 sanza ya misato 2020, alobaki ete mboka na ye ezokoka te kobundisa maladi oyo mpo bazangi likoki ya kokota na bazando ya mokili mobimba mpo na bitumbu ya États-Unis epesa Iran. Kobima ya maladi oyo ezosenga États-Unis basalela mayele ya malamu mpo na bato na mikili mosusu ya bozwi, ata mpe kolongono ya nzoto ya mokili mobimba, kolongono ya nzoto ya bana, congé ya kofuta mpo na libota, mpe lisengi makasi ya kozwa mosolo mpe kolongono ya nzoto ya bato nyonso. 	Iranian President Hassan Rouhani wrote an open letter to international leaders asking for help on March 14, 2020, saying his country is unable to fight the disease because they lack access to international markets for with US sanctions against Iran. The emergence of this disease will require the United States to implement better strategies for people in other developed countries, including universal health, children&#39;s health, paid family leave, and a strong demand for funding as well public health.
1209	en	ln	 Political analysts anticipated it may negatively affect Donald Trump's chances of re-election in the 2020 presidential election.Diplomatic relations between Japan and South Korea worsened due to the pandemic. 	 Bato oyo basosolaka makambo ya politiki bakanisaki ete ekoki kokitisa ba chance oyo Donald Trump aza na yango mpo na maponi ya 2020. Boyokani na ye na Japon mpe Corée ya sude ebebi makasi mpo na maladi mabe oyo. 	Political analysts speculated that it could reduce Donald Trump’s chances for the 2020 elections.His relations with Japan and South Korea have been severely damaged by the epidemic.
1210	en	ln	" South Korea criticized Japan's ""ambiguous and passive quarantine efforts"" after Japan announced anybody coming from South Korea will be placed in two weeks' quarantine at government-designated sites. "	 Corée ya sude elobaki mabe mpo na “milende eyebani te mpe ya kozanga ntina ya quarantaine” ya Japon ntango Japon alobaki ete bato nyonso oyo bauti na Corée ya sude bakotya bango na quarantaine mposo mibale na bisika oyo guvernema ekobongisa. 	South Korea criticized Japan’s “unknown and pointless quarantine efforts” when Japan said all South Korean immigrants would be quarantined for two weeks in government-designated facilities.
1211	en	ln	 The South Korean society was initially polarized on President Moon Jae-in's response to the crisis. 	 Na ebandeli bato ya Corée ya sude basepelaki te na makambo prezida Moon Jae-in asalaki mpo na kobundisa virisi. 	South Koreans were initially unhappy with President Moon Jae-in&#39;s efforts to fight the virus.
1212	en	ln	 Many Koreans signed petitions either calling for the impeachment of Moon over what they claimed to be government mishandling of the outbreak, or praising his response.The pandemic has allowed countries to pass emergency legislation in response. 	 Bato mingi ya Corée batyaki maboko na mokanda oyo ezosenga Moon atika mosala mpo bango bamoni azokoka te kobundisa maladi oyo, to mpo na kokumisa makambo azosala. Maladi oyo epesi mikili nzela ya kobimisa mbeko mpo na kobundisa yango.	Many Koreans signed a petition calling for Moon to resign because they felt he was unable to fight the disease, or to praise what he was doing. This disease has allowed countries to develop laws to combat it.
1213	en	ln	 Some commentators have expressed concerns that it could allow governments to strengthen their grip on power. 	 Bato mosusu balobaki bazali komitungisa mpo yango epesi baguvernema libaku ya kokangama na bokonzi na bango.	Some people said they are concerned that this gives governments an opportunity to cling to their powers.
1214	en	ln	 In Hungary, its parliament voted to allow the prime minister, Viktor Orbán, to rule by decree indefinitely, suspend parliament as well as elections and punish those deemed to have spread false information about the virus and the government's handling of the crisis. 	 Na Hongrie, parlema esalaki vote mpo na kopesa premier ministre, Viktor Orbán, nzela na koyangela libela, na kolongola bato ya parlema mosala mpe koboya maponi esalema mpe kopesa etumbu na bato oyo amoni ete bapanzaki bansango ya lokuta mpo na virisi mpe ndenge guvernema ezolandela maladi oyo. 	In Hungary, parliament voted to allow Prime Minister Viktor Orbán to rule indefinitely, dismissing members of parliament and boycotting elections and punishing those he found spreading false information about the virus and the government&#39;s response to the disease that.
1215	en	ln	 The coronavirus outbreak has been blamed for several instances of supply shortages, stemming from globally increased usage of equipment to fight the outbreaks, panic buying, and disruption to factory and logistic operations. 	 Kobima ya coronavirisi esali ete bafunda bato mingi mpo na kozanga bisaleli, banda na mposa makasi ya kozala na bisaleli mpo na kobundisa maladi oyo, kosomba bisomba-somba, mpe kozanga biloko na ba-izine mpe biloko mosusu. 	The outbreak of the coronavirus has led to many complaints about lack of equipment, from the desperate need for equipment to fight the disease, shopping, and lack of supplies in factories and other facilities.
1216	en	ln	 The United States Food and Drug Administration has issued warnings about shortages of drugs and medical equipment due to increased consumer demand and supplier disruption. 	 Ministere ya bilei mpe ya bankisi ya États-Unis epesi likebi mpo na kozanga bankisi mpe bisaleli mpo bato basengi biloko mingi koleka mpe stoke esili. 	The U.S. Food and Drug Administration has focused attention on shortages of medicines and equipment due to overwhelming demand and depleted stocks.
1217	en	ln	 Several localities also witnessed panic buying that led to shelves being cleared of grocery essentials such as food, toilet paper, and bottled water, inducing supply shortages. 	 Na bisika mingi mpe bato bakomi kosomba bisomba-somba, yango esali ete biloko esila na ba magazin, ndakisa bilei, papier ya wese, mpe milangi ya mai mpe stoke ya biloko. 	In many places, people are also buying, causing stores to run out of food, paper, and water bottles and stocks.
1218	en	ln	 The technology industry in particular has been warning about delays to shipments of electronic goods. 	 Industrie ya teknolozi ekebisi makasi ndenge biloko ya elektronike ezoumela na kokoma.	The technology industry has strongly warned of the writing delays of electronic products.
1219	en	ln	 According to WHO director-general Tedros Adhanom, the demand for personal protection equipment has risen 100-fold. 	 Mpo na diretere général ya OMS Tedros Adhanom, mposa ya bilamba ya kobatela nzoto emati mbala 100. 	For WHO Director-General Tedros Adhanom, the demand for protective clothing has increased 100-fold.
1220	en	ln	 This demand has led to the increase in prices of up to twenty times the normal price and also induced delays on the supply of medical items for four to six months. 	 Mposa oyo esali ete bantalo ya biloko emata mbala zomi na mibale mpe elobaki ete bisaleli ya kimonganga ekozala na retard ya basanza minei to motoba. 	This demand has led to a twelve-fold increase in prices and predicted a delay of four to six months in medical equipment.
1221	en	ln	 It has also caused a shortage of personal protective equipment worldwide, with the WHO warning that this will endanger health workers. 	 Esali pe ete na mokili mobimba bato bazanga bilamba ya kobatela nzoto, mpe OMS ekebisi ete ekotya kolongono ya nzoto ya minganga na likama. 	It has also led to a global shortage of protective clothing, and the WHO warns it will endanger the health of doctors.
1222	en	ln	 In Australia, the pandemic provided a new opportunity for daigou shoppers to sell Australian products into China. 	 Na Australie, maladi mabe epesi libaku na bateki ya daigou bateka biloko ya Australie na Chine. 	In Australia, epidemics have provided an opportunity for daigou vendors to sell Australian goods in China.
1223	en	ln	 The activity has created a shortage of baby formula in some supermarkets and was subsequently banned by the Australian government.Despite the high prevalence of COVID-19 cases in Northern Italy and the Wuhan region, and the ensuing high demand for food products, both areas have been spared from acute food shortages. 	 Yango esali ete bazanga bilei ya babebe na bazando mosusu ya minene mpe guvernema ya Australie apekisaki yango. Ata bato mingi mpenza bazozwa COVID-19 na norde ya Italie mpe na Wuhan, mpe ezosenga bilei ezanga; bisika nyonso mibale wana bazangi mpenza bilei. 	This has resulted in a shortage of baby food in some major markets and a ban by the Australian government. Although the highest number of people infected with COVID-19 in northern Italy and Wuhan, and food shortages; both places are severely food insecure.
1224	en	ln	 Measures by China and Italy against the hoarding and illicit trade of critical products have been successful, avoiding acute food shortages that were anticipated in Europe as well as in North America. 	 Bibongiseli bazwi na Chine mpe na Italie esalisa na kolonga na kobundisa mombongo wana ya mabe ya biloko ya ntina, kosala ete bilei esila te na Eropa mpe na Amerika ya norde ndenge bakanisaki. 	Organizations in China and Italy have helped to successfully combat this illegal trade in commodities, preventing food shortages in Europe and North America as expected.
1225	en	ln	 Northern Italy with its significant agricultural production has not seen a large reduction, but prices may increase according to industry representatives. 	 Norde ya Italie na ndenge basalaki mingi misala ya bilanga ekiti mingi mpenza, kasi bantalo ekoki komata na kotalela biloko oyo ezobima. 	Northern Italy in its intensification of agricultural activities has decreased very considerably, but prices may rise in proportion to output.
1226	en	ln	 Empty food shelves were only encountered temporarily, even in Wuhan city, while Chinese government officials released pork reserves to assure sufficient nourishment of the population. 	 Ba etagere ezangi bilei esalemaki kaka moke, ata na engumba, mpe bakonzi ya Chine babimisaki bangulu oyo babombaka mpo bato nyonso bazanga te bilei. 	Few food-free shelves were created, even in the city, and Chinese authorities released pet pigs to ensure that everyone would not run out of food.
1227	en	ln	 Similar laws exist in Italy requiring food producers to keep reserves for such emergencies. 	 Mibeko ya ndenge moko eza na Italie oyo ezosenga bato basalaka bilei babombaka bilei mpo na ntango ya mpasi. 	Similar laws exist in Italy that require food producers to store food for emergencies.
1228	en	ln	 Damage to the global economy has been felt in China: according to a media report on 16 March, the economy in China was very hard hit in the first two months of 2020 due to the measures taken by the government to curtail virus spread, and retail sales plunged 20.5%. 	 Mpasi oyo ebimi na nkita ya mokili mobimba ya esimbi mpe Chine: bansango ya bapanzi-nsango elobi ete na mokolo ya 16 sanza ya misato, nkita ya Chine ebebaki makasi na basanza mibale ya liboso ya 2020 mpo na bikateli guvernema ezwaki mpo na kokanga virisi nzela epanzana te, mpe ntalo ya biloko emataki na 20,5%. 	The impact on the global economy and China: media reports said that on March 16, China&#39;s economy deteriorated sharply in the first two months of 2020 due to government measures to contain the virus did not expand, and prices rose 20.5%.
1229	en	ln	 As mainland China is a major economy and manufacturing hub, the viral outbreak has been seen to pose a major destabilizing threat to the global economy. 	 Eteni ya Chine oyo eza na mabele eza eteni ya monene na nkita ya mpe na bakompani na ngo, kobima ya virisi ezobebisa makasi mpenza nkita ya mokili mobimba. 	China&#39;s land share is a major part of the economy and its companies, the outbreak of the virus is severely damaging the global economy.
1230	en	ln	 Agathe Demarais of the Economist Intelligence Unit has forecast that markets will remain volatile until a clearer image emerges on potential outcomes. 	 Agathe Demarais ya de serivice ya renseignement ya makambo ya nkita elobi ete bazando ekozala kaka bongobongo kino makambo ekozonga ndenge ezalaka. 	Agathe Demarais of the de serivice of economic intelligence said markets would remain unchanged until things returned to normal.
1231	en	ln	 In January 2020, some analysts estimated that the economic fallout of the epidemic on global growth could surpass that of the 2002–2004 SARS outbreak. 	 Na sanza ya liboso 2020, bato mosusu balobaki ete kokwea ya nkita na mokili mobimba ekoki koleka oyo esalemaki na kobima ya SARS na 2002-2004. 	By January 2020, some have predicted a worldwide economic collapse that could surpass that of the 2002-2004 SARS outbreak.
1232	en	ln	 One estimate from an expert at Washington University in St. Louis gave a $300+ billion impact on the world's supply chain that could last up to two years. 	 Bolukiluki moko na iniversite ya Washington na St. Louis alobi ete tokozanga mbongo koleka badolare 300 miliard na bisaleli na mokili, mbongo tokokaki kosalela mbula mibale. 	A study by the University of Washington in St. Louis. Louis says we will run out of more than $300 billion in equipment in the world, money we could use for two years.
1233	en	ln	" The Organization of the Petroleum Exporting Countries (OPEC) reportedly ""scrambled"" after a steep decline in oil prices due to lower demand from China. "	 Lisanga ya mikili oyo etekaka petrole (OPEP) elobi ete “bakwea” ndenge ntaolo ya essance ekoti mpo bato ya Chine bazosenga yango mingi lisusu te. 	The Organization of Petroleum Exporting Countries (OPEC) said it had “fallen” as gasoline prices fell as Chinese demand increased.
1234	en	ln	 Global stock markets fell on 24 February due to a significant rise in the number of COVID-19 cases outside mainland China. 	 Zando ya mokili mobimba ebebaki na mokolo ya 24 sanza ya mibale mpo na motango ya bato oyo bazalaki na COVID-19 emataki mingi na Chine. 	Global markets fell on February 24 as the number of COVID-19 cases soared in China.
1235	en	ln	 On 27 February, due to mounting worries about the coronavirus outbreak, various U.S. stock indexes including the NASDAQ-100, the S&amp;P 500 Index, and the Dow Jones Industrial Average posted their sharpest falls since 2008, with the Dow falling 1,191 points, the largest one-day drop since the financial crisis of 2007–08. 	 Na mokolo ya 27 sanza ya mibale, mpo na basusi mingi na ntina ya kobima ya coronavirisi, ba indice mingi ya bazando ya Etats-Unis ata mpe NASDAQ-100, S&amp; indice P 500, mpe Dow Jones ekitaki makasi na ndenge esala te banda 2008, mpe Dow ekitaki na bapoint 1 191, kokita makasi na mokolo moko mpamba banda mpasi oyo ezalaki na 2007-08. 	On February 27, due to widespread concerns about the outbreak of the coronavirus, many US market indices including the NASDAQ-100, S&amp; P 500 index, and Dow Jones fell sharply to their lowest level since , and the Dow fell 1,191 points, the sharpest drop in just one day since the 2007-08 crisis.
1236	en	ln	 All three indexes ended the week down more than 10%. 	 Ba indice nyonso misato esukisaki mposo na nse ya 10%. 	All three indices ended the week down 10%.
1237	en	ln	 On 28 February, Scope Ratings GmbH affirmed China's sovereign credit rating, but maintained a Negative Outlook. 	 Na mokolo ya 28 sanza ya mibale, Scope Ratings GmbH endimaki valeur ya guvernema ya Chine, kasi ezalaki kaka malamu te. 	On February 28, Scope Ratings GmbH approved the Chinese government’s valuation, but it was still not good enough.
1238	en	ln	 Stocks plunged again based on coronavirus fears, the largest fall being on 16 March. 	 Biloko esilaki lisusu mpo na bobangi ya coronavirisi, kokita ya makasi ezalaki na mokolo ya 16 sanza ya misato. 	Supplies ran out again due to coronavirus fears, the sharpest drop being on March 16th.
1239	en	ln	 Many consider an economic recession to be likely. 	 Bato mingi bakanisi ete nkita ekowea mpenza.	Many people think that the economy will collapse.
1240	en	ln	 Economist Mohamed El-Erian praised central banks' and states' timely emergency measures. 	 Moto ya Nkita Mohamed El-Erian akumisaka babanke centrales mpe mikili mpo na bibongiseli ya malamu bazwaki na lombango. 	Economist Mohamed El-Erian praises central banks and countries for the effective measures they have taken in haste.
1241	en	ln	 Central banks are reacting more quickly than they did to the 2008 financial crash. 	 Babanke ya centrales bazosala makambo noki koleka ndenge basalaki na mpasi ya nkita ya 2008. 	Central banks are reacting faster than they did in the 2008 economic crisis.
1242	en	ln	 Tourism is one of the worst affected sectors due to travel bans, closing of public places including travel attractions, and advice of governments against any travel all over the world. 	 Tourisme ezali esika ekonyokwama makasi mpenza mpo na bipekiseli ya kosala mibembo, mpe bakangi bisika ya bato mingi ata mpe bisika ya kitoko ya kokende kotala, mpe ndenge baguvernema ezopekisa kosala mobembo na mokili mobimba. 	Tourism is an area that will suffer very severely due to travel restrictions, and the closure of popular attractions including beautiful tourist destinations, as well as government restrictions on international travel.
1243	en	ln	 As a consequence, numerous airlines have cancelled flights due to lower demand, including British Airways, China Eastern Airlines, and Qantas, while British regional airline Flybe collapsed. 	 Yango wana, bampepo mingi ekati mibembo na yango mpo bato moke nde baza na mposa ya kosala mobembo, ata mpe British Airways, Chinese Eastern Airlines, mpe Quantas, kasi British regional airline Flybe ekwei. 	As a result, many airlines have cut flights because fewer people want to travel, including British Airways, Chinese Eastern Airlines, and Quantas, but British regional airline Flybe has collapsed.
1244	en	ln	 The impact on the cruise line industry was at a level never seen before. 	 Bopusi na yango na mobembo ya mai eza makasi na nivo moko emonana nanu te. 	Its impact on marine traffic is severe on a level never seen before.
1245	en	ln	 Several train stations and ferry ports have also been closed. 	 Bisika mingi oyo train etelemaka mpe mabongo, ekangama. 	Many train stops and beaches, closed.
1246	en	ln	 The epidemic coincided with the Chunyun, a major travel season associated with the Chinese New Year holiday. 	 Maladi mabe eyei nzela moko na Chunyun, eleko monene ya mobembo oyo esalamaka na ntango ya fete ya mbula ya sika na Chine. 	The plague comes along with Chunyun, the main travel season that takes place during the Chinese New Year celebration.
1247	en	ln	 A number of events involving large crowds were cancelled by national and regional governments, including annual New Year festivals, with private companies also independently closing their shops and tourist attractions such as Hong Kong Disneyland and Shanghai Disneyland. 	 Makambo mingi oyo esangisaka bato mingi, bapekisaki yango na bagurnema ya bituka, ata mpe bafete ya mbula ya sika; bakompani ya prive mpe ekangai baboutique na bango mpe bisika bato bayaka kotala na ndakisa Hong Kong Disneyland mpe Shanghai Disneyland. 	Many social events were banned by provincial gurnemas, including New Year&#39;s celebrations; private companies have also closed their boutiques and tourist attractions such as Hong Kong Disneyland and Shanghai Disneyland.
1248	en	ln	 Many Lunar New Year events and tourist attractions have been closed to prevent mass gatherings, including the Forbidden City in Beijing and traditional temple fairs. 	 Bafeti mingi ya mbula ya mpe bisika bapaya bayaka kotala, bakanga yango mpo na kopekisa bato mingi basala makita, ata mpe Forbidden City na Beijing mpe bafete ya makoko ya bokoko. 	Many annual festivals and tourist attractions have been closed to prevent mass gatherings, including Beijing&#39;s Forbidden City and traditional festivals.
1249	en	ln	 In 24 of China's 31 provinces, municipalities and regions, authorities extended the New Year's holiday to 10 February, instructing most workplaces not to re-open until that date. 	 Na 24 na kati ya 31 bituka, bamboka mpe bisika mingi na Chine, bakonzi bapusaki feti ya mbula ya sika na mokolo ya 10 sanza ya mibale, mpe eyebisaki bisika mingi ya mosala ete efongwama te kino na date wana. 	In 24 of 31 provinces, cities and many areas in China, authorities pushed the New Year holiday to February 10, and told many workplaces not to open until that date.
1250	en	ln	 These regions represented 80% of the country's GDP and 90% of exports. 	 Bituka wana ezali 80% ya bomengo ya mboka mpe 90% ya mbongo eutaka na biloko batekaka. 	These provinces account for 80% of the country’s wealth and 90% of the money comes from the products they sell.
1251	en	ln	 Hong Kong raised its infectious disease response level to the highest and declared an emergency, closing schools until March and cancelling its New Year celebrations.The retail sector has been impacted globally, with reductions in store hours or temporary closures. 	 Hong Kong ematisaki mibeko na ye mpo na kobundisa maladi mpe elobelaki etat d’urgence, ekangaki biteyelo kino na sanza ya misato mpe epekisaki fete ya mbula ya sika. Mombongo ebebisa mpenza na mokili mobimba, ba boutique bakitisi bangonga ya mosala to bakangi yango mpo na ntango moke. 	Hong Kong tightened its anti-disease measures and declared a state of emergency, closed schools until March and banned New Year&#39;s celebrations. Trade has been severely disrupted around the world, with shops reducing opening hours or closing temporarily.
1252	en	ln	 Visits to retailers in Europe and Latin America declined by 40%. 	 Kosomba biloko na ba boutique mike ekita na Eropa mpe na Amerique Latine na 40%. 	Shopping at small boutiques fell in Europe and Latin America by 40%.
1253	en	ln	 North America and Middle East retailers saw a 50–60% drop. 	 Mombongo ya bato ya Amerika ya norde mpe ya moyen Orient oyo batekaka biloko basombi ekiti na 50-60%. 	The business of North Americans and Middle Easterners selling purchases has dropped by 50-60%.
1254	en	ln	 This also resulted in a 33–43% drop in foot traffic to shopping centres in March compared to February. 	 Ememaki kokita ya 33-43% na bato ya makolo oyo bazokende na esika baboutique ezalaka na sanza ya misato soki tokokanisi yango na sanza ya mibale. 	It led to a 33-43% drop in foot traffic to the boutique area in March compared to February.
1255	en	ln	 Shopping mall operators around the world imposed additional measures, such increased sanitation, installation of thermal scanners to check the temperature of shoppers, and cancellation of events.According to a United Nations Economic Commission for Latin America estimate, the pandemic-induced recession could leave between 14 and 22 million more people in extreme poverty in Latin America than would have been in that situation without the pandemic. 	 Bato batekaka na bazando na mokili mobimba, batyeli bango mibeko mosusu, na ndakisa kolongola mikrobe, kotya ba scanner mpo na kozwa temperature ya basombi, mpe kokanga makambo ya kosangana. Na kotalela ministere ya nkita ya Etats-Unis mpo na Amerique Latine, balobi ete mpasi ya maladi oyo ekosala ete bato kati ya 14 mpe 22 milio ya bato bakozala bobola makasi na Amerique Latine koleka soki maladi oyo ebimaki te. 	Sellers in markets around the world are subject to additional restrictions, including disinfection, installation of temperature scanners for shoppers, and closure of gatherings. According to the US Department of Economic Affairs for Latin America, the impact of the epidemic is estimated to result in between 14 and 22 million people living in extreme poverty in Latin America than if the epidemic had not occurred.
1256	en	ln	 In January and February 2020, during the height of the epidemic in Wuhan, about 5 million people in China lost their jobs. 	 Na sanza ya liboso mpe ya mibale na 2020, ntango bato mingi mpenza babelaki na Wuhan, bato pene ya bamilio 5o na Chine babungisaki mosala na bango. 	In January and February 2020, when the Wuhan outbreak hit the country, nearly 5o million people in China lost their jobs.
1257	en	ln	 Many of China's nearly 300 million rural migrant workers have been stranded at home in inland provinces or trapped in Hubei province.In March 2020, more than 10 million Americans lost their jobs and applied for government aid. 	 Bato mingi na kati ya bato bamilio 300 ya Chine oyo basalaka na bamboka bakangami na bituka to na etuka ya Hubei. Na sanza ya misato 2020, bato ya Amerika koleka bamilio 10 babungisaki misala na bango mpe basengaki lisungi na guvernema. 	Most of China’s 300 million rural workers are confined to the provinces or Hubei province. By March 2020, more than 10 million Americans have lost their jobs and are seeking government assistance.
1258	en	ln	 The coronavirus outbreak could cost 47 million jobs in the United States and unemployment rate may hit 32%, according to estimates by the Federal Reserve Bank of St. Louis.The lockdown in India has left tens of millions of Indian migrant workers (who are paid through daily wages) unemployed.The survey from the Angus Reid Institute found that 44% of Canadian households have experienced some type of unemployment.Nearly 900,000 workers lost their jobs in Spain since it went into lockdown in mid-March 2020. 	 Kobima ya coronavirisi esali ete bato bamilio 47 babungisa misala na Etats-Unis mpe kozanga mosala emati na 32%, na kotalela bantalo euti na banke Federal ya St Louis. Confinement na Inde esali ete bamilio ya bato oyo baliaka na mosala ya (oyo bafutaka bango mokolo na mokolo) bazangi mosala. Ankete ya Institut Angus Reid emoni ete bato ya mabota ya Canada 44% bazangi mosala na lolenge moko boye. Pene ya bato ya mosala 900 000 babungisaki misala na Espagne banda confinement ebandaki na katikati ya sanza ya misato 2020. 	The outbreak of the coronavirus has cost 47 million people their jobs in the United States and unemployment has risen by 32 percent, according to figures from the Federal Reserve Bank of St Louis. The lockdown in India has left millions of (daily paid) eaters unemployed. The Angus Reid Institute survey found that 44% of Canadian tribes are unemployed in some way. Nearly 900,000 workers have lost their jobs in Spain since the lockdown began in mid-March
1259	en	ln	 During the second half of March, 4 million French workers applied for temporary unemployment benefits and 1 million British workers applied for a universal credit scheme.Almost half a million companies in Germany have sent their workers on a government-subsidized short-time working schemes known as Kurzarbeit. 	 Na eteni ya mibale ya sanza ya misato, bato ya France bamilio 4 oyo basalaka mosala basalaki demande mpo na kozwa matomba ya ntango mokuse ya kozanga mosala mpe bato ya Grande-Bretagne milio 1 oyo basalaka mosala basalaki demande mpo babimisa mwanga ya kodefisa bango mbongo. Katikati ya milio moko ya bakompani ya Allemagne basengaki bato na bango ya mosala baluka lisalisi na manaka ya ntango mokuse oyo babengaka Kurzarbeit. 	In the second half of March, 4 million French workers applied for short-term unemployment benefits and 1 million British workers applied for a loan scheme. Half a million German companies have asked their employees to seek help with short-term programs called Kurzarbeit.
1260	en	ln	 The German short-time work compensation scheme has been adopted by France and Britain. 	 Bato ya France mpe Grande-Bretagne bandima kosalela mobeko ya Allemagne oyo etali kofuta mbongo na ntango mokuse. 	The French and British agreed to apply the German short-term compensation law.
1261	en	ln	 The performing arts and cultural heritage sectors have been profoundly affected by the pandemic, impacting organizations' operations as well as individuals—both employed and independent—globally. 	 Misala ya art mpe ya makambo ya bonkoko ebebisami makasi na maladi mabe oyo; ezonyokola masanga mpe bato mokomoko, eza baoyo bazali na mosala mpe baoyo basalaka misala na bango moko, na mokili mobimba. 	Art and cultural activities have been severely affected by this epidemic; it affects communities and individuals, both employed and self-employed, worldwide.
1262	en	ln	 Arts and culture sector organizations attempted to uphold their (often publicly funded) mission to provide access to cultural heritage to the community, maintain the safety of their employees and the public, and support artists where possible. 	 Bato ya misala ya art mpe ya culture bamekaki kolanda kosala misala na bango (oyo mbala mingi mbongo eutaka na bato) mpo na kolanda kosepelisa bato ya bisika bafandi, kosala ete bato na bango ya mosala mpe bato nyonso bazala na libateli, mpe kosalisa ba-artiste soki likoki ezali. 	Arts and culture practitioners have attempted to pursue their (usually privately funded) activities in order to continue entertaining communities, ensuring the safety of their workforce and the public, and serving the artist if possible.
1263	en	ln	 By March 2020, across the world and to varying degrees, museums, libraries, performance venues, and other cultural institutions had been indefinitely closed with their exhibitions, events and performances cancelled or postponed. 	 Na sanza ya misato 2020, na mokili mobimba mpe na banivo ekeseni, ba musee, babiblioteke, bisika ya masano, mpe bisika mosusu ya culture, bakanga yango mpenza; mpe biloko oyo bato bayaka kotala, masano oyo basalaka kuna ekosalema te to babongoli date na yango. 	By March 2020, all over the world and at different levels, museums, libraries, theaters, and other cultural venues are completely closed; and tourist attractions, performances canceled or rescheduled.
1264	en	ln	 In response there were intensive efforts to provide alternative services through digital platforms.Another recent and rapidly accelerating fallout of the disease is the cancellation of religious services, major events in sports, and other social events, such as music festivals and concerts, technology conferences, and fashion shows. 	 Yango wana, bato basalaki milende mingi mpo na kozwa mwango mosusu ya kosala mosala na nzela ya internet. Likambo mosusu ya mpasi eza ndenge bapekisa mangomba basala makita te, bapekisa makambo ya sports, mpe makambo mosusu ya bomoi ya bato, na ndakisa bafete ya miziki mpe ba concert, makita ya technologie mpe ba defile de mode.	As a result, there has been a lot of effort to come up with an online alternative. Another difficult issue is the ban on religious meetings, sports, and other social events, such as music festivals and concerts, technology meetings and fashion shows.
1265	en	ln	 The film industry has also experienced disruption.The Vatican announced that Holy Week observances in Rome, which occur during the last week of the Christian penitential season of Lent, have been cancelled. 	 Mosala ya bafilme mpe ezosalama lisusu te. Vatican elobaki ete bafete ya mposo ya mosantu na Rome, oyo esalemaka na mposo ya nsuka ya eleko ya kokila bilei, ekosalema te. 	The film industry is also no longer available. The Vatican said that Holy Week celebrations in Rome, which take place during the last week of Lent, would not take place.
1266	en	ln	 Many dioceses have recommended older Christians to stay at home rather than attending Mass on Sundays; some churches have made church services available via radio, online live streaming or television while others are offering drive-in worship. 	 Badiocese mingi esengi Bakristo oyo baza mibange bafanda olie ya kokende na misa na mikolo ya Eyenga; mangombe mosusu bazosala makita na bango na nzela ya radio, na internet na steaming en direct to na televizio mpe basusu bazosala makita na balabala. 	Many dioceses require older Christians to stay instead of attending Mass on Sundays; some churches hold their meetings via radio, internet live steaming or television and others hold meetings on the streets.
1267	en	ln	 With the Roman Catholic Diocese of Rome closing its churches and chapels and St. Peter's Square emptied of Christian pilgrims, other religious bodies also cancelled services and limited public gatherings in churches, mosques, synagogues, temples and gurdwaras. 	 Badiocese ya Katolika ya Roma ekangaki bandako ya nzambe na yango mpe St. Peter’s Square ebimisaki Bakristo mpo etikala mpamba, mangomba mosusu mpe bakati makita na bango mpe etya mibeko na makita ya bato nyonso na ndako ya nzambe, na ba mosquee, na basinagoge, na batempelo mpe na ba-eklezia. 	Roman Catholic dioceses closed their churches and St. John&#39;s. Peter&#39;s Square left Christians empty, other religions also cut their meetings and imposed restrictions on public gatherings in churches, mosques, synagogues, temples and churches.
1268	en	ln	 Iran's Health Ministry announced the cancellation of Friday prayers in areas affected by the outbreak and shrines were later closed, while Saudi Arabia banned the entry of foreign pilgrims as well as its residents to holy sites in Mecca and Medina. 	 Ministre ya kolongono ya nzoto ya Iran alobaki ete losambo ya mokolo ya mitano na bisika oyo virisi ezali ekosalema lisusu te mpe bakangaki batempelo na nsima, kasi Arabie Saudite episi bana-mboka mpe bapaya na kokende na losambo Mecque mpe Medine. 	Iran&#39;s health minister said Friday prayers in virus-affected areas would be canceled and mosques closed afterwards, but Saudi Arabia has banned citizens and foreigners from traveling to Mecca and Medina.
1269	en	ln	 The pandemic has caused the most significant disruption to the worldwide sporting calendar since the Second World War. 	 Maladi oyo ebebisi mpenza manaka ya sport na mokili mobimba koleka banda etumba ya mibale ya mokili mobimba. 	This disease has wreaked havoc on sporting programs around the world more than since the second world war.
1270	en	ln	 Most major sporting events have been either cancelled or postponed, including the 2019–20 UEFA Champions League, 2019–20 Premier League, UEFA Euro 2020, 2019–20 NBA season, and 2019–20 NHL season. 	 Ba evenement mingi ya sport bakati yango to tabongoli date na yango, na ndakisa Champions League ya 2019-20 ya UEFA, Championnat ya Angleterre ya 2019-20, Euro 2020 ya UEFA, saison 2019-20 ya NBA, mpe saison 2019-20 ya NHL. 	Many sporting events have been cut or changed their dates, including the 2019-20 UEFA Champions League, 2019-20 English Championship, UEFA Euro 2020, the 2019-20 NBA season, and the 2019-20 season of The NHL.
1271	en	ln	" The outbreak disrupted plans for the 2020 Summer Olympics, which were originally scheduled to start at the end of July; the International Olympic Committee announced on 24 March that the event will be ""rescheduled to a date beyond 2020 but not later than summer 2021"".Casinos and other gaming venues worldwide have closed and live poker tournaments have been either postponed or cancelled. "	" Kobima ya maladi oyo ebebisi programe ya jeux olympique ya eleko ya molunge 2020, oyo esengelaki kobanda mpe kosuka na nsuka ya sanza ya nsambo; Comité olympique international elobaki na mokolo ya 24 sanza ya misato ete bakotya ""date ya sika na nsima ya 2020 kasi ekozala liboso ya eleko ya molunge 2021"". Masano ya casino mpe bisika mosusu ya masano na mokili mobimba bakangi yango mpe masano ya pocker en direct babongoli date na yango to ekosalema lisusu te. "	The outbreak has disrupted the schedule for the 2020 Summer Olympics, scheduled to begin and end in late July; The International Olympic Committee said on March 24 that it would set a &quot;new date later than 2020 but before the summer of 2021&quot;. Casino games and other gaming venues around the world have been shut down and live poker games have been rescheduled or will no longer be held.
1272	en	ln	 This has led many gamblers to move online, with many online gambling sites reporting significant increases in their rates of new sign-ups.The entertainment industry has also been affected, with various music groups suspending or cancelling concert tours. 	 Yango esali ete bato mingi bakoma kosala masono na internet, mpe basite mingi ya masano na internet ekomi na bato mingi mpenza ya sika. Industrie ya masano mpe ezonyokwama, bituluku mingi ya miziki bazwi congé to bakati ba tournée na bango ya ba concert. 	This has led to a growing number of online gaming sites, and many online gaming sites have reached a huge number of new users. The entertainment industry has also suffered, with many bands taking leave or cutting their concert tours.
1273	en	ln	 Many large theatres such as those on Broadway also suspended all performances. 	 Bisika mingi ya minene ya teyatre na ndakisa oyo ya Broadway mpe elobi ete masano nyonso ekosalema te. 	Many major theater venues in this Broadway example also state that not all performances will be performed.
1274	en	ln	" Some artists have explored ways to continue to produce and share work over the internet as an alternative to traditional live performance, such as live streaming concerts or creating web-based ""festivals"" for artists to perform, distribute, and publicize their work. "	 Ba-artiste mosusu bazoluka ndenge ya kolanda kobeta miziki mpe kokabola misala na bango na internet olie ya kosala ba concert en direct, na ndakisa bazobeta ba concert na streaming en direct to bazosala “bafeti” na internet mpo ba artiste babeta ba concert, mpe kosala piblisite ya mosala na bango. 	Some artists are looking for ways to continue playing music and sharing their work online instead of performing live, such as live streaming concerts or creating online “parties” for artists to perform, and perform advertising their work.
1275	en	ln	 Online, numerous coronavirus-themed Internet memes have spread as many turn to humour and distraction amid uncertainty. 	 Na internet, masolo mingi oyo ezolobela coronavirisi etondi mpo bato mosusu bakomisi yango lisolo ya kosekisa mpe eleko ya kolekisela ntango ata toyebi te ndenge ekosuka. 	On the Internet, many stories about the coronavirus are full because some people have made it a joke and a hobby even though we do not know how it will end.
1276	en	ln	 Since the outbreak of COVID-19, heightened prejudice, xenophobia, and racism have been noted toward people of Chinese and East Asian descent, and against people from hotspots in Europe, the United States and other countries. 	 Banda kobima ya COVID-19, bato bakomi koyina makasi, kozwa makanisi mabe, mpe koyina mpo na mposo ya nzoto bato ya Chine mpe bato oyo bankoko na bango bauta na Asie ya este, mpe bato ya Eropa, ya Éats-Unis mpe ya mikili mosusu oyo maladi wana ezali mingi. 	Since the outbreak of COVID-19, there has been an increase in prejudice, prejudice, and racism against Chinese and people of East Asian descent, as well as against Europeans, the United States, and other countries others in which the disease is common.
1277	en	ln	 Incidents of fear, suspicion, and hostility have been observed in many countries, particularly in Europe, East Asia, North America, and the Asia-Pacific region. 	 Bapanzi-nsango emonisi ete na mikili mingi, mingimingi na Eropa, na Asie ya este, na Amerique ya norde, mpe na mikili ya Asie Pacifique, makambo ya kobangisa bato, ya kozwela bango makanisi mabe, mpe ya koyina bango emonani mingi. 	The media reports that in many countries, especially in Europe, East Asia, North America, and Asia Pacific, intimidation, prejudice, and hatred are commonplace.
1278	en	ln	 Reports from February (when the majority of the cases had still been confined to China) have documented racist sentiments expressed in various groups worldwide of Chinese people deserving the virus or receiving what has been claimed as justified retribution. 	 Barapore ya sanza ya mibale (ntango bato mingi ya maladi bazalaki kaka na Chine) elobelaki mayoki ya koyina bato ya Chine euti na mokili mobimba, mpe bato mingi bazalaki koloba ete ebongi mpenza virisi wana ezwa bato ya Chine mpo na kofuta bango. 	The February outbreak (when most of the cases were still in China) sparked anti-Chinese sentiment from around the world, and many argued that the virus deserved to hit the Chinese in return.
1279	en	ln	 Some countries in Africa have also seen a rise in anti-Chinese sentiment. 	 Na mikili mosusu ya Afrika mpe bakomi koyina mingi bato ya Chine. 	Other African countries have also become increasingly hostile to the Chinese.
1280	en	ln	 Many residents of Wuhan and Hubei have reported discrimination based on their regional origin. 	 Bato mingi ya Wuhan mpe ya Hubei balobi ete bato bazomona bango mpamba mpo na esika bauta. 	Many people in Wuhan and Hubei say they are stigmatized because of their background.
1281	en	ln	 There has been support for the Chinese, both on and offline, and towards those in virus-stricken areas. 	 Bato mingi bazopesa bato ya Chine maboko, na internet mpe na libanda ya internet mpe bazosunga baoyo bazali na bamboka oyo virisi ezali. 	Many people are supporting the Chinese people, both online and offline, and helping those in countries where the virus is endemic.
1282	en	ln	 Following the progression of the outbreak to new hotspot countries, people from Italy, the first country in Europe to experience a serious outbreak of COVID-19, could also be subjected to suspicion and xenophobia.Citizens in countries including Malaysia, New Zealand, Singapore, and South Korea initially signed petitions lobbying to ban Chinese people from entering their countries in an effort to stop the disease. 	 Na kotalela bokoli ya virisi na mikili oyo ekoti mingi, bato ya Italie, mokili ya liboso ya Eropa oyo maladi ya COVID-19 ezwaki bato mingi, bato bakoki mpe kokoma mpe kobanda koyina bango mpe kozwela bango makanisi mabe. Bato ya mikili lokola Malaisie, Nouvelle-Zelande, Singapour, mpe Corée ya sude batyaki maboko na mokanda mpo na kopekisa bato ya Chine na kokota na mboka na bango mpo na kosilisa maladi wana. 	Given the spread of the virus in the most infected countries, people in Italy, the first European country to be infected with COVID-19, may also become subject to hatred and prejudice. Countries like Malaysia, New Zealand, Singapore, and South Korea have signed a petition to ban Chinese from entering their country to eradicate the disease.
1283	en	ln	 In Japan, the hashtag #ChineseDontComeToJapan trended on Twitter. 	 Na Japon, bazokoma na Twitter #BatoyaChineBoyaTenaJapon ezotambola mingi. 	In Japan, the Twitter hashtag #ComeChinaComeNoJapan is trending.
1284	en	ln	 Chinese people as well as other Asians in the United Kingdom and the United States have reported increasing levels of racist abuse, as well as assaults. 	 Bato ya Chine mpe bato mosusu ya Asie oyo baza na Royaume-Uni mpe na États-Unis balobi ete bato bakomi koyina bango mingi mpo na mposo na bango mpe bazoluka kosala bango mabe. 	Chinese and other Asians in the UK and the US have reported increasing racial hatred and targets.
1285	en	ln	" U.S. president Donald Trump has faced criticism for referring to the coronavirus as the ""Chinese Virus"", a term considered by critics to be racist and anti-Chinese. "	 Prezida ya États-Unis Donald Trump abengaki coronavirisi ‘’virisi ya bato ya Chine’’, maloba oyo bato balobi eza koyina bato ya mpo na mposo na bango mpe koyina bango mpenza. 	US President Donald Trump has called the coronavirus a &#39;&#39;Chinese people&#39;s virus,&#39;&#39; a term that has been described as racist and hateful.
1286	en	ln	 Protesters in Ukraine attacked buses carrying Ukrainian and foreign evacuees from Wuhan to Novi Sanzhary. 	 Na Ukraine bato babundisaki babisi oyo ezalaki komema bato ya Ukraine mpe bapaya oyo bawutaki Wuhan, ezalaki komema bango na Novi Sanzhary. 	In Ukraine people attacked buses carrying Ukrainians and foreigners from Wuhan, taking them to Novi Sanzhary.
1287	en	ln	 Students who come from Northeast India, which shares a border with China, and study in major Indian cities have reportedly experienced harassment related to the coronavirus outbreak. 	 Bana ya kelasi oyo bawutaki na norde este ya Inde, oyo ekaboli ndelo na Chine, mpe bayekolaka na bingumba minenne ya Inde balobi ete bato bazonykola bango mpe na kobima ya coronavirisi. 	Schoolchildren from northeastern India, which shares a border with China, and studying in major Indian cities say they are also being bullied by the outbreak of the coronavirus.
1288	en	ln	" The Bharatiya Janata Party's State unit president in West Bengal Dilip Ghosh stated that the Chinese had destroyed nature and ""that's why the God took revenge against them."" "	 Prezida ya parti ya etuka ya Bharatiya Janata na West Bengal Dilip Ghosh alobaki ete bato ya Chine babebisi mokili “yango wana Nzambe azopesa bango etumbu.” 	Bharatiya Janata Party (BJP) West Bengal state president Dilip Ghosh said the Chinese have ruined the world “so God is punishing them.”
1289	en	ln	" The remarks were later condemned by the Chinese consulate in Kolkata, calling it ""erroneous"".In China, xenophobia and racism agains non-Chinese residents has been inflamed by the pandemic, with foreigners described as ""foreign garbage"" and targeted for ""disposal"". "	 Consolat ya Chine na Kolkata, akweisaka makambo mpe alobaki te eza “libunga.” Na Chine, xenophobie mpe racisme epai ya bato oyo bafandaka te na Chine ekomi mingi mpo na maladi oyo, mpe bazobenga bapaya “bosoto ya bapaya” mpe baza na likanisi ya “kobwaka” bango. 	The Chinese consul in Kolkata, dismissed the incident and did not say it was a “mistake.” In China, xenophobia and racism towards people who don’t live in China has become more prevalent due to this disease, and they refer to foreigners as “foreign garbage” and have the idea of “throwing” them away.
1290	en	ln	 Many newspapers with paywalls have removed them for some or all of their coronavirus coverage. 	 Bazulunalu mingi oyo eza na paywalls elongoli makambo mosusu to nyonso oyo balobaki mpo na coromavirisi. 	Many newspapers with paywalls have removed some or all of their coverage of the coronavirus.
1291	en	ln	 Many scientific publishers made scientific papers related to the outbreak available with open access. 	 Bato mingi oyo babimisaka bansango ya siansi basali mikanda ezolobela maladi oyo mpe moto nyonso akoki kotanga yango ya ofele. 	Many scientific journals have produced books on the disease that are free for anyone to read.
1292	en	ln	 Some scientists chose to share their results quickly on preprint servers such as bioRxiv. 	 Bato mosusu ya siansi baponi kotya ba résultat na bango noki na bisika neti bioRxiv. 	Some scientists have chosen to post their results quickly on sites like bioRxiv.
1293	en	ln	 Emerging infectious disease – Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode 	 Maladi mabe oyo ezobima - maladi mabe oyo ezouta na bavirisi, mbala mingi eza lolenge ya sika to ezopesama na lolenge ya sika 	Emerging disease - a serious disease caused by viruses, usually a new strain or transmitted by a new strain
1294	en	ln	 Globalization and disease – Overview of globalization and disease transmission 	 Mokili mobimba mpe maladi - Botaleli ya maladi na mokili mobimba mpe ndenge ezopanzana	Globalization and Disease - An overview of global disease and its spread
1295	en	ln	 List of epidemics and pandemics – A list of death tolls due to infectious disease 	 Bankombo ya maladi mpe maladi mabe - Liste ya motango ya bato bakufi mpo bazwaki maladi yango	Names of Diseases and Epidemics - A list of the number of people who have died from contracting the disease
1296	en	ln	 Wildlife smuggling and zoonoses – Health risks associated with the trade in exotic wildlife 	 Kobebisa biloko ya zamba me banyama - Makama ya kolongonoo ya nzoto euti na koteka banyama ya zamba	Destruction of wildlife me animals - Health risks from the sale of wildlife
1297	en	ln	 Laboratory testing for the respiratory coronavirus disease 2019 (COVID-19) and the associated SARS-CoV-2 virus includes methods that detect the presence of virus and those that detect antibodies produced in response to infection. 	 Ba-ekzame ya maladi ya mpema ya coronavirisi 2019 (COVID-19) mpe ya virisi SARS-CoV-2 oyo eza na boyokani na yango etaleli mpe mayele ya koyeba virisi mpe mayele ya koyeba ba anticorps oyo ebotamaka mpo na kobundisa maladi. 	Tests for the 2019 coronavirus (COVID-19) and related SARS-CoV-2 respiratory viruses also examine virus detection and innate antibody detection.
1298	en	ln	 The presence of viruses in samples is confirmed by RT-PCR, which detects the coronavirus'  RNA. 	 Kozala ya virisi na kati ya ba échantillon endimisami na RT-PCR, oyo emonaka coronavirisi RNA. 	The presence of the virus in the samples was confirmed by RT-PCR, which detects coronavirus RNA.
1299	en	ln	 This test is specific and is designed to only detect the RNA of the SARS-CoV-2 virus. 	 Ekzame oyo eza ya sikisiki mpe mokano na yango eza kaka ya komona RNA ya virisi SARS-COV-2. 	This test is specific and its purpose is only to detect the RNA of the SARS-COV-2 virus.
1300	en	ln	 It is used to confirm very recent or active infections. 	 Basalelaka yango mpo na komona maladi ya sika to maladi ya kala oyo eza na nzoto. 	It is used to detect new or old diseases in the body.
1301	en	ln	 Detection of antibodies (serology) can be used both for diagnosis and population surveillance. 	 Komona ba anticorps (serologie) ekoki kosalema mpo na diagnostic mpe kokengela bato. 	Detection of antibodies (serology) can be done for diagnosis and surveillance.
1302	en	ln	 Antibody tests show how many people have had the disease, including those whose symptoms were too minor to report or who were asymptomatic. 	 Ekzame ya ba anticorps elakisaka motango ya bato oyo bazali na maladi, ata mpe baoyo bilembo na yango eza moke mpenza mpo emonana to oyo baza te na bilembo na yango. 	Antibody tests show the number of people who are sick, including those with very few or no symptoms.
1303	en	ln	 An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. 	 Taux ya solo ya bato bazokufa na maladi oyo mpe nivo ya immunité ya bato nyonso ekoki koyebana na ba résulat ya ekzame oyo. 	The actual mortality rate and the overall immunity level can be determined from the results of this test.
1304	en	ln	 Due to limited testing, as of March 2020 no countries had reliable data on the prevalence of the virus in their population. 	 Lokola ba-ekzame ezali kosalema mingi te, na sanza ya misato 2020 ata mokili moko te ezalaki na bansango ya solo ezomonisa ndenge virisi ezopalangana kati na bato na bango. 	Because of the low number of tests, as of March 2020 no country had accurate reports of the spread of the virus among their populations.
1305	en	ln	 By 23 March, no country had tested more than 3% of their population, and there are massive variations in how much testing has been done across countries. 	Na mokolo ya 23 sanza ya misato, ata mokili moko te esalaki ekzame na bato na bango 3%, mpe bokeseni eza mingi na ndenge mikili mingi ezalaki kosala ekzame oyo. 	As of March 23, no country had tested 3% of its population, and there are many differences in how many countries tested.
1306	en	ln	 This variability is also likely to be significantly affecting reported case fatality rates, which are likely to be significantly over-estimated in some countries. 	 Bokeseni oyo ekoki kozala mpe na bopusi makasi na taux ya liwa, oyo ndenge ezomonana ekozala moke mpenza na mikili mingi. 	This difference may also have a serious impact on the mortality rate, which as it turns out would be very low in most countries.
1307	en	ln	 Using real-time reverse transcription polymerase chain reaction (rRT-PCR) the test can be done on respiratory samples obtained by various methods, including nasopharyngeal swab or sputum sample. 	 Na kosalela ndenge makambo esalemaka na nsima ya ekzame ya transcription ya kobaluka ya polymerase (rRT-PCR) ekoki kosalema na ba échantilon ya mpema oyo bazwaki na lolenge mingi, ata mpe kozwa ndambo ya miyoyo kati na zolo to échantillon ya kosukosu. 	Using a reverse transcription polymerase reverse transcription test (rRT-PCR) approach it is possible to perform breath samples taken in a number of ways, including taking a slice of mucus from the nose or a cough sample.
1308	en	ln	 Results are generally available within a few hours to 2 days. 	 Mbala mingi ba résultat ebimaka nsima ya mwa bangonga to mikolo 2. 	Results usually appear within a few hours or 2 days.
1309	en	ln	 The RT-PCR test performed with throat swabs is only reliable in the first week of the disease. 	 Ekzame ya RT-PCR oyo esalemi na kosukosu ebimisaka résultat ya malamu kaka soki maladi eza na mposo ya liboso. 	A cough-based RT-PCR test produces a positive result only when the patient is present in the primary skin.
1310	en	ln	 Later on the virus can disappear in the throat while it continues to multiply in the lungs. 	 Na nsima virisi ekoki kolimwa na mongongo kasi ezokoba kobotama na bapoumon. 	The virus may then disappear from the voice but continue to reproduce in the lungs.
1311	en	ln	 For infected people tested in the second week, alternatively sample material can then be taken from the deep airways by suction catheter or coughing up material (sputum) can be used. 	 Mpo na bato ya maladi oyo basali ekzame na mposo ya mibale, bakoki kosala yango na kozwana mayi na kati mpenza ya nzela ya kopema ya kati na nzela ya cathetere to mayi ya kosokusu. 	For patients who have had the test in the second week, it can be done by swapping fluids deep into the central respiratory tract with a catheter or cough fluid.
1312	en	ln	 One of the early PCR tests was developed at Charité in Berlin in January 2020 using real-time reverse transcription polymerase chain reaction (rRT-PCR), and formed the basis of 250,000 kits for distribution by the World Health Organization (WHO). 	 Moko ya ekzame ya PCR ya liboso babandisaki yango na Charité na Berlin na sanza ya yambo 2020 na kosalelaka makambo esalemaka na nsima ya transcription ya kobaluka ya polymerase (rRT-PCR), mpe esalaki na kosala biloko 250 000 ya kosala ekzame oyo organisation mondiale de la santé (OMS) ekabolaki. 	One of the first PCR tests was launched by the Charity in Berlin in January 2020 using polymerase reverse transcription (rRT-PCR), and has resulted in the development of 250,000 test kits by the global organization the health (WHO) shared.
1313	en	ln	 The United Kingdom had also developed a test by 23 January 2020.The South Korean company Kogenebiotech developed a clinical grade, PCR-based SARS-CoV-2 detection kit (PowerChek Coronavirus) on 28 January 2020. 	 Royaume-Uni esalaki mpe biloko ya ekzame na mokolo ya 23 sanza ya yambo 2020. Kompani moko ya Corée ya sude Kogenebioch esalaki apareyi moko, PC -ewuta na SARS-CoV-2 (PowerChek Coronavirisi) na mokolo ya 28 sanza ya yambo 2020. 	The UK also developed test kits on 23 January 2020. South Korean company Kogenebioch developed a device, PC -based for SARS-CoV-2 (PowerChek Coronavirisi) on 28 January
1314	en	ln	" It looks for the ""E"" gene shared by all beta coronaviruses, and the RdRp gene specific to SARS-CoV-2.In China, BGI Group was one of the first companies to receive emergency use approval from China's National Medical Products Administration for a PCR-based SARS-CoV-2 detection kit.In the United States, the Centers for Disease Control and Prevention (CDC) is distributing its 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel to public health labs through the International Reagent Resource. "	 Elukakaba gene “E” nyonso oyo eza na ba coronavirisi beta nyonso mpe ba gene RdRp ya sikisiki ya SARS-CoV-2. Na Chine, lisanga BGI ezalaki kompani ya liboso oyo oyo bazwaki ndingisa ya lisanga elandelaka makambo nyonso ya bankisi na Chine mpo na kosala apareyi ya PCR mpo kosala ekzame ya SARS-COV-2. Na États-Unis, bacentre ya kolandela mpe kobundisa maladi (CDC) ezali kokabola biloko na yango kosala ekzame ya coronavirisi ya sika-2019 (2019-nCoV) na ntango ya solo RT-PCR Diagnostic Panel na balaboratoire yato nyonso na lisalisi ya International Reagent Resource. 	It looks for all the “E” genes in all beta coronaviruses and the specific RdRp genes of SARS-CoV-2 In China, the BGI group was the first company to receive a license from the pharmaceutical industry in China to develop a PCR device for testing for SARS-COV-2 In the United States, the Centers for Disease Control and Prevention (CDC) is distributing its resources testing the new coronavirus-2019 (2019-nCoV) real-time RT-PCR Diagnosis Panel to all yato laboratories using International Reagent Resource.
1315	en	ln	 One of three genetic tests in older versions of the test kits caused inconclusive results due to faulty reagents, and a bottleneck of testing at the CDC in Atlanta; this resulted in an average of fewer than 100 samples a day being successfully processed throughout the whole of February 2020. 	 Na ba-ekzame na biso misato ya gene na bamodele ya kala, biloko ya kosala ekzame ezalaki kobimisa ba résultat ya malamu te, mpe mpasi mpasi ya kosala ekzame na CDC na Atlanda; esalaki ete basala ba-ekzame na ba échantillon 100 na mokolo na sanza ya mibale 2020. 	In our three genetic tests on older models, the test kits were producing incorrect results, and the difficulty of testing at the CDC in Atlanta; conducted tests on 100 samples per day in February
1316	en	ln	 Tests using two components were not determined to be reliable until 28 February 2020, and it was not until then that state and local laboratories were permitted to begin testing. 	Kosalela biloko mibale ntango mpo na kosala ba ekzame emonanaki ete ezosala malamu te na mokolo ya 28 sanza ya mibale 2020, mpe nsima na yango nde balaboratoire ya etuka mpe ya bamboka bazwaki ndingisa ya kobanda kosala ba ekzama. 	The use of two devices when testing was found to be ineffective on February 28, 2020, after which regional and rural laboratories were allowed to start testing.
1317	en	ln	 The test was approved by the Food and Drug Administration under an Emergency Use Authorization.US commercial labs began testing in early March 2020. 	 Ministere ya Bilei mpe Bankisi endimaka ba ekzame na nse ya ndingisa ya mbalakaka. Balaboratoire ya Etats-Unis ebandaki kosalisa ba ekzame na ebandeli ya sanza ya misato 2020. 	The Ministry of Food and Drugs approves tests under emergency authorization. US laboratories began testing in early March
1318	en	ln	 As of 5 March 2020 LabCorp announced nationwide availability of COVID-19 testing based on RT-PCR. 	 Na mokolo ya 5 sanza ya misato 2020 LabCorp elobaki ete bato ya mboka mobimba bakoki kobanda kosala ekzame ya COVID-19 na lisalisi ya RT-PCR. 	On March 5, 2020 LabCorp announced that the public can begin testing for COVID-19 using RT-PCR.
1319	en	ln	 Quest Diagnostics similarly made nationwide COVID-19 testing available as of 9 March 2020. 	 Ndenge moko, Quest Diagnostics endimaka babanda kosala bato nyonso ya mboka ba ekzame COVID-19 na mokolo ya 9 sanza ya misato 2020. 	Similarly, Quest Diagnostics agrees to start public COVID-19 testing on March 9,
1320	en	ln	 No quantity limitations were announced; specimen collection and processing must be performed according to CDC requirements. 	 Balobaki te motango ya nsuka; kozwa ba echantillon mpe kosala ba ekzame esengeli kosalama na kolanda mibeko ya CDC. 	They didn’t say the final number; sampling and testing should be done in accordance with CDC guidelines.
1321	en	ln	 In Russia, the COVID-19 test was developed and produced by the State Research Center of Virology and Biotechnology VECTOR. 	Na Russie, basalaki biloko ya kosalisa ekzame ya COVID-19 na centre ya bolukiluki ya bavirisi mpe biotecnologie VECTOR. 	In Russia, COVID-19 test kits were developed at the VECTOR virus research and biotechnology center.
1322	en	ln	 On 11 February 2020 the test was registered by the Federal Service for Surveillance in Healthcare.On 12 March 2020, Mayo Clinic was reported to have developed a test to detect COVID-19 infection.On 13 March 2020, Roche Diagnostics received FDA approval for a test which could be performed within 3.5 hours in high volume, thus allowing one machine to do approximately 4,128 tests in a 24-hour period. 	 Na mokolo ya 11 sanza ya mibale 2020 ministere ekengelaka kolongono ya nzoto endimaka kosalisa ba ekzame. Na mokolo ya 12 sanza ya misato 2020, balobaki ete lopitalo Mayo ebimisaka mashine ya kosala ekzame ya COVID-19. Na mokolo ya 13 sanza ya misato 2020, FDA endimaki ete Roch Diagnostics basala ba ekzame oyo basengelaki kosala na bangonga 3,5 na motango ya mingi, epesaki mashine moko libaku ya kosala ba ekzame pene ya 4 128 na eleko ya bangonga 24. 	On February 11, 2020 the health ministry approved the tests. On March 12, 2020, it was announced that Mayo Hospital is releasing a COVID-19 testing machine. On March 13, 2020, the FDA approved Roch Diagnostics to run scheduled tests in a maximum of 3.5 hours, giving one machine the opportunity to run approximately 4,128 tests in a 24-hour period.
1323	en	ln	 On 19 March 2020, the FDA issued emergency use authorization (EUA) to Abbott Laboratories for a test on Abbott's m2000 system; the FDA had previously issued similar authorization to Hologic, LabCorp, and Thermo Fisher Scientific. 	 Na mokolo ya 19 sanza ya misato 2020, FDA endimaki ete balaboratoire ya Abbott esala ekzame na systeme ya Abbott ya m2000; FDA esi endimaki basalela Hologic, LabCorp, mpe Thermo Fisher Scientific. 	On March 19, 2020, the FDA approved Abbott Laboratories to test the Abbott m2000 system; The FDA has already approved the use of Hologic, LabCorp, and Thermo Fisher Scientific.
1324	en	ln	 On 21 March 2020, Cepheid similarly received EUA from the FDA for a test that takes about 45 minutes. 	Na mokolo ya 21 sanza ya misato 2020, Cepheid mpe azwaki ndingisa ya EUA ewutaki na FDA mpo na kosala ekzame oyo ewumelaka kaka miniti 45. 	On March 21, 2020, Cepheid also received EUA approval from the FDA for a test lasting only 45 minutes.
1325	en	ln	 The FDA has approved a test that uses isothermal nucleic acid amplification technology instead of PCR. 	 FDA endimaki basala ekzame oyo esengaka kosalela mayele ya aside isothermique nucleique na esika ya PCR. 	The FDA approved a test that requires the use of isothermal nucleic acid technology instead of PCR.
1326	en	ln	 Since this does not require a series of alternating temperature cycles this method can deliver positive results in as little as five minutes and negative results in 13 minutes. 	 Lokolo esengaka te kobongolaka temperature, metode oyo ekoki kopesa resultat ya bato oyo baza na maladi na nse ya miniti mitano mpe ya bato oyo baza na yango te na nse ya miniti 13. 	The foot does not require temperature regulation, this method can give results for people with disease in less than five minutes and people without it in less than 13 minutes.
1327	en	ln	 There are currently about 18,000 of these machines in the U.S. and Abbott expects to ramp up manufacturing to deliver 50,000 tests per day.A test which uses a monoclonal antibody which specifically binds to the nucleocapsid protein (N protein) of the novel coronavirus is being developed in Taiwan, with the hope that it can provide results in 15 to 20 minutes just like a rapid influenza test. 	 Eza sikoyo na bamashine peno ya 18 000 na Etats-Unis mpe bato ya mayele ya Abbott bakosala ba ekzame 50 000 na mokolo moko. Ekzame oyo basalelaka anticorps moko boye elongo na baproteine ya nuclecapside (proteine N) ya cornovirisi ya sika, baza na ksoala yango na Taiwan, na elikya ete ekoki kobimisa ba resultat nsima ya miniti 15 to 20 kaka ndenge ezalaka mpo na ekzame ya grippe. 	There are now 18,000 peno machines in the United States and Abbott scientists will perform 50,000 tests a day. The test, which uses a specific antibody in combination with the nuclecapside (N protein) proteins of the new cornovirus, is being developed in Taiwan, hoping to produce results after 15 or 20 minutes just like a flu test.
1328	en	ln	" A March 2020 literature review concluded that ""chest radiographs are of little diagnostic value in early stages, whereas CT [computed tomography] findings may be present even before symptom onset."" "	 Na sanza ya misato 2020 zulunalu elobaki ete “ba ekzame ya radio ya ntolo eza na ntina mingi te na bitambe ya ebandeli, kasi CT [tomographie esalamaka na ordinatere] ekoki kozala ata liboso bilembo ebanda komonana.” 	In March 2020 the journal reported that “chest x-rays are less important in the early stages, but CT [computed tomography] may be available even before symptoms appear.”
1329	en	ln	 Typical features on CT include bilateral multilobar ground-glass opacificities with a peripheral, asymmetric and posterior distribution. 	 Biloko ya CT eza na ndakisa batala-tala ya multilateral ya pete elongo na peripherique, asymetrique mpe elongo ya libanda. 	CT devices include simple multilateral views with peripheral, asymmetric and external views.
1330	en	ln	 Subpleural dominance, crazy paving and consolidation develop as the disease evolves. 	 Sous-pleural ezalaka monene, nguya ya makasi mpenza mpe bokasi ntango maladi ezopalangana. 	The subpleural is thick, very strong force and stiffness when the disease spreads.
1331	en	ln	 A study comparing PCR to CT in Wuhan at the point of origin of the current pandemic has suggested that CT is significantly more sensitive than PCR, though less specific, with many of its imaging features overlapping with other pneumonias and disease processes. 	 Bolukiluki moko oyo ekokanisaki PCR na CT na Wuhan na ebandeli ya maladi oyo elobi ete CT eza makasi mingi koleka PCR, kasi eza na ba resultat ya sikisiki te, mpe bafoto na yango mosusu elekaka likolo ya maladi ya pneumonie mpe maladi mosusu. 	A study comparing PCR and CT in Wuhan early in the outbreak says that CT is much more powerful than PCR, but has less accurate results, and some of its photos are passed over for pneumonia and other diseases.
1332	en	ln	" As of March 2020, the American College of Radiology recommends that ""CT should not be used to screen for or as a first-line test to diagnose COVID-19"".As of March 2020, the CDC recommends PCR for initial screening. "	 Na sanza ya misato 2020, College ya Amerika ya radiologie elobaki ete “basalela CT te mpo na mpo na komona to neti ekzame ya liboso mpo na komona COVID-19.” Na sanza ya misato 2020, CDC elobaki bato basalela PCR na ebandeli. 	In March 2020, the American College of Radiology stated that “CT should not be used for for detection or as a primary test for detection of COVID-19.” In March 2020, the CDC recommended that people use PCR initially.
1333	en	ln	 Part of the immune response to infection is the production of antibodies including IgM and IgG. 	 Mpo na kobundisa maladi tokoki kobotisa ba anticoprs ata mpe IgG na IgG. 	To fight disease we can breed anticoprs including IgG to IgG.
1334	en	ln	 These can be used to detect infection in individuals starting 7 days or so after the onset of symptoms, to determine immunity, and in population surveillance.Assays can be performed in central laboratories (CLT) or by point-of-care testing (PoCT). 	 Bakoki kosalela yango mpo na koyeba maladi na bato banda na mikolo 7 to mingi nsima ya komonana ya bilembo, mpo na koyeba makasi ya kobundisa maladi, mpe kokengela bato. Komeka ekoki kosalema na balaboratoire central (CLT) to na esika ya kosalisa ekzame (PocT). 	They can be used for diagnosis in humans as early as 7 days or more after the onset of symptoms, for measuring immune strength, and for surveillance. Testing can be done at a central laboratory (CLT) or at a testing center (PocT).
1335	en	ln	 The high-throughput automated systems in many clinical laboratories will be able to perform these assays but their availability will depend on the rate of production for each system. 	Ba systeme ya mpasi mingi ya automatique na balaboratoire ya balopitalo mingi ekokoka kosala ba ekzame wana kasi makoki na bango etalelama na motango ya bato oyo systeme mokomoko ekoki kosala. 	The more complex automated systems in many hospital laboratories will be able to perform these tests but their capacity is limited by the number of people each system can handle.
1336	en	ln	 For CLT a single specimen of peripheral blood is commonly used, although serial specimens can be used to follow the immune response. 	 Mpo na CLT basalelaka mbala mingi echantillon moke ya makila, ata bakoki kosalela ba echantillon mingi mpo na koyeba makasi ya nzoto ya kobundisa maladi. 	For CLT a small blood sample is typically used, even though multiple samples may be used to determine immune strength.
1337	en	ln	 For PoCT a single specimen of blood is usually obtained by skin puncture. 	 Mpo na PoCT mbala mingi bazwaki echantillon moko ya makila na mposo ya nzoto na tonga. 	For PoCT a single cutaneous blood sample was usually taken from the tonga.
1338	en	ln	 Unlike PCR methods an extraction step is not needed before assay.On March 26, 2020, the FDA named 29 entities that provided notification to the agency as required and are now therefore able to distribute their antibody tests. 	 Na kokesena na PCR, bametode ya kobimisa etambe eza na ntina te liboso ya kobanda. Na mokolo ya 26 sanza ya misato 2020, FDA eponaki bisika 29 oyo bapesaka bango rapore ndenge esengeli mpe sikoyo bakoki kokabola ba ekzame na bango ya anticorps. 	Unlike PCR, step extraction methods are not necessary before starting. As of March 26, 2020, the FDA designated 29 facilities that report to them as required and can now share their antibody tests.
1339	en	ln	 As of April 7, 2020, only a single test has been approved by the FDA under an emergency use authorization.In late March 2020, Euroimmun Medical Laboratory Diagnostics and Epitope Diagnostics received European approvals for their test kits, which can detect IgG and IgA antibodies against the virus in blood samples. 	 Na mokolo 7 ya sanza ya minei,2020, FDA endimaki kaka ekzame moko na ntango ya urgence. Na nsuka ya sanza ya misato 2020, Euroimmun Medical Laboratory Diagnostics mpe Epitope Diagnostics bazwaka ndingisa ya Eropa mpo babanda kosalela bamashine na bango ya kosala ekzame, oyo ekoki komona ba anticorps IgG na IgA na ba echantillon ya makila oyo eza na virisi. 	As of April 7,2020, the FDA approved only one emergency test. By the end of March 2020, Euroimmun Medical Laboratory Diagnostics and Epitope Diagnostics will receive European approval to start using their testing machines, which can detect IgG and IgA antibodies in viral blood samples.
1340	en	ln	 The testing capacity is several hundred samples within hours and therefore much faster than the conventional PCR assay of viral RNA. 	 Baza na makoki ya kosala ba ekzame mingi na ba echantillon na ngonga moko mpe bakosala noki koleka PCR ya momeseno mpo na ekzame ya virisi RNA. 	They have the ability to perform multiple tests on samples per hour and will perform faster than conventional PCR for virus RNA testing.
1341	en	ln	 The antibodies are usually detectable 14 days after the onset of the infection.In early April, the UK found none of the antibody test kits it purchased were sufficiently good to use. 	 Mbala mingi ba anticorps emonanaka mikolo 14 nsima ya kobanda ya maladi. Na ebandeli ya sanza ya minei, Royaume-Uni emonaki ete ata bamashine moko te ya kosala ya ekzame oyo basombaki ezala malamu. 	Antibodies are usually detected 14 days after the onset of illness. In early April, the UK discovered that none of the test machines it had bought were up to par.
1342	en	ln	" Hong Kong has set up a scheme where suspected patients can stay home, ""emergency department will give a specimen tube to the patient"", they spit into it, send it back and get a test result a while after.The British NHS has announced that it is piloting a scheme to test suspected cases at home, which removes the risk of a patient infecting others if they come to a hospital or having to disinfect an ambulance if one is used.In drive-through testing for COVID-19 for suspected cases, a healthcare professional takes sample using appropriate precautions. "	 Hong Kong ebimisaka mayele ya kotika na ndako bato oyo bazokanisa ete baza na maladi, “ministere ya urgence ekopesa bato ya maladi tube moko,” bakobwaka nsoyi kuna, bakozongisa yango, nsima batindi yango mpo na ekzame. NHS ya Grande-Bretagne elobaki ete bazosala mayele moko ya kosalisa ekzame na bato oyo bakanisi baza na maladi na ndako, ebongo ekopekisa moto ya maladi apesa bato mosusu maladi soki ayei na lopitalo to kosala kopetola ambulance soki basaleli yango mpo na moto moko. Na kosalaka ba ekzame ya COVID-19 na bato oyo bakanisi baza na maladi, monganga moko azwaka echantillon na bokengi mpenza. 	Hong Kong develops a method of leaving suspected cases at home, “the emergency ministry will give the patients a tube,” they will spit in there, regurgitate it, then send it for testing. Britain&#39;s NHS said it was developing a method of testing suspected patients at home, so it would prevent a patient from infecting others if they came to hospital or cleaning an ambulance if it was used for one person. By performing COVID-19 tests on people who are suspected of being sick, a doctor takes a sample very securely.
1343	en	ln	 Drive-through centers have helped South Korea do some of the fastest, most-extensive testing of any country.In Germany, the National Association of Statutory Health Insurance Physicians said on 2 March, that it had a capacity for about 12,000 tests per day in the ambulatory setting and 10.700 had been tested in the prior week. 	 Ba centre oyo ezalaka na mituka esalisi Coree ya sude na kosala ba ekzame na lombango mpe na bato mingi na mokili mobimba. Na Allemange lisanga ya mboka mpo na assurance ya kolongono ya nzoto ya minganga elobaki na mokolo ya 2 sanza ya misato, ete eza na makoki ya kosala ba ekzame pene ya 12 000 na mokolo moko na ba-ambulance mpe basalaki bato 10 700 na mposo oyo elekaki. 	The vehicle-based centers have helped South Korea conduct tests faster and more widely than the rest of the world. In Germany the national association for medical health insurance said on March 2, that it has the capacity to conduct about 12,000 tests a day in ambulances and conducted 10,700 people this week passed away.
1344	en	ln	 Costs are borne by the health insurance when the test is ordered by a physician. 	 Mosolo efutamaka na assurance ya maladi soki ekzame yango esengami na monganga. 	The cost is covered by health insurance if the test is ordered by a doctor.
1345	en	ln	 According to the president of the Robert Koch Institute, Germany has an overall capacity for 160,000 tests per week. 	 Mpo na prezida ya eteyelo ya Robert Koch, Allemagne eza na makoki ya kosala ba ekzame 160 000 na mposo moko. 	According to the president of the Robert Koch School, Germany has the capacity to conduct 160,000 tests a week.
1346	en	ln	 As of 19 March drive in tests were offered in several large cities. 	 Na mokolo ya 19 sanza ya misato ba ekzame bapesaki bingumba mingi ya minene likoki ya kosala ba ekzame. 	On March 19 the examinations enabled most of the larger cities to hold examinations.
1347	en	ln	 As of 26 March 2020 the total number of tests performed in Germany was unknown, because only positive results are reported. 	 Na mokolo ya 26 sanza ya misato 2020, motango ya bato oyo basalaki bango ekzame na Allemagne eyebanaki te, mpo balobeli kaka bato oyo bakangaki na maladi. 	As of March 26, 2020, the number of tests in Germany was unknown, as only patients are mentioned.
1348	en	ln	" A first lab survey revealed that as of calendar week 12/2020 a total of at least 483,295 samples were tested up to and including week 12/2020 and 33,491 samples (6.9%) tested positive for SARS-CoV-2.In Israel, researchers at Technion and Rambam Hospital developed and tested a method for testing samples from 64 patients simultaneously, by pooling the samples and only testing further if the combined sample is found to be positive.In Wuhan a makeshift 2000-sq-meter emergency detection laboratory named ""Huo-Yan"" (Chinese: 火眼, or ""Fire Eye"" in English) was opened on 5 February 2020 by BGI, which can process over 10,000 samples a day. "	 Ankete ya liboso ya laboratoire oyo esalemaki na mposo ya 12/2020 emonisi ete basalaki ekzame na ba echantillon pene ya 483 295 mpe etalelaki mposo ya 12/2020 mpe ba echantillon 33 491 (6,9%) bazalaki na maladi ya SARS-COV-2. Na Israele, bato basalaka bolukiluki na lopitalo Technion and Rambam basalaki metode ya sika mpe basalaki ba ekzame na ba echantillon na bato 64 na mbala moko, na kotyaka ba echantillon mpe kaka kosala ba ekzame ya ba echantillon mingi ezalaki na maladi. Na Wuham laboratoire ya 2000-sq-metre ya likama esalemaki bapesi nkombo ‘Huo-Yan’’ (Kishinwa: 火眼 , to “liso ya moto” na Lingala) ebandaki mosala mokolo ya 5 sanza ya mibale 2020 na BGI, oyo ekoki kosala ekzame ya ba echantillon 10 000 na mokolo moko. 	The first laboratory survey conducted in the week of 12/2020 showed that approximately 483,295 samples were tested and covered the week of 12/2020 and 33,491 samples (6.9%) were positive for SARS-COV-2 2. In Israel, researchers at the Technion and Rambam Hospital developed a new method and performed tests on samples from 64 people at a time, by depositing samples and just testing more samples was sick. In Wuham a 2000-sq-metre disaster laboratory named &#39;Huo-Yan&#39;&#39; (Kishinwa: 火眼 , or “human eye” in English) was commissioned on February 5, 2020 by BGI, which can conduct tests of 10,000 samples per day.
1349	en	ln	 With the construction overseen by BGI-founder Wang Jian and taking 5-days, modelling has show cases in Hubei would have been 47% higher and the corresponding cost of the tackling the quarantine would have doubled if this testing capacity hadn't come on line. 	 Na mosala ya kotanga ekambami na mobandisi ya BGI Wang Jian mpe ezwaki mikolo 5, kosala biloko ya Hubei elingaki kozala 47% ya koleka mpe ekokani na ntalo ya kotya bato na quarantaine elingaki komata mbala mibale soki babandisaka te mosala oyo ya kosala ekzame. 	With the counting process led by BGI founder Wang Jian and taking 5 days, Hubei’s manufacturing would have been 47% more expensive and equivalent to the cost of quarantined people would have doubled if they do not initiate this screening process.
1350	en	ln	 The Wuhan Laboratory has been promptly followed by Huo-Yan labs in Shenzhen, Tianjin, Beijing, and Shanghai, in a total of 12 cities across China. 	 Huo-Yan na Shenzehen, Tianjin, Beijing, na Shanghai, elandaki noki laboratoire ya Wuhan, na mobimba bingumba 12 ya Chine elanda bango. 	Huo-Yan in Shenzehen, Tianjin, Beijing, and Shanghai, soon followed the Wuhan lab, in total 12 Chinese cities followed suit.
1351	en	ln	 By 4 March 2020 the daily throughput totals were 50,000 tests per day.Open source, multiplexed designs released by Origami Assays have been released that can test as many as 1122 patient samples for COVID19 using only 93 assays .  These balanced designs can be run in small laboratories without the need for robotic liquid handlers. 	 Na mokolo ya 4 sanza ya misato 2020 ba ekzame oyo bazalaki kosala na mokolo ekomaki 50 000. Mokanda moko, midele ya multiplexe oyo Origami Assays ebimisaki, ekoki kosala ekzame ya ba echantillon ya bato ya maladi ya COVID19 na bato ya maladi 1 122 na kosalela kaka ba assays 93.  Midele ya malamu ekoki kosalelama na balaboratoire ya mike kozanga lisungi ya ba robot. 	As of March 4, 2020, the daily tests reached 50,000. A single, multiplexed model developed by Origami Assays can test COVID19 patient samples from 1,122 patients in use only assays 93. Good models can be used in small laboratories without the assistance of robots.
1352	en	ln	 By March, shortages and insufficient amounts of reagent has become a bottleneck for mass testing in the EU and UK and the US. 	 Na sanza ya misato, kozanga bankisi mpo na kosala bato mingi ba ekzame ekomaki motungisi ya monene na Union Européenne, na Royaume-Uni mpe na Etats-Unis. 	In March, a shortage of medicines for mass screenings became a major concern in the European Union, the UK and the US.
1353	en	ln	 This has led some authors to explore sample preparation protocols that involve heating samples at 98 °C (208 °F) for 5 minutes to release RNA genomes for further testing.On 31 March it was announced United Arab Emirates was now testing more of its population for Coronavirus per head than any other country, and was on track to scale up the level of testing to reach the bulk of the population. 	 Yango etindi bakomi mosusu na kobongisa mayele ya kosalela ba echantillono oyo ezosenge kotya yango na moto na temperature ya 98 °C (208 °F) na miniti 5 mpo na kobimisa ba genome RNA mpo na kosala ba ekzame mosusu. Na mokolo ya 31 sanza ya misato balobaki ete elobaki ete Emirats Arabe Unies eza na kosala bato na yango mingi ekzame ya coronavirisi na mokolo koleka mikili nyonso mosusu, mpe basalaki deja ekzame yango na bato na bango mingi mpenza. 	This has prompted some authors to develop methods using samples that involve incubation at 98 °C (208 °F) for 5 minutes to extract RNA genomes for further experiments. On March 31 it reportedly said that the UAE is testing more of its people per day than any other country, and has already tested a large number of its people.
1354	en	ln	" This was through a combination of drive-through capability, and purchasing a population-scale mass-throughput laboratory from Group 42 and BGI (based on their ""Huo-Yan"" emergency detection laboratories in China). "	 Esalemaki na nzela ya mayele ya ndenge na ndenge, mpe kosombela bato na bango biloko mingi ya kosala ekzame ya laboratoire na Group 42 mpe BGI (na kolande “Huo-Yan” na bango ya balaboratoire ya lombangu ya koyeba maladi na Chine). 	It was done through a variety of methods, and buying their people more laboratory test kits from Group 42 and BGI (according to their “Huo-Yan” of rapid diagnostic laboratories in China).
1355	en	ln	 Constructed in 14 days, the lab is capable of conducting tens of thousands RT-PCR tests per day and is the first in the world of this scale to be operational outside of China. 	 Etongami na mikolo 14, laboratoire ekoki kosala ba ekzame mingi mpenza ya RT-PCR na mokolo mpe ezali laboratoire ya liboso ya nguya ndenge oyo, oyo bazosalela na libanda ya Chine. 	Built in 14 days, the laboratory can run very many RT-PCR tests per day and is the first laboratory of this kind of power, being deployed outside China.
1356	en	ln	 Different testing recipes targeting different parts of the coronavirus genetic profile were developed in China, France, Germany, Hong Kong, Japan, and the United States. 	 Bazomeka mayele mingi ya kosala ba ekzame na biteni mingi ya coronavirisi na Chine, France, Allemagne, Hong Kong, Japon, mpe na Etats-Unis. 	Several testing strategies are being tested for several parts of the coronavirus in China, France, Germany, Hong Kong, Japan, and the United States.
1357	en	ln	 The World Health Organization adopted the German recipe for manufacturing kits sent to low-income countries without the resources to develop their own. 	 Organisation mondiale de la sante endimaki mayele ya Allemange ya kosala mashine ya kosala ba ekzame ya kotinda na mikili ya bobola oyo baza na makoki te ya kosala ya bango moko. 	The World Health Organization has approved Germany&#39;s plan to develop a testing machine to be sent to poor countries that cannot afford to develop their own.
1358	en	ln	 The German recipe was published on 17 January 2020; the protocol developed by the United States Centers for Disease Control was not available until 28 January, delaying available tests in the U.S.China and the United States had problems with the reliability of test kits early in the outbreak, and these countries and Australia were unable to supply enough kits to satisfy demand and recommendations for testing by health experts. 	 Mayele ya Allemagne ebimaki na mokolo ya 17 sanza ya liboso 2020; mayele oyo ba centre ya kobundisala maladi na Etats-Unis ezalaki nanu te kino na mokolo ya 28 sanza ya liboso; esalaki ete ba ekzame ya Etats-Unis ezala te. Chine na Etats-Unis bazalaki na mutungisi na ebandeli mpo bamashine na bango ya kosala ekzame ezalaki malamu te, mpe mikili wana na Australie bazalaki na makoki te kopesa motanga ya bamashine ebongi mpo eyokana na lisengi ya minganga. 	The German intelligence was published on January 17, 2020; skills that disease control centers in the United States did not yet have until the 28th of the first month; resulted in no US examinations. China and the United States were concerned initially because their testing machines were inadequate, and those countries in Australia were unable to supply the appropriate number of machines to suit physician demand.
1359	en	ln	 In contrast, experts say South Korea's broad availability of testing helped reduce the spread of the novel coronavirus. 	 Na bokeseni, minganga balobi ete lokola Coree ya sude ezalaki na makoki ya kosala ba ekzame, esali ete coronavirisi ya sika epalangana mingi te. 	In contrast, doctors say South Korea&#39;s testing capabilities have slowed the spread of the new coronavirus.
1360	en	ln	 Testing capacity, largely in private sector labs, was built up over several years by the South Korean government. 	 Makoki ya kosala ekzame, mingimingi na balabotoire ya bato bango moko, esalemaki na bambula mingi na guvernema ya Coree ya sude. 	Testing capabilities, especially in private laboratories, were developed over many years by the South Korean government.
1361	en	ln	 On 16 March, the World Health Organization called for ramping up the testing programmes as the best way to slow the advance of COVID-19 pandemic.High demand for testing due to wide spread of the virus caused backlogs of hundreds of thousands of tests at private U.S. labs, and supplies of swabs and chemical reagents became strained. 	 Na mokolo ya 16 sanza ya misato, Organisation mondiale de la sante elobaki ete baprograme ya kosala ba ekzame eza lolenge ya malamu koleka ya kolembisa na liboso maladi mabe ya COVID-19. Mposa makasi ya kosala ba ekzame na ndenge maladi epalanganaki esalaki ete baloboratoire mingi ya Etats-Unis bazalaki na makoki ya kosala ba ekzame mpe bazangaki biloko ya kozwa mai ya nzoto mpe bankisi ya kotya na ekzame mpo na komona maladi. 	On March 16, the World Health Organization said screening programs are the best way to slow the spread of COVID-1 The intense need for testing at the rate of disease outbreak meant that many laboratories in the United States lacked testing capacity and lacked bodily fluid samples and diagnostic drugs.
1362	en	ln	 In March 2020 China reported problems with accuracy in their test kits. 	 Na sanza ya misato 2020 Chine elobaki ete bamashine na bango ya kosala ba ekzame ezosala malamu te. 	In March 2020 China said their testing machines were not working properly.
1363	en	ln	" In the United States, the test kits developed by the CDC had ""flaws;"" the government then removed the bureaucratic barriers that had prevented private testing.Spain purchased test kits from Chinese firm  Shenzhen Bioeasy Biotechnology Co Ltd, but found that results were inaccurate. "	 Na Etats-Unis, bamashine ya kosala ekzame oyo CDC esalaki ezalaki “na mbeba,” yango wana guvernema alongolaki mibeko oyo epekisaki ba laboratoire ya prive basala ba ekzame. Espagne esombaki bamashine ya kosala ba ekzame na kompani moko ya Chine, nkombo na yango Shenzhen Bioeasy Biotechnology Co Ltd, kasi bamonaki ete ba resultat ezalaki ya solo te. 	In the United States, the testing machines developed by the CDC were “defective,” so the government lifted regulations preventing private laboratories from conducting tests. Spain bought testing machines from a Chinese company, Shenzhen Bioeasy Biotechnology Co Ltd, but the results were found to be inaccurate.
1364	en	ln	 The firm explained that the incorrect results may be a result of a failure to collect samples or use the kits correctly. 	 Kompani yango elobaki ete ba resultat ya mabe ekoki kozala mpo bazozwa ba echantillon malamu te to bazosalela machine mabe. 	The company said the poor results could be due to incorrect sampling or misuse of the machine.
1365	en	ln	 The Spanish ministry said it will withdraw the kits that returned incorrect results, and would replace them with a different testing kit provided by Shenzhen Bioeasy.80% of test kits the Czech Republic purchased from China gave wrong results.Slovakia purchased 1.2 million test kits from China which were found to be inaccurate. 	 Ministere ya Espagne elobaki ete ekolongola bamashine oyo ebimisaki ba resultat ya mabe, mpe na esika na yango bakotya bamashine mosusu oyo euti na Shenzhen Bioeasy. 80% ya bamashine ya kosala ba ekzame oyo Republique Tcheque esombaki na Chine epesaki ba resultat ya mabe. Slovaquie esombaki bamashine 1,2 milio ya kosala ba ekzame na Chine kasi ezalaki ya mabe. 	The Spanish ministry said it would scrap the machines that produced negative results, replacing them with machines from Shenzhen Bioeasy. 80% of testing machines purchased from China by the Czech Republic gave negative results. Slovakia bought 1.2 million testing machines from China but they were substandard.
1366	en	ln	" Prime Minister Matovič suggested these be dumped into the Danube.Ateş Kara of the Turkish Health Ministry said the test kits Turkey purchased from China had a ""high error rate"" and did not ""put them into use.""The UK purchased 3.5 million test kits from China but in early April 2020 announced these were not usable. "	 Premier ministre Matovič alobaki ete babwaka yango na Danube. Ates Kara ministre ya kolongono ya nzoto ya Turquie alobaki ete bamashine oyo Turquie esombaki na Chine ezalaki ya “mabe makasi” mpe bapesaki yango te “mpo basalela yango.” Royaume-Uni asombaki 3,5 milio ya bamashine ya kosala ba ekzame na Chine kasi na ebandeli ya sanza ya minei 2020 balobaki ete likoki ya kosalela yango ezalaki te. 	Prime Minister Matovič said they threw it into the Danube. Turkish Health Minister Ates Kara said the machines Turkey bought from China were of “extremely bad quality” and were not supplied “for use.” The UK bought 3.5 million testing machines from China but by early April 2020 they were said to be unusable.
1367	en	ln	 Testing, followed with quarantine of those who tested positive and tracing of those with whom the SARS-CoV-2 positive people had had contact, resulted in positive outcomes. 	 Kosala ba ekzame, na nsima kotya na quarantaine ya bato oyo baza na maladi mpe kolandela bato oyo bakutanaki na bato oyo bazali na SARS-COV-2, ebutaki mbuma malamu. 	Testing, followed by quarantine of patients and follow-up of contacts with SARS-COV-2 patients, has yielded positive results.
1368	en	ln	 Researchers working in the Italian town of Vò, the site of the first COVID-19 death in Italy, conducted two rounds of testing on the entire population of about 3,400 people, about ten days apart. 	 Bato basalaka bolukiluki oyo bazosala na engumba Vò na Italie, na esika oyo moto ya liboso akufaki na COVID-19 na Italie, basalaka ba ekzame mbala mibale na bato nyonso pene ya 3 400, na eleko ya mikolo pene na zomi. 	The researchers in the Italian city of Vò, the site of Italy&#39;s first COVID-19 death, tested a total of about 3,400 people twice over a period of about ten days.
1369	en	ln	 About half the people testing positive had no symptoms, and all discovered cases were quarantined. 	 Pene ya katikati ya bato bazalaki te na bilembo ya maladi, mpe bato nyonso oyo bakangaki bango na maladi, batyaki bango na quarantaine. 	About half of the population had no symptoms, and all those caught infected were quarantined.
1370	en	ln	 With travel to the commune restricted, this eliminated new infections completely. 	 Lokolo bapekisaki mobembo na esika wana, esalaki ete bato mosusu bazwa te maladi wana ata moke. 	The ban on travel in the area prevented others from contracting the disease at all.
1371	en	ln	 With aggressive contact tracing, inbound travel restrictions, testing, and quarantining, the 2020 coronavirus pandemic in Singapore has proceeded much more slowly than in other developed countries, but without extreme restrictions like forced closure of restaurants and retail establishments. 	 Kolandela mpenza bato oyo bakutanaki na bato ya maladi, kopekisa mibembo, kosalisa ba ekzame, mpe kotya bato na quarantaine, coronavirisi 2020 na Singapour epanzanaki malamu koleka na mikili mosusu ya bobola, kasi kozanga bipekiseli ya makasi neti kokanga ba restaurant mpe bisika ya koteka. 	With close contact monitoring, travel restrictions, testing, and quarantine, the 2020 coronavirus in Singapore spread better than in other poor countries, but without strict restrictions such as closing restaurants and shops.
1372	en	ln	 Many events have been cancelled, and Singapore did start advising residents to stay at home on 28 March, but schools reopened on time after holiday break on 23 March. 	 Bakangi ba evenement mingi, mpe Singapour ebandi koyebisa bato bafanda na ndako na mokolo ya 28 sanza ya misato, kasi biteyelo bafungolaki na ntango ya feti ya mokolo ya 23 sanza ya misato. 	Many events have been cancelled, and Singapore has started telling people to stay home on March 28, but schools opened during the March 23 holiday.
1373	en	ln	 Several other countries have also managed the pandemic with aggressive contact tracing, inbound travel restrictions, testing, and quarantining, but with less aggressive lock-downs, such as Iceland and South Korea. 	 Mikili mingi mosusu basalaka mpe makambo na makasi mpo na kobundisa maladi mabe oyo, balandelaki bato oyo bakutanaka na bato ya maladi, bapekisaki bato na kosala mibembo, basalaki ba ekzame, mpe batyaki bato na quarantaine kasi basusu basalaka te makambo na makasi na ndakisa Islande na Coree ya sude. 	Many other countries have also taken aggressive measures to combat the disease, monitoring contacts, travel restrictions, testing, and quarantine but others do not take aggressive measures such as Iceland South Coree.
1374	en	ln	 A statistical study has found that countries that have tested more, relative to the number of deaths, have much lower case fatality rates, probably because these countries are better able to detect those with only mild or no symptoms. 	 Bolukiluki oyo etaleli bansango emonaki ete mikili oyo esalisaka ba ekzame mingi, na oyo etali motango ya bato bakufi, bato mingi te bakufaki, mbala mosusu mikili wana bazalaki na makoki ya komona bato oyo bazalaki na bilembo ya moke to bazalaki na yango te. 	News-based research found that countries with higher screening rates, in terms of mortality rates, had fewer deaths, perhaps because those countries were able to identify people with mild or no symptoms.
1375	en	ln	 WHO recommends that countries that do not have testing capacity and national laboratories with limited experience on COVID-19 send their first five positives and the first ten negative COVID-19 samples to one of the 16 WHO reference laboratories for confirmatory testing. 	 OMS elobi ete mikili oyo eza na makoki ya kosala ba ekzame mpe balaboratoire ya leta oyo eyebi malamu te COVID-19 batinda ba resultat ya liboso ya bato ya maladi mpe ba resultat zomi ya liboso ya bato oyo bamoni ete baza te na COVID-19 na moko ya balaboratoire 16 oyo OMS endimaka mpo batalela yango lisusu. 	The WHO says countries with testing capacity and public laboratories that are not familiar with COVID-19 should send the first results of patients and the first ten results of people who test negative for COVID-19 to one of 16 WHO-approved laboratories for review.
1376	en	ln	 Out of the 16 reference laboratories, 7 are in Asia, 5 in Europe, 2 in Africa, 1 in North America and 1 in Australia. 	 Na kati ya balaboratoire 16 oyo endimama, 7 ezali na Asie, 5 na Eropa, 2 na Afrika, 1 na Amerique ya norde mpe 1 na Australie. 	Of the 16 accredited laboratories, 7 are located in Asia, 5 in Europe, 2 in Africa, 1 in North America and 1 in Australia.
1377	en	ln	 In the following chart, the column “Positive as % of tests” is influenced by the country's testing policy. 	 Na tableau elandi, molongo “% ya bato bakangi na maladi” esalemi na kolanda bibongiseli ya mokili wana ezwi mpo na kosala ba ekzame. 	In the next table, the rank “% of people infected” is based on the organizations in the world that take to testing.
1378	en	ln	 A country that only tests people admitted to hospitals will have a higher positive as % of tests than a country that tests all citizens, whether or not they are showing symptoms, other things being equal. 	 Mokili oyo ezosalisa ekzame kaka na bato oyo bakoti lopitalo ekozala na % ya mingi ya bato oyo bakangi na maladi koleka mikili oyo ezosalisa bato nyonso ekzame, eza baza na bilembo to baza na yango te. 	A country that tests only hospitalized people will have a higher % of infections than countries that test everyone, whether they have symptoms or not.
1379	en	ln	 Hand washing (or handwashing), also known as hand hygiene, is the act of cleaning one's hands for the purpose of removing soil, grease, microorganisms, or other unwanted substances. 	Kosokola maboko, oyo babengi mpe bopeto ya maboko, ezali kopetola maboko mpo na kolongola mabele, mafuta, mikrobe, mpe mbindo mosusu.	Hand washing, also called hand hygiene, is the cleaning of hands to remove dirt, grease, germs, and other contaminants.
1380	en	ln	" Hand washing with soap consistently at certain ""critical moments"" during the day prevents the spread of many diseases, for example diarrhoea and cholera, which are transmitted through fecal–oral route. "	Kosokola maboko na sabuni mbala mingi na bantango “mosusu ya ntina” na mokolo ekangaka maladi nzela epanzana te na bato mingi, na ndakisa pulupulu, oyo eutaka na nyei mpe epesamaka na monoko.	Washing hands with soap often at “essential” times of the day prevents diseases from spreading to many people, such as measles, which is caused by saliva and is transmitted orally.
1381	en	ln	 People can also become infected with respiratory diseases such as influenza or the common cold, for example, if they do not wash their hands before touching their eyes, nose, or mouth (i.e., mucous membranes). 	Bato bakoki mpe kokoma na maladi ya kopema lokola grippe to maladi ya malili, na ndakisa, soki bazali kosokola maboko te liboso ya kosimba miso, zolo, to monoko (na ndakisa bisika oyo mayi ya nzoto elekaka).	People can also become infected with respiratory illnesses such as the flu or colds, for example, if they don’t wash their hands before touching their eyes, nose, or mouth (such as bodily fluid passages).
1382	en	ln	 The five critical moments during the day where washing hands with soap is important include: before and after defecation, after cleaning a child's bottom or changing nappies, before feeding a child, before eating and before and after preparing food or handling raw meat, fish, or poultry. 	Bangonga mitano ya ntina mingi na mokolo ntango oyo kosokola maboko na sabuni ezali ntina ezali: liboso mpe nsima ya kosumba, nsima ya kopetola masoko ya mwana to kolongola kush, liboso ya koleisa mwana, liboso ya kolya mpe nsima ya kolamba bilei to kosimba mosuni ya mobesu, mbisi, to soso.	The five most important hours of the day when washing hands with soap is important are: before and after shopping, after cleaning the baby&#39;s mouth or removing kush, before feeding the baby, before eating and after cooking food or handling meat a mouse, a fish, or a mouse.
1383	en	ln	 If water and soap are not available, hands can be cleaned with ash.The World Health Organization recommends washing hands: 	Soki mai na sabuni ezali te, okoki kopetola maboko na putulu. Organisation mondiale ya Sante elendisi kosokola maboko:	If soap and water are not available, you can clean your hands with dust. The World Health Organization recommends hand washing:
1384	en	ln	 Before, during, and after preparing food. 	Liboso ya kolamba bilei, ntango ozali kolamba mpe na nsima.	Before, during and after preparing food.
1385	en	ln	 Before and after caring for a sick person. 	Liboso mpe nsima ya kosalisa moto ya maladi.	Before and after treatment of the patient.
1386	en	ln	 After changing the diapers or cleaning up a child who has used the toilet. 	Nsima ya kolongola mpe kolatisa mwana kush to kosokola mwana oyo auti na wese.	After removing and dressing the baby kush or washing the baby from the wese.
1387	en	ln	 After blowing your nose, coughing or sneezing. 	Nsima ya kosimba zolo, kokosola, to kosala itche.	After touching the nose, coughing, or itching.
1388	en	ln	 After touching animal, animal feed, or animal waste. 	Nsima ya kosimba banyama, bilei ya banyama, to bosoto ya banyama.	After handling animals, animal feed, or animal waste.
1389	en	ln	 Medical hand hygiene refers to hygiene practices related to medical procedures. 	Bopeto ya maboko mpo na minganga ezali kotalela makambo ya bopeto na ntango ya kosala mosala ya monganga.	Hand hygiene for physicians addresses aspects of hygiene during the practice of medicine.
1390	en	ln	 Hand washing before administering medicine or medical care can prevent or minimize the spread of disease. 	Kosokola maboko liboso ya kopesa nkisi to ya kasalisa moto ya maladi ekoki kokanga maladi nzela epanzana te to epanzana mingi te.	Washing hands before administering medicine or treating a patient can prevent the disease from spreading or spreading more.
1391	en	ln	 The main medical purpose of washing hands is to cleanse the hands of pathogens (bacteria, viruses, or other microorganisms that can cause disease) and chemicals which can cause harm or diseases. 	Ntina ya makasi ya kosokola maboko mpo na minganga ezali mpona kolongola biloko mabe (mikrobe, bavirisi, to bamikrobe misusu ya moke oyo ekoki kopesa maladi) mpe biloko mosusu oyo ekoki kosala biso mabe to kopesa maladi.	The main purpose of hand washing for doctors is to remove harmful substances (germs, viruses, or other microorganisms that can cause disease) and other substances that can harm or cause disease.
1392	en	ln	 This is especially important for people who handle food or work in the medical field, but also an important practice for the general public. 	Eza ntina mingi mpo na bato oyo basimbaka bilei to basalaka mosala ya monganga, kasi ezali mpe ntina mpona bato nyonso.	It is especially important for people who handle food or work as a doctor, but it is also important for everyone.
1393	en	ln	 Hand washing has many health benefits, including minimizing the spread of influenza, coronavirus, and other infectious diseases; preventing infectious causes of diarrhea; decreasing respiratory infections; 	Kosokola maboko ezali na matomba ebele ya malamu mpona kolongono ya nzoto, na ndakisa kokitisa kopalangana ya grippe, ya coronavirisi, mpe ya maladi mosusu; kokanga nzela na biloko ememaka pulupulu; mpe kokitisa maladi ya mpema;	Hand washing has many health benefits, such as reducing the spread of the flu, coronavirus, and other diseases; blocking the road to objects that carry pneumonia; and reduce respiratory disease;
1394	en	ln	 and reducing infant mortality rate at home birth deliveries. 	mpe kokitisa motango ya liwa ya bana ya mike oyo babotamaka na ndako.	and reducing infant mortality at home.
1395	en	ln	 A 2013 study showed that improved hand washing practices may lead to small improvements in the length growth in children under five years of age. 	Na 2013 bolukiluki moko oyo emonisaki ete ezaleli ya kosokola maboko ekoki kobongola mwa moke bokoli ya bana oyo bakokisi naino te mbula 5.	In 2013 a study that found that hand washing behavior can slightly alter the development of children under 5 years of age.
1396	en	ln	 In developing countries, childhood mortality rates related to respiratory and diarrheal diseases can be reduced by introducing simple behavioral changes, such as hand washing with soap. 	Na mikili ya bobola, motango ya liwa ya bana oyo bakufaka na maladi ya mpema mpe na pulupulu ekoki kokita kaka soki tobongoli bizaleli, na ndakisa kosokola maboko na sabuni.	In poor countries, child mortality from respiratory diseases and pneumonia can be reduced only by changing behaviors, such as washing hands with soap.
1397	en	ln	 This simple action can reduce the rate of mortality from these diseases by almost 50%. 	Likambo oyo ya moke ekoki kokitisa motango ya liwa ya bana na maladi oyo na pene ya 50%.	This small step can reduce the child mortality rate in this disease by about 50%.
1398	en	ln	 Interventions that promote hand washing can reduce diarrhoea episodes by about a third, and this is comparable to providing clean water in low income areas. 	Misala oyo ezali kolendisa kosokola maboko ekoki kokotisa maladi ya pulupulu mbala misato, mpe ezali ntina ndenge moko na kopesa mai ya peto na mikili ya bobola.	Practices that promote hand washing can triple the risk of tuberculosis, and are equally important as providing clean water in poor countries.
1399	en	ln	 48% of reductions in diarrhoea episodes can be associated with hand washing with soap.Hand washing with soap is the single most effective and inexpensive way to prevent diarrhea and acute respiratory infections (ARI), as automatic behavior performed in homes, schools, and communities worldwide. 	48% ya kokita ya maladi ya pulupulu ekoki kouta na kosokola maboko na sabuni. Kosokola maboko na sabuni lolenge ya pete koleka mpe ya ntalo mingi te ya kokanga nzela na maladi neti pulupulu mpe maladi ya mpema (ARI), ezali ezaleli ya ntina oyo tosengeli kozala na yango na bandako, na biteyelo, mpe na bisika nyonso na mokili mobimba.	48% of the reduction in pneumonia can be attributed to washing hands with soap. Washing hands with soap is the easiest and cheapest way to prevent diseases such as pneumonia and respiratory infections (ARI), and is an important habit to have in homes, schools, and everywhere around the world . . . .
1400	en	ln	 Pneumonia, a major ARI, is the number one cause of mortality among children under five years old, taking the lives of an estimated 1.8 million children per year. 	Pneumonie maladi makasi ya ARI, ezali maladi ya liboso oyo ebomaka bana mingi oyo bazali na mbu nse ya mitano, ebomaka bana pene ya 1.8 milio mbula nyonso.	ARI pneumonia is the leading cause of death among children in the sea, killing nearly 1.8 million children each year.
1401	en	ln	 Diarrhea and pneumonia together account for almost 3.5 million child deaths annually. 	Pulupulu na pneumonie ebomaka bana pene ya 3,5 milio mbula nyonso.	Measles and pneumonia kill about 3.5 million children each year.
1402	en	ln	 According to UNICEF, turning hand washing with soap before eating and after using the toilet into an ingrained habit can save more lives than any single vaccine or medical intervention, cutting deaths from diarrhea by almost half and deaths from acute respiratory infections by one-quarter. 	UNICEF alobi ete, kokomisa kosokola maboko na sabuni liboso ya kolya mpe nsima ya kouta na wese bizaleli ya kati na biso ekoki kobikisa bato mingi koleka mangwele to nkisi nyonso, ekokitisa motango ya bato bazali kokufa na pulupulu na katikati mpe bato bazali kokufa na maladi makasi ya mpema na ndambo moko na kati ya minei.	According to UNICEF, making washing hands with soap before meals and after going to bed a habit of ours could save more lives than any vaccine or medicine, halve the number of deaths from pneumonia and deaths from serious illnesses of breath in one-fourth.
1403	en	ln	 Hand washing is usually integrated together with other sanitation interventions as part of water, sanitation and hygiene (WASH) programmes. 	Kosokola maboko ezalaka mingimingi elongo na baprograme mosusu ya kosalela mai, kopetola mpe kolongono ya nzoto (KOSOKOLA).	Hand washing is usually accompanied by other water use, sanitation and hygiene programs (WASHING).
1404	en	ln	 Hand washing also protects against impetigo which is transmitted through direct physical contact. 	Kosokola maboko ebatelaka mpe na impetigo oyo epesamaka soki bato basimbani.	Hand washing also protects against contact-transmitted impetigo.
1405	en	ln	 A small detrimental effect of hand washing is that frequent hand washing can lead to skin damage due to drying of the skin. 	Mabe moko kaka ya kosokola maboko ezali ete kosokola maboko mbala mingi ekoki kobebisa mposo ya nzoto mpe ekoki kokausa yango.	The only downside to hand scrubbing is that frequent hand scrubbing can damage the skin and dry it out.
1406	en	ln	 A 2012 Danish study found that excessive hand washing can lead to an itchy, flaky skin condition known as hand eczema or hand dermatitis, which is especially common among health-care workers. 	Bolukiluki moko ya Danemark ya 2012 emonaki ete kolekisa ndelo na kosokola maboko ekoki kopesa mokosa, kolongola bamposo na maboko oyo ebengami eczema to dermatite ya maboko, oyo ekomelaka mingi minganga.	A 2012 Danish study found that excessive hand washing can cause a skin rash called eczema or hand dermatitis, which is commonly prescribed by doctors.
1407	en	ln	 Too frequent hand washing is also seen as one of the symptoms of obsessive-compulsive disorder (OCD). 	Kosokola maboko koleka ndelo ezali mpe moko ya bilembo ya maladi ebengami maladi ya likama ya motungisi (OCD).	Excessive hand washing is also one of the symptoms of obsessive-compulsive disorder (OCD).
1408	en	ln	 There are five critical times during the day where washing hands with soap is important to reduce fecal-oral transmission of disease: after using the bathroom (urination, defecation), after cleaning a child's bottom (changing nappies), before feeding a child, before eating and before/after preparing food or handling raw meat, fish, or poultry. 	Ezali na bantango mitano ya ntina na moko oyo kosokola maboko na sabuni ezali ntina mingi mpo na kokitisa motango ya kopesa maladi longwa na nyei ekota na monoko: nsima ya kouta na wese (kosuba, kosumba), nsima ya kosokola mwana masoko (kolongola mpe kolatisa kush), liboso ya koleisa mwana, liboso ya kolya mpe liboso/nsima ya kolamba bilei to ya kosimba mosuni ya mobesu, to soso.	There are five important times in one when washing hands with soap is critical to reducing the rate of transmission from saliva into the mouth: after coming out of the toilet (washing, rinsing), after washing the baby’s genitals (removing and dressing). kush), before feeding, before meals and before/after cooking food or handling raw meat, or rat.
1409	en	ln	 Other occasions when correct handwashing technique should be practiced in order to prevent the transmission of disease include before and after treating a cut or wound; after sneezing, coughing, or blowing your nose; after touching animal waste or handling animals; and after touching garbage. 	Mabaku mosusu ntango oyo kosokola maboko malamu esengeli kozala ezaleli mpo na kokanga maladi nzela ya kopanzana ezali kosokola maboko liboso mpe nsima ya kosalisa mpota; nsima ya kosala itye, ya kokosola, ya kosimba zolo; nsima ya kosimba bosoto ya banyama to ya kosimba banyama; mpe nsima ya kosimba bosoto.	Other occasions when proper hand washing should be a habit to arrest the spread of disease are hand washing before and after wound treatment; after making itye, of coughing, of touching the nose; after handling animal waste or handling animals; and after handling dirt.
1410	en	ln	 In many countries, there is a low rate of hand washing with soap. 	Na mikili mingi, bato mingi te basokolaka maboko na sabuni.	In many countries, few people wash their hands with soap.
1411	en	ln	 A study of hand washing in 54 countries in 2015 found that on average, 38.7% of households practiced hand washing with soap.A 2014 study showed that Saudi Arabia had the highest rate of 97 percent; the United States near the middle with 77 percent; and China with the lowest rate of 23 percent.Several behaviour change methodologies now exist to increase uptake of the behaviour of hand washing with soap at the critical times.Group hand washing for school children at set times of the day is one option in developing countries to engrain hand washing in children's behaviors. 	Bolukiluki moko na ntina ya kosokola maboko oyo esalemaki na mikili 54 na 2015 emonisi ete, bandako 38,7% basokolaka maboko na sabuni. Na 2014 bolukiluki moko emonisaki ete Arabie Saudite eza na motango makasi 97 pourcent; États-Unis ezalaki pene ya kati na 77 pourcent; mpe Chine na nse makasi na 23 pourcent. Misala mingi ezali lelo oyo ebongoli bizaleli ya kosokola maboko na mai mpe sabuni na bantango ya ntina. Kosokola maboko elongo moko mpo na bana ya kelasi na bangonga oyo etyama na mokolo ezali likanisi moko na mikili ya bobola mpo na kokotisa yango na bizaleli ya bana.	A survey on hand washing conducted in 54 countries in 2015 found that 38.7% of households wash their hands with soap. In 2014 a survey found that Saudi Arabia has a whopping 97 percent; The United States was near the middle at 77 percent; and China sharply down at 23 percent. Several practices exist today that change hand washing behaviors with soap and water at critical times. Washing hands together for school children at set times of the day is an idea in developing countries to instill in children&#39;s behaviour.
1412	en	ln	" The ""Essential Health Care Program"" implemented by the Department of Education in the Philippines is an example of at scale action to promote children's health and education. "	“Programe ya Ntina mpo na Kolongono ya Nzoto” oyo emekamaki Minstere ya Mateya ya Philippines eza ndakisa ya misala mpona kokolisa kolongono ya nzoto ya bana mpe kotanga na bango.	The “Essential Health Program” piloted by the Philippine Ministry of Education is an example of activities to promote children&#39;s health and education.
1413	en	ln	 Deworming twice a year, supplemented with washing hands daily with soap, brushing teeth daily with fluoride, is at the core of this national program. 	Kolongola misopo mbala mibale na mbula, elongo moko na kosokola maboko mikolo nyonso na sabuni, kosokola mino mikolo nyonso na nkisi ya mino, ezali makambo ya ntina mingi ya programe ya mboka.	Twice-yearly defecation, along with daily hand washing with soap, daily toothpaste brushing, are the most important aspects of the village program.
1414	en	ln	 It has also been successfully implemented in Indonesia. 	Basi basalela yango na Indonésie mpe ebimisa mbuma kitoko.	It has been used in Indonesia with wonderful results.
1415	en	ln	 Removal of microorganisms from skin is enhanced by the addition of soaps or detergents to water. 	Kolongola mikrobe na mposo ya nzoto esalemaka malamu soki babakisa kosalela sabuni to nkisi ya koboma mikrobe na mai.	Skin decontamination is best accomplished by supplementing the use of soap or water disinfectant.
1416	en	ln	 The main action of soaps and detergents is to reduce barriers to solution, and increase solubility. 	Mosala makasi ya sabuni mpe bankisi ya bopeto ezali mpona kofungola nzela ya kosalisa, mpe komatisa makasi na yango.	The power of soaps and cleaning products is to open the way for treatment, and increase its effectiveness.
1417	en	ln	 Water alone is an inefficient skin cleanser because fats and proteins, which are components of organic soil, are not readily dissolved in water. 	Kaka mai mpe ekoki kopetola malamu mposo ya nzoto mpo mafuta na baproteine, oyo bazali ya mabele, mai ekokaka te koboma yango na kati ya mayi.	Only water can also cleanse the skin effectively because oils and proteins, which are earthy, cannot be killed by water in water.
1418	en	ln	 Cleansing is, however, aided by a reasonable flow of water.. 	Kasi, kopetolama esalemaka malamu soki babakiseli yango mai oyo ekoki.	Cleaning, however, is best accomplished when sufficient water is added.
1419	en	ln	 Solid soap, because of its reusable nature, may hold bacteria acquired from previous uses. 	Sabuni ya makasi, mpo bakoki kosalela yango lisusu, ekoki kozala na mikrobe euti na bato basalelaki yango liboso.	Hard soap, because it can be reused, can contain germs from previous users.
1420	en	ln	 A small number of studies which have looked at the bacterial transfer from contaminated solid soap have concluded transfer is unlikely as the bacteria are rinsed off with the foam. 	Mwa ndambo ya bolukiluki oyo esalemaki mpo na komona ndenge sabuni ya makasi elekisaka mikrobe na bato mosusu elobaki ete ekoki te kopesa mikrobe mpo bapangusaka mikrobe na fulufulu.	Some studies on the transmission of germs from hard soaps have suggested that they are less contagious because they wipe germs off with a slime.
1421	en	ln	" The CDC still states ""liquid soap with hands-free controls for dispensing is preferable"". "	Kasi, CDC elobi ete “sabuni ya mai oyo ezangi esika ya kosimba ezali malamu mingi mpo na kokanga maladi nzela epanzana te.”	However, the CDC says that “contactless liquid soap is the best way to prevent the spread of disease.”
1422	en	ln	 Antibacterial soaps have been heavily promoted to a health-conscious public. 	Bato mingi balobi ete ezali malamu bato oyo bakipaka kolongono ya nzoto basalela sabuni oyo ezali na nkisi ebomaka mikrobe.	Many people recommend that health-conscious people use antiseptic soap.
1423	en	ln	 To date, there is no evidence that using recommended antiseptics or disinfectants selects for antibiotic-resistant organisms in nature. 	Na mokolo ya lelo, eza na elembeli moko te ezali komonisa ete bazali kolendisa bato na kosalela antiseptique to nkisi ya koboma mikrobe oyo bapona mpona koboma mikrobe oyo ya mokili	To date, there is no evidence that the use of antiseptics or disinfectants of choice to kill these global bacteria is being encouraged
1424	en	ln	 However, antibacterial soaps contain common antibacterial agents such as triclosan, which has an extensive list of resistant strains of organisms. 	Kasi, mbala mingi sabuni ezali na nkisi ebomaka mikrobe ezalaka na nkisi ya koboma mikrobe neti triclosan, oyo ezali na mingi ya bamikrobe balendaka na mokili.	However, soaps often contain antibiotics such as triclosan, which contains most of the world&#39;s bacteria.
1425	en	ln	 So, even if antibiotic resistant strains aren't selected for by antibacterial soaps, they might not be as effective as they are marketed to be. 	Yango wana, ata soki ba antibiotique oyo elendaka eponami te na sabuni ezali na nkisi ya koboma mikrobe, ntango mosusu ezalaka makasi te ndenge elibami.	Therefore, even if the antibiotics that are not selected in soap have antimicrobial properties, they are sometimes not as strong as claimed.
1426	en	ln	 Besides the surfactant and skin-protecting agent, the sophisticated formulations may contain acids (acetic acid, ascorbic acid, lactic acid) as pH regulator, antimicrobially active benzoic acid and further skin conditioners (aloe vera, vitamins, menthol, plant extracts).A comprehensive analysis from the University of Oregon School of Public Health indicated that plain soaps are as effective as consumer-grade anti-bacterial soaps containing triclosan in preventing illness and removing bacteria from the hands. 	Longola biloko ya likolo mpe oyo ebatelaka mposo ya nzoto, bankisi ya mindondo ekoki kozala na aside (aside asetique, aside ascrobique, aside lastique) neti ebongiselo ya pH, aside benzoique oyo ebomaka mikrobe, mpe biloko mosusu elembisaka mposo ya nzoto (aloe vera, bavitamine, menthole, biloko euti na banzete). Bolukiluki ya Université ya Oregon ya Kolongono ya nzoto ya bato nyonso emonisi ete sabuni oyo ezali kati na biso esalisaka mingi ndenge moko na sabuni ezali na nkisi ya koboma mikrobe ezalaka na triclosan mpona kobundisa maladi mpe kolongola mikrobe na maboko.	In addition to topical and protective ingredients, complex medications may contain acids (acetic acid, ascrobic acid, rubber acid) such as pH regulators, antibacterial benzoic acid, and other skin softeners (aloe vera, vitamins, menthol, plant extracts). Research by the University of Oregon Public Health shows that the soap in us is as effective as soap containing a disinfectant containing triclosan to fight infection and remove germs from hands.
1427	en	ln	 Hot water that is comfortable for washing hands is not hot enough to kill bacteria. 	Mai ya moto ya kosokola maboko oyo ezali na moto makasi te ebomaka mikrobe te.	Low-temperature hot water for washing hands does not kill germs.
1428	en	ln	 Bacteria grow much faster at body temperature (37 °C). 	Mikrobe ekolaka noki na nzoto oyo ezali na temperature ya (37 °C).	Bacteria grow faster at a body temperature of (37 °C).
1429	en	ln	 However, warm, soapy water is more effective than cold, soapy water at removing natural oils which hold soils and bacteria. 	Kasi, mai ya moto, oyo ezali na sabuni esalisaka mingi kolongola mafuta mpe mabele mpe mikrobe koleka mai ya malili.	However, hot, soapy water is more effective at removing grease and dirt and germs than cold water.
1430	en	ln	 Contrary to popular belief however, scientific studies have shown that using warm water has no effect on reducing the microbial load on hands. 	Kasi na kokesena na makanisi ya bato mingi, bolukiluki ya bato ya siansi emonisi ete kosalela mai ya moto esalisaka te na kolongola mikrobe na maboko.	But contrary to popular belief, scientific research shows that using hot water does not help remove germs from hands.
1431	en	ln	 A hand sanitizer or hand antiseptic is a non-water-based hand hygiene agent. 	Nkisi ya kopetola maboko to antiseptique ya maboko eza nkisi ya kopetola maboko oyo esalelaka mai te.	Hand sanitizer or hand antiseptic is a hand sanitizer that doesn’t use water.
1432	en	ln	 In the late 1990s and early part of the 21st century, alcohol rub non-water-based hand hygiene agents (also known as alcohol-based hand rubs, antiseptic hand rubs, or hand sanitizers) began to gain popularity. 	Na nsuka ya mibu 1990 mpe na ebandeli ya siekle ya 21, nkisi ya kopetola maboko oyo esalelaka mai te (oyo babengaka mpe alcol ya kopetola maboko, antiseptique ya maboko, to nkisi ya maboko, ebandaki kosalelama mingi.	In the late 1990s and early 21st century, non-water hand sanitizers (also called hand sanitizers, hand antiseptics, or hand sanitizers, became popular.
1433	en	ln	 Most are based on isopropyl alcohol or ethanol formulated together with a thickening agent such as Carbomer (polymer of acrylic acid) into a gel, or a humectant such as glycerin into a liquid, or foam for ease of use and to decrease the drying effect of the alcohol. 	Mingi basalaka yango na alcol isopropyle to ethanole elongo na eloko neti Carbomer (polymer ya aside acrylique) na gel, to humectant na ndakisa glycerine na mai, to fulufulu mpo na kosalela yango malamu mpe kolembisa makasi ya kokausa ya alcol.	Most are made with isopropyl alcohol or ethanol along with something like Carbomer (an acrylic acid polymer) in a gel, or a humectant such as glycerin in water, or a solution to make it easier to use and weaken the drying effect of the alcohol.
1434	en	ln	 Adding diluted hydrogen-peroxide increases further  the antimicrobial activity.Hand sanitizers containing a minimum of 60 to 95% alcohol are efficient germ killers. 	Kobakisa hydrogene-peroxide ya maimai ematisaka mosala ya nkisi ebomaka mikrobe. Nkisi ya koboma mikrobe oyo ezali na alcol 60 kino 95% ezali makasi na koboma mikrobe.	The addition of liquid hydrogen-peroxide increases the antimicrobial activity of the drug. Disinfectants containing 60 to 95% alcohol are potent in killing bacteria.
1435	en	ln	 Alcohol rub sanitizers kill bacteria, multi-drug resistant bacteria (MRSA and VRE), tuberculosis, and some viruses (including HIV, herpes, RSV, rhinovirus, vaccinia, influenza, and hepatitis) and fungi. 	Nkisi ya koboma mikrobe ezali na alcol ebomaka mikrobe, mikrobe oyo ekufaka te na nkisi ya mbuma (MRSA mpe VRE), tuberculose, mpe bavirisi mosusu (ata mpe SIDA, herpes, RSV, rhinovirisi, mangwele, grippe mpe hepatite) mpe champignon.	Disinfectants include alcohol kills germs, fruit resistant bacteria (MRSA and VRE), tuberculosis, and other viruses (including AIDS, herpes, RSV, rhinoviruses, vaccines, influenza, and hepatitis) and fungus.
1436	en	ln	 Alcohol rub sanitizers containing 70% alcohol kill 99.97% (3.5 log reduction, similar to 35 decibel reduction) of the bacteria on hands 30 seconds after application and 99.99% to 99.999% (4 to 5 log reduction) of the bacteria on hands 1 minute after application.Hand sanitizers are most effective against bacteria and less effective against some viruses. 	Nkisi ya kopetola maboko oyo ezali na alcol 70% ebomaka 99,97% (ekitisaka log na 3,5, mpe ekotisaka decibel na 35) ya mikrobe na maboko basegonde 30 nsima ya kosalela yango mpe 99,99% kino na 99,999% (ekitisaka log na 4 kino 5) ya mikrobe na maboko miniti 1 nsima ya kosalela yango. Nkisi ya kopetelo maboko ezali makasi mingi na koboma mikrobe kasi ezali makasi te na koboma bavirisi mosusu.	A 70% alcohol hand sanitizer kills 99.97% (reduces the log by 3.5, and introduces a decibel to 35) of germs on hands 30 seconds after use and 99.99% to 99.999% (reduces). log with 4 to 5) of bacteria on hands 1 minute after application. Hand sanitizer is very effective at killing germs but not at killing some viruses.
1437	en	ln	 Alcohol-based hand sanitizers are almost entirely ineffective against norovirus (or Norwalk) type viruses, the most common cause of contagious gastroenteritis.Enough hand antiseptic or alcohol rub must be used to thoroughly wet or cover both hands. 	Nkisi ya kopetola maboko oyo ezali na alcol ekokaka ata moke te bavirisi ebengami norovirisi (to Norwalk), oyo epanzaka mbala mingi mikrobe na misopo. Esengeli kosala antiseptique to alcol ya kosokola maboko na mingi oyo ekopɔlisa mpenza maboko nyonso mibale to ekotonda likolo na yango.	Alcohol-based hand sanitizers are never effective against viruses called norovirus (or Norwalk), which often spread bacteria in the urine. Antiseptic or hand rubbing alcohol should be applied in large quantities that will completely soak both hands or saturated the surface.
1438	en	ln	 The front and back of both hands and between and the ends of all fingers are rubbed for approximately 30 seconds until the liquid, foam or gel is dry. 	Liboso mpe nsima ya maboko nyonso mibale mpe katikati ya maboko mpe kosokola bansuka ya manzaka na basegonde 30 kino mai, fulufulu to gel ekokauka.	Front and back of both hands and middle of hands and scrub ends of sleeves for 30 seconds until water, slurry or gel dries.
1439	en	ln	 Finger tips must be washed well too, rubbing them in both palms.The US Center for Disease Control and Prevention recommends hand washing over hand sanitizer rubs, particularly when hands are visibly dirty. 	Esengaka kosokola mpe nsonge ya manzaka, kokutanisa yango na maboko nyonso mibale. Centre ya États-Unis mpona kolandela maladi mpe kobatela yango elobi ezali malamu mingi kosokola maboko na esika ya kosalela nkisi ya kopetola maboko, mingimingi soki maboko ezali mpenza mbindo.	It requires sewing and the tip of the handle, meeting it with both hands. The US Centers for Disease Control and Prevention says it is better to wash your hands than to use hand sanitizer, especially if your hands are very dirty.
1440	en	ln	 The increasing use of these agents is based on their ease of use and rapid killing activity against micro-organisms; however, they should not serve as a replacement for proper hand washing unless soap and water are unavailable. 	Bato bazali kosalela mingi nkisi ya mai ya kopetola maboko mpo ezali pete na kosalela mpe ebomaka mikrobe noki; kasi, tokoki kosalela yango te na esika ya kosokola maboko malamu na mai, kasi tokosalela yango kaka soki mai na savon ezali te.	Liquid hand sanitizers are increasingly used because they are easy to use and kill germs quickly; however, we cannot use it instead of washing our hands thoroughly with water, but we will use it only when soap and water are not available.
1441	en	ln	 Frequent use of alcohol-based hand sanitizers can cause dry skin unless emollients and/or skin moisturizers are added to the formula. 	Kosalela mbala mingi nkisi ya kopetola maboko ezali na alcol ekoki kokausa mposo ya nzoto longola kaka soki babakisa na kati na yango biloko ekomisaka maboko sembesembe.	Frequent use of alcohol-based hand sanitizer can dry out the skin unless hand conditioning agents are added.
1442	en	ln	 The drying effect of alcohol can be reduced or eliminated by adding glycerin and/or other emollients to the formula. 	Bakoki kolembisa to kolongola makasi ya alcol ya kokausa maboko soki babakisi glycerine mpe/to biloko mosusu oyo ekomisaka maboko sembesembe.	They can weaken or eliminate the alcohol’s severity of hand drying by adding glycerin and/or other smoothing agents.
1443	en	ln	 In clinical trials, alcohol-based hand sanitizers containing emollients caused substantially less skin irritation and dryness than soaps or antimicrobial detergents. 	Na ntango ya komeka mangwele na bato, bankisi ya kopetola maboko esalemi na alcol oyo ezali na biloko ekomisaka maboko pete, esalaki mokusa moke na mposo ya nzoto mpe ekausaki maboko mingi te neti basavon to bankisi oyo ebomaka mikrobe.	During human trials, alcohol-based hand sanitizers contained softening agents, caused less dryness in the skin and did not dry the hands as much as soaps or disinfectants.
1444	en	ln	 Allergic contact dermatitis, contact urticaria syndrome or hypersensitivity to alcohol or additives present in alcohol hand rubs rarely occur. 	Mbala mingi mposo ya nzoto ekomaki te motane, ebimisaki te bambuma mpe eboyaki te bankisi esalemi na alcol to oyo batyaki bilangwiseli mosusu.	The skin often did not turn red, rash, or resist alcohol-based or drug-based medications.
1445	en	ln	 The lower tendency to induce irritant contact dermatitis became an attraction as compared to soap and water hand washing. 	Bato bakomaki kosepela mingi na kosalela bankisi oyo ekomisaka te mposo ya nzoto motane kasi te sabuni na mai mpo na kosokola maboko.	People became more interested in using anti-tank products but not soap and water for hand washing.
1446	en	ln	 Despite their effectiveness, non-water agents do not cleanse the hands of organic material, but simply disinfect them. 	Ata ezali makasi, bankisi ya kopela maboko oyo ezali na mai elongolaka te na maboko na biloko ya organique, kasi epetolaka yango kaka.	Even though they’re strong, wet hand sanitizers don’t manually strip the hands of organics, but still clean them.
1447	en	ln	 It is for this reason that hand sanitizers are not as effective as soap and water at preventing the spread of many pathogens, since the pathogens still remain on the hands. 	Yango wana bankisi ya kopetola maboko ezali kosalisama mingi te soki tokokanisi yango na sabuni mpe mai mpo na kokanga mikrobe mingi nzela epanzana te, mpo mikrobe etikalaka na maboko.	That is why hand sanitizers are less effective than soap and water to prevent more germs from spreading, as germs remain on the hands.
1448	en	ln	 Alcohol-free hand sanitizer efficacy is heavily dependent on the ingredients and formulation, and historically has significantly under-performed alcohol and alcohol rubs. 	Makasi ya bankisi ya kopetola maboko ezangi alcol eutaka mingi na biloko babakisaka na kati mpe na ndenge basalaka yango, mpe emonani ete eleki te nkisi ezali na alcol mpe oyo ezali na ntuku nsambo ya alcol.	The strength of alcohol-free hand sanitizers is largely derived from the additives and formulation, and does not appear to be superior to alcohol-based and seventy-alcohol medications.
1449	en	ln	 More recently, formulations that use benzalkonium chloride have been shown to have persistent and cumulative antimicrobial activity after application, unlike alcohol, which has been shown to decrease in efficacy after repeated use, probably due to progressive adverse skin reactions. 	Kala mingi te, bankisi oyo batyaka chlorure ya benzalkonium ezalaki koboma mpenza mikrobe nsima ya kopakola yango, na bokeseni na alcol, oyo emonanaki ete makasi na yango esilaka soki basaleli yango mingi, mbala mosusu mpo ezalaka na ba matoma mingi na mposo ya nzoto.	Until recently, benzalkonium chloride sprays were highly antibacterial after application, unlike alcohol, which was found to lose its potency with excessive use, perhaps because of its high porosity in the skin.
1450	en	ln	 Many people in low-income communities cannot afford soap and use ash or soil instead. 	Na bisika ya bobola, bato bakoki kosomba sabuni mpe kosalela putulu to mabele na esika na yango.	In poor areas, people can buy soap and use dust or dirt instead.
1451	en	ln	 Ash or soil may be more effective than water alone, but may be less effective than soap. 	Putulu to mabele ekoki kozala makasi mingi koleka mai yango moko, kasi ezali makasi te neti sabuni.	Dust or soil may be much harder than water itself, but it is not as hard as soap.
1452	en	ln	 One concern is that if the soil or ash is contaminated with microorganisms it may increase the spread of disease rather than decrease it. 	Eloko moko ezali kotungisa ezali ete soki mabele to putulu ezali na mikrobe ekoki kosala maladi epanzana mingi na esika ya kokanga yango nzela epanzana mingi te.	One concern is that contaminated soil or dust can increase the spread of disease rather than prevent it from spreading.
1453	en	ln	 Like soap, ash is also a disinfecting agent because in contact with water, it forms an alkaline solution. 	Neti sabuni, putulu ezali mpe epetolaka mpo soki esangani na mai, esalaka solution ya alkaline.	Like soap, dust is also cleaning because when mixed with water, it forms an alkaline solution.
1454	en	ln	 WHO recommended ash or sand as alternative to soap when soap is not available. 	OMS ezali kolendisa kosalela putulu to zelo na esika ya sabuni soki sabuni ezali te.	WHO recommends using dust or sand instead of soap when soap is not available.
1455	en	ln	 Correct handwashing technique recommended by the US Centers for Disease Control  for prevention of transmission of disease includes the following steps: 	Mayele ebongi ya kosokola maboko elendisami na bacentre ya kobatela maladi ya États-Unis mpo kokanga maladi nzela epanzana te ezali oyo elandi:	Proper hand washing techniques recommended by the US Centers for Disease Control to prevent the spread of infection are as follows:
1456	en	ln	 Wet hands with warm or cold running water. 	Kopolisa maboko na mai ya moto to ya malili oyo ezali kotambola.	Polish hands with running hot or cold water.
1457	en	ln	 Running water is recommended because standing basins may be contaminated, while the temperature of the water does not seem to make a difference. 	Balobaki kosalela mai ezali kotambola mpo basani oyo efandi esika moko ekoki kozala na mikrobe, mpe temperature ya mai ezali na ntina moko te.	They said water usage is moving because toys sitting together can be contaminated, and the temperature of the water is of no consequence.
1458	en	ln	 Lather hands by rubbing them with a generous amount of soap, including the backs of hands, between fingers, and under nails. 	Kopolisa maboko na kopakolaka yango sabuni mingi, ata mpe na nsima ya maboko, na kati ya misapi, mpe na nse ya manzaka.	Polish your hands with plenty of soap, including the backs of your hands, between your fingers, and under your arms.
1459	en	ln	 Soap lifts germs from the skin, and studies show that people tend to wash their hands more thoroughly when soap is used rather than water alone. 	Sabuni ebomaka mikrobe na mposo ya nzoto, mpe bolukiluki emonisi ete mbala mingi bato basokolaka maboko malamumalamu mpe ngonga molai soki soki sabuni esalemi aski kasi te soki basaleli mai yango moko.	Soap kills germs on the skin, and research shows that people often wash their hands thoroughly and for long periods of time if the soap is used but not if the water itself is used.
1460	en	ln	 Scrub for at least 20 seconds. 	Pakola sabuni ata mpo na basegonde 20.	Apply soap for at least 20 seconds.
1461	en	ln	 Scrubbing creates friction, which helps remove germs from skin, and scrubbing for longer periods removes more germs. 	Kosala bongo esalisaka na kolongola mikrobe na mposo ya nzoto, mpe kopokola ntango molai ebomaka mikrobe mingi.	This helps to remove germs from the skin, and prolonged scrubbing kills many germs.
1462	en	ln	 Rinse well under running water. 	Pangusa maboko malamu na mai oyo ezali kobima.	Rinse hands thoroughly with running water.
1463	en	ln	 Rinsing in a basin can recontaminate hands. 	Kopangusa na sani ekoki kosala ete maboko ezwa lisusu bamikrobe.	Wiping with a bucket can lead to further infection of the hands.
1464	en	ln	 Dry with a clean towel or allow to air dry. 	Kokausa na elamba ya peto to tika ekauka na mopepe.	Dry with a clean cloth or let air dry.
1465	en	ln	 Wet and moist hands are more easily recontaminated.The most commonly missed areas are the thumb, the wrist, the areas between the fingers, and under fingernails. 	Maboko oyo ezali na mai ezwaka mikrobe noki.Esika oyo mbala mingi esokolamana malamu te ezali mosapi ya monene, poignet, bisika ezali na katikati ya misapi, mpe na nse ya manzaka.	Wet hands are more susceptible to infection.The most common areas that are not washed properly are the thumb, wrist, areas between the fingers, and under the sleeves.
1466	en	ln	 Artificial nails and chipped nail polish may harbor microorganisms. 	Manzaka ya lekuta mpe biloko ya kopangusa manzaka ekoki kozala na mikrobe.	Fake hands and hand wipes can be contaminated.
1467	en	ln	 Moisturizing lotion is often recommended to keep the hands from drying out; dry skin can lead to skin damage which can increase the risk for the transmission of infection. 	Balendisaka mbala mingi kosalela mafuta ya kopakola mpona kosalisa maboko ekauka te; maboko ya kokauka ekoki kobebisa mposo ya nzoto mpe ekoki kosala moto azwa maladi kozanga mpasi.	The use of ointment is often recommended to help prevent dry hands; dry hands can damage the skin and make a person easily infected.
1468	en	ln	" Various low-cost options can be made to facilitate hand washing where tap-water and/or soap is not available e.g. pouring water from a hanging jerrycan or gourd with suitable holes and/or using ash if needed in developing countries.In situations with limited water supply (such as schools or rural areas in developing countries), there are water-conserving solutions, such as ""tippy-taps"" and other low-cost options. "	Mafuta mingi ya kopakola ya ntalo mingi te ekoki kosalelama mpo na kosalisa na kosokola maboko esika mai mpe/to sabuni ezali te na ndakisa kosopa mai longwa na eloko to kopo ezali na likolo mpe ezali na madusu ebongi mpe/to kosalela putulu soki esengeli na mikili ya bobola. Soki mai ezali mingi te (na ndakisa na biteyelo na bamboka na mikili ya bobola), bazali te na makoki ya kobatela mai, na ndakisa “tippy-taps” mpe lolenge mosusu oyo esengaka mbongo mingi te.	Many inexpensive lubricating oils can be used to help wash hands where water and/or soap is not available by for example pouring water from a container or cup with a top and suitable nozzles and/or using dust if required in countries of poverty. When water is scarce (such as in schools in rural areas in developing countries), they do not have the means to conserve water, such as “tippy-taps” and other low-cost methods.
1469	en	ln	 A tippy-tap is a simple technology using a jug suspended by a rope, and a foot-operated lever to pour a small amount of water over the hands and a bar of soap. 	Tippy-tap ezali mayele ya pete ya kosalela mebki oyo batye na likolo mpe bakangi na nsinga, mpe esimbani na nsinga mpona kosopa mwa mai na likolo ya maboko mpe sabuni.	A tippy-tap is a simple technique of using a tablecloth placed on top and tied to a rope, and connected to a rope to pour some water and soap on the hands.
1470	en	ln	 Effective drying of the hands is an essential part of the hand hygiene process, but there is some debate over the most effective form of drying in public washrooms. 	Kokausa maboko malamu ezali na ntina mingi mpo na kolongono ya nzoto, kasi ntembe ezali mingi na oyo etali lolenge ya malamu ya kokausa maboko na bawese ya bato mingi.	Proper hand drying is essential for good health, but there is much controversy about the best way to dry hands in many communities.
1471	en	ln	 A growing volume of research suggests paper towels are much more hygienic than the electric hand dryers found in many washrooms. 	Bolukiluki mingi ezali kosalisa ete elamba ya kosokola maboko ezali malamu mingi koleka machine ya kokausa maboko oyo ezalaka na bawese mingi.	Many studies support that a hand wash cloth is much better than a hand dryer with many devices.
1472	en	ln	 In 2008, a study was conducted by the University of Westminster, London, and sponsored by the paper-towel industry the European Tissue Symposium, to compare the levels of hygiene offered by paper towels, warm-air hand dryers and the more modern jet-air hand dryers. 	Na 2008, bolukiluki moke esalemaki na Université Westminster, na Londres, mpe oyo mosolo na yango eutaka na kompani European Tissue Symposium, oyo esalaka elamba ya kokausa maboko, mpona kososola bokeseni ya bilamba ya kokausa maboko, machine ya kokausa maboko mpe machine ya sika ya kokausa maboko.	In 2008, a small study was conducted at the University of Westminster, London, and funded by the European Tissue Symposium, a hand dryer, to understand the differences between hand dryers, hand dryers and new dry hands.
1473	en	ln	 After washing and drying hands with the warm-air dryer, the total number of bacteria was found to increase on average on the finger pads by 194% and on the palms by 254%. 	Nsima ya kosokola mpe kokausa maboko na machine ya kokausa maboko, motango ya mikrobe emataki na misapi na 194% mpe na maboko na 254%.	After washing and drying hands in a hand dryer, bacteria counts rose on fingers by 194% and hands by 254%.
1474	en	ln	 Drying with the jet-air dryer resulted in an increase on average of the total number of bacteria on the finger pads by 42% and on the palms by 15%. 	Nsima ya kosokola mpe kokausa maboko na machine ya kokausa maboko, motango ya mikrobe emataki na misapi na 42% mpe na maboko na 15%.	After washing and drying hands in a hand dryer, bacteria counts rose on fingers by 42% and hands by 15%.
1475	en	ln	 After washing and drying hands with a paper towel, the total number of bacteria was reduced on average on the finger pads by up to 76% and on the palms by up to 77%.The scientists also carried out tests to establish whether there was the potential for cross contamination of other washroom users and the washroom environment as a result of each type of drying method. 	Nsima ya kosokola mpe kokausa maboko na elamba ya kokausa maboko, motango ya mikrobe ekitaki, na misapi ekomaka 76% mpe na maboko ekomaki 77%. Bato ya siansi basalaki mpe baekzame mpona koyeba soki ete bato oyo bazalaki kosalela bawese mpe kati ya bawese epanzaki mikrobe nsima ya bandenge mingi ya kokausa maboko.	After washing and drying the hands with a hand drying cloth, the bacterial count decreased, reaching 76% on the fingers and 77% on the hands. Scientists also tested whether people who used and inside the towels spread germs after several types of hand drying.
1476	en	ln	 The jet-air dryer, which blows air out of the unit at claimed speeds of 180 m/s (650 km/h; 400 mph), was capable of blowing micro-organisms from the hands and the unit and potentially contaminating other washroom users and the washroom environment up to 2 metres away. 	Machine ya kokausa maboko, oyo ebimisaka mopepe na vitese ya 180 m/s (650 km/h; 400 mph), ekokaki kontinda bamikrobe ya mike na maboko na bisika kati na wese mpe kosimba bato misusu kati ya wese na molai ya 2 metele.	The hand dryer, which produces air at a speed of 180 m/s (650 km/h; 400 mph), could send tiny germs by hand into the spaces between the sewers and touch other people in the sewer up to 2 meters high.
1477	en	ln	 Use of a warm-air hand dryer spread micro-organisms up to 0.25 metres from the dryer. 	Kosalela machine ya kokausa maboko epanzaka bamikrobe ya mike mosika na 0,25 metele uta esika machine ezali.	Using a hand dryer disperses microorganisms away from 0.25 meters from the machine location.
1478	en	ln	 Paper towels showed no significant spread of micro-organisms.In 2005, in a study conducted by TÜV Produkt und Umwelt, different hand drying methods were evaluated. 	Bilamba ya kokausa maboko elakisaki ata moko ya bamikrobe ya mike epanzanaki. Na 2005, na bolukiuki moko esalemaki na TÜV Produkt und Umwelt, batalelaki bandenge mingi ya kokausa maboko.	Hand drying cloths showed any of the microorganisms had broken out. In 2005, in a research conducted by TÜV Produkt und Umwelt, several methods of hand drying were examined.
1479	en	ln	 The following changes in the bacterial count after drying the hands were observed: 	Bamonaki bokeseni oyo elandi na motango ya mikrobe nsima ya kokausa maboko:	They found the following differences in bacterial counts after hand drying:
1480	en	ln	 Many different hand dryer manufacturers exist, and hand driers have been compared against drying with paper towels. 	Bakompani mingi oyo esalaka bamachine ya kokausa maboko ezali, mpe bakeseni bamachine ya kokausa maboko na bilamba ya kokausa maboko.	Many companies that make hand dryers exist, and they distinguish hand dryers from cloth dryers.
1481	en	ln	 Hand washing using hand sanitizing wipes is an alternative during traveling in the absence of soap and water. 	Kokausa maboko na kosalela bilamba ya kokausa maboko ezali lolenge mosusu ya kokausa maboko na ntango ya mobembo soki sabuni na mai eza te.	Drying hands using hand drying cloths is an alternative way to dry hands during travel if soap and water is not available.
1482	en	ln	 Alcohol-based hand sanitizer should contain at least 60% alcohol. 	Bankisi ya kopetola maboko ya alcol esengeli kozala na 60% ya alcol.	Alcohol hand sanitizers should contain 60% alcohol.
1483	en	ln	 Medical hand-washing became mandatory long after Hungarian physician Ignaz Semmelweis discovered its effectiveness (in 1846) in preventing disease in a hospital environment. 	Bato bakomaki kosalela mingi bankisi ya kosokola maboko ntango mingi nsima ya ntango wana moto moko ya physique ya Hongrois Ignaz Semmelweis amonaki makasi na yango (na 1846) mpona kokanga maladi nzela epanzana te na bisika lopitalo.	Hand sanitizers became widely used long after the Hungarian physicist Ignaz Semmelweis discovered their power (in 1846) to prevent the spread of disease in hospitals.
1484	en	ln	 There are electronic devices that provide feedback to remind hospital staff to wash their hands when they forget. 	Ezali na bamachine mingi oyo ekundwelaka bato ya lepitalo na kosokola maboko soki babosani kosala yango.	There are many machines that remind hospital staff to wash their hands if they forget to do so.
1485	en	ln	 One study has found decreased infection rates with their use. 	Bolukiluki moko emonaki ete motango ya kopanza maladi ekitaki soki bazali kosalela yango.	One study found that the rate of infection decreased with use.
1486	en	ln	 Medical hand-washing is for a minimum of 15 seconds, using generous amounts of soap and water or gel to lather and rub each part of the hands. 	Bankisi ya kosokola maboko ezali mpona basegonde 15, kosalela mai mpe na sabuni mingi to mafuta ya kopakola na bisika nyonso ya loboko.	Hand sanitizers are available for 15 seconds, using water and plenty of soap or oil to apply to all parts of the hand.
1487	en	ln	 Hands should be rubbed together with digits interlocking. 	Esengeli konika maboko elongo moko na kosangisaka yango na kati ya baninga.	The hands should be rubbed together by joining them in partners.
1488	en	ln	 If there is debris under fingernails, a bristle brush may be used to remove it. 	Soki ezali na mbindo na nse ya manzaka, tokoki kosalela mwa eloko mpo na kolongola yango.	If there is dirt under the sleeve, we can use a small amount to remove it.
1489	en	ln	 Since germs may remain in the water on the hands, it is important to rinse well and wipe dry with a clean towel. 	Mpo mikrobe ekoki kotikala na mai na maboko, ezali ntina mingi kolongola mai wana mpe kopangusa yango na elamba ya peto.	Because germs can remain in the hands, it is important to remove the water and wipe it with a clean cloth.
1490	en	ln	 After drying, the paper towel should be used to turn off the water (and open any exit door if necessary). 	Na nsima ya kokausa, esengeli kosalela elamba ya kokausa mpona kokanga mai (mpe kofongola porte ya kobima soki ezali).	After drying, a dry cloth should be used to trap water (and open the exit door if available).
1491	en	ln	 This avoids re-contaminating the hands from those surfaces. 	Yango esalisaka na kopekisa maboko ezwa mikrobe na bisika wana.	This helps prevent hands from getting infected in these areas.
1492	en	ln	" The purpose of hand-washing in the health-care setting is to remove pathogenic microorganisms (""germs"") and avoid transmitting them. "	Mokano ya kosokola maboko na kolongono ya nzoto ezali ya kolongola mbindo (“mikrobe”) mpe kopesa yango te na bato mosusu.	The goal of hygienic hand washing is to remove contaminants (“germs”) and not to pass them on to others.
1493	en	ln	 The New England Journal of Medicine reports that a lack of hand-washing remains at unacceptable levels in most medical environments, with large numbers of doctors and nurses routinely forgetting to wash their hands before touching patients, thus transmitting microorganisms. 	Zulunalu ya Angleterre ya sika oyo elobelaka makambo ya kimonganga elobi ete na balepital bato mingi mpenza bazosokola maboko te, mpe minganga na mafulume mingi babosanaka mbala mingi kosokola maboko liboso ya kosimba bato ya maladi, nde bongo bapesaka bango mikrobe.	The latest British medical journal reports that in hospitals the vast majority of people do not wash their hands, and many doctors and nurses often forget to wash their hands before touching patients, thus passing on germs.
1494	en	ln	 One study showed that proper hand-washing and other simple procedures can decrease the rate of catheter-related bloodstream infections by 66 percent.The World Health Organization has published a sheet demonstrating standard hand-washing and hand-rubbing in health-care sectors. 	Bolukiluki moko emonisaki ete kosokola maboko malamu mpe ndege mosusu ya pete ekoki kokitisa motango ya kopesa bato maladi ya makila na 66%. Organisation Mondiale ya Santé ebimisa mokanda moko ezali na mibeko etali kosokola maboko mpe kopangusa yango mpo na minganga.	One study found that proper hand washing and other simple measures can reduce the incidence of blood-borne diseases by 66%. The World Health Organization has published a document with guidelines on hand washing and drying for doctors.
1495	en	ln	 The draft guidance of hand hygiene by the organization can also be found at its website for public comment. 	Tokoki komona toli ya liboso ya kosokola maboko ya organization mpe ekoki mpe kozwama na siteweb na yango mpona maloba ya bato nyonso.	We can see the organization’s first hand washing advice and can also be found on its website for public comment.
1496	en	ln	 A relevant review was conducted by Whitby et al. 	Whitby na baninga na ye basalaki botaleli ya ntina.	A critical review was conducted by Whitby et al.
1497	en	ln	 Commercial devices can measure and validate hand hygiene, if demonstration of regulatory compliance is required. 	Bamachine oyo batekaka ekoki komeka mpe koloba soki maboko ezali peto, soki lolenge ya bopeto oyo basengi ekoki.	The machines sold can measure and state if the hands are clean, if the requested level of hygiene is sufficient.
1498	en	ln	" The World Health Organization has ""Five Moments"" for washing hands: "	Organisation Mondiale ya Santé eza na “Bangonga Mitano” mpo na kosokola maboko:	The World Health Organization has “Five Hours” for hand washing:
1499	en	ln	 after exposure to blood/body fluids 	nsima ya kosimba makila/mai ya nzoto	after handling blood/body fluids
1500	en	ln	 before an aseptic task, and 	liboso ya kosala mosala oyo ya kobatela maboko na mikrobe, mpe	before doing this hand-proofing exercise, too
1501	en	ln	" after patient care.The addition of antiseptic chemicals to soap (""medicated"" or ""antimicrobial"" soaps) confers killing action to a hand-washing agent. "	nsima ya kosalisa moto ya maladi. Kobakisa antiseptique na sbuni (sabuni “oyo ezali na nkisi” to sabuni “ebomaka mikrobe”) esalisaka nkisi ya kosokola maboko na koboma mikrobe.	after treating the patient. Adding an antiseptic to sbuni (“medicated” soap or “antibacterial” soap) helps the hand sanitizer disinfect.
1502	en	ln	 Such killing action may be desired prior to performing surgery or in settings in which antibiotic-resistant organisms are highly prevalent.To 'scrub' one's hands for a surgical operation, it is necessary to have a tap that can be turned on and off without touching it with the hands, some chlorhexidine or iodine wash, sterile towels for drying the hands after washing, and a sterile brush for scrubbing and another sterile instrument for cleaning under the fingernails. 	Koboma mikrobe ekoki kozala ntina liboso ya kosala lipaso to na bisika oyo mikrobe ezalaka mingi mpenza. ‘Koningisa’ maboko mpo na lipaso, soki ezali ntina ezala na pompe oyo okoki kofungola mai to kokanga esengeli te basimba yango na maboko, mwa chlorhexidine to mai ya iodine, elamba ezangi mikrobe mpo na kokausa maboko nsima ya kosokola yango, mpe linyuka ezangi mikrobe mpona kolongola mbindo mpe eloko mosusu ezangi mikrobe mpona kolongola mbindo na manzaka.	Disinfection may be necessary before surgery or in areas where bacterial infection is very high. &#39;Shake&#39; hands for surgery, if necessary with a pump that you can turn on or off, some chlorhexidine or iodine water, a sterile cloth to dry hands after washing, and a sterile rag to remove dirt and another sterile material to remove dirt from hands.
1503	en	ln	 All jewelry should be removed. 	Esengeli kolongola mayaka nyonso.	All pearls should be removed.
1504	en	ln	 This procedure requires washing the hands and forearms up to the elbow, usually 2–6 minutes. 	Lolende oyo esengeli kosokola maboko mpe liboso ya maboko kino katikati ya loboko, mingimingi na miniti 2-6.	This method should scrub the palms and forearms to the middle of the palm, usually for 2-6 minutes.
1505	en	ln	 Long scrub-times (10 minutes) are not necessary. 	Koweumela na konika (miniti 10) ezali ntina te.	Prolonged grinding (10 minutes) is not necessary.
1506	en	ln	 When rinsing, water on the forearms must be prevented from running back to the hands. 	Ntango ozali kopangusa, oesengeli kokanga nzela mpo mai oyo ezali na liboso ya maboko eleka te na nsima ya maboko.	When wiping, you need to block the water from the front of the hands to the back of the hands.
1507	en	ln	 After hand-washing is completed, the hands are dried with a sterile cloth and a surgical gown is donned. 	Nsima ya kosilisa kosokola maboko, esengeli kokausa maboko na elamba ezangi mikrobe mpe kolata gan ya minganga.	After hand washing is completed, hands should be dried with a sterile cloth and a medical glove should be worn.
1508	en	ln	 To reduce the spread of germs, it is better to wash the hands or use a hand antiseptic before and after tending to a sick person. 	Mpona kokanga mikrobe nzela ekabwana te, ezali malamu na kosokola maboko to kosalela antiseptique ya maboko liboso mpe nsima ya kosalisa moto ya maladi.	To prevent germs from spreading, it is best to wash hands or use hand antiseptic before and after treating the patient.
1509	en	ln	 For control of staphylococcal infections in hospitals, it has been found that the greatest benefit from hand-cleansing came from the first 20% of washing, and that very little additional benefit was gained when hand cleansing frequency was increased beyond 35%. 	Mpona kotalela maladi ya staphylocoque na balepital, emonani ete matomba ya monene ya kosokola maboko eyaki nsima ya kosokola maboko 20% ya liboso, mpe mwa litomba wana ezwamaki ntango bazalaki kosokola maboko na 35%.	For the assessment of staphylococcal infections in hospitals, it appears that the greatest benefits of hand washing came after the first 20% of hands were washed, and this small benefit was found when hands were washed at 35%.
1510	en	ln	 Washing with plain soap results in more than triple the rate of bacterial infectious disease transmitted to food as compared to washing with antibacterial soap.Comparing hand-rubbing with alcohol-based solution with hand washing with antibacterial soap for a median time of 30 seconds each showed that the alcohol hand-rubbing reduced bacterial contamination 26% more than the antibacterial soap. 	Kosokola na sabuni ekolisaka motango ya kopanza mikrobe ya maladi mbala misato na bilei soki tokokanisi yango na kosokola maboko na sabuni oyo ezali na nkisi ya koboma mikrobe. Bokeseni ya kopetola maboko na nkisi oyo ezali na alcol, kosokola maboko na sabuni ezali na nkisi ya koboma mikrobe na basegonde 30 ekitisaka motango ya kopanza mikrobe na 26% koleka soki basabuni ezali na nkisi ya koboma mikrobe.	Washing with soap triples the rate of spreading pathogens in food compared to washing hands with disinfectant soap. A combination of alcohol-based hand sanitizer, hand washing with disinfectant soap for 30 seconds reduces the spread of germs by 26% compared to if the soaps contain disinfectant.
1511	en	ln	 But soap and water is more effective than alcohol-based hand rubs for reducing H1N1 influenza A virus and Clostridium difficile spores from hands.Interventions to improve hand hygiene in healthcare settings can involve education for staff on hand washing, increasing the availability of alcohol-based hand rub, and written and verbal reminders to staff. 	Kasi sabuni na mai ezali makasi mingi koleka bankisi oyo ezali na alcol ya kopakola mpona kokotisa virisi A ya grippe H1N1 mpe clostridiume difficile spores na maboko. Milende ya kobongisa mosala kopetola maboko na balopitalo ekoki kosenga koteya bato ya mosala na kosokola maboko, kosala ete bato bazali na bankisi mingi ya kopetola maboko ezali na alcol, mpe makundoli ya kokoma mpe ya monoko na bato ya mosala.	But soap and water are much more effective than alcohol-based sprays at getting H1N1 influenza A virus and Clostridium difficile spores into the hands. Efforts to improve performance hand hygiene in hospitals may involve educating staff in hand hygiene, ensuring availability of most alcohol-based hand sanitizers, and written and verbal reminders to staff.
1512	en	ln	 There is a need for more research into which of these interventions are most effective in different healthcare settings. 	Ezali na bolukiluki mingi mpo na koyeba nini ya mayele oyo ekosalisa na bisika mingi mpo na kolongono ya nzoto.	There is a lot of research into which of these strategies will help in many areas of health.
1513	en	ln	 In developing countries, hand washing with soap is recognized as a cost-effective, essential tool for achieving good health, and even good nutrition. 	Emonani ete na mikili ya bobola, kosokola maboko na sabuni ezali na ntalo malamu, ntina mingi mpo na kozala nzoto kolongono, mpe nkutu ntina mpo na kolya bilei ya malamu.	It turns out that in developing countries, hand washing with soap is affordable, essential to good health, and even essential to a healthy diet.
1514	en	ln	 However, a lack of reliable water supply, soap or hand washing facilities in people's homes, at schools and at the workplace make it a challenge to achieve universal hand washing behaviors. 	Kasi, kozanga mai, sabuni, bisika ya kosokola maboko na ndako, na biteyelo mpe na bisika ya mosala ezali kosala ete ezala mpasi mpo bato nyonso bakoma na ezaleli ya kosokola maboko.	However, the lack of water, soap, hand washing facilities at home, schools and workplaces makes it difficult for everyone to adopt hand washing habits.
1515	en	ln	 For example, in most of rural Africa hand washing taps close to every private or public toilet are scarce, even though cheap options exist to build hand washing stations. 	Na ndakisa, na bamboka mingi ya Afrika bisika ya kosokola maboko pene ya bawese ya bato to ya piblik ezali mingi te, ata ete maponi ya ntalo moke ezali mpona kosala bisika ya kosokola maboko.	For example, in many African countries there are few hand washing facilities near private or public toilets, although there are cheaper options for hand washing facilities.
1516	en	ln	 However, low hand washing rates rather can also be the result of engrained habits rather than due to a lack of soap or water. 	Kasi, kosokola maboko mbala mingi te ekoki kozala ezaleli moko oyo bato bamesana na yango kasi ezali te mpo bazangi sabuni na mai.	However, infrequent hand washing may be a habit but not a lack of soap and water.
1517	en	ln	 The promotion and advocacy of hand washing with soap can influence policy decisions, raise awareness about the benefits of hand washing and lead to long-term behavior change of the population. 	Kotombola mpe kolendisa kosokola maboko na sabuni ekoki kopusa kopona mibeko, pusa maloba ya ntina ya kosokola maboko mpe kosalisa bato babongola mpenza bizaleli na bango.	Promoting and encouraging hand washing with soap can influence policy choices, push key hand-washing slogans and help people radically change their behaviour.
1518	en	ln	 For this to work effectively, monitoring and evaluation are necessary. 	Mpo esalama malamu, kolandela mpe botaleli ezali ntina mingi.	For it to be done properly, monitoring and evaluation is essential.
1519	en	ln	" A systematic review of 70 studies found that community-based approaches are effective at increasing hand washing in LMICs, while social marketing campaigns are less effective.One example for hand washing promotion in schools is the ""Three Star Approach"" by UNICEF that encourages schools to take simple, inexpensive steps to ensure that students wash their hands with soap, among other hygienic requirements. "	"Kotalela bolukiluki 70 emonisaki ete kolendisa ezaleli ya kosokola maboko na bamboka ezali ntina mingi na LMICs, kasi kotelemela kopanza maloba ezali kosapema mingi te. Ndakisa moko ya kolendisa kosokola maboko na biteyelo ""Mayele Misato"" ya UNICEF oyo azali kolendisa biteyelo basala makambo ya pete, ya ntalo mingi te oyo ekokoki kosala bana ya kelasi basokola maboko na sabuni, kati ya bibongiseli mosusu mpona bopeto."	A review of 70 studies revealed that promoting hand washing behavior in rural areas is particularly important in LMICs, but resistance to spreading rumors is less persuasive. An example of encouraging hand washing in schools is UNICEF&#39;s &quot;Three Strategies&quot; which encourages schools to develop simple, inexpensive activities that can encourage school children to wash their hands with soap, among other hygiene measures.
1520	en	ln	 When minimum standards are achieved, schools can move from one to ultimately three stars. 	Soki biteyelo elongi kokotisa mwa bizaleli malamu, bakoki sikoyo koleka na oyo ya makasi.	If schools succeed in instilling some positive values, they can now move on to stronger ones.
1521	en	ln	 Building hand washing stations can be a part of hand washing promotion campaigns that are carried out in order to reduce diseases and child mortality. 	Kotonga bisika ya kosokola maboko ekoki kozala na kati ya makambo ya kotambola kopanza sango ya kosokola maboko oyo ezali kosalema mpo na kokitisa bokono mpe kufa ya bana.	Construction of hand washing facilities can be included in the campaign to spread the word about hand washing that is being done to reduce child morbidity and mortality.
1522	en	ln	 Global Hand washing Day is another example of an awareness-raising campaign that is trying to achieve behavior change.As a result of the 2019-20 coronavirus pandemic, UNICEF promoted the adoption of a handwashing emoji. 	Mokolo ya kosokola maboko mpo na bato nyonso ezali ndakisa mosusu ya kapanza sango oyo ezali kosalisa bato na kobongola bizaleli. Ndenge maladi mabe ya coronavirisi 2019-20 ebimi, UNICEF azali kolendisa kobimisa emoji ya bosokoli maboko.	A public hand washing day is another example of a campaign that is helping people change behavior. As the 2019-20 coronavirus pandemic emerges, UNICEF is encouraging the release of a hand washing emoji.
1523	en	ln	 Few studies have considered the overall cost effectiveness of hand washing in developing countries in relationship to DALYs averted. 	Bolukiluki mosusu etaleli motuya nyonso ya kosokola maboko na mikili ya bobola na oyo etali likebisi ya DALYs.	Other research considers the total cost of hand washing in developing countries in terms of DALYs warning.
1524	en	ln	 However, one review suggests that promoting hand washing with soap is significantly more cost-effective than other water and sanitation interventions. 	Kasi, botaleli moko elakisi ete kolendisa kosokola maboko na sabuni esengaka mbongo mingi te soki tokokanisi yango na banzela mosusu na ndakisa mai mpe mayele mosusu ya kotya bopeto.	However, one analysis shows that promoting hand washing with soap is cost-effective compared to other options such as water and other sanitation methods.
1525	en	ln	" The importance of hand washing for human health – particularly for people in vulnerable circumstances like mothers who had just given birth or wounded soldiers in hospitals – was first recognized in the mid 19th century by two pioneers of hand hygiene: the Hungarian physician Ignaz Semmelweis who worked in Vienna, Austria and Florence Nightingale, the English ""founder of modern nursing"". "	"Ntina ya kosokola maboko mpo na kolongono ya nzoto ya mingimingi mpo na bato oyo baza na likama na ndakisa bamama oyo bauti kobota to basoda bazoki oyo bazali na balopitalo – bandimaki yango na mbala ya liboso na katikati ya siekle ya 19 na bato mibale oyo babandisaki mosala ya kosokola maboko: Ignaz Semmelweis, monganga ya Hongrois, oyo asalaki na Vienne, na Autriche mpe Florence Nightingale, moto ya Angleterre “oyo abandaki mosala ya mafulume""."	The importance of hand washing for health especially for vulnerable people such as new mothers or wounded soldiers in hospitals – was first recognized in the mid-19th century by two pioneers of hand washing: Ignaz Semmelweis, a Hungarian physician, who worked in Vienna, Austria and Florence Nightingale, an Englishwoman “who pioneered nursing”.
1526	en	ln	 At that time most people still believed that infections were caused by foul odors called miasmas. 	Na ntango wana, bato mingi bazalaki kondima kaka ete maladi euta na bansolo ya mabe oyo babengaki miasme.	At the time, most people simply believed that illness was caused by foul smells called miasms.
1527	en	ln	 In the 1980s, foodborne outbreaks and healthcare-associated infections led the United States Centers for Disease Control and Prevention to more actively promote hand hygiene as an important way to prevent the spread of infection. 	Na mibu 1980, kobima ya maladi euti na bilei mpe ya maladi euti na kosalisa bato ya maladi, epusaki ba centre ya États-Unis oyo ebundisaka maladi mpe ebatelaka yango na kolendisa mingi lisusu bopeto ya maboko mpe koloba ete ezali ntina mingi mpo na kokanga maladi nzela epanzana te.	In the 1980s, outbreaks of foodborne illness and patient care prompted the US centers of disease control and control to further promote hand hygiene and tout its importance in disease containment the road does not break.
1528	en	ln	 The outbreak of swine flu in 2009 and the COVID-19 pandemic in 2020 led to increased awareness in many countries of the importance of washing hands with soap to protect oneself from such infectious diseases. 	Kobima ya grippe ya bangulu na 2009 mpe ya maladi mabe ya COVID-19 na 2020, epusi bato ya mikili mingi batya likebi na ntina ya kosokola maboko na sabuni mpona komitabela na maladi mabe ya ndenge wana.	The outbreak of swine flu in 2009 and the pandemic of COVID-19 in 2020, has prompted international attention to the importance of washing hands with soap to protect against such pandemics.
1529	en	ln	" For example, posters with ""correct hand washing techniques"" were hung up next to hand washing sinks in public toilets and in the toilets of office buildings and airports in Germany. "	"Na ndakisa, bapankarte bakoma ""lolenge ya malamu ya kosokola maboko"" batyaki yango pene ya bisika ya kosokola maboko ya bawese ya bato nyonso mpe na bawese ya babiro mpe ba aeroport na Allemagne."	For example, signs with the words &quot;good hand washing practices&quot; were placed near hand washing facilities in public toilets and at office and airport toilets in Germany.
1530	en	ln	" The phrase ""washing one's hands of"" something, means declaring one's unwillingness to take responsibility for the thing or share complicity in it. "	"Maloba ""kosokola maboko ya moto na"" likambo moko, elingi koloba koboya kozwa mokumba mpona eloko moko to koboya kosangana na yango."	The words &quot;to wash one&#39;s hands in&quot; something, means to refuse to take responsibility for something or to refuse to participate in it.
1531	en	ln	 It originates from the bible passage in Matthew where Pontius Pilate washed his hands of the decision to crucify Jesus Christ, but has become a phrase with a much wider usage in some English communities. 	Ebimelaki na eteni ya biblia esika Matayo akoma ete Ponte Pilato asokolaki maboko na ekateli ya kobaka Yesu Klisto na ekulusu, kasi ekoma maloba oyo bato basalelaka mingi na bamboka oyo bato balobaka Anglais.	It appeared in the part of the bible where Matthew records that Pontius Pilate washed his hands of the decision to crucify Jesus Christ, but it has become common saying in English-speaking countries.
1532	en	ln	 In Shakespeare's Macbeth, Lady Macbeth begins to compulsively wash her hands in an attempt to cleanse an imagined stain, representing her guilty conscience regarding crimes she had committed and induced her husband to commit. 	Na lisapo ya Shakespeare ebengami Macbeth, Mama Macbeth abandi kosokola maboko oyo esengami mpo na kopetola mbindo oyo ezalaki kaka na makanisi, oyo elakisi bososoli na ye ya mabe na makambo mabe ya kobuka mibeko oyo ye asalaki mpe apusaki mobali na ye na kosala.	In Shakespeare&#39;s play Macbeth, Mother Macbeth begins the required washing of hands to cleanse the uncleanness that was only in the mind, which shows her wrong understanding of the crimes she committed and incited her husband to commit.
1533	en	ln	 It has also been found that people, after having recalled or contemplated unethical acts, tend to wash hands more often than others, and tend to value hand washing equipment more. 	Emonani ete nsima ya kokundwela bato bizaleli ya mabe to soki bango moko bakaniseli yango, mbala mingi bakosokola maboko koleka bato mosusu, mpe bazali na matondo mingi na biloko esalisaka na kosokola maboko.	It turns out that after being reminded of bad behavior or if they think about it themselves, they are more likely to wash their hands than others, and they are more grateful for hand sanitizers.
1534	en	ln	" Furthermore, those who are allowed to wash their hands after such a contemplation are less likely to engage in other ""cleansing"" compensatory actions, such as volunteering. "	Lisusu, bato oyo bapesi bango nzela ya kosokola maboko nsima ya makanisi wana mingi basanganaka lisusu te na makambo misusu ya makasi ya “bopeto,” na ndakisa kosala mosala ya komipesa.	Furthermore, people who are allowed to wash their hands after these considerations often no longer participate in other strict “cleanliness” activities, such as volunteering.
1535	en	ln	 Religions prescribe hand washing for both hygienic and symbolic purposes.Symbolic hand washing, using water but no soap to wash hands, is a part of ritual hand washing featured in many religions, including Bahá'í Faith, Hinduism, tevilah and netilat yadayim in Judaism, Lavabo in Christianity, and Wudhu in Islam.Religions also prescribe hygienic hand washing, especially after certain actions. 	Na losambo, mangomba esengaka kosokola maboko mpo na bopeto mpe ya elilingi. Kosokola maboko ya elilingi, oyo basalelaka mai kasi sabuni te mpo na kosokola maboko, ezali bindimeli ya kosokola maboko na mangomba mingi, na ndakisa na lingomba ya Bahá'í, ya Hindou, ya tevilah mpe na netilat yadayim na lingomba ya Bayuda, Lavabo na lingomba ya Boklisto mpe Wudhu na lingomba ya ba Mizilma. Mangomba esengaka mpe bato basokola maboko mpo na bopeto, mingimingi nsima ya kosala makambo moko boye.	In worship, churches require hand washing for cleanliness and symbolism. Symbolic hand washing, in which water and not soap is used to wash the hands, is a hand washing belief in many religions, such as the Bahá&#39;í, Hindu, tevilah and netilat yadayim in Judaism, Lavabo na the Christian religion and Wudhu in the Muslim religion. Religions also require people to wash their hands for hygiene, especially after certain activities.
1536	en	ln	 Hinduism, Judaism and Islam mandate washing of hands after using the toilet. 	Lingomba ya Hindu, ya Bayuda mpe ya ba Mizilma batya mobeko ete bato basokola maboko nsima ya kokende na wese.	Hinduism, Judaism, and Islam require hand washing after going to the toilet.
1537	en	ln	 And, Hinduism, Buddhism, Sikhism, Judaism and Islam mandate washing of hands before and after every meal. 	Lisusu, lingomba ya Hindu, ya Bouddha, ya Sikhi, ya Bayuda mpe ya Mizilma batya mobeko bato basokola maboko liboso mpe nsima ya kolya.	In addition, Hinduism, Buddhism, Sikhism, Judaism, and Islam require hand washing before and after meals.
1538	en	ln	 Workplace hazard controls for COVID-19 	 Biloko ya komibatela na makama na mosala COVID-19 	Occupational safety equipment COVID-1
1539	en	ln	 Workplace hazard controls for COVID-19 are the application of occupational safety and health methodologies for hazard controls to the prevention of coronavirus disease 2019 (COVID-19). 	 Biloko ya komibatela na mosala mpo na COVID-19 eza kosalela mayele etali libateli mpe kolongono ya nzoto mpo na kokanga nzela ete maladi ya coronavirisi 2019 (COVID-19) epanzana te. 	Occupational protective equipment for COVID-19 is using safety and health strategies to prevent the spread of the coronavirus 2019 (COVID-19).
1540	en	ln	 The proper hazard controls in the workplace depend on the worksite and job task, based on a risk assessment of sources of exposure, disease severity in the community, and risk factors of individual workers who may be vulnerable to contracting COVID-19. 	 Lolenge ya malamu ya komibatela na mosala etaleli esika mosala esalemaka mpe mosala yango, etaleli makama ya komitika na makambo ya makama, ndenge maladi ekoti esika bofandi, mpe makama oyo bato ya mosala bakoki kozala na risque ya kozwa maladi ya COVID-19. 	The best way to protect yourself in the workplace depends on the workplace and the job, the risks of exposure to hazardous conditions, the prevalence of disease in your area, and the risks that workers may be exposed to.
1541	en	ln	 According to the U.S. Occupational Safety and Health Administration (OSHA), lower exposure risk jobs have minimal occupational contact with the public and other coworkers, for which basic infection prevention measures are recommended, including hand washing, encouraging workers to stay home if they are sick, respiratory etiquette, and maintaining routine cleaning and disinfecting of the work environment. 	 Na kotalela ministre ya libateli mpe santé ya États-Unis (OSHA), mosala eza na makama moke eza mosala oyo esengaka kokutana na bato mosusu mpe baninga ya mosala mingi te, oyo esengaka kosalela mayele ya ntina ya libateli, na ndakisa kosokola maboko, kolendisa bato ya mosala na kotikala na ndako soki bazobela, babelaka maladi ya mpema, mpe kozala na ezaleli ya kotya bopeto mpe ya kopetola esika ya mosala. 	According to the U.S. Department of Health and Safety (OSHA), low-risk work is work that requires minimal contact with other people and co-workers, which requires the use of basic safety techniques, such as hand washing, reinforcement employees by staying home if they are sick, suffering from respiratory diseases, and by maintaining cleanliness and hygiene in the workplace.
1542	en	ln	 Medium exposure risk jobs include those that require frequent or close contact with people who are not known or suspected with COVID-19, but may be infected due to ongoing community transmission or international travel. 	 Mosala ya likama ya katikati eza misala oyo esengaka kokutana mbala mingi to na pembeni na bato oyo oyebi to baoyo bakoki kozala na COVID-19, kasi bakoki kozala na maladi mpo bakutanaka na bato mingi to basalaka mibembo na mikili mingi. 	Moderate risk occupation is occupation that requires frequent or close contact with people you know or may have COVID-19, but who may become ill because of extensive contact or international travel.
1543	en	ln	 This includes workers who have contact with the general public such as in schools, high-population-density work environments, and some high-volume retail settings. 	 Yango etali bato ya mosala oyo bakutanaka na bato mingi na ndakisa na biteyelo, na bisika ya mosala oyo bato bazalaka mingi, mpe na bisika mosusu oyo bato bazalaka mingi. 	This applies to professionals who encounter many people such as schools, busy workplaces, and other public places.
1544	en	ln	 Hazard controls for this group, in addition to basic infection prevention measures, include ventilation using high-efficiency air filters, sneeze guards, and having personal protective equipment available in case a person with COVID-19 is encountered. 	 Komibatela na makama na etuluku oyo, longola makambo bato nyonso basalaka mpo na komibatela na maladi, esengeli kosalela ventillateur oyo eza na bafiltre ya makasi mpenza, komibatela liboso ya kosala itche, mpe kozala na bisaleli ya komibatela soki okutani na moto oyo aza na maladi ya COVID-19. 	Safety precautions in this group, in addition to what everyone else does to protect themselves from illness, include using a ventilator with very tight filters, protecting yourself before itching, and having personal protective equipment if you come across someone with COVID-1
1545	en	ln	 OSHA considers healthcare and mortuary workers exposed to known or suspected person with COVID-19 to be at high exposure risk, which increases to very high exposure risk if workers perform aerosol-generating procedures on, or collect or handle specimens from, known or suspected person with COVID-19. 	 OSHA etalelaka minganga mpe bato basalaka na morgue ete baza bato oyo bayebani to likoki ezali bakutana na moto aza na COVID-19 baza na likama ya monene, mpe esalaka ete bato oyo basalaka misala ya aerosol to basimbaka to bazwaka ba échantillon, ya bato oyo baza na COVID-19 to baoyo bakoki kozala na yango. 	OSHA considers physicians and morgue personnel who are known or likely to have contact with someone with COVID-19 to be at high risk, and makes it necessary for persons who perform aerosol operations or handle or collect samples, of persons who are with COVID-19 or those who may have it.
1546	en	ln	 Hazard controls appropriate for these workers include engineering controls such as negative pressure ventilation rooms, and personal protective equipment appropriate to the job task. 	Komibatela malamu na makama mpo na bato yo basalaka misala oyo ekoki kozala komibatela na bandako oyo eza na mopepe ya mabe ya ventillateur, mpe kozala na bilamba ya malamu ya libateli mpo na mosala wana.	Proper protection from hazards for people you do these jobs may include protecting yourself from ventilated buildings, and having the right protective clothing for that job.
1547	en	ln	 COVID-19 outbreaks can have several effects within the workplace. 	 Kobima ya COVID-19 ekoki kozala na makama mingi na esika ya mosala. 	The outbreak of COVID-19 can be very dangerous in the workplace.
1548	en	ln	 Workers may be absent from work due to becoming sick, needing to care for others, or from fear of possible exposure. 	 Bato ya mosala bakoki kozala te na mosala mpo bazobela, bazobatela bato mosusu, to bazobanga mbala mosusu bakokutana na moko aza na maladi wana. 	Workers may not be at work because they are sick, caring for others, or afraid of meeting someone with the disease.
1549	en	ln	 Patterns of commerce may change, both in terms of what goods are demanded, and the means of acquiring these goods (such as shopping at off-peak hours or through delivery or drive-through services). 	 Lolenge ya kosala mombongo ekoki kobongwana, ekoki kozala na biloko bato bazoluka kosomba, mpe ndenge ya kozwa biloko yango (na ndakisa kosomba na ntango bato baza mingi to na nzela ya misala ya livraison à domicile). 	The nature of the transaction may change, there may be products that people are looking to buy, and the availability of those products (such as buying during peak hours or through home delivery services).
1550	en	ln	 Lastly, shipments of items from geographic areas severely affected by COVID-19 may be interrupted.An infectious disease preparedness and response plan can be used to guide protective actions. 	 Ya nsuka, bakoki kopekisa kokende kotika biloko na bisika oyo maladi ya COVID-19 eza mingi. Komibongisa na maladi ekoki kosalisa na koyeba nini tokosala mpo na komibatela. 	Finally, drop-offs in high-risk areas may be restricted. Preparing for illness can help determine what we will do to protect ourselves.
1551	en	ln	 Plans address the levels of risk associated with various worksites and job tasks, including sources of exposure, risk factors arising from home and community settings, and risk factors of individual workers such as old age or chronic medical conditions. 	 Baplan ezolobela nivo ya likama oyo eza na bisika ya mosala mpe misala, ata mpe bato oyo okokutana na bango, makambo ezosala makama ekoma mingi na ndako mpe bisika mosusu, mpe makama oyo bato ya mosala na ndakisa mibange to bato oyo baza na maladi esilaka te baza na yango. 	The plans address the level of risk in workplaces and activities, including the people you will come into contact with, the increased risk factors in the home and elsewhere, and the chronic risks faced by workers such as the elderly or the sick they have it.
1552	en	ln	 They also outline controls necessary to address those risks, and contingency plans for situations that may arise as a result of outbreaks. 	 Ezolobela mpe ndenge ya kolandela mpo na kobongisa makama wana, mpe lolenge ya kobongisa makambo oyo ekoki kobima mpo na maladi oyo. 	It also discusses how to monitor for correcting these risks, and how to improve the consequences of this disease.
1553	en	ln	 Infectious disease preparedness and response plans may be subject to national or subnational recommendations. 	 Komibongisa na maladi mabe mpe makambo ya kosala mpo na kobundisa yango ekosalema na kolanda mibeko ya ekolo to ya mboka. 	Epidemic preparedness and response measures shall be implemented in accordance with national or local legislation.
1554	en	ln	 Objectives for response to an outbreak include reducing transmission among staff, protecting people who are at higher risk for adverse health complications, maintaining business operations, and minimizing adverse effects on other entities in their supply chains. 	 Lolenge malamu ya kobundisa yango etali makambo mpo na maladi oyo etali na ndakisa kokitisa ndenge ekoki kopanzana kati ya bato ya mosala, kobatela bato oyo baza na likama monene mpo baza na maladi ya kala, kokoba kosala mosala, mpe kosala makambo mpo ebebisa te mosala ya bakompani mosusu oyo basalaka elongo na bino. 	The best way to combat it depends on issues for the disease related to for example reducing the likelihood of it spreading among the workforce, protecting people at high risk because they have pre-existing conditions, continuing to work, and taking steps to avoid disrupting the work of other companies that work with you.
1555	en	ln	 The disease severity in the community where the business is located affects the responses taken. 	 Makambo bokosala ekotalela ndenge oyo maladi yango ekoti na bongo na bino. 	Your actions will depend on how the disease has entered your brain.
1556	en	ln	 The hierarchy of hazard controls is a framework widely used in occupational safety and health to group hazard controls by effectiveness. 	 Koyeba ndenge moto na moto akosala makambo mpo na komibatela na makama eza mwango endimami mpo na kobatela bato ya mosala mpe kolongono ya nzoto ya bato mingi na kotalela bokasi na yango. 	Individual safety precautions are an accepted method of protecting workers and the health of many people depending on their effectiveness.
1557	en	ln	 Where COVID-19 hazards cannot be eliminated, the most effective controls are engineering controls, followed by administrative controls, and lastly personal protective equipment. 	 Bisika bakoki kolongola te makama ya COVID-19, lolenge ya malamu koleka ya kobundisa yango eza kotalelaka ba mashine, nsima kotalela ya bakonzi, mpe na nsuka kopesa moto na moko bisaleli ebongi mpo na komibatela. 	Where the risks of COVID-19 cannot be eliminated, the best way to combat them is to assess machinery, then assess authorities, and finally provide individuals with appropriate protective equipment.
1558	en	ln	 Engineering controls involve isolating employees from work-related hazards without relying on worker behavior, and can be the most cost-effective solution to implement. 	 Kotalela ba mashine elakisi kotya bato ya mosala mosika na makama ya mosala kozanga kobebisa bizaleli malamu ya mosala, mpe ekoki kozala lolenge ya malamu ya kosala makambo. 	Checking machines means keeping workers away from work hazards without compromising work ethic, and can be a better way of doing things.
1559	en	ln	 Administrative controls are changes in work policy or procedures that require action by the worker or employer. 	 Botaleli ya bakonzi ezali kobongola lolenge ya kosala mosala oyo ezosenga patron to moto ya mosala abongola ndenge na ye ya kosala. 	Executive review is a change in the way work is done that requires the employer or employee to change their way of doing things.
1560	en	ln	 Personal protective equipment (PPE) is considered less effective than engineering and administrative controls, but can help prevent some exposures. 	 Bisaleli ya komibatela (PPE) eza makasi mingi te soki tokokanisi yango na botaleli ya ba mashine to ya bakonzi, kasi ekoki kosalisa na kokima makama mosusu. 	Personal protective equipment (PPE) is less powerful than mechanical or official checks, but it can help avoid certain hazards.
1561	en	ln	 All types of PPE must be selected based upon the hazard to the worker, properly fitted as applicable (e.g., respirators), consistently and properly worn, regularly inspected, maintained, and replaced, as necessary, and properly removed, cleaned, and stored or disposed of to avoid contamination. 	 Bosengeli kopona lolenge nyonso ya PPE na kotalela makama oyo eza mpo na moto ya mosala, soki ebongi mpenza (na ndakisa biloko esalisaka na kopema), kolata yango malamu mpe ntango nyonso, kobatela yango, mpe kotya ya sika, soki esengami, mpe kolongola yango malamu, kosokola yango, kobongisa to kobwaka yango mpo emema maladi te. 	You should select each type of PPE based on the hazards to the worker, if appropriate (such as respirators), wear it properly and regularly, maintain it, and replace it, if necessary, and remove it properly, wash, prepare or dispose of them to prevent disease.
1562	en	ln	 According to the U.S. Occupational Safety and Health Administration (OSHA), lower exposure risk jobs have minimal occupational contact with the public and other coworkers. 	 Na kotalela ministere ya libateli mpe kolongono ya nzoto (OSHA), makama ya moke na mosala eza oyo esengaka kokutana na bato mingi te mpe baninga ya mosala mingi te.	According to the Department of Health and Safety (OSHA), the least hazardous occupational hazards are those that require minimal contact with people and colleagues.
1563	en	ln	 Basic infection prevention measures recommended for all workplaces include frequent and thorough hand washing, encouraging workers to stay home if they are sick, respiratory etiquette including covering coughs and sneezes, providing tissues and trash receptacles, preparing for telecommuting or staggered shifts if needed, discouraging workers from using others' tools and equipment, and maintaining routine cleaning and disinfecting of the work environment. 	 Lolenge ya malamu ya komibatela mpo maladi epanzana te na mosala oyo endimami eza kosokola maboko mbala na mbala, kolendisa bato ya mosala na kotikala na ndako soki bazobela, soki babelaka maladi ya mpema, kozipa monoko to zolo soki bakosoli to basali itche, kozala bilamba ya kopangusa mpe esika ya kobwaka yango, kobongisa bisaleli ya kosolola na mosika to mosusu soki eza ntina kopekisa bato ya mosala basalela bisaleli ya bato mosusu, mpe kobatela bizaleli ya kotya bopeto mpe kopetola esika ya mosala. 	The best way to protect yourself from the spread of disease in the approved workplace is to wash your hands frequently, encourage workers to stay home if they are sick, if they have a respiratory illness, cover your mouth or nose if they sneeze or itch, wear clothing cleaning and disposal, repairing remote or other communication equipment if necessary to prevent workers from using other people&#39;s equipment, and maintaining cleanliness and hygiene in the workplace.
1564	en	ln	 Prompt identification and isolation of potentially infectious individuals is a critical step in protecting workers, customers, visitors, and others at a worksite. 	 Koyeba noki bato oyo bakoki kozala na maladi mpe kotya bango mosika na basusu eza lolenge ya malamu mingi ya kobatela bato ya mosala, basombi, bapaya, mpe bato mosusu na esika ya mosala. 	Early identification and isolation of potentially ill individuals is the most effective way to protect employees, shoppers, guests, and others in the workplace.
1565	en	ln	 The U.S. Centers for Disease Control and Prevention (CDC) recommends that employees who have symptoms of acute respiratory illness are to stay home until they are free of fever, signs of a fever, and any other symptoms for at least 24 hours without the use of fever-reducing or other symptom-altering medicines, and that sick leave policies are flexible, permit employees to stay home to care for a sick family member, and that employees are aware of these policies. 	 Ba centre ya kobundisa maladi mabe mpe kobatela bato na yango (CDC) ya États-Unis ezolendisa ete bato ya mosala oyo baza na bilembo ya maladi ya makasi ya mpema batikala na ndako kino fievre, bilembo ya fievre, mpe bilembo mosusu ekosila ata na bangonga 24 kozanga kosala nkisi ya kokitisa fievre to nkisi mosusu mpo na bilembo mosusu, mpe batya mibeko malamu mpo na congé ya malamu, kopesa bato ya mosala nzela ya kotikala na ndako mpo na kobatela bato ya libota oyo bazobela, mpe ete bato ya mosala basengeli koyeba mibeko wana. 	The U.S. Centers for Disease Control and Prevention (CDC) encourages workers with symptoms of severe respiratory illness to stay home until fever, febrile symptoms, and other symptoms resolve even within hours 24 failure to develop fever reducers or other treatments for certain symptoms, and establish better policies for effective leave, allowing staff to stay home to care for sick family members, and that staff should be aware these rules.
1566	en	ln	 According to OSHA, medium exposure risk jobs include those that require frequent or close contact within six feet (1.8 m) of people who are not known or suspected COVID-19 patients, but may be infected with SARS-CoV-2 due to ongoing community transmission around the business location, or because the individual has recent international travel to a location with widespread COVID-19 transmission. 	 Na kotalela OSHA, likama ya katikati na mosala etali makambo neti bato oyo bakutanaka na bato mingi to bazalaka pene ya bametre 1,8 ya bato oyo baza na COVID-19 to oyo bazokanisa bakoki kozala na yango, kasi bakoki kozwa SARS-CoV-2 mpo maladi yango ezopanza mingi na esika bofandi na esika ya mosala, to mpo bato basalaki mobembo kala te na mikili mosusu esika COVID-19 ezopanzana mingi. 	According to OSHA, a moderate occupational hazard refers to situations such as people who have close contact with or are within 1.8 meters of people who have COVID-19 or are suspected of having it, but may be infected with SARS-CoV-2 because the disease is more prevalent in the workplace, or because people have recently traveled to other countries where COVID-19 is more prevalent.
1567	en	ln	 These include workers who have contact with the general public such as in schools, high-population-density work environments, and some high-volume retail settings.Engineering controls for this and higher risk groups include installing high-efficiency air filters, increasing ventilation rates, installing physical barriers such as clear plastic sneeze guards, and installing a drive-through window for customer service.Administrative controls for this and higher risk groups include encouraging sick workers to stay at home, replacing face-to-face meetings with virtual communications, establishing staggered shifts, discontinuing nonessential travel to locations with ongoing COVID-19 outbreaks, developing emergency communications plans including a forum for answering workers’ concerns, providing workers with up-to-date education and training on COVID-19 risk factors and protective behaviors, training workers who need to use protecting clothing and equipment how to use it, providing resources and a work environment that promotes personal hygiene, requiring regular hand washing, limiting customers' and the public's access to the worksite, and posting signage about hand washing and other COVID-19 protective measures.Depending on the work task, workers with at least medium exposure risk may need to wear personal protective equipment including some combination of gloves, a gown, a face shield or face mask, or goggles. 	 Etali bato ya mosala oyo bakutanaka na bato ya ndenge na ndenge na ndakisa na biteyelo, na esika ya mosala oyo bato bazalaka mingi mpenza, mpe na bisika mosusu ya bato mingi. Kobatela ya ba mashine mpo na bato ya boye esengaka kotya bafiltre ya makasi ya mopepe, kosala ete ba ventilateur ebaluka makasi, kotya biloko ekabolaka bato neti biloko oyo elekisaka te mopepe ya itche, mpe kotya madesu na fenetre mpo na baoyo bazoyamba bakiliya. Libateli ya bakonzi mpo na bituluku ya likama mingi ezosenga kolendisa bato ya mosala oyo bazobela batikala na ndako, kosala makita na internet na esika ya kozala na esika moko, kotya mibeko mpo na kolongola mibembo ezangi ntina na bisika oyo COVID-19 ezali, kosala mayele ya kosolola ata mpe ba forume mpo na kolandela mikakatano ya bato ya mosala, kopesa bato ya mosala bansango ya sika mpe formation ebongi mpo na makama ya COVID-19 mpe makambo ya kosala mpo na komibatela, kopesa formation na bato ya mosala oyo basengeli kosalela bilamba ya komibatela mpe koyebisa bango ndenge ya kosalela yango, kopesa bango bisaleli mpe basala na esika oyo eza peto, ezosenga kosokola maboko mbala na mbala, kosala ete bakiliya na bato mosusu bakotaka mingi te na esika ya mosala, mpe kotya bilembo ya kosokola maboko mpe bibongiseli mosusu ya komibatela na COVID-19. Na kotalela mosala bazosala, bato ya mosala oyo baza na likama ya katikati basengeli kolata bilamba na bango ya komibatela na ndakisa bagan, blouse, masque ya elongi, to maneti ya komibatela.	It applies to professionals who encounter a wide variety of people such as in schools, in a very busy workplace, and in other public places. Maintaining machines for such people requires installing strong air filters, turning fans strong, installing separators such as itche air barriers, and installing window dressings for customer receptionists. Official protection for high-risk groups will require encouraging sick workers to stay at home, holding meetings online instead of in one place, setting rules to eliminate unnecessary travel to COVID-19 areas, developing strategies communication including forums to monitor workforce problems, provide workers with updates and appropriate training on COVID-19 risks and protective measures, provide training to workers who need to use clothing of self-care and instruction, providing equipment and working in a clean environment, requiring frequent hand washing, limiting access to the workplace by customers and others, and installing hand washing signs and facilities another way to protect yourself from COVID-1 Depending on the job they are doing, workers at moderate risk should wear their protective clothing such as gloves, blouses, face masks, or protective goggles.
1568	en	ln	 Workers in this risk group rarely require use of respirators. 	 Bato ya mosala oyo baza na etuluku oyo, esengaka mpenza te basalela biloko esalisaka na kopema. 	Workers in this group do not necessarily need to use respirators.
1569	en	ln	 If a person becomes sick on an airplane, proper controls to protect workers and other passengers include separating the sick person from others by a distance of 6 feet, designating one crew member to serve the sick person, and offering a face mask to the sick person or asking the sick person to cover their mouth and nose with tissues when coughing or sneezing. 	 Soki moto moko abeli na avion, lolenge ya malamu ya kobatela bato ya mosala mpe bato mosusu ezali kokabola ye na bato mosusu na distance ya 6 pied, kopona moto moko ya equipage mpo akipe moto wana ya maladi, mpe kopesa masque ya elongi to kosenga moto wana ya maladi azipa monoko na zolo na ye na elamba ntango azokosola to azosala itche. 	If someone falls ill on an airplane, the best way to protect crew and others is to isolate them from others at a distance of 6 feet, designate one crewmember to care for that sick person, and provide a face mask or ask for someone the patient should cover his mouth and nose with a cloth when sneezing or itching.
1570	en	ln	 Cabin crew should wear disposable medical gloves when tending to a sick traveler or touching body fluids or potentially contaminated surfaces, and possibly additional personal protective equipment if the sick traveler has fever, persistent cough, or difficulty breathing. 	 Bato ya mosala oyo baza na cabine basengeli kolata bagan ntango bazosalisa moto azosala mobembo oyo azobela to kosimba mai ya nzoto to esika nyonso oyo ekoki kopesa bango maladi, mpe komibatela mingi lisusu soki moto yango ya maladi azobela fievre, kosukosu oyo ezosila te, to azopema na mpasi. 	Cabin crew should wear gloves when treating a sick passenger or touching body fluids or any potentially infectious surface, and take extra precautions if the patient has a fever, persistent cough, or wheezing with difficulty.
1571	en	ln	 Gloves and other disposable items should be disposed of in a biohazard bag, and contaminated surfaces should be cleaned and disinfected afterwards.For commercial shipping, including cruise ships and other passenger vessels, hazard controls include postponing travel when sick, and self-isolating and informing the onboard medical center immediately if one develops a fever or other symptoms while on board. 	 Bagan mpe biloko mosusu oyo babwaka nsima ya kosalela esengeli kobwakama na esika ebongi, mpe bosengeli kopetola mpe kolongola mikrobe na bisika oyo ezwi mikrobe. Mpo na maswa ya mombongo, ata mpe bato de croisière mpe bato mosusu oyo baza nakati, komibatela elimboli koboya kosala mobembo soki ozobela, mpe komifandela mpe koyebisa minganga oyo baza nakati mbala moko soki moto moko oyo aza na kati aza na fievre to bilembo ya maladi mosusu. 	Bagan and other post-use waste should be disposed of properly, and contaminated areas should be cleaned and disinfected. For merchant ships, including cruise ships and other passengers, self-care means refraining from traveling if you are sick, and staying safe and notifying the doctors on board immediately if anyone on board has a fever or symptoms some.
1572	en	ln	 Ideally, medical follow-up should occur in the isolated person's cabin.For schools and childcare facilities, CDC recommends short-term closure to clean or disinfect if an infected person has been in a school building regardless of community spread. 	 Eza malamu kolandela santé ya moto wana ya maladi na esika oyo batye ye. Mpo na biteyelo to bisika ya kobatela bana, CDC ezosenga kokanga esika wana na ntango moke mpo na kopetola to kolongola mikrobe soki moto moko ya maladi azalaki na lopango ya eteyelo ezala maladi epanzani mingi to te esika bofandi. 	It is good to monitor the health of the patient in the placement. For schools or child care centers, the CDC will require a temporary closure of the facility for cleaning or disinfection if a sick person was on school grounds whether or not the disease is widespread where you live.
1573	en	ln	 When there is minimal to moderate community transmission, social distancing strategies can be implemented such as canceling field trips, assemblies, and other large gatherings such as physical education or choir classes or meals in a cafeteria, increasing the space between desks, staggering arrival and dismissal times, limiting nonessential visitors, and using a separate health office location for children with flu-like symptoms. 	 Soki bokono ezopanza mingi mpenza te na kati ya bato, bokoki kosalela mayele ya kopekisa bato bakutana na ndakisa kopekisa mibembo, mayangani, mpe makita mosusu ya minene na ndakisa education physique to korale na biteyelo to kolya na restaurant, ata mpe distance ezokabola babiro, kozelazela na ntango ya koya to ya kokende, koboya bavisite ezangi ntina, mpe kosalela babiro ya minganga ekeseni mpo na bana oyo bazali na bilembo ya grippe. 	If the disease is not very widespread, you can use contact prevention measures such as banning travel, conventions, and other large gatherings such as physical education or choir in schools or restaurant meals, even distance separating offices, waiting during arrival or departure, avoiding unnecessary visits, and using separate medical offices for children with flu symptoms.
1574	en	ln	 When there is substantial transmission in the local community, in addition to social distancing strategies, extended school dismissals may be considered.For law enforcement personnel performing daily routine activities, the immediate health risk is considered low by CDC. 	 Soki maladi epanzani mingi esika bofandi, longola mayele ya koyebisa bato bamifandela, bokoki kokanga biteyelo mpo na ntango ya mwa molai. Mpo na bapolisi oyo bazosala mosala na bango bo momeseno, CDC elobi ete likama na bango eza na nivo ya se. 	If the disease is widespread in your area, in addition to evacuation measures, you may be able to close schools for a longer period of time. For routine police officers, the CDC says their risk is at a lower level.
1575	en	ln	 Law enforcement officials who must make contact with individuals confirmed or suspected to have COVID-19 are recommended to follow the same guidelines as emergency medical technicians, including proper personal protective equipment. 	 Bakonzi ya bapolisi oyo basengeli kokutana na bato oyo baza na COVID-19 to oyo bakoki kozala na yango, esengeli batosa mibeko ya ndenge moko na oyo minganga batosaka, ata mpe kolata bisaleli malamu mpo na komibatela. 	Police officers who have to deal with people who have or may have COVID-19 should follow the same rules as doctors, including wearing proper protective equipment.
1576	en	ln	 If close contact occurs during apprehension, workers should clean and disinfect their duty belt and gear prior to reuse using a household cleaning spray or wipe, and follow standard operating procedures for the containment and disposal of used PPE and for containing and laundering clothes. 	 Soki bosimba moto ntango bozokanga ye, bato wana basengeli kopetola mpe kolongola mikrobe na nkamba na bango ya mosala mpe na bisaleli na bango liboso ya kosalela yango, bakosala yango na lisalisi ya aspirateur mpe kolanda mibeko etali komibatela mpe kobwaka biloko oyo PPE epesi mpe ya kobatela mpe kosokola bilamba. 	If you touch someone while holding them, they should clean and disinfect their work clothes and equipment before use, using a vacuum cleaner and following the precautions and disposal of PPE and safety equipment and washing clothes.
1577	en	ln	 OSHA considers certain healthcare and mortuary workers to be at high or very high categories of exposure risk. 	 OSHA etalelaka bato mosusu oyo basalaka mosala ya monganga mpe oyo basalaka na morgue ete baza na likama makasi to baza na kati ya bato oyo baza na likama makasi. 	OSHA considers certain medical and mortuary personnel to be high-risk or in the high-risk category.
1578	en	ln	 High exposure risk jobs include healthcare delivery, support, laboratory, and medical transport workers who are exposed to known or suspected COVID-19 patients. 	 Misala ya likama makasi eza na ndakisa kobotisa, kosalisa, laboratoire, mpe bato oyo bamema bato ya maladi oyo baza na COVID-19 to bakoki kozala na yango. 	High-risk occupations include maternity, treatment, laboratory, and transportation of patients who have or may have COVID-1
1579	en	ln	 These become very high exposure risk if workers perform aerosol-generating procedures on, or collect or handle specimens from, known or suspected COVID-19 patients. 	 Bakomaka na likama makasi soki bazosala misala ya aerosol, to bazozwa to bazosalela ba échantillon euti na bato oyo baza na COVID-19 to bakoki kozala na yango. 	They become at greater risk if they engage in aerosol activities, or collect or use samples from people who have or may have COVID-1
1580	en	ln	 Aerosol-generating procedures include intubation, cough induction procedures, bronchoscopies, some dental procedures and exams, or invasive specimen collection. 	 Misala ya aerosol eza misala neti intubation, kosalisa kosukosu, bronchoscopie, to misala to ba ekzame mosusu ya mino, to kozwa ba écahntillon. 	Aerosol services include services such as intubation, cough treatment, bronchoscopy, or other dental procedures or examinations, or taking specimens.
1581	en	ln	 High exposure risk mortuary jobs include workers involved in preparing the bodies of people who had known or suspected cases of COVID-19 at the time of their death; these become very high exposure risk if they perform an autopsy.Additional engineering controls for these risk groups include isolation rooms for patients with known or suspected COVID-19, including when aerosol-generating procedures are performed. 	 Likama makasi ya misala ya morgue etali bato oyo basalaka mosala ya kobongisa bibembe ya bato oyo bakufaki na COVID-19 na ntango bakufi to oyo bato oyo bakanisi ete bazalaki na yango; bazalaka na likama makasi soki basali ekzame na nsima mpo na koyeba soki bakufaki na maladi nini. Likama mosusu mpo na bango eza soki bazosalisa bato oyo baza na COVID-19 to oyo bakanisi baza na yango na bashambre na bango, ata mpe ntango bazosala misala ya aerosol. 	The high risk of mortuary operations involves persons engaged in preparing the bodies of persons who have died of COVID-19 at the time of their deaths or who are suspected to have been in contact with them; they are at higher risk if they are later tested for cause of death. Another risk for them is if they are treating people with or suspected of having COVID-19 in their rooms, even when doing aerosol activities.
1582	en	ln	 Specialized negative pressure ventilation may be appropriate in some healthcare and mortuary settings. 	 Kotinda mwa mopepe ya ventilateur ekoki kozala malamu na balopitalo mosusu mpe na ba morgue. 	Sending some ventilator air may be appropriate in some hospitals and mortuaries.
1583	en	ln	 Specimens should be handled with Biosafety Level 3 precautions. 	 Esengeli kosalela ba échantillon na kolanda nivo ya libateli ya bio 3. 	Samples must be handled in accordance with the bio 3 safety level.
1584	en	ln	 The World Health Organization (WHO) recommends that incoming patients be separated into distinct waiting areas depending on whether they are a suspected COVID-19 case.In addition to other PPE, OSHA recommends respirators for those who work within 6 feet of patients known to be, or suspected of being, infected with SARS-CoV-2, and those performing aerosol-generating procedures. 	 Organisation mondiale de la santé (OMS) elobi ete eza malamu kokabola bato ya maladi na bisika ya kozela ekeseni na kotalela soki bozokanisa baza na maladi ya COVID-19 to te. Longola likanisi ya kosala biloko esalisaka na kopema oyo PPE, OSHA elobeli mpo na bato oyo bazosala na distance ya 6 pied na bato oyo bayebani baza na SARS-CoV-2, oyo bozokanisa baza na yango, to oyo bazwi yango, mpe kosala misala mosusu ya aerosol. 	The World Health Organization (WHO) says it is best to separate patients in different waiting areas based on whether they are suspected of having COVID-19 or not. In addition to the concept of respiratory aids that PPE, OSHA mentions for people working within 6 feet of people who are known to have SARS-CoV-2, who you suspect have, or have been infected, and perform other tasks of aerosol.
1585	en	ln	 In the United States, NIOSH-approved N95 filtering facepiece respirators or better must be used in the context of a comprehensive, written respiratory protection program that includes fit-testing, training, and medical exams. 	 Na États-Unis, biloko esalisaka na kopema N95 oyo endimami na NIOSH to ya malamu koleka esengeli kosalelama mingi na makambo ya komibatela na maladi ya mpema na ndakisa test ya ajustement, formation, mpe ba-ekzame ya monganga. 	In the United States, N95 respirators approved by NIOSH or better should be widely used in respiratory prevention situations such as adjustment testing, training, and clinical examinations.
1586	en	ln	 Other types of respirators can provide greater protection and improve worker comfort.The WHO does not recommend coveralls, as COVID-19 is a respiratory disease rather than being transmitted through bodily fluids. 	 Lolenge mosusu ya biloko esalisaka na kopema ebatelaka mingi mpe esalisaka bato basala malamu. OMS endimaka te biloko ezipaka elongi mobimba, mpo COVID-19 eza maladi ya mpema mpe epanzanaka te na nzela ya mai ya nzoto. 	Other types of respirators are more protective and improve performance. The WHO does not approve of full face masks, because COVID-19 is a respiratory disease and is not spread through body fluids.
1587	en	ln	 WHO recommends only a surgical mask for point-of-entry screening personnel. 	 OMS ezosenga kaka kosalela masque ya minganga mpo bato oyo bazosalisa ba ekzame. 	The WHO still requires the use of medical masks for people undergoing tests.
1588	en	ln	 For those who are collecting respiratory specimens from, caring for, or transporting COVID-19 patients without any aerosol-generating procedures, WHO recommends a surgical mask, goggles, or face shield, gown, and gloves. 	 Mpo na bato oyo bazozwa ba échantilllon ya maladi ya mpema na bato ya maladi, kobatela bango, to komema bato oyo bazobela COVID-19 kozanga kosala misala ya aerosol, OMS ezondima kosalela masque ya minganga, maneti ya libateli, to eloko ya kobatela elongi, blouse, mpe bagan. 	For persons collecting respiratory samples from patients, caring for, or transporting persons with COVID-19 without aerosol procedures, WHO recommends the use of a medical mask, protective goggles, or face shield, blouse, and bagan.
1589	en	ln	 If an aerosol-generating procedure is performed, the surgical mask is replaced with an N95 or FFP2 respirator. 	 Soki bosali misala ya aerosol, na esika ya masque ya minganga, bokosalela eloko esalisaka na kopema N95 to FFP2. 	If you perform aerosol tasks, instead of a medical mask, you will use an N95 or FFP2 respirator.
1590	en	ln	 Given that the global supply of PPE is insufficient, WHO recommends minimizing the need for PPE through telemedicine, physical barriers such as clear windows, allowing only those involved in direct care to enter a room with a COVID-19 patient, using only the PPE necessary for the specific task, continuing use of the same respirator without removing it while caring for multiple patients with the same diagnosis, monitoring and coordinating the PPE supply chain, and discouraging the use of masks for asymptomatic individuals. 	 Mpo biloko nyonso oyo PPE ezopesa ekoki te, OMS azondima kosalela mingi te PPE na telemedecine, bipekiseli mpo bato bakutana te na ndakisa bafenetre ya polele, kopesa nzela na minganga na kokota na shambre ya moto oyo azobela COVID-19, kosalela kaka PPE oyo eza ntina mpo na mosala ya sikisiki, kokoba kosalela eloko kaka moko esalisaka na kopema kozanga kolongola yango ntango azosalisa bato mingi oyo bazobela maladi moko, kobatela mpe kosalela malamu ba PPE mosusu, mpe kolendisa te kosalela bamasque mpo na bato oyo baza na bilembo te. 	Because of the insufficient availability of PPE, WHO will accept limited use of PPE in telemedicine, restrictions on contact such as open windows, allowing doctors to enter the room of a COVID-19 patient, using only available PPE important for specific work, continue to use the same respiratory aid without removing it when treating multiple patients, maintain and use other PPE properly, and do not encourage the use of masks for people without symptoms.
1591	en	ln	 FROM: Katherine Maher, Wikimedia Foundation CEO 	 EUTI NA: Katherine Maher, CEO ya fondation Wikimedia	FROM: Katherine Maher, CEO of the Wikimedia foundation
1592	en	ln	 TO: All Wikimedia Foundation staff 	 NA: Basali nyonso ya fondation Wikimedia 	TO: All Wikimedia foundation staff
1593	en	ln	 SUBJECT LINE: [Covid-19] Lightening the load and preparing for the future 	 MOTO YA LIKAMBO: [Covid-19] Kongengisa nzela mpe komibongisa mpo na mikolo ezoya 	MAN OF THE CASE: [Covid-19] Lighting the way and preparing for the future
1594	en	ln	 SEND DATE/TIME: 14 March, 2020, 00:24 UTC 	 DATE/NTANGO ETINDAMI: Mokolo ya 14 sanza ya misato 2020, 00:24 UTC 	DATE/TIME SENT: March 14, 2020, 00:24 UTC
1595	en	ln	 LICENSING: CC0: No rights reserved 	 NDINGISA: CC0: Eza na lotomo moko te	PERMISSION: CC0: No rights
1596	en	ln	 We find ourselves in remarkable circumstances this month. 	 Na sanza oyo tokutani mpenza na makambo ya kokamwa. 	This month we have experienced some wonderful things.
1597	en	ln	 The COVID-19 epidemic is something that makes clear our global human interconnectedness and the responsibilities we have to one another. 	 Maladi ya COVID-19 emonisa mpenza polele ete toza ya kosangana bamoko na basusu mpe toza na mikumba mpo na bato mosusu. 	The COVID-19 pandemic has made it very clear that we are interconnected and have responsibilities to others.
1598	en	ln	 We don’t have precedent for its challenges, but we do know that our best response relies on the sort of global empathy, cooperation, and community building that sits at the heart of this organization. 	 Toyebi te bampasi oyo ekobimisa te, kasi toyebi ete milende na biso ya malamu ya kobundisa yango esimbami na makasi, boyokani, mpe bato ya mboka oyo baza ntina mingi na lisanga oyo. 	We don’t know the hardships it won’t cause, but we do know that our best efforts to combat them are based on the strength, cooperation, and community members who are so important to this community.
1599	en	ln	 The camaraderie and care we have seen among all of our colleagues over email, calls, and chats is a remarkable validation of the incredible humans we are fortunate enough to work with. 	 Boninga mpe bolingo oyo tomoni na kati ya baninga na biso nyonso na ba email, kobenga na telefone, mpe masolo ezondimisa mpenza ete tosalaka na bato ya malamu mpenza. 	The friendliness and warmth we’ve seen in all of our partners in emails, phone calls, and conversations definitely confirms that we work with excellent people.
1600	en	ln	 I couldn’t be more grateful and proud to count you all as colleagues. 	 Napesa bango bino baninga nyonso matondi mingi mpe nazanga na esengo ya kotyela bino motema. 	I thank them all you friends very much and miss the pleasure of trusting you.
1601	en	ln	 Last week, someone shared with me their appreciation for our work. 	 Na mposo eleki, moto moko ayebisaka ngai ndenge basepelaka na mosala na biso. 	Last week, someone tells me how much they like our work.
1602	en	ln	 They reminded me how meaningful it is for the world to be able to turn to Wikipedia right now, and what a powerful symbol it is for this critical resource to remain online and available to all. 	 Ekundwelaki ngai ndenge eza ntina mingi ete bato bakende na Wikipedia kaka sikoyo, mpe eza elembo makasi emonisi ete misala ya ntina esengeli kozala na internet mpe bato nyonso bazala na likoki ya komona yango. 	It reminded me how important it is that people go to Wikipedia right now, and it’s a strong indication that important work should be online and accessible to everyone.
1603	en	ln	 Your work makes this possible, whether you keep the sites stay up or our colleagues paid or our communities safe. 	 Mosala na bino nde esalisaka mpo esalema bongo, ezala bozotya bansango ya sika na basite to kofuta baninga na biso to kobatela mboka na biso. 	Your work is what makes that happen, whether you are posting news or paying our friends or protecting our country.
1604	en	ln	 The world needs the information that Wikipedia provides, now more than ever. 	 Sikoyo mpenza, mokili eza na mposa ya bansango oyo Wikipedia epesaka. 	Right now, the world needs the information that Wikipedia provides.
1605	en	ln	 This is a moment in which not only what we do, but how we do it, will make a meaningful impact on the world. 	 Oyo eza eleko oyo makambo ekozala na ntina mingi mpo na mokili eza kaka te makambo tozosala, kasi mpe ndenge tosalaka yango. 	This is a time when things that matter most to the world are not just what we do, but also how we do it.
1606	en	ln	 Because of the importance of this mission and your role in it, we will be making some significant adjustments to how we work together, starting this coming week. 	 Mpo mosala oyo mpe mokumba na bino eza ntina mingi, tokobongola ndenge tosalaka elongo, kobanda na mposo oyo. 	Because this work and your responsibility is so important, we will change the way we work together, starting this week.
1607	en	ln	 Adjustments to our work and schedules 	 Mbongwana na mosala mpe manaka na biso 	Changes in our work and schedule
1608	en	ln	 As Robyn mentioned previously, the c-team met last night to discuss our approach and schedule for the coming days and months. 	 Ndenge Robyn autaki kolobela yango, etuluku c ekutanaki na butu eleki mpo na kolobela lolenge na biso ya kosala mosala mpe manaka na biso na mikolo mpe basanza ezoya. 	As Robyn just mentioned, group c met last night to discuss our approach and schedule over the coming days and months.
1609	en	ln	 In that conversation, we considered what we thought would be an appropriate response to what we’re facing and the best way to keep the organization sustainable during this time. 	 Na masolo wana, tolobelaka makambo oyo tokanisi eza lolenge ya malamu ya kobunda na makambo oyo tozokutana na yango mpe lolenge ya malamu ya kosala ete organisation na biso ekoba kosala na eleko oyo. 	In those conversations, we talk about what we think is the best way to tackle the issues we’re facing and the best way to ensure our organization continues to operate during this period.
1610	en	ln	 Overwhelmingly we wanted to remove stress and support our mission for the long term. 	 Toza na mposa ya kolongola mitungisi mpe kopesa maboko na mosala na biso mpo na ntango ya molai. 	We need to take the stress away and contribute to our work for the long term.
1611	en	ln	 If you need to dial back, that’s okay. 	 Soki olingi kobenga biso, eza mabe te. 	If you want to call us, it’s okay.
1612	en	ln	 For all staff, contractors, and contract workers: 	 Mpo na bakonzi, ba entrepreneur mpe bato ya mosala nyonso: 	For officials, contractors and all professionals:
1613	en	ln	 our daily working expectations will be about 4 hours a day, or 20 hours a week until further notice. 	 ngonga na biso ya mosala ya mokolo na mokolo ekozala bangonga 4, to bangonga 20 na mposo moko kino tokobongola yango. 	our daily work hours will be 4 hours, or 20 hours per week until we change it.
1614	en	ln	 We’re not declaring a holiday - if you are able to work more normal hours, the mission can use you. 	 Tolobi te ete bozwi congé - soki oza na likoki ya kosala bangonga mingi koleka, bakoki kosalela yo. 	We don&#39;t say you&#39;ve got leave - if you&#39;re able to work more hours, you can be used.
1615	en	ln	 However, the world is unpredictable right now, and whether you need to care for loved ones, get groceries, or go to the doctor, your well-being is our priority. 	 Kasi, makambo ezobima na mokili eyebani te sikoyo, mpe soki ekosenga obatela moto moko oyo olingaka, okende kosomba bilei, to kokende kokutana na monganga, santé na ye esengeli kozwa esika ya liboso. 	However, the world is uncertain now, and if you have to care for a loved one, go shopping, or see a doctor, his or her health must come first.
1616	en	ln	 We are not tracking your time. 	 Tozolandela te ntango na yo ya mosala. 	We do not track your working hours.
1617	en	ln	 If you are sick, do not work. 	 Soki ozobela, koya te na mosala. 	If you are sick, don’t come to work.
1618	en	ln	 This should go without saying, but we’re saying it. 	 Esengeli kosalema kozanga toloba yango, kasi tozoloba yango. 	It has to happen without us saying it, but we are saying it.
1619	en	ln	 No sick days or PTO required - just tell your manager and help your team revise calendars and schedules to make sure key areas of work are covered. 	 Oza te na ntina ya mikolo ya maladi to PTO - yebisa kaka mokonzi na yo mpe salisa baninga ya mosala bayeba ndenge ya kobongisa manaka mpo misala ya ntina ekobaka kosalema. 	You don&#39;t need sick days or PTO - just let your boss know and help co-workers figure out how to adjust the schedule so important tasks keep getting done.
1620	en	ln	 (If you are diagnosed positive for COVID-19, please let Bryan within T&amp;C Ops know so T&amp;C can help with support and make sure your situation gets appropriate attention from management). 	 (Soki bakangi yo maladi ya COVID-19, tosengi yo oyebisa Bryan within T&amp;C Ops ebongo T&amp;C akoki kosunga yo mpe kosalisa yo mpo bakonzi batyela yo likebi ebongi). 	(If you are diagnosed with COVID-19, please notify Bryan within T&amp;C Ops so T&amp;C can assist you and help you get proper attention from the authorities).
1621	en	ln	 Hourly folks will be fully paid. 	 Bakofuka ngonga ya mosala nyonso. 	They will blow every working hour.
1622	en	ln	 We have already said, and are recommitting to honor our commitments to our contractors and hourly staff colleagues. 	 Tosi tolobaki yango, mpe tozozongeli komipesa na biso mpo na kotosa boyokani na biso na ba entrepeneur na biso mpe baninga ya mosala oyo basalaka na bangonga eyebani. 	We have already said that, and we reiterate our commitment to honor our agreements with our contractors and colleagues who work defined hours.
1623	en	ln	 Everyone will be paid on the basis of their usual hours worked during normal circumstances. 	 Bakofuta bato nyonso na kotalela bangonga oyo basalaka mbala na mbala ntango makambo esalemaka bo momeseno. 	All will be paid based on regular hours worked when things are normal.
1624	en	ln	 This includes if you are sick and unable to work. 	 Etaleli mpe soki ozobela to ozokoka te kosala. 	It also depends on whether you are sick or unable to work.
1625	en	ln	 If you want to work, we support you. 	 Soki olingi kosala, tokosalisa yango. 	If you want to work, we will help it.
1626	en	ln	 Many people use work as a way of channeling their stress with the world around us. 	 Bato mingi basalelaka mosala lokola eleko esalisaka bango na kokabola mitungisi na bango na bato oyo bakutanaka na bango. 	Many people use work as a season to help them share their concerns with the people they meet.
1627	en	ln	 What we do can be incredibly rewarding, especially during times like this. 	 Oyo tosalaka ekoki kosalisa mingi mpenza, mingimingi na bantango neti oyo. 	What we do can be very helpful, especially at times like these.
1628	en	ln	 Again, this is about your self-care. 	 Lisusu, ezotalela ndenge omibatelaka. 	Also, it depends on how you protect yourself.
1629	en	ln	 Our ask is that you communicate with your manager, so we know what to expect and can adjust accordingly. 	 Tozosenga ete osolola na mokonzi na yo, mpo toyeba makambo tokosala mpe nasala mbongwana ebongi. 	We ask that you talk to your boss, so that we know what we will do and make appropriate changes.
1630	en	ln	 Some work is considered essential. 	 Misala mosusu etalelami ete eza ya ntina mingi. 	Some activities are considered critical.
1631	en	ln	 There are some things that we must keep doing. 	 Eza na makambo mosusu oyo tosengeli kokoba kosala. 	There’s some things we need to continue to do.
1632	en	ln	 The SRE, HR Ops, Trust &amp; Safety, and Fundraising teams (among others) do critical work that may need additional support. 	 Masanga ya SRE, HR Ops, Trust &amp; Safety, and Fundraising (na kati na yango) esalaka misala ya ntina oyo ekoki kosenga lisungi mosusu. 	The SRE, HR Ops, Trust &amp; Safety, and Fundraising groups (including) perform important functions that may require additional support.
1633	en	ln	 We’ll begin a process with all departments to assess current objectives and shift our focus to supporting what’s essential for our mission. 	 Tokobanda mosala moko na badepartema nyonso mpo na koyeba mikano na biso ya sika mpe kotya likebi sikoyo na kopesa maboko na makambo ya ntina ya mosala na biso. 	We will embark on a process across all departments to identify our new objectives and focus now on contributing to the core areas of our work.
1634	en	ln	 There’s plenty to do for all of us, we just will all focus on the most essential projects. 	 Biso nyonso toza na mosala mingi, kasi tokotya likebi na misala ya ntina mingi. 	We are all busy, but we will focus on the more important tasks.
1635	en	ln	 Slowing now won’t hurt later. 	 Kolembisa sikoyo ekosala biso mpasi te na nsima. 	Tiring out now won’t hurt us later.
1636	en	ln	 We do not plan to go “double-time to catch up” once the pandemic has passed. 	 Toza te na likanisi ya “kosala mbala mibale koleka mpo na ko recuperer” soki maladi esili. 	We don’t have the idea of “working twice as hard to recover” once the illness is gone.
1637	en	ln	 You will not be expected to work extra hours to meet deadlines which are now unrealistic. 	 Tokosenga biso te bosalaka ba heure supplémentaire mpo na kosilisa mosala na badate na yango oyo eza ntina te sikoyo. 	We will not ask you to work overtime to complete the work on dates that are not necessary now.
1638	en	ln	 We accept that circumstances have changed, and will work to set new targets and timelines where appropriate. 	 Tozondima ete makambo ebongwani, mpe tokobongisa makambo mpo na komityela mikano ya sika mpe badate bisika oyo eza mpenza ntina. 	We will acknowledge that things have changed, and we will adjust to set new goals and dates where they really matter.
1639	en	ln	 What happens with the APP (Annual Planning)? 	 Nini ekokomela APP (planification annuelle)? 	What will happen to the APP (annual planning)?
1640	en	ln	 To adjust to our new reality and daily working hour expectations, we intend to adjust the timeline for the delivery of our 2020-2021 Annual Plan. 	 Mpo komesana na makambo ya sika mpe bangonga ya mosala ya mokolo na mokolo, tozolinga kobongola ntango oyo tokobimisa planification annuelle na biso ya 2020-2021. 	To adapt to new conditions and daily working hours, we are planning to change the timing of the release of our 2020-2021 annual planning.
1641	en	ln	 Our intention is to propose an extension of our 2019-2020 plan that allows more time for budgeting to allow employees to prioritize critical work, self-care, and care for loved ones while accommodating those who need or wish to work a reduced schedule over the next few weeks. 	 Likanisi na biso eza ya kosenga babakisa mikolo na planification na biso ya mobu 2019-2020 mpo tozala na likoki ya kobongisa makambo ya mbongo oyo ekosalisa bato na biso ya mosala batya likebi nanu na misala ya ntina, komibatela, mpe kobatela bato oyo balingaka ntango tozotalela baoyo basengeli to balingi kosala ngonga moko na bamposo ezoya. 	Our intent is to request an extension to our 2019-2020 planning so that we are able to make financial arrangements that will help our workforce first focus on essential services, protecting ourselves, and caring for loved ones while we care those who need or want to work an hour in the coming weeks.
1642	en	ln	 This timeline extension greatly reduces current planning workloads and pressure across the whole organization. 	 Kobakisa mikolo ekotisa mpenza mosala ya kobongisa makambo ya sikoyo mpe pression na organisation mobimba. 	Extending the dates will definitely introduce current processing and pressure across the organization.
1643	en	ln	 We will introduce our proposal to the Board next week and will update delegates and teams on the next steps as soon as we have confirmation. 	 Tokotinda likanisi na biso na bakonzi na mposo ezoya mpe koyebisa mimonisi mpe ba-ekipe na biso makambo ya kosala nsima soki tozwi eyano ya bakonzi. 	We will send our proposal to the authorities next week and inform our representatives and teams of the next steps once we receive a response from the authorities.
1644	en	ln	 Thank you to the APP team for your leadership in this. 	 Topesa matondi na ekipe ya APP ndenge bokambi misala oyo. 	We thank the APP team for leading these activities.
1645	en	ln	 Office status, exposure, and cleaning 	 Statut ya biro, kozala na likama ya maladi, mpe kotya bopeto 	Office status, exposure to disease, and establishing hygiene
1646	en	ln	 Last week, we learned that one of our SF-based colleagues may have been exposed to the COVID-19 virus. 	 Na mposo eleki, bayebisaki biso ete mbala mosusu moninga na biso moko akutanaki na moto moko oyo aza na virisi COVID-19. 	Last week, we were told that a friend of ours may have been in contact with someone with the COVID-19 virus.
1647	en	ln	 However, out of an abundance of caution, we employed an antiviral cleaning crew to disinfect all surfaces in the San Francisco office. 	 Kasi, mpo na kokeba makasi, tosalelaki nkisi ebomaka virisi mpo na kopetola bisika nyonso na biro ya Francisco. 	However, as a precaution, we used disinfectant to clean everywhere in Francisco&#39;s office.
1648	en	ln	 They utilized a hospital-grade anti-viral solution to disinfect every surface, as well as the lobby and elevator banks accessing our floor. 	 Basalelaki nkisi ya koboma mikrobe oyo basalelaka na balopitalo mpo na kopetola bisika nyonso, eza esika ya kokotela mpe ba elevateur oyo ememaka na biro na biso. 	Hospital disinfectants were used to clean everywhere, including the entrance and the elevators that lead to our office.
1649	en	ln	 The building is employing its own duty-of-care protocol utilizing products that support the safety of their tenants. 	 Basalelaka ndako yango esalelaka mibeko na yango moko. 	They use the building uses its own rules.
1650	en	ln	 We feel comfortable that the office will be well-prepared for when we decide to return. 	 Toza motema ya kokita mpo toyebi ete biro ekozala malamu mpenza ntango tokozonga kuna. 	We are relieved because we know the office will be perfectly fine when we get back there.
1651	en	ln	 Our DC office is located in a WeWork, which has shared its COVID-19 protocol with us and all DC-based staff members. 	 Biro na biso ya DC eza na WeWork, oyo eyebisi biso mibeko na bango ya komibatela COVID-19 mpe epesi yango na basali nyonso ya DC. 	Our DC office has WeWork, which informs us of their COVID-19 safety policies and provides them to all DC employees.
1652	en	ln	 As of last week, our DC office moved to a fully remote setup in line with the guidance shared with San Francisco. 	 Na mposo eleki, babongisaki biro na biso ya DC mpo bato babanda kosala mosika na kolanda litambwisi oyo eutaki na San Francisco. 	Last week, our DC office was upgraded so people could start working remotely following the guidance from San Francisco.
1653	en	ln	 As some of our NYC-based colleagues know, we have also been in discussion about leasing a location in Brooklyn. 	 Ndenge baninga na biso mosusu ya NYC bayebi, tozalaki mpe na masolo mpo na koluka esika na Brooklyn. 	As some of our NYC friends know, we were also in talks about finding a location in Brooklyn.
1654	en	ln	 These discussions are continuing but may be delayed. 	 Masolo oyo ezolandaka kasi oyo kozela. 	Ongoing stories but wait.
1655	en	ln	 Some of our colleagues are working remotely for the first time. 	 Baninga na biso mosusu bazosala na mosika mpo na mbala ya liboso. 	Some of our friends are working remotely for the first time.
1656	en	ln	 Our long-time remote colleagues know that it can be an adjustment, and wanted to offer you some advice: 	 Baninga na biso ya kala oyo basalaka mosika bayebi ete ekoki kozala mbongwana, mpe tolingaki kopesa bino mwa batoli: 	Our longtime remote colleagues know it can be a change, and we wanted to give you some tips:
1657	en	ln	 Limit the length of meetings to at most one or two hour increments. 	 Kosala ete makita ezwa ngonga moko to mibale. 	Keep meetings to an hour or two.
1658	en	ln	 If longer sessions are required, consider how they can be broken up over the course of several days. 	 Soki esengeli kozwa ntango mingi, botala soki bokoki kosala yango mokemoke na mikolo mingi. 	If it takes more time, see if you can do it gradually over several days.
1659	en	ln	 Clearly define the meeting, have an agenda, and send reading materials in advance. 	 Boyeba polele ntina ya likita, makambo bokolobela, mpe botinda makambo ya kokanga na liboso. 	Clearly identify the purpose of the meeting, what you will discuss, and send closing details up front.
1660	en	ln	 Make video the default, with tools like Google Docs and Zoom to facilitate live collaboration and connection. 	 Boyebisa video oyo bakosalela, na bisaleli neti Google Doc mpe Zoom mpo masolo ya en direct eleka malamu mpe connection eza bien. 	Specify the video they will use, with tools like Google Doc and Zoom to make the live chat go smoothly and the connection is good.
1661	en	ln	 Have a lead to facilitate every meeting, someone to monitor the chat for questions and track the speaker list, and someone to help take notes (or do collaborative note-taking). 	 Bozala na mokambi mpo likita nyonso esalema malamu, moto oyo akoyanola na chat mpo na mituna oyo bazotuna mpe bapiste oyo eza na liste ya balobi, mpe moto oyo ekosalisa na kozwa banote (to bosalisana na kozwa banote). 	Have a moderator to keep every meeting running smoothly, someone to answer the chat for FAQs and tracks on the speaker list, and someone to help take notes (or help each other take notes).
1662	en	ln	 Send an email to tech support if you need a comfortable headset. 	 Botindela ba support informatique email soki boza na mposa ya ba écouteur ya malamu.	Please email computer support if you need better headphones.
1663	en	ln	 Use your wellness reimbursement for snacks. 	 Bosalela mbongo ya bien être mpo na bilei. 	Use welfare money for food.
1664	en	ln	 Join the #remoties channel in Slack to talk with your colleagues about distributed work 	 Kota na chaine #remoties na Slack mpo na kosolola na baninga na yo na ntina na mosala 	Join the #remoties channel on Slack to chat with your friends about the project
1665	en	ln	 The HR Operations team is looking into webinar-based ergonomics guidance to support the increase in distributed work across the Foundation. 	 Ekipi ya HR ezozela makita ya internet mpo na litambwisi ekosalisa na kolandela mosala ya mingi oyo eza mpo na Fondation. 	The HR team looks forward to online meetings for guidance will help monitor the overwhelming workload available to the Foundation.
1666	en	ln	 This past week we asked all community grant recipients to cancel Wikimedia-funded public events, such as editathons, until the WHO declares the pandemic to be over. 	 Na mposo eleki, toyebisaka bato nyonso na kokata makutani nyonso ya bato nyonso oyo Wikipedia efutaka mbongo, na ndakisa editathons, kino ntango OMS akoloba maladi mabe esili. 	Last week, we informed the public by canceling all Wikipedia-sponsored public gatherings, such as editathons, until the WHO declared the plague over.
1667	en	ln	 We let them know that we understood that our request for cancellations and other restrictions could make it impossible to complete their agreed-upon grant activities and that no one would be penalized for having to delay or modify those goals. 	 Tokoyebisa bango ete toyebi ete kosenga kokata makutani wana mpe bipekiseli mosusu ekoki kosala ete ezala mpasi na kosala makambo oyo toyokanaki mpe ekozala foti ya moto moko te ndenge topusi date to tobongoli mikano oyo. 	We will let them know that we recognize that requesting these appointments and other restrictions may make it difficult to carry out our agreements and that it is not anyone&#39;s fault that we have postponed or changed these meetings.
1668	en	ln	 This coming week we will follow up with additional guidance on Wikimania and other regional and thematic community conferences. 	 Na mposo ezoya, tokotya mibeko mosusu na Wikimania mpe na makita mosusu ya bituka mpe ya mito ya makambo. 	Next week, we will post more rules at Wikimania and other regional and thematic meetings.
1669	en	ln	 The general sentiment from around the global community seems to be both sadness at the disruption but relief at the clarity and ability to focus on their own communities, Wikimedia and otherwise. 	 Mayoki ya bato na biso ya mokili mobimba eza ya mawa ndenge tokati misala oyo kasi motema ekiti na bandimbola mpe makoki ya kotya likebi na bituluku na bango, Wikimedia, mpe makambo mosusu. 	The feelings of our people around the world are sad that we have cut these services but relieved by the explanations and the ability to focus on their groups, Wikimedia, and other things.
1670	en	ln	 Going forward, the CRT is working to set up a page on Meta-Wiki to provide a space for the community to monitor the impact and follow our communications with them. 	 Mpo na kokokisa yango, CRT ezali komilengela mpo na kosala nkasa ya Meta-Wiki mpo kopesa bituluku esika ya kolandela bopusi mpe masolo na biso na bango. 	To this end, CRT is preparing to create Meta-Wiki pages to give groups a place to track our impact and conversations with them.
1671	en	ln	 Staying in touch around COVID-19 related issues 	 Kokoba koyeba makambo etali COVID-19 	Keep up to date with COVID-1
1672	en	ln	 We’ll be sending an invitation to your calendars for next Thursday, 14:00 UTC/07:00 PT for a special staff meeting. 	 Tokotinda libyangi na kalandrie na biso na mokolo ya minei, na , 14:00 UTC/07:00 PT mpo na likita ya ntina ya bato ya mosala. 	We will send out an invitation in our calendar on Thursday, at , 14:00 UTC/07:00 PT for an important staff meeting.
1673	en	ln	 We’ll use this time to share additional updates, answer your questions and spend some time connecting with each other. 	 Tokosalela ngonga wana mpo na koyebisa bino makambo mosusu ya sika, kopesa biyano na mituna na bino mpe kolekisa ntango na mokomoko na bino. 	We will use that time to update you, answer your questions, and spend time with each of you.
1674	en	ln	 We’re in this together and here to help however we can. 	 Toza elongo na likambo oyo mpe kosalisa bino na ndenge tokoki. 	We are with this and helping you as much as we can.
1675	en	ln	 In the meantime, you can continue to find the information from this email, and all other essential COVID-19 related information, on Office Wiki. 	 Ntango bozozela, bokoki kokoba kolanda nsango eza na email oyo, mpe bansango mosusu ya ntina etali COVID-19, na Office Wiki. 	While you wait, you can continue to follow the information in this email, and other important information about COVID-19, on the Office Wiki.
1676	en	ln	 The CRT will keep these pages updated and all the information in one place. 	 CRT ekokoba kotya bansango ya sika na bankasa oyo mpe kotya bansango nyonso esika moko. 	CRT will continue to update these pages and put all the information together.
1677	en	ln	 We are also working to maintain regular communications with staff who reside in countries that are currently significantly affected. 	 Tozosala mpe makasi mpo na kokoba kosolola na bato na biso oyo bafandaka na mikili oyo maladi ebeti bango makasi. 	We are also working hard to keep in touch with our people living in countries that have been hit hard by the disease.
1678	en	ln	 If you have any questions about travel, events, a major workstream, or coverage challenge, or anything else you may need help with, please don’t hesitate to notify and work with the CRT. 	 Soki boza na motuna na nyonso etali mobembo, makita, mosala, to lolenge ya kolonga bampasi, to likambo nyonso mosusu oyo ezosenga lisalisi, bokakatana te na koyebisa mpe kosala elonga na CRT. 	If you have any questions about travel, meetings, work, or how to cope with adversity, or anything else that requires help, please do not hesitate to let CRT know and make a success of it.
1679	en	ln	 We’re here to help provide support and liaise as needed. 	 Tozali wana mpo kopesa lisungi mpe lisalisi soki esengeli. 	We are there to provide support and assistance if needed.
1680	en	ln	 If you have a confidential or sensitive matter, please email Bryan Judan - Director of HR International Global Operations. 	 Soki oza na likambo ya sekele to ya ntina, komela Bryan Judan - diretere ya misala ya mokili mobimba ya HR. 	If you have a confidential or sensitive issue, please contact Bryan Judan - global HR operations director.
1681	en	ln	 None of these changes should be seen as an abandonment of our work and obligations. 	 Moto moko te asengeli komona bambongwana oyo neti kotika mikumba mpe mosala na biso. 	No one should see these changes as giving up our responsibilities and work.
1682	en	ln	 Rather, they are a recognition that at this moment, our work and obligations will likely need to adapt in a way we have not in the past. 	 Kasi, ezali kondima ete na eleko oyo, mosala mpe mikumba na biso ekobongwana na ndenge oyo ebongwana nanu te. 	Rather, it is an acknowledgment that in this era, our work and responsibilities will change in ways that have never changed before.
1683	en	ln	 These are the steps we believe are necessary to support this one another so that we can continue to work, provide our movement with the support they need, and the world with the service they rely on. 	 Eza bitambe oyo tokanisi eza ntina mpo na kosalisana mpo tokoba kosala, kopesa etuluku na biso lisungi eza na yango mposa, mpe kosalela mokili mosala oyo etyelaka motema. 	They are steps we think are important to help each other keep working, give our group the support it needs, and serve the world the work it trusts.
1684	en	ln	 Our planned work will be there waiting for us when the time comes. 	 Mosala na biso oyo tobongisa ekozela biso kino ntango ekokoka. 	Our prepared work will await us until the time is right.
1685	en	ln	 For now, it is time to support one another and create space for the important work that will be coming in the weeks and potentially months ahead. 	 Sikoyo eza ntango ya kosalisana mpe kosala bisika mpo na mosala ya ntina oyo ekoya na bamposo mpe mbala mosusu na basanza ezoya. 	Now is the time to help each other and make room for the important work that will come in the weeks and perhaps months ahead.
1686	en	ln	 We need all of you to make that happen, and so we need you all to take care of yourself and your families so that you can be at your best when the need arises. 	 Toza na mposa na bino nyonso mpo esalema, yango wana tozosenga bino nyonso bomibatela mpe bobatela mabota na bino mpo bazala mpenza makasi ntango mposa ekozala. 	We need all of you to make it happen, so we’re asking you all to take care of yourselves and your families to be really strong when the need arises.
1687	en	ln	 Now, please -- wash your hands and don’t touch your face! 	 Sikoyo, tosengi biso -- bosukola maboko mpe bosimba elongi te! 	Now, please -- wash your hands and don&#39;t touch your face!
1688	en	ln	 Katherine, the CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, and Tony S), and the rest of the Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, and Toby N). 	 Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, mpe Tony S), mpe ekipe mobimba ya bakambi (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, na Toby N). 	Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, and Tony S), and the entire leadership team (Grant I, Heather W, Jaime V). , Janeen U , Lisa S , Robyn A , Ryan M , and Toby N ).
1689	en	ln	b'Angiotensin-converting enzyme 2 (ACE2) is an enzyme attached to the outer surface (cell membranes) of cells in the lungs, arteries, heart, kidney, and intestines.	Angiotensin ezali kokoma enzyme 2 (ACE2) ezali enzyme moko oyo ezali na libanda ya (membranes ya cellule) mimpulupulu, misisa, motema, bangei na misopo. 	Angiotensin is becoming enzyme 2 (ACE2) is an enzyme found in the outer (cell membranes) of the lungs, muscles, heart, spleen and kidneys.
1690	en	ln	ACE2 counters the activity of the related angiotensin-converting enzyme (ACE) by reducing the amount of angiotensin-II and increasing Ang(1-7) making it a promising drug target for treating cardiovascular diseases.ACE2 also serves as the entry point into cells for some coronaviruses.	ACE2 ekangaka mosala ya kobalola angiotensin na enzyme (ACE) na kokitisa boni ya engiotensin-II mpe komatisa ang(1-7) kokomisa yango kisi y amakasi mpona kosalisa maladi ya motema. ACE2 mpe esalisamaka mpona kokota bacoronavirisi. 	ACE2 inhibits the conversion of angiotensin to enzyme (ACE) by reducing the amount of angiotensin-II and increasing ang(1-7) making it a potent drug for the treatment of heart disease. ACE2 is also used to enter coronaviruses.
1691	en	ln	The human version of the enzyme is often referred to as hACE2.	Enzyme ya nzoto ya bato ebengami hACE2.	The human body enzyme is designated hACE2.
1692	en	ln	Angiotensin-converting enzyme 2 is a zinc containing metalloenzyme located on the surface of endothelial and other cells.	Angiotensin kokoma enzyme 2 ezali metalloenzyme oyo ezali na Zinx na likolo ya endothelial mpe bacellule misusu. 	Angiotensin becoming enzyme 2 is a metalloenzyme that contains Zinx on the surface of endothelial and other cells.
1693	en	ln	ACE2 protein contains an N-terminal peptidase M2 domain and a C-terminal collectrin renal amino acid transporter domain.	Protein ya ACE2 ezali na N-terminal peptidase M2 mpe C-terminal ya kozwa ya zolo ya komema amono acid. 	The ACE2 protein contains an N-terminal peptidase M2 and a C-terminal receptive nose ammono acid carrier.
1694	en	ln	ACE2 is a single-pass type I membrane protein, with its enzymatically active domain exposed on the surface of cells in lungs and other tissues.	ACE2 esali type ya membrane ya protein kaka ya moko, na mosala na ye ya kokoma enzyme na libanda ya bacellule mpe baposo misusu. 	ACE2 forms a protein membrane type of only one, with its function of becoming an enzyme on the outside of cells and other weeks.
1695	en	ln	The extracellular domain of ACE2 is cleaved from the transmembrane domain by another enzyme known as sheddase, and the resulting soluble protein is released into the blood stream and ultimately excreted into urine.	Esika ya extracellular ya ACE2 euti na transmembrane na enzyme mosusu oyo babengi sheddase, nsima protein ekobima ekokota makila nsima ekobima na nzela ya masuba. 	The extracellular site of ACE2 is derived from the transmembrane by another enzyme called sheddase, then the protein will be released into the bloodstream then excreted through the urine.
1696	en	ln	ACE2 is present in most organs: ACE2 is attached to the cell membrane of mainly lung type II alveolar cells, enterocytes of the small intestine, arterial and venous endothelial cells and arterial smooth muscle cells in most organs.	ACE2 ezali na kati ya baorgan mingi: ACE2 ekangami na membrane ya cellule ya mimpulupulu ya type II ya bacellule ya alveolarenterocytes ya misopo ya moke, misisa mpe bavein ya endothelial mpe muscle ya pete ya cellule ya misisa na baorgans.	ACE2 is present in many organs: ACE2 is bound to the lung type II cell membrane of small intestinal alveolarenterocyte cells, endothelial vessels and vessels and vascular cell smooth muscle in organs.
1697	en	ln	ACE2 mRNA expression is also found in the cerebral cortex, striatum, hypothalamus, and brainstem.	ACE2 mRNA ezali mpe na cortez, striatum, ypothalamus, mpe brainstem. 	ACE2 mRNA is also present in the cortex, striatum, ypothalamus, and brainstem.
1698	en	ln	The primary function of ACE2 is to act as a counter balance to ACE.	Mosala ya liboso ya aCE2 ezali kosala mosala ya ACE. 	The primary function of aCE2 is to activate ACE.
1699	en	ln	ACE cleaves angiotensin I hormone into the vasoconstricting  angiotensin II.	ACE ekangisaka ba hormone ya I ya angiotensin na vasoconstriction ya angiotensin II. 	ACE binds angiotensin I hormones and angiotensin II vasoconstriction.
1700	en	ln	ACE2 in turn cleaves the carboxyl-terminal amino acid phenylalanine from angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) and hydrolyses it into the vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).	ACE2 ekangamaka na carboxyl-terminal amino acid phenylalanine na angiotensin II (Asp-Arg-Tyr-Ile-His-Pro-pPhe) mpe kohydrolyse yango na kati ya vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH). 	ACE2 binds to the carboxyl-terminal amino acid phenylalanine in angiotensin II (Asp-Arg-Tyr-Ile-His-Pro-pPhe) and cohydrolyzes it into the vasodilator angiotensin (1-7), (H-Asp-Arg-Val- Tyr-Ile-His-Pro-OH).
1701	en	ln	ACE2 can also cleave a number of other peptides including [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, and ghrelin.	ACE2 ekoki mpe kokangama na bapeptides mingi lekola [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, na ghrelin. 	ACE2 can also bind to several peptides such as [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, and ghrelin.
1702	en	ln	ACE2 also regulates the membrane trafficking of the neutral amino acid transporter SLC6A19 and has been implicated in Hartnup's disease.	ACE2 ebongisaka mpe embouteillage ya membrane ya neutral amino acid oyo ememaka SLC6A19 mpe ezalaki na maladi ya Hartnup. 	ACE2 also regulates membrane packing of neutral amino acid carrying SLC6A19 and was present in Hartnup disease.
1703	en	ln	As a transmembrane protein, ACE2 serves as the main entry point into cells for some coronaviruses, including HCoV-NL63; SARS-CoV (the virus that causes SARS); and SARS-CoV-2 (the virus that causes COVID-19).	Lekola protein ya transmembrane, ACE2 ezali esika ya liboso ya kokota ya bacellule ya coronavirisi, mpe HCoV-NL63; SARS-CoV (virisi oyo SARS euti); mpe SARS-CoV-2 (virisi oyo COVID-19 euti). 	As a transmembrane protein, ACE2 is the primary cell entry site for coronaviruses, and HCoV-NL63; SARS-CoV (SARS-derived virus); and SARS-CoV-2 (the virus from which COVID-19 is caused).
1704	en	ln	More specifically, the binding of the spike S1 protein of SARS-CoV and SARS-CoV2 to the enzymatic domain of ACE2 on the surface of cells results in endocytosis and translocation of both the virus and the enzyme into endosomes located within cells.	Na kososola malamu, kokangama ya nsonge ya protein ya S1 ya SARS-CoV na SARS-CoV2 na enzyme ya ACE2 na likolo ya bacellule ekomema endocytosis mpe kotambwisa virisi ya enzyme elongo moko na kati ya endosomes oyo ezali na kati ya bacellule. 	Intuitively, binding of the S1 protein peak of SARS-CoV and SARS-CoV2 to the ACE2 enzyme on the cell surface would lead to endocytosis and guidance of the enzyme virus together into intracellular endosomes.
1705	en	ln	This entry process also requires priming of the S protein by the host serine protease TMPRSS2, the inhibition of which is under current investigation as a potential therapeutic.This has led some to hypothesize that decreasing the levels of ACE2, in cells, might help in fighting the infection.	Esika ya kokota oyo esengi kobongisa protein S na serine protease TMPRSS2, oyo ezali bazali kososola therapy oyo ekoki kosimba. Oyo etindi bato misusu bakitisa ACE2, na kati ya bacellules, mpona komeka kobundela infection. 	This entry point requires the conversion of protein S to the serine protease TMPRSS2, which is are understood potential therapy. This has led some people to lower ACE2, in cells, to try to fight infection.
1706	en	ln	However, multiple professional societies and regulatory bodies have recommended continuing standard ACE inhibitor and ARB therapy.	Kasi, basociete mini ya bayekoli mpe ya mibeko balobi ete esengeli bakenda kaka liboso na ACE oyo esengami mpe na therapie ya ARB. 	However, the academic and legal mini-societies say they should still go ahead with the recommended ACE and ARB therapy.
1707	en	ln	"A systematic review and meta-analysis published on July 11, 2012, found that ""use of ACE inhibitors was associated with a significant 34% reduction in risk of pneumonia compared with controls."""	Lisosoli moko ya system mpe ya etid-ya-meta oyo babimisaki na mokolo ya 11 sanza ya nsambo 2012 emonaki ete ‘’kosalisa ACE ekokitisa na 34% chance ya pneumonia’’. 	A system and etid-ya-meta opinion published on July 11, 2012 found that &#39;&#39;ACE treatment will reduce by 34% the chance of pneumonia&#39;&#39;.
1708	en	ln	"Moreover, ""the risk of pneumonia was also reduced in patients treated with ACE inhibitors who were at higher risk of pneumonia, in particular those with stroke and heart failure."	Kasi mpe, ‘’risk ya pneumonia ekitaki mpe na bato oyo basalisaki bango na ACE bato oyo bakokaki kozwa pneumonia noki, lekola ba oyo bazalaki kobela motema. 	But also, &#39;&#39;the risk of pneumonia also decreased in people treated with ACE people who could develop pneumonia earlier, such as those with heart disease.
1709	en	ln	"Use of ACE inhibitors was also associated with a reduction in pneumonia related mortality, although the results were less robust than for overall risk of pneumonia."""	Kosalisa ACE esanganaki mpe na kokitisa pneumonia mpo bato bakufa te, kasi baresulta ezalaki makasi mingi te na oyo ya risk ya pneumonia.’’ 	ACE treatment was also associated with a reduction in pneumonia so that people didn&#39;t die, but the results were less robust than those for pneumonia risk.&#39;&#39;
1710	en	ln	Recombinant human ACE2 (rhACE2) is surmised to be a novel therapy for acute lung injury, and appeared to improve pulmonary hemodynamics and oxygen saturation in piglets with a lipopolysaccharide-induced acute respiratory distress syndrome.	Recombinant ya bato ACE2 (rhACE2) ezali therapie ya sika mpona mpasi ya mimpulupulu, mpe ezalaki kosalisa pulmonary hemodynaci mpe ekotonda ya oxygen na kati ya bangulu na lypopolysaccharie kati ya syndrome ya mpasi ya kopema. 	Recombinant human ACE2 (rhACE2) is a new therapy for lung disease, and has been used to treat pulmonary hemodynaci and oxygen saturation in pigs with lypopolysaccharia in respiratory distress syndrome.
1711	en	ln	The half-life of rhACE2 in human beings is about 10 hours and the onset of action is 30 minutes in addition to the course of effect (duration) of 24 hours.	Bomoi ya moke ya rhACE2 na kati ya bato ezali bangonga 10 mpe ekosala mosala na baminute 30 elongo moko na ngonga 24. 	The minimum lifespan of rhACE2 in humans is 10 hours and it will work for 30 minutes together with 24 hours.
1712	en	ln	Several findings suggest that rhACE2 may be a promising drug for those with intolerance to classic renin-angiotensin system inhibitors (RAS inhibitors) or in diseases where circulating angiotensin II is elevated.Infused rhACE2 has been evaluated in clinical trials for the treatment of acute respiratory distress syndrome.	Ba etid mingi elobi ete rhACE2 ekoki kozala kisi ya malamu mpona ba oyo nzoto eboyi renin-angiotensin (RAS inhibitors) to bamaldi angiotensin oyo ezali kotambo ezali makasi. rhACE2 esosolami na kati ya clinic mpona kosalisa maladi ya mpasi ya kopema. 	Many etid suggest that rhACE2 may be a good treatment for those who are renin-angiotensin resistant (RAS inhibitors) or patients with severe circulating angiotensin. rhACE2 is understood in the clinic for the treatment of respiratory distress syndrome.
1713	en	ln	"b'COVID-19 apps are mobile software applications designed to aid contact tracing in response to the 2019-20 coronavirus pandemic, i.e. the process of identifying persons (""contacts"") who may have been in contact with an infected individual."	B’COVID-19 apps ezali baaplication ya telephone oyo esalemi mpona kolanda bato oyo bakoki kozala na maladi ya pandemi ya coronavirisi ya 2019-20. Lekola, ndenge ya koyeba (‘’bato’’) oyo bakokaki kozala esika moko na moto oyo azalaki na maladi.	B&#39;COVID-19 apps are mobile applications designed to track potential cases of the 2019-20 coronavirus pandemic. Measure, how to identify (&#39;&#39;people&#39;&#39;) who may have been in contact with the patient.
1714	en	ln	Numerous applications were developed or proposed, with official government support in some territories and jurisdictions.	Baaplication mingi esalemaki, mpe na lisungi ya gouvernema na bisika misusu.	Many applications were developed, also with government support elsewhere.
1715	en	ln	Several frameworks for building contact tracing apps have been developed.	Ba ndenge mingi ya kolandela bato esalemaki na baaplication ya telephone.	Many forms of tracking have been implemented in mobile applications.
1716	en	ln	Privacy concerns have been raised, especially about systems that are based on tracking the geographical location of app users.	Bato basepekali te na ndenge ezali kotia miso na basekele ya bato, lekola basystem oyo ezali kolanda esika oyo bato bazali.	People are not happy with the way it is eyeing people’s secrets, like location-tracking systems.
1717	en	ln	Less intrusive alternatives include the use of Bluetooth signals to log a user's proximity to other cellphones.	Ya kotia miso mingi te na kati ya basekele ya bato ezali basignal ya Bluetooth oyo ekoyebisa moto soki azali pene na ba telephone misusu.	Not to put too many eyes into people&#39;s secrets are Bluetooth signals that will tell someone if they are near other phones.
1718	en	ln	On 10 April 2020, Google and Apple jointly announced that they would integrate functionality to support such Bluetooth-based apps directly into their Android and iOS operating systems.	Na mokolo ya 10 sanza ya minei 2020, Google na Apple balobaki ete bakotia basystem ya kosunga application ya Bluetooth wana na kati ya Android na iOS.	On April 10, 2020, Google and Apple said that they would include systems to support that Bluetooth application within Android and iOS.
1719	en	ln	In China, the Chinese government, in conjunction with Alipay, has deployed an app that allows citizens to check if they have been in contact with people that have COVID-19.	Na Chine, gouvernema ya Chine, elongo moko na Alipay, esali application oyo esungi bato ya mboka koyeba soki bazalaki pene na moto oyo azali na COVID-19.	In China, the Chinese government, together with Alipay, has developed an application that helps citizens know if they have been close to someone with COVID-1
1720	en	ln	It is in use across more than 200 Chinese cities.In Singapore, an app called TraceTogether is being used.	Ezali kosalema kati na bigumba 200 na Chine, na Singapore, application moko nkombo TraceTogether ezali kosalema.	Taking place among 200 cities in China, in Singapore, an application named TraceTogether is taking place.
1721	en	ln	"The app was developed by local IT community, released as open source and will be handed over to the government.North Macedonia launched ""StopKorona!"", a Bluetooth-based app to trace exposure with potentially infected persons and  provide a fast response to healthcare authorities."	Bato ya mayele ya IT na kati ya egumba moto basalaki application yango, babimisaki yango mpona moto nyonso asalisa mpe bako pesa yango na gouvernema. Macedoine ya Nord ebimisaki ‘’StopKorona!’’, application ya Bluetooth oyo ekomona soki moto amipesi na maladi epayi ya moto oyo azali na maladi mpe kosunga etumba ya gouvernema na kolongono.	IT professionals in the city developed the application, released it for everyone to use and will submit it to the government. Northern Macedonia launched &#39;&#39;StopKorona!&#39;&#39;, a Bluetooth application that will detect if a person has transmitted the disease to someone who is sick and support the government&#39;s fight against health.
1722	en	ln	The app was developed by the Ministry of Communication and Technology and Ministry of Health.	App esalemaki na Minisere ya Communication mpe ya Technologie na Ministere ya Kolongono.	The app was developed by the Ministry of Communication and Technology in the Ministry of Health.
1723	en	ln	As of 14 April 2020, the app was awaiting approval by the Google Play Store and Apple App Store.	Na mokolo ya 14 sanza ya minei 2020, application ezalaki kozela endimelo ya Google Play na ya Apple App Store.	As of April 14, 2020, the application was awaiting Google Play and Apple App Store approval.
1724	en	ln	"On 12 April, the government stated that the contact tracing app was in an advanced stage of development, and would be available for deployment within weeks.A similar app is planned in Ireland, and in France (""StopCovid"")."	Na mokolo ya 12 sanza ya minei, gouvernema elobaki application ya kolandela bato ekomaki mosika, mpe bakokoka kosalela yango na ba poso oyo ezali koyaka. Application mosusu ya boye ezali kosalema na Ireland, mpe na France (‘’StopCovid’’).	On April 12, the government said the tracking application had come a long way, and they would be able to use it in the coming weeks. Another such app is being implemented in Ireland, and in France (&#39;&#39;StopCovid&#39;&#39;).
1725	en	ln	Both Australia and New Zealand are considering apps based on Singapore's TraceTogether app and BlueTrace protocol.Russia intends to introduce a geofencing app for patients diagnosed with COVID-19 living in Moscow, designed to ensure they do not leave home.	Australie na Nouvelle Zealand balingi kosalela application oyo ezali na Singapore TraceTogether mpe BlueTrace protocol. Russie ezali kosala application oyo ekomona bato oyo bazali na COVID-19 oyo bazali kofanda na Moscow, ekosalema mpona kolandela bango mpo ete babima libanda ya ndako te.	Australia and New Zealand plan to use an application that includes Singapore TraceTogether and BlueTrace protocol. Russia is developing an application that will detect people with COVID-19 living in Moscow, will be used to track them so they don’t leave their homes.
1726	en	ln	Ross Anderson, professor of security engineering at Cambridge University, listed a number of potential practical problems with app-based systems, including false positives and the potential lack of effectiveness if takeup of the app is limited to only a small fraction of the population.	Ross Anderson, molakisi ya securite ya ingenieur na universite ya Cambridge, ayebisaki makambo mingi oyo ekoki kosalema na ba system ya application oyo, lekola bapositives ya lekuta, mpe mpasi mpona etambola malamu mpo ete application ekoki kosalisa kaka bato ndabo ya mboka.	Ross Anderson, professor of engineering security at the University of Cambridge, described many of the potential issues with these application systems, such as false positives, and the difficulty of running smoothly because the application can only serve local people.
1727	en	ln	"Addressing concerns about the spread of misleading or harmful ""coronavirus"" apps, Apple set limits on which types of organizations could add coronavirus-related apps to its App Store, limiting them to only ""official"" or otherwise reputable organizations."	Kolandela mitungisi na makambo yo ‘baaplication ya coronavirisi’ ekoki komema, Apple atie limit na baorganization oyo bakoki kotia application na App Store, kosukisa yango kaka na basali ya ‘’gouvernema’’ to baorganization misusu oyo eyebani makasi.	Following concerns about the consequences of you &#39;coronavirus applications&#39;, Apple has limited the number of organizations that can upload applications to the App Store, limiting them to &#39;&#39;government&#39;&#39; employees or other well-known organizations.
1728	en	ln	Google and Amazon have implemented similar restrictions.	Google na Amazon mpe ekotisi mibeko wana.	Google and Amazon have also introduced these rules.
1729	en	ln	Privacy campaigners voiced their concern regarding the implications of mass surveillance using coronavirus apps, in particular about whether surveillance infrastructure created to deal with the coronavirus pandemic will be dismantled once the threat has passed.	Bato yo bazila kobundela bonsoni ya kobomba ba sekekele ya bato mpona kokengela, bamituni soki bisika ya kosala mosala yango na ndenge ya malamu ezali mpe soki ekobebisama nsima ya coronavirisi	People who have been fighting the shame of keeping people&#39;s secrets for protection have wondered if there are safe places to do this work and if they will be destroyed after the coronavirus
1730	en	ln	Amnesty International and over 100 other organizations issued a statement calling for limits on this kind of surveillance.	Amesty International baorganization misusu 100 babengi bato batia mibeko na bolandela bato oyo eko salema.	Amesty International 100 other organizations have called for people to set rules and follow up on what will happen.
1731	en	ln	The organisations declared eight conditions on governmental projects:	Baorganizations bakomaki batoli nsambo oyo gouvernema ekoki kolandela:	The organizations wrote down seven recommendations the government can follow:
1732	en	ln	"surveillance would have to be ""lawful, necessary and proportionate"";"	Kokengela esalema nakotosa ‘’mibeka mpe na ndenge y amalamu’’.	Ensuring that it is done I will obey the &#39;&#39;laws and in a good way&#39;
1733	en	ln	extensions of monitoring and surveillance would have to have sunset clauses;	Esengeli ezala nan tango ya kosukisa kokengela;	It must be nan time to end the surveillance;
1734	en	ln	the use of data would have to be limited to COVID-19 purposes;	Mitango ekosalema kaka mpona COVID-19;	Counts will be made for COVID-19 only;
1735	en	ln	data security and anonymity would have to be protected and shown to be protected based on evidence;	Esengeli babetala makambo ya bato mpe bankombo na bango mpe esengeli balakisa te bazali kosala yango;	They should check people&#39;s details and names and should not show that they are doing so;
1736	en	ln	digital surveillance would have to avoid exacerbating discrimination and marginalisation;	Kokengela na ndenge ya ordinateur esalema na kati ya koyina basusu te ;	Computerized surveillance is not conducted in the midst of hatred of others;
1737	en	ln	any sharing of data with third parties would have to be defined in law;	Kokabola mitango na bato libanda ya mosala oyo esengeli episama na mibeko oyo ekomami;	Distribution of figures to persons outside the workplace must be provided in writing;
1738	en	ln	there would have to be safeguards against abuse and the rights of citizens to respond to abuses;	Esengeli ezala na ndenge ya kobatela bato ya mboka mpe kosunga soki moko amona mpasi mpona mosali oyo;	It should be in a way that protects the community and helps if anyone suffers from this worker;
1739	en	ln	"meaningful participation by all ""relevant stakeholders"" would be required, including that of public health experts and marginalised groups.The German Chaos Computer Club (CCC) and Reporters Without Borders (Reporter ohne Grenzen) (RSF) also issued checklists."	‘’Moyo nyonso azala na kati ya mosala oyo’’ mpona ‘’bato’’ nyonso esengelami, mpe oyo ya basali ya kolongono ya bato mpe ba oyo bazali na bato ya kobatela bango te. German Chaos Computer Club (CCC) mpe na Reporters Without Borders (Reporter ohne Grenzen) (RSF) mpe bakomaki ya bango batoli.	&#39;&#39;Everyone should be involved&#39;&#39; for all &#39;&#39;people&#39;&#39; is required, including those of public health workers and the vulnerable. The German Chaos Computer Club (CCC) and Reporters Without Borders (Reporter ohne Grenzen) (RSF) also wrote their own recommendations.
1740	en	ln	The proposed Google/Apple plan intends to address the problem of persistent surveillance by removing the tracing mechanism from their device operating systems once it is no longer needed.	Plan ya Google na ya Apple ekobenda matoyi na likambo ya kokengela oyo na kolongola system yango soki ntina na yango ezali lisusu te.	Both Google and Apple&#39;s plan will address this oversight by removing the system when it is no longer needed.
1741	en	ln	Some countries used network-based location tracking instead of apps, eliminating both the need to download an app and the ability to avoid tracking.	Bamboka misusu basalisaki kolanda bato na reseau kasi na application te, yango esengi te bato bazala na application mpe bakoki kokima ekengeli.	Some countries have helped track people on the network but not on the application, which does not require people to have an application and can escape surveillance.
1742	en	ln	In Israel, network-based tracking was approved.	Na Israel, kolandela na reseau endimamaki.	In Israel, network monitoring was approved.
1743	en	ln	Network-based solutions that have access to raw location data have significant potential privacy problems.	Kolandela na reseau oyo elakisi wapi moto azali ezali mpe kotia miso na makambo oyo esengeli te.	Tracking on a network that means where someone is is also keeping an eye on things that shouldn’t be.
1744	en	ln	However, not all systems with central servers need to have access to personal location data; a number of privacy-preserving systems have been created that use central servers only for intercommunication (see section below).	Kasi, basystem nyonso te esengeli eyeba esika oyo moto azali; ba system mingi oyo ebatelaka kokengela ya bato esalemi na intercommunication (tala section ya nse).	However, not all systems need to be location-aware; many systems that maintain human surveillance are based on intercommunication (see lower section).
1745	en	ln	In South Korea, a non-app-based system was used to perform contact tracing.	Na Core ya Sud, balandelaki na oyo esengi te bato bazala na application.	In South Core, they followed up with not requiring people to have an application.
1746	en	ln	Instead of using a dedicated app, the system gathered tracking information from a variety of sources including mobile device tracking data and card transaction data, and combined these to generate notices via text messages to potentially-infected individuals.	Na oyo basalela application, bazwaki ba information na bisika mingi lekola telephone, bakarte ya mbongo, mpe basalisi yango mpona koyebisa bato na SMS bakoki kozala na maladi.	Using the application, they collected information from many places such as phones, credit cards, and used it to notify people by SMS that they might be sick.
1747	en	ln	In addition to using this information to alert potential contacts, the government has also made the location information publicly available, something permitted because of far-reaching changes to information privacy laws after the MERS outbreak in that country.	Mpe bayebisaki ba oyo mpe balekaki nzela wana, mpe gouvernema asalaki ete bato nyonso ba yeba esika yango, eloko oyo ezali ya malamu na kati ya mibeko mpo ete esalemaki na pandemi ya MERS oyo esalemaki na kati ya mboka.	And they notified those who also passed that route, and the government made sure the public knew about the location, which is legal because it happened in a domestic MERS pandemic.
1748	en	ln	This information is available to the public via a number of apps and websites.Countries including Germany considered using both centralized and privacy-preserving systems.	Information oyo moto nyonso akoki komona yango na baapplication mingi mpe ba siteweb. Bamboka lekola Germany balingaki basalela system ya kati na oyo eko batela kokengela ya bato.	This information is available to anyone in many apps and websites. Countries like Germany would use an internal system that would keep people safe.
1749	en	ln	As of 6 April 2020, the details had not yet been released.	Na mokolo ya 6 sanza ya minei 2020, babimisaki yango naino te.	As of April 6, 2020, it has not yet been released.
1750	en	ln	Privacy-preserving contact tracing is a well-established concept, with a substantial body of research literature dating back to at least 2013.As of 7 April 2020, over a dozen expert groups were working on privacy-friendly solutions, such as using Bluetooth Low Energy (BLE) to log a user's proximity to other cellphones.	Kolandela eyebani malamu, na ba etid mingi uta 2013. Na mokolo ya 7 sanza ya minei 2020, bayekoli mingi koleka zomi na mibale bazalaki kosala basystem oyo eko batela kokengela ya bato, lekola bluetooth Low Energy (BLE) mpona ko yebisa telephone soki ezali pene ya mosusu.	Tracking is well known, with several etid since 2013. As of April 7, 2020, more than a dozen researchers were developing systems that will keep people safe, such as bluetooth Low Energy (BLE) to notify a phone when it is nearby of the other.
1751	en	ln	However, PEPP-PT is a co-ordination effort which contains both centralised and decentralised approaches, and is not a single protocol.Decentralised protocols include Decentralized Privacy-Preserving Proximity Tracing (DP-PPT/DP-3T), Temporary Contact Numbers (TCN, fka Contact Event Numbers, CEN), Privacy Sensitive Protocols and Mechanisms for Mobile Contact Tracing (PACT) and others.	Kasi, PEPP-PT ezali makasi ya mosala ya kati na ya libanda, mpe ezali na toli moko te ya kosalela yango. Ba protocol ya libanda ezali keloka Decentralized Privacy-Preserving Proximity Tracing (DP-PPT/DP-3T), Temporary Contact (TCN. fka Contact Event Numbers, CEN) Privacy Sensible Protocols na Mechanisms ya Kolandela bato na telephone.	However, PEPP-PT is a strength of internal and external activity, and there is no recommendation for its use. External protocols include Decentralized Privacy-Preserving Proximity Tracing (DP-PPT/DP-3T), Temporary Contact (TCN. fka Contact Event Numbers, CEN) Privacy Sensitive Protocols and Telephone Tracking Mechanisms.
1752	en	ln	In these protocols, identifiable personal data never leaves the device, and all matching happens on-device.	Na baprotocol oyo, makambo ya kati ya moto ekobima te, mpe nyonso ekosalema kaka na telephone.	With these protocols, no personal information will be revealed, and everything will be done over the phone.
1753	en	ln	The Privacy Group at MIT Media Lab has been developing SafePaths, a platform for using privacy-preserving techniques when collecting and using location or path intersection data to track the spread of COVID-19.	Group Prive na MIT Media Lab ezali kosala SafePaths, esika ya kosalela mosala ya kobatela makambo ya bato ntango bazali kozwa makambo mpe kosalisa esika oyo to kolandela bisika oyo bato bakutani mpona kolandela kopalangana ya COVID-19.	The Private Group at the MIT Media Lab is developing SafePaths, a privacy-enhancing platform that collects and helps location or track contact areas to track the spread of COVID-1
1754	en	ln	"It is based on research from the whitepaper ""Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic"" released in March 2020.Another similar effort is the SafeTrace platform by Enigma MPC, a company developing privacy technologies that was also originally founded at the MIT Media Lab."	Euti na etid ya mokanda ya mpembe ‘’Apps Gone Rogue: Kobatela makambo ya bato na pandemi ‘’ Ebimaki na sanza ya misato 2020. Mosala mosusu ezalaki ya SafeTrade ya Enigma MPZ, companie oyo ezali kosala batechnology ya kobatela makambo ya bato oyo babandaki uta mosala na bango na MIT Media Lab.	From the etid white paper &#39;&#39;Apps Gone Rogue: Protecting Privacy in a Pandemic &#39;&#39; Published in March 2020. Another project was SafeTrade by Enigma MPZ, a company developing privacy technologies that started since their work at the MIT Media Lab.
1755	en	ln	SafeTrace utilizes secure hardware technologies to allow users to share sensitive location and health data with other users and officials, without compromising the privacy of that data.	SafeTrade ezali kosalisa bamachine ya technologie oyo ebombaka makambo ya bato mpo été bato bapona soki balingi kopesa esika oyo bazali mpe makambo ya kolongono na bango na bato misusu mpe bato ya gouvernema, kasi nako buka mibeko ya kobomba mitango te.	SafeTrade is helping technology machines that store personal information so that people can choose whether they want to share their location and health information with others and government officials, but I will not break privacy laws.
1756	en	ln	On 5 April 2020, the global TCN Coalition was founded by groups that had coalesced around what was essentially the same approach and largely overlapping protocols, with the goal to reduce fragmentation, and enable global interoperability of tracing and alerting apps, a key aspect of achieving widespread adoption.	Na mokolo ya 5 sanza ya minei 2020, Coalition ya mokili ya TCN ebandaki na lisanga ya bato oyo bayokanaki na ndenge ya kosala makambo, mpo été bato bamona mpasi mingi te, mpe kosalisa interporabilite ya mokili na kolanda mpe koalerte ba applications, ezalaki ntina mpona mokili nyonso ebanda kosalela yango.	On April 5, 2020, the TCN Global Coalition was launched by a group of people who agreed on how to do things, so that people don’t suffer too much, and helping global interporability by tracking and alerting applications, was important for the whole world starts using it.
1757	en	ln	On 9 April 2020, the Singaporean government announced that it had open-sourced the BlueTrace protocol used by its official government app.	Na mokolo ya 9 sanza ya minei 2020, gouvernema ya Singapore elobaki été ezalaki na baprotocol ya BlueTrace oyo bato na bango ya gouvernema bazali kosalela.	On April 9, 2020, the Singapore government said it had BlueTrace protocols in use by its government officials.
1758	en	ln	On 10 April 2020, Google and Apple, the companies that control the Android and iOS mobile platforms, announced an initiative for contact tracing, which they claimed would preserve privacy, based on a combination of Bluetooth Low Energy technology and privacy-preserving cryptography.	Na mokolo ya 10 sanza ya minei 2020, Google na Apple, Bacompanie oyo basali Android na IOS balobaki mosala moko ebandi mpona kosunga kolandela ya bato kasi ekobatela mpe basekele ya bato, ekosalema na technologie ya Bluetooth Low Energy mpe na oyo ezali kobomba makambo ya bato Cryptography.	On April 10, 2020, Google and Apple, The companies that made Android and IOS said a project has been launched to support tracking of people but will also protect people’s privacy, will be based on Bluetooth Low Energy technology and with privacy Cryptography.
1759	en	ln	They also published specifications of the core technologies used in the system.	Babimisi mpe mokanda oyo elakisaki technologie ya kati oyo bakosalela.	They also published a document outlining the internal technology they would use.
1760	en	ln	According to Apple and Google, the system is intended to be rolled out in three stages:	Mpona Apple na Google, system ekosalema na batep misato:	For Apple and Google, the system will be implemented in three steps:
1761	en	ln	rollout of tools to enable governments to create official privacy-preserving coronavirus tracing apps	Kobongisa biloko oyo bakosala application yango ya kolandela bato mpona kosunga gouvernema na kobatela makambo ya bato.	Develop the products for the tracking application to help the government protect people&#39;s information.
1762	en	ln	integration of this functionality directly into iOS and AndroidGoogle and Apple plan to address the take-up and persistent surveillance problems by first distributing the system through operating system updates, and later removing it in the same way once the threat has passed.	Kokotisa yango na IOS mpe na AndroidGoogle mpe Apple alingi kolandela makambo ya kobomba makambo ya bato na kokotisa system yango na basystem oyo ezali kotambola, mpe nsima kolongola yango ndenge wana kaka	Introducing it to IOS and AndroidGoogle and Apple want to monitor privacy issues by incorporating the system into running systems, and then removing it just like that
1763	en	ln	b'Drug repositioning (also known as drug repurposing, re-profiling, re-tasking or therapeutic switching) is the repurposing of an approved drug for the treatment of a different disease or medical condition than that for which it was originally developed.	Kobongisa b’Drug (oyo babengi mpe kisi ya kosalisa) ezali kosalisa kisi oyo ezali mpona kobikisa maladi to condition oyo baselelaki yango mpona.	Drug preparation (also called therapeutic medicine) is the treatment of a drug that is intended to cure the disease or condition for which it was used.
1764	en	ln	This is one line of scientific research which is currently being pursued to develop safe and effective COVID-19 treatments.	Ezali liloba moko ya etid ya science oyo bazali kolandela mpona kosala kisi ya malamu mpona COVID-19.	It is a term of the scientific etid that is being pursued to develop a better cure for COVID-1
1765	en	ln	Other research directions include the development of a COVID-19 vaccine and convalescent plasma transfusion.SARS-CoV-2 has about 66 druggable proteins, each of which has multiple ligand binding sites.	Ba etid misusu elandi nzela ya koluka vaccin mpona COVID-19 mpe transfusion ya plasma. SARS-CoV-2 ezali na bakisi 66, nyonso ezali na ligand oyo esimbi yango.	Some etid have followed the path of finding a vaccine for COVID-19 and plasma transfusion. SARS-CoV-2 contains 66 compounds, all with a binding ligand.
1766	en	ln	Analyzing those binding sites provide the reasonable project of developing effective antiviral drug against COVID-19 proteins.	Komona bisika oyo esimbani pesa mosala oyo ekoki kosalema mpona komona makasi ya kisi mpona COVID-19.	Identifying these areas provide a possible workflow to determine the effectiveness of the drug for COVID-1
1767	en	ln	Of the most important SARS-CoV-2 target proteins are papain-like protease, RNA dependent RNA polymerase, helicase, S protein, and ADP ribophosphatase.	Mpona SARS-CoV-2 ya ntina makasi, baprotein bazali lekola pa papain ya protease, RNA oyo etali polymerase ya RNA, helicase, S protein, na ADP ribophosphatase.	For the most important SARS-CoV-2, proteins are like pa papain protease, RNA-related RNA polymerase, helicase, S protein, and ADP ribophosphatase.
1768	en	ln	Hussein A A, et al studied several candidate compounds which then optimized and analyzed for their skeleton similarity with the highest similar approved drugs in order to accelerate a potent anti-SARS-CoV-2 drug development in his preclinical study to be recommended in a clinical study design.	Hussein AA na etid ya al batangi combinaison ya bato mingi emonanaki basosolaki skelet komona soki ekokami na kisi oyo ekoki kopusa koluka kisi ya SARS-CoV-2 lekola ndenge ya koluka kisi.	Hussein AA and etid of al readers a combination of many people appeared to have understood the skeleton to see if it was written in a drug that could prompt the search for a cure for SARS-CoV-2 as a drug search.
1769	en	ln	Chloroquine is an anti-malarial medication that is also used against some auto-immune diseases.	Chloroquine ezali kisi ya palu oyo esalamaka mpona bamaladi ya system immune.	Chloroquine is a palu drug used for immune system diseases.
1770	en	ln	On 18 March, the WHO announced that chloroquine and the related hydroxychloroquine would be among the four drugs studied as part of the Solidarity clinical trial.	Na mokolo ya 18 sanza ya misato, OMS elobaki ete Chloroquine na Hydroxycloroquine ekozala na kati ya bakisi minei kati ya Bomoko ya komeka bakisi.	On March 18, the WHO announced that Chloroquine and Hydroxychloroquine would be included in the four drugs in the Drug Testing Committee.
1771	en	ln	New York governor Andrew Cuomo announced that New York State trials of chloroquine and hydroxychloroquine would begin on 24 March.On 28 March, the FDA authorized the use of hydroxychloroquine sulfate and chloroquine phosphate under an Emergency Use Authorization (EUA).	Gouverneur ya New Andrew Cumo alobaki Egumba ya New York komeka chloroquine na hydroxychloroquine ekobanda mokolo ya 24 sanza ya misato. Na sanza ya misato mokolo ya 28, FDA endimaki basalela hydroxychloroquine sulfate na chloroquine phosphate na Likama Ya Kondimela yango mpona Kosalisa (EUA).	New York Governor Andrew Cumo said New York City will begin testing chloroquine and hydroxychloroquine on March On March 28, the FDA approved the use of hydroxychloroquine sulfate and chloroquine phosphate in the Emergency of Acceptance for Treatment (EUA).
1772	en	ln	The treatment has not been approved by the FDA's clinical trials process and is authorized under the EUA only as an experimental treatment for emergency use in patients who are hospitalized but are not able to receive treatment in a clinical trial.	FDA endimaki te bameka kisi kasi endimamaki kati na EUA lekola kisi ya komeka mpona bato ya kobela oyo bazali na kati ya likama oyo bazali na lepital kasi bakoki kozwa kisi te.	The FDA did not approve the drug for trials but it was approved in the US as an experimental drug for at-risk patients who are hospitalized but cannot get treatment.
1773	en	ln	"The CDC has said that ""the use, dosing, or duration of hydroxychloroquine for prophylaxis or treatment of SARS-CoV-2 infection"" are not yet established."	CDC elobi ‘kosalela, dose, mpe wumela ya hydroxychloroquine mpona kisi ya SARS-CoV-2’’ eyebani te.	The CDC says the &#39;use, dose, and duration of hydroxychloroquine for SARS-CoV-2 treatment&#39;&#39; are unknown.
1774	en	ln	"Doctors have said they are using the drug when ""there's no other option""."	Banganga balobi bazali kosalela kisi yango soki ‘’kisi mosusu ezali te’’.	Doctors say they are using the drug when &#39;&#39;there is no alternative&#39;&#39;.
1775	en	ln	A Turkish research team in Istanbul is conducting a small study on the use of chloroquine in combination with zinc, vitamin A, vitamin C and vitamin D.	Etid ya turkey oyo ezali kosalema na Istanbul ezali komona ndenge chloroquine ekosala soki bavukisi yango na Zinc, Vitamin A, Vitamin C na Vitamin D.	The current turkey etid in Istanbul is seeing the effect of chloroquine when combined with Zinc, Vitamin A, Vitamin C and Vitamin D.
1776	en	ln	Large studies are underway at Duke University and the University of Oxford.	Ba etid ya minene ezali kosalema na universite ya Duke mpe na Universite ya Oxford.	Larger etids are being conducted at Duke University and Oxford University.
1777	en	ln	NYU Langone Medical School is conducting a trial on the safety and efficacy of preventative use of hydroxychloroquine.	Kelasi ya banganga na NYU Langone ezali komeka komona bolamu mpe mosala ya hydroxychloroquine.	A class of doctors at NYU Langone is trying to see the efficacy and effectiveness of hydroxychloroquine.
1778	en	ln	"Chinese clinical trials in Wuhan and Shenzhen claimed to show favipiravir was ""clearly effective""."	Na Chine, komeka ya bakisi na Wuhan mpe na Shenzhen elakisaki ete Favipavir ezalaki ‘’makasi mpenza’’.	In China, drug trials in Wuhan and Shenzhen showed that Favipavir was &#39;&#39;very potent&#39;&#39;.
1779	en	ln	35 patients in Shenzhen tested negative in a median of 4 days, while the length of illness was 11 days in the 45 patients who did not receive it.	Bato ya kobela 35 na Shenzhen bamonaki bango negative kati na mikolo 4, kasi wumela ya maladi ezali mikolo 11 kati na bato ya kobela 45 oyo bazwaki kisi te.	Thirty-five patients in Shenzhen tested negative within 4 days, but the duration of illness is 11 days among 45 untreated patients.
1780	en	ln	In a study conducted in Wuhan on 240 patients with pneumonia, half were given favipiravir and half received umifenovir.	Na Etid oyo basalaki na Wuhan na bato ya kobela 240 oyo bazalaki na pneumonia, ndambo bapesaki bango favipiravir ndambo mosusu umifenovir.	In the Etid conducted in Wuhan with 240 patients with pneumonia, half were given favipiravir and half umifenovir.
1781	en	ln	The Italian Pharmaceutical Agency reminded the public that the existing evidence in support of the drug is scant and preliminary.	Agence ya pharmacy ya Italie epesaki toli na bato ete baresulta ya kisi ezali nani kaka na ebandeli.	The Italian pharmacy agency advised people that the results of medication are who only at first.
1782	en	ln	On 2 April, Germany announced that it would purchase the drug from Japan for its stockpile, and use the military to deliver the drug to university hospitals, where the drug will be used to treat COVID-19 patients.	Na mokolo ya 2 ya sanza ya minei, Germany elobaki ete ekosomba kisi wana na Japan, bako salisa limpimgo mpona komema bango bakisi yango na balepital ya universite, bisika oyo kisi ekosalema mpona kosalisa bato bazali kobela na COVID-19.	On April 2, Germany said it would buy the drug from Japan, using a limpimgo to transport the drugs to university hospitals, where the drug will be used to treat patients with COVID-1
1783	en	ln	According to the South China Morning Post, Shinzo Abe has made overtures to the Trump administration about purchasing the drug.The drug may be less effective in severe cases of illness where the virus has already multiplied.	Mpona basango ya South Chine Morning Post, Shinzo Abe akebisi biro ya Trump na kosomba kisi wana. Kisi yango ekoki kozala makasi mingi te na bato oyo bazali kobela makasi mpe virisi ekomi mingi na kati ya nzoto.	According to the South China Morning Post, Shinzo Abe warned Trump&#39;s office against buying the drug. The drug may be less effective in people who are seriously ill and the virus has multiplied in the body.
1784	en	ln	It may not be safe for use by pregnant women or those trying to conceive.	Ekoki kozala malamu te mpona basi ya zemi to ba oyo bazali koluka zemi.	It may not be suitable for pregnant women or those seeking pregnancy.
1785	en	ln	"One study of lopinavir/ritonavir (Kaletra), a combination of the antivirals lopinavir and ritonavir, concluded that ""no benefit was observed""."	Etid moko ya lopinavir/ritonavir (Kaletra), combinaison ya lopinavir na ritonavir esalaki ‘’Eloko te ya makasi’’.	An etid of lopinavir/ritonavir (Kaletra), the combination of lopinavir and ritonavir caused &#39;&#39;Nothing serious&#39;&#39;.
1786	en	ln	The drugs were designed to inhibit HIV from replicating by binding to the protease.	 Bakisi yango esalema mpona kopekisa virisi ya VIH ekoma mingi na kati ya nzoto.	These drugs are designed to prevent the HIV virus from multiplying in the body.
1787	en	ln	A team of researchers at the University of Colorado are trying to modify the drugs to find a compound that will bind with the protease of SARS-CoV-2.There are criticisms within the scientific community about directing resources to repurposing drugs specifically developed for HIV/AIDS.	Etid oyo esali bayekoli na Universite ya Colorado bazali kobongisa kisi yango mpona kosala kisi oyo ekosimba ya SARS-CoV-2. Misusu basepeli te mpo ete bazali kosalela biloko oyo esengeli basala bakisi mpona VIH/SIDA.	Researchers at the University of Colorado are developing the drug to develop an effective vaccine against SARS-CoV-2 Some are unhappy because they are using the necessary products to make drugs for HIV/AIDS.
1788	en	ln	The WHO included lopinavir/ritonavir in the international Solidarity trial.	OMS ekotisaki lopinavir/ritonavir na bakisi ya komeka na mokili.	WHO has included lopinavir/ritonavir in experimental drugs.
1789	en	ln	Remdesivir was created and developed by Gilead Sciences as a treatment for Ebola virus disease and Marburg virus infections . Gilead Sciences subsequently discovered that Remdesivir had antiviral activity in vitro against multiple filo-, pneumo-, paramyxo-, and corona- viruses .	Remdesivir esalemaki na Gilead Sciences lekola kisi ya virisi ya maladi ya Ebola mpe virisi ya maladi Marburg . Gilead Sciences moto emonaki remdesivir ezali na ntina na mosala ya vitro na kobundela ba filo- mingi, pneumo-, paramyzo-, mpe corona virisi .	Remdesivir was developed by Gilead Sciences as a drug for Ebola virus and Marburg virus Gilead Sciences fire found remdesivir has useful in vitro activity in fighting many filo-, pneumo-, paramyzo-, and corona virisi .
1790	en	ln	One issue with antiviral treatment is the development of resistance through mutations that can lead to more severe disease and transmission.	 Likambo moko oyo kisi yango ezali makasi na yango ya kolenda soki virisi ekomi makasi mingi mpona nzoto mpe ekomi kotumbola bamaladi ya makasi mpe kopalangana na kati ya bato.	One thing the drug is able to do is fight if the virus becomes too strong for the body and starts causing serious illness and spreading among people.
1791	en	ln	Some early pretrial studies suggest remdesivir may have a high genetic barrier to resistance.There are several clinical trials underway, including two conducted by Cleveland University Hospitals; one for people with moderate illness and another for those with more severe illness.	 Ba Etid moko ya liboso elobi ete Remdesivir ekoki kozala makasi mingi. Baetid mingi ezali kosalema, lokola mibale oyo universite ya Cleaveland ezali kosala; moko mpona bato oyo bazali kobela makasi te mpe mosusu mpona ba oyo bazali kobela makasi.	Some leading Etid states that Remdesivir may be too strong. More baetids are being held, such as two being held by the University of Cleaveland; one for the less seriously ill and the other for the more seriously ill.
1792	en	ln	There are three ongoing clinical trials of intravenous vitamin C for people who are hospitalized and severely ill with COVID-19; two placebo controlled (China, Canada) and one with no control (Italy).	Mosala misato ya komeka bakisi ezali kosalema na komona Vitamin C mpona bato oyo bazali kobela makasi na COVID-19; ba placebo mibale enladani (Chine, Canada) mpe moko oyo bazali kolanda te (Italie).	Three clinical trials are underway to see Vitamin C for people who are seriously ill with COVID-19; two placebos enladani (China, Canada) and one non-adherent (Italy).
1793	en	ln	New York State began trials for the antibiotic azithromycin on 24 March 2020.	New York ebandaki komeka kisi babengi azithromycin na mokolo ya 24 sanza ya misato 2020.	New York began testing azithromycin on March 24,
1794	en	ln	Japan's National Center for Global Health and Medicine (NCGM) is planning a clinical trial for Teijin's Alvesco (ciclesonide), an inhaled corticosteroid for asthma, for the treatment of pre-symptomatic patients infected with the novel coronavirus.	 ya mboka ya Japan mpona Kolongono ya bato nyonso mpe ya bakisi (NCGM) ezali kobongama mpona komeka Kisi ya Teijin nkombo Alvesco (ciclesonide), kisi ya mpema mpona Asthme mpona kosalisa bato oyo bazali kobela na coronavirisi ya sika.	The National Center for Public Health and Medicine (NCGM) is preparing to test Teijin&#39;s Drug Alvesco (ciclesonide), a respiratory drug for asthma, to treat patients with the new coronavirus.
1795	en	ln	A form of angiotensin-converting enzyme 2, a Phase II trial is underway with 200 patients to be recruited from severe, hospitalized cases in Denmark, Germany, and Austria to determine the effectiveness of the treatment.	Angiotensin moko oyo ekomaka enzyme 2, komeka ya Phase II ebandi na bato ya kobela 200 oyo bazali kobela makasi na lepital na Denmark, Germany na Austria mpona komona soki kisi yango ezali makasi.	An angiotensin that records enzyme 2, a Phase II trial has begun in 200 critically ill patients in hospitals in Denmark, Germany and Austria to see if the drug is effective.
1796	en	ln	Researchers from the Montreal Heart Institute in Canada are currently studying the role of colchicine in reducing inflammation and pulmonary complications in patients suffering from mild symptoms of COVID-19.	Ba etid na insitut ya Canada ya Montreal oyo emonaki mitena bazali kotanga mosala ya colchicine na kokitisa kovimba mpe bacomplication ya kopema na bato oyo bazalali na basymptomi moke na COVID-19.	Researchers at the Montreal Canadian instit that found the mites are studying the role of colchicine in reducing inflammation and respiratory complications in people with mild symptoms of COVID-1
1797	en	ln	The study, named COLCORONA, is recruiting 6000 adults aged 40 and over who were diagnosed with COVID-19 and experience mild symptoms not requiring hospitalization.	Etid, oyo babengi COLCORONA, ezali na bankombo ya bato 6000 bambula 40 emati oyo bamonaki na COVID-19 mpe bazalaki na basymptomi moke oyo esengaki te bakota lepital.	Etid, called COLCORONA, has the names of 6,000 people over the age of 40 who have been diagnosed with COVID-19 and have mild symptoms that do not require hospitalization.
1798	en	ln	Women who are pregnant or breastfeeding or who do not have an effective contraceptive method are not eligible.	 Basi oyo bazali na zemi to bazali komelisa mwana mabele to bazali na bakisi ya malamu ya kopekisa zemi te bakoki kokota te.	Women who are pregnant or breastfeeding or not on adequate contraception may not enter.
1799	en	ln	Several anticoagulants are being tested in Italy.	Baanticoagulants mingi bazali kososola yango na ekzame na Italie.	Many anticoagulants are detected on examination in Italy.
1800	en	ln	Low-molecular-weight heparin is being widely used to treat patients, prompting the Italian Medicines Agency to publish guidelines on its use.	Kilo ya molecule ya nse ezali kosalema mingi mpona kosalisa bato ya maladi, etindi Agence ya bakisi ya Italie ekoma batoli ya kosalela yango.	Low molecular weight is increasingly being used to treat patients, prompting the Italian Medicines Agency to write recommendations for its use.
1801	en	ln	A multicenter study on 300 patients researching the use of enoxaparin sodium at prophylaxis and therapeutic dosages was announced in Italy on April 14.	Etid na bato ya kobela 300 oyo bazalaki komona mosala ya enoxaparin sodium na prophylaxis mpe na dose na yango ebandaki na Italie na sanza ya minei mokolo ya 14.	Etid in 300 patients experiencing the role of enoxaparin sodium in prophylaxis and dosing was launched in Italy on April 14th.
1802	en	ln	Since SARS-CoV-2 is a virus, considerable scientific attention has been focused on repurposing approved anti-viral drugs that were developed for prior outbreaks such as MERS, SARS, and West Nile virus.	Lekola SARS-CoV-2 ezali virisi, ezalii kososolama makasi mpo esalema lisusu, ezali bakisi oyo basalelaki ntango ya pandemi ya MERS, SARS na virisi ya West Nile.	Since SARS-CoV-2 is a virus, it is strongly understood to be reproduced, it is the drugs used during the MERS, SARS and West Nile virus pandemics.
1803	en	ln	Ribavirin: ribavirin was recommended for COVID-19 treatment according to Chinese 7th edition guidelines	Ribavirin: ribavirin ezali malamu mpona COVID-19 nsima ya toli ya 7 ya Chine	Ribavirin: ribavirin is effective for COVID-19 after China&#39;s 7th recommendation
1804	en	ln	Umifenovir: umifenovir was recommended for COVID-19 treatment according to Chinese 7th edition guidelines	Umefenovir: Umifenovir ezali malamu mpona COVID-19 nsima ya toli ya 7 ya Chine	Umefenovir: Umifenovir is effective for COVID-19 after China&#39;s 7th recommendation
1805	en	ln	Some antibiotics that have been identified as potentially repurposable as COVID-19 treatments:	Bakisi misusu mpe emonani malamu mpona kosalisa COVID-19:	Other drugs have also been shown to be effective in treating COVID-19:
1806	en	ln	Tocilizumab (Anti-IL-6 receptor): Approved by China.	Tocilizumab (Anti-IL-6 receptor): Endimami na Chine.	Tocilizumab (Anti-IL-6 receptor): Approved in China.
1807	en	ln	Also trials in Italy and China. and see Tocilizumab#COVID-19.	Mpe komeka na Italie na Chine. Mpe mona Tocilizumab#COVID-19.	And try in Italy and China. And see Tocilizumab#COVID-1
1808	en	ln	b'A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19).	Vaccin ya b’COVID-19 ezali ya solo te mpona virisi ya 2019 (COVID-19).	The vaccine is not true for the 2019 virus (COVID-19).
1809	en	ln	Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.	Ata vaccin moko te eleki etap ya komeka, mosala mingi ezali kosalema mpona kosala vaccin oyo ekoleka.	While no vaccine has passed the testing stage, much work is being done to develop a vaccine that will pass.
1810	en	ln	In late February 2020, the World Health Organization (WHO) said it did not expect a vaccine against SARS-CoV-2, the causative virus, to become available in less than 18 months.	Na nsuka ya sanza ya mibale 2020, Organisation Mondial ya Sante (OMS) elobi bazalaki kozela vaccin ya SARS-CoV-2 te, virisi ya makambo, ezwama moke ya baposo 18. 	By the end of February 2020, the World Health Organization (WHO) said it was not expecting a vaccine for SARS-CoV-2, the virus of the events, to be available for less than 18 weeks.
1811	en	ln	Five vaccine candidates were in Phase I safety studies in April.	 Bavaccin mitano bazalaki na phase I ya na sanza ya minei. 	Five vaccines were in phase I of in April.
1812	en	ln	COVID-19 was identified in December 2019.	COVID-19 emonanaki na sanza ya zomi na mibale 2019.	COVID-19 was discovered in December
1813	en	ln	A major outbreak spread around the world in 2020, leading to considerable investment and research activity to develop a vaccine.	Epanlanganaki makasi na mokili na 2020, esengaki mbongo mingi mpe baetid mpona kosala vaccin.	It was widespread in the world by 2020, requiring a lot of money and time to develop a vaccine.
1814	en	ln	Many organizations are using published genomes to develop possible vaccines against SARS-CoV-2.	Baorganisation mingi bazali kosalisa bagenome oyo babimisaki mpona koluka vaccin ya SARS-CoV-2.	Many organizations are using the genomes they have released to find a vaccine for SARS-CoV-2
1815	en	ln	Stated in April, imperatives of the CEPI initiative for vaccine development are speed, manufacturing capacity, deployment at scale, and global access.	Balokaki na sanza ya minei, makasi ya CEPI ya koluka vaccin ezali mbango na bango, makasi ya kosala yango na ndenge ya monene, ya kotambwisa yango bisika mingi, mpe mpona mokili ezwa yango.	They said in April that CEPI&#39;s strength in finding a vaccine is their speed, the strength to do it on a large scale, to run it in many places, and for the world to get it.
1816	en	ln	In April, CEPI scientists reported that 10 different technology platforms were under research and development during early 2020 to create an effective vaccine against COVID-19.	Na sanza ya minei, bayekoli ya science ya CEPI balobaki ete ba ndenge ya technology 10 ezali kosalema na etid na ebandeli ya 2020 mpona kosala vaccin ya makasi ya kobundela COVID-19.	In April, CEPI scientists said 10 technologies are being developed by early 2020 to develop a potent vaccine against COVID-1
1817	en	ln	Major platform targets advanced into Phase I safety studies include:	Bisika mingi basibakomaki na phase I ya etid komona soki vaccin ezali malamu:	Several places have reached phase I of etid to see if the vaccine is effective:
1818	en	ln	nucleic acid (DNA and RNA) (Phase I developer and vaccine candidate: Moderna, mRNA-1273)	Acid ya nucleic (DNA na RNA) (Kobongisa ya phase I mpe candida ya vaccin: Moderna, mRNA-1273)	Nucleic acid (DNA and RNA) (Phase I and candida preparation of vaccine: Moderna, mRNA-1273)
1819	en	ln	viral vector (Phase I developer and vaccine candidate: CanSino Biologics, adenovirus type 5 vector)	ba vector ya viral (Phase I ya etid mpe candida: Biologie ya CanSino, adenovirus ya ndenge ya bavectir 5) 	viral vectors (Phase I of etid and candida: CanSino biology, vector-type adenovirus 5)
1820	en	ln	As reported by CEPI scientists in April, 115 total vaccine candidates are in early stages of development, with 78 confirmed as active projects (79, according to the Milken Institute), and 37 others announced, but with little public information available (presumed to be in planning or being designed).	Ndenge bayekoli ya science ya CEPI elobi na sanza ya minei, 115 ya bavaccin bazalaki na ebandeli ya kosalema na 78 endimamaki lekola baprojets (79, elobi Insitu ya Milken), mpe 37 misusu, kasi bato bayebi mingi te na makambo yango (ezali kobongisama to ezali kosalema).	As CEPI scientists said in April, 115 vaccines were in early development with 78 approved as projects (79, says Milken&#39;s Insitu), and 37 others, but little is known about them (being developed or is being done).
1821	en	ln	A Phase I-II trial conducts preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, and at multiple sites, while determining more precise, effective doses.	Na phase I-II ya komeka bamonaka soki kisi ezali malamu mpe basalaka baekzame ya immune, esalemaka na bato ba mponami te, ba placebo ya kolandela, mpe bisika mingi, mpe koyeba, dose nini.	In phase I-II trials they see if the drug is effective and do immune tests, done in unselected people, follow-up placebos, and multiple sites, and determine, what dose.
1822	en	ln	Phase III trials typically involve more participants, including a control group, and test effectiveness of the vaccine to prevent the disease, while monitoring for adverse effects at the optimal dose.	Phase III ya komeka ezalaka na bato mingi mpe ekip ya kolandela yango, mpe baekzame ya komona soki kisi ezali kosimba na kopekisa maladi, nyonso na kolandela mosala ya dose oyo bapesi.	A Phase III trial consists of a large number of subjects and a monitoring team, as well as trials to see if the drug is affected by disease control, all by monitoring the activity of a given dose.
1823	en	ln	"Of 79 vaccine candidates in active development (confirmed as of early April 2020), 74 were not yet in human evaluation (still in ""preclinical"" research)."	Na bavaccin 79 oyo ezali kosalema uta ebandeli ya sanza ya minei 2020), 74 bakomaki na bato te (bazalaki kaka na komeka ya etid ya ‘clinic’).	Of the 79 vaccines in development since early April 2020), 74 have not reached humans (they were only in &#39;clinical&#39; trials).
1824	en	ln	Around 24 January 2020 in Australia, the University of Queensland announced that it is investigating the potential of a molecular clamp vaccine that would genetically modify viral proteins in order to stimulate an immune reaction.	Na Australie na mokolo ya 24 sanza ya liboso 2020, Universite ya Queensland elobaki ete ezali kososola soki molecule moko ya vaccin eko sala mosala na protein viral mpona kotumbola reaction ya immune.	In Australia on January 24, 2020, the University of Queensland said it was investigating whether a vaccine molecule would work with a viral protein to boost the immune response.
1825	en	ln	Around 24 January 2020 in Canada, the International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan announced the commencement of work on a vaccine, aiming to start human testing in 2021.	Na sanza ya liboso mokolo ya 24 2020 na Canada, Esika ya International ya Bavaccin (VIDO-InterVac) na universite ya Saskatchewan elobaki ete babandaki mosala ya koluka vaccin, bakoki kobanda komeka na bato na 2021.	On January 24, 2020 in Canada, the International Vaccine Center (VIDO-InterVac) at the University of Saskatchewan announced that it had begun research into a vaccine, with human trials likely to begin in
1826	en	ln	Vaccine development projects were announced at the Chinese Center for Disease Control and Prevention on 26 January 2020, and the University of Hong Kong on 28 January.	Misala ya koluka vaccin ebandaki na Esika ya kolandela mpe kopekisa bamaladi na Chinese na mokolo ya 26 sanza ya liboso 2020, mpe na universite ya hong kong sanza ya liboso mokolo ya 28.	Vaccine research began at the Chinese Center for Disease Control and Prevention on January 26, 2020, and at the University of Hong Kong on January
1827	en	ln	Around 29 January 2020, Janssen Pharmaceutical Companies, led by Hanneke Schuitemaker, announced that it had begun work on developing a vaccine.	Na mokolo ya 29 sanza ya liboso 2020, Janssen Pharmaceutical Companies, oyo mokonzi Hanneke Schuitemaker, balobaki ete babandaki mosala ya kosala vaccin.	On January 29, 2020, Janssen Pharmaceutical Companies, headed by Hanneke Schuitemaker, announced that they had started work on the vaccine.
1828	en	ln	Janssen is co-developing an oral vaccine with its biotechnology partner, Vaxart.	Janssen azali kosala vaccin ya komela na moninga na ye ya biotechnology, vaxart.	Janssen is developing an oral vaccine with his biotechnology partner, vaxart.
1829	en	ln	On 18 March 2020, Emergent BioSolutions announced a manufacturing partnership with Vaxart to develop the vaccine.	Na mokolo ya 18 sanza ya misato 2020, Emergent BioSolutions alobaki ye na moninga Vaxart bazali koluka vaccin.	On March 18, 2020, Emergent BioSolutions said it and friend Vaxart were looking for a vaccine.
1830	en	ln	On 8 February 2020, the laboratory OncoGen in Romania published a paper on the design of a vaccine with similar technology to the one used for cancer neoantigen vaccination therapy.	Na mokolo ya 8 sanza ya mibale 2020, laboratoire ya OncoGen na Romanie bakomaki manuskri na ndenge ya vaccin na technology moko oyo ezali kosalema mpona vaccin mpe kisi mpona cancer.	On February 8, 2020, the OncoGen laboratory in Romania wrote a vaccine manuscript on a technology being developed for a vaccine and drug for cancer.
1831	en	ln	On 25 March the head of the research institute announced that they had finalized the synthesis of the vaccine and were beginning the tests.	Na mokolo ya 25 sanza ya misato mokonzi na institu ya etid alobaki basilisaki synthese babandaki na ekzame.	On March 25 the official at the etid institute said they finished the synthesis began with the examination.
1832	en	ln	On 27 February 2020, a Generex subsidiary company, NuGenerex Immuno-Oncology, announced they were beginning a vaccine project to create an Ii-Key peptide vaccine against COVID-19.	Na mokolo ya 27 sanza ya mibale 2020, Companie moko ya moke ya Generex, NuGenerex Immuni-Ongologie, balobaki bazali kobanda projet ya vaccin kosala li-key peptide ya vaccin mpona COVID-19.	On February 27, 2020, a Generex subsidiary, NuGenerex Immuni-Ongologie, announced it was launching a vaccine project to develop a li-key peptide vaccine for COVID-1
1833	en	ln	"They wanted to produce a vaccine candidate that could be tested in humans ""within 90 days."""	Balingaki basala candida ya vaccin oyo bakokaki komeka n abato’’na mikolo 90’’.	They wanted to develop a vaccine candida that could be tested on people&#39;&#39;in 90 days&#39;
1834	en	ln	On 5 March 2020, Washington University in St. Louis announced its projects to develop a vaccine.	Na mokolo ya 5 sanza ya misato 2020, universite ya Washington na St Louis balobaki babandaki mosala ya koluka vaccin.	On March 5, 2020, Washington University in St Louis said it had begun the search for a vaccine.
1835	en	ln	On 5 March 2020, the United States Army Medical Research and Materiel Command at Fort Detrick and the Walter Reed Army Institute of Research in Silver Spring, both in western Maryland, announced they were working on a vaccine.	Na mokolo ya 5 sanza ya misato 2020, Etid ya limpimgo mpona kolongono na Etats Unis mpe Materiel Command na Fort Detrick mpe Institu ya limpimgo ya Walter Reed, nyonso mibale na oust ya Maryland, balobaki bazali kosala vaccin.	On March 5, 2020, the US Department of Health and Human Services and Materiel Command at Fort Detrick and the Walter Reed Institute of Health, both in eastern Maryland, said they were developing the vaccine.
1836	en	ln	Around 10 March 2020, Emergent Biosolutions announced that it had teamed with Novavax Inc.	Na 10 sanza ya misato 2020, Emergent Biosolutions elobaki kakomi kosala na Novavax Inc.	On March 10, 2020, Emergent Biosolutions announced it was working with Novavax Inc. on March 10,
1837	en	ln	in the development and manufacture of a vaccine.	Na koluka mpe kosala vaccin.	In vaccine search and development.
1838	en	ln	The partners further announced plans for preclinical testing and a Phase I clinical trial by July 2020.	Balobaki mpe bakobanda baekzame ya clinic mpe phase I ya komeka ya clinic na sanza ya nsambo 2020.	They also said they would begin clinical trials and phase I clinical trials in July 2020.
1839	en	ln	On 12 March 2020, India's Health Ministry announced they are working with 11 isolates, and that even on a fast track it would take at least around one-and-a-half to two years to develop a vaccine.	Na mokolo ya 12 sanza ya misato 2020, Minister ya kolongono na Inde balobaki bazali kosala mosala na 11 ya mopanzi, mpe ata soki bazalaki kokende noki ekozwa bango moko na ndambo to bambula mibale mpona kosala vaccin.	On March 12, 2020, the Health Minister in India said they were working on 11 sides, and even if they were going soon it would take themselves half or two years to develop the vaccine.
1840	en	ln	On 12 March 2020, Medicago, a biotechnology company in Quebec City, Quebec, reported development of a coronavirus-like particle under partial funding from the Canadian Institutes for Health Research.	Na mokolo ya 12 sanza ya misato 2020, Medicago, companie ya biotechnology na egumba ya Quebec, Quebec balobaki bazali kosala particle moko oyo ezali lekola ya coronavirisi na mbongo ndambo euti Institu ya Canada mpona etid ya kolongono.	On March 12, 2020, Medicago, a biotechnology company in Quebec City, Quebec said it was developing a particle that mimics the coronavirus with funding in part from the Canadian Institutes of Health.
1841	en	ln	The vaccine candidate is in laboratory research, with human testing planned for July or August 2020.	Vaccin ezali na etid ya laboratoire, bako banda komeka na bato na sanza ya nsambo to mwambe 2020.	The vaccine is in laboratory etid, they will start testing in humans in July or August
1842	en	ln	"Earlier that week, The Guardian reported that the US President Donald Trump had offered CureVac ""'large sums of money' for exclusive access to a Covid-19 vaccine"", against which the German government protested."	Na ebandeli ya poso oyo, Guardian ereportaki ete Mokambi ya Etats Unis Donald Trump apesaki ‘CureVac’ mbongo ebele mpona kozwa vaccin ya COVID-19’’ gouvernema ya Germani atelemaki yango.	Earlier this week, the Guardian reported that US President Donald Trump had offered &#39;CureVac&#39; a large sum of money to develop a COVID-19 vaccine&#39;&#39; the German government opposed.
1843	en	ln	On 17 March 2020, American pharmaceutical company Pfizer announced a partnership with German company BioNTech to jointly develop a mRNA-based vaccine.	Na mokolo ya 17 sanza ya misato 2020, companie ya bakisi ya Amerik Pfizer elobaki bazali kosangana na company na Germany babengi BioNTech mpona kosala vaccin oyo euti na mRNA.	On March 17, 2020, American pharmaceutical company Pfizer said it was partnering with a German company called BioNTech to develop an mRNA-based vaccine.
1844	en	ln	mRNA-based vaccine candidate BNT162, currently in pre-clinical testing with clinical trials expected to begin in April 2020.	BNT162 candida ya vaccin oyo euti na mRNA, ezali na ekzame ya clinic eoyo ekobanda sanza ya minei 2020.	BNT162 candida mRNA-derived vaccine, is in clinical trial ewhich will start April
1845	en	ln	In Italy on 17 March 2020, Takis Biotech, an Italian biotech company announced they will have pre-clinical testing results in April 2020 and their final vaccine candidate could begin human testing by fall.	Na Italie na mokolo ya 17 sanza ya misato 2020, Takis Biotech, companie ya biotech ya Italie balobaki bakozala na baresulta ya ekzame ya liboso ya clinic na sanza ya minei 2020 mpe vaccin na bango ya suka ekoki komekama na bato na ntango ya moyi.	In Italy on March 17, 2020, Takis Biotech, an Italian biotech company said they will have the results of the first clinical trial in April 2020 and their final vaccine can be tested in humans during the day.
1846	en	ln	In France on 19 March 2020, the Coalition for Epidemic Preparedness Innovations (CEPI) announced a US$4.9 million investment in a COVID-19 vaccine research consortium involving the Institut Pasteur, Themis Bioscience (Vienna, Austria), and the University of Pittsburgh, bringing CEPI's total investment in COVID-19 vaccine development to US$29 million.	Na France na mokolo ya 19 sanza ya misato 2020, Coalition ya kobongama mpona epidemic mpe innovation (CEPI) elobaki bazali na US$4.9 milion na etid ya ekip ya vaccin ya COVID-19 na Insitu Pasteur, Themis Bioscience (Vienna, Austria), mpe universite ya pittsburgh, oyo ememi mbongo nyonso ya CEPI mpona COVID-19 na US$29 milio.	In France on March 19, 2020, the Coalition for Epidemic Preparedness and Innovation (CEPI) said it has US$4.9 million in funding for a COVID-19 vaccine team at Insitu Pasteur, Themis Bioscience (Vienna, Austria), and the University of Pittsburgh, which brings the total CEPI funding for COVID-19 to US$29 million.
1847	en	ln	CEPI's other investment partners for COVID-19 vaccine development are Moderna, Curevac, Inovio, Novavax, the University of Hong Kong, the University of Oxford, and the University of Queensland.	Bato misusu na ekipi ya CEPI mpona vaccin ya COVID-19 ezali Moderna, Curevac, Inovio, Novavax, Universite ya hong kong, universite ya Oxford, mpe universite ya Queensland.	Other members of the CEPI team for the COVID-19 vaccine include Moderna, Curevac, Inovio, Novavax, the University of Hong Kong, the University of Oxford, and the University of Queensland.
1848	en	ln	On 20 March 2020, Russian health officials announced that scientists have begun animal testing of six different vaccine candidates.	Na mokolo ya 20 sanza ya misato 2020, bato ya kolongono ya Russie balobaki ete bayekoli ya science babandaki komeka bavaccin motoba na banyama.	On March 20, 2020, Russian health officials said scientists had begun testing six vaccines on animals.
1849	en	ln	Imperial College London researchers announced on 20 March 2020 that they are developing a self-amplifying RNA vaccine for COVID-19.	College Imperial ya bato ya etid ya Londres balobaki ete mokolo ya 20 sanza ya misato 2020 bako banda kosala vaccin ya RNA mpona COVID-19.	The Imperial College of London&#39;s etid have announced that on 20 March 2020 they will start developing an RNA vaccine for COVID-1
1850	en	ln	The vaccine candidate was developed within 14 days of receiving the sequence from China.	Candida ya vaccin esalemaki na mikolo 14 nsima ya kozwa toli epayi ya Chine.	Candida vaccine was developed within 14 days after receiving a tip from China.
1851	en	ln	In late March, the Canadian government announced C$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian companies and universities, such as the Medicago and University of Saskatchewan initiatives.	Na nsuka ya sanza ya misato, gouvernema ya Canada elobali mbongo C$275 milio mpona ba etid 96 mpona etumba ya COVID-19, mpe bacandida ya bavaccin mingi na bacompanie mpe bauniversite ya Canada, lekola na Medicago mpe mosala na universite ya Saskatchewan.	In late March, the Canadian government announced C$275 million for 96 etid for the fight against COVID-19, and several vaccine candidates from Canadian companies and universities, such as Medicago and work at the University of Saskatchewan.
1852	en	ln	"Around the same time, the Canadian government announced C$192 million specifically for developing a COVID-19 vaccine, with plans to establish a national ""vaccine bank"" of several new vaccines that could be used if another coronavirus outbreak occurs."	Na ngambo ya ntango moko, loyalo ya ekolo Canada esakolaki ba millon ya dollar C$192 ezalaki mingi-mingi mpo na kokolisa vaccin ya COVID-19, na likanisi babongisa “banki ya vaccin” ya ekolo mpó na ba vaccin ebele ya sika eko kosalamela soki pasi mosusu ya coronavirusi eyei. 	Meanwhile, the Canadian government announced $192 million was mainly for developing a COVID-19 vaccine, with the idea of setting up a national “vaccine bank” for more new vaccines if they are developed another coronavirus pandemic has arrived.
1853	en	ln	"On 2 April 2020, researchers at the University of Pittsburgh School of Medicine reported on testing of PittCoVacc, a possible COVID-19 vaccine in mice, stating that ""MNA delivered SARS-CoV-2 S1 subunit vaccines elicited potent antigen-specific antibody responses [in the mice] that were evident beginning 2 weeks after immunization."""	"Na 2 Avril 2020, bakundoli ya Sikola ya Medicine ya Université ya Pittsburgh bapesaki lapolo ya tesite ya PittCoVacc, mutu eko kozala vaccin ya COVID-19 na bampuku, balobaki ete ""MNA ebimisaki SRAS-CoV-2 S1 sous-unité ya vaccin emonanaki lokola antigene-specifiki ya ba anticorps ya makasi na biyano [na bampuku] ezalaki yasolo baposo 2 sima ya botie mangwele."""	On April 2, 2020, University of Pittsburgh School of Medicine researchers reported on the PittCoVacc test, a potential COVID-19 vaccine in mice, stating that &quot;MNA produced the SRAS-CoV-2 S1 vaccine subunit identified as antigen-specific strong antibody responses [in flies] were indeed 2 weeks after vaccination.&quot;
1854	en	ln	In Canada on 16 April 2020, the University of Waterloo School of Pharmacy announced design of a DNA-based vaccine candidate as a possible nasal spray.	Na Canada na16 Avril 2020, Sikola ya Pharmacie ya Université ya Waterloo esakolaki bobongisi ya vaccin likolo ya DNA ezwama lokola kisi ya kopompé na zolo.	In Canada on16 April 2020, the University of Waterloo Pharmacy Seminar announced the development of a DNA-based vaccine available as a nasal spray.
1855	en	ln	Using bacteriophages, the DNA will be designed to replicate inside human bacteria to produce harmless virus-like particles, which may stimulate the immune system to produce antibodies against the SARS-CoV-2 virus.	Na bosaleli ya balei ya baniama, DNA ekobongisama mpóna korepliqué kati ya baniama ya bato mpo ebota ba ndambo mike-mike ya ba virusi ebelisaka te, mutu eko koimité systemi immune mpo ebota ba anticorps ebundisa virusii ya SRAS-CoV-2 	With the use of animal feed, the DNA will be prepared for replication in human animals to produce small fragments of the virus that do not cause infection, the person will commit the immune system to produce antibodies against the SRAS-CoV-2 virus
1856	en	ln	In March 2020, the US government, industry, and three universities pooled resources to access supercomputers from IBM, combined with cloud computing resources from Hewlett Packard Enterprise, Amazon, Microsoft, and Google.	Na Mars 2020, loyalo ya E.U., industrie, pe ba université misatu batiaki ba resource esika moko mpo bakota na baordinateur super ya IBM, basangisa na misala ya ordinateur nuage ya Hewlett Packard Enterprise, Amazon, Microsoft, na Google.	In March 2020, the EU government, industry, and three universities put resources together to join IBM’s supercomputers, combined with the cloud computing operations of Hewlett Packard Enterprise, Amazon, Microsoft, and Google.
1857	en	ln	Some vaccines have heterologous effects, also called non-specific effects.	Ba vaccin mosusu ezali na ba effet heterologue, óyo ebengamaka lisúsu ba effet non-specifiki.	Some vaccines have heterologous effects, also called non-specific effects.
1858	en	ln	That means they can have benefits beyond the disease they prevent.	Yangó elingi koloba bakoki kozala na babenefice sima ya bokono bazo pekisa.	This means they can have benefits after the disease is prevented.
1859	en	ln	A further randomized trial in Australia is seeking to enrol 4,170 healthcare workers.	Bomeki lisúsu ya libaku na ekolo ya Australie ezo luka ekomisa basali ya sante 4,170.	Another opportunity test in Australia seeks to recruit 4,170 health workers.
1860	en	ln	It is possible vaccines in development will not be safe or effective.	Ekokí kozala ete ba vaccin bazo lengela ekozala malamu te basalela na kimia pe lolenge elongobani.	The vaccines being developed may not be suitable for safe and effective use.
1861	en	ln	Early research to assess vaccine efficacy using COVID-19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and non-human primates, indicate a need for biosafety-level 3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.	Likundoli ya yambo mpóna koevalué ba vaccin lolenge ebongi na bosaleli ya COVID-19-specifiki ya modeli ya bibwele, lokola mpuku ya ACE2-transgeniki, bibwele mosusu ya laboratoire, na ba primate ya makako, ezo lakisa mosapi na kimia ya bamesure ya niveau 3 ya confinement mpóna komanipulé ba virusi ya bomoi, pe boyokani ya bato ya mikili mpóna bosaleli ya banzéla standarde ya kimia.	The first recommendation for evaluating vaccines appropriately in the use of COVID-19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and macaque primates, points to the silence of level 3 measurements of containment to manipulate live viruses, and international cooperation for the use of standard peaceful methods.
1862	en	ln	Vaccines against SARS and MERS have been tested in non-human animal models.	Ba vaccin ya tembe na SRAS pe MERS esi esalami momekano na bamodeli ya bato te.	The suspect vaccines in SRAS and MERS have not been tested in human models.
1863	en	ln	As of 2020, there is no cure or protective vaccine for SARS that has been shown to be both safe and effective in humans.	Tii na mobu 2020, kisi to vaccin eza kaka te mpo esilisa to epekisa SARS pe epesama na kimia pe bolongi na nzoto ya bato.	By 2020, there is simply no cure or vaccine for SARS and it can be safely and successfully administered to humans.
1864	en	ln	According to research papers published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around the world.There is also no proven vaccine against MERS.	Na bolandi ya bapapela ya bokundoli ebimaki na mibu 2005 pe 2006, boyebeli na bokolisi ya ba vaccin ya sika pe bakisi mpóna kosilisa bokono ya SARS ezalaki priorité mpóna ba loyalo na ba agence ya sante ya bato na mokili mobimba. Lisúsu vaccin ya bondimi mpóna MERS.pe ezali te	Following the summary papers published in 2005 and 2006, knowledge in the development of new vaccines and drugs to treat SARS was a priority for stakeholders in public health agencies around the world. Also there is no reliable vaccine for MERS
1865	en	ln	When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.	Ntángo MERS engindaki, ezalaki kondimama ete bokundoli ya SRAS óyo esi esalamaki eko kopesa template ya ntina mpóna bokolisi ba vaccin na therapi ya tembe na infection ya MERS-CoV 	When MERS emerged, it was believed that the SRAS findings already established would provide a useful template for the development of vaccines in the therapy of suspicion of MERS-CoV infection
1866	en	ln	As of March 2020, there was one (DNA based) MERS vaccine which completed phase I clinical trials in humans, and three others in progress, all of which are viral-vectored vaccines, two adenoviral-vectored (ChAdOx1-MERS,  BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).	Tii Mars2020, vaccin moko ya MERS (esalamaki likolo ya DNA) mutu esukisaki etapi I ya mimekano ya cliniki ya bato, pe misato mosusu ezalaki na nzela, nionso ya bango eza bavaccins a virusi vectoré, mibale ya adenoviral-vectoré (ChAdOx1-MERS,  BVRS-GamVac), na moko MVA-vectoré (MVA-MERS-S).	As of March2020, one MERS vaccine (based on DNA) has completed phase I human clinical trials, and three more are in the pipeline, all of which are vectored a virus vaccines, two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).
1867	en	ln	Social media posts have promoted a conspiracy theory claiming the virus behind COVID-19 was known and that a vaccine was already available.	Ba affiche ya media sociale esi etomboli likanisi ya complot ezo loba ete virusi etindiki COVID-19 eyebanaki pe vaccin esi esalama mpóna yango.	Social media posters have already raised the idea of a conspiracy saying that the virus that caused COVID-19 was known and a vaccine had been developed for it.
1868	en	ln	The patents cited by various social media posts reference existing patents for genetic sequences and vaccines for other strains of coronavirus such as the SARS coronavirus.	Ba patente ba affiche ya media sociale ya lolenge bazali kocité ezali referé na ba patente ya kala mpóna ba sequence genetiki pe ba vaccin mpo na lolenge mosusu ya coronavirusi lokola coronavirusi ya SRAS.	The patents the social media posters of the type they are citing refer to previous patents for genetic sequences and vaccines for other types of coronaviruses such as the SRAS coronavirus.
1869	en	ln	b'Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Mabela ya b'Coronavirusi ya 2019 (COVID-19) ezali pasi ya infection ya mabela ebendami na coronavirusi 2 ya syndrome ya songe ya bopemi (SRAS-CoV-2).	The 2019 Coronavirus (COVID-19) is a disease of the breast infection caused by the respiratory syndrome coronavirus 2 (SRAS-CoV-2).
1870	en	ln	Common symptoms include fever, cough, and shortness of breath.	Ba symptome ya ba tango mingi etie nakati fievre, kosukosu, na pema bokuse.	Symptoms often include fever, cough, and shortness of breath.
1871	en	ln	Other symptoms may include fatigue, muscle pain, diarrhea, sore throat, loss of smell, and abdominal pain.	Ba symptome mosusu eko kotía nakati kolemba, misuni pasi, pulu-pulu, mongongo pasi, koyóka solo, libumu pasi.	Other symptoms will include fatigue, muscle aches, fever, sore throat, hearing loss, abdominal pain.
1872	en	ln	The time from exposure to onset of symptoms is typically around five days but may range from two to fourteen days.	Bandá bozwi ti bobandi ya basymptome eza ngambo ya mikolo mitano kasi eko komata mikolo mibale ti zomi na minei.	The onset of symptoms is five days but will increase to two to fourteen days.
1873	en	ln	While the majority of cases result in mild symptoms, some progress to viral pneumonia and multi-organ failure.	Ba cas mingi ezalaka nango na basymptome ya pete, kasi mosusu esukaka na panzi mabe pe kopola ya ba organe.	Most cases have mild symptoms, but some end in malignant breakdown and organ decay.
1874	en	ln	As of 17 April 2020, more than 2.24 million cases have been reported across 210 countries and territories, resulting in more than 153,000 deaths.	Na 17 Avril 2020, koleka ba million 2.24 ya ba cas esi epesami lapolo na bikólo pe bingunda 210, mutu esúkeli na liwâ ya bato koleka 153,000.	As of April 17, 2020, more than 2.24 million cases have been reported in 210 countries and territories, resulting in more than 153,000 deaths.
1875	en	ln	More than 568,000 people have recovered.The virus is primarily spread between people during close contact, often via small droplets produced by coughing, sneezing, or talking.	Koleka lotango ya bato 568,000 bazongi konungonu. yango virusi mingi-mingi epalanganaka kati ya bato baza na ngambo, mingi-mingi na biteni mike-mike ya nsoi ebimaka na kokosola, kosala kesia to koloba.	More than 568,000 people have returned to Konungonu. so the virus is usually spread among the guilty, usually in tiny pieces of saliva that come out of coughing, sneezing or talking.
1876	en	ln	While these droplets are produced when breathing out, they usually fall to the ground or onto surfaces rather than being infectious over long distances.	Biténi ya nsoi yango ebimaka pe tángo ya kopema, kasi mingi-mingi ekwéyaka na mabelé to esika ya ngambo ezalaka na infection ya bobwakami mosika te.	These pieces of saliva also come out during breathing, but usually fall to the ground or the side area is not infected with distant disposal.
1877	en	ln	People may also become infected by touching a contaminated surface and then touching their eyes, nose, or mouth.	Bato pe bako kokoma na infection soki bazali kosimba bisika eza contaminé pe sima basimbi miso, zolo, to monoko na bango.	People will also become infected if they touch contaminated areas and then touch their eyes, nose, or mouth.
1878	en	ln	The virus can survive on surfaces up to 72 hours.	virusii eko kozala ya bomoi na esika tii bangonga 72.	virusii will be viable locally for up to 72 hours.
1879	en	ln	It is most contagious during the first three days after the onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease.The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab.	Ezalaka na motungisi makasi mikolo misato ya yambo ya ebandeli ya basymtome, kasi bopalangani eko kozala nango liboso basymtome emonana pe na ntango ya sima ya maladi. Methode standarde ya diagnostiki eza na reaction na chaine ya bozongi sima na temps reel ya bokomi ya polymerase (rRT-PCR) na swabi sima ya zolo.	It is most troublesome the first three days of symptom onset, but the spread will be there before symptoms appear and during the later stages of the disease. The standard method of diagnosis consists of a backward chain reaction with real-time polymerase writing (rRT-PCR) on a swab behind the nose.
1880	en	ln	The use of masks is recommended for those who suspect they have the virus and their caregivers.	Bosáleli ya masike na elongi etindami mpóna bato bazo kanisela bango baza na virusi pe bakengeli na bango.	The use of masks is recommended for people who are thought to be infected and their guardians.
1881	en	ln	Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use, and others requiring their use.	Etindi ya bosaleli ya masike na bato banso na publiki ekesani, na ntina ete bakonzi mosusu bazo boya basalela yango, basusu bazo tinda yango, pe basusu bazo loba esengeli basalela yango.	The mandate for the use of masks by the public varies, with some authorities refusing to use them, others enforcing them, and others saying they should be used.
1882	en	ln	Currently, there is no vaccine or specific antiviral treatment for COVID-19.	Mikolo ya lelo, vaccin to kisi ya kobelesa COVID-19 ezali te.	There is currently no vaccine or cure for COVID-1
1883	en	ln	Local transmission of the disease has been recorded in most countries across all six WHO regions.	Bokaboli ya esika moko ya maladi esi ekomami na ebele ya bikolo na bingunda nyónso motóba ya OMS.	The distribution of a disease area has already been documented in a number of countries in all six WHO countries.
1884	en	ln	Those infected with the virus may be asymptomatic or develop flu-like symptoms such as fever, cough, fatigue, and shortness of breath.	Bato bazwi infection ya virusi bakoki kozala asymptomatiki to bako kokolisa basymtome ekokani na óyo ya grippe, ndakisa fievre, kosu-kosu, kolemba, pema mokuse.	People infected with the virus may be asymptomatic or develop flu-like symptoms, such as fever, cough, fatigue, shortness of breath.
1885	en	ln	Emergency symptoms include difficulty breathing, persistent chest pain or pressure, confusion, difficulty waking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.	Ba symptome ya bombango etie nakati kopema na pasi, pasi ezo sila te kati ya tolo to pression, kobunga makanisi, kolamoka na pasi, pe elongi to mbebo ekomi bule; kenge ya monganga noki eluki botosi soki basymptome ya boye eza. 	Symptoms of acute pain include painful breathing, persistent pain in the chest or pressure, loss of consciousness, painful awakening, and whitening of the face or cheeks; immediate medical attention seeks obedience if such symptoms are present.
1886	en	ln	Less commonly, upper respiratory symptoms such as sneezing, runny nose or sore throat may be seen.	Bambala mike, basymptome ya pema ya likolo lokola ba kesia, kotanga zolo to pasi na mongongo eko kozala.	Rarely, upper respiratory symptoms such as wheezing, runny nose or sore throat will be present.
1887	en	ln	Gastrointestinal symptoms such as nausea, vomiting and diarrhoea have been observed in varying percentages.	Ba symptome gastrointestinale lokola posa ya kosanza, kosanza pe pulu-pulu esi emonani na porcentage ekesani.	Gastrointestinal symptoms such as nausea, vomiting and diarrhea have already been seen in varying percentages.
1888	en	ln	Some cases in China initially presented only with chest tightness and palpitations.	Ba cas mosusu na Chine na ebandeli elakisaki kaka tolo kokanga pe motema kobeta.	Some cases in China initially showed only stuffy nose and heart palpitations.
1889	en	ln	In some, the disease may progress to pneumonia, multi-organ failure, and death.	Na bato mosusu, kobéla eko kokoma pasi ya panzi, ba organe ebele eko kopola, pe liwa.	In some people, the disease will become severe pain, multiple organ failure, and death.
1890	en	ln	This is called the incubation period.	óyo ebengamaka ntango ya incubation.	this is called the incubation period.
1891	en	ln	The incubation period for COVID-19 is typically five to six days but may range from two to 14 days.	Ntngo ya incubation mpóna COVID-19 eza mingi-mingi mikolo mitano ti motoba kasi range mikolo mibale ti 14.	The incubation period for COVID-19 is usually five to six days but ranges from two to 14 days.
1892	en	ln	97.5% of people who develop symptoms will do so within 11.5 days of infection.Reports indicate that not all who are infected develop symptoms.	97.5% ya bato bazwaka basymtome bamonaka yango kati ya mikolo 11.5 ya bozwi infection. Ba lapolo elakisi bato banso ya infection te babimaka basymtome.	97.5% of people develop symptoms within 11.5 days of infection. Reports indicate not all infected people develop symptoms.
1893	en	ln	The role of these asymptomatic carriers in transmission is not yet fully known; however, preliminary evidence suggests that they may contribute to the spread of the disease.	Ntína ya bamemi asymptomatiki yango na bokaboli naino eyebani mobimba penza te; kasi nde bilembo ya ebandeli ekaniseli ete baza na mosala na bopanzi kobéla.	The cause of these asymptomatic carriers in the division is not yet fully understood; rather, the early signs suggest that they are involved in spreading the disease.
1894	en	ln	The proportion of infected people who do not display symptoms is currently unknown and being studied, with the Korea Centers for Disease Control and Prevention (KCDC) reporting that 20% of all confirmed cases remained asymptomatic during their hospital stay.	Ndámbo ya lotango ya bato ya infection baye balakisaka basymptome te sik’oyo eyebani te pe ezo yekolama, na bacentre ya Korea mpóna Controle pe bopekisi ya Makono (KCDC) epesi lapolo ete 20% ya bacas nyónso baconfirmaki eza kaka asymptomatiki na bofandi na lopitalo.	The proportion of infected people who do not show symptoms is currently unknown and is being studied, with the Korea Centers for Disease Control and Prevention (KCDC) reporting that 20% of all confirmed cases remain asymptomatic during hospitalization.
1895	en	ln	China's National Health Commission began including asymptomatic cases in its daily cases on 1 April; of the 166 infections on that day, 130 (78%) were asymptomatic at the time of testing.	Comission Nationale ya Santé ya Chine esi ebandi kotia nakati bacas asymptomatiki na bacas ya moko-na-mokolo na 1 April; na 166 ya bakwoso nyónso ya mokolo wana, 130 (78%) ezalaki asymptomatiki na ntango ya tesite.	China&#39;s National Health Commission has already begun classifying asymptomatic cases as one-a-day cases on April 1; of the 166 total wounds that day, 130 (78%) were asymptomatic at the time of the test.
1896	en	ln	Both sputum and saliva can carry large viral loads.	Milelu na nsoi eko kozala na kilo monene ya virusi.	The saliva and saliva will carry a large load of virus.
1897	en	ln	Loud talking releases more droplets than normal talking.	Koloba ya makasi elekaka matanga mingi na koloba ya normale.	Loud speech outweighs many funerals with normal speech.
1898	en	ln	A study in Singapore found that an uncovered cough can lead to droplets travelling up to 4.5 meters (15 feet).	 Liyekoli moko ya Singapore emoni ete kosu-kosu ezangi bozipi eko komema matanga na 4.5 metres (15 pied). 	A Singapore study found that uncovered kosu-kosu will carry funerals up to 4.5 meters (15 feet).
1899	en	ln	Though the virus is not generally airborne, the National Academy of Science has suggested that bioaerosol transmission may be possible and air collectors positioned in the hallway outside of people's rooms yielded samples positive for viral RNA.	Atako virusi yango mingi-mingi ebotamaka nango na mopepe te, Academy National ya Science elobi bokabli na bioaerosol nde eko kosalama pe bikongoli ya mopepe na bacoridore libanda ya masuku ya bato epesi ba echantillon ya positife mpóna virusi RNA.	Although the virus is not usually born in the air, the National Academy of Sciences says bioaerosol distribution will be the most common and air samples in corridors outside people&#39;s homes have provided positive samples for the RNA virus.
1900	en	ln	Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolised and thus result in airborne spread.	 Ba operation ya monganga mosusu lokola kotia tiyo na kati pe Resisitasio Cardiopulmonaire(CPR) ekoki kosala ete matanga ya kopema ekota na mopepe bongo kopanzana na mopepe. 	Other medical operations such as tube insertion and Cardiopulmonary Resuscitation (CPR) can cause breathing fluid to enter the air and spread in the air.
1901	en	ln	While there are concerns it may spread via feces, this risk is believed to be low.The virus is most contagious when people are symptomatic; while spread may be possible before symptoms emerge, the risk is low.	Souci eza ete eko kopalangana na niei, likama yango ezo ndimama na niveau yase. virusii ezalaka makasi mingi na bokabwani soki bato baza symptomatiki; ta ko bopalangani eko kosalama liboso basymptome ebima, likama eza nase.	The concern is that it will spread to niei, the danger is accepted at a low level. virusii is more severe in isolation when people are symptomatic; ta the spread will happen before symptoms appear, the risk is low.
1902	en	ln	The European Centre for Disease Prevention and Control (ECDC) says while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.The virus survives for hours to days on surfaces.	Centre ya Europa mpóna Controle pe Bopekisi ya Maladie (ECDC) elobi ta ko eyebani penza na moi te ndenge nini eza pasi te maladi epalangana, moto moko mingi-mingi apesaka kpokoso na bato mibale to misato mosusu. virusii ekoki kowumela ba ngonga molai na likolo ya biloko.	The European Center for Disease Control and Prevention (ECDC) says it is not clear how easy it is for the disease to spread, one person usually infecting two or three others. virusii can persist for hours on surfaces.
1903	en	ln	Specifically, the virus was found to be detectable for one day on cardboard, for up to three days on plastic (polypropylene) and stainless steel (AISI 304), and for up to four hours on 99% copper.	 Na specifiki, virusi emonanaki kowumela likolo ya carton mokolo mobimba, tii mokolo misato na plastiki (polypropylene) pe ebendé ezanga rouille (AISI 304), pe tii bangonga minei na 99% ya cuivre.	Specifically, the virus was found to persist on cardboard for a whole day, up to three days in plastic (polypropylene) and stainless steel (AISI 304), and up to four hours in 99% copper.
1904	en	ln	This, however, varies depending on the humidity and temperature.	Kasi, yango nde ekesanaka na botali humidité pe température.	However, that’s what differs in terms of humidity and temperature.
1905	en	ln	Soap and detergent are also effective if correctly used; soap products degrade the virus' fatty protective layer, deactivating it, as well as freeing them from skin and other surfaces.	Savo pe detergent ezalaka pe makasi soki esalameli lolenge elongobani; ba produit ya savo ekataka poso ya mafúta ebatelaka virusi, elongolaka bango, elongo na kolongola yango na poso to bisika mosusu.	Soap and detergent are also strong when used properly; soap products cut the oily skin protects the virus, removes them, along with removing it from the skin or other areas.
1906	en	ln	Other solutions, such as benzalkonium chloride and chlorhexidine gluconate (a surgical disinfectant), are less effective.In a Hong Kong study, saliva samples were taken a median of two days after the start of hospitalization.	Basolution mosusu, lokola chloride ya benzalkonium pe gluconate ya chlorhexidine (desinfectant ya chirurgie), eza pete. Na boyekoli ya Hong Kong, ba echantillon ya nsoi bakongolaki kati ya mikolo mibale sima ya bokoti lopitalo.	Some solutions, such as benzalkonium chloride and chlorhexidine gluconate (surgical disinfectant), are mild. In the Hong Kong study, fecal samples were collected between two days after hospitalization.
1907	en	ln	In five of six patients, the first sample showed the highest viral load, and the sixth patient showed the highest viral load on the second day tested.	Na mitano ya babeli motoba, echantillon ya liboso elakisi kilo ya virusi emata na nsuka, ebongo mobeli ya motoba azalaki na kilo ya virusi emata mokolo ya mibale ya tesite.	In five of the six patients, the first sample shows an increased viral load at the end, then the sixth patient had an increased viral load the second day of testicular.
1908	en	ln	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel severe acute respiratory syndrome coronavirus, first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan.	Syndrome ya pasi mingi ya pema ya coronavirusi 2 (SRAS-CoV-2) eza coronavirusi ya sika ya pasi makasi ya syndrome ya kopema, elongolamaki mbala liboso na bato misato babelaki panzi ekangana na bato ya pasi makasi ya pema na Wuhan.	Severe respiratory syndrome coronavirus 2 (SRAS-CoV-2) is a new severe respiratory syndrome coronavirus, first isolated from three people who were sick with the outbreak associated with severe respiratory syndrome in Wuhan.
1909	en	ln	All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.	Bikilakila nionso ya virusi ya sika SRAS-CoV-2 ezalaka na bacoronavirusi ekangana na mokili.	All vaccines of the new SRAS-CoV-2 virus contain coronaviruses attached to the world.
1910	en	ln	Outside the human body, the virus is killed by household soap, which bursts its protective bubble.SARS-CoV-2 is closely related to the original SARS-CoV.	Libanda ya nzoto ya moto, virusi ebomamaka na savon ya ndáko, mutu epasolaka boule ebatelaka yango. SRAS-CoV-2 ekangani mingi na SRAS-CoV ya ebandeli.	Outside the human body, the virus is killed with household soap, the person who tears the ball protects it. SRAS-CoV-2 is closely related to the original SRAS-CoV.
1911	en	ln	The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme angiotensin-converting enzyme 2 (ACE2), which is most abundant in the type II alveolar cells of the lungs.	Mipululu mizali ba organe ezwaka mingi kpokoso ewutaka na COVID-19 mpo virusi ekotaka na cellula eyambaka ye na nzela ya enzyme angiotensin-convertisant enzyme 2 (ACE2), mutu ezali mingi na bacellula alveole type II ya mampulu.	The lungs are the organs most affected by COVID-19 because the virus enters the host cell through the enzyme angiotensin-converting enzyme 2 (ACE2), the person is most abundant in alveolar type II cells of the lungs.
1912	en	ln	"The virus uses a special surface glycoprotein called a ""spike"" (peplomer) to connect to ACE2 and enter the host cell."	"virusi esalelaka surface speciale ya glycoproteine ebengamaka ""spike"" (peplomer) mpóna kokanga yango na ACE2 pe ekota na cellula moyambi."	the virus uses a special glycoprotein surface called a &quot;spike&quot; (peplomer) to bind to ACE2 and enter the host cell.
1913	en	ln	Acute cardiac injury was found in 12% of infected people admitted in hospital in Wuhan, China, and is more frequent in severe disease.	Bozoki ya grave ya motema emonanaki na 12% ya bato ya kpokoso bakotisamaki na lopitalo na Wuhan, Chine, pe ezalaka mingi na maladi ya pasi makasi.	Severe heart injury was observed in 12% of patients hospitalized in Wuhan, China, and is more common in critical illness.
1914	en	ln	Rates of cardiovascular symptoms is high, owing to the systemic inflammatory response and immune system disorders during disease progression, but acute myocardial injury may also be related to ACE2 receptors in the heart.	Taux ya basymtome cardiovasculaire emata, eza mpóna reaction ya inflamation systemiki na pasi ya systemi immune ntango kobéla ezo kola, kasi bozoki ya songe ya myocardiaki eko pe kokangana na ba recepteur ya ACE2 na motema.	The increased rate of cardiovascular symptoms is due to a reaction of systemic inflammation to immune system pain as the disease progresses, but myocardial injury will also bind to ACE2 receptors in the heart.
1915	en	ln	ACE2 receptors are highly expressed in the heart and are involved in heart function.	Ba recepteur ya ACE2 emonanaka mingi na motema pe esalisaka na bosali ya motema.	ACE2 receptors are commonly expressed in the heart and contribute to cardiac function.
1916	en	ln	A high incidence of thrombosis (31%) and venous thromboembolism (25%) have been found in ICU patients with COVID-19 infections and may be related to poor prognosis.Autopsies of people who died of COVID-19 have found diffuse alveolar damage (DAD), and lymphocyte-containing inflammatory infiltrates within the lung.	Incidence ebuta ya thrombose (31%) pe thromboembolisme ya ba misisa monene (25%) emonani na ba malade ya USI baza na kpokoso ya COVID-19 pe eko kozala na bokangani na prognostiki ya bopoto. Mapasoli ma bakufa ya COVID-19 elakisi mbeba ya alveole diffuse(AAD), pe lymphocyte-eza na infiltrate inflammatoire nakati ya poumon.	A high incidence of thrombosis (31%) and major venous thromboembolism (25%) has been observed in USI patients with COVID-19 and will be associated with clinical prognosis. Surgeries of COVID-19 deceased show diffuse alveolar damage(AAD), and lymphocyte-containing inflammatory infiltrate in the lung.
1917	en	ln	Although SARS-COV-2 has a tropism for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyperinflammation.	Ata ko SRAS-COV-2 eza na tropisme mpóna ACE2-expressing epithelial cells ya nzela ya kopemela, babeli ya COVID-19 ya makasi bazalaka na basymptome ya hyperinflammation systemiki.	Although SRAS-COV-2 has a tropism for ACE2-expressing airway epithelial cells, severe COVID-19 patients have symptoms of systemic hyperinflammation.
1918	en	ln	In particular, pathogenic GM-CSF-secreting T-cells were shown to correlate with the recruitment of inflammatory IL-6-secreting monocytes and severe lung pathology in COVID-19 patients.	Na ebatiseli, na bacellula T ya GM-CSF-ebimisaka bapathogene elakisamaki ete ezali na correlation na recrutement ya bamoncyte IL-6 ebimisaka inflammasio pe pathologie ya pasi mabe ya lipili na malade ya COVID-19.	In baptism, pathogenic GM-CSF-producing T cells have been shown to correlate with monocyte recruitment IL-6 produces inflammation and painful liver pathology in COVID-19 patients.
1919	en	ln	Lymphocytic infiltrates have also been reported at autopsy.	Ba infiltrate lymphocytiki esi esalameli lisusu lapolo na bopasoli.	The lymphocytic infiltrate has been further reported at surgery.
1920	en	ln	The WHO has published several testing protocols for the disease.	OMS asi apublié baprotocole ebele ya tesite mpóna bokono yango.	WHO has already published several testosterone protocols for the disease.
1921	en	ln	The standard method of testing is real-time reverse transcription polymerase chain reaction (rRT-PCR).	Methode standarde mpóna bosalisi tesite eza bokomi na temps réel inverse ya reaction ya chaine ya polymerase (rRT-PCR). 	The standard method for testosterone diagnosis is real-time reverse polymerase chain reaction (rRT-PCR).
1922	en	ln	The test is typically done on respiratory samples obtained by a nasopharyngeal swab; however, a nasal swab or sputum sample may also be used.	Tesite na particulié esalamelaka na ba echantillon ya pema bazwaka na bosaleli ya tige motongo ya zolo ti na mongongo; kasi bako kosalela pe tige ya zolo to echantillon ya crachat.	Testis in particular is done on breath samples taken using the nasal to vocal cords; but they will also use a nose stick or sputum sample.
1923	en	ln	Results are generally available within a few hours to two days.	 Baresulta ekoyebana mingi-mingi kati ya ba ngonga mike elandaka to na mikolo mibale.	Results will be known usually within the next few hours or two days.
1924	en	ln	Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.	Bakoki kosalela batesite ya makila, kasi yango esengaka ba echantillon mibale ya makila babendi baposo mibale ekabwana pe ba resultat ezangi valele moke ya noki-noki.	Blood tests can be used, but this requires two blood samples drawn two weeks apart and the results are of little immediate value.
1925	en	ln	Chinese scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so laboratories across the world could independently develop polymerase chain reaction (PCR) tests to detect infection by the virus.	Bakundoli ya Chine bazalaki na makoki ma ko isolé lolenge ya coronavirusi pe bapubliaki sequence genetiki bongo ba laboratoire ya mokili mobimba bakoka kokolisa na kimpwanza batesite ya reaction ya chaine polymerase (PCR) mpóna kodetecté kpokoso na virusi.	Chinese researchers were able to isolate the coronavirus strain and publish the genetic sequence so laboratories around the world could freely develop polymerase chain reaction (PCR) kits to detect defects in the virus.
1926	en	ln	As of 4 April 2020, antibody tests (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.	Na 4 Avril 2020, tesite ya anticorps (mutu eko kodetecté bakpokoso ya actif pe soki moto asi azwaki kpokoso kala) ezalaki na bokolisi, kasi naino na bosaleli mingi te.	As of April 4, 2020, antibody testing (which will detect active vaccines and if a person has already been vaccinated) was in development, but not yet in widespread use.
1927	en	ln	The Chinese experience with testing has shown the accuracy is only 60 to 70%.	Experience ya bato ya Chine na bosali ya tesite elakisi ete bosolo nayango eza kaka 60 ti 70%.	Chinese experience with testing shows that its accuracy is only 60 to 70%.
1928	en	ln	The FDA in the United States approved the first point-of-care test on 21 March 2020 for use at the end of that month.Diagnostic guidelines released by Zhongnan Hospital of Wuhan University suggested methods for detecting infections based upon clinical features and epidemiological risk.	FDA na Etats-Unis asi andimaki esika ya liboso ya bosali tesite ya depistage na 21 Mars 2020 po bato basalelaka na suka sanza. Milongo ya lisungi ya diagnostiki na Lopitalo ya Zhongnan ya Université ya Wuhan ekanisi ba methodi mpóna kodetecté ba kpokoso ose ya bikilakila ya cliniki pe likama ya epidemiologie.	The US FDA has already approved the first screening test site on March 21, 2020 for use at the end of the month. Diagnostic support groups at Zhongnan Hospital of Wuhan University have developed methods for detecting clinical drug deficiencies and epidemiological risk.
1929	en	ln	Bilateral multilobar ground-glass opacities with a peripheral, asymmetric and posterior distribution are common in early infection.	Ba opacité ya multilbare ya kitala-tala ya mabele ngambo mibale na peripherique, asymetrique pe bokaboli ya sima emonanaka mingi na ba kpokoso ya yambo.	Multilbare opacities of both sides of the earth&#39;s surface in the periphery, asymmetric and posterior division are common in early defects.
1930	en	ln	Subpleural dominance, crazy paving (lobular septal thickening with variable alveolar filling), and consolidation may appear as the disease progresses.	Dominance subpleurale, pavement ya liboma (kovimba ya lobe septale na botondisi ya alveole ekesanaka), pe consolidation eko komonana tango maladi ezo kola.	Subpleural dominance, cleft pavement (septal lobe swelling and alveolar filling vary), and consolidation will become apparent as the patient progresses.
1931	en	ln	Few data are available about microscopic lesions and the pathophysiology of COVID-19.	Badonnée mike kaka esi ebimi etali ba lesion microscopiki pe pathophysiologia ya COVID-19.	Only limited data have been published regarding the microscopic lesions and pathophysiology of COVID-1
1932	en	ln	The main pathological findings at autopsy are:	Makundoli ma principale na autopsia mazali::	The principal findings at the autopsy are::
1933	en	ln	Macroscopy: pleurisy, pericarditis, lung consolidation and pulmonary oedema	Macroscopia: pleuresie, pericarditite, consolidation ya lipili pe oedema ya lipululu.	Macroscopy: pleurisy, pericarditis, urine consolidation and sputum edema.
1934	en	ln	Four types of severity of viral pneumonia can be observed:	Bandenge minei ya koswa ya pasi mingi na panzi eko komonana:	Four types of very painful bites on the pan will appear:
1935	en	ln	mild pneumonia: pulmonary oedema, pneumocyte hyperplasia, large atypical pneumocytes, interstitial inflammation with lymphocytic infiltration and multinucleated giant cell formation	panzi ya pete: panzi ya oedèma, hyperplasie pneumocyte, ba pneumocyte atypiki ya monene, inflammasio interstitiale na infiltration ya lymphocytiki pe formation ya cellula multinucleate ya kabakata	mild spread: edema spread, pneumocyte hyperplasia, large atypical pneumocytes, interstitial inflammation with lymphocytic infiltration and multinucleate kabakata cell formation
1936	en	ln	severe pneumonia: diffuse alveolar damage (DAD) with diffuse alveolar exudates.	panzi ya pasi makasi: bopanzani mabe ya alveole (DAD) bopanzani ya ba exudate ya alveole.	severe painful burst: alveolar dysfunction (DAD) dissolution of alveolar exudates.
1937	en	ln	DAD is the cause of acute respiratory distress syndrome (ARDS) and severe hypoxemia.	DAD eza esika ewutaka syndrome ya pasi ya songe ya matáta ya kopema (ARDS) pe pasi mabe ya hypoxemie.	DAD is the source of acute respiratory distress syndrome (ARDS) and severe hypoxemia.
1938	en	ln	healing pneumonia: organisation of exudates in alveolar cavities and pulmonary interstitial fibrosis	bosilisi ya panzi: bobongisi ya ba exudate kati ya mabulu ya alveole pe fibrose ya lipili interstitiale.	rupture resolution: repair of exudates between alveolar cavities and interstitial lipid fibrosis.
1939	en	ln	Blood: disseminated intravascular coagulation (DIC); leukoerythroblastic reaction	Makila: bokangami na bopalangani ya makila na intravesicula (DIC); reactio ya leukoerythroblastiki	Blood: binding to intravesicula diffusion (DIC); leukoerythroblastic reaction
1940	en	ln	Preventive measures to reduce the chances of infection include staying at home, avoiding crowded places, washing hands with soap and water often and for at least 20 seconds, practising good respiratory hygiene and avoiding touching the eyes, nose or mouth with unwashed hands.	Ba mezile mpóna bopekisi pe bokitisi ya makama ya kozwa kpokoso etie nakati bofandi na ndako, bokimi ya bisika ya bato mingi, bosokoli maboko na savo na mai mbala mingi molai ba seconde 20, bosaleli ya peto ya pema pe kotika kosimba miso, zolo to monoko na maboko ya mbindo.	Measures for prevention and risk reduction include staying at home, avoiding public places, washing hands with soap and water usually for 20 seconds, using clean breath and avoiding touching eyes, nose or mouth with dirty hands.
1941	en	ln	The CDC recommends covering the mouth and nose with a tissue when coughing or sneezing and recommends using the inside of the elbow if no tissue is available.	Botindi ya CDC ezali bozipi monoko na zolo na muswale tango ya bokosoli na bosali kesia pe ezo tinda bosaleli ya bogunzami ya liboko soki muswale ezangi.	The CDC recommendation is to cover the mouth and nose with a mouthpiece during digestion and chest pain and recommends the use of hand gloves if a mouthpiece is not available.
1942	en	ln	Proper hand hygiene after any cough or sneeze is encouraged.	Bopéto ya solo sima ya bokosoli na bosali kesia esengami na molende.	True cleanliness after cleansing and kesia is required diligently.
1943	en	ln	The CDC has recommended the use of cloth face coverings in public settings, in part to limit transmission by asymptomatic individuals.Social distancing strategies aim to reduce contact of infected persons with large groups by closing schools and workplaces, restricting travel and cancelling large public gatherings.	CDC atindi bosaleli ya elámba mpóna kozipa elongi na publiki, na ndámbo mpóna kokáta bopalangani ya bato baza asymptomatiki. Bastrategie ya bobombi distance kati ya bato ebongisami mpóna kokitisa bosangani ya bato bazali na infection pe bokangí basikola pe bisika ya bosali, bopekisi mibémbo pe bokangí ya bisika bato ebele basanganaka.	The CDC recommends the use of a mask in public, in part to cut the spread of asymptomatic people. Social distancing strategies are designed to reduce the spread of infected people and the closure of workplaces and workplaces, travel restrictions and the closure of public places.
1944	en	ln	Distancing guidelines also include that people stay at least 6 feet (1.8 m) apart.	Masungi ya bobombi distance pe etatoli ete bato batikala toloba 6 feet (1.8 m) na bokabwani.	Distance keeping support also ensures that people stay say 6 feet (1.8 m) apart.
1945	en	ln	"There is no medication known to be effective at preventing COVID-19.As a vaccine is not expected until 2021 at the earliest, a key part of managing COVID-19 is trying to decrease the epidemic peak, known as ""flattening the curve""."	"Kísi eza te óyo eyebani mpóna kopekisa na bokasi pasi ya COVID-19. Lokóla vaccin ezo zelama te esíla kosalama ti 2021 na elikia, ndámbo ya fungola mpóna kogéré COVID-19 eza komeka kokitisa songe ya ngomba ya epidemia, yango ebengami ""kokómisa courbe platte""."	There is no known cure to effectively prevent the pain of COVID-1 With a vaccine not expected to be developed until 2021 hopefully, part of the key to managing COVID-19 is trying to reduce the mountain peak of the epidemic, which is called &quot;flattening the curve&quot;
1946	en	ln	The CDC also recommends that individuals wash hands often with soap and water for at least 20 seconds, especially after going to the toilet or when hands are visibly dirty, before eating and after blowing one's nose, coughing or sneezing.	 CDC esengi bato basokola maboko ba mbala ebele na sabuni na mai mpóna baseconde 20, nsima ya kokenda na kabine to tango maboko ezo monana na mbindo, liboso ya kolia bilei; mpe nsima ya kopopola zolo, kokosola, mpe kosala kesia. 	The CDC recommends that people wash their hands several times with soap and water for 20 seconds, after going to the toilet or when hands appear dirty, before eating food; and after blowing the nose, sneezing, and chewing.
1947	en	ln	It further recommends using an alcohol-based hand sanitiser with at least 60% alcohol, but only when soap and water are not readily available.For areas where commercial hand sanitisers are not readily available, the WHO provides two formulations for local production.	Elandeli kotinda bosaleli ya biloko basala na alcoholi ya 60% mpóna kotia bopeto na maboko, kasi kaka tango savo na mayi ezali te. Na bisika biye bizalaka na mambi ma kosomba basanitiseur ya bopeto ya maboko óyo batekaka te, OMS ekotisi baformule ya bobotisi yango na esika.	It continues to recommend the use of 60% alcohol-based products to keep hands clean, but only when soap and water are not available. In areas where it is not possible to purchase commercial hand sanitizers, WHO has introduced local formulas.
1948	en	ln	In these formulations, the antimicrobial activity arises from ethanol or isopropanol.	Na baformula yango, bosali ya bobomi mikolobi etombokaka uta na ethanole to isopropanole.	In these formulas, the killing activity of the scavengers is derived from ethanol or isopropanol.
1949	en	ln	"Hydrogen peroxide is used to help eliminate bacterial spores in the alcohol; it is ""not an active substance for hand antisepsis""."	"Basalelaka peroxide ya hydrogene mpóna kosalisa na bolongoli ya mabulu ya mikolobe na alcoholi; ezali ""subistance elamuka te mpóna antisepsiki ya maboko""."	Hydrogen peroxide is used to help remove pits from alcohol; it is &quot;not awakened substance for hand antisepsis&quot;
1950	en	ln	Glycerol is added as a humectant.	Babakisaka glyceroli mpóna komouillé.	Glycerol is added for moistening.
1951	en	ln	People are managed with supportive care, which may include fluid therapy, oxygen support, and supporting other affected vital organs.	Bato bazo salisama na ba soin ya lisungi mutu eko kotia nakati therapi ya bamai, lisungi ya oxygene, pe kosunga ba organe mosusu ezwá kpokoso.	People are being treated with supportive care that will include water therapy, oxygen support, and supporting other organs that have been affected.
1952	en	ln	The CDC recommends that those who suspect they carry the virus wear a simple face mask.	CDC azo tinda ete bato bazo kanisa bazo Mama virusi yango balataka masike ya sempele na elongi.	The CDC is recommending that people who think they are breastfeeding the virus wear masks.
1953	en	ln	Extracorporeal membrane oxygenation (ECMO) has been used to address the issue of respiratory failure, but its benefits are still under consideration.	Bopesi oxygene na nzela ya membrane ya libanda ya nzoto (ECMO) esalameli mpóna kosilisa pasi ya pema mabe, kasi bolamo nango eza naíno na boyekoli.	Extracorporeal membrane oxygenation (ECMO) has been used to treat shortness of breath, but its effectiveness is still under study.
1954	en	ln	Personal hygiene and a healthy lifestyle and diet have been recommended to improve immunity.	Bopeto ya moto ye moko na mode de vie pe diete ya bilei etindami mpóna kobongisa immunité.	Personal hygiene and lifestyle and food diet are recommended to improve immunity.
1955	en	ln	Supportive treatments may be useful in those with mild symptoms at the early stage of infection.The WHO and Chinese National Health Commission have published recommendations for taking care of people who are hospitalised with COVID-19.	Lisungi na batraitement eko kozala na ntina mpóna bato baza na basymptome ya pete na tango ya ebandeli ya kopkoso. OMS na Comité Nationale ya Santé ya Chine basi bapublié mitindo mpóna kosalisa bato baza na mbéto ya lopitálo mpóna COVID-19.	Support with treatment will be important for people with mild symptoms during the onset of cough. The WHO and China&#39;s National Health Committee have published guidelines for treating people in hospital beds for COVID-1
1956	en	ln	Intensivists and pulmonologists in the U.S. have compiled treatment recommendations from various agencies into a free resource, the IBCC.	Ba intensiviste na ba pulmonologue na E.U. basi babongisi mitindo ya traitement ewuti na ba agence ya ndenge na ndenge na ba resource ya ofele, IBCC.	Intensivists and pulmonologists in the EU women have organized treatment types from a variety of agencies with free resources, IBCC.
1957	en	ln	As of April 2020, there is no specific treatment for COVID-19.	Na sanza ya Avril 2020, traitement specifiki ezangi mpóna COVID-19.	As of April 2020, there is no specific treatment for COVID-1
1958	en	ln	For symptoms, some medical professionals recommend paracetamol (acetaminophen) over ibuprofen for first-line use.	mpóna basymptome, minganga mosusu bazo tinda bosaleli ya paracetamol (acetaminophene) esika ya ibuprofene na etumba ya ebandeli.	for symptoms, some doctors recommend the use of paracetamol (acetaminophen) instead of ibuprofen in the initial battle.
1959	en	ln	Precautions must be taken to minimise the risk of virus transmission, especially in healthcare settings when performing procedures that can generate aerosols, such as intubation or hand ventilation.	Baprecaution esengeli ezwama mpóna kokitisa likama ya bokaboli ya virusi, mingi-mingi na bisika ya minganga bazo pesa lisalisi óyo eko kobimisa ba aerosole lokola botie ya batiyo to mopepe ya kopepa na maboko.	Precautions should be taken to reduce the risk of virus transmission, especially in medical settings that will produce aerosols such as the use of tubes or hand blowers.
1960	en	ln	For healthcare professionals caring for people with COVID-19, the CDC recommends placing the person in an Airborne Infection Isolation Room (AIIR) in addition to using standard precautions, contact precautions and airborne precautions.The CDC outlines the guidelines for the use of personal protective equipment (PPE) during the pandemic.	Mpo na basali ya sante bazo kengela bato ya bokono ya COVID-19, CDC azo tinda botie ya moto na Disuku ya Bokabolami ya infection Ebotamaka na Mopepe (AIIR) na bobakisi ya ba precaution standarde, baprecauton ya contacki pe baprecaution ya mopepe. CDC apesi masungi mpóna bosaleli ya bisaleli ya bobateli ya moto yemoko (PPE) na ntango ya pandemi.	For health workers caring for people with COVID-19, CDC is recommending fire placement in the Airborne Infection Isolation Room (AIIR) in addition to standard precautions, contact precautions and airborne precautions. CDC provides guidance for the use of personal protective equipment (PPE) during a pandemic.
1961	en	ln	The recommended gear is: PPE gown, respirator or facemask, eye protection, and medical gloves.When available, respirators (instead of facemasks) are preferred.	Materiel bazo tinda osalela eza:: Elamba ya PPE, respirateur to masike ya elongi, libateli ya miso, pe bagan ya monganga.Tango ekozala, ba respirateur (na esika ya bizipeli ya elongi) elingama koleka.	The materials they recommend you use are:: PPE clothing, respirator or face mask, eye protection, and medical gown.When available, respirators (instead of face masks) are preferred.
1962	en	ln	N95 respirators are approved for industrial settings but the FDA has authorised the masks for use under an Emergency Use Authorisation (EUA).	Ba respirateur N95 endimami mpóna bisika ya industrie, kasi FDA asi apesi ndíngisa mpóna bosaleli ya ba masike ose ya Ndingisa ya Bosáleli na Bombángo (EUA).	N95 respirators are approved for industrial uses, but the FDA has already approved the use of masks under the Emergency Use Authorization (EUA).
1963	en	ln	They are designed to protect from airborne particles like dust but effectiveness against a specific biological agent is not guaranteed for off-label uses.	Esi ebongisama mpóna kobatela moto na pusiele ezalaka na mopepe kasi bolamo nayango na bokati ya bolekisi ya mikolobe eza garanti te na bosaleli na yango.	It is already designed to protect fire from airborne dust but its effectiveness in cutting the passage of days is not guaranteed by its use.
1964	en	ln	When masks are not available, the CDC recommends using face shields or, as a last resort, homemade masks.	Ntango bamasike eza te, CDC etindi bosaleli ya ba pareface to, na bozangi nionso, masike esalami na ndako.	When masks are not available, CDC recommends the use of paraphernalia or, in the absence of any, homemade masks.
1965	en	ln	Most cases of COVID-19 are not severe enough to require mechanical ventilation or alternatives, but a percentage of cases are.	Ba cas ngambo ya nyonso ya COVID-19 eza nango songe molai te mpo esenga bosaleli ya mopepe ya masini to ba alternatifi, kasi pourcent ya ba cas ezo senga yango.	All cases of COVID-19 do not have a long tail to require the use of mechanical ventilation or alternatives, but a percentage of cases do.
1966	en	ln	The type of respiratory support for individuals with COVID-19 related respiratory failure is being actively studied for people in hospital, with some evidence that intubation can be avoided with a high flow nasal cannula or bi-level positive airway pressure.	Type ya soutien ya pema mpóna bato ya pasi ekangami na kopola ya pema ya COVID-19 ezo yekolama makasi mpóna bato baza na lopitalo, na elembo ete botie na tiyo eko kokima na bolekisi mopepe makasi na cannule na nzela ya pema to na pression positive ya nivo mibale.	The type of respiratory support for patients associated with COVID-19 respiratory collapse is being intensively studied for people in the hospital, with the indicator that insertion will escape by passing a strong air through the cannula through the respiratory tract or positive pressure of two levels.
1967	en	ln	Whether either of these two leads to the same benefit for people who are critically ill is not known.	Kasi eyebani te soki ta moko ya bango mibale ezo mema babenefice ya ndenge moko mpóna bato bazo bela makasi.	But it is not known whether ta one of the two brings the same benefits for people who are seriously ill.
1968	en	ln	Some doctors prefer staying with invasive mechanical ventilation when available because this technique limits the spread of aerosol particles compared to a high flow nasal cannula.Severe cases are most common in older adults (those older than 60 years, and especially those older than 80 years).	Minganga mosusu bazo mpóna masini ya mopepe ya kati ya nzoto soki ezali na ntina ete tekiniki óyo epekisaka bopalangani ya biteni mike-mike na mopepe mutu esalamka na bosaleli ya cannule ya mopepe ya makasi na zolo. Ba cas makasi emonanaka mingi na bato bakolo (baye baleki mibu 60, pe mingi-mingi penza baye baleki mibu 80).	Some physicians choose an internal ventilation machine if it is necessary that the technique that prevents the diffusion of particles in the head air is done with the use of a forced air cannula in the nose. Severe cases are more common in older people (over 60 years of age, and especially those over 80 years of age).
1969	en	ln	Many developed countries do not have enough hospital beds per capita, which limits a health system's capacity to handle a sudden spike in the number of COVID-19 cases severe enough to require hospitalisation.	Bikolo mingi ya dévelopé bizangi ba mbeto ekoka na lopitalo mpóna moto moko-moko, yango nde etie ndelo na systemi ya sante mpóna koyamba na bombango nomba ya bacas ya COVID-19 ya songe ekoka mpo bakota lopitalo.	Many developed countries do not have enough hospital beds per person, which limits the health system to quickly accommodate enough COVID-19 cases to be hospitalized.
1970	en	ln	One study in China found 5% were admitted to intensive care units, 2.3% needed mechanical support of ventilation, and 1.4% died.	Liyekoli moko na Chine emonaki ete na 5% ya bato bayambaki na ba unité ya soin intensif, 2.3% bazalaki ose ya bosaliseli ya masini ya mopepe, pe 1.4% bakufaki.	A study in China found that of 5% of people admitted to intensive care units, 2.3% were ventilatory, and 1.4% died.
1971	en	ln	In China, approximately 30% of people in hospital with COVID-19 are eventually admitted to ICU.	Na Chine, ngambo ya 30% ya bato bakotaka lopitalo mpóna COVID-19 basukelaka koyambama na USI.	In China, about 30% of people hospitalized for COVID-19 end up being admitted to the USI.
1972	en	ln	Mechanical ventilation becomes more complex as acute respiratory distress syndrome (ARDS) develops in COVID-19 and oxygenation becomes increasingly difficult.	Bopési mopepe na masini ekomi compliqué mingi mpóna pasi ya syndrome ya songe ya kopema (ARDS) ezo kola na COVID-19 pe bopesi oxygene ezo koma penza pasi mingi .	Mechanical ventilation has become more complicated as the pain of respiratory distress syndrome (ARDS) is developing with COVID-19 and oxygen delivery is becoming increasingly difficult
1973	en	ln	Ventilators capable of pressure control modes and high PEEP are needed to maximise oxygen delivery while minimising the risk of ventilator-associated lung injury and pneumothorax.	Ba ventilateur óyo eza na mode eko kocontrolé pression na PEEP ya likolo ezo lingama mpóna ko maximisé bopesi ya oxygene elongo na bokitisi ya likama ya bozoki ya lipili ewutaka na mopepe pe panzi ya tolo.	Pressure-controlled ventilators with high PEEP are required to maximize oxygen delivery along with reducing the risk of airborne lung injury and chest expansion.
1974	en	ln	High PEEP may not be available on older ventilators.	PEEP ya makasi eko kozanga na baventilateur ya kala.	Strong PEEP will fail with older ventilators.
1975	en	ln	Research into potential treatments started in January 2020, and several antiviral drugs are in clinical trials.	Boluki na batraitement eko kosalisa ebandaki na Janvier 2020, pe bakisi ya antivirusi ebele ezo mekama na cliniki.	Research into treatments that will help began in January 2020, and several antiviral drugs are being tested in the clinic.
1976	en	ln	Remdesivir appears to be the most promising.	Remdesivir ezo monana na elaka mingi koleka nionso.	Remdesivir looks the most promising of all.
1977	en	ln	Although new medications may take until 2021 to develop, several of the medications being tested are already approved for other uses or are already in advanced testing.	Ata ko bakisi ya sika eko kozwa ti 2021 mpóna kokomelisa, ebele ya bakisi bazali kotesité esi endimami mpóna kosalela na makono mosusu to ekomi mosika mpóna batesite.	Although new drugs will take until 2021 to be registered, many of the drugs being tested are already approved for use in other diseases or are far from being tested.
1978	en	ln	Antiviral medication may be tried in people with severe disease.	Bakisi ya antivirusi eko komekama na nzoto ya bato baza na bokono makasi.	Antiviral drugs will be tested on people with severe illness.
1979	en	ln	The WHO recommended volunteers take part in trials of the effectiveness and safety of potential treatments.The FDA has granted temporary authorisation to convalescent plasma as an experimental treatment in cases where the person's life is seriously or immediately threatened.	OMS azo tinda bato ya bolingi bakota na momekano mpóna bolamo na kimia ya bisaleli ya bakísi ezo bongisama. FDA asi apesi ndíngisa ya mikolo mokuse na plasma ya babiki likolo ya lisalisi ya momekano na bacas óyo emonani bomoi ya moto eza somo to elingi solo kokatana noki-noki.	WHO is sending volunteers to participate in a test for the safety and security of medical devices being developed. The FDA has already granted short-term approval to survivor plasma for trial treatment in cases where life appears to be life-threatening or imminent.
1980	en	ln	It has not undergone the clinical studies needed to show it is safe and effective for the disease.	Ezwi naino boyekoli ya cliniki elingami te mpóna kolakisa ete ezali ya kimia pe malamu mpóna kosukisa bokono.	It has not yet received the desired clinical studies to show that it is safe and effective in treating the disease.
1981	en	ln	In February 2020, China launched a mobile app to deal with the disease outbreak.	Na Février 2020, Chine abimisaki app ya mobile mpóna koluka kosilisa pandemie.	In February 2020, China launched a mobile app to try to end the pandemic.
1982	en	ln	Users are asked to enter their name and ID number.	Basaleli basengami batia kombo pe numero ya ID nabango.	Users are required to enter their name and ID number.
1983	en	ln	The app is able to detect 'close contact' using surveillance data and therefore a potential risk of infection.	App eza na mambi ya koyeba ‘contacki ya ngambo’ na bosaleli ya badonnée ya bokengeli ebongo nde likama eko koya mpóna kpokoso.	The app has the features of identifying &#39;side contacts&#39; and the use of surveillance data so that the risk will come for the error.
1984	en	ln	Every user can also check the status of three other users.	Mosaleli moko-moko akoki pe kovérifié etat ya basaleli mosusu misato.	Each user can also verify the status of three other users.
1985	en	ln	If a potential risk is detected, the app not only recommends self-quarantine, it also alerts local health officials.Big data analytics on cellphone data, facial recognition technology, mobile phone tracking and artificial intelligence are used to track infected people and people whom they contacted in South Korea, Taiwan and Singapore.	Soki likama ezo ya ekoki komonana, app ekotinda kaka moto amitia na quarantaine te kasi lisusu ekoyebisa bakonzi ya santé ya esika.Badonnée minene ya bososoli na fonimobile, tekinologi ya boyebeli elongi, trackage ya ba fonimobile, na mayele ya bonganga bizali kosalamela mpóna kotracké bato ya kpokoso bazo sala contacki na Korea ya Sudi, Taiwan pe Singapore.	If a threat is detected, the app will not only send a person to quarantine but also notify local health authorities.Huge intelligence data on fonimobile, facial recognition technology, fonimobile tracking, and medical technology are being used to track people of trouble they are making contact with South Korea, Taiwan and Singapore.
1986	en	ln	In March 2020, the Israeli government enabled security agencies to track mobile phone data of people supposed to have coronavirus.	Na Mars 2020, loyalo ya Israeli apesaki ndíngisa na ba agence ya kimia ba tracké badonnée ya bafoni mobile ya bato bakaniselaki bazali na coronavirusi.	In March 2020, the Israeli government allowed law enforcement agencies to track mobile phone data of people suspected of having the coronavirus.
1987	en	ln	The measure was taken to enforce quarantine and protect those who may come into contact with infected citizens.	Mezile wana ezwamakii mpo etia bokasi na quarantaine pe ebatela bato baye bako kozala na contacki na bacitoyen bazali na kpokoso.	The measures were taken to strengthen quarantine and protect people who will be in contact with vulnerable citizens.
1988	en	ln	Also in March 2020, Deutsche Telekom shared aggregated phone location data with the German federal government agency, Robert Koch Institute, in order to research and prevent the spread of the virus.	Lisusu na Mars 2020, Deutsche Telekom akabolaka esika ya badonnée ya bafoni esangana na agence ya federasio ya Alemania, Institut Robert Koch, mpóna kokundola pe kopekisa bopalangani ya virusi.	Also in March 2020, Deutsche Telekom shares a joint phone database with the German federal agency, the Robert Koch Institute, to monitor and prevent the spread of viruses.
1989	en	ln	Russia deployed facial recognition technology to detect quarantine breakers.	Russie abimisaki tekinologi ya boyebeli elongi mpóna koyeba babuki ya quarantaine.	Russia has developed facial recognition technology to identify quarantine violators.
1990	en	ln	"Italian regional health commissioner Giulio Gallera said he has been informed by mobile phone operators that ""40% of people are continuing to move around anyway""."	"Commissaire ya santé regionale ya Italie Giulio Gallera alobaki azwaki liyebisi na ba operateur ya bafoni mobile ete ""40% ya bato bazo koba nabango kokendeke bisika""."	Italy&#39;s regional health commissioner Giulio Gallera said he had received notice from mobile phone operators that &quot;40 percent of people continue to travel&quot;
1991	en	ln	German government conducted a 48 hours weekend hackathon with more than 42.000 participants.	Loyalo ya Alemania asalaki na suka posa moko bangonga 48 ya hackathoni na participant koleka 42.000.	The German loyalo made finally a wish 48 hours of hackathon with more than 42,000 participant.
1992	en	ln	Also the president of Estonia, Kersti Kaljulaid, made a global call for creative solutions against the spread of coronavirus.	Lisusu prezida ya Estonia, Kersti Kaljulaid, asalaki bobengi ya mokili mobimba mpóna koluka mayele ya likolo mpóna kosukisa bopalangani ya coronavirusi.	Estonian President Kersti Kaljulaid also made an international call for advanced measures to end the spread of the coronavirus.
1993	en	ln	Individuals may experience distress from quarantine, travel restrictions, side effects of treatment or fear of the infection itself.	Bato moko-moko bako koyoka pasi ya kobungisa elikia na quarantaine, bopekisa ya mibembo, ba effet secondaire ya traitement to kobanga mpóna kpokoso yango.	Individuals will suffer from loss of hope in quarantine, travel restrictions, side effects of treatment or fear of the problem.
1994	en	ln	"BBC quoted Rory O'Connor in saying, ""Increased social isolation, loneliness, health anxiety, stress and an economic downturn are a perfect storm to harm people's mental health and wellbeing."""	"BBC alandi Rory O'Connor na koloba, ""bobakisi bokabwani na bato, bofandi moto-na-moto yemoko, kobanga-banga na nzoto pasi, stressi pe kozanga bozwi ezali mbula kake ezo sala mabe na mito ya bato na bolamo nabango."""	The BBC quoted Rory O&#39;Connor as saying, &quot;Increased isolation, isolation, physical pain, stress and poverty are the years that are affecting people&#39;s well-being.
1995	en	ln	The disease may take a mild course with few or no symptoms, resembling other common upper respiratory diseases such as the common cold.	Kobela eko kozwa nzela ya pete na basymptome moke eko kozala kaka lokola bapasi mike-mike ya nzela ya kopema, lokola malili ma bato banso.	The illness will take an easier course with fewer symptoms it will be just like minor respiratory tract infections, like the common cold.
1996	en	ln	Mild cases typically recover within two weeks, while those with severe or critical diseases may take three to six weeks to recover.	Ba cas ya pete mingi-mingi esilaka nango sima ya baposo mibale, kasi baye bazalaka na mabela ya pasi mingi ewumelaka banda poso misato ti motoba po esila.	Mild cases usually resolve after two weeks, but those with more severe breast cancer take three to six weeks to resolve.
1997	en	ln	Pregnant women may be at higher risk for severe infection with COVID-19 based on data from other similar viruses, like SARS and MERS, but data for COVID-19 is lacking.In some people, COVID-19 may affect the lungs causing pneumonia.	Basi ya zemi bako kozala na likama ya makasi mpóna infection ya songe ya COVID-19 ose ya badonnée ya bavirusi óyo ekokana, lokola SRAS pe MERS, kasi badonnée mpóna COVID-19 eza kozanga. Na bato mosusu, COVID-19 eko ko affecté balipili pe panzi.	Pregnant women will be at increased risk for COVID-19 mosquito infection ose data on similar viruses, such as SRAS and MERS, but data for COVID-19 are lacking. In some people, COVID-19 will affect peppers and pancakes.
1998	en	ln	In those most severely affected, COVID-19 may rapidly progress to acute respiratory distress syndrome (ARDS) causing respiratory failure, septic shock or multi-organ failure.	Na baye baza affecté mabe mingi, COVID-19 eko kokoma na bombango syndrome ya songe ya kobela ya pema (ARDS) epesaka kopola ya bopemi, shoki scepitiki to kobeba ya ba organe ebele.	In those most severely affected, COVID-19 will rapidly develop acute respiratory disease syndrome (ARDS) causing respiratory failure, skeptical shock or multiple organ damage.
1999	en	ln	Complications associated with COVID-19 include sepsis, abnormal clotting and damage to the heart, kidneys and liver.	Mikakatano ekanganaka na COVID-19 etie nakati sepsis, bokangami ya makila mabe pe bobebi na motema, bangei pe libale.	Complications associated with COVID-19 include sepsis, blood clots and damage to the heart, kidneys and liver.
2000	en	ln	Clotting abnormalities, specifically an increase in prothrombin time, have been described in 6% of those admitted to hospital with COVID-19, while abnormal kidney function is seen in 4% of this group.	Bokangani ya mabe ya makila, mingi-mingi bomati na ngonga na prothrombine, esi esosolamaki na 6% ya bato baye bandimamaki na lopitalo mpóna COVID-19, kasi kosala ya mabe ya ngei emonani na 4% ya bato ya lisanga.	Adverse blood clotting, especially an hourly increase in prothrombin, has already been detected in 6% of people admitted to hospital for COVID-19, but adverse blood pressure is seen in 4% of the community.
2001	en	ln	Approximately 20-30% of people who present with COVID-19 demonstrate elevated liver enzymes (transaminases).	Mokuse ya 20-30% ya bato bazali na COVID-19 balakisi komata ya ba enzyme na ngei (batransaminase).	Around 20-30% of people with COVID-19 show elevated enzymes in the liver (transaminases).
2002	en	ln	According to the same report, the median time between onset of symptoms and death was ten days, with five being spent hospitalised.	Na bolandi ya lapolo yango kaka, ngonga ya kati banda ebandeli ti bobimi ya basymptome pe liwa ezalaki mikolo zomi, mitano nayango eza na bokoti lopitalo.	According to the same report, the median time from onset to symptom onset and death was ten days, five of which are hospitalizations.
2003	en	ln	However, patients transferred to an ICU had a median time of seven days between hospitalisation and death.	Bongo, bato babeli batindamaki na USI bazalaki na ngonga ya kati ya mikolo sambo banda bokoti lopitalo ti liwa.	Thus, patients referred to the USI had a median time of seven days from admission to death.
2004	en	ln	In a study of early cases, the median time from exhibiting initial symptoms to death was 14 days, with a full range of six to 41 days.	Na boyekoli ya bacas ya yambo, ngonga ya kati banda bobimi ya basymtome ya liboso ti liwa ezalaki mikolo 14, na molongo etonda banda motoba ti 41 ya mikolo.	In early case studies, the median time from the appearance of first symptoms to death was 14 days, with a full range from six to 41 days.
2005	en	ln	In a study by the National Health Commission (NHC) of China, men had a death rate of 2.8% while women had a death rate of 1.7%.	Na boyekoli esalami na Commission Nationale ya Santé (NHC) ya Chine, bato-mibali bazalaki na lotango ya bawá ya 2.8% bôngó bato-bâsi bazalaki na 1.7%.	In a study by China&#39;s National Health Commission (NHC), men had a mortality rate of 2.8% and women 1.7%.
2006	en	ln	Histopathological examinations of post-mortem lung samples show diffuse alveolar damage with cellular fibromyxoid exudates in both lungs.	Ba exame ya histopathologie ya ba echantillon ya lipili ya mutu ya kokufa elakisi bopanzani ya alveole na ba exudate ya fibromyxoide ya cellula ya mapili nionso mibale.	Histopathological examinations of dead head liver samples show alveolar involvement and fibromyxoid exudates of both liver cells.
2007	en	ln	Viral cytopathic changes were observed in the pneumocytes.	Bambongwana na cytopathiki ya virusi emonanaki na kati ya bapneumocyte.	Changes in viral cytopathicity were observed in pneumocytes.
2008	en	ln	The lung picture resembled acute respiratory distress syndrome (ARDS).	Foto ya lipili ekokani na pasi ya syndrome ya songe ya pema (ARDS).	The picture of the pill resembles the pain of respiratory distress syndrome (ARDS).
2009	en	ln	In 11.8% of the deaths reported by the National Health Commission of China, heart damage was noted by elevated levels of troponin or cardiac arrest.	Na pourcent 11.8% ya bato bakufa basalelaki lapolo na Commission Nationale ya Santé ya Chine, mbeba ya motema emonanaki na banivo emata ya troponine to bokangami ya motema.	In 11.8% of the deaths reported by the National Health Commission of China, heart damage was seen with increased levels of troponin or cardiac arrest.
2010	en	ln	According to March data from the United States, 89% of those hospitalised had preexisting conditions.Availability of medical resources and the socioeconomics of a region may also affect mortality.	Na bolandi ya badonnée ya Mars óyo ewutaki na Etats-Unis, 89% ya baye bakotisamaki na lopitalo bazalaki na kobéla liboso. Ba resource ya monganga na ba condisio socio economiki ya engunda eko ko affecté taux ya liwa.	According to the March data from the United States, 89% of those admitted to the hospital had a pre-existing condition. Medical resources and socio-economic conditions of the refuge will affect the mortality rate.
2011	en	ln	Estimates of the mortality from the condition vary because of those regional differences, but also because of methodological difficulties.	Ba estimasio ya lotango ya bato bazalaki kokufa mpóna bokono ekesani na ntina ya mbongwana ya bingunda, kasi pe na ntina ya pasi ya methodologie.	Estimates of the number of people dying from disease vary due to changes in equipment, but also due to methodological difficulties.
2012	en	ln	The under-counting of mild cases can cause the mortality rate to be overestimated.	Botangi yase ya bacas ya pete eko kosala ete taux ya liwa ekoma surestimé.	Underestimation of simple cases will cause the mortality rate to become overestimated.
2013	en	ln	However, the fact that deaths are the result of cases contracted in the past can mean the current mortality rate is underestimated.	Kási, lokola liwa ya bato ewutaki na kobéla bato bazwaki kala, óyo eko koloba ete lotango ya liwa ya mikol’oyo ezali sousetimé.	However, since the deaths were caused by previously contracted diseases, this would mean that the current death toll is underestimated.
2014	en	ln	Smokers were 1.4 times more likely to have severe symptoms of COVID-19 and approximately 2.4 times more likely to require intensive care or die compared to non-smokers.Concerns have been raised about long-term sequelae of the disease.	Bameli ya likaya baza na libaku ya 1.4 ya kobéla pasi ya basymtome ya makasi ya COVID-19 pe ngambo 2.4 ya bambala koleka mpóna bosaleli ya soin intensif to kokufa soki bacomparé bango na bato bamelaka likaya te. Kobanga ebimi na bapasi ya mikolo ekolanda bokono.	Smokers are 1.4 times more likely to suffer from severe symptoms of COVID-19 and 2.4 times more likely to die from intensive care use compared to nonsmokers. Fear has emerged from the suffering of the days following the disease.
2015	en	ln	The Hong Kong Hospital Authority found a drop of 20% to 30% in lung capacity in some people who recovered from the disease, and lung scans suggested organ damage.	Mokonzi ya Lopitalo ya Hong Kong amonaki bokiti ya 20% ti 30% na makasi ya lipili na bato babikaki na bokono yango, pe ba scanné ya lipili ezo lakisa kobeba ya ba organe.	The head of the Hong Kong Hospital found a 20% to 30% drop in liver strength in people who survived the disease, and liver scans show organ damage.
2016	en	ln	This may also lead to post-intensive care syndrome following recovery.	Yangó ekoki pe komema lisúsu syndrome ya sima ya intensifi kolanda bobiki.	This can also lead to post-intensive syndrome following recovery.
2017	en	ln	As of March 2020, it was unknown if past infection provides effective and long-term immunity in people who recover from the disease.	Na Mars 2020, eyebanaki te soki kpokoso eleki eko kopesa immunité ya malamu pe ya ntango molai na bato babikaki na bokono yango.	As of March 2020, it was not known whether the previous round would provide better and longer-lasting immunity to survivors.
2018	en	ln	Immunity is seen as likely, based on the behaviour of other coronaviruses, but cases in which recovery from COVID-19 have been followed by positive tests for coronavirus at a later date have been reported.	Immunité ezo monana lokola eko kosalama, ose ya bizaleli ya bacoronavirusi mosusu, kasi bacas ya bato babíka na COVID-19 balandamaki na tesite ya positif mpóna coronavirusi na dati ya sima esalameli lapolo.	Immunity appears to be developing, ose the characteristics of some coronaviruses, but cases of COVID-19 survivors were followed up with a positive test for the virus at a later reported date.
2019	en	ln	These cases are believed to be worsening of a lingering infection rather than re-infection.	Ba cas ya boye ezo ndimama ete eza bokiti na ngambo mabe ya bokono ezo sila te kasi kpokoso ya sika te.	Such cases are believed to be a decline in the worst side of the disease that is not going away but not a new problem.
2020	en	ln	The virus is thought to be natural and have an animal origin, through spillover infection.	virusi óyo ezo kaniselama ya mokili pe ebimeli na niama, na bosopani ya infection.	this virus is thought to be global and has appeared in animals, in an outbreak of infection.
2021	en	ln	The actual origin is unknown, but by December 2019 the spread of infection was almost entirely driven by human-to-human transmission.	Esika ewuti penza eyebani te, kasi nde na Decemba 2019 bopalangani ya kpokoso ezali toloba nionso kokabolama na moto apesi na moto.	The exact origin is unknown, but in December 2019 the spread of the problem is let’s say all shared from person to person.
2022	en	ln	A study of the first 41 cases of confirmed COVID-19, published in January 2020 in The Lancet, revealed the earliest date of onset of symptoms as 1 December 2019.	Liyekoli ya ba cas 41 ya yambo ya COVID-19 endimamaka, ezalaki publié na Janvier 2020 na The Lancet, elobi ete dati basymtome ebandaki liboso ezalaki 1 Decemba 2019.	The study of the first 41 confirmed cases of COVID-19, published in January 2020 in The Lancet, said the date the symptoms first started was December 1,
2023	en	ln	Official publications from the WHO reported the earliest onset of symptoms as 8 December 2019.	Bapublicasio officielle ya OMS epesi lapolo ete basymtome ya yambo ebandaki na 8 Decemba 2019.	Official WHO publications report that the first symptoms began on 8 December
2024	en	ln	Several measures are commonly used to quantify mortality.	Bamezile ebele ezo salamela mingi mpóna lotango ya bato bóni bazo kufa.	Several measures are commonly used for the number of deaths.
2025	en	ln	These numbers vary by region and over time and are influenced by the volume of testing, healthcare system quality, treatment options, time since initial outbreak and population characteristics such as age, sex and overall health.	 Matango maye mazo kesana na bisika mingi mpe na bolandi ntango pe ezo landa monene ya lotango ya batesite, bolamo ya systemi ya santé, ba mpóna ya traitement, ntango ya banda bopalangani ya yambo, pe ya ba characteristiki ya populasio lokola âge, sexe, pe santé mobimba ya moto. 	These figures vary across sites and over time and depend on the size of the site population, health system quality, treatment options, time since first outbreak, and population characteristics such as age, sex, and the overall health of the person.
2026	en	ln	In late 2019, WHO assigned the emergency ICD-10 disease codes U07.1 for deaths from lab-confirmed SARS-CoV-2 infection and U07.2 for deaths from clinically or epidemiologically diagnosed COVID-19 without lab-confirmed SARS-CoV-2 infection.The death-to-case ratio reflects the number of deaths divided by the number of diagnosed cases within a given time interval.	Na mibu ya suka ya 2019, OMS apesaki na mabela ba code ya bombango ICD-10 ya ba code U07.1 mpóna bawá bawuti na lab-confirmé ya kpokoso ya SARS-CoV-2 pe U07.2 mpóna bawá bawuti na cliniki to diagnostiki ya epidemiologie COVID-19 kozanga ba confirmé yango na lab kpokoso ya SARS-CoV-2. Ratio ya bawá na bacas ezo lakisa lotango ya bawá kokabola na lotango ya bacas basala diagnositiki kati ya intervale ya ntango epesamaki.	In late 2019, WHO assigned ICD-10 emergency codes of codes U07.1 for deaths from lab-confirmed SARS-CoV-2 infection and U07.2 for deaths from clinic or diagnosis of COVID-19 epidemiology without confirmed lab failure of SARS-CoV-2 The death-to-case ratio represents the number of deaths divided by the number of cases diagnosed within a given time interval.
2027	en	ln	Based on Johns Hopkins University statistics, the global death-to-case ratio is 6.9% (153,822/2,240,191) as of 17 April 2020.	 Na bolandi ba statistiki ya Johns Hopkins University, ratio ya mokili mobimba ya bawá na ba cas ya mabela ezali 6.9% (153,822/2,240,191) uta mokolo ya 17 Avril 2020. 	According to Johns Hopkins University statistics, the global ratio of deaths to ground cases is 6.9% (153,822/2,240,191) as of April 17,
2028	en	ln	The number varies by region.Other measures include the case fatality rate (CFR), which reflects the percent of diagnosed individuals who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected individuals (diagnosed and undiagnosed) who die from a disease.	Lotango ezo kesana engunda na engunda. Bamezile mosusu etie nakati taux ya bato bazo kufa (CFR), mutu ezo lakisa pourcentage ya bato bazali diagnositiké óyo bazo kufa na bokono, na taux ya koboma ya kpokoso (IFR), mutu ezo lakisa pourcentage ya bato bazwi kpokoso (bazala diagnostiké to diagnostiké te) óyo bazo kufa na bokono.	Lotango varies from engunda to engunda. Other measures include the mortality rate (CFR), which represents the percentage of diagnosed people who die of the disease, and the infectious fatality rate (IFR), which represents the percentage of people with disease (whether diagnosed or diagnosed). not) who are dying of disease.
2029	en	ln	These statistics are not time bound and follow a specific population from infection through case resolution.	Bastatistiki óyo ekangami na ntango te, ezo landa nde populasio specifiki uta bozwi ya infection ti suka ya cas. 	These statistics are not time-bound, rather they follow the specific population from the acquisition of infection to the end of the case.
2030	en	ln	While not all infected people develop antibodies, the presence of antibodies may provide information about how many people have been infected.	Atako bato banso te bazwi kpokoso bazo kolisa ba anticorps, kozala na ba anticorps eko kopesa nsango etali bato boni bakokaki kozwa kpokoso.	Although not all infected people develop antibodies, having antibodies will provide information about how many people could have been infected.
2031	en	ln	In the epicentre of the outbreak in Italy, Castiglione d'Adda, a small village of 4600, 80 (1.7%) are already dead.	Na esika ya epicentre ya bopalangani ya bokono na Italie, Castiglione d'Adda, mboka moke ya bato 4600, 80 (1.7%) bawuti kokufa.	In the epicenter of the outbreak in Italy, Castiglione d&#39;Adda, a small town of 4600 people, 80 (1.7%) have recently died.
2032	en	ln	In Gangelt, the disease was spread by Carnival festivals, and spread to younger people, causing a relatively lower mortality, and not all COVID-19 deaths may have been formally classified as such.	Na Gangelt, bokono epalanganaki uta bafeti ya Carnavale, pe ekotelaki bana bilenge, ebendaki lotango kamwa moke ya bawei pe nyonso te bato bakufaki na COVID-19 bazalaki classifié ndenge wana .	In Gangelt, the disease spread from Carnival celebrations, and infected young children, attracting a surprisingly low number of deaths and not all people who died of COVID-19 were classified that way
2033	en	ln	Furthermore, the German health system has not been overwhelmed.	Na kobakisa, systemi ya Santé ya ba Allemania ezalaki na pasi elekaki ndelo te.	In addition, the German Health system was not excessively difficult.
2034	en	ln	In the Netherlands, about 3% may have antibodies, as assessed from blood donors.	Na Netherlanda, ngambo ya 3% bakoki kozala na ba anticorps, lolenge ba evalué bango na bapesi ya makila.	In the Netherlands, around 3% may have antibodies, the way they were evaluated by blood donors.
2035	en	ln	69 (0.004% of the population) have been confirmed to have died from COVID-19.	69 (0.004% ya bato nyonso) bazali kondimama bakufeli na bokono ya COVID-19.	69 (0.004% of total) are confirmed dead of COVID-1
2036	en	ln	The impact of the pandemic and its mortality rate are different for men and women.	Mabé ya pandemie na lotango ya kobomela bato ekeseni kati ya mibali na bâsi.	The severity of the pandemic and the number of homicides vary between men and women.
2037	en	ln	Mortality is higher in men in studies conducted in China and Italy.	Taux ya koboma bato babali eleki óyo ya bato bâsi ose ya boyekoli esalami na Chine pe Italie.	The murder rate of males is higher than that of females ose studies conducted in China and Italy.
2038	en	ln	The highest risk for men is in their 50s, with the gap between men and women closing only at 90.	Likáma ya emati mpóna mibali na mibu 50, bongo bokabwani kati ya mibali na bâsi ezo kangama na ba 90.	The risk increases for men in their 50s, so the gender gap closes in the 90s.
2039	en	ln	In China, the death rate was 2.8 percent for men and 1.7 percent for women.	Na Chine, lotango ya liwa ezalaki 2.8 pourcent mpóna mibali pe 1.7 pourcent mpóna bâsi.	In China, the death rate was 2.8 percent for men and 1.7 percent for women.
2040	en	ln	The exact reasons for this sex-difference is not known, but genetic and behavioural factors could be a reason.	Ntina mpóna bokeseni kati ya bâsi na mibali eyebani penza te, kasi eko kozala genetiki na bafacteur ya bizaleli.	The reason for the gender difference is not fully understood, but it will be genetic and behavioral factors.
2041	en	ln	Sex-based immunological differences, lesser prevalence of smoking in women and men developing co-morbid conditions such as hypertension at a younger age than women could have contributed to the higher mortality in men.	Bokeseni ya immunologie likolo ya sexe, bosaleli moke ya cigareti na bâsi na mibali na bokolisi ya ba condisio ya bokangani mpóna koboma lokola hypertension ya mibu ya bilenge koleka bâsi eko komatisa lotango likolo na bawá na mibali.	Sex-related immunological differences, lower cigarette use in women and men and the development of lethal risk factors such as hypertension of younger ages than women will increase the number of deaths in men.
2042	en	ln	In Europe, 57% of the infected individuals were men and 72% of those died with COVID-19 were men.	Na Europa, 57% ya bato bazwaki kpokoso bazalaki mibali pe 72% ya baye bakufaki na COVID-19 bazalaki mibali.	In Europe, 57% of the cases were male and 72% of the deaths from COVID-19 were male.
2043	en	ln	As of April 2020, the US government is not tracking sex-related data of COVID-19 infections.	Na ntango ti Avril 2020, loyalo ya E.U. azalaki naye kosala lotango na badonnée ya bâsi to mibali ya COVID-19 te.	As of April 2020, the EU authority had not yet counted data on women or men of COVID-1
2044	en	ln	Research has shown that viral illnesses like Ebola, HIV, influenza and SARS affect men and women differently.	Bokundoli elakisi ete bokono ya bavirusi lokola Ebola, HIV, grippe pe SRAS etungisa mibali na basi na bokeseni.	The findings show that viral infections such as Ebola, HIV, influenza and SRAS affect men and women differently.
2045	en	ln	A higher percentage of health workers, particularly nurses, are women, and they have a higher chance of being exposed to the virus.	Pourcentage emata ya basali ya sante, mingi-mingi ba infirmier, bazali bâsi, ebongo nde baza na lotango ya likama emata mpóna kozala pembeni ya virusi.	An increasing percentage of health workers, especially nurses, are women, so they have an increased risk of being exposed to the virus.
2046	en	ln	"The World Health Organization announced on 11 February 2020 that the official name of the disease would be ""COVID-19""."	"Organizasio Mondiale mpóna Santé atatolaki na 11 Février 2020 ete kombo ya bokonzi ya bokono yango ekozala ""COVID-19""."	The World Health Organization confirmed on February 11, 2020 that the official name of the disease will be &quot;COVID-1
2047	en	ln	WHO chief Tedros Adhanom Ghebreyesus explained that CO stands for corona, VI for virus, D for disease, and 19 for when the outbreak was first identified: 31 December 2019.	Mokonzi ya OMS Tedros Adhanom Ghebreyesus alimboli ete CO eza mpóna corona, VI mpóna virusi, D mpóna bokono, pe 19 mobu bopalangani eyebani mbala ya yambo: 31 Decemba 2019.	WHO Director-General Tedros Adhanom Ghebreyesus explained that CO is for corona, VI for virus, D for disease, and 19 year outbreak first known: 31 December
2048	en	ln	The name had been chosen to avoid references to a specific geographical location (e.g. China), animal species or group of people, in line with international recommendations for naming aimed at preventing stigmatisation.The virus that causes COVID-19 is named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	Kómbó epónama mpóna koboya bolakisi ya mosapi na esika specifiki ya geographi (ndakisa, Chine), esipeci ya niama to lisanga ya bato, na molongo ya mambi matindami na mikili nionso mpóna bopesi kombo bakaniseli ekopekisa stigima. virusi óyo ebendaka COVID-19 ebengami syndrome ya kanda ya songe ya pema coronavirusi 2 (SARS-CoV-2).	The name chosen to avoid pointing the finger at a specific geographical location (eg, China), animal species or community, in a series of international guidelines for naming ideas will prevent stigma. the virus that causes COVID-19 is called respiratory syndrome coronavirus 2 (SARS-CoV-2).
2049	en	ln	"The WHO additionally uses ""the COVID-19 virus"" and ""the virus responsible for COVID-19"" in public communications."	"OMS na kobakisa azo salela ""le COVID-19 virusi"" pe ""le virusi responsable de COVID-19"" na bopesi nsango na bato ."	WHO additionally uses &quot;the COVID-19 virus&quot; and &quot;the virus responsible for COVID-19&quot; in communicating with the public
2050	en	ln	"Both the disease and virus are commonly referred to as ""coronavirus""."	"Nionso mibale bokono na virusi ezo bengama mingi-mingi kaka ""coronavirusi""."	Both disease and virus are usually called just &quot;coronavirus&quot;
2051	en	ln	"During the initial outbreak in Wuhan, China, the virus and disease were commonly referred to as ""coronavirus"" and ""Wuhan coronavirus""."	"Na ntango ya bopalangani ya yambo na Wuhan, Chine, virusi na bokono ezalaki nyonso mibale kobengama ""coronavirusi"" pe ""Wuhan coronavirusi""."	During the first outbreak in Wuhan, China, the virus and the disease were both called &quot;coronavirus&quot; and &quot;Wuhan coronavirus&quot;
2052	en	ln	In January 2020, WHO recommended 2019-nCov and 2019-nCoV acute respiratory disease as interim names for the virus and disease in accordance with 2015 guidance against using locations in disease and virus names.	Na Janvier 2020, OMS atindaki bazwa 2019-nCov pe 2019-nCoV bokono ya songe ya pasi ya pema lokola bakombo ya bozeli mpóna virusi pe bokono na bolandi lisungi ya 2015 esika ya boponi bakombo ya bokono pe virusi.	In January 2020, WHO submitted 2019-nCov and 2019-nCoV respiratory syndrome as waiting lists for viruses and diseases following the 2015 guidelines for the selection of disease and virus names.
2053	en	ln	The official names COVID-19 and SARS-CoV-2 were issued on 11 February 2020.	Ba nkombo ya bokonzi COVID-19 pe SRAS-CoV-2 ebimaki mokolo ya 11 Février 2020.	The official names COVID-19 and SRAS-CoV-2 were released on February 11,
2054	en	ln	Due to capacity limitations in the standard supply chains, some digital manufacturers are printing healthcare material such as nasal swabs and ventilator parts.	Ose ya ndelo na ba standard ya molongo ya bobimisi bisaleli monganga, basali mosusu ya biloko ya digitale bazali ko imprimé materiel ya lopitalo lokola batige ya zolo pe ba ndambo ya ventilateur.	Bounded by standard medical device production line standards, some digital goods manufacturers are printing hospital hardware such as nose rods and ventilator parts.
2055	en	ln	In one example, when an Italian hospital urgently required a ventilator valve, and the supplier was unable to deliver in the timescale required, a local startup reverse-engineered and printed the required 100 valves overnight.	Na ndakisa moko, ntango lopitalo moko ya Italie ezalaki na posa ya valve ya ventilateur noki-noki, bongo mosali na yango akokaki te kotinda yango na ngonga elingamaki, kompani moko ya esika esalelaki ingénierie inverse pe e imprimaki ba valve 100 balukaki na butu moko.	In one example, when an Italian hospital urgently needed a ventilator valve, so the manufacturer could not deliver it on time, a local company reverse engineered and printed the 100 valves they wanted overnight.
2056	en	ln	After the initial outbreak of COVID-19, conspiracy theories, misinformation and disinformation emerged regarding the origin, scale, prevention, treatment and other aspects of the disease and rapidly spread online.	Sima ya bopalangani ya yambo ya COVID-19, ba theorie ya complot pe nsango ya lokutá ebimaki na likambo etali esika ya ebandeli, echelle, prevensio, traitement pe makambo mosusu ya bokono epalanganaki mbángo na Interneti.	After the first outbreak of COVID-19, conspiracy theories and false information about the origin, scale, prevention, treatment and other aspects of the disease spread rapidly on the Internet.
2057	en	ln	Humans appear to be capable of spreading the virus to some other animals.	Bato bamonani ete bazali na mambi ma kopalangasa virusi na baniama mosusu.	Humans appear to have a history of spreading the virus to other animals.
2058	en	ln	The study failed to find evidence of viral replication in pigs, ducks, and chickens.	Liyekoli yango elongaki te mpóna komona elembo ya mbotama ya virusi na bangulu, mabata, pe basusu.	The study failed to find signs of virus birth in pigs, goats, and others.
2059	en	ln	No medications or vaccine is approved to treat the disease.	Bakisi to vaccin ta moko te esi endimami mpóna ko traité bokono yango.	No drugs or vaccines have been approved to treat the disease.
2060	en	ln	International research on vaccines and medicines in COVID-19 are underway by government organisations, academic groups and industry researchers.	Bokundoli ya bato ya mikili mingi yase na likambo ya bavaccin na bakísi etali COVID-19 ebandi kosalama ose ya ba organizasio ya loyalo, mangomba ya bato ya mayele pe bakundoli ya industrie.	International awareness raising on COVID-19 vaccines and drugs has begun to be conducted ose of health organisations, professional bodies and industry representatives.
2061	en	ln	"In March, the World Health Organization initiated the ""SOLIDARITY Trial"" to assess treatment effects of four existing antiviral compounds with the most promise of efficacy."	"Na Mars, Organisio Mondiale ya Santé ebandaki óyo babengi ""Essai ya SOLIDARITE"" mpóna koyekola ba effet ya traitement ya b antivirusi composé óyo epesi elikia ya makasi ya lisalisi."	In March, the World Health Organization launched the so-called &quot;SOLIDARITY Trial&quot; to study the effects of a compound antiviral treatment that offers strong hope of treatment.
2062	en	ln	There is no available vaccine, but various agencies are actively developing vaccine candidates.	Vaccin esalami naino te, kasi ba agence ebele bazo tia molende mpóna kokolisa bavaccin ekoki kondimama.	A vaccine has not yet been developed, but many agencies are working to develop vaccines that can be approved.
2063	en	ln	Previous work on SARS-CoV is being utilised because SARS-CoV and SARS-CoV-2 both use the ACE2 receptor to enter human cells.	Mosala esalamaki liboso mpóna SRAS-CoV ezo salamela na ntína ete SRAS-CoV na SRAS-CoV-2 nionso mibale ezo salela moyambi ACE2 mpóna kokota na bacellula ya moto.	Previous work on SRAS-CoV is based on the fact that both SRAS-CoV and SRAS-CoV-2 use the ACE2 receptor to enter human cells.
2064	en	ln	There are three vaccination strategies being investigated.	Bastrategie ya vaccinasio ezali misato bazo lukela.	There are three vaccination strategies being pursued.
2065	en	ln	First, researchers aim to build a whole virus vaccine.	Ya yambo, bakundoli batie likanisi na botongi ya vaccin ya virusi mobimba.	First, the researchers focus on the construction of a complete viral vaccine.
2066	en	ln	The use of such a virus, be it inactive or dead, aims to elicit a prompt immune response of the human body to a new infection with COVID-19.	Bosáleli ya virusi ya boye, ezala ya koningana to ya kokufa, eluki ko bimisa noki eyano ya Immunité ya nzoto ya moto ya kpokoso ya sika na COVID-19.	The use of such viruses, whether moving or dead, seeks to quickly trigger the immune response of the newly challenged person to COVID-1
2067	en	ln	A second strategy, subunit vaccines, aims to create a vaccine that sensitises the immune system to certain subunits of the virus.	Strategie ya mibale, vaccin ya sous-unité, ezo luka ebimisa vaccin óyo ekosensitisé systemi ya Immunité na basous-unité ya solo ya virusi.	The second strategy, the subunit vaccine, seeks to produce a vaccine that sensitizes the Immune systemi to the actual subunits of the virus.
2068	en	ln	In the case of SARS-CoV-2, such research focuses on the S-spike protein that helps the virus intrude the ACE2 enzyme receptor.	Na cas ya SRAS-CoV-2, bokundoli ya boye etie miso na baproteine ya spicule-S óyo esalisaka virusi ekota nakati ya moyambi ya enzyme ACE2 .	In the case of SRAS-CoV-2, such a finding focuses on the spicule-S proteins that facilitate viral entry into the ACE2 enzyme receptor .
2069	en	ln	A third strategy is that of the nucleic acid vaccines (DNA or RNA vaccines, a novel technique for creating a vaccination).	Strategie ya misato ezali óyo ya bavaccin ya acide nucleiki (DNA to bavaccin RNA, tekiniki ya sika mpóna kobongisa vaccinasio).	The third strategy is that of nucleic acid vaccines (DNA or RNA vaccines, a new technology for improving vaccination).
2070	en	ln	Experimental vaccines from any of these strategies would have to be tested for safety and efficacy.On 16 March 2020, the first clinical trial of a vaccine started with four volunteers in Seattle.	Ba vaccin bazo experimenté na bosaleli ya ba strategie yango esengeli ezala tesité mpóna securité pe bolamo ya bosaleli. Na16 Mars 2020, momekano ya yambo ya vaccin na cliniki ebandaki na bato minei ya bolingi na Seattle.	Vaccines are being experimented with these strategies should be tested for safety and efficacy. On16 March 2020, the first clinical trial of the vaccine began with four volunteers in Seattle.
2071	en	ln	The vaccine contains a harmless genetic code copied from the virus that causes the disease.Antibody dependent enhancement has been suggested as a potential challenge for vaccine development for SARS-COV-2, but this is controversial.	Vaccin eza na kati nango code genetiki ya bokono te basali kopi uta na virusi mutu epesaka bokono. Bobakisi ya bokasi ezo dépendre na anticorps esi ekaniselami na esika ya etumba eko kozala mpóna bokolisi ya vaccin ya SRAS-COV-2, kasi óyo eza naino likambo ya koswanela.	The vaccine does not contain the genetic code of the disease they have copied from the virus that causes the disease. Increased antibody-dependent efficacy is already thought to be on the battlefield for the development of an SRAS-COV-2 vaccine, but this remains controversial.
2072	en	ln	There are more than 300 active clinical trials underway as of April 2020.	Mimekano ya cliniki eza kosalema eza koleka 300 na sanza ya Avril 2020. 	There are more than 300 ongoing clinical trials as of April
2073	en	ln	Seven trials were evaluating already approved treatments for malaria, including four studies on hydroxychloroquine or chloroquine.	Mimekano sambo mizali koyekola batraitement óyo esi endimami mpóna malaria, tia nakati minei eza koyekola hydroxychloroquine to chloroquine.	Seven trials are studying treatments already approved for malaria, while four are studying hydroxychloroquine or chloroquine.
2074	en	ln	Repurposed antiviral drugs make up most of the Chinese research, with nine phase III trials on remdesivir across several countries due to report by the end of April.	Bakisi ya antivirusi babongeseli ntina mosusu esali ngambo ya nyonso ya mayekoli ya ba Chinois, na ba phase III libwa ya mimekano na remdesivir ezo salama na bikolo ebele biye bikopesa lapolo na suka Avril.	Improved antiviral drugs for another reason make up all of the Chinese trials, with nine phase III trials with remdesivir underway in several countries that will report by the end of April.
2075	en	ln	A dynamic review of clinical development for COVID-19 vaccine and drug candidates was in place, as of April 2020.Several existing antiviral medications are being evaluated for treatment of COVID-19, including remdesivir, chloroquine and hydroxychloroquine, lopinavir/ritonavir and lopinavir/ritonavir combined with interferon beta.	Botalololi ya dynaimiki ya bokolisi na cliniki ya vaccin mpóna COVID-19 na kisi ekoki kondimama esi ebelemi na Avril 2020.Bakisi ya antivirusi ebele óyo esi esalama ezali koyekolama mpóna traitement ya COVID-19, tia nakati remdesivir, chloroquine pe hydroxychloroquine, lopinavir/ritonavir pe lopinavir/ritonavir esangana na interferon beta.	Clinical evaluation of the development of a vaccine for COVID-19 in a drug can be approved as early as April 2020. Several existing antiviral drugs are being studied for the treatment of COVID-19, including remdesivir, chloroquine and hydroxychloroquine, lopinavir/ritonavir and lopinavir/ritonavir in combination with interferon beta.
2076	en	ln	There is tentative evidence for efficacy by remdesivir, as of March 2020.	Elembo ebandaki komonana mpóna bolamu ya remdesivir, na Mars 2020.	The signs began to appear for the benefit of remdesivir, in March
2077	en	ln	Clinical improvement was observed in patients treated with compassionate-use remdesivir.	Bobakisi ya bolamu ya cliniki emonanaki na bato ya bokono bazwaki traitement ya boyóki mawa remdesivir.	Increased clinical well-being was observed in patients receiving the compassion therapy remdesivir.
2078	en	ln	Phase III clinical trials are being conducted in the US, China and Italy.Chloroquine, previously used to treat malaria, was studied in China in February 2020, with preliminary results.	Mimekano ya cliniki Phase III mizali kosalema na E.U., Chine pe Italie. Chloroquine, óyo basalelaki liboso mpóna kotraité malaria, eyekolamaki na Chine na Février 2020, na mabimi ma yambo.	Phase III clinical trials are underway in the EU, China and Italy. Chloroquine, which was previously used to treat malaria, was studied in China in February 2020, with preliminary results.
2079	en	ln	However, there are calls for peer review of the research.	Kási, mabéngi mazali ete bato ya mayele batalolola mabimi ma makundoli.	However, there are calls for scholars to examine the outcomes of the memories.
2080	en	ln	Korean and Chinese Health Authorities recommend the use of chloroquine.	Bakónzi ya Santé ya Korea pe Chine bazo tinda basalela chloroquine.	Health officials in Korea and China are recommending the use of chloroquine.
2081	en	ln	However, the Wuhan Institute of Virology, while recommending a daily dose of one gram, notes that twice that dose is highly dangerous and could be lethal.	Kási, Institut ya Virologie ya Wuhan, ntango bazo tinda doze ya gamma moko mokolo-na-mokolo, bayebisi ete mibale ya doze yango ezali mabe mingi penza pe ekoki koboma.	However, the Wuhan Institute of Virology, while sending one gamma dose daily, reported that two of the doses are very harmful and can be fatal.
2082	en	ln	On 28 March 2020, the FDA issued an emergency use authorisation for hydroxychloroquine and chloroquine at the discretion of physicians treating people with COVID-19.The Chinese 7th edition guidelines also include interferon, ribavirin or umifenovir for use against COVID-19.	Na 28 Mars2020, FDA abimisaki ndíngisa ya bosaleli ya bombango mpóna hydroxychloroquine pe chloroquine na bobombi sekelé ya minganga miye mizali kotraité babeli ya COVID-19.Edition 7 ya bato ya Chine ebakisaki lisusu interferon, ribavirin to umifenovir mpóna koboma COVID-19.	On March 28, 2020, the FDA issued emergency use approval for hydroxychloroquine and chloroquine in confidential medical conditions treating patients with COVID-1
2083	en	ln	Preliminary data indicate that high doses of ribavirin are necessary to inhibit SARS-CoV-2 in vitro.	Badonnée ya yambo ezo lakisa ete ba doze ya likolo ya ribavirin ezali na ntina monene mpóna kobeta SRAS-CoV-2 in vitro.	Preliminary data suggest that high doses of ribavirin are critical for knocking down SRAS-CoV-2 in vitro.
2084	en	ln	Nitazoxanide has been recommended for further in vivo study after demonstrating low concentration inhibition of SARS-CoV-2.Studies have demonstrated that initial spike protein priming by transmembrane protease serine 2 (TMPRSS2) is essential for entry of SARS-CoV-2 via interaction with the ACE2 receptor.	Nitazoxanide esi etindami mpóna boyekolii in vivo ekolanda sima ya bolakisi concentrasio ya moke ya inhibisio ya SRAS-CoV-2. Mayekoli malakisi ete bokotisi ya specule ya proteine ya ebandeli na bosaleli ya protéase ya transmembrane serine 2 (TMPRSS2) ezali na ntina monene penza mpóna bokoti ya SRAS-CoV-2 na nzela ya interacsio na moyambi ya ACE2.	Nitazoxanide has already been submitted for further in vivo studies after demonstration of a low concentration of SRAS-CoV-2 inhibition. Studies have shown that incorporation of the initial protein specule using transmembrane serine protease 2 (TMPRSS2) is critical for SRAS-CoV-2 entry through interaction with the ACE2 receptor.
2085	en	ln	The studies of chloroquine and hydroxychloroquine with or without azithromycin have major limitations that have prevented the medical community from embracing these therapies without further study.Oseltamivir does not inhibit SARS-CoV-2 in vitro and has no known role in COVID-19 treatment.	Mayekoli ya chloroquine na hydroxychloroquine na to kozanga azithromycine ezali na bandelo ya makasi óyo eye kosala ete lisanga ya bato ya bakisi babóya koyamba ba thérapie kozanga liyekoli ya bolandi. Oseltamivir ebetaka nango SRAS-CoV-2 in vitro te pe eza na mosala te óyo eyebani na traitement ya COVID-19.	Studies of chloroquine and hydroxychloroquine with or without azithromycin have serious limitations that have resulted in the pharmaceutical community refusing to embrace therapies without a follow-up study. Oseltamivir does not knock down SRAS-CoV-2 in vitro and has no known activity in the treatment of COVID-1
2086	en	ln	Cytokine storm can be a complication in the later stages of severe COVID-19.	Tempete ya cytokine eko kozala pasi mabe ya etape ya suka ya COVID-19 ya makasi.	The cytokine storm will be the worst pain of the last stage of severe COVID-1
2087	en	ln	There is evidence that hydroxychloroquine may have anti-cytokine storm properties.Tocilizumab has been included in treatment guidelines by China's National Health Commission after a small study was completed.	Elembo ezo monana ete hydroxychloroquine eko kozala na ba propriété ya kopekisa tempete cytokine.Tocilizumab esi ekotisami na masungi ya traitement na Comission Nationale ya Santé ya Chine sima ya bosilisi ya liyekoli ya moke.	There is a sign that hydroxychloroquine will have cytokine storm prevention properties.Tocilizumab has already been included in treatment support by the National Health Commission of China after the completion of a small study.
2088	en	ln	It is undergoing a phase 2 non randomised test at the national level in Italy after showing positive results in people with severe disease.	Bazali kosala sik’óyo phase 2 ya tesite non-randomisé na niveau ya ekolo mobimba na Italie sima ya bolakisi bambuma malamu na bato bazali na bokono ya makasi.	A nationwide phase 2 non-randomized testosterone trial is currently underway in Italy after demonstrating positive results in people with advanced disease.
2089	en	ln	Combined with a serum ferritin blood test to identify cytokine storms, it is meant to counter such developments, which are thought to be the cause of death in some affected people.	Bosangisi yango na tesite ya makila ya serum ferritin mpóna ko yebela, esalami mpóna kopekisa bokoli, yango mutu ekaniselami kozala esika liwa ewutaka mpóna kamwa ndámbo ya bato bazwi kpokoso.	Combined with a serum ferritin blood test for detection, it is designed to inhibit growth, which is thought to be the cause of death for a surprising proportion of people with the disease.
2090	en	ln	The interleukin-6 receptor antagonist was approved by the FDA based on retrospective case studies for treatment of steroid refractory cytokine release syndrome induced by a different cause, CAR T cell therapy, in 2017.	Moyambi ya tembe interleukin-6 endimamaka na FDA ose ya malandeli ya mayekoli masalamaka liboso mpóna traitement ya syndrome ya botiki steroide cytokine refractaire esalama na ntina ekesana, cellula ya therapi CAR T, na 2017.	The suspected interleukin-6 receptor was approved by the FDA ose following previous studies for the treatment of refractory cytokine steroid withdrawal syndrome done for a different purpose, the CAR T therapy cell, in
2091	en	ln	To date, there is no randomised, controlled evidence that tocilizumab is an efficacious treatment for CRS.	Na mokolo ya lelo, elembo ya randomisé pe controlé ezali te mpóna bondimi ete tocilizumab eza kisi ya solo na CRS.	To date, there is no randomized and controlled evidence for confirmation that tocilizumab is a definitive treatment in CRS.
2092	en	ln	Transferring purified and concentrated antibodies produced by the immune systems of those who have recovered from COVID-19 to people who need them is being investigated as a non-vaccine method of passive immunisation.	Bolekisi ya ba anticorps bapurifiaki pe bacocentraki óyo ewuti na systeme immune ya bato babikaki na bokono ya COVID-19 na nzoto ya baye bazali na mposa na yango ezo landama bokundoli mpo ezala methodi ezanga vaccin na immunizasio passifi.	The transfer of purified and concentrated antibodies from the immune system of COVID-19 survivors into the body of those in need is followed by a reminder to be a vaccine-free method in passive immunization.
2093	en	ln	This strategy was tried for SARS with inconclusive results.	Esaleli ya boye bamekaki yango kasi ebotaki mbuma te.	Such a device was tried but to no avail.
2094	en	ln	Viral neutralisation is the anticipated mechanism of action by which passive antibody therapy can mediate defence against SARS-CoV-2.	Neutralizasio ya virusi ezali nzela bazo kanisela ekozala mosala óyo therapi ya ba anticorps passifi ekokoka komediaté bobateli ya tembe na SRAS-CoV-2.	Virus neutralization is the anticipated pathway by which passive antibody therapy could mediate dubious protection against SRAS-CoV-2.
2095	en	ln	Other mechanisms however, such as antibody-dependent cellular cytotoxicity and/or phagocytosis, may be possible.	Banzela mosusu kasi, ndakisa cytotoxicité pe/to phagocytose ya cellula dependant na anticorps eko kosala.	Other pathways however, for example cytotoxicity and/or antibody-dependent cell phagocytosis will operate.
2096	en	ln	Other forms of passive antibody therapy, for example, using manufactured monoclonal antibodies, are in development.	Ba ndenge mosusu ya therapi passive ya anticorps, ndakisa, bosaleli ya ba anticorps monocloniki basali na masini, ezali kokolisama.	Other forms of passive antibody therapy, for example, the use of automated monoclonal antibodies, are being developed.
2097	en	ln	Production of convalescent serum, which consists of the liquid portion of the blood from recovered patients and contains antibodies specific to this virus, could be increased for quicker deployment.	Mobombisi ya serum ya babeli bazo bika na bokono, mutu ezalaka na ndambo ya makila ya mayi ewuti na bato babiki pe eza na ba anticorps specifiki na virusi yango, ekoki ebákisama mpóna bokaboli yango na bombango.	The serum storage of recovering patients, a person who has a fraction of the blood from survivors and contains specific antibodies to the virus, can be increased for rapid division.
2098	en	ln	Coronavirus diseases, a group of closely related syndromes	Mabela ya coronavirusi, liboke ya basyndrome óyo ekangana kamwa mingi	The coronavirus breast, a group of syndromes that are surprisingly close
2099	en	ln	Li Wenliang, a doctor at Central Hospital of Wuhan, who later contracted and died of COVID-19 after raising awareness of the spread of the virus.	Li Wenliang, monganga ya Lopitalo Centrale ya Wuhan, ye mutu azwaki kpokoso ya COVID-19 na suka akufaki sima ya bomatisi boyebi ya bopalangani ya virusi yango.	Li Wenliang, a doctor at Wuhan Central Hospital, who was infected with the virus eventually died after raising awareness of the spread of the virus.
